Citrus Sinensis ID: 013125
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 449 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.694 | 0.693 | 0.679 | 1e-139 | |
| Q6P647 | 415 | Casein kinase I isoform d | yes | no | 0.873 | 0.944 | 0.526 | 1e-125 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.873 | 0.944 | 0.526 | 1e-125 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | no | no | 0.679 | 0.733 | 0.628 | 1e-124 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.679 | 0.733 | 0.625 | 1e-124 | |
| P49674 | 416 | Casein kinase I isoform e | yes | no | 0.679 | 0.733 | 0.625 | 1e-124 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | yes | no | 0.657 | 0.732 | 0.644 | 1e-124 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | no | no | 0.657 | 0.721 | 0.641 | 1e-123 | |
| P48730 | 415 | Casein kinase I isoform d | no | no | 0.657 | 0.710 | 0.638 | 1e-123 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.657 | 0.710 | 0.638 | 1e-123 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 495 bits (1275), Expect = e-139, Method: Compositional matrix adjust.
Identities = 233/343 (67%), Positives = 277/343 (80%), Gaps = 31/343 (9%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG+ G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF
Sbjct: 61 GGT--------------------------GVPNVKWFGVEGDYNVLVMDLLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RK SLK+VLMLADQMI R+E+ HS+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAK
Sbjct: 95 FCSRKLSLKSVLMLADQMINRVEFFHSKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD TT++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQ
Sbjct: 155 KYRDSTTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKA TKKQKY++I EKKVST IE LC+ +P+EFASYFHYC+SL FD +PDY +LKR+F
Sbjct: 215 GLKAGTKKQKYERISEKKVSTSIEALCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRV 343
DLF REG+ FD+VFDWTILKYQQ+Q T P SR N V
Sbjct: 275 DLFIREGFQFDYVFDWTILKYQQSQLTA-----PPSRALNPAV 312
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 232/441 (52%), Positives = 306/441 (69%), Gaps = 49/441 (11%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPTIKWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKY--------QQTQKTKSQDLLPASRVTNSRVMP-MRTDKL 351
+LF R+G+ +D+VFDW +LK+ + ++ + ++ L R +R +P + +L
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKFGANRAAEDAERERREREERLRHPRNPAARGLPSTASGRL 334
Query: 352 KGVNDASCSAEVLECRGSYNRT-RPDADMQHRPSVAEKM--------SSDHHFGKHS--- 399
+G + + S + + N + RP + M+ V+ ++ SS G+
Sbjct: 335 RGTQEVTPSTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNVSSSDLTGRQETSR 394
Query: 400 MGNASIPS--ASFVLPSTFNR 418
M + IPS AS LPST +R
Sbjct: 395 MSTSQIPSRVASSGLPSTVHR 415
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 232/441 (52%), Positives = 306/441 (69%), Gaps = 49/441 (11%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + +E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPTIKWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQT--------QKTKSQDLLPASRVTNSRVMP-MRTDKL 351
+LF R+G+ +D+VFDW +LK+ + ++ + ++ L +R R +P + +L
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKFGASRAAEDAERERREREERLRHTRNPAVRGLPSTASGRL 334
Query: 352 KGVNDASCSAEVLECRGSYNRT-RPDADMQ---------HRPSVAEKMSSDHHFGKHS-- 399
+G + + S + + N + RP + M+ HR + SSD + +
Sbjct: 335 RGTQEVTPSTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNVSSSDLTSRQDTSR 394
Query: 400 MGNASIPS--ASFVLPSTFNR 418
M + IPS S LPST +R
Sbjct: 395 MSTSQIPSRVTSSGLPSTVHR 415
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 208/331 (62%), Positives = 261/331 (78%), Gaps = 26/331 (7%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ T E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPSIKWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EF++Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQD 331
+LF R+G+ +D+VFDW +LK+ + + D
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKFGAARNPEDMD 305
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 207/331 (62%), Positives = 261/331 (78%), Gaps = 26/331 (7%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPSIKWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EF++Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQD 331
+LF R+G+ +D+VFDW +LK+ + + D
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKFGAARNPEDVD 305
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1142), Expect = e-124, Method: Compositional matrix adjust.
Identities = 207/331 (62%), Positives = 261/331 (78%), Gaps = 26/331 (7%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPSIKWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EF++Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQD 331
+LF R+G+ +D+VFDW +LK+ + + D
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKFGAARNPEDVD 305
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1141), Expect = e-124, Method: Compositional matrix adjust.
Identities = 207/321 (64%), Positives = 257/321 (80%), Gaps = 26/321 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + T E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPTIKWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKY 321
+LF R+G+ +D+VFDW +LK+
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 206/321 (64%), Positives = 256/321 (79%), Gaps = 26/321 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPTIKWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKY 321
+LF R+G+ +D+VFDW +LK+
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 442 bits (1138), Expect = e-123, Method: Compositional matrix adjust.
Identities = 205/321 (63%), Positives = 256/321 (79%), Gaps = 26/321 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPTIRWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKY 321
+LF R+G+ +D+VFDW +LK+
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 442 bits (1138), Expect = e-123, Method: Compositional matrix adjust.
Identities = 205/321 (63%), Positives = 256/321 (79%), Gaps = 26/321 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPTIRWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKY 321
+LF R+G+ +D+VFDW +LK+
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 449 | ||||||
| 224092300 | 431 | predicted protein [Populus trichocarpa] | 0.937 | 0.976 | 0.733 | 0.0 | |
| 359484562 | 433 | PREDICTED: casein kinase I isoform delta | 0.937 | 0.972 | 0.703 | 1e-178 | |
| 388495184 | 431 | unknown [Lotus japonicus] | 0.930 | 0.969 | 0.697 | 1e-176 | |
| 356523722 | 430 | PREDICTED: casein kinase I isoform delta | 0.933 | 0.974 | 0.703 | 1e-176 | |
| 356513159 | 430 | PREDICTED: casein kinase I isoform delta | 0.933 | 0.974 | 0.705 | 1e-176 | |
| 224142173 | 424 | predicted protein [Populus trichocarpa] | 0.922 | 0.976 | 0.691 | 1e-174 | |
| 356531301 | 426 | PREDICTED: casein kinase I isoform delta | 0.917 | 0.967 | 0.691 | 1e-172 | |
| 357500563 | 424 | Casein kinase I isoform delta-like prote | 0.919 | 0.974 | 0.685 | 1e-171 | |
| 356495220 | 662 | PREDICTED: casein kinase I isoform delta | 0.904 | 0.613 | 0.698 | 1e-171 | |
| 449530861 | 433 | PREDICTED: casein kinase I isoform delta | 0.937 | 0.972 | 0.668 | 1e-169 |
| >gi|224092300|ref|XP_002309549.1| predicted protein [Populus trichocarpa] gi|222855525|gb|EEE93072.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/451 (73%), Positives = 364/451 (80%), Gaps = 30/451 (6%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEIFLA+H+ + EIVAVKIEN TKHPQLLYEAK+YKIL
Sbjct: 1 MERIIGEKYKLGRKIGSGSFGEIFLATHIHSGEIVAVKIENRSTKHPQLLYEAKLYKILG 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GI NIKW GVDGEDNVLV+DLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIANIKWCGVDGEDNVLVIDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVLMLADQMIARIEY+H +GFLHRDIKPDNFLMGLGRKA+QVY+IDFGLAK
Sbjct: 95 YCGRKFSLKTVLMLADQMIARIEYMHVKGFLHRDIKPDNFLMGLGRKASQVYVIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRDPTT++HI YRENKNLTGTARYASCNTHLGIEQSRRDDLES+GYVLLYFLRGSLPWQ
Sbjct: 155 RYRDPTTHQHITYRENKNLTGTARYASCNTHLGIEQSRRDDLESIGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATKKQKYDKICEKK+STPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 GLKAATKKQKYDKICEKKLSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ----DLLPASRVTNSRVMPMRTDKLKGVND 356
DLF+REG++FDFVFDWTILKY+QTQ+ K Q DL P SRVT+SR M M +K KGVN
Sbjct: 275 DLFTREGFEFDFVFDWTILKYKQTQRPKPQPQSSDLQPNSRVTSSRAMAMDLNKDKGVNG 334
Query: 357 ASCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTF 416
AS SAEV + RGS RPD MQ S + +++D+ KH+M NAS+PS SFV PS
Sbjct: 335 ASYSAEVADHRGSNKVARPDTHMQLGSSFSRNVTADNPLDKHNMNNASMPSTSFVPPSAS 394
Query: 417 NRNFQKPEGPDEAANIGRGHGNKTGASSSWM 447
R+F K +G +A NIGRG GN+ GASS M
Sbjct: 395 RRDFMKLDGSTDAVNIGRGLGNRAGASSRLM 425
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484562|ref|XP_002284044.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297738784|emb|CBI28029.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1628), Expect = e-178, Method: Compositional matrix adjust.
Identities = 316/449 (70%), Positives = 349/449 (77%), Gaps = 28/449 (6%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+HVDT EIVAVKIENS TKHPQLLYEAK+Y +LQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYNLLQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIP I+W G+DG+DN+LVLDLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPGIRWSGIDGDDNILVLDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVLMLADQMI RIEYVHS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKTVLMLADQMITRIEYVHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDSTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATKKQKYDKICEKK+STPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 GLKAATKKQKYDKICEKKLSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ-DLLPASRVTNSRVMPMRTDKLKGVNDASC 359
DLF+REGY+FD++FDWTILKYQQTQK+++Q L PA+ ++SR M M D+ +G +AS
Sbjct: 275 DLFTREGYEFDYIFDWTILKYQQTQKSRTQPQLSPAAGGSSSRAMAMDVDRHQGGINASY 334
Query: 360 SAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRN 419
SAE E S N S + +SS+ K+ + +A +PS SF L RN
Sbjct: 335 SAEATERIRSSNAAASSGIRMQFKSTGKNLSSESPAEKNIVSDAHMPSTSFSLAGFSKRN 394
Query: 420 FQKPEGPDEAANIG-RGHGNKTGASSSWM 447
KP P E N GH NK G SSSW+
Sbjct: 395 APKPMLPTETTNTAHHGHTNKIGPSSSWI 423
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388495184|gb|AFK35658.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1613), Expect = e-176, Method: Compositional matrix adjust.
Identities = 314/450 (69%), Positives = 348/450 (77%), Gaps = 32/450 (7%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIP +W GVDGEDNVLVLDLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPGTRWSGVDGEDNVLVLDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVLMLADQMI RIEY HS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKTVLMLADQMITRIEYAHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD +TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDSSTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATKKQKYDKIC+KK+STPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 GLKAATKKQKYDKICQKKLSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ---DLLPASRVTNSRVMPMRTDKLKGVNDA 357
DLF+REGYDFD+VFDWTILKYQQ+QK Q L P +NSRV+PM D +G+N
Sbjct: 275 DLFAREGYDFDYVFDWTILKYQQSQKNAVQPSLSLQPVPVASNSRVIPMDADNHQGLN-- 332
Query: 358 SCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFN 417
+ S V E S N +Q + V +SS++ K+ G +++PS S+ ++ N
Sbjct: 333 AYSGHVKERIRSGNAATSGVKIQLKSPVGRNLSSENPLDKNIFGESNMPSTSYPAGAS-N 391
Query: 418 RNFQKPEGPDEAANIGRGHGNKTGASSSWM 447
R KP EA+N G+G G+K SSSWM
Sbjct: 392 RTSLKPAFSAEASNPGQGQGSKIAPSSSWM 421
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523722|ref|XP_003530484.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1612), Expect = e-176, Method: Compositional matrix adjust.
Identities = 315/448 (70%), Positives = 347/448 (77%), Gaps = 29/448 (6%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIPNIKW G+DGEDNVLV+DLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPNIKWSGIDGEDNVLVIDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVL+LADQMI RIEYVHS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKTVLLLADQMITRIEYVHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDSTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATKKQKYDKIC+KK+STPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 GLKAATKKQKYDKICQKKLSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKS-QDLLPASRVTNSRVMPMRTDKLKGVNDASC 359
DLF+REGYDFD+VFDWTILKYQQ+QK L P +NSR P+ D +G+N +
Sbjct: 275 DLFAREGYDFDYVFDWTILKYQQSQKNVMLPPLSPVPGASNSRATPIDVDSHQGLN--AY 332
Query: 360 SAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRN 419
S V E + + T +Q + V + +S ++ K+ G A+IPS SF ST RN
Sbjct: 333 SGHVKERIRAGDATGSGVKIQFKSPVGKNLSYENPLDKNIFGEANIPSTSFSPASTSKRN 392
Query: 420 FQKPEGPDEAANIGRGHGNKTGASSSWM 447
K EA+N G G+K G SSSWM
Sbjct: 393 SLKQSLSAEASNPGHAQGSKMGPSSSWM 420
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513159|ref|XP_003525281.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 623 bits (1607), Expect = e-176, Method: Compositional matrix adjust.
Identities = 316/448 (70%), Positives = 346/448 (77%), Gaps = 29/448 (6%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIPNIKW G+DGEDNVLV+DLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPNIKWSGIDGEDNVLVIDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVLMLADQMI RIEYVHS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKTVLMLADQMITRIEYVHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDSTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATKKQKYDKIC+KK+STPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 GLKAATKKQKYDKICQKKLSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKS-QDLLPASRVTNSRVMPMRTDKLKGVNDASC 359
DLF+R+GYDFD+VFDWTILKYQQ+QK L P +NSR +PM D +G+N S
Sbjct: 275 DLFARDGYDFDYVFDWTILKYQQSQKNVMLPPLSPVPGASNSRAIPMDIDNHQGLN--SY 332
Query: 360 SAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRN 419
S V E + + T +Q + V + +S + K+ G A+IPS SF ST RN
Sbjct: 333 SGHVKERIRAGDATGSGVKIQFKSPVGKNLSYEKPLDKNIFGEANIPSTSFSPASTSQRN 392
Query: 420 FQKPEGPDEAANIGRGHGNKTGASSSWM 447
K EA+N G G+K G SSS M
Sbjct: 393 SLKQSLSAEASNPGHAQGSKIGPSSSLM 420
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142173|ref|XP_002324433.1| predicted protein [Populus trichocarpa] gi|222865867|gb|EEF02998.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1590), Expect = e-174, Method: Compositional matrix adjust.
Identities = 309/447 (69%), Positives = 344/447 (76%), Gaps = 33/447 (7%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVA+KIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAIKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIP+IKW GVDGEDN LVLDLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPSIKWSGVDGEDNALVLDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVLMLADQMI RIEYVHS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKTVLMLADQMITRIEYVHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDATTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATKKQKYDKICEKK+STPIEVLCKSHP EFASY HYC SLTFDQRPDYGFLKRLF
Sbjct: 215 GLKAATKKQKYDKICEKKLSTPIEVLCKSHPVEFASYMHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCS 360
DLFS GY+FD+VFDWTI+KYQQ QK +SQ + +S + + +G ++A S
Sbjct: 275 DLFSHGGYEFDYVFDWTIIKYQQAQKNRSQPRSSPNPACSSHAVQTDMENHQGSHNACYS 334
Query: 361 AEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNF 420
+E++ G P MQ + + + + SD H K ++ + IPS SF + T R+
Sbjct: 335 SEIMRSTG------PGIRMQSKSGLGKNLISDIHADK-NIVSQHIPSTSFQVGGTSKRHA 387
Query: 421 QKPEGPDEAANIGRGHGNKTGASSSWM 447
KP P+E+AN GH NK G SSSW+
Sbjct: 388 SKPVLPNESANPAHGHNNKIGPSSSWI 414
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531301|ref|XP_003534216.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1578), Expect = e-172, Method: Compositional matrix adjust.
Identities = 312/451 (69%), Positives = 345/451 (76%), Gaps = 39/451 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGAKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIP+IKW GVDGEDNVLV+DLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPSIKWCGVDGEDNVLVMDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLK+VLMLADQM+ RIEYVHS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKSVLMLADQMMTRIEYVHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDSTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
LKAATKKQKYDKICEKKVSTPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 NLKAATKKQKYDKICEKKVSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ---DLLPASRVTNSRVMPMRTDKLKGVNDA 357
DLF+REGY+FD+VFDWTILKY+Q QK + Q +P + ++S MPM D +G
Sbjct: 275 DLFTREGYEFDYVFDWTILKYKQAQKNRVQPHISTVPGT--SSSPAMPMDVDNHRG---- 328
Query: 358 SCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFN 417
SAE ++ S N T +Q + V + + S+ K+ G ++IPS S+ + T
Sbjct: 329 DVSAERIK---SGNVTGSGVKIQFKSPVGKILGSEKPLDKNIFGESNIPSTSYSIAGTSR 385
Query: 418 RNFQKPEGPDEAANIGRGHG-NKTGASSSWM 447
RN KP EA G G G NK G SSSW+
Sbjct: 386 RNTMKPALSTEAPKPGHGQGSNKIGPSSSWI 416
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357500563|ref|XP_003620570.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|357500745|ref|XP_003620661.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495585|gb|AES76788.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495676|gb|AES76879.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 308/449 (68%), Positives = 346/449 (77%), Gaps = 36/449 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+RIIG K+KLGRKIGSGSFGEI+LA+H+DT EIVAVKIE TKHPQLLYEAK+Y ILQ
Sbjct: 1 MDRIIGDKFKLGRKIGSGSFGEIYLATHIDTFEIVAVKIETGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIP+I+W GVDGEDNVLV+DLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPSIRWSGVDGEDNVLVMDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVLMLADQM+ RIEYVHS+GFLHRDIKPDNFLMGLGRKAN VY+IDFGLAK
Sbjct: 95 YCGRKFSLKTVLMLADQMMTRIEYVHSKGFLHRDIKPDNFLMGLGRKANLVYVIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDSTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
LKAATKKQKYDKICEKKVSTPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFL+RLF
Sbjct: 215 NLKAATKKQKYDKICEKKVSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLRRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ-DLLPASRVTNSRVMPMRTDKLKGVNDASC 359
+LF+REGY FD+VFDWTILKYQQ+QK+++Q + P +N+R MPM D +G +
Sbjct: 275 ELFAREGYKFDYVFDWTILKYQQSQKSRAQPHISPVPVASNNRAMPMDIDNQQG----NV 330
Query: 360 SAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRN 419
SAE + S N T Q + S + ++S++ GK+ G A+IPS S ++ RN
Sbjct: 331 SAEQIR---SDNATSSGVKFQFKSSGGKNLASENPLGKNIFGEATIPSTSHSFEAS-RRN 386
Query: 420 FQKPEGPDEAANIGRGHG-NKTGASSSWM 447
KP EAAN G G +K G SSS M
Sbjct: 387 SLKPSASTEAANHRHGQGSSKIGPSSSRM 415
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495220|ref|XP_003516477.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1563), Expect = e-171, Method: Compositional matrix adjust.
Identities = 306/438 (69%), Positives = 337/438 (76%), Gaps = 32/438 (7%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERII KYKLGRKIGSGSFGEI+LA+++DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIICAKYKLGRKIGSGSFGEIYLATNIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIPNIKW GVDGEDNVLV+DLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPNIKWCGVDGEDNVLVMDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLK+VLMLADQM+ RIEYVHS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKSVLMLADQMMTRIEYVHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD +TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDSSTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
LKAATKKQKYDKICEKKVSTPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 NLKAATKKQKYDKICEKKVSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSR-VMPMRTDKLKGVNDAS- 358
DLF+REGY+FD+VFDWTILKYQQ QK + Q + T+S MPM D +G+N S
Sbjct: 275 DLFAREGYEFDYVFDWTILKYQQAQKNRVQSRISTVPGTSSSPAMPMDVDNHRGINAYSG 334
Query: 359 -CSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFN 417
+AE ++ S N T +Q + V + + S+ K+ G A+IPS S+ + T
Sbjct: 335 DVTAERIK---SGNVTGSGVKIQFKSPVGKNLGSEKPLDKNIFGEANIPSTSYSVAGTSR 391
Query: 418 RNFQKPEGPDEAANIGRG 435
RN KP EA N G G
Sbjct: 392 RNTLKPALSTEAPNPGHG 409
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449530861|ref|XP_004172410.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1549), Expect = e-169, Method: Compositional matrix adjust.
Identities = 300/449 (66%), Positives = 344/449 (76%), Gaps = 28/449 (6%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MER+IG KYKLGRKIGSGSFGEI+LA+H++T EIVAVKIEN+ TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERVIGGKYKLGRKIGSGSFGEIYLATHIETFEIVAVKIENNKTKHPQLLYEAKLYSILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GGS GIP KW G+DGE+NVLVLDLLGPSLEDLFV
Sbjct: 61 GGS--------------------------GIPATKWSGIDGEENVLVLDLLGPSLEDLFV 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
YC RKFSLKTVLMLADQMI RIEYVHS+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK
Sbjct: 95 YCGRKFSLKTVLMLADQMITRIEYVHSKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+YRD TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ
Sbjct: 155 RYRDATTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATKKQKYDKICEKK+STPIEVLCKSHP EFASYFHYC SLTFDQRPDYGFLKRLF
Sbjct: 215 GLKAATKKQKYDKICEKKLSTPIEVLCKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-PASRVT-NSRVMPMRTDKLKGVNDAS 358
DLF+RE Y+FD+VFDWTI+KYQQ+QK ++Q + P T N PM + +G +
Sbjct: 275 DLFAREEYEFDYVFDWTIIKYQQSQKNRTQPRVSPVVGGTHNHHATPMEGESRQGGFNTY 334
Query: 359 CSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNR 418
SAEV + S N + P + + + +SSD+ +++ + + ++SF +
Sbjct: 335 SSAEVTDRVRSDNVSSPAVRLHFKQPTPKNLSSDNALDMNALNDPRMATSSFTPAGSSRG 394
Query: 419 NFQKPEGPDEAANIGRGHGNKTGASSSWM 447
N KP E+ N +G+G++ G SSSW+
Sbjct: 395 NSSKPLQSTESPNRVQGNGHRIGPSSSWI 423
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 449 | ||||||
| TAIR|locus:2117778 | 415 | ckl3 "casein kinase I-like 3" | 0.772 | 0.836 | 0.685 | 6.2e-157 | |
| TAIR|locus:2117843 | 414 | ckl4 "casein kinase I-like 4" | 0.761 | 0.826 | 0.681 | 1.2e-153 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.570 | 0.588 | 0.744 | 2.3e-129 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.565 | 0.564 | 0.751 | 2.1e-128 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.806 | 0.768 | 0.575 | 2.7e-128 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.777 | 0.733 | 0.576 | 5.5e-128 | |
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.523 | 0.505 | 0.796 | 1e-126 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.536 | 0.556 | 0.775 | 5.6e-126 | |
| TAIR|locus:2176431 | 480 | ckl8 "casein kinase I-like 8" | 0.605 | 0.566 | 0.715 | 8.1e-125 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.507 | 0.492 | 0.807 | 1.5e-123 |
| TAIR|locus:2117778 ckl3 "casein kinase I-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1265 (450.4 bits), Expect = 6.2e-157, Sum P(2) = 6.2e-157
Identities = 246/359 (68%), Positives = 279/359 (77%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149
GIP IKW+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIE+VHS+G
Sbjct: 64 GIPRIKWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEFVHSKG 123
Query: 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 209
+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYASCN
Sbjct: 124 YLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYASCN 183
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 269
THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVLCK+
Sbjct: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVLCKN 243
Query: 270 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKS 329
HP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD++FDWTI+KYQQ QK+++
Sbjct: 244 HPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIFDWTIIKYQQAQKSRN 303
Query: 330 QD-LLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVAEK 388
Q +P S +N R MP+ T +G + S AE E S N P + + +
Sbjct: 304 QSQAVPGS--SNPRAMPVDTSNHRGGPNISYEAEASERVRSANAIGPSPQINNNTAAGRT 361
Query: 389 MSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSWM 447
DH K N ++PS S T RN GP E +N G G GN+TG +SS+M
Sbjct: 362 PGFDHPVHK----NMNMPSTSLSPAGTSKRNV----GP-ETSNSGYGSGNRTGWTSSFM 411
|
|
| TAIR|locus:2117843 ckl4 "casein kinase I-like 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1241 (441.9 bits), Expect = 1.2e-153, Sum P(2) = 1.2e-153
Identities = 244/358 (68%), Positives = 281/358 (78%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149
GIP I+W+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIEYVHS+G
Sbjct: 64 GIPRIRWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEYVHSKG 123
Query: 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 209
+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYASCN
Sbjct: 124 YLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYASCN 183
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 269
THLGIEQ RRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVLCKS
Sbjct: 184 THLGIEQGRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVLCKS 243
Query: 270 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKS 329
HP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD+++DWTI+KYQQ+QKT+S
Sbjct: 244 HPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIYDWTIIKYQQSQKTRS 303
Query: 330 QD-LLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVAEK 388
Q +P S +N+R +PM T +G S A+V + N + P Q +V
Sbjct: 304 QSQAVPGS--SNARAIPMDTSNHRGGTKISHEAQVSDRVRPANASGPSP--QINTAVGRS 359
Query: 389 MSSDHHFGKHSMGNASIPSASFVLPS-TFNRNFQKPEGPDEAANIGRGHGNKTGASSS 445
+ D H N ++PS++ + P+ T RN +PE +N G G GNKTG +S
Sbjct: 360 LGFDQ---VHK--NMNMPSSTSLSPAGTSKRNV-RPE----TSNSGFGSGNKTGGWTS 407
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1050 (374.7 bits), Expect = 2.3e-129, Sum P(2) = 2.3e-129
Identities = 192/258 (74%), Positives = 227/258 (87%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149
G+PNIKW+GV+G+ N LV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+EY HS+
Sbjct: 64 GVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFHSKS 123
Query: 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 209
FLHRD+KPDNFLMGLGR+ANQV+IIDFGLAKKYRD TT++HIPYRENKNLTGTARYAS N
Sbjct: 124 FLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYASMN 183
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 269
THLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE LC+
Sbjct: 184 THLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESLCRG 243
Query: 270 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTK- 328
+P+EFASYFHYC+SL FD +PDYG+LKR+F DLF REG+ FD+VFDWTILKYQQ+Q T
Sbjct: 244 YPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLTAP 303
Query: 329 -SQDLLPASRVTNSRVMP 345
S+ L+ + T++ + P
Sbjct: 304 PSRGLVSPAVGTSAGLPP 321
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1056 (376.8 bits), Expect = 2.1e-128, Sum P(2) = 2.1e-128
Identities = 194/258 (75%), Positives = 226/258 (87%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149
G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ HS+
Sbjct: 64 GVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFHSKS 123
Query: 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 209
FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYAS N
Sbjct: 124 FLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYASMN 183
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 269
THLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE LC+
Sbjct: 184 THLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEALCRG 243
Query: 270 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTK- 328
+P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG+ FD+VFDWTILKYQQ+Q T
Sbjct: 244 YPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLTAP 303
Query: 329 -SQDLLPASRVTNSRVMP 345
S+ L PA V S +P
Sbjct: 304 PSRALNPA--VGTSAALP 319
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1070 (381.7 bits), Expect = 2.7e-128, Sum P(2) = 2.7e-128
Identities = 214/372 (57%), Positives = 257/372 (69%)
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGG--IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
++L H +H + ++ GG +PN+KWYGV+G+ NV+V+DLLGPSLEDLF YC
Sbjct: 37 VKLESVKTKHPQLHYESKLYMLLQGGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYC 96
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
RK SLKTVLMLADQ+I R+E++H+RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKY
Sbjct: 97 NRKLSLKTVLMLADQLINRVEFMHTRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKY 156
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
RD T+RHIPYRENKNLTGTARYAS NTHLG+EQSRRDDLE+LGYVL+YFL+GSLPWQGL
Sbjct: 157 RDLQTHRHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGL 216
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
KA TKKQKYD+I EKKV+TPIEVLCK+ P+EF SYF YC+SL FD +PDY +LKRLF DL
Sbjct: 217 KAGTKKQKYDRISEKKVATPIEVLCKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDL 276
Query: 303 FSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAE 362
F REGY FD+VFDWT+LKY Q + + T + + K + E
Sbjct: 277 FIREGYQFDYVFDWTVLKYPQIGSSSGSSSRTRNHTTANPGLTAGASLEK--QERIAGKE 334
Query: 363 VLECRGS-----YNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFN 417
E R S ++R P A R A + S D KH G++ P +S S+
Sbjct: 335 TRENRFSGAVEAFSRRHP-ATSTTRDRSASRNSVDGPLSKHPPGDSERPRSSSRYGSSSR 393
Query: 418 RNFQKPEGPDEA 429
R P A
Sbjct: 394 RAIPSSSRPSSA 405
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1061 (378.5 bits), Expect = 5.5e-128, Sum P(2) = 5.5e-128
Identities = 207/359 (57%), Positives = 260/359 (72%)
Query: 59 LQGGSKIRLVVFHVD--HVIIHALTIIFSSTLGG--IPNIKWYGVDGEDNVLVLDLLGPS 114
+Q G ++ + + +V H +H + ++ GG IPNIKW+GV+G+ +V+V+DLLGPS
Sbjct: 29 VQTGEEVAVKLENVKTKHPQLHYESKLYMLLQGGSGIPNIKWFGVEGDYSVMVIDLLGPS 88
Query: 115 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
LEDLF YC RK +LKTVLMLADQ++ R+E++H+RGFLHRDIKPDNFLMGLGRKANQVYII
Sbjct: 89 LEDLFNYCNRKLTLKTVLMLADQLLNRVEFMHTRGFLHRDIKPDNFLMGLGRKANQVYII 148
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234
DFGL KKYRD T++HIPYRENKNLTGTARYAS NTHLG+EQSRRDDLESLGYVL+YFL+
Sbjct: 149 DFGLGKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLK 208
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294
GSLPWQGLKA TKKQKYD+I EKKVSTPIEVLCK+ P+EF SYFHYC+SL FD +PDY +
Sbjct: 209 GSLPWQGLKAGTKKQKYDRISEKKVSTPIEVLCKNQPSEFVSYFHYCRSLRFDDKPDYSY 268
Query: 295 LKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNS---RVMPM-RTDK 350
LKRLF DLF REGY FD+VFDWT+LKY Q + T P+ R ++
Sbjct: 269 LKRLFRDLFIREGYQFDYVFDWTVLKYPQIGSSSGSSSRTRHHTTAKPGFNADPIERQER 328
Query: 351 LKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSAS 409
+ G + ++ +++R P R + S D F K + G++ ++S
Sbjct: 329 ILGKE--TTRYKIPGAVEAFSRRHPTTTSSPRDRSRSRNSDDGPFSKQTHGDSERANSS 385
|
|
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 1.0e-126, Sum P(2) = 1.0e-126
Identities = 188/236 (79%), Positives = 214/236 (90%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149
G+PN+KWYGV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI RIE+VH +
Sbjct: 64 GVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVHQKS 123
Query: 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 209
FLHRDIKPDNFLMGLGR+ANQVY+IDFGLAKKYRD + ++HIPYRENKNLTGTARYAS N
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD-SNHQHIPYRENKNLTGTARYASMN 182
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 269
THLGIEQSRRDDLESLG+VL+YFL+GSLPWQGLKA KKQKY+KI EKKVST IE LC+
Sbjct: 183 THLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEALCRG 242
Query: 270 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 325
+P+EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 243 YPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 5.6e-126, Sum P(2) = 5.6e-126
Identities = 187/241 (77%), Positives = 215/241 (89%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149
GIPN+KWYGV+G+ NVLV+DLLGPSLEDLF YC+R+FSLKTVLMLADQMI R+E++HS+
Sbjct: 64 GIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIHSKS 123
Query: 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 209
+LHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD +T+RHIPYRENK+L GT RYAS N
Sbjct: 124 YLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYASLN 183
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 269
THLGIEQSRRDD+ESLGY+L+YFL+GSLPWQGLKA KKQKYDKI EKKVST IE LC+
Sbjct: 184 THLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETLCRG 243
Query: 270 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKS 329
HP EFASYFHYC+SL FD +PDY +LKRLF +LF REG+ FDFVFDWT+ KYQQ+Q
Sbjct: 244 HPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQSGNP 303
Query: 330 Q 330
Q
Sbjct: 304 Q 304
|
|
| TAIR|locus:2176431 ckl8 "casein kinase I-like 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 8.1e-125, Sum P(2) = 8.1e-125
Identities = 196/274 (71%), Positives = 222/274 (81%)
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGG--IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
++L H +H + ++ GG IP++KWYGV+GE N +V+DLLGPS+EDLF YC
Sbjct: 37 VKLEPARARHPQLHYESKLYMLLQGGTGIPHLKWYGVEGEYNCMVIDLLGPSMEDLFNYC 96
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
R+F+LKTVLMLADQMI R+EY+H RGFLHRDIKPDNFLMGLGRKANQVYIID+GLAKKY
Sbjct: 97 SRRFNLKTVLMLADQMINRVEYMHVRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 156
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
RD T+RHIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YFLRGSLPWQGL
Sbjct: 157 RDLQTHRHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
+A TKKQKYDKI EKK TP+EVLCKS P EF SYF Y +SL F+ +PDY +LKRLF DL
Sbjct: 217 RAGTKKQKYDKISEKKRLTPVEVLCKSFPPEFTSYFLYVRSLRFEDKPDYPYLKRLFRDL 276
Query: 303 FSREGYDFDFVFDWTILKYQQTQKTKSQDLLPAS 336
F REGY FD+VFDWTILKY Q S P S
Sbjct: 277 FIREGYQFDYVFDWTILKYPQFSSGSSSSSKPRS 310
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1031 (368.0 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
Identities = 184/228 (80%), Positives = 209/228 (91%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149
GIP++KW+GV+GE NV+V+DLLGPSLEDLF YC RKFSLKTVLMLADQMI R+EY+H+RG
Sbjct: 64 GIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMHTRG 123
Query: 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 209
FLHRDIKPDNFLMGLGRKA+QVY+ID+GLAKKYRD T++HIPYRENKNLTGTARYAS N
Sbjct: 124 FLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 269
THLG+EQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKYDKI EKK+ TP+EVLCKS
Sbjct: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVLCKS 243
Query: 270 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 317
+P EF SYFHYC+SL F+ +PDY +LKRLF DLF REGY D++FDWT
Sbjct: 244 YPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT 291
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.5906 | 0.6547 | 0.6901 | yes | no |
| P49674 | KC1E_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6253 | 0.6792 | 0.7331 | yes | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6386 | 0.6570 | 0.7108 | yes | no |
| Q6P647 | KC1D_XENTR | 2, ., 7, ., 1, 1, ., 1 | 0.5260 | 0.8730 | 0.9445 | yes | no |
| Q7T2E3 | KC1DA_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.6448 | 0.6570 | 0.7320 | yes | no |
| P42168 | KC1A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.5877 | 0.7015 | 0.9237 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6323 | 0.6570 | 0.7108 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5765 | 0.6837 | 0.6214 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6401 | 0.6414 | 0.7890 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.6230 | 0.6570 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6006 | 0.6726 | 0.9349 | yes | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.5260 | 0.8730 | 0.9445 | N/A | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6253 | 0.6792 | 0.7331 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_VI1653 | hypothetical protein (431 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 449 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-28 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.001 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 0.001 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.002 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.002 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.002 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.002 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.002 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.002 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.002 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.002 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.004 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.004 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 77/292 (26%), Positives = 111/292 (38%), Gaps = 53/292 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSK 64
Y+L RK+GSGSFG ++ A H T +IVAVKI K E ++ +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILR------- 53
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVY 121
+ H PNI + + + LV++ DLF Y
Sbjct: 54 ------RLSH-----------------PNIVRLIDAFEDKDHLYLVMEYCEGG--DLFDY 88
Query: 122 CRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
R S +A Q++ +EY+HS G +HRD+KP+N L+ + V I DFGLA
Sbjct: 89 LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLD---ENGVVKIADFGLA 145
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLP 238
KK GT Y + L G + D+ SLG +L L G P
Sbjct: 146 KK-------LLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ G + Q +I + S E C + +RP
Sbjct: 199 FSGENILDQLQLIRRILGPPLEFDEPKWS-SGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 68/226 (30%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKIRLVVFH 71
+G G FG ++LA T + VA+KI E+S + +LL E ++ K L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH---------- 50
Query: 72 VDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFS 127
PNI K YGV D LV++ G SL+DL K S
Sbjct: 51 --------------------PNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLS 90
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 187
+L + Q++ +EY+HS G +HRD+KP+N L L +V + DFGL+K
Sbjct: 91 EDEILRILLQILEGLEYLHSNGIIHRDLKPENIL--LDSDNGKVKLADFGLSKLLTSDK- 147
Query: 188 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYF 232
K + GT Y + LG S + D+ SLG +L
Sbjct: 148 ------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-30
Identities = 90/341 (26%), Positives = 138/341 (40%), Gaps = 49/341 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
Y++ RK+G GSFGE++LA ++VA+K+ E+ + + L E ++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY 121
I + + D LV++ + G SLEDL
Sbjct: 58 --------------------------PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK 91
Query: 122 CRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
R S L + Q+++ +EY+HS+G +HRDIKP+N L L R V +IDFGLA
Sbjct: 92 IGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL--LDRDGRVVKLIDFGLA 149
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ---SRRDDLESLGYVLLYFLRGS 236
K DP + IP + ++ GT Y + LG+ S D+ SLG L L G
Sbjct: 150 KLLPDPGSTSSIPALPSTSV-GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
Query: 237 LPWQGLKAATKKQK-YDKICEKKVSTPIEVLCKSHPAEFASYFH--YCQSLTFDQRPDYG 293
P++G K ++ + I E + L S+P + + L D +
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
Query: 294 FLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLP 334
L HDL + D + L L P
Sbjct: 269 SSSDLSHDLLAHL---KLKESDLSDLLKPDDSAPLRLSLPP 306
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 53/272 (19%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKI 65
Y++ K+G GSFG+++LA T ++VA+K+ + ++L E KIL+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREI---KILK----- 52
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVY 121
+ H PNI + Y V D + LV++ G L DL
Sbjct: 53 -----KLKH-----------------PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK 90
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
R + S Q+++ +EY+HS+G +HRD+KP+N L+ + V + DFGLA++
Sbjct: 91 -RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLD---EDGHVKLADFGLARQ 146
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQ 240
GT Y + LG + D+ SLG V+LY L G P+
Sbjct: 147 LDPGEK--------LTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFP 197
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 272
G + + KI + K P S A
Sbjct: 198 G--DDQLLELFKKIGKPKPPFPPPEWDISPEA 227
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 93/318 (29%), Positives = 151/318 (47%), Gaps = 55/318 (17%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
I G ++K+ + IG G FG ++ H N+ VA KIEN ++ ++ E VY +
Sbjct: 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVA-KIEN--LENETIVMETLVYNNI 65
Query: 60 QGGSKIRL--VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGED------NVLVLDLL 111
KI L + ++DH+ GIP K+YG ++L+ L
Sbjct: 66 YDIDKIALWKNIHNIDHL--------------GIP--KYYGCGSFKRCRMYYRFILLEKL 109
Query: 112 GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 169
+ +++F + C+ K +K ++ M+ +EY+H G H DIKP+N +M G N
Sbjct: 110 VENTKEIFKRIKCKNKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPEN-IMVDGN--N 163
Query: 170 QVYIIDFGLAKKYRDPTTNRHIPY-RENKNL-TGTARYASCNTHLGIEQSRRDDLESLGY 227
+ YIID+G+A + +HI Y +E K+L GT YA + H G +RR DLESLGY
Sbjct: 164 RGYIIDYGIASHF--IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGY 221
Query: 228 VLLYFLRGSLPWQGLKA------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 281
+L + LPW+G A K ++ E K+ K+ +
Sbjct: 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI------KNANKFIYDFIECV 275
Query: 282 QSLTFDQRPDYGFLKRLF 299
L+++++PDY L ++F
Sbjct: 276 TKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 69/247 (27%), Positives = 112/247 (45%), Gaps = 50/247 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGS 63
+++ G KIG G+FG+++ A ++DT E++AVK I+++ K ++ E KV ++L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL---- 56
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDN-VLVLDLL--GPSLEDLF 119
H PN+ K+YGV+ V + G +LE+L
Sbjct: 57 ---------KH-----------------PNLVKYYGVEVHREKVYIFMEYCSGGTLEELL 90
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ R + + Q++ + Y+HS G +HRDIKP N + + + DFG A
Sbjct: 91 EH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCA 146
Query: 180 KKYRDPTTNRHIPYREN-KNLTGTARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRG 235
K ++ TT E ++L GT Y + G + R D+ SLG V+L G
Sbjct: 147 VKLKNNTT----TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 236 SLPWQGL 242
PW L
Sbjct: 203 KRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 69/254 (27%), Positives = 104/254 (40%), Gaps = 53/254 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+K G+ IG GSF + LA +TN+ A+KI + K I +
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILD------------KRQLIKEK------- 43
Query: 69 VFHVDHVII--HALTIIFSSTLGGIPNI-KWYGV--DGEDNV-LVLDLL--GPSLEDLFV 120
V +V I LT L G P I K Y D E+N+ VL+ G L+ ++
Sbjct: 44 --KVKYVKIEKEVLTR-----LNGHPGIIKLYYTFQD-EENLYFVLEYAPNGELLQ--YI 93
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
K A +++ +EY+HS+G +HRD+KP+N L+ K + I DFG AK
Sbjct: 94 RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAK 150
Query: 181 KYRDPT-------------TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY 227
+ + R + GTA Y S + DL +LG
Sbjct: 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGC 210
Query: 228 VLLYFLRGSLPWQG 241
++ L G P++G
Sbjct: 211 IIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 57/239 (23%), Positives = 90/239 (37%), Gaps = 51/239 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ +IG G+ G +F A +T E VA+K Q L E K LQ
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA---LQ--- 54
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
H + L +F G VLV++ + L ++
Sbjct: 55 -------ACQHPYVVKLLDVFP--------------HGSGFVLVMEYMPSDLSEVLRDEE 93
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
R V ++ + Y+H+ G +HRD+KP N L+ + I DFGLA+ +
Sbjct: 94 RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFS 150
Query: 184 DPTTNRHIP------YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236
+ + YR + L G +Y G+ DL ++G + L GS
Sbjct: 151 EEEPRLYSHQVATRWYRAPELLYGARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 62/245 (25%), Positives = 97/245 (39%), Gaps = 55/245 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
++ G +G GSFG ++LA DT E++AVK + + L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--- 57
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLL-----GPSLED 117
H PNI ++YG + ++ L++ G SL
Sbjct: 58 --------------H-------------PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS 90
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
L + K + Q++ + Y+HS G +HRDIK N L+ V + DFG
Sbjct: 91 L-LKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG---VVKLADFG 146
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLR 234
AK+ D T ++ GT + + G E R D+ SLG ++
Sbjct: 147 CAKRLGDIETG-----EGTGSVRGTPYWMAPEVIR---GEEYGRAADIWSLGCTVIEMAT 198
Query: 235 GSLPW 239
G PW
Sbjct: 199 GKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 51/195 (26%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTK---HPQLLYEAKVYKILQ 60
+Y+ G+K+G G++ ++ A +T IVA+K E K + L E K+ + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLF 119
H ++I L +F + N+ LV + + LE +
Sbjct: 61 ----------H-PNIIG--LLDVFGH---------------KSNINLVFEFMETDLEKVI 92
Query: 120 VYCRRKFSLKTVLMLAD-----QMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
+ K VL AD M R +EY+HS LHRD+KP+N L+ + +
Sbjct: 93 ---KDK---SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKL 143
Query: 174 IDFGLAKKYRDPTTN 188
DFGLA+ + P
Sbjct: 144 ADFGLARSFGSPNRK 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 47/237 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
+++ KIG G FGE++ A H T + VA+K+ S K +++ E ++ K
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-------- 52
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVY 121
H PNI K+YG + ++ +V++ G SL+DL
Sbjct: 53 -----KCKH-----------------PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS 90
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ + + + +++ +EY+HS G +HRDIK N L+ +V +IDFGL+ +
Sbjct: 91 TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL--TSDG-EVKLIDFGLSAQ 147
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238
D + + GT + + G + D+ SLG + G P
Sbjct: 148 LSDT--------KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-16
Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 63/278 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHV 72
+G GSFG++ L DT ++ A+K+ K ++ + IL +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILS----------RI 50
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRR--KFS 127
+H I L Y E+ + LVL+ G +LF + + +FS
Sbjct: 51 NHPFIVKL---------------HYAFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFS 91
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 185
+ A +++ +EY+HS G ++RD+KP+N L L + + + DFGLAK+
Sbjct: 92 EERARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGS 148
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245
TN GT Y + LG + D SLG +L L G P+ A
Sbjct: 149 RTN---------TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY---AE 196
Query: 246 TKKQKYDKICEKKVSTP----------IEVLCKSHPAE 273
+K+ Y+KI + + P I L + P +
Sbjct: 197 DRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK 234
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 52/261 (19%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
++ + +G+GSFG + L H + + A+KI L +AK+ K+ Q
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKI----------LSKAKIVKLKQ-------- 44
Query: 69 VFHVDHVI--IHALTIIFSSTLGGIPNIKWYGVDGEDNVL--VLDLLGPSLEDLFVYCRR 124
V+HV+ L I L + YG +D+ L V++ + +LF + R+
Sbjct: 45 ---VEHVLNEKRILQSIRHPFL-----VNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRK 94
Query: 125 --KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+F A Q++ +EY+HS ++RD+KP+N L+ + I DFG AK+
Sbjct: 95 SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV 151
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 241
+ T L GT Y + L + D +LG +L+Y L G P+
Sbjct: 152 KGRT----------YTLCGTPEYLAPEIILSKGYGKAVDWWALG-ILIYEMLAGYPPF-- 198
Query: 242 LKAATKKQKYDKICEKKVSTP 262
Q Y+KI E KV P
Sbjct: 199 -FDDNPIQIYEKILEGKVRFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 77/292 (26%), Positives = 115/292 (39%), Gaps = 77/292 (26%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAK------- 54
+Y + R IG G GE++LA + VA+K EN + L EAK
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRFLREAKIAADLIH 61
Query: 55 -----VYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLD 109
VY I G + + + I TL + W + L +
Sbjct: 62 PGIVPVYSICSDGD-----------PVYYTMPYIEGYTLKSLLKSVW-----QKESLSKE 105
Query: 110 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 169
L K S+ L + ++ A IEYVHS+G LHRD+KPDN L+GL
Sbjct: 106 L------------AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FG 150
Query: 170 QVYIIDFGLAK------------KYRDPTTNRH---IPYRENKNLTGTARYASCNTHLGI 214
+V I+D+G A + IP + + GT Y + LG+
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK----IVGTPDYMAPERLLGV 206
Query: 215 EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-KVSTPIEV 265
S D+ +LG +L L S P+ +++K KI + + +PIEV
Sbjct: 207 PASESTDIYALGVILYQMLTLSFPY-------RRKKGRKISYRDVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 50/201 (24%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMR----- 56
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDL 118
+DH PN+ K GV + E +V++ + G L
Sbjct: 57 --------KLDH-----------------PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSY 91
Query: 119 FVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
R K SL +L A Q IAR +EY+ S+ F+HRD+ N L+G + V I DFG
Sbjct: 92 LRKNRPKLSLSDLLSFALQ-IARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFG 147
Query: 178 LAKKYRD----PTTNRHIPYR 194
L++ D +P R
Sbjct: 148 LSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (177), Expect = 6e-14
Identities = 49/191 (25%), Positives = 72/191 (37%), Gaps = 54/191 (28%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
Y+ K+G G++G ++ A T EIVA+K KIRL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-------------------------KIRL- 34
Query: 69 VFHVDHVIIHALTIIFSSTLGGI--------PNI-KWYGVDGEDN--VLVLDLLGPSLED 117
+ I S+ L I PNI K V + LV + D
Sbjct: 35 --------DNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD---MD 83
Query: 118 LFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
L Y S + + Q++ + Y HS LHRD+KP N L+ + + +
Sbjct: 84 LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLA 140
Query: 175 DFGLAKKYRDP 185
DFGLA+ + P
Sbjct: 141 DFGLARAFGIP 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 51/298 (17%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIR 66
K+ G IG G++G ++LA +V T E++AVK Q+ E + S+ +
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVK---------QV--ELPATIAGRHDSRQK 49
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGI--PNIKWY-GVDGEDNVLVLDL---LGPSLEDLFV 120
+V + I TL + NI Y G + + L + L G S+
Sbjct: 50 DMVKALRSEI---------ETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL- 99
Query: 121 YCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
R +F + V +Q++ + Y+HS+G LHRD+K DN L+ I DFG+
Sbjct: 100 --RTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK---ISDFGI 154
Query: 179 AKKYRDPTTNRHIPYRENKNLTGT----ARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234
+KK D N +N ++ G+ A + G S + D+ SLG V+L
Sbjct: 155 SKKSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFA 207
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTPI--EVLCKSHPAEFASYFHYCQSLTFDQRP 290
G PW +A K+ K+ + PI +V P + + C ++ D RP
Sbjct: 208 GRRPWSDEEAI---AAMFKLGNKRSAPPIPPDVSMNLSPVA-LDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 41/237 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
++L R IG G+FG++ + DT ++ A+K N + + + V +L R +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ----KCVEKGSVRNVLNE----RRI 53
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGV-DGEDNVLVLDLLGPSLEDLFVYC--RRK 125
+ ++H + L WY D E+ LV+DLL DL + + K
Sbjct: 54 LQELNHPFLVNL---------------WYSFQDEENMYLVVDLLLGG--DLRYHLSQKVK 96
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
FS + V +++ +EY+HS+G +HRDIKPDN L+ + V+I DF +A
Sbjct: 97 FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIA------ 147
Query: 186 TTNRHIPYRENKNLT-GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ T GT Y + S D SLG LRG P++G
Sbjct: 148 ---TKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 69/259 (26%), Positives = 110/259 (42%), Gaps = 54/259 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSK 64
Y+ +IG G++G+++ A + T E+VA+K +EN P + E K +LQ
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK---LLQ---- 53
Query: 65 IRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
+ H I+ I+ S G I +V + + L L
Sbjct: 54 ------KLRHPNIVRLKEIVTSKGKGSI-------------YMVFEYMDHDLTGLLDSPE 94
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY- 182
KF+ + Q++ ++Y+HS G LHRDIK N L + + + DFGLA+ Y
Sbjct: 95 VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNIL--INNDGV-LKLADFGLARPYT 151
Query: 183 ---RDPTTNRHIP--YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237
TNR I YR + L G RY + D+ S+G +L G
Sbjct: 152 KRNSADYTNRVITLWYRPPELLLGATRYGP-----EV------DMWSVGCILAELFLGKP 200
Query: 238 PWQGLKAATKKQKYDKICE 256
+QG +T+ ++ +KI E
Sbjct: 201 IFQG---STELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 46/183 (25%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+LG+K+G G+FGE++ T VAVK G + L EA + K
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMK----- 56
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDL 118
+ H PNI + GV GE +V + + G L D
Sbjct: 57 --------KLSH-----------------PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91
Query: 119 FVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
K +LK +L +A Q IA+ +EY+ S+ F+HRD+ N L + V I DFG
Sbjct: 92 LRKHGEKLTLKDLLQMALQ-IAKGMEYLESKNFVHRDLAARNCL--VTEN-LVVKISDFG 147
Query: 178 LAK 180
L++
Sbjct: 148 LSR 150
|
Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 46/183 (25%), Positives = 71/183 (38%), Gaps = 38/183 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSK 64
Y+ KIG G++G ++ A T EIVA+K S L E K+ K L +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 65 IRL--VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
I+L V H + LV + + L L
Sbjct: 61 IKLLDVFRHKGDL-----------------------------YLVFEFMDTDLYKLIKDR 91
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+R + Q++ + + HS G LHRD+KP+N L+ + + DFGLA+ +
Sbjct: 92 QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSF 148
Query: 183 RDP 185
P
Sbjct: 149 GSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 67/263 (25%), Positives = 111/263 (42%), Gaps = 38/263 (14%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
I G++G +FLA T +I A+K+ K ++ + +V ++L + L +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKV----IKKADMIRKNQVDQVLT--ERDILSQAQSPY 54
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGV----DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT 130
V+ + L Y V G D +L+ +G ED+
Sbjct: 55 VVKLYYSFQGKKNL--------YLVMEYLPGGDLASLLENVGSLDEDVARIY-------- 98
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNR 189
+++ +EY+HS G +HRD+KPDN L+ + + DFGL+K N
Sbjct: 99 ----IAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINL 151
Query: 190 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 249
+ +E+K + GT Y + LG S+ D SLG +L FL G P+ G T ++
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEE 208
Query: 250 KYDKICEKKVSTPIEVLCKSHPA 272
+ I K+ E + S A
Sbjct: 209 IFQNILNGKIE-WPEDVEVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 51/202 (25%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMR----- 56
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDL 118
+DH PNI K GV + E ++V++ + G L D
Sbjct: 57 --------KLDH-----------------PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDY 91
Query: 119 FVYCRRKF-SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
R K SL +L A Q IAR +EY+ S+ F+HRD+ N L+G V I DF
Sbjct: 92 LRKNRPKELSLSDLLSFALQ-IARGMEYLESKNFIHRDLAARNCLVGEN---LVVKISDF 147
Query: 177 GLAKKYRD----PTTNRHIPYR 194
GL++ D +P R
Sbjct: 148 GLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (166), Expect = 1e-12
Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 46/187 (24%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
KY++ ++IG GSFG+++L ++ +K + N K L E K+ K L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL---- 56
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLF 119
+H PNI K+Y E L V++ G L
Sbjct: 57 ---------NH-----------------PNIIKYYESFEEKGKLCIVMEYADGGDLSQKI 90
Query: 120 ---VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIID 175
+ F + +L Q+ ++Y+HSR LHRDIKP N FL V + D
Sbjct: 91 KKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGD 146
Query: 176 FGLAKKY 182
FG++K
Sbjct: 147 FGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 31/204 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGSK 64
Y++ K+G G+FGE++ A + T +VA+K I K L E K+ K L+ +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 124
+ L+ V+ G + + Y + DL G L
Sbjct: 70 VPLIDMAVERPDKS------KRKRGSVYMVTPY--------MDHDLSG-----LLENPSV 110
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
K + + Q++ I Y+H LHRDIK N L+ + I DFGLA+ Y
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDG 167
Query: 185 PTTNRHIPYRENKNLTGTARYASC 208
P P + GT +Y +
Sbjct: 168 P-----PPNPKGGGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
K+ + +IG G++G+++ A DT E+VA V+++N P + E K+ + L +
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
+ L D AL + D LV + + L L
Sbjct: 68 IVNLKEIVTDK--QDALD---------------FKKDKGAFYLVFEYMDHDLMGLLESGL 110
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY- 182
FS + Q++ + Y H + FLHRDIK N L+ Q+ + DFGLA+ Y
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYN 167
Query: 183 ---RDPTTNRHIP--YRENKNLTGTARYA------SCNTHLG 213
P TN+ I YR + L G RY SC LG
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 201
+E +H RG +HRDIKP+N L+ + + + DFGL++ ENK G
Sbjct: 110 VEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKFVG 155
Query: 202 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 261
T Y + T LG+ + D SLG V+ FL G P+ A T +D I ++++
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRINW 212
Query: 262 PIEV 265
P EV
Sbjct: 213 PEEV 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 36/188 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGS 63
Y+LG IG G+FG ++ +++T + VA+K I K ++ E + K L+ +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 64 KIRLVVFHVDHVIIH-ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
++ + ++ L + +L I IK +G SL ++VY
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQI--IKKFG-----------PFPESLVAVYVY- 106
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
Q++ + Y+H +G +HRDIK N L K V + DFG+A K
Sbjct: 107 --------------QVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKL 149
Query: 183 RDPTTNRH 190
D + +
Sbjct: 150 NDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 33/193 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
KY+ KIG G+FGE+F A H T +IVA+K +EN P L E K+ ++L+ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
+ L+ I ++ G LV + L L
Sbjct: 73 VVNLIE------ICRTKATPYNRYKGSF-------------YLVFEFCEHDLAGLLSNKN 113
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
KF+L + + ++ + Y+H LHRD+K N L+ K + + DFGLA+ +
Sbjct: 114 VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFS 170
Query: 184 DPT-------TNR 189
TNR
Sbjct: 171 LSKNSKPNRYTNR 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 36/180 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAK-VY---KILQGG 62
+Y+L + IGSG++G + A T VA+K I N AK + K+L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLID---AKRILREIKLLR-- 54
Query: 63 SKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
H+ H II L I+ P D D +V +L+ L +
Sbjct: 55 --------HLRHENIIGLLDIL-------RPP---SPEDFNDVYIVTELMETDLHKVI-K 95
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 180
+ + + Q++ ++Y+HS +HRD+KP N L+ +N + I DFGLA+
Sbjct: 96 SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 33/116 (28%), Positives = 47/116 (40%), Gaps = 26/116 (22%)
Query: 138 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD------------- 184
++ ++ VH GF+HRDIKPDN L + + + + DFGL KK
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNIL--IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 185 --PTTNRHIPYRENKNLT-------GTARYASCNTHLGIEQSRRDDLESLGYVLLY 231
N + R++K GT Y + G D SLG V+LY
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILY 221
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 60/247 (24%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+++ G +GSGSFG ++ ++D + AVK + G +
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVK----------------EVSLADDGQTGQE 44
Query: 68 VVFHVDHVIIHALTIIFSSTLGGI--PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVY 121
V ++ I + L + PNI ++ G + E++ L L+L+ G SL L
Sbjct: 45 AVKQLEQEI---------ALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL-- 93
Query: 122 CRRKF-SLKTVL--MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+K+ S + + Q++ +EY+H R +HRDIK N L+ V + DFG+
Sbjct: 94 --KKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGM 148
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYF 232
AK+ + + K+ G+ + A + D+ SLG +L
Sbjct: 149 AKQV--------VEFSFAKSFKGSPYWMAPEVIAQQGGY-----GLAADIWSLGCTVLEM 195
Query: 233 LRGSLPW 239
G PW
Sbjct: 196 ATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 34/190 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGS 63
KY++ +G G++G + + T EIVA+K E+ L E KV + L+
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR--- 58
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
H I L F G + Y LV + + +L +L
Sbjct: 59 ----------HENIVNLKEAFRR--KG----RLY--------LVFEYVERTLLELLEASP 94
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
V Q++ I Y HS +HRDIKP+N L+ ++ + + DFG A+ R
Sbjct: 95 GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALR 151
Query: 184 DPTTNRHIPY 193
+ Y
Sbjct: 152 ARPASPLTDY 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 35/242 (14%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK----ILQGG 62
++ G+ +G G+FG ++L VDT +AVK P+ E + +L+
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
R+V ++ L+I GG ++K L G E +
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGG--SVKDQ----------LKAYGALTETV---- 105
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
RK++ Q++ +EY+HS +HRDIK N L A V + DFG +K
Sbjct: 106 TRKYTR--------QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASK-- 152
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
R T K++TGT + S G R+ D+ S+G ++ L PW
Sbjct: 153 RLQTICSSGTGM--KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
Query: 243 KA 244
+A
Sbjct: 211 EA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 30/187 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
YK+ KIG G+F E+ A T + A+K KH + L + + +Q +R +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK---KHFKSLEQVNNLREIQA---LRRL 54
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL 128
H + I+ + ++F G + LV +L+ +L +L +R
Sbjct: 55 SPHPN--ILRLIEVLFDRKTGRL-------------ALVFELMDMNLYELIKGRKRPLPE 99
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 188
K V Q++ ++++H G HRDIKP+N L+ K + + + DFG +
Sbjct: 100 KRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIY 150
Query: 189 RHIPYRE 195
PY E
Sbjct: 151 SKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 18/148 (12%)
Query: 117 DLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+LF Y R +FS T L A +++ +EY+HS+ ++RD+KP+N L+ K + +
Sbjct: 87 ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLT 143
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234
DFG AKK RD T L GT Y + ++ D +LG ++ L
Sbjct: 144 DFGFAKKLRDRTW----------TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTP 262
G P+ Y+KI K+ P
Sbjct: 194 GYPPFFD---DNPFGIYEKILAGKLEFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 41/211 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGS 63
+Y+ KIG G++G ++ A TNE +A+K +E P + E + K +Q G+
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 64 KIRLV-VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL-LGPSLEDLFVY 121
+RL V H + L ++F LDL L ++ +
Sbjct: 63 IVRLQDVVHSEK----RLYLVFE---------------------YLDLDLKKHMDSSPDF 97
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ +KT L Q++ I Y HS LHRD+KP N L + R+ N + + DFGLA+
Sbjct: 98 AKNPRLIKTYLY---QILRGIAYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARA 152
Query: 182 YRDPT-TNRH----IPYRENKNLTGTARYAS 207
+ P T H + YR + L G+ Y++
Sbjct: 153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 37/184 (20%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP---QLLYEAKVYKIL 59
+G +YK IGSG++G + A + + VA+K I ++ + L E K+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR-- 59
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF 119
H H I A+ I G D +D +V+DL+ L +
Sbjct: 60 -----------HFKHDNIIAIRDILRPP----------GADFKDVYVVMDLMESDLHHI- 97
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ---VYIIDF 176
++ + + + + Q++ ++Y+HS +HRD+KP N L+ N+ + I DF
Sbjct: 98 IHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDF 151
Query: 177 GLAK 180
G+A+
Sbjct: 152 GMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 36/183 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQ-LLYEAKVYKILQGGS 63
KY+ KIG G++G +F A + +T+EIVA V++++ P L E + K L+ +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 64 KIRLV-VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
+RL V H D LT++F + L+ F C
Sbjct: 61 IVRLYDVLHSDK----KLTLVF------------------------EYCDQDLKKYFDSC 92
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+ V Q++ + + HS LHRD+KP N L+ K ++ + DFGLA+ +
Sbjct: 93 NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
Query: 183 RDP 185
P
Sbjct: 150 GIP 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 7e-10
Identities = 61/250 (24%), Positives = 93/250 (37%), Gaps = 49/250 (19%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSKIRLVVF 70
+G GS G ++ H T +I A+K + QLL E K +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKT-------------LR 54
Query: 71 HVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKF 126
+ P + K YG + +VL+ + G SL DL K
Sbjct: 55 SCES-----------------PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-KI 96
Query: 127 SLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
+ +A Q++ ++Y+H+ R +HRDIKP N L+ +V I DFG++K +
Sbjct: 97 PEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENT 153
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245
+ GT Y S G S D+ SLG LL G P+
Sbjct: 154 LDQCN-------TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206
Query: 246 TKKQKYDKIC 255
+ + IC
Sbjct: 207 SFFELMQAIC 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 30/173 (17%)
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+L+ R F T ++ EY+H+RG ++RD+KP+N L+ V ++
Sbjct: 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLV 135
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY- 231
DFG AKK K T GT Y + L D SLG +LLY
Sbjct: 136 DFGFAKKL----------KSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYE 184
Query: 232 FLRGSLPWQGLKA-----------ATKKQKYDKICEKKVSTPIEVLCKSHPAE 273
L G P+ K ++ +K I+ L + +P E
Sbjct: 185 LLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 8e-10
Identities = 51/190 (26%), Positives = 74/190 (38%), Gaps = 64/190 (33%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSKIR 66
YK KIG G+ GE++ A+ T + VA+K ++ +L+ E + K +
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK------ 73
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL--------GPSLEDL 118
H PNI VD D+ LV D L G SL D+
Sbjct: 74 -----------H-------------PNI----VDYYDSYLVGDELWVVMEYMDGGSLTDI 105
Query: 119 FVYCRRKFSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGL-GRKAN 169
+ + + IA + EY+HS+ +HRDIK DN L+ G
Sbjct: 106 ITQNFVR--------MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--- 154
Query: 170 QVYIIDFGLA 179
V + DFG A
Sbjct: 155 -VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 52/261 (19%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+++G +G+GSFG + +A H T E A+K K ++L +V + Q S +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKC----LKKREILKMKQVQHVAQEKS----I 71
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE-----DLFVYCR 123
+ + H I + F E+ V L LE +LF + R
Sbjct: 72 LMELSHPFIVNMMCSFQD---------------ENRVYFL------LEFVVGGELFTHLR 110
Query: 124 R--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ +F +++ EY+HS+ ++RD+KP+N L L K + V + DFG AKK
Sbjct: 111 KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKK 167
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
D T L GT Y + + D ++G +L F+ G P+
Sbjct: 168 VPDRTF----------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
Query: 242 LKAATKKQKYDKICEKKVSTP 262
T + Y+KI ++ P
Sbjct: 218 ---DTPFRIYEKILAGRLKFP 235
|
Length = 329 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 70/271 (25%), Positives = 103/271 (38%), Gaps = 79/271 (29%)
Query: 13 RKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSKIR 66
+K+G G+FGE++ VAVK + L EA+V K
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMK--------- 51
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLLG---PS 114
+ H PN+ + GV + E LVL DLL S
Sbjct: 52 ----KLGH-----------------PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKS 90
Query: 115 LEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
+ SLK +L A Q IA+ +EY+ S+ F+HRD+ N L+G + V I
Sbjct: 91 RPVFPSPEKSTLSLKDLLSFAIQ-IAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKI 146
Query: 174 IDFGLAKKYRDP-----TTNRHIPYR----ENKNLTGTARYASCNTHLGIEQSRRDDLES 224
DFGL++ D T +P R E + + + +S D+ S
Sbjct: 147 SDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE------SLKDGIFTS-----KS---DVWS 192
Query: 225 LGYVLLY--FLRGSLPWQGLKAATKKQKYDK 253
G VLL+ F G+ P+ GL + K
Sbjct: 193 FG-VLLWEIFTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 32/238 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIR 66
K+ G IGSGSFG ++L + + E++AVK +E + + L +I
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAR--EIA 58
Query: 67 LVV-FHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 125
L+ ++++ + + + + L NI V G +L+ G + E+ V R
Sbjct: 59 LLKELQHENIVQYLGSSLDADHL----NIFLEYVPGGSVAALLNNYG-AFEETLV---RN 110
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR-- 183
F Q++ + Y+H+RG +HRDIK N L+ + I DFG++KK
Sbjct: 111 F--------VRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEAN 159
Query: 184 --DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
TN P +L G+ + + +R+ D+ SLG +++ L G P+
Sbjct: 160 SLSTKTNGARP-----SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 34/180 (18%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSKIRLVV 69
+I G++G ++ A T EIVA +K+E P L E + LQ +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN------ 65
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL 128
I+ ++ S L D + +V++ + L+ L ++ F
Sbjct: 66 ------IVTVKEVVVGSNL--------------DKIYMVMEYVEHDLKSLMETMKQPFLQ 105
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 188
V L Q+++ + ++H LHRD+K N L+ + I DFGLA++Y P
Sbjct: 106 SEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKP 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 74/303 (24%), Positives = 126/303 (41%), Gaps = 62/303 (20%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
KL RK+G+G FGE+++ + T + VAVK GT P+ L EA++ K L+ ++L
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL- 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGV--DGEDNVLVLDLLGP-SLEDLFVYCR-- 123
Y V + E +V + + SL D + +
Sbjct: 67 ----------------------------YAVCSEEEPIYIVTEYMSKGSLLD---FLKSG 95
Query: 124 --RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+K L ++ +A Q+ + Y+ SR ++HRD+ N L+G I DFGLA+
Sbjct: 96 EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARL 152
Query: 182 YRDPTTNRHIPYRENK-NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 238
D + + K + TA A+ I + D+ S G +LL G +P
Sbjct: 153 IED---DEYTAREGAKFPIKWTAPEAANYGRFTI----KSDVWSFG-ILLTEIVTYGRVP 204
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 298
+ G+ T ++ +++ E+ P C P E C ++RP + +L+
Sbjct: 205 YPGM---TNREVLEQV-ERGYRMPRPPNC---PEELYDLMLQCWDKDPEERPTFEYLQSF 257
Query: 299 FHD 301
D
Sbjct: 258 LED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 51/206 (24%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKI 65
Y+L IG G+ ++ A + NE VA+K E T +L E +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC------ 56
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVY 121
+H PN+ K+Y + L V+ L G SL D+
Sbjct: 57 -------NH-----------------PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKS 92
Query: 122 CRRK-----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
+ + TVL +++ +EY+HS G +HRDIK N L+G + V I DF
Sbjct: 93 SYPRGGLDEAIIATVL---KEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADF 146
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGT 202
G++ D + K GT
Sbjct: 147 GVSASLADGGDRTR---KVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 22/180 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y+ +GSG++G + A + VAVK L++ + Y+ ++RL
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYR------ELRL 67
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
+ H+ H + L +F+ + + LV +L+G L ++ V C+ K S
Sbjct: 68 LK-HMKHENVIGLLDVFTPATSI--------ENFNEVYLVTNLMGADLNNI-VKCQ-KLS 116
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 187
+ V L Q++ ++Y+HS G +HRD+KP N + + ++ I+DFGLA++ D T
Sbjct: 117 DEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+ L IG GSFGE++ A TN++VA+K+ + L EA+
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--------LEEAE------------- 40
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR 123
D + I F S P I K+YG + G ++++ G S DL
Sbjct: 41 -----DEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG- 93
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
K + + +++ +EY+H G +HRDIK N L+ + V + DFG++ +
Sbjct: 94 -KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLT 149
Query: 184 DPTTNRH 190
+ R+
Sbjct: 150 STMSKRN 156
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 76/300 (25%), Positives = 123/300 (41%), Gaps = 52/300 (17%)
Query: 9 YKLGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+++ +KIG G F E++ A+ +D + K++ ++E K Q K
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ---------IFEMMDAKARQDCVKEID 54
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVL--VLDLLGP-SLEDLFVYCR 123
++ ++H PN IK+ EDN L VL+L L + Y +
Sbjct: 55 LLKQLNH-----------------PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFK 97
Query: 124 RKFSL---KTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLA 179
++ L +TV Q+ + +E++HSR +HRDIKP N F+ G V + D GL
Sbjct: 98 KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLG 153
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
+ + TT H +L GT Y S + + D+ SLG +L P+
Sbjct: 154 RFFSSKTTAAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
Query: 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE-FASYFHYCQSLTFDQRPDYGFLKRL 298
G K +C+K L H +E C DQRPD G++ ++
Sbjct: 207 YG-----DKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 15/143 (10%)
Query: 92 PNI-KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVH 146
PNI +Y +DN L++++ G +L D V + + F + VL Q+++ + Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 147 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 206
G LHRDIK N + KA + + DFG++K Y + + GT Y
Sbjct: 119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGS-------EYSMAETVVGTPYYM 168
Query: 207 SCNTHLGIEQSRRDDLESLGYVL 229
S G++ + + D+ +LG VL
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 64/300 (21%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKIR 66
+ L RK+GSG FGE++ + VA+KI + K E + K L+ I
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--- 123
L A+ GE ++ +L+ L + R
Sbjct: 67 L----------FAVC-----------------SVGEPVYIITELMEKG--SLLAFLRSPE 97
Query: 124 -RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+ + +++ +A Q+ + Y+ + +HRD+ N L+G + DFGLA+
Sbjct: 98 GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCK---VADFGLARLI 154
Query: 183 RDP---TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSL 237
++ ++++ IPY+ TA A+ + S + D+ S G +LLY F G +
Sbjct: 155 KEDVYLSSDKKIPYK------WTAPEAASHGTF----STKSDVWSFG-ILLYEMFTYGQV 203
Query: 238 PWQGLKAATKKQKYDKICEK-KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296
P+ G + YD+I ++ P + C P E C + + RP + L+
Sbjct: 204 PYPG---MNNHEVYDQITAGYRMPCPAK--C---PQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 51/184 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
Y+L ++IGSG++G+++ A + T E+VA+K+ L ++I+Q +I +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--------LEPGDDFEIIQQ--EISM 53
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCR 123
+ H PNI ++G + L V++ G SL+D++ R
Sbjct: 54 LK-ECRH-----------------PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR 95
Query: 124 RKFSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
L++ IA + Y+H G +HRDIK N L+ + V + D
Sbjct: 96 GP--------LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLAD 144
Query: 176 FGLA 179
FG++
Sbjct: 145 FGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 2e-08
Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 5/62 (8%)
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKK 181
+ FS + + Q++ + ++H GF HRD+KP+N L G V I DFGLA++
Sbjct: 93 GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV----VKIADFGLARE 148
Query: 182 YR 183
R
Sbjct: 149 IR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 38/176 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+L RK+G+G FGE++ +T VAVK GT P+ L EA++ K L+ I+L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL- 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRR 124
Y V E +V +L+ G LE L R
Sbjct: 67 ----------------------------YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR 98
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
L ++ +A Q+ + + Y+ ++ ++HRD+ N L+G + N + DFGLA+
Sbjct: 99 ALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 63/186 (33%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGT--------------KHPQLLYEAK 54
KIG G++G ++ A T EIVA+K E+ G HP ++ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV---R 62
Query: 55 VYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPS 114
+ ++ +K+ LV +D + + P L P
Sbjct: 63 LLDVVHSENKLYLVFEFLDLDLKKYMD--------SSPLTG---------------LDPP 99
Query: 115 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
L ++Y Q++ I Y HS LHRD+KP N L+ + + +
Sbjct: 100 LIKSYLY---------------QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLA 141
Query: 175 DFGLAK 180
DFGLA+
Sbjct: 142 DFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 43/135 (31%), Positives = 62/135 (45%), Gaps = 39/135 (28%)
Query: 103 DNVL-VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD---------------------QMIA 140
DNVL LD+L P D F + + T LM +D Q++
Sbjct: 59 DNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 141 RIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP------- 192
++Y+HS G LHRDIKP N L+ +N + I DFGLA+ +P ++H+
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDESKHMTQEVVTQY 169
Query: 193 YRENKNLTGTARYAS 207
YR + L G+ Y S
Sbjct: 170 YRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 73/291 (25%), Positives = 114/291 (39%), Gaps = 79/291 (27%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+IGSG+ G ++ H T + A+K+ + T Q+ E + IL+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE---ILRD------- 128
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI----KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 124
V+H PN+ + +GE VL+ + G SLE + +
Sbjct: 129 ---VNH-----------------PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ 168
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK---K 181
+ +A Q+++ I Y+H R +HRDIKP N L+ + V I DFG+++ +
Sbjct: 169 FLA-----DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKIADFGVSRILAQ 220
Query: 182 YRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRD----DLESLGYVLLYFLR 234
DP + GT Y S NT L D D+ SLG +L F
Sbjct: 221 TMDPCNSS----------VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYL 268
Query: 235 GSLPW----QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 281
G P+ QG A+ +C +S P E + EF + C
Sbjct: 269 GRFPFGVGRQGDWASL-------MCAICMSQPPEAPATASR-EFRHFISCC 311
|
Length = 353 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 56/193 (29%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-GTKHPQLLYEAKVYKILQGGSK 64
++L IG G++G+++ A H T ++VA+KI + + ++ E Y IL+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILR---- 57
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-------DGEDNV-LVLDLL-GPS 114
+ +H PNI +YG +D + LV++L G S
Sbjct: 58 -----KYSNH-----------------PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS 95
Query: 115 LEDLFVYCRRKFSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGR 166
+ DL K K L ++ IA I Y+H +HRDIK N L+
Sbjct: 96 VTDLV-----KGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---T 147
Query: 167 KANQVYIIDFGLA 179
K +V ++DFG++
Sbjct: 148 KNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 25/152 (16%)
Query: 99 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158
V+G D +L +G L V R + +TVL L EY+H+ G +HRD+KPD
Sbjct: 83 VEGGDCATLLKNIGA----LPVDMARMYFAETVLAL--------EYLHNYGIVHRDLKPD 130
Query: 159 NFLM-GLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRE-------NKNLTGTARYASCN 209
N L+ +G + + DFGL+K TTN + + E +K + GT Y +
Sbjct: 131 NLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
L + D ++G +L FL G +P+ G
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 66/255 (25%), Positives = 112/255 (43%), Gaps = 47/255 (18%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFH 71
+G GSFG++FL + D ++ A+K+ T L +V ++ R ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT----LKVRDRVRTKME-----RDILAE 54
Query: 72 VDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLK 129
V+H I L F T G K Y L+LD L DLF ++ F+ +
Sbjct: 55 VNHPFIVKLHYAFQ-TEG-----KLY--------LILDFLRGG--DLFTRLSKEVMFTEE 98
Query: 130 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 189
V ++ ++++HS G ++RD+KP+N L+ + + + DFGL+K+ D
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID----- 150
Query: 190 HIPYRENK--NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 247
E K + GT Y + ++ D S G ++ L GSLP+QG +
Sbjct: 151 ----HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG---KDR 203
Query: 248 KQKYDKICEKKVSTP 262
K+ I + K+ P
Sbjct: 204 KETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 55/302 (18%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ ++L
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL- 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRK 125
Y V E+ + ++ G L+ L +
Sbjct: 67 ----------------------------YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY 98
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRD 184
L ++ +A Q+ + + YV ++HRD++ N L+G N V + DFGLA+ D
Sbjct: 99 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIED 154
Query: 185 PTTNRHIPYRENK-NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGL 242
N + + K + TA A+ I + D+ S G +L +G +P+ G+
Sbjct: 155 ---NEYTARQGAKFPIKWTAPEAALYGRFTI----KSDVWSFGILLTELTTKGRVPYPGM 207
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
++ D++ E+ P C P C ++RP + +L+ D
Sbjct: 208 ---VNREVLDQV-ERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260
Query: 303 FS 304
F+
Sbjct: 261 FT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 48/235 (20%), Positives = 95/235 (40%), Gaps = 50/235 (21%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSKIRLVV 69
++G+G+ G + H T +I+AVK +E + Q+L E + +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDI-------------L 53
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNI-KWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRK 125
+ P I +YG +G+ ++ + + G SL+ + + +
Sbjct: 54 HKCNS-----------------PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR 96
Query: 126 FSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
+ + +A ++ + Y+H +HRD+KP N L+ Q+ + DFG++ + +
Sbjct: 97 IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVN 153
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
K GT+ Y + G + S + D+ SLG L+ G P+
Sbjct: 154 SLA---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 92 PNIKWYG---VDGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEY 144
PNI Y ++ + +V+DL+ G L + F + K F+ + + + QM+ + Y
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 145 VHSRGFL-HRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+H + HRD+ P+N ++G + ++V I DFGLAK+
Sbjct: 129 LHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 39/233 (16%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
+ +G GSFG++FLA TN+ A+K K +L + V + + R++
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKA----LKKDVVLMDDDVECTM---VEKRVLSLAW 53
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKT 130
+H + L F + E+ V++ L DL + + KF L
Sbjct: 54 EHPFLTHLYCTFQTK--------------ENLFFVMEYLNGG--DLMFHIQSCHKFDLPR 97
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTN 188
A ++I ++++HS+G ++RD+K DN L+ + I DFG+ K+ D T
Sbjct: 98 ATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKTC 154
Query: 189 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
GT Y + LG + + D S G +L L G P+ G
Sbjct: 155 ---------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 72/300 (24%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSK 64
+ +Y+ +GSG++G + + DT + V ++ +++ + Y+ +
Sbjct: 15 VPERYQNLSPVGSGAYGSV--CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR------E 66
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 124
+RL+ H+ H + L +F+ +++ + D LV L+G L ++ V C+
Sbjct: 67 LRLLK-HMKHENVIGLLDVFTPA----RSLEEF----NDVYLVTHLMGADLNNI-VKCQ- 115
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
K + V L Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+ D
Sbjct: 116 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD 172
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243
T T Y + L + ++ D+ S+G ++ L G + G
Sbjct: 173 EMT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG-- 220
Query: 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303
T K+ + V TP L K +E A +Y QSLT Q P K F ++F
Sbjct: 221 --TDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQSLT--QMP-----KMNFANVF 269
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 53/233 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
KY+ R +G G+FG + L ++V +K +E E +V K+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--- 57
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVLVLDLL---GPSLEDLF 119
H PN I++Y ED L++ + G +L +
Sbjct: 58 --------------H-------------PNIIEYYENFLEDKALMIVMEYAPGGTLAEYI 90
Query: 120 V-YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
C T+L Q++ + +VH++ LHRD+K N L+ + V I DFG+
Sbjct: 91 QKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL--DKHKMVVKIGDFGI 148
Query: 179 AKKYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVL 229
+K I ++K T GT Y S G +++ D+ +LG VL
Sbjct: 149 SK----------ILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 66/193 (34%)
Query: 8 KY-KLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGT-----------------KHP 47
KY KL KIG GS+G +F + +T +IVA+K +E+ KHP
Sbjct: 2 KYEKLS-KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 48 QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLV 107
L+ +V++ K+ LV + DH +++ L P GV
Sbjct: 61 NLVNLIEVFR---RKRKLHLVFEYCDHTVLN--------ELEKNPR----GVP------- 98
Query: 108 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167
+ +K ++ Q + + + H +HRD+KP+N L+ K
Sbjct: 99 -----------------EHLIKKIIW---QTLQAVNFCHKHNCIHRDVKPENILI---TK 135
Query: 168 ANQVYIIDFGLAK 180
Q+ + DFG A+
Sbjct: 136 QGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 33/180 (18%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQLLYEAKVYKILQGGSKIR 66
KL R IG G++G ++ A + EIVA V+++N P + +I
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIP-----------ISSLREIT 58
Query: 67 LVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 125
L++ ++ H I+ ++ L I LV++ L L
Sbjct: 59 LLL-NLRHPNIVELKEVVVGKHLDSI-------------FLVMEYCEQDLASLLDNMPTP 104
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
FS V L Q++ ++Y+H +HRD+K N L+ + I DFGLA+ Y P
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 45/188 (23%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSK 64
Y+ +IG G++G ++ A ++T VA+K + S P L E + K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 65 IRLV----VFHVDHV--IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
+V V H + LT++F VD +DL
Sbjct: 61 PNIVRLLDVCHGPRTDRELK-LTLVFEH------------VD---------------QDL 92
Query: 119 FVYCRR----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
Y + +T+ L Q++ ++++HS +HRD+KP N L+ QV I
Sbjct: 93 ATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIA 149
Query: 175 DFGLAKKY 182
DFGLA+ Y
Sbjct: 150 DFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 63/236 (26%), Positives = 93/236 (39%), Gaps = 55/236 (23%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
+K+ +KIG G F ++ A + +VA+K E K Q L E + K L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL---- 59
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVLVLDLLGPSLEDL---- 118
DH PN IK+ E+N L + L DL
Sbjct: 60 ---------DH-----------------PNVIKYLASFIENNELNIVLELADAGDLSRMI 93
Query: 119 --FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIID 175
F +R +T+ Q+ + +E++HS+ +HRDIKP N + A V + D
Sbjct: 94 KHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGD 149
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 231
GL + + TT H +L GT Y S + + D+ SLG LLY
Sbjct: 150 LGLGRFFSSKTTAAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLG-CLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 70/292 (23%), Positives = 112/292 (38%), Gaps = 61/292 (20%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGSKIRLVV 69
+IG G+FGE+F N VAVK T P L L EA++ K + +RL+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 129
+ I+ GG D + L GP L+ +K
Sbjct: 61 VCTQK---QPIYIVMELVQGG------------DFLTFLRTEGPRLK-----------VK 94
Query: 130 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN- 188
++ + + A +EY+ S+ +HRD+ N L+ + N + I DFG++++ D
Sbjct: 95 ELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS 151
Query: 189 ----RHIPYR-ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 241
+ IP + RY+S D+ S G +LL+ F G++P+
Sbjct: 152 TGGMKQIPVKWTAPEALNYGRYSS-----------ESDVWSFG-ILLWEAFSLGAVPY-- 197
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293
A Q+ + E+ V P LC P C QRP +
Sbjct: 198 --ANLSNQQTREAIEQGVRLPCPELC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 47/295 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+L +K+G+G FGE+++ + + N VAVK GT P+ L EA++ K L+ ++L
Sbjct: 9 QLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLY 67
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL 128
V I+ +T S G + + + DGE L L P+L D
Sbjct: 68 AV-VSEEPIYIVTEYMSK--GSLLD---FLKDGEGRALKL----PNLVD----------- 106
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 188
+A Q+ A + Y+ ++HRD++ N L+G G I DFGLA+ D N
Sbjct: 107 -----MAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK---IADFGLARLIED---N 155
Query: 189 RHIPYRENK-NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 246
+ + K + TA A+ I + D+ S G +L + +G +P+ G+
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTI----KSDVWSFGILLTELVTKGRVPYPGM---N 208
Query: 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
++ +++ E+ P C P C ++RP + +L+ D
Sbjct: 209 NREVLEQV-ERGYRMPCPQDC---PISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 60/301 (19%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+++ +KIG G F E++ A+ + VA+K + +++ ++ ++ +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALK-------------KVQIFDLMDAKARADCI 50
Query: 69 -----VFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVLVLDLLGPSLEDL---- 118
+ ++H PN IK+Y EDN L + L DL
Sbjct: 51 KEIDLLKQLNH-----------------PNVIKYYASFIEDNELNIVLELADAGDLSRMI 93
Query: 119 --FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIID 175
F +R KTV Q+ + +E++HSR +HRDIKP N F+ G V + D
Sbjct: 94 KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGD 149
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235
GL + + TT H +L GT Y S + + D+ SLG +L
Sbjct: 150 LGLGRFFSSKTTAAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGF 294
P+ G K +C+K L H E + C + ++RPD +
Sbjct: 203 QSPFYG-----DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITY 257
Query: 295 L 295
+
Sbjct: 258 V 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 50/197 (25%), Positives = 76/197 (38%), Gaps = 44/197 (22%)
Query: 10 KLGRKIGSGSFGEIFL----ASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGG 62
K R +G G FG++ L ++ T E+VAVK E E + K L
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL--- 63
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGV--DGEDNVLVLDLLGPSLEDLFV 120
H I +K+ G + L L + L L
Sbjct: 64 ----------YHENI----------------VKYKGCCSEQGGKGLQLIMEYVPLGSLRD 97
Query: 121 YC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
Y + K +L +L+ A Q+ + Y+HS+ ++HRD+ N L+ V I DFGLA
Sbjct: 98 YLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLA 154
Query: 180 KKYRDPTTNRHIPYREN 196
K P + + RE+
Sbjct: 155 KAV--PEGHEYYRVRED 169
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 32/178 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
YKLG IG+GSFG ++ A +DT+E VA+K KV + Q ++ L+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK---------------KVLQDPQYKNRELLI 112
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV---LVLDLLGPSLEDLF-VYCRR 124
+ +++H+ IIF K E N+ +V++ + ++ Y R
Sbjct: 113 MKNLNHI-----NIIFLKDYYYTECFK----KNEKNIFLNVVMEFIPQTVHKYMKHYARN 163
Query: 125 KFSLKTVL--MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+L L + + Q+ + Y+HS+ HRD+KP N L + + + + DFG AK
Sbjct: 164 NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDP 185
Q++ + Y+HS LHRD+KP N +MG G + V I D GLA+ + P
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 31/172 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY KIG G+ G ++ A V T + VA+K N LQ K L
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-----------------LQQQPKKEL 62
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF 126
II+ + ++ + I N + Y V E V++ L G SL D+
Sbjct: 63 --------IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CM 112
Query: 127 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ + + + +E++HS +HRDIK DN L+G+ V + DFG
Sbjct: 113 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 31/172 (18%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
KL +K+G+G FGE+++ + + + VA+K G+ P+ L EA + K LQ +RL
Sbjct: 9 KLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL- 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL 128
+A+ T I I Y +G ++D L K ++
Sbjct: 67 ---------YAVV-----TQEPIYIITEYMENGS----LVDFLKTP-------EGIKLTI 101
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
++ +A Q+ + ++ + ++HRD++ N L+ + I DFGLA+
Sbjct: 102 NKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y+ +++GSG++G + S +D V I+ L+ + Y+ ++RL
Sbjct: 16 RYRDLKQVGSGAYGTV--CSALDRRTGAKVAIKKLYRPFQSELFAKRAYR------ELRL 67
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
+ H+ H + L +F+ L ++ D LV+ +G L L + K S
Sbjct: 68 LK-HMKHENVIGLLDVFTPDL----SLD----RFHDFYLVMPFMGTDLGKLMKH--EKLS 116
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ L QM+ ++Y+H+ G +HRD+KP N + + ++ I+DFGLA++
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 32/180 (17%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-QLLYEAK-VYKILQGGSK 64
+Y+ +GSG++G++ A T VA+K P Q AK Y+ +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSAIHAKRTYR------E 64
Query: 65 IRLVVFHVDHVIIHALTIIF--SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
+RL+ H+DH + L +F +S+L D +D LV L+G L ++
Sbjct: 65 LRLLK-HMDHENVIGLLDVFTPASSLE----------DFQDVYLVTHLMGADLNNIVK-- 111
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 181
+K S + L Q++ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN----IAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 49/185 (26%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY++ +K+G G++G ++ A T E+VA+K K++ +
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK---------------KIFDAFRN------ 46
Query: 68 VVFHVDHVIIHALT--------IIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLE-D 117
T I+F LG PNI K V +N + L+ +E D
Sbjct: 47 ------------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD 94
Query: 118 LFVYCRRKFSLKTVLM--LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
L R L+ V + Q++ ++Y+HS +HRD+KP N L L V + D
Sbjct: 95 LHAVIRANI-LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNIL--LNSDCR-VKLAD 150
Query: 176 FGLAK 180
FGLA+
Sbjct: 151 FGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 60/267 (22%), Positives = 100/267 (37%), Gaps = 53/267 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGS 63
Y++ IG GSFG + +I+ K + G + QL+ E + + L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL---- 56
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC 122
K +V + D +I + ++ +V++ G L L C
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLY---------------------IVMEYCEGGDLAQLIQKC 95
Query: 123 RRKFSL---KTVLMLADQMIARIEYVHSRG-----FLHRDIKPDN-FLMGLGRKANQVYI 173
+++ + + + Q++ + H+R LHRD+KP N FL N V +
Sbjct: 96 KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA----NNNVKL 151
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233
DFGLAK ++ K GT Y S + + D+ SLG ++
Sbjct: 152 GDFGLAKILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC 204
Query: 234 RGSLPWQGLKAATKKQKYDKICEKKVS 260
S P+ A + Q KI E K
Sbjct: 205 ALSPPFT---ARNQLQLASKIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y + +G G+FG + A T + VA+K P L + Y+ L+
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVL--AKRTYRELK------- 61
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
++ H+ H I +L+ IF S L ED V +LLG L L R
Sbjct: 62 LLKHLRHENIISLSDIFISPL-------------EDIYFVTELLGTDLHRLLT--SRPLE 106
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ + Q++ ++YVHS G +HRD+KP N L+ + + I DFGLA+
Sbjct: 107 KQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 37/170 (21%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVD 73
K+G GS+G ++ A H +T ++VA+K+ +++ E + K
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS------------ 57
Query: 74 HVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLLGP-SLEDLFVYCRRKFSLK 129
P I K+YG ++ L V++ G S+ D+ + + +
Sbjct: 58 ------------------PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE 99
Query: 130 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + Q + +EY+HS +HRDIK N L+ + Q + DFG++
Sbjct: 100 EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 34/176 (19%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--SKIR 66
Y+L +++GSG++G+++ A ++ T E+ AVKI K+ G S I+
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKI----------------IKLEPGDDFSLIQ 54
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRK 125
+F V + F S L E + ++ G SL+D++ +
Sbjct: 55 QEIFMVKECKHCNIVAYFGSYLSR-----------EKLWICMEYCGGGSLQDIY-HVTGP 102
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
S + + + + + Y+HS+G +HRDIK N L+ V + DFG+A K
Sbjct: 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 60/257 (23%), Positives = 100/257 (38%), Gaps = 41/257 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G+FG+++ DT I A+K+ + + + K G I + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVL 132
I L F + D LV D + S +LF + ++ +FS
Sbjct: 56 PFIVGLKFSFQTD--------------SDLYLVTDYM--SGGELFWHLQKEGRFSEDRAK 99
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRH 190
+++ +E++H ++RD+KP+N L+ + + DFGL+K + TTN
Sbjct: 100 FYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTTN-- 154
Query: 191 IPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 249
GT Y + L + ++ D SLG ++ G W A +Q
Sbjct: 155 -------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQ 204
Query: 250 KYDKICEKKVSTPIEVL 266
Y I KV P VL
Sbjct: 205 MYRNIAFGKVRFPKNVL 221
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 75/298 (25%), Positives = 120/298 (40%), Gaps = 72/298 (24%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
KIG G+FG+++ + N VAVK T L + K K LQ ++
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK-----TCRSTLPPDLKR-KFLQEAE----ILKQY 49
Query: 73 DHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---F 126
DH PNI K GV + +V++L+ L + R+K
Sbjct: 50 DH-----------------PNIVKLIGVCVQKQPIYIVMELV--PGGSLLTFLRKKKNRL 90
Query: 127 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----- 181
++K +L ++ A +EY+ S+ +HRD+ N L+G N + I DFG++++
Sbjct: 91 TVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGI 147
Query: 182 YRDPTTNRHIPYR----ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRG 235
Y + IP + E N RY S D+ S G +LL+ F G
Sbjct: 148 YTVSDGLKQIPIKWTAPEALN---YGRYTS-----------ESDVWSYG-ILLWETFSLG 192
Query: 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293
P+ G+ + +Q ++I E P LC P E C + + RP +
Sbjct: 193 DTPYPGM---SNQQTRERI-ESGYRMPAPQLC---PEEIYRLMLQCWAYDPENRPSFS 243
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 60/245 (24%), Positives = 98/245 (40%), Gaps = 38/245 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG GSFG++ LA H + AVK+ + +L + + I+ S+ +++ +V H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKV----LQKKAILKKKEEKHIM---SERNVLLKNVKH 55
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVL 132
+ L F + K Y VLD + +LF + +R+ F
Sbjct: 56 PFLVGLHFSFQTA------DKLY--------FVLDYINGG--ELFYHLQRERCFLEPRAR 99
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 192
A ++ + + Y+HS ++RD+KP+N L+ + + DFGL K+ +
Sbjct: 100 FYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT---- 152
Query: 193 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 252
GT Y + R D LG VL L G P+ A + YD
Sbjct: 153 ---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD 206
Query: 253 KICEK 257
I K
Sbjct: 207 NILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVD 73
KIG GSFGE+F T ++VA+KI + ++ + +L + ++
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM 133
++ L II GG LDLL P D + + T+L
Sbjct: 71 YLKDTKLWIIMEYLGGGS---------------ALDLLEPGPLD-------ETQIATILR 108
Query: 134 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 193
+++ ++Y+HS +HRDIK N L+ + +V + DFG+A + D R+
Sbjct: 109 ---EILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN--- 159
Query: 194 RENKNLTGTARYASCNTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 238
GT + + I+QS D D+ SLG + +G P
Sbjct: 160 ----TFVGTPFWMAPEV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 45/209 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSKIR 66
KL K+G G++ +F T +VA+K +E+ + E + K L+ + +
Sbjct: 9 KLD-KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 67 LVVFHVDHVIIH---ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
L H IIH LT++F + L L+ C
Sbjct: 68 L------HDIIHTERCLTLVF------------------------EYLDSDLKQYLDNCG 97
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
S+ V + Q++ + Y H R LHRD+KP N L+ + ++ + DFGLA+
Sbjct: 98 NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKS 154
Query: 184 DPT---TNRHIP--YRENKNLTGTARYAS 207
PT +N + YR L G+ Y++
Sbjct: 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 13/106 (12%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-PYRE 195
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA R TN + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA---RTACTNFMMTPY-- 182
Query: 196 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
T Y + LG+ D+ S+G ++ ++GS+ +QG
Sbjct: 183 ----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSKI 65
KY+ +G GS+G + H +T +IVA+K +E+ K V KI +I
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKM--------VKKIAM--REI 51
Query: 66 RLV-VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCR 123
R++ ++++ L +F + Y LV + + + L+DL Y
Sbjct: 52 RMLKQLRHENLV--NLIEVFRR------KKRLY--------LVFEFVDHTVLDDLEKYPN 95
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-- 181
V Q++ IE+ HS +HRDIKP+N L+ ++ V + DFG A+
Sbjct: 96 -GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLA 151
Query: 182 -----YRDPTTNRHIPYRENKNLTGTARY 205
Y D R YR + L G +Y
Sbjct: 152 APGEVYTDYVATRW--YRAPELLVGDTKY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 50/293 (17%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGG 62
+ ++ G+ +G G+FG ++L VDT +A K + P+ E ++L+
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 63 SKIRLVVFH---VDHVIIHALTIIFSSTLGGI--PNIKWYGVDGEDNVLVLDLLGPSLED 117
R+V ++ D LTI GG +K YG E
Sbjct: 62 QHERIVQYYGCLRDRAE-KTLTIFMEYMPGGSVKDQLKAYGALTES-------------- 106
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
RK++ Q++ + Y+HS +HRDIK N L A V + DFG
Sbjct: 107 ----VTRKYT--------RQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFG 151
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237
+K+ + + +++TGT + S G R+ D+ SLG ++ L
Sbjct: 152 ASKRLQTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
PW +A KI + + + SH +E A F C + RP
Sbjct: 208 PWAEYEAMA---AIFKIATQPTNPQL----PSHISEHARDFLGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 61/249 (24%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSK 64
Y+ K+G GS+ ++ ++VA+K+ E GT + EA + K L+ +
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANI 65
Query: 65 IRLVVFHVDHVIIHA---LTIIFSSTLGGIPNI--KWYGVDGEDNVLVLDLLGPSLEDLF 119
+ L H IIH LT++F + K G +NV LF
Sbjct: 66 VLL------HDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENV-----------KLF 108
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
++ Q++ + Y+H R LHRD+KP N L+ ++ + DFGLA
Sbjct: 109 LF---------------QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLA 150
Query: 180 KKYRDPT---TNRHIP--YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234
+ P+ +N + YR L G+ Y++C D+ +G + + ++
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCL-----------DMWGVGCIFVEMIQ 199
Query: 235 GSLPWQGLK 243
G + G+K
Sbjct: 200 GVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 29/182 (15%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVD 73
+IG GSFG ++ A++ TNE+VAVK ++ Y K Q K + ++ V
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVK---------KMSYSGK-----QTNEKWQDIIKEVK 73
Query: 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTV 131
F L I++ G +++ LV++ S DL ++ +
Sbjct: 74 ----------FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 123
Query: 132 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 191
+ + + Y+HS +HRDIK N L+ + QV + DFG A K +
Sbjct: 124 AAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGT 180
Query: 192 PY 193
PY
Sbjct: 181 PY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 43/233 (18%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVD 73
+IG GSFGE++ T E+VA+KI + ++ + +L + ++
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVL 132
++ L II GG LDLL P LE+ ++ T+L
Sbjct: 71 YLKGTKLWIIMEYLGGGS---------------ALDLLKPGPLEETYI--------ATIL 107
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 192
+++ ++Y+HS +HRDIK N L+ + V + DFG+A + D R+
Sbjct: 108 R---EILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-- 159
Query: 193 YRENKNLTGTARYASCNTHLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGL 242
GT + + I+QS D D+ SLG + +G P L
Sbjct: 160 -----TFVGTPFWMAPEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 61/250 (24%), Positives = 98/250 (39%), Gaps = 38/250 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG GSFG++ LA AVK+ T +L + + I+ ++ +++ ++ H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKT----ILKKKEQNHIM---AERNVLLKNLKH 55
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVL 132
+ L F + E VLD + +LF + +R+ F
Sbjct: 56 PFLVGLHYSFQTA--------------EKLYFVLDYVNGG--ELFFHLQRERCFLEPRAR 99
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 192
A ++ + I Y+HS ++RD+KP+N L+ V + DFGL K+ +P
Sbjct: 100 FYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVEPEET---- 152
Query: 193 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 252
GT Y + R D LG VL L G P+ + Q YD
Sbjct: 153 ---TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD 206
Query: 253 KICEKKVSTP 262
I K + P
Sbjct: 207 NILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 57/244 (23%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G++G ++ HV T +VA+KI N T + + + + + S++R
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV---SDIQREVALLSQLRQ------- 58
Query: 75 VIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM 133
PNI K+YG L GP L + Y S++T++
Sbjct: 59 --------------SQPPNITKYYGSY---------LKGPRLWIIMEYAEGG-SVRTLMK 94
Query: 134 ---LADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+A++ I+ I +Y+H G +HRDIK N L+ V + DFG+A
Sbjct: 95 AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALL 151
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
++ R GT + + G + D+ SLG + G+ P+
Sbjct: 152 NQNSSKR-------STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
Query: 242 LKAA 245
+ A
Sbjct: 205 VDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 23/173 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y +++GSG++G + A T E VA+K + + ++ + Y+ L
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYREL-------T 66
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
++ H+ H + L +F+S + G + +D LV+ + L+ + + S
Sbjct: 67 LLKHMQHENVIGLLDVFTSAVSG--------DEFQDFYLVMPYMQTDLQKIMGH---PLS 115
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
V L QM+ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 29/173 (16%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
+ +G G+FGE+ LA VDT + A+K + +L +V + R ++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKT----LRKKDVLLRNQVAHV----KAERDILAEA 58
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKT 130
D+ + L +Y +DN+ V+D + P + + + R F
Sbjct: 59 DNEWVVRL---------------YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDL 102
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
++ +E VH GF+HRDIKPDN L+ + + + DFGL +R
Sbjct: 103 ARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 20/42 (47%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
IE VH GF+HRDIKPDN L+ + + + DFGL +R
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+M ++ +H G++HRD+KP+NFL+ + + + DFGL+K
Sbjct: 109 EMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 8/107 (7%)
Query: 106 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165
LV + L L+ C S+ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-- 138
Query: 166 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 207
+ ++ + DFGLA+ PT +N + YR L G++ Y++
Sbjct: 139 -ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 29/173 (16%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
+ +G G+FGE+ LA VDT+ + A+K + +L +V + R ++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKT----LRKKDVLNRNQVAHV----KAERDILAEA 58
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKT 130
D+ + L +Y +DN+ V+D + P + + + R + F
Sbjct: 59 DNEWVVKL---------------YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVL 102
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
++ IE VH GF+HRDIKPDN L+ L + + DFGL +R
Sbjct: 103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 45/230 (19%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVD 73
+IG GSFGE+F T ++VA+KI + ++ + +L + ++
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTV 131
++ L II GG LDLL GP E F + T+
Sbjct: 71 YLKGTKLWIIMEYLGGGS---------------ALDLLRAGPFDE---------FQIATM 106
Query: 132 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 191
L +++ ++Y+HS +HRDIK N L+ + V + DFG+A + D R
Sbjct: 107 L---KEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKR-- 158
Query: 192 PYRENKNLTGTARYASCNTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 238
GT + + I+QS D D+ SLG + +G P
Sbjct: 159 -----NTFVGTPFWMAPEV---IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 55/240 (22%), Positives = 103/240 (42%), Gaps = 42/240 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSK 64
+ G+++G+G+F + A V T ++AVK + N+ ++ + +V + L+ +
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSE------QEEVVEALR--KE 53
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGED---NVLVLDLLGPSLEDLFV 120
IRL+ ++H P+I + G ED N+ V + G S+ L +
Sbjct: 54 IRLMA-RLNH-----------------PHIIRMLGATCEDSHFNLFVEWMAGGSVSHL-L 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLA 179
F ++ +Q++ + Y+H +HRD+K N L+ G++ + I DFG A
Sbjct: 95 SKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR---LRIADFGAA 151
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
+ T L GT + + G + R D+ S+G V++ PW
Sbjct: 152 ARLAAKGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 57/244 (23%), Positives = 99/244 (40%), Gaps = 41/244 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGGSK 64
++LG+ +G G+FG ++L DT +AVK + P+ E ++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 65 IRLVVFH--VDHVIIHALTIIFSSTLGGI--PNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
R+V ++ + + L+I GG +K YG E+
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN----------------- 106
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
RK++ Q++ + Y+HS +HRDIK N L V + DFG +K
Sbjct: 107 -VTRKYT--------RQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+ + + K++TGT + S G R+ D+ S+G ++ L PW
Sbjct: 155 RLQTIC----LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210
Query: 241 GLKA 244
+A
Sbjct: 211 EFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 31/176 (17%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
KL +K+G+G FGE+++A++ + + VAVK G+ + L EA V K LQ ++L
Sbjct: 9 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL- 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL 128
HA+ T I I + G +LD L K L
Sbjct: 67 ---------HAVV-----TKEPIYIITEFMAKGS----LLDFLKSDEGS-------KQPL 101
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
++ + Q+ + ++ R ++HRD++ N L+ + I DFGLA+ D
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 42/239 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G FGE++ DT ++ A+K + K K+ QG + ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKC-----------LDKKRIKMKQGET------LALNE 44
Query: 75 VIIHALTIIFSSTLGGIPNI--KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLK 129
I+ +L + G P I Y D + +LDL+ DL + + FS
Sbjct: 45 RIMLSLV-----STGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEA 97
Query: 130 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 189
+ A ++I +E++H+R ++RD+KP N L+ + V I D GLA + ++
Sbjct: 98 EMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-----SK 149
Query: 190 HIPYRENKNLTGTARYASCNT-HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 247
P+ GT Y + G+ D SLG +L LRG P++ K K
Sbjct: 150 KKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 35/188 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
Y+ KIG G++G+++ A +T ++VA+K ++ G P L E + ++L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-PTALREISLLQMLSES 60
Query: 63 SKI-RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
I RL+ V+HV G P++ LV + L L+
Sbjct: 61 IYIVRLL--DVEHVE----------EKNGKPSL----------YLVFEYLDSDLKKFMDS 98
Query: 122 CRRKFS----LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
R KT+ Q++ + + H G +HRD+KP N L + ++ + I D G
Sbjct: 99 NGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLG 156
Query: 178 LAKKYRDP 185
L + + P
Sbjct: 157 LGRAFSIP 164
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 1e-05
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 40/234 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY KIG G+ G ++ A V T + VA++ N LQ K L
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-----------------LQQQPKKEL 63
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRK 125
II+ + ++ + I N + Y V E V++ L G SL D+ C +
Sbjct: 64 --------IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
+ V + + +E++HS +HRDIK DN L+G+ V + DFG +
Sbjct: 116 GQIAAV---CRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE 169
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
+ R + GT + + + D+ SLG + + + G P+
Sbjct: 170 QSKR-------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 41/228 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG GSFG++ DT I A+K + ++ ++V L R V+ V+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK----TIRKAHIVSRSEVTHTLAE----RTVLAQVNC 52
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVL 132
I L F S E LVL + +LF + +R +F L
Sbjct: 53 PFIVPLKFSFQSP--------------EKLYLVLAFINGG--ELFHHLQREGRFDLSRAR 96
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK--KYRDPTTNRH 190
+++ +E +H ++RD+KP+N L+ + + DFGL K D TN
Sbjct: 97 FYTAELLCALENLHKFNVIYRDLKPENILLDY---QGHIALCDFGLCKLNMKDDDKTN-- 151
Query: 191 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238
GT Y + LG ++ D +LG VLLY + LP
Sbjct: 152 -------TFCGTPEYLAPELLLGHGYTKAVDWWTLG-VLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 31/173 (17%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
KLG IG G FG++ L + + VAVK +++ T L EA V L+ + ++L+
Sbjct: 9 KLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL 128
+ ++ +T + G ++ L R +L
Sbjct: 67 GVVLQGNPLYIVTEYMAK-------------------------GSLVDYLRSRGRAVITL 101
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
L A + +EY+ + F+HRD+ N L+ + + DFGLAK+
Sbjct: 102 AQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 29/169 (17%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
R+IG GSFG ++ A V TNE+VA+K ++ Y K Q K + ++ V
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIK---------KMSYSGK-----QSNEKWQDIIKEV 76
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKT 130
F + +I++ G ++ LV++ S DL ++
Sbjct: 77 K----------FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE 126
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + + + Y+HS +HRDIK N L+ + QV + DFG A
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLL------YEAKVYKIL 59
L R++G G+FG++FLA S +VAVK K P L EA++ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 64
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF 119
Q ++ D L ++F G N K+ G D ++++D G +
Sbjct: 65 QHEHIVKFYGVCGDG---DPLIMVFEYMKHGDLN-KFLRAHGPDAMILVD--GQPRQ--- 115
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + L +L +A Q+ + + Y+ S+ F+HRD+ N L+G V I DFG++
Sbjct: 116 --AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS 170
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLP 238
RD + + YR + R+ + + + + D+ S G +L F G P
Sbjct: 171 ---RDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
Query: 239 W 239
W
Sbjct: 226 W 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 32/120 (26%), Positives = 53/120 (44%), Gaps = 16/120 (13%)
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--Y 182
+F A ++I ++++H +G ++RD+K DN L+ K + I DFG+ K+
Sbjct: 92 RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMN 148
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 241
+ + GT Y + G + + D S G VLLY L G P+ G
Sbjct: 149 GEGKAS---------TFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 30/176 (17%)
Query: 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKI 65
K +++G G FG++ L + +T E VAVK
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVK----------------SLNHSGEEQHR 50
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRR 124
F + I+ L G+ G L+++ L SL D R
Sbjct: 51 S--DFEREIEILRTLDHENIVKYKGVC----EKPGGRSLRLIMEYLPSGSLRDYLQRHRD 104
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ +LK +L+ + Q+ ++Y+ S+ ++HRD+ N L+ + V I DFGLAK
Sbjct: 105 QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 55/299 (18%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+L K+G G FGE+++ + T + VA+K GT P+ L EA++ K L+ + L
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL- 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGP-SLEDLFVYCRRKF 126
Y V E+ + +V + +G SL D K+
Sbjct: 67 ----------------------------YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKY 98
Query: 127 -SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRD 184
L ++ +A Q+ + Y+ ++HRD++ N L+G N V I DFGLA+ D
Sbjct: 99 LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADFGLARLIED 154
Query: 185 PTTNRHIPYRENK-NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGL 242
N + + K + TA A+ I + D+ S G +L + +G +P+ G+
Sbjct: 155 ---NEYTARQGAKFPIKWTAPEAALYGRFTI----KSDVWSFGILLTELVTKGRVPYPGM 207
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
++ +++ E+ P C P C D+RP + +++ D
Sbjct: 208 ---VNREVLEQV-ERGYRMPCPQGC---PESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 62/247 (25%), Positives = 98/247 (39%), Gaps = 42/247 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG GSFG++ LA H + AVK+ K E K I+ ++ +++ +V H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQK--HIM---AERNVLLKNVKH 55
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVL 132
+ L F + + VLD + +LF + +R+ F
Sbjct: 56 PFLVGLHYSFQTA--------------DKLYFVLDYVNGG--ELFFHLQRERSFPEPRAR 99
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP--TTNRH 190
A ++ + + Y+HS ++RD+KP+N L+ V + DFGL K+ + TT+
Sbjct: 100 FYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKTTS-- 154
Query: 191 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 250
GT Y + R D LG VL L G P+ A +
Sbjct: 155 -------TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EM 204
Query: 251 YDKICEK 257
YD I K
Sbjct: 205 YDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 8/107 (7%)
Query: 106 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165
LV + L L+ C ++ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 166 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 207
+ ++ + DFGLA+ PT +N + YR L G+ Y++
Sbjct: 139 -ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 31/167 (18%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G+FGE+ L DT I A+KI + +L + +V I R ++ D
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKI----LRKADMLEKEQVAHI----RAERDILVEADG 60
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL---KTV 131
+ + F D + L+++ L D+ +K +L T
Sbjct: 61 AWVVKMFYSFQ--------------DKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQ 104
Query: 132 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+A+ ++A I+ +H GF+HRDIKPDN L+ V + DFGL
Sbjct: 105 FYIAETVLA-IDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 53/239 (22%), Positives = 109/239 (45%), Gaps = 40/239 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKI 65
++L + +G+G++G++FL V D+ ++ A+K+ T ++ +AK + + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKAT----IVQKAKTTEHTRTERQ- 56
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYC-- 122
V+ H F TL Y + + L+LD + +LF +
Sbjct: 57 ---------VLEHIRQSPFLVTLH-------YAFQTDTKLHLILDYINGG--ELFTHLSQ 98
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
R +F + V + + +++ +E++H G ++RDIK +N L+ V + DFGL+K++
Sbjct: 99 RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF 155
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPW 239
+ R + GT Y + + G + + D S+G ++ L G+ P+
Sbjct: 156 HEDEVERAY------SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 46/237 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY KIG G+ G +F A V T + VA+K N LQ K L
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-----------------LQKQPKKEL 62
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI----KWYGVDGEDNVLVLDLLGPSLEDLFV-YC 122
++ + +++ L PNI + V E V++ L G SL D+ C
Sbjct: 63 IINEI--LVMKELKN---------PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC 111
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+ + V + + +E++H+ +HRDIK DN L+G+ V + DFG +
Sbjct: 112 MDEAQIAAV---CRECLQALEFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQI 165
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
+ R + GT + + + D+ SLG + + + G P+
Sbjct: 166 TPEQSKR-------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G+FGE+ L DT + A+KI + +L + +V I R ++ D
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKI----LRKADMLEKEQVGHI----RAERDILVEADS 60
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL---KTV 131
+ + + F L + L+++ L D+ +K +L +T
Sbjct: 61 LWVVKMFYSFQDKL--------------NLYLIMEFLPGG--DMMTLLMKKDTLTEEETQ 104
Query: 132 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+A+ ++A I+ +H GF+HRDIKPDN L+ V + DFGL
Sbjct: 105 FYIAETVLA-IDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 18/75 (24%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 181
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 182 YRDPTTNRHIPYREN 196
YR P + Y+EN
Sbjct: 183 YRAPEVILGMGYKEN 197
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 55/228 (24%), Positives = 107/228 (46%), Gaps = 40/228 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
KIG GS G + +A+ T + VAVK ++ + +LL+ V I++ +H
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV--IMRD--------YHH 78
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTV 131
++V+ +++S Y V E V++ L G +L D+ + R + + TV
Sbjct: 79 ENVVD-----MYNS----------YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV 123
Query: 132 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 191
+ ++ + Y+H++G +HRDIK D+ L+ ++ + DFG + ++ +
Sbjct: 124 CL---SVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQ-----VSKEV 172
Query: 192 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
P R K+L GT + + + D+ SLG +++ + G P+
Sbjct: 173 PKR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 42/186 (22%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGS 63
+ KY + IG G++G + A + +TNE VA+K I N+ + K+L+
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR--- 59
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
H+DH + A+ I P + D +V +L+ L +
Sbjct: 60 -------HLDHENVIAIKDIMP------PPHR---EAFNDVYIVYELMDTDLHQI----- 98
Query: 124 RKFSLKTVLMLAD--------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYII 174
+++ L+D Q++ ++Y+HS LHRD+KP N L+ AN + I
Sbjct: 99 ----IRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKIC 150
Query: 175 DFGLAK 180
DFGLA+
Sbjct: 151 DFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 37/173 (21%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
R+IG GSFG ++ A V TNE+VA+K ++ Y K Q K + ++ V
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIK---------KMSYSGK-----QSNEKWQDIIKEV 66
Query: 73 D--HVIIHALTIIFSSTLGGIPNIK----WYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF 126
+ H TI + ++ W LV++ S D+ ++
Sbjct: 67 RFLQQLRHPNTIEYKGCY-----LREHTAW---------LVMEYCLGSASDILEVHKKPL 112
Query: 127 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + + + Y+HS +HRDIK N L+ + V + DFG A
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 45/206 (21%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSKIRLV- 68
KIG G++G ++ + T +IVA+K +E+ P + E + K LQ + + L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 69 VFHVD---HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 125
V + ++I L++ L +P ++ + L ++Y
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--------------MDAELVKSYLY---- 108
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
Q++ I + HSR LHRD+KP N L+ + + DFGLA+ + P
Sbjct: 109 -----------QILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIP 154
Query: 186 T---TNRHIP--YRENKNLTGTARYA 206
T+ + YR + L G+ RY+
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 5e-05
Identities = 13/30 (43%), Positives = 24/30 (80%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK 38
YK+ +++G G+FG ++LA + +T E+VA+K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK 30
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 54/246 (21%), Positives = 97/246 (39%), Gaps = 54/246 (21%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
++L R +G+G++G++FL V D ++ A+K+ T +H + E +V +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT--ERQVLE 59
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLED 117
++ LV H L +I GG +
Sbjct: 60 AVRRCP--FLVTLHYAFQTDTKLHLILDYVNGG--------------------------E 91
Query: 118 LF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
LF +Y R F+ V + +++ ++++H G ++RDIK +N L+ V + D
Sbjct: 92 LFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTD 148
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD--DLESLGYVLLYFL 233
FGL+K++ R + GT Y + G D SLG + L
Sbjct: 149 FGLSKEFLAEEEERAYSF------CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
Query: 234 RGSLPW 239
G+ P+
Sbjct: 203 TGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 40/234 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY KIG G+ G ++ A + T + VA+K N LQ K L
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-----------------LQQQPKKEL 62
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRK 125
II+ + ++ + I N + Y V E V++ L G SL D+ C +
Sbjct: 63 --------IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 114
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
+ V + + ++++HS +HRDIK DN L+G+ V + DFG +
Sbjct: 115 GQIAAV---CRECLQALDFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE 168
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
+ R + GT + + + D+ SLG + + + G P+
Sbjct: 169 QSKR-------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 35/184 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
+Y+ +IG G++G ++ A + VA V+++ + P + E + K L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE--- 57
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYC 122
DH I L + +++ D E V LV + + +DL Y
Sbjct: 58 -------AFDHPNIVRLMDVCATSR----------TDRETKVTLVFEHVD---QDLRTYL 97
Query: 123 RR----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ +T+ L Q + ++++H+ +HRD+KP+N L+ G QV + DFGL
Sbjct: 98 DKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGL 154
Query: 179 AKKY 182
A+ Y
Sbjct: 155 ARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 50/235 (21%)
Query: 13 RKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFH 71
R +G+GSFG + LA++ + + VA+K ++K+ K Q
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIK----------RFEKSKIIKQKQ----------- 74
Query: 72 VDHV-----IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR-- 124
VDHV I++ + F L YG +++ L L L + F + RR
Sbjct: 75 VDHVFSERKILNYINHPFCVNL--------YGSFKDESYLYLVLEFVIGGEFFTFLRRNK 126
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
+F A Q++ EY+ S ++RD+KP+N L+ K + + DFG AK
Sbjct: 127 RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAK---- 179
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
+ L GT Y + L + + D +LG + L G P+
Sbjct: 180 ------VVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 34/178 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRL- 67
KL +K+G+G FGE+++ + ++ + VAVK GT Q L EA + K LQ +RL
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 68 -VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF 126
VV + + I I Y G +LD L K
Sbjct: 68 AVVTKEEPIYI----------------ITEYMAKGS----LLDFLKSDEGG-------KV 100
Query: 127 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
L ++ + Q+ + Y+ + ++HRD++ N L+ ++ I DFGLA+ D
Sbjct: 101 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 30/119 (25%), Positives = 57/119 (47%), Gaps = 14/119 (11%)
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
+F L A +++ ++++HS+G ++RD+K DN ++ + + I DFG+ K+
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKEN-- 146
Query: 185 PTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ +N+ T GT Y + G++ + D S G +L L G P+ G
Sbjct: 147 -------VFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 57/279 (20%)
Query: 13 RKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKI---R 66
+ +G G +G++F V DT +I A+K+ L +A + + + + R
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKV----------LKKATIVRNQKDTAHTKAER 51
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK- 125
++ V H I L F + GG K Y L+L+ L +LF++ R+
Sbjct: 52 NILEAVKHPFIVDLIYAFQT--GG----KLY--------LILEYLSGG--ELFMHLEREG 95
Query: 126 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
F T ++ +E++H +G ++RD+KP+N L+ V + DFGL K+
Sbjct: 96 IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIH 152
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244
T H GT Y + + + D SLG ++ L G+ P+ A
Sbjct: 153 EGTVTH-------TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT---A 202
Query: 245 ATKKQKYDKICEKKVSTP----------IEVLCKSHPAE 273
+K+ DKI + K++ P ++ L K +P+
Sbjct: 203 ENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS 241
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 30/240 (12%)
Query: 11 LGRKIGSGSFGEIFLASHVD-----TNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
L R++G G+FG++FLA + +VAVK + S EA++ LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--- 65
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
+V F+ V L ++F G N K+ G D VL+ + P+
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLN-KFLRAHGPDAVLMAEGNRPA--------- 115
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
+ + +L +A Q+ A + Y+ S+ F+HRD+ N L+G + V I DFG++ R
Sbjct: 116 -ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---R 168
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 242
D + + YR + R+ + + + + D+ SLG VL F G PW L
Sbjct: 169 DVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 27/180 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
+G G FGE+ + T +I A+K+ K LL + V F +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKV----MKKSVLLAQETV-------------SFFEEE 51
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM 133
I ++ S IP +++ D ++ LV++ G L L +F
Sbjct: 52 RDILSI-----SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF 106
Query: 134 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIP 192
+++ I VH G++HRDIKP+N L+ + + + DFG A + + N +P
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTANKMVNSKLP 163
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 45/192 (23%), Positives = 73/192 (38%), Gaps = 50/192 (26%)
Query: 12 GRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGT--------------KHPQLLYEAK 54
G K+G G++G ++ A D E +IE +G KHP ++ K
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 55 VYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPS 114
V+ + K+ L+ + +H + H + +S P
Sbjct: 66 VF-LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP---------------------- 102
Query: 115 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYI 173
+ V L Q++ I Y+H+ LHRD+KP N L MG G + +V I
Sbjct: 103 ---------MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153
Query: 174 IDFGLAKKYRDP 185
D G A+ + P
Sbjct: 154 ADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 20/67 (29%), Positives = 34/67 (50%), Gaps = 5/67 (7%)
Query: 117 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DLF Y R L+ + + +++ + Y+H RG +HRD+K +N + + +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLG 227
Query: 175 DFGLAKK 181
DFG A K
Sbjct: 228 DFGAACK 234
|
Length = 392 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 94 IKWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 150
I+ YGV + +V +L LG L+ L F + T+ A Q+ + Y+ S+ F
Sbjct: 59 IRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+HRD+ N L+ K V I DFGL +
Sbjct: 119 IHRDLAARNILLASDDK---VKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 29/169 (17%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
R+IG GSFG ++ A V +E+VA+K ++ Y K Q K + ++ V
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIK---------KMSYSGK-----QSNEKWQDIIKEV 66
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKT 130
F L I++ G ++ LV++ S DL ++
Sbjct: 67 R----------FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + + + Y+HS +HRD+K N L+ + V + DFG A
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 54/185 (29%)
Query: 11 LGRKIGSGSFGEIFLASHVD-TNEIVAV-----KIENSGTKHPQLLYEAKVYKILQGGSK 64
LGR IG G FG+++ ++ NE +AV K S + + L EA + +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF----- 64
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDL-----LGPSLED 117
DH P+I K GV E+ V +V++L L L+
Sbjct: 65 --------DH-----------------PHIVKLIGVITENPVWIVMELAPLGELRSYLQ- 98
Query: 118 LFVYCRRKFSLK--TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
K+SL ++++ + Q+ + Y+ S+ F+HRDI N L+ + V + D
Sbjct: 99 -----VNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGD 150
Query: 176 FGLAK 180
FGL++
Sbjct: 151 FGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
KIG GS G + +A + VAVK+ + + +LL+ V I++ +V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV--IMRDYQHQNVVEMY- 84
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL 132
K Y V E VL+ L G +L D+ R + + +
Sbjct: 85 ----------------------KSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIA 120
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLAKKYRDPTTNRHI 191
+ + ++ + Y+HS+G +HRDIK D+ L+ L GR V + DFG + ++ +
Sbjct: 121 TVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQ-----ISKDV 171
Query: 192 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
P R K+L GT + + D+ SLG +++ + G P+
Sbjct: 172 PKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 30/214 (14%)
Query: 1 MERIIGVKYK-LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
M I +Y G +G G++G++ A T +IVA+K KV KI+
Sbjct: 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIK---------------KV-KII 45
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI--PNI----KWYGVDGEDNVLVLDLLGP 113
+ + + V IH T+ + I NI Y V+G+ LV+D++
Sbjct: 46 EISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY-VEGDFINLVMDIMAS 104
Query: 114 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
L+ + + + + V + Q++ + +H F+HRD+ P N + I
Sbjct: 105 DLKKVV-DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKI 160
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 207
DFGLA++Y P + +++ + S
Sbjct: 161 ADFGLARRYGYPPYSD--TLSKDETMQRREEMTS 192
|
Length = 335 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 38/181 (20%)
Query: 13 RKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
R +G G FG++ L + +T E VAVK + + K +IL+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN------- 62
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN----VLVLDLL-GPSLEDLFVYCR 123
++H + V K+ G+ ED L+++ L SL++ +
Sbjct: 63 LYHENIV-------------------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK 103
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
K +LK L A Q+ ++Y+ SR ++HRD+ N L+ +QV I DFGL K
Sbjct: 104 NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE 160
Query: 184 D 184
Sbjct: 161 T 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 54/191 (28%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAV-KIENSGTKHPQL----LYEAKVYKIL 59
+G +Y+ IG G++G + A+H T VA+ KI S +H L E K+ +
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILR-- 58
Query: 60 QGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
H II L II + D +V +L+ L L
Sbjct: 59 -----------RFKHENIIGILDIIRPPSFESF----------NDVYIVQELMETDLYKL 97
Query: 119 FVYCRRKFSLKTVLMLAD--------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN- 169
+KT L++ Q++ ++Y+HS LHRD+KP N L+ N
Sbjct: 98 ---------IKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNC 143
Query: 170 QVYIIDFGLAK 180
+ I DFGLA+
Sbjct: 144 DLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 40/256 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+++ + IG G+FGE+ + + +++ A+KI N ++L A+ + R V
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW----EMLKRAETACFREE----RDV 54
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL-LGPSLEDLFVYCRRKFS 127
+ + D+ I L F D + LV+D +G L L +
Sbjct: 55 LVNGDNQWITTLHYAFQ--------------DENNLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 187
+M+ I+ VH ++HRDIKPDN LM + + + DFG K + T
Sbjct: 101 EDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT 157
Query: 188 NRHIPYRENKNLTGTARYASCNTHLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGL 242
++ GT Y S +E + D SLG + L G P+
Sbjct: 158 ------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-- 209
Query: 243 KAATKKQKYDKICEKK 258
A + + Y KI K
Sbjct: 210 -AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 16/39 (41%), Positives = 23/39 (58%), Gaps = 3/39 (7%)
Query: 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
I+ +H G++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 47/225 (20%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 196
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+ T+ PY
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART--AGTSFMMTPY--- 185
Query: 197 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 256
T Y + LG+ D+ S+G ++ ++G + + G +++K+ E
Sbjct: 186 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIE 239
Query: 257 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 316
++ TP K +Y + RP Y GY F+ +F
Sbjct: 240 -QLGTPCPEFMKKLQPTVRTY--------VENRPKYA-------------GYSFEKLFPD 277
Query: 317 TIL----KYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDA 357
+ ++ + + ++++DLL S+++ + K V++A
Sbjct: 278 VLFPADSEHNKLKASQARDLL-------SKMLVIDASKRISVDEA 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 43/247 (17%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKIL 59
V ++LG+ +G G+FGE++L DT +AVK + + + L E ++ K L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI--PNIKWYGVDGEDNVLVLDLLGPSLED 117
+ ++ D L+I GG +K YG E+
Sbjct: 62 RHDRIVQYYGCLRDPEE-KKLSIFVEYMPGGSIKDQLKAYGALTEN-------------- 106
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
R+++ Q++ + Y+HS +HRDIK N L A V + DFG
Sbjct: 107 ----VTRRYT--------RQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFG 151
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237
+K+ + + K++TGT + S G R+ D+ S+ ++ L
Sbjct: 152 ASKRIQ----TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
Query: 238 PWQGLKA 244
PW +A
Sbjct: 208 PWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 59/263 (22%), Positives = 105/263 (39%), Gaps = 60/263 (22%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+K+ +K+G GS+G ++ + N+ A+K + G+ + +A ++IR++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--------NEIRIL 53
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRK 125
V+H PNI Y +DG N L + + DL ++
Sbjct: 54 A-SVNH-----------------PNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKR 93
Query: 126 FSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYII-DF 176
+ ++ +Q I RI + +H + LHRD+K N L AN + I D
Sbjct: 94 KKKRK--LIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANIL----LVANDLVKIGDL 147
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236
G++K + I GT Y + G S + D+ SLG +L +
Sbjct: 148 GISKVLKKNMAKTQI---------GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
Query: 237 LPWQG-----LKAATKKQKYDKI 254
P++ L+ ++ KY I
Sbjct: 199 PPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + IE VH GF+HRDIKPDN L+ + + + DFGL+
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 102 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161
+D LV++L+ +L + + + + + L QM+ I+++HS G +HRD+KP N +
Sbjct: 95 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 221
+ + + I+DFGLA+ T+ PY T Y + LG+ D
Sbjct: 152 V---KSDCTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVD 200
Query: 222 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 281
+ S+G ++ +R + + G +++K+ E ++ TP K +Y
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 252
Query: 282 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 334
+ RP Y L F LF + D ++ + + ++++DLL P
Sbjct: 253 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 299
Query: 335 ASRVT 339
A R++
Sbjct: 300 AKRIS 304
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 42/241 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G FGE++ DT ++ A+K + K K+ QG + ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKC-----------LDKKRIKMKQGET------LALNE 44
Query: 75 VIIHALTIIFSSTLGGIPNI--KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLK 129
I+ +L + G P I Y D + +LDL+ DL + + FS K
Sbjct: 45 RIMLSLV-----STGDCPFIVCMTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEK 97
Query: 130 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 189
+ A ++I +E++H+R ++RD+KP N L+ + V I D GLA + +
Sbjct: 98 EMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHA 154
Query: 190 HIPYRENKNLTGTARYASCNT-HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 248
+ GT Y + G D SLG +L LRG P++ K K
Sbjct: 155 SV---------GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
Query: 249 Q 249
+
Sbjct: 206 E 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 68/261 (26%), Positives = 104/261 (39%), Gaps = 44/261 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y++ +KIG GSFG+I+LA +E +K E TK P EA SK +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIK-EIDLTKMPVKEKEA---------SKKEV 50
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-- 125
++ + H + F ++ E+ L + + DL R+
Sbjct: 51 ILLAK---MKHPNIVTFFASFQ------------ENGRLFIVMEYCDGGDLMKRINRQRG 95
Query: 126 --FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKY 182
FS +L Q+ ++++H R LHRDIK N FL G A + DFG+A++
Sbjct: 96 VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQL 152
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
D GT Y S + + D+ SLG VL P++G
Sbjct: 153 NDSM-------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG- 204
Query: 243 KAATKKQKYDKICEKKVSTPI 263
Q KIC+ + PI
Sbjct: 205 --NNLHQLVLKICQGYFA-PI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 38/190 (20%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
KIG GS G + +A+ T VAVK + + +LL+ V I++ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV--IMRD--------YQH 75
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL 132
+++ ++SS L V E V++ L G +L D+ + R + + +
Sbjct: 76 PNIVE-----MYSSYL----------VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIA 118
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 192
+ ++ + ++H++G +HRDIK D+ L+ +V + DFG + ++ +P
Sbjct: 119 TVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVP 170
Query: 193 YRENKNLTGT 202
R K+L GT
Sbjct: 171 RR--KSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 6/66 (9%)
Query: 117 DLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
DL+ Y + L V +A Q+++ I+Y+H G +HRDIK +N L+ + +
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICL 301
Query: 174 IDFGLA 179
DFG A
Sbjct: 302 GDFGAA 307
|
Length = 461 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 45/178 (25%)
Query: 15 IGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+G G+FG + L + +T E+VAVK +++S +H + E ++ K LQ
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-------- 63
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGV---DGEDNV-LVLDLLGP--SLEDLFVYC 122
H I +K+ GV G N+ LV++ L P SL D
Sbjct: 64 -----HDNI----------------VKYKGVCYSAGRRNLRLVMEYL-PYGSLRDYLQKH 101
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
R + + +L+ A Q+ +EY+ S+ ++HRD+ N L+ N+V I DFGL K
Sbjct: 102 RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 42/196 (21%)
Query: 1 MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
MER I +K+KLG G +GE++ + VAVK ++ + + L EA V K
Sbjct: 3 MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 58
Query: 59 LQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
++ + ++L+ + +T + YG +L
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMT-----------YG------------------NL 89
Query: 119 FVYCRR--KFSLKTVLML--ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
Y R + + V++L A Q+ + +EY+ + F+HRD+ N L+G + + V +
Sbjct: 90 LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVA 146
Query: 175 DFGLAKKYRDPTTNRH 190
DFGL++ T H
Sbjct: 147 DFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 61/195 (31%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGT--------------KHPQLL 50
+K K+G G++ ++ + T EIVA+K + GT KH ++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 51 YEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL 110
+++ ++ +K+ LV ++D ++K Y +D LD
Sbjct: 62 ---RLHDVIHTENKLMLVFEYMDK------------------DLKKY-MDTHGVRGALD- 98
Query: 111 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 170
P+ F Y Q++ I + H LHRD+KP N L+ K +
Sbjct: 99 --PNTVKSFTY---------------QLLKGIAFCHENRVLHRDLKPQNLLIN---KRGE 138
Query: 171 VYIIDFGLAKKYRDP 185
+ + DFGLA+ + P
Sbjct: 139 LKLADFGLARAFGIP 153
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 73/298 (24%)
Query: 14 KIGSGSFGEIF--LASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIRL 67
++GSG+FG + + + + VAVKI + P +LL EA V + L +R+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL--LGPSLEDLFVYCRRK 125
+ GI + E +LV++L LGP + F+ +
Sbjct: 62 I---------------------GI-------CEAESWMLVMELAELGPL--NKFLQKNKH 91
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY--IIDFGLAK--- 180
+ K + L Q+ ++Y+ F+HRD+ N L+ Q Y I DFGL+K
Sbjct: 92 VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL-----VTQHYAKISDFGLSKALG 146
Query: 181 ---KYRDPTTNRHIPYRENKNLTGTARYA-SCNTHLGIEQSRRDDLESLGYVLLY--FLR 234
Y T+ P + YA C + S + D+ S G VL++ F
Sbjct: 147 ADENYYKAKTHGKWPVK---------WYAPECMNYYKF--SSKSDVWSFG-VLMWEAFSY 194
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292
G P++G+K Q + +++ P + P E C + D+RP +
Sbjct: 195 GQKPYKGMKGNEVTQMIES--GERMECP-----QRCPPEMYDLMKLCWTYGVDERPGF 245
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 191
+L Q++ ++ VHSR +HRD+K N FLM G + + DFG +K+Y D +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 192 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 32/130 (24%), Positives = 53/130 (40%), Gaps = 11/130 (8%)
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
F + A Q+I +E++H R ++RD+KP+N L+ V I D GLA + +
Sbjct: 90 PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELK 146
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243
K GT Y + G D +LG L + G P++ K
Sbjct: 147 GGKK--------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198
Query: 244 AATKKQKYDK 253
+K++ +
Sbjct: 199 EKVEKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 21/143 (14%)
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-- 181
+F A +++ ++++H RG ++RD+K DN L+ + I DFG+ K+
Sbjct: 91 GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGI 147
Query: 182 -YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 239
T GT Y + D +LG VLLY L G P+
Sbjct: 148 LGGVTT----------STFCGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSPF 196
Query: 240 QGLKAATKKQKYDKICEKKVSTP 262
+G + + + I E +V P
Sbjct: 197 EG---DDEDELFQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKI 65
++L + +G+G++G++FL V DT ++ A+K+ + L+ +AK ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKV----LQKAALVQKAKT---VEHTRTE 54
Query: 66 RLVVFHVDH----VIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLF- 119
R V+ HV V +H Y E + L+LD + S ++F
Sbjct: 55 RNVLEHVRQSPFLVTLH------------------YAFQTEAKLHLILDYV--SGGEMFT 94
Query: 120 -VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+Y R FS V + ++I +E++H G ++RDIK +N L+ V + DFGL
Sbjct: 95 HLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGL 151
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSL 237
+K++ R + GT Y + G + D SLG ++ L G+
Sbjct: 152 SKEFLSEEKERTYSF------CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
Query: 238 PW 239
P+
Sbjct: 206 PF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
Q++ ++Y+HS LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 15/130 (11%)
Query: 112 GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168
G SL+ ++ +++ K + +A+ ++ + Y+HSR +HRDIKP N L+ +
Sbjct: 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRK 141
Query: 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228
QV + DFG++ + + TGT+ Y + G S D+ SLG
Sbjct: 142 GQVKLCDFGVSGELVNSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLT 192
Query: 229 LLYFLRGSLP 238
LL + P
Sbjct: 193 LLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 185
Q++ I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 44/184 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ IG GS+G + A T E VA+K N +H ++L E K+ ++L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR--- 57
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI----KWYGVDGEDNVLVLDLLGPSLEDLF 119
H D I+ I+ + +I + D + D L P F
Sbjct: 58 -------HPD--IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF 108
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN---QVYIIDF 176
+Y Q++ ++Y+H+ HRD+KP N L AN ++ I DF
Sbjct: 109 LY---------------QLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDF 147
Query: 177 GLAK 180
GLA+
Sbjct: 148 GLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 24/93 (25%), Positives = 48/93 (51%), Gaps = 14/93 (15%)
Query: 89 GGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 147
G+P Y VD E+ +V++ + G L+D+ ++ +++A++ H
Sbjct: 396 AGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG------NPELVRKVGEIVAKL---HK 446
Query: 148 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
G +H D+ NF++ + +++Y+IDFGL K
Sbjct: 447 AGIVHGDLTTSNFIV----RDDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 34/168 (20%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G+FGE+ + +T ++ A+KI N ++L A+ + R V+ + D
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREE----RDVLVNGDR 60
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL-LGPSLEDLFVYCRRKFSLKTVLM 133
I L F D + LV+D +G L L KF +
Sbjct: 61 RWITNLHYAFQ--------------DENNLYLVMDYYVGGDLLTLL----SKFEDRLPED 102
Query: 134 LAD----QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
+A +M+ I+ VH G++HRDIKPDN L+ K + + DFG
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 13/129 (10%)
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
F + L A +++ +E +H ++RD+KP+N L+ + I D GLA K
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVK---- 151
Query: 186 TTNRHIPYREN-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244
IP E+ + GT Y + + D LG ++ + G P++G K
Sbjct: 152 -----IPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
Query: 245 ATKKQKYDK 253
K+++ D+
Sbjct: 207 KVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 22/69 (31%), Positives = 40/69 (57%), Gaps = 11/69 (15%)
Query: 114 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
SL ++ Y + ++K + ++ ++Y+H G +HRD+KPDN L+ +N+ +I
Sbjct: 93 SLLHIYGYFDEEMAVKYI----SEVALALDYLHRHGIIHRDLKPDNMLI-----SNEGHI 143
Query: 174 --IDFGLAK 180
DFGL+K
Sbjct: 144 KLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 15/100 (15%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 193
Q++ + +VHS+ +HRDIK N L+ GL V + DFG +K Y ++
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSD----- 199
Query: 194 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233
+ GT Y + S++ D+ SLG VLLY L
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 62/250 (24%), Positives = 94/250 (37%), Gaps = 44/250 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG GSFG++ LA + AVK+ +++ K K + + L +V H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKV-----LQKKIVLNRKEQKHIMAERNVLLK--NVKH 55
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVL 132
+ L F +T E VLD + +LF + + R F
Sbjct: 56 PFLVGLHYSFQTT--------------EKLYFVLDFVNGG--ELFFHLQRERSFPEPRAR 99
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNR 189
A ++ + + Y+HS ++RD+KP+N L+ V + DFGL K+ D TT
Sbjct: 100 FYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDTTT-- 154
Query: 190 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 249
GT Y + D LG VL L G P+ A +
Sbjct: 155 --------TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---E 203
Query: 250 KYDKICEKKV 259
YD I K +
Sbjct: 204 MYDNILHKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 14/126 (11%)
Query: 117 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+LF + R+ F+ + ++++ +EY+HSR ++RDIK +N ++ K + I
Sbjct: 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKIT 137
Query: 175 DFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233
DFGL K+ D T + GT Y + + R D LG V+ +
Sbjct: 138 DFGLCKEGISDGATMK--------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 234 RGSLPW 239
G LP+
Sbjct: 190 CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 24/171 (14%), Positives = 58/171 (33%), Gaps = 36/171 (21%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
+ + G ++L +E +KI S K E + ++L
Sbjct: 4 KLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLAR----------- 50
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTV 131
+ +P + G + L+++ + G +L+++ + + +
Sbjct: 51 -KGLP-------------VPKVLASGESDGWSYLLMEWIEGETLDEV-----SEEEKEDI 91
Query: 132 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+++A++ + H D+ P N L+ + IID+ A
Sbjct: 92 AEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 10/83 (12%)
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNR 189
V + Q++ + Y+H + LHRD+KP N L+ LG ++ + DFGLA+ P+
Sbjct: 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG----ELKLADFGLARAKSIPSQTY 160
Query: 190 H-----IPYRENKNLTGTARYAS 207
+ YR L G Y+S
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSS 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 9e-04
Identities = 36/128 (28%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 196
Q+I+ +E++H R ++RD+KP+N L+ V I D GLA + +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 197 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKI 254
K GT + + G E D +LG L + RG +G K K+ K +I
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRI 213
Query: 255 CEKKVSTP 262
V+ P
Sbjct: 214 LNDSVTYP 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 45/178 (25%)
Query: 13 RKIGSGSFGEIFLASHVDTN--EI-VAVKI---ENSGTKHPQLLYEAKVYKILQGGSKIR 66
+++G G+FG + ++ + E+ VAVK E+ + L EA V L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL------- 53
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYC 122
DH P I + GV GE +LV++L LGP L+ ++
Sbjct: 54 ------DH-----------------PCIVRLIGVCKGEPLMLVMELAPLGPLLK--YLKK 88
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
RR+ + + LA Q+ + Y+ S+ F+HRD+ N L+ +Q I DFG+++
Sbjct: 89 RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 97 YGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155
Y VD E+ ++V++ + G L+DL + +++ ++ HS G +H D+
Sbjct: 67 YFVDPENFIIVMEYIEGEPLKDLIN--SNGMEELELSREIGRLVGKL---HSAGIIHGDL 121
Query: 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
N ++ ++Y+IDFGLA+ +D
Sbjct: 122 TTSNMIL----SGGKIYLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 11/94 (11%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 195
Q+I I + H +HRDIKP+N L+ N V + DFG A+ + + + Y
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLI----SHNDVLKLCDFGFARNLSEGSNANYTEY-- 161
Query: 196 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229
T Y S LG + D+ S+G +L
Sbjct: 162 ----VATRWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 65/312 (20%), Positives = 112/312 (35%), Gaps = 88/312 (28%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSKIRLVVFH 71
IG G+FG + H + I+AVK + +LL + V I
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI------ 65
Query: 72 VDHVIIHALTIIFSSTLGGIPNIKWYGV---DGEDNVLVLDLLGPSLEDL--FVYCRRKF 126
+K+YG +G D + ++L+ SL+ +VY K
Sbjct: 66 ----------------------VKFYGALFREG-DCWICMELMDISLDKFYKYVYEVLK- 101
Query: 127 SLKTVLMLADQMIARIEYVHSRGF---------LHRDIKPDNFLMGLGRKANQVYIIDFG 177
++ ++++ +I + +HRD+KP N L L R N + + DFG
Sbjct: 102 -----SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL--LDRNGN-IKLCDFG 153
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRD------DLESLGYV 228
++ + D R A C ++ I+ S RD D+ SLG
Sbjct: 154 ISGQLVDSIAK--------------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199
Query: 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFA----SYFHYCQSL 284
L G P+ + +D++ + V +L S EF+ ++ + C
Sbjct: 200 LYEVATGKFPYPKWNSV-----FDQLTQ-VVKGDPPILSNSEEREFSPSFVNFINLCLIK 253
Query: 285 TFDQRPDYGFLK 296
+RP Y L
Sbjct: 254 DESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 12/48 (25%), Positives = 25/48 (52%), Gaps = 7/48 (14%)
Query: 138 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
++ ++ H G +H D+ N ++ +++Y+IDFGL K +
Sbjct: 102 LVGKL---HKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEI 142
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 60/256 (23%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
+ LG+ +G G FG++ +A + ++ VAVK +++ T L+ E ++ K
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGG-IPNIKWYGVDGEDNVLVLDLLGPSLE 116
++ I + ++ + T G + + Y G + P ++
Sbjct: 73 MIGKHKNI--------------INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 117 DLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
F C+ + + K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKI 175
Query: 174 IDFGLAK-----KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228
DFGLA+ Y TTN +P K + A + TH + D+ S G V
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-V 224
Query: 229 LLY--FLRGSLPWQGL 242
LL+ F G P+ G+
Sbjct: 225 LLWEIFTLGGSPYPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 17/45 (37%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+++ ++ +HS GF+HRD+KPDN L+ K+ + + DFG K
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
Q++ + +H G +HRDIKP+N L+ + QV IIDFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
Q++ ++++HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 49/180 (27%)
Query: 11 LGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIR 66
+++GSG FG + L +D VA+K+ G + EAKV L
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID----VAIKMIREGAMSEDDFIEEAKVMMKLS------ 57
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCR 123
H PN ++ YGV + +V + + + L Y R
Sbjct: 58 -----------H-------------PNLVQLYGVCTKQRPIFIVTEYM--ANGCLLNYLR 91
Query: 124 R---KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
K + +L + + +EY+ S GF+HRD+ N L+G + N V + DFGLA+
Sbjct: 92 ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 54/230 (23%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFH 71
G +G G++G ++ + +++AVK T + L E K Y+ LQ + + H
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSN-VLAAE-KEYEKLQEEVDLLKSLKH 61
Query: 72 VDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV 131
V+ ++ + T + +T+ +I V G +L+ GP E V+C+
Sbjct: 62 VN-IVQYLGTCLDDNTI----SIFMEFVPGGSISSILNRFGPLPE--PVFCK-------- 106
Query: 132 LMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 190
Q++ + Y+H+ +HRDIK +N LM G + +IDFG A++ H
Sbjct: 107 --YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRL--AWVGLH 158
Query: 191 IPYREN-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
+ K++ GT + + R+ D+ S+G + G P
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.001
Identities = 23/81 (28%), Positives = 40/81 (49%), Gaps = 8/81 (9%)
Query: 103 DNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159
+VL++D + DLF + K S V + Q++ + +H +H DIK +N
Sbjct: 83 GHVLIMDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLEN 139
Query: 160 FLMGLGRKANQVYIIDFGLAK 180
L R +++Y+ D+GL K
Sbjct: 140 VL--YDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 8/76 (10%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----I 191
Q++ + + HS LHRD+KP N L+ + + DFGLA+ + P T H +
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTL 164
Query: 192 PYRENKNLTGTARYAS 207
YR + L G Y++
Sbjct: 165 WYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 59/259 (22%), Positives = 107/259 (41%), Gaps = 36/259 (13%)
Query: 53 AKVYKIL--QGGSKIRLVVFHVDHVIIHALTIIFS--STLGGIPNI-KWYG-------VD 100
KV+K+L + GSK + + H I + ++ L PN+ K+YG +
Sbjct: 32 GKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91
Query: 101 GEDNVLVLDLL-GPSLEDL---FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156
G+ LVL+L G S+ DL F+ + + + + + ++++H +HRD+K
Sbjct: 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVK 151
Query: 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA-----SCNTH 211
+N L+ V ++DFG++ + T+ R R N ++ GT + +C
Sbjct: 152 GNNILLTTE---GGVKLVDFGVSAQL---TSTRL---RRNTSV-GTPFWMAPEVIACEQQ 201
Query: 212 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 271
L R D+ SLG + G P L K + + P +
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP-----ELWS 256
Query: 272 AEFASYFHYCQSLTFDQRP 290
EF + C + +++RP
Sbjct: 257 NEFNDFIRKCLTKDYEKRP 275
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 24/71 (33%), Positives = 41/71 (57%), Gaps = 7/71 (9%)
Query: 116 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
EDL ++ +L+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I D
Sbjct: 169 EDL---YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICD 222
Query: 176 FGLAKK-YRDP 185
FGLA+ Y+DP
Sbjct: 223 FGLARDIYKDP 233
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 59/254 (23%), Positives = 96/254 (37%), Gaps = 60/254 (23%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGSK 64
+++ KIG GSFG +F + A+K + + + + EA+V
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARV--------- 52
Query: 65 IRLVVFHVDHVIIHALTIIFSSTL-GGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
L ++I + + S L G NI Y +G+ + L+ G L + V+
Sbjct: 53 --LAKLDSSYIIRY-----YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW- 104
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK- 181
+F ++ +L LA ++HS+ LHRDIK N + + V I D G+AK
Sbjct: 105 --RFFIQILLGLA--------HLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLL 151
Query: 182 ---------------YRDPTTNRHIPYRENKNL--TGTARYASCNTHLGIEQSRRDDLES 224
Y P PY E ++ G Y C D +
Sbjct: 152 SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF------DANN 205
Query: 225 LGYVLLYFLRGSLP 238
G ++L +RG P
Sbjct: 206 QGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 60/283 (21%), Positives = 106/283 (37%), Gaps = 43/283 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y + R +G GSFG L HV++++ A+K + P K ++ K +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK----EIRLP------KSSSAVEDSRKEAV 50
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
++ + H I A F + G + + Y G+ + G + F
Sbjct: 51 LLAKMKHPNIVAFKESFEAD-GHLYIVMEYCDGGDLMQKIKLQRG-----------KLFP 98
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 187
T+L QM ++++H + LHRDIK N + + +V + DFG A+ P
Sbjct: 99 EDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA 155
Query: 188 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 247
GT Y + + + D+ SLG +L P+Q A +
Sbjct: 156 YAC-------TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ---ANSW 205
Query: 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
K K+C+ P+ P+ ++ F + P
Sbjct: 206 KNLILKVCQGSYK-PL-------PSHYSYELRSLIKQMFKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 36/168 (21%), Positives = 77/168 (45%), Gaps = 27/168 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVD 73
++G G+FG+++ A + +T + A K+ TK + L + V +I ++
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMV--------EIEILATCNH 68
Query: 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM 133
I+ L + W DG+ +++ G +++ + + R + + +
Sbjct: 69 PYIVKLLGAFY-----------W---DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114
Query: 134 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ QM+ ++Y+HS +HRD+K N L+ L + + DFG++ K
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 40/181 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY +KIG GSFG+ L + + +K N P+ E++ K
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR---------KEVA 51
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRR 124
V+ ++ H PNI Y E+N +V+D DL+
Sbjct: 52 VLSNMKH-----------------PNIVQYQESFEENGNLYIVMDYCEGG--DLYKKINA 92
Query: 125 K----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLA 179
+ F +L Q+ +++VH R LHRDIK N FL K + + DFG+A
Sbjct: 93 QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148
Query: 180 K 180
+
Sbjct: 149 R 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 53/214 (24%), Positives = 80/214 (37%), Gaps = 61/214 (28%)
Query: 8 KYKLGRKIGSGSFGEIF--LASHVDTNEI---VAVKIEN---SGTKHPQLLYEAKVYKIL 59
K L R++G GSFG ++ LA V E VA+K N S + + L EA V K
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK-- 64
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGV--DGEDNVLVLDLLGPSLED 117
F+ HV ++ GV G+ ++V++L+ D
Sbjct: 65 ---------EFNCHHV------------------VRLLGVVSTGQPTLVVMELMA--KGD 95
Query: 118 LFVYCR------RKFSLKTVLMLAD--QMIARI----EYVHSRGFLHRDIKPDNFLMGLG 165
L Y R L QM A I Y+ ++ F+HRD+ N ++
Sbjct: 96 LKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA-- 153
Query: 166 RKANQVYIIDFGLAK-----KYRDPTTNRHIPYR 194
+ V I DFG+ + Y +P R
Sbjct: 154 -EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 54/195 (27%), Positives = 77/195 (39%), Gaps = 55/195 (28%)
Query: 11 LGRKIGSGSFGEIF--LASHVDTNEI---VAVKI---ENSGTKHPQLLYEAKVYKILQGG 62
L R +G G+FGE++ L D + + VAVK S L EA
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA--------- 60
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDN--VLVLDLL-GPSLEDL 118
L++ +H NI + GV E ++L+L+ G L+
Sbjct: 61 ----LIMSKFNH-----------------QNIVRLIGVSFERLPRFILLELMAGGDLKSF 99
Query: 119 FVYCR----RKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKAN 169
R R SL K +L A + +Y+ F+HRDI N L+ G GR A
Sbjct: 100 LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159
Query: 170 QVYIIDFGLAKK-YR 183
I DFG+A+ YR
Sbjct: 160 ---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 40/177 (22%), Positives = 81/177 (45%), Gaps = 36/177 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
++L ++IGSG++G+++ A +V+T E+ A+K+ L+ G
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-----------------LEPGE----- 48
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRR 124
D ++ I+ NI ++G + L + + G SL+D++ +
Sbjct: 49 ----DFAVVQQEIIMMKDCKH--SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY-HVTG 101
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
S + ++ + + + Y+HS+G +HRDIK N L+ V + DFG++ +
Sbjct: 102 PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQ 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 8/77 (10%)
Query: 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----I 191
Q++ + Y H R LHRD+KP N L+ + ++ + DFGLA+ P+ T + +
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 192 PYRENKNLTGTARYASC 208
YR L G+ Y++
Sbjct: 168 WYRPPDVLLGSTEYSTS 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 53/227 (23%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHV 72
KIG GS G + +A+ + ++VAVK ++ + +LL+ V I++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVV--IMRD--------YQH 76
Query: 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL 132
++V+ +++S Y V E V++ L G +L D+ + R +
Sbjct: 77 ENVVE-----MYNS----------YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 121
Query: 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 192
LA ++ + +H++G +HRDIK D+ L+ +V + DFG + ++ +P
Sbjct: 122 CLA--VLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQ-----VSKEVP 171
Query: 193 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
R K+L GT + + + D+ SLG +++ + G P+
Sbjct: 172 RR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 54/234 (23%), Positives = 86/234 (36%), Gaps = 51/234 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKV-YKILQGGS 63
+Y L +++G GSFG ++L +K+ G +P +A ++L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
+V FH + A II +G D L+ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEY------------CEGRD-----------LDCKLEELK 97
Query: 124 ---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ S V Q++ + Y+H R LHRD+K N + K N + I DFG+++
Sbjct: 98 HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSR 153
Query: 181 KYR---DPTTNRHIPYRENKNLTGTARYASCN--THLGIEQSRRDDLESLGYVL 229
D T TGT Y S H G + + D+ SLG +L
Sbjct: 154 LLMGSCDLAT----------TFTGTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 48/229 (20%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL-VVFHVD 73
+G G+ G ++ A H+ T I+AVK+ I L + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKV-------------------------IPLDITVELQ 43
Query: 74 HVIIHALTIIFSSTLGGIPNIKWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT 130
I+ L I++ I I +YG V+ ++ + G SL+ VY RK
Sbjct: 44 KQIMSELEILYKCDSPYI--IGFYGAFFVENRISICTEFMDGGSLD---VY--RKIPEHV 96
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 190
+ +A ++ + Y+ S LHRD+KP N L+ QV + DFG++ + +
Sbjct: 97 LGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVNSIA--- 150
Query: 191 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
K GT Y + G + D+ SLG + G P+
Sbjct: 151 ------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 45/191 (23%), Positives = 72/191 (37%), Gaps = 39/191 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
K LG IG G FG + + T + VAVK L E V L + +RL
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 68 VVFHVDHVIIH-ALTIIFS-STLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 125
+ VI+H L I+ + G + N F+ R +
Sbjct: 65 L-----GVILHNGLYIVMELMSKGNLVN-------------------------FLRTRGR 94
Query: 126 F--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
S+ +L + + +EY+ S+ +HRD+ N L+ + + DFGLA+
Sbjct: 95 ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS 151
Query: 184 DPTTNRHIPYR 194
N +P +
Sbjct: 152 MGVDNSKLPVK 162
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 33/184 (17%)
Query: 9 YKLGRKIGSGSFG---EIFLASHVDTNEIVAVKIE----NSGTKHPQLLYEAKVYKILQG 61
+ LGR +G G FG E L S + + VAVK+ S + + L EA K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMK---- 56
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIP---NIKWYGVDGE-DNVLVLDLLGPSLED 117
F +VI + S G +P I + G+ L++ +G E+
Sbjct: 57 -------EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG---EE 106
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
F L+T++ + + +EY+ S+ F+HRD+ N ++ + V + DFG
Sbjct: 107 PF-----TLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFG 158
Query: 178 LAKK 181
L+KK
Sbjct: 159 LSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 3/36 (8%)
Query: 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
++ +HS GF+HRD+KPDN L+ K+ + + DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 73/315 (23%), Positives = 122/315 (38%), Gaps = 75/315 (23%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGG 62
G+ +G+G+FG++ A S D VAVK+ ++ L+ E K+ L G
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL--G 96
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGG----IPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
+ +V ++ + T+GG I YG DL
Sbjct: 97 NHENIV------------NLLGACTIGGPILVITEYCCYG------------------DL 126
Query: 119 FVYCRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+ RRK +L+ +L + Q+ + ++ S+ +HRD+ N L+ G+ I
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---IC 183
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLTGTAR----YASCNTHLGIEQSRRDDLESLGYVLL 230
DFGLA R I N + G AR + + + + D+ S G +LL
Sbjct: 184 DFGLA---------RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG-ILL 233
Query: 231 Y--FLRGSLPWQGLKAATKKQKYDKICEK-KVSTPIEVLCKSHPAEFASYFHYCQSLTFD 287
+ F GS P+ G+ +K Y I E +++ P PAE C
Sbjct: 234 WEIFSLGSNPYPGMPVDSK--FYKLIKEGYRMAQPEHA-----PAEIYDIMKTCWDADPL 286
Query: 288 QRPDYGFLKRLFHDL 302
+RP + + +L
Sbjct: 287 KRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 26/180 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+++ + IG G+FGE+ + T I A+KI N ++L A+ + R V
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW----EMLKRAETACFREE----RNV 54
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL-LGPSLEDLFVYCRRKFS 127
+ + D I L F D LV+D +G L L +
Sbjct: 55 LVNGDCQWITTLHYAFQ--------------DENYLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 187
+M+ I +H ++HRDIKPDN L+ + + + DFG K T
Sbjct: 101 EDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGT 157
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 19/75 (25%), Positives = 39/75 (52%), Gaps = 7/75 (9%)
Query: 117 DLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 172
+LF +R+ S + A +++ +EY+H G ++RD+KP+N L+ ++ +
Sbjct: 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIM 143
Query: 173 IIDFGLAKKYRDPTT 187
+ DF L+K+
Sbjct: 144 LSDFDLSKQSDVEPP 158
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 14/126 (11%)
Query: 117 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+LF + R+ FS ++++ ++Y+HS ++RD+K +N ++ K + I
Sbjct: 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKIT 137
Query: 175 DFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233
DFGL K+ D T K GT Y + + R D LG V+ +
Sbjct: 138 DFGLCKEGITDAAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 234 RGSLPW 239
G LP+
Sbjct: 190 CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 449 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.32 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.19 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.13 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.09 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.98 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.65 | |
| PLN02236 | 344 | choline kinase | 96.57 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.45 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.24 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.1 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.67 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.32 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.3 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.83 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.63 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 93.57 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.42 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 93.37 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 93.0 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.91 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-60 Score=410.66 Aligned_cols=298 Identities=68% Similarity=1.180 Sum_probs=288.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
-|++++|+++++||+|+||.+|+|....+|+.||||++.+...++++..|.++++.|++..
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~------------------- 71 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGV------------------- 71 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCC-------------------
Confidence 4788999999999999999999999999999999999999999999999999999999886
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++|.+++|+.+..+.++|||++|.+|.+++..|.+.|+.++++.++.||+..++|+|.+++|||||||+|+|+
T Consensus 72 -------GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLM 144 (341)
T KOG1163|consen 72 -------GIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLM 144 (341)
T ss_pred -------CCchhhhhccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceee
Confidence 8999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.+.-...+.|+|||+|+.+.+..+..|+||++...++||++|++...+.+.+.++++|+.|+|++|.++..|.+||++.
T Consensus 145 Glgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 145 GLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 99888899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccccc
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQ 322 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~ 322 (449)
.+....+++.+|.+.+++.+++.+|+++|.+|.-++.+|..+.+++.|+|..|.+.|+-++...+...|..|||.+++.+
T Consensus 225 ka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk 304 (341)
T KOG1163|consen 225 KAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK 304 (341)
T ss_pred chhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998854
Q ss_pred cccc
Q 013125 323 QTQK 326 (449)
Q Consensus 323 ~~~~ 326 (449)
..+.
T Consensus 305 ~~q~ 308 (341)
T KOG1163|consen 305 SQQS 308 (341)
T ss_pred hhcc
Confidence 4443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-57 Score=411.46 Aligned_cols=291 Identities=58% Similarity=1.011 Sum_probs=281.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
|+|-.|+++++||+|+||++++|+..-+++.||||.+....+.+++.-|.+.++.|.+..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~-------------------- 84 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTE-------------------- 84 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCC--------------------
Confidence 788999999999999999999999999999999999988888999999999999998776
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+||.+++||.++.+..||+|++|.+|.|++..|+++|+.++++.+|.||+.-++|+|++.+|+|||||+|+||+
T Consensus 85 ------GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 85 ------GIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred ------CCCceeeeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cC--CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 164 LG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 164 ~~--~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
.. .+...|.++|||+|+.++++.+..|+||++.+++.||++||+...++|.+.++++|+.|||.++++++.|.+||+|
T Consensus 159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 63 3456899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccc
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
+++...++++.+|.+.+-..+++++|.++|.+|..++.+...+++++-|+|+.+..+|.+++...++.+|..|||..+.
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999998766
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=372.07 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=214.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---------CchhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
-+.+.|.+.+.||+|+||.|-+|....|++.||||+++++. +.....+|+++|++|+|+++++.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~------- 241 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI------- 241 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE-------
Confidence 46788999999999999999999999999999999987652 12235799999999999976654
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
+.+....+..||||||+ ||.|.+.+.. .+.+.+..-+.+++||+.||.|||+.||+||
T Consensus 242 --------------------~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HR 300 (475)
T KOG0615|consen 242 --------------------KDFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHR 300 (475)
T ss_pred --------------------eeeeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccc
Confidence 44556778889999999 9999998875 5678888899999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC---CCccchHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLL 230 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlG~il~ 230 (449)
||||+|||+..++++..+||+|||+|+......- .+++|||+.|.|||++.+.. +..++|+||+||+||
T Consensus 301 DiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf--------m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLf 372 (475)
T KOG0615|consen 301 DIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF--------MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLF 372 (475)
T ss_pred cCCcceEEeccCCcceEEEecccchhhcccccee--------hhhhcCCccccChhheecCCeecccchheeeeccceEE
Confidence 9999999998766789999999999998764332 36899999999999998765 345889999999999
Q ss_pred HHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 231 el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
-+++|.+||.+..... .....|..+++..- +..|...+++..+|+..+|..||++||+..+..+
T Consensus 373 vcLsG~pPFS~~~~~~--sl~eQI~~G~y~f~-p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 373 VCLSGYPPFSEEYTDP--SLKEQILKGRYAFG-PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred EEeccCCCcccccCCc--cHHHHHhcCccccc-ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 9999999998755432 23444556665544 4567788899999999999999999999876644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=366.33 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=216.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+-.+.|++++.||+|+||+||.++.++|++.+|+|++++.. .......|..||..++|+.
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPF--------------- 86 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPF--------------- 86 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCc---------------
Confidence 33578999999999999999999999999999999987652 2334778888888887774
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++.+.+.+.+.+..|||+||+ ||.|...++. .+.|++..++.++.+|+.||.|||++|||||||||
T Consensus 87 ------------iv~l~ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKP 153 (357)
T KOG0598|consen 87 ------------IVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKP 153 (357)
T ss_pred ------------EeeeEEecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCH
Confidence 555666778889999999999 8899998886 67899999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+ +..|+|+|+|||+|+........ ..+++||+.|||||++.+..|+..+|+||||+++|||++|.+
T Consensus 154 ENILL---d~~GHi~LtDFgL~k~~~~~~~~-------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 154 ENILL---DEQGHIKLTDFGLCKEDLKDGDA-------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred HHeee---cCCCcEEEeccccchhcccCCCc-------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 99999 59999999999999865544332 357899999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHHHhcCCCCCcc
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD----YGFLKRLFHDLFSREGYDFDFV 313 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~----~~~l~~~l~~~~~~~~~~~~~~ 313 (449)
||.+.+. ...+.+|...+...+.. .++.+.++++...+..+|++|.. +.+| ....+-..
T Consensus 224 PF~~~~~---~~~~~~I~~~k~~~~p~----~ls~~ardll~~LL~rdp~~RLg~~~d~~~i----------k~HpfF~~ 286 (357)
T KOG0598|consen 224 PFYAEDV---KKMYDKILKGKLPLPPG----YLSEEARDLLKKLLKRDPRQRLGGPGDAEEI----------KRHPFFKG 286 (357)
T ss_pred CCcCccH---HHHHHHHhcCcCCCCCc----cCCHHHHHHHHHHhccCHHHhcCCCCChHHh----------hcCccccc
Confidence 9988543 35666666666443322 24689999999999999999963 3333 23455556
Q ss_pred ccccc
Q 013125 314 FDWTI 318 (449)
Q Consensus 314 ~dw~~ 318 (449)
.||+.
T Consensus 287 inW~~ 291 (357)
T KOG0598|consen 287 INWEK 291 (357)
T ss_pred CCHHH
Confidence 77754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=375.42 Aligned_cols=265 Identities=26% Similarity=0.374 Sum_probs=222.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+|++++.||+|+|++|++|+++.+++.+||||+.+. .+.+...+|..+|..|.+..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hP------------------ 134 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHP------------------ 134 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCC------------------
Confidence 5799999999999999999999999999999997653 44556788889999985332
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.++++-+.++..+|+|+||+ +|+|.++++. -+.|++..++.++.||+.||+|||++|||||||||+||
T Consensus 135 --------givkLy~TFQD~~sLYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENI 205 (604)
T KOG0592|consen 135 --------GIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI 205 (604)
T ss_pred --------CeEEEEEEeecccceEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 5666666677888999999999 9999999987 46799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCcccc----ccC--CCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP----YRE--NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|+ +++++++|+|||.|+.+........-| +.. ..+++||+.|.+||++.+...+..+|||+||||||+|+.
T Consensus 206 LL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla 282 (604)
T KOG0592|consen 206 LL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA 282 (604)
T ss_pred eE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc
Confidence 99 699999999999999876543321111 111 257999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccc
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVF 314 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~ 314 (449)
|.+||.+.+.. -.+++|+...+.+| +++|+.+.+|+.++|..||.+|++.++|.+ +.|....
T Consensus 283 G~PPFra~Ney---liFqkI~~l~y~fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~V 344 (604)
T KOG0592|consen 283 GQPPFRAANEY---LIFQKIQALDYEFP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGV 344 (604)
T ss_pred CCCCCccccHH---HHHHHHHHhcccCC-----CCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccC
Confidence 99999987654 45566666677666 667899999999999999999999987755 3444556
Q ss_pred ccccc
Q 013125 315 DWTIL 319 (449)
Q Consensus 315 dw~~l 319 (449)
||+.+
T Consensus 345 dw~nl 349 (604)
T KOG0592|consen 345 DWENL 349 (604)
T ss_pred Chhhh
Confidence 77653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=357.33 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=201.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|.+.++||+|+||+||+|++.+++..||||.+.... ..+.+..|+++|+.++|+|++.++.
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d------------- 76 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLD------------- 76 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEE-------------
Confidence 78999999999999999999999999999999876553 2334789999999999998776654
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+....++.||||||| ||+|.+++.. .+.+++.+++.++.||+.||++||+++||||||||+|||
T Consensus 77 --------------~~~~~~~i~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 77 --------------CIEDDDFIYLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred --------------EEecCCeEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 346678999999999 8999999986 457999999999999999999999999999999999999
Q ss_pred eecCCCC---CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 162 MGLGRKA---NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 162 l~~~~~~---~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
++..... -.+||+|||+|+.+..... ..+++|++.|||||++....|+.|+|+||+|+++|+|++|+.|
T Consensus 142 Ls~~~~~~~~~~LKIADFGfAR~L~~~~~--------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 142 LSTTARNDTSPVLKIADFGFARFLQPGSM--------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred eccCCCCCCCceEEecccchhhhCCchhH--------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC
Confidence 9754222 6799999999998774432 4589999999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
|......+ .+..+.......+... ........+++...+..++.+|-++..
T Consensus 214 f~a~t~~e---L~~~~~k~~~~~~~~~--~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 214 FDAETPKE---LLLYIKKGNEIVPVLP--AELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred ccccCHHH---HHHHHhccccccCchh--hhccCchhhhhhHHHhcCccccCchHH
Confidence 98765443 3333322222222211 222345668888888888888877654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=361.86 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=212.0
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..+.+.++.||+|+.|+||+|+++.|++.+|+|++.... ...++.+|+++++..++++++.+++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~yg------------- 144 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYG------------- 144 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeE-------------
Confidence 347788899999999999999999999999999984432 2446899999999998887665544
Q ss_pred hhcccCCCcCeeEEecccCC-eeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 013125 83 IFSSTLGGIPNIKWYGVDGE-DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDN 159 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~N 159 (449)
++.... ..+|+|||| ||+|.++++. .+++++..+-.++.+++.||.|||+ ++||||||||+|
T Consensus 145 --------------aF~~~~~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsN 209 (364)
T KOG0581|consen 145 --------------AFYSNGEEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSN 209 (364)
T ss_pred --------------EEEeCCceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHH
Confidence 334444 589999999 9999999886 4679999999999999999999996 899999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ +..+.|||+|||.|....+.. .++++||..|||||.+.+..|+.++||||||++++||++|+.||
T Consensus 210 lLv---NskGeVKicDFGVS~~lvnS~---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~ 277 (364)
T KOG0581|consen 210 LLV---NSKGEVKICDFGVSGILVNSI---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPY 277 (364)
T ss_pred eee---ccCCCEEeccccccHHhhhhh---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCC
Confidence 999 589999999999998776652 36899999999999999999999999999999999999999999
Q ss_pred CCCh--hhcHHHHHHHHHHhhcCCCHHHhhcc-ChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 240 QGLK--AATKKQKYDKICEKKVSTPIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 240 ~~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.... .....+.+..|+.. +++.+..+ ++++|++++..||+.||.+||++++|.+ +.+++.
T Consensus 278 ~~~~~~~~~~~~Ll~~Iv~~----ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~ 340 (364)
T KOG0581|consen 278 PPPNPPYLDIFELLCAIVDE----PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKK 340 (364)
T ss_pred CCcCCCCCCHHHHHHHHhcC----CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhh
Confidence 8741 23345556555543 33444444 7999999999999999999999998855 444443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=374.30 Aligned_cols=251 Identities=28% Similarity=0.405 Sum_probs=220.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+|+.++.||+|||+.||.+++..+|+.||+|++.+. ...+.+.+|++|.+.|+|++++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~--------------- 82 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQ--------------- 82 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEe---------------
Confidence 5799999999999999999999999999999997652 33456899999999999997554
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.|+++.+++|||+|+| .++|..+++ ..+.+++.+++.+++||+.||.|||+.+|||||||..|+
T Consensus 83 ------------f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl 149 (592)
T KOG0575|consen 83 ------------FYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL 149 (592)
T ss_pred ------------eeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence 555678889999999999 889988888 478899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ +++.+|||+|||||.....+... ..++|||+.|.|||++.+...+..+||||+|||||-|++|++||+
T Consensus 150 fL---~~~~~VKIgDFGLAt~le~~~Er-------k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 150 FL---NENMNVKIGDFGLATQLEYDGER-------KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred ee---cCcCcEEecccceeeeecCcccc-------cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 99 58889999999999988755432 358999999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.. ...+.+.+|....+..|. .++.+.++||..+|+.+|.+||+.++|.. .++|+.
T Consensus 220 tk---~vkety~~Ik~~~Y~~P~-----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff~~ 274 (592)
T KOG0575|consen 220 TK---TVKETYNKIKLNEYSMPS-----HLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFFKS 274 (592)
T ss_pred cc---hHHHHHHHHHhcCccccc-----ccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhhhC
Confidence 64 345677888777777775 44789999999999999999999988844 566643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=347.42 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=212.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh----HHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~----~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|+.+.++|+|+||.||+|+++.||+.||||.+....+++. .++|+++|+.|+|+|++.++.++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF----------- 70 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF----------- 70 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----------
Confidence 579999999999999999999999999999999877655443 68999999999999988765432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
......+||+|||..++.+.+......++.+.++.+++|++.|+.|+|++++|||||||+|||+
T Consensus 71 ----------------rrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi 134 (396)
T KOG0593|consen 71 ----------------RRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI 134 (396)
T ss_pred ----------------HhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE
Confidence 3457789999999999888888777789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ .++.+||+|||+|+....+... ...++.|.+|+|||.+.| -.|+..+||||+||++.||++|.+.|.|
T Consensus 135 t---~~gvvKLCDFGFAR~L~~pgd~-------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 135 T---QNGVVKLCDFGFARTLSAPGDN-------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred e---cCCcEEeccchhhHhhcCCcch-------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 6 8899999999999988764431 346788999999999988 6799999999999999999999999999
Q ss_pred ChhhcHHHHHHHHHHhhcCCC-----------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTP-----------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.++.+....+.+.++...+.- .+.-..+...-+.+++..|+..||++|++.+++..
T Consensus 205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 205 RSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 887766655555443322111 12222333456889999999999999999888743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=357.33 Aligned_cols=263 Identities=26% Similarity=0.351 Sum_probs=220.1
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh----HHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~----~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+.|+.+++||+|.||.||+|++..+|+.||+|.+..+...+. ..+|+.||+.|.|+|++.+.+...+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~-------- 187 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS-------- 187 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe--------
Confidence 4578999999999999999999999999999998776554333 5799999999999999887665432
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.....+|||+|||..+|.-++...+-+|+..+++.|+.||+.||+|||++||+|||||.+|||
T Consensus 188 -----------------~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiL 250 (560)
T KOG0600|consen 188 -----------------KLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNIL 250 (560)
T ss_pred -----------------cCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceE
Confidence 134688999999999999998876678999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
| |..+.+||+|||||+.+....... ....+.|.+|++||+++|.. |+..+|+||.||||.||+.|++.|+
T Consensus 251 i---dn~G~LKiaDFGLAr~y~~~~~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 251 I---DNNGVLKIADFGLARFYTPSGSAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred E---cCCCCEEeccccceeeccCCCCcc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 9 689999999999999887655322 35678899999999999875 9999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCC-------C--------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVST-------P--------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~-------~--------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
|....+..+.+.++|+..... | +.+..+.++....+|+..+|.+||++|.++.+.++
T Consensus 322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~-- 399 (560)
T KOG0600|consen 322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ-- 399 (560)
T ss_pred CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--
Confidence 988887777777765421110 0 23345667888889999999999999999876533
Q ss_pred HHHHH
Q 013125 300 HDLFS 304 (449)
Q Consensus 300 ~~~~~ 304 (449)
.++|.
T Consensus 400 seyF~ 404 (560)
T KOG0600|consen 400 SEYFT 404 (560)
T ss_pred Ccccc
Confidence 45553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=366.26 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=215.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
..++++++||+|.||+||+|++.. ...||+|.++..... +.+.+|+++|+.|+|++++++++++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~-------------- 270 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVC-------------- 270 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEE--------------
Confidence 345678999999999999999953 347999998876443 5688999999999999988888775
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..++..||||||+ .|+|.++++. .+..+...+.+.++.||++||+||+++++|||||.+.||||+
T Consensus 271 -------------~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~ 337 (468)
T KOG0197|consen 271 -------------TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD 337 (468)
T ss_pred -------------ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec
Confidence 3445789999999 9999999986 466799999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
++..|||+|||||+...+.. |.......-+..|+|||++....++.++||||||++||||+| |+.||.++
T Consensus 338 ---~~~~vKIsDFGLAr~~~d~~------Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 338 ---EDLVVKISDFGLARLIGDDE------YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred ---cCceEEEcccccccccCCCc------eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 88999999999999544333 222334455788999999999999999999999999999999 99999998
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
...+..+.+ +.....|.+..| |+++.++|..||..+|++||+|+.+...|++++..
T Consensus 409 sn~ev~~~l----e~GyRlp~P~~C---P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 409 SNEEVLELL----ERGYRLPRPEGC---PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CHHHHHHHH----hccCcCCCCCCC---CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 876544443 456666666544 99999999999999999999999999888887654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=361.63 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=213.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chh--HHHHHHHHHHHc-CCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQ--LLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~--~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~ 79 (449)
++-+||.++++||.|.||.||+|+.+.+++.||||.++..-. +++ -++|++.|++|+ |++++.+..+..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~------- 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR------- 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh-------
Confidence 456899999999999999999999999999999998776522 333 478999999999 998877654332
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
......++|||||..+|.++++..++.|++..++.|++||+.||+|+|.+|+.||||||+|
T Consensus 80 -------------------d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPEN 140 (538)
T KOG0661|consen 80 -------------------DNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPEN 140 (538)
T ss_pred -------------------ccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhh
Confidence 2334899999999999999999888889999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||+. ....|||+|||+|+...... || ..++.|.+|+|||+++.. -|+.++|||++|||++|+.+-++.
T Consensus 141 iLi~---~~~~iKiaDFGLARev~Skp-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL 209 (538)
T KOG0661|consen 141 ILIS---GNDVIKIADFGLAREVRSKP-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL 209 (538)
T ss_pred eEec---ccceeEecccccccccccCC-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence 9994 48899999999999776543 22 467889999999987754 589999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhc----------------------CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKV----------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
|.|.+..+...++..+++... ..++..+..+++.+..++|..|+.+||.+||++.+..
T Consensus 210 FPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 210 FPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 999877655444444332111 1123344555788999999999999999999998875
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 290 ~ 290 (538)
T KOG0661|consen 290 Q 290 (538)
T ss_pred c
Confidence 5
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.27 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=211.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCce-EEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI-VAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~-vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.....+.+.||+|+||+||+|.+. |.. ||+|++..... ...+.+|+.+|..|+|+|++.+++.+.
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~-------- 109 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT-------- 109 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--------
Confidence 345567788999999999999984 455 99999876432 236899999999999999888777653
Q ss_pred hhhhcccCCCcCeeEEecccCC-eeEEEEecC-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGE-DNVLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIK 156 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~-g~sL~~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~g-iiHrDLk 156 (449)
+.. ..+|||||+ +|+|.+++.. ..+.+++..++.++.||+.||+|||+++ |||||||
T Consensus 110 -------------------~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK 170 (362)
T KOG0192|consen 110 -------------------SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLK 170 (362)
T ss_pred -------------------CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccC
Confidence 223 689999999 9999999987 3778999999999999999999999999 9999999
Q ss_pred CCcEEeecCCCCC-eEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc--CCCCCccchHHHHHHHHHHHH
Q 013125 157 PDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 157 p~Nill~~~~~~~-~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwSlG~il~el~ 233 (449)
|+|||+. ... ++||+|||+++....... ......||..|||||++. +..|+.++||||||+++|||+
T Consensus 171 ~~NiLv~---~~~~~~KI~DFGlsr~~~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~ 240 (362)
T KOG0192|consen 171 SDNILVD---LKGKTLKIADFGLSREKVISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL 240 (362)
T ss_pred hhhEEEc---CCCCEEEECCCccceeeccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH
Confidence 9999994 665 999999999987664321 123478999999999999 568999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
||+.||.+.... +....++......+++. .+|+.+..+|..||..||..||+|.+|...|+.+....
T Consensus 241 t~~~Pf~~~~~~---~~~~~v~~~~~Rp~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 241 TGEIPFEDLAPV---QVASAVVVGGLRPPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred HCCCCCCCCCHH---HHHHHHHhcCCCCCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 999999987763 33333443444433333 35899999999999999999999999999998876643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=340.95 Aligned_cols=245 Identities=25% Similarity=0.320 Sum_probs=204.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..|+|+++||.|+||+||+|.+..++..||.|.++-+. .......|+.+|+.|+|+|++..+...
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----------- 87 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----------- 87 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh-----------
Confidence 45999999999999999999999999999999766332 123478899999999999988764311
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHS--RG--FLHRD 154 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~--~g--iiHrD 154 (449)
+..+..-.+||||+| +|+|..+++.. ++.|+++++++++.|++.||..+|+ .. |+|||
T Consensus 88 --------------f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRD 153 (375)
T KOG0591|consen 88 --------------FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRD 153 (375)
T ss_pred --------------hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeecc
Confidence 112334478999999 99999888733 5679999999999999999999999 55 99999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||.||+++ .+|.|||+|||+++.+....+.. .+++|||.||+||.+.+.+|+.++||||+||++|||+.
T Consensus 154 IKPaNIFl~---~~gvvKLGDfGL~r~l~s~~tfA-------~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca 223 (375)
T KOG0591|consen 154 IKPANIFLT---ANGVVKLGDFGLGRFLSSKTTFA-------HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA 223 (375)
T ss_pred CcchheEEc---CCCceeeccchhHhHhcchhHHH-------HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh
Confidence 999999994 89999999999999888766543 48899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
-++||.|. ...+.-.+|.++.++..+.. -++.++..|+..|+..|++.||+.
T Consensus 224 L~~PF~g~---n~~~L~~KI~qgd~~~~p~~---~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 224 LQSPFYGD---NLLSLCKKIEQGDYPPLPDE---HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cCCCcccc---cHHHHHHHHHcCCCCCCcHH---HhhhHHHHHHHHHccCCcccCCCc
Confidence 99999985 33445556666655433322 336889999999999999999983
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=328.22 Aligned_cols=287 Identities=22% Similarity=0.302 Sum_probs=218.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.||..+++||+|.||.||+|++.+||+.||||.++.... .-...+|++.|+.++|++++.++...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F----------- 70 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF----------- 70 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----------
Confidence 589999999999999999999999999999998876533 23579999999999999987765432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
...+..-||+||+..+|...++.....++..+++.|+.|++.||+|||++.|+||||||.|+|+
T Consensus 71 ----------------~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi 134 (318)
T KOG0659|consen 71 ----------------PHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI 134 (318)
T ss_pred ----------------cCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE
Confidence 4556788999999999999999878889999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ .++.+||+|||+|+.+..+.... ...+-|.+|+|||.+.|.. |+..+||||.|||+.||+.|.+.|.|
T Consensus 135 s---~~g~lKiADFGLAr~f~~p~~~~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG 204 (318)
T KOG0659|consen 135 S---SDGQLKIADFGLARFFGSPNRIQ-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG 204 (318)
T ss_pred c---CCCcEEeecccchhccCCCCccc-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence 5 89999999999999988765432 1226799999999999875 89999999999999999999999999
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccc--ccc
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW--TIL 319 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw--~~l 319 (449)
.++.+....+..+ +..|.+..|.++. ++.++...-....|..+ .+|.....+. +|. .++
T Consensus 205 ~sDidQL~~If~~----LGTP~~~~WP~~~-~lpdY~~~~~~P~~~~~-----------~lf~aas~d~---ldLl~~m~ 265 (318)
T KOG0659|consen 205 DSDIDQLSKIFRA----LGTPTPDQWPEMT-SLPDYVKIQQFPKPPLN-----------NLFPAASSDA---LDLLSKML 265 (318)
T ss_pred CchHHHHHHHHHH----cCCCCcccCcccc-ccccHHHHhcCCCCccc-----------cccccccHHH---HHHHHhhh
Confidence 8776554444333 3344444442211 22223222222222222 1111111111 111 678
Q ss_pred cccccccccccccCCCCccccCCCCcccccc
Q 013125 320 KYQQTQKTKSQDLLPASRVTNSRVMPMRTDK 350 (449)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (449)
.|+|.+|.++++++.|+++.+ ...+....+
T Consensus 266 ~ynP~~Rita~qaL~~~yf~~-~P~pt~~~~ 295 (318)
T KOG0659|consen 266 TYNPKKRITASQALKHPYFKS-LPLPTPPSK 295 (318)
T ss_pred ccCchhcccHHHHhcchhhhc-CCCCCChhh
Confidence 889999999999999999887 333443333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=341.85 Aligned_cols=287 Identities=23% Similarity=0.349 Sum_probs=227.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+.|+.+++|++|+||.||+|+|++|++.||+|.++-+.... ..++|+.+|..++|+||+..-.+.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv---------- 145 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV---------- 145 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe----------
Confidence 57899999999999999999999999999999887654433 2589999999999999887665543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
|.+-+.+|||||||..+|..++....++|...+++.+..|++.||+|||...|+|||||++|+|+
T Consensus 146 ---------------G~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm 210 (419)
T KOG0663|consen 146 ---------------GSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL 210 (419)
T ss_pred ---------------ccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee
Confidence 45667799999999999999999888899999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
. ..|.+||+|||+|+.+..+.. .....+.|.+|+|||++++.. |+..+|+||+|||+.||+++++.|.|
T Consensus 211 ~---~~G~lKiaDFGLAR~ygsp~k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 211 S---HKGILKIADFGLAREYGSPLK-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred c---cCCcEEecccchhhhhcCCcc-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 5 889999999999998877632 235778899999999999876 89999999999999999999999999
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-HHhcCCCCCccccccccc
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL-FSREGYDFDFVFDWTILK 320 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~-~~~~~~~~~~~~dw~~l~ 320 (449)
....+...++.. .+..|.+..|.++..- ...-.....+-| +..+...|... +...+++. --.++.
T Consensus 281 ~sE~dQl~~If~----llGtPte~iwpg~~~l-----p~~k~~~f~~~p-yn~lr~kF~~~~lse~g~~L----ln~llt 346 (419)
T KOG0663|consen 281 KSEIDQLDKIFK----LLGTPSEAIWPGYSEL-----PAVKKMTFSEHP-YNNLRKKFGALSLSEQGFDL----LNKLLT 346 (419)
T ss_pred CchHHHHHHHHH----HhCCCccccCCCcccc-----chhhccccCCCC-chhhhhhccccccchhHHHH----HHHHhc
Confidence 776654444433 3446667666554320 000012222333 33355544433 22222211 126788
Q ss_pred ccccccccccccCCCCccccCC
Q 013125 321 YQQTQKTKSQDLLPASRVTNSR 342 (449)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~ 342 (449)
|+|.+|.++.+++.|.||.+..
T Consensus 347 ~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 347 YDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred cCccccccHHHhhcccccccCC
Confidence 9999999999999999998755
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=352.36 Aligned_cols=270 Identities=24% Similarity=0.336 Sum_probs=211.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+--+.|++++.||+|+||+||+|+.+.||+.+|+|++++..- ......|..+|..-.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d------------------ 199 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD------------------ 199 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC------------------
Confidence 345789999999999999999999999999999999886432 112444555554433
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.+.++++++.+.+.+++||||||+ ||++..++.. ...|++..++.++.+++.||+-||..|+|||||||
T Consensus 200 ---------s~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKP 269 (550)
T KOG0605|consen 200 ---------SPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKP 269 (550)
T ss_pred ---------CCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCCh
Confidence 336777888889999999999999 9999999886 66799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCC------------------Ccccc-----cc-----------------CCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTT------------------NRHIP-----YR-----------------ENK 197 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~------------------~~~~~-----~~-----------------~~~ 197 (449)
+|+|| |..|++||+|||||..+..... ....+ .+ ...
T Consensus 270 dNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 270 DNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred hheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 99999 6999999999999964322000 00001 00 123
Q ss_pred CCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhh--cCCCHHHhhccChHHHH
Q 013125 198 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFA 275 (449)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~ 275 (449)
+.+|||-|+|||++.+..|+..||+||||||+|||+.|.+||.+..+. +.+.+|+.-+ +..|...-+ .++..
T Consensus 347 StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~---~T~rkI~nwr~~l~fP~~~~~---s~eA~ 420 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ---ETYRKIVNWRETLKFPEEVDL---SDEAK 420 (550)
T ss_pred cccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhhhccCCCcCcc---cHHHH
Confidence 578999999999999999999999999999999999999999986654 4555555444 444544332 58999
Q ss_pred HHHHHHhCCCCCCCCC---HHHHHHHHHHHHHhcCCCCCcccccccccc
Q 013125 276 SYFHYCQSLTFDQRPD---YGFLKRLFHDLFSREGYDFDFVFDWTILKY 321 (449)
Q Consensus 276 ~l~~~~l~~~p~~Rp~---~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~ 321 (449)
+||.+|+. ||++|.. +++|.+ ..|....||..+..
T Consensus 421 DLI~rll~-d~~~RLG~~G~~EIK~----------HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLGSKGAEEIKK----------HPFFKGVDWDHLRE 458 (550)
T ss_pred HHHHHHhc-CHHHhcCcccHHHHhc----------CCccccCCcchhhc
Confidence 99999998 9999976 444433 45666678865543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=329.51 Aligned_cols=235 Identities=23% Similarity=0.342 Sum_probs=206.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
-++|++++.||.|+||.|.+++++.++..+|+|+++++.- .+...+|..+|+.+.|+.++++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l------------- 109 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKL------------- 109 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEE-------------
Confidence 3679999999999999999999999999999999876532 2235778888888887765544
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.+...+....||||||. ||-|..+++. .++|+.+.++.++.||+.||+|||+++|++|||||+|
T Consensus 110 --------------~~t~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPEN 174 (355)
T KOG0616|consen 110 --------------YGTFKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPEN 174 (355)
T ss_pred --------------EEeeccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHH
Confidence 33445778999999999 8999999887 4579999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ |..|.+||+|||.|+.....+ .++|||+.|+|||++...+|+.++|+||||+++|||+.|.+||
T Consensus 175 iLl---D~~G~iKitDFGFAK~v~~rT----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF 241 (355)
T KOG0616|consen 175 LLL---DQNGHIKITDFGFAKRVSGRT----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPF 241 (355)
T ss_pred eee---ccCCcEEEEeccceEEecCcE----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 999 689999999999999877653 3789999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCC
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 289 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 289 (449)
....+ .+.+.+|+..++..|.- +..++++|+...++.|-.+|
T Consensus 242 ~~~~~---~~iY~KI~~~~v~fP~~-----fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 242 YDDNP---IQIYEKILEGKVKFPSY-----FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCCh---HHHHHHHHhCcccCCcc-----cCHHHHHHHHHHHhhhhHhh
Confidence 98665 57889999999988843 37899999999999998888
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=356.47 Aligned_cols=305 Identities=21% Similarity=0.305 Sum_probs=221.7
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~ 79 (449)
++.++.||.|++.||+|+||.|-+|+|.+|++.|||||+++... ..+...|+.+|..|+ +.+-...
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~------------ 248 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY------------ 248 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe------------
Confidence 45667799999999999999999999999999999999987643 445678999999988 3321111
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
++..++.++...+|.|||+|+++.+|.++++... ..|++..++.++.||+.||.+||+.||||+||||+
T Consensus 249 ----------n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPE 318 (586)
T KOG0667|consen 249 ----------NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPE 318 (586)
T ss_pred ----------eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChh
Confidence 6677788889999999999999999999998653 46999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+-.. ....|||+|||.|......-. ....+..|+|||+|+|.+|+.++||||||||++||.+|.+.
T Consensus 319 NILL~~~-~r~~vKVIDFGSSc~~~q~vy----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 319 NILLKDP-KRSRIKVIDFGSSCFESQRVY----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred heeeccC-CcCceeEEecccccccCCcce----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 9999543 345899999999976543321 55678899999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHH-------HhCCCCCCCCCHHHHHHHHHHHHHhcCC---
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY-------CQSLTFDQRPDYGFLKRLFHDLFSREGY--- 308 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~-------~l~~~p~~Rp~~~~l~~~l~~~~~~~~~--- 308 (449)
|.|.+..+ .+..|++....+|...+. .... ...++.. |-..+-.+-....+....++........
T Consensus 388 fpG~ne~D---Ql~~I~e~lG~Pp~~mL~-~~~~-~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~ 462 (586)
T KOG0667|consen 388 FPGDNEYD---QLARIIEVLGLPPPKMLD-TAKK-AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPG 462 (586)
T ss_pred cCCCCHHH---HHHHHHHHhCCCCHHHHH-hccc-cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCC
Confidence 99976654 445555555544433221 1111 1222222 2222200000111111111111111000
Q ss_pred -----------CCCcccc--cccccccccccccccccCCCCccccCCCC
Q 013125 309 -----------DFDFVFD--WTILKYQQTQKTKSQDLLPASRVTNSRVM 344 (449)
Q Consensus 309 -----------~~~~~~d--w~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (449)
+.....| -.+++++|..|.+..+++.|+|++.....
T Consensus 463 ~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 463 SRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred CcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccccc
Confidence 0011122 27789999999999999999999866544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=338.51 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=202.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.+|..++.||+|+||.||++.+.++++.+|||.+.... ..+.+.+|+++|..|+|+++++..+...
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~------------ 84 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSS------------ 84 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccc------------
Confidence 46889999999999999999999999999999765431 1345899999999999998777655321
Q ss_pred cccCCCcCeeEEecccC-CeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYGVDG-EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~-~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
... ..+++.|||+ +|+|.+++...+.++++..++.+.+||++||+|||++|||||||||+|||+
T Consensus 85 --------------~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl 150 (313)
T KOG0198|consen 85 --------------SRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL 150 (313)
T ss_pred --------------cccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE
Confidence 112 3689999999 999999999766589999999999999999999999999999999999999
Q ss_pred ecCCC-CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 163 GLGRK-ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 163 ~~~~~-~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
. . ++.+||+|||+++........ ........||+.|||||++... ...+.+|||||||++.||+||+.||.
T Consensus 151 ~---~~~~~~KlaDFG~a~~~~~~~~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 151 D---PSNGDVKLADFGLAKKLESKGTK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred e---CCCCeEEeccCcccccccccccc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 4 5 689999999999876641111 1223467899999999999953 34469999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.. ......+..+..... .+.+...++++.++++..|+..+|.+||++.++.+
T Consensus 224 ~~--~~~~~~~~~ig~~~~---~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 224 EF--FEEAEALLLIGREDS---LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred hh--cchHHHHHHHhccCC---CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 74 122223333333331 22444567899999999999999999999988744
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=343.22 Aligned_cols=247 Identities=28% Similarity=0.391 Sum_probs=208.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-------CCchhHHHHHHHHHHHc-CCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-------~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~ 75 (449)
...++|++++.||+|+||.|++|.+..+++.||+|+++.. .....+.+|+.+++.+. |++++++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~---- 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF---- 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence 4568999999999999999999999999999999987764 12335668999999999 88776665432
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
......|+||||+ ||+|.+.+.. ..++.+..++.+++||+.|++|||++||+|||
T Consensus 90 -----------------------~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRD 145 (370)
T KOG0583|consen 90 -----------------------ATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRD 145 (370)
T ss_pred -----------------------ecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCC
Confidence 4456699999999 8899999998 78899999999999999999999999999999
Q ss_pred CCCCcEEeecCCCC-CeEEEEeecceeeec-CCCCCccccccCCCCCCCCccccccccccCCC-C-CccchHHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKA-NQVYIIDFGLAKKYR-DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-Q-SRRDDLESLGYVLL 230 (449)
Q Consensus 155 Lkp~Nill~~~~~~-~~vkL~DfGla~~~~-~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-s~~~DvwSlG~il~ 230 (449)
|||+|||+. .+ +.+||+|||++.... ... ...+.+||+.|+|||++.+.. | +.++||||+|++||
T Consensus 146 LK~ENilld---~~~~~~Kl~DFG~s~~~~~~~~--------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy 214 (370)
T KOG0583|consen 146 LKPENILLD---GNEGNLKLSDFGLSAISPGEDG--------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILY 214 (370)
T ss_pred CCHHHEEec---CCCCCEEEeccccccccCCCCC--------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHH
Confidence 999999994 56 899999999998774 222 135889999999999999987 7 48999999999999
Q ss_pred HHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 231 el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.|++|..||..... ...+.+|....+..|.-.. +++++.|+..|+..+|.+|+++.+|.
T Consensus 215 ~ml~G~~PF~d~~~---~~l~~ki~~~~~~~p~~~~----S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 215 VLLCGRLPFDDSNV---PNLYRKIRKGEFKIPSYLL----SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHhCCCCCCCccH---HHHHHHHhcCCccCCCCcC----CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 99999999987433 3455556666665553221 78899999999999999999998885
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=330.08 Aligned_cols=257 Identities=22% Similarity=0.254 Sum_probs=199.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecC----CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+..+|..++.||+|+||.|+.|.+..+++.||||.+.. .....+..+|+++++.++|+|++.........
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~------ 93 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP------ 93 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc------
Confidence 45678889999999999999999999999999997652 23345689999999999999988876554321
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
....-+.+|+|+|+|+.+|..+++. ++.++...+..+++||++||+|+|+.+|+||||||.|+
T Consensus 94 ----------------~~~~f~DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNl 156 (359)
T KOG0660|consen 94 ----------------SRDKFNDVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNL 156 (359)
T ss_pred ----------------cccccceeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhhe
Confidence 1124577899999999999999885 55699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +.++.+||+|||+|+......... .....+.|.+|+|||++. ...|+..+||||+|||+.||++|++.|
T Consensus 157 l~---n~~c~lKI~DFGLAR~~~~~~~~~-----~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 157 LL---NADCDLKICDFGLARYLDKFFEDG-----FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred ee---ccCCCEEeccccceeeccccCccc-----chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 99 588999999999999876431111 124678899999999765 456999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCC--------------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.|.+....... |......+ +...+..+.++...+|++++|..||.+|++++
T Consensus 229 pG~d~v~Ql~l---I~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~ 305 (359)
T KOG0660|consen 229 PGKDYVHQLQL---ILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE 305 (359)
T ss_pred CCCchHHHHHH---HHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH
Confidence 98654433322 22222222 22333444555666666666666666666655
Q ss_pred HH
Q 013125 294 FL 295 (449)
Q Consensus 294 ~l 295 (449)
+.
T Consensus 306 eA 307 (359)
T KOG0660|consen 306 EA 307 (359)
T ss_pred HH
Confidence 43
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=333.06 Aligned_cols=268 Identities=21% Similarity=0.334 Sum_probs=217.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|.-|+||+|+...++..+|+||+.+. .+..+...|.+||..+.|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHP------------------- 137 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHP------------------- 137 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCC-------------------
Confidence 5788999999999999999999999999999998764 2333567788888888876
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.+|.++......++.||||||| ||+|..+++.. ++.|++..++.|+.+++.||+|||-.|||+|||||+|
T Consensus 138 --------FlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 138 --------FLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred --------ccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 6777877788899999999999 99999999865 5679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCC-----------------------------c-c------------------c
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTN-----------------------------R-H------------------I 191 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~-----------------------------~-~------------------~ 191 (449)
||| .++|+|.|+||.|+.......+. . . -
T Consensus 210 ILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae 286 (459)
T KOG0610|consen 210 ILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE 286 (459)
T ss_pred eEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence 999 58999999999998643210000 0 0 0
Q ss_pred cc-cCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccC
Q 013125 192 PY-RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 270 (449)
Q Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (449)
|- ...++++||-.|.|||++.|..-+.++|+|+||+++|||++|..||.|.... +.+..|+......|-.. ..
T Consensus 287 p~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---~Tl~NIv~~~l~Fp~~~---~v 360 (459)
T KOG0610|consen 287 PTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---ETLRNIVGQPLKFPEEP---EV 360 (459)
T ss_pred CCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---hhHHHHhcCCCcCCCCC---cc
Confidence 00 1235788999999999999999999999999999999999999999986654 55666666655555322 33
Q ss_pred hHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHHHhcCCCCCccccccccc
Q 013125 271 PAEFASYFHYCQSLTFDQRPD----YGFLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 271 ~~~~~~l~~~~l~~~p~~Rp~----~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
+...++||...|.+||.+|.. +.+|++ +.|....+|..+.
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK~----------HpFF~gVnWaLir 404 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR----------HPFFEGVNWALIR 404 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhhc----------CccccCCChhhee
Confidence 578999999999999999987 444433 5666677887554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=349.64 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=205.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+--++|++++.||+|+||+|++|..+.+++.+|||+++++ ++.+....|.+|+.....
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~----------------- 427 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANR----------------- 427 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhcc-----------------
Confidence 4457899999999999999999999999999999998876 334457888888877652
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
||.+.+++.++...+++|+||||+ ||++..+. ....|++..++.|+..++.||.|||++||||||||.
T Consensus 428 ---------HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKL 496 (694)
T KOG0694|consen 428 ---------HPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKL 496 (694)
T ss_pred ---------CCeEeecccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecch
Confidence 235666677778889999999999 77733222 246799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+ |..|++||+|||+++....... ...+++||+.|+|||++.+..|++++|+|||||+||||+.|..
T Consensus 497 dNiLL---D~eGh~kiADFGlcKe~m~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~ 566 (694)
T KOG0694|consen 497 DNLLL---DTEGHVKIADFGLCKEGMGQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGES 566 (694)
T ss_pred hheEE---cccCcEEecccccccccCCCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCC
Confidence 99999 6899999999999986543222 2368999999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
||.|.+.. +.+..|+......| ..++.+...+|+.++..+|++|..+
T Consensus 567 PF~gddEe---e~FdsI~~d~~~yP-----~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 567 PFPGDDEE---EVFDSIVNDEVRYP-----RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCHH---HHHHHHhcCCCCCC-----CcccHHHHHHHHHHhccCcccccCC
Confidence 99986543 56667777666655 3458899999999999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=336.84 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=209.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+....+ .+.+|++|++.|+|+|++.++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~-------------- 67 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEML-------------- 67 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHH--------------
Confidence 57999999999999999999999999999999887653322 378999999999999866542
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+++...+.|+|.||+-|+|..++.+ ...++++.+..+++|++.||.|||+.+|+|||+||.|||+
T Consensus 68 -------------esfEt~~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl 133 (808)
T KOG0597|consen 68 -------------ESFETSAHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL 133 (808)
T ss_pred -------------HhhcccceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee
Confidence 23467789999999997799999987 6789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.++.+|++|||+|+.+...+. ......||+.|||||+..+.+|+..+|+||+||++|||+.|++||...
T Consensus 134 ---~~~~~~KlcdFg~Ar~m~~~t~-------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 134 ---EKGGTLKLCDFGLARAMSTNTS-------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred ---cCCCceeechhhhhhhcccCce-------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 5899999999999998765432 235778999999999999999999999999999999999999999864
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.- .+.+..|.......|. .....|..+++..+..||.+|.+..++..
T Consensus 204 si---~~Lv~~I~~d~v~~p~-----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 SI---TQLVKSILKDPVKPPS-----TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HH---HHHHHHHhcCCCCCcc-----cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 32 3455556555555554 44789999999999999999999877644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=342.16 Aligned_cols=247 Identities=22% Similarity=0.369 Sum_probs=206.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
..|...++||+|+.|.||.|....+++.||||.+... ...+-+++|+.+|+.++|+|+++++...
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy------------- 339 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY------------- 339 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-------------
Confidence 5788999999999999999999999999999987654 4455689999999999999987764321
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..++..|+||||+ ||+|.|++.. ..+++.++..+.++++.||+|||.+||||||||.+|||++
T Consensus 340 --------------lv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~ 403 (550)
T KOG0578|consen 340 --------------LVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT 403 (550)
T ss_pred --------------cccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec
Confidence 2337899999999 9999999874 4489999999999999999999999999999999999995
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
.++.+||+|||++..+...... ..+.+||+.|||||++....|+.++||||||++++||+.|.+||-...
T Consensus 404 ---~~g~vKltDFGFcaqi~~~~~K-------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~ 473 (550)
T KOG0578|consen 404 ---MDGSVKLTDFGFCAQISEEQSK-------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN 473 (550)
T ss_pred ---cCCcEEEeeeeeeeccccccCc-------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence 7888999999999887765542 368899999999999999999999999999999999999999998644
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+. ..+..|.... . |.-.....++++|++++.+||..|+++|+++.+|++
T Consensus 474 Pl---rAlyLIa~ng-~-P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 474 PL---RALYLIATNG-T-PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred hH---HHHHHHhhcC-C-CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 32 2222222221 1 111223456789999999999999999999998855
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=336.36 Aligned_cols=263 Identities=19% Similarity=0.319 Sum_probs=203.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecc
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVD 73 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~ 73 (449)
+|-.++|++.++||+|+||.||+|.+. .+++.||||++..... ...+.+|+.++..+ +|++++.+++.+
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-- 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC-- 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe--
Confidence 456789999999999999999999853 3456799999875432 23578899999998 788766654432
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----------------------------
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------------------------- 123 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~----------------------------- 123 (449)
.......++||||+ +++|.+++....
T Consensus 81 ------------------------~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (338)
T cd05102 81 ------------------------TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRR 136 (338)
T ss_pred ------------------------cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccc
Confidence 12345679999999 899998886431
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeE
Q 013125 124 --------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171 (449)
Q Consensus 124 --------------------------------~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~v 171 (449)
..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~ 213 (338)
T cd05102 137 IEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVV 213 (338)
T ss_pred cccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcE
Confidence 2477889999999999999999999999999999999994 67899
Q ss_pred EEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHH
Q 013125 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 250 (449)
Q Consensus 172 kL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~ 250 (449)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .
T Consensus 214 kl~DfG~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~ 285 (338)
T cd05102 214 KICDFGLARDIYKDPDY-----VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---E 285 (338)
T ss_pred EEeecccccccccCcch-----hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---H
Confidence 99999999865432211 11234456788999999999999999999999999999997 999998754321 1
Q ss_pred HHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 251 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 251 ~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
+........... .....++++.+++..||..||.+||++.+|.+.|++++..
T Consensus 286 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 286 FCQRLKDGTRMR---APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111111 1235578999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=321.91 Aligned_cols=258 Identities=20% Similarity=0.278 Sum_probs=210.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC---CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+-.+.|++.+.||.|.-++||+|+...+++.||||+++.+ ++.+.+.+|++.|..++|+|++..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~------------ 90 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYH------------ 90 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEE------------
Confidence 3467899999999999999999999999999999998754 3345789999999999999866543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
..+..+...|+||.|| +|++.++++.. ...|++..+..|+++++.||.|||.+|.||||||+.
T Consensus 91 ---------------~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAg 155 (516)
T KOG0582|consen 91 ---------------CSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAG 155 (516)
T ss_pred ---------------EEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccc
Confidence 3445678899999999 99999999843 556999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC--CCCccchHHHHHHHHHHHHhCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlG~il~el~~G~ 236 (449)
|||| +++|.|||+|||.+..+..... ..-++- +.++||++|||||++... .|+.|+||||||++..||++|.
T Consensus 156 nILi---~~dG~VkLadFgvsa~l~~~G~--R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~ 229 (516)
T KOG0582|consen 156 NILI---DSDGTVKLADFGVSASLFDSGD--RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGH 229 (516)
T ss_pred cEEE---cCCCcEEEcCceeeeeecccCc--eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCC
Confidence 9999 5899999999998877665442 222333 788999999999996643 5999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcC-----CCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVS-----TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||..+.+.. ..+.+ ++...+ .......+.++..|++++..|+..||.+||++.++..
T Consensus 230 aPf~k~pPmk--vLl~t-Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 230 APFSKYPPMK--VLLLT-LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccCChHH--HHHHH-hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 9999876542 11222 222221 1122233455678999999999999999999988755
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=353.99 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=219.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
-....+..+.||+|+||+||+|+.. +....||||.++..... .+|.+|++++..|+|+|+++++++|
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC----- 558 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC----- 558 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----
Confidence 3456788999999999999999874 23457999999876554 4599999999999999999998887
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------CC----CCHHHHHHHHHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------RK----FSLKTVLMLADQMIARI 142 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------~~----~~~~~~~~i~~qil~~L 142 (449)
.+++..|||+||| .|+|.+++..+. .. ++..+.+.|+.||+.||
T Consensus 559 ----------------------~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM 616 (774)
T KOG1026|consen 559 ----------------------REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGM 616 (774)
T ss_pred ----------------------ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHH
Confidence 4678999999999 999999997642 22 78899999999999999
Q ss_pred HHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchH
Q 013125 143 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDL 222 (449)
Q Consensus 143 ~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 222 (449)
+||-++.+|||||..+|+||+ +...|||+|||+++..-..++ |+....-.-+.+||+||.|...+++.++||
T Consensus 617 ~YLs~~~FVHRDLATRNCLVg---e~l~VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDV 688 (774)
T KOG1026|consen 617 EYLSSHHFVHRDLATRNCLVG---ENLVVKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDV 688 (774)
T ss_pred HHHHhCcccccchhhhhceec---cceEEEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhh
Confidence 999999999999999999995 899999999999997766554 344434455789999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 223 ESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 223 wSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|||||+|||+++ |+.||.+..+.+..+. |..+.+ .+.+ +++|.++++||..||..+|.+||+|++|...|+.
T Consensus 689 Ws~GVvLWEIFsyG~QPy~glSn~EVIe~---i~~g~l-L~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 689 WSFGVVLWEIFSYGKQPYYGLSNQEVIEC---IRAGQL-LSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hhhhhhhhhhhccccCcccccchHHHHHH---HHcCCc-ccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 999999999998 9999999887654444 333333 2223 5669999999999999999999999999999998
Q ss_pred HHHhc
Q 013125 302 LFSRE 306 (449)
Q Consensus 302 ~~~~~ 306 (449)
.....
T Consensus 762 ~~~~s 766 (774)
T KOG1026|consen 762 WAQAS 766 (774)
T ss_pred HHhcC
Confidence 76654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=329.05 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=207.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
...|+.++.||+|+||.||+|.+..+++.||+|++...... +.+..|+.++..++++++..++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yy-------------- 77 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYY-------------- 77 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhh--------------
Confidence 45788999999999999999999999999999998866443 3477899999888886654433
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.....+...+++|||| ||++.++++. +..+.+..+..++++++.||.|||+++.+|||||+.|||
T Consensus 78 -------------gsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil 143 (467)
T KOG0201|consen 78 -------------GSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANIL 143 (467)
T ss_pred -------------hheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceeccccccccee
Confidence 2334667889999999 9999999885 344588888899999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+. ..+.+||+|||.+-........ ..+++||+.|||||++.+..|+.++||||||++++||++|.+||..
T Consensus 144 ~s---~~g~vkl~DfgVa~ql~~~~~r-------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 144 LS---ESGDVKLADFGVAGQLTNTVKR-------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred Ee---ccCcEEEEecceeeeeechhhc-------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 96 5699999999999877655432 2689999999999999988999999999999999999999999998
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
..+...... .-...++.+...+.+.+++++..||..||+.||++.+|.. +++++.
T Consensus 214 ~hPmrvlfl-------Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk~ 268 (467)
T KOG0201|consen 214 LHPMRVLFL-------IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK--HKFIKR 268 (467)
T ss_pred cCcceEEEe-------ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh--hHHHHh
Confidence 776321111 1112233444567889999999999999999999988754 444444
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=339.24 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=207.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
|..+...++++||+|.||+||+|++.. .||||+++-+...+ .|.+|+.+|++-+|.|++.+.+.+
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-------- 457 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-------- 457 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh--------
Confidence 556778899999999999999999954 49999988664433 488999999999999877665533
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.+... .||+.+| |.+|..++.-...+|.+.+.+.|++||++||.|||.++|||||||..
T Consensus 458 -------------------~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSn 517 (678)
T KOG0193|consen 458 -------------------MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSN 517 (678)
T ss_pred -------------------cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcccc
Confidence 33333 8999999 78899888876788999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC---CCCCccchHHHHHHHHHHHHhC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il~el~~G 235 (449)
||++ .+++.|||+|||++..-..-.... ....-.|...|||||+++. .+|++.+|||||||++|||++|
T Consensus 518 NIFl---~~~~kVkIgDFGLatvk~~w~g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 518 NIFL---HEDLKVKIGDFGLATVKTRWSGEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG 589 (678)
T ss_pred ceEE---ccCCcEEEecccceeeeeeecccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence 9999 467999999999986533211110 1234567889999999984 4589999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
.+||.. ... .+.+..+..+.+.+.......++|.++++|+..||..++++||.|.+|...|++++.
T Consensus 590 ~lPysi-~~~--dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 590 ELPYSI-QNR--DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCCcCC-CCh--hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 999984 222 233333334434455555667789999999999999999999999999998887655
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=323.66 Aligned_cols=279 Identities=26% Similarity=0.445 Sum_probs=196.8
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCC---CceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+.++.+++|++.++||+|+||.||+|.+..+ +..+|+|+...... .+..|...++.+.+...+..
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~--~~~~e~~~~~~~~~~~~~~~---------- 73 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE--TIVMETLVYNNIYDIDKIAL---------- 73 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC--chhhHHHHHHhhhhHHHHHH----------
Confidence 3578899999999999999999999998777 67788887543322 23334433333322211110
Q ss_pred hhhhhhhcccCCCcCeeEEecccCC----eeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGE----DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
+..+....+.+++.+..++.... ..+++++++..++.+++.. ...++...++.++.|++.||+|||+++|+||
T Consensus 74 --~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr 150 (294)
T PHA02882 74 --WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHG 150 (294)
T ss_pred --HHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 01111223345666655544332 4578999998888888765 3446788899999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+ +..+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||+
T Consensus 151 DiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 151 DIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred CCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999 46789999999999876543221111111123457999999999999999999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHH--HHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYD--KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
+|++||.+........... .... .+... ......+|.++.+++..||.++|++||+|.+|.+.|
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIK-RLHEG-KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHH-Hhhhh-hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999998763322111110 0111 11100 112345688999999999999999999999998765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.71 Aligned_cols=252 Identities=24% Similarity=0.298 Sum_probs=201.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
=+|+-.+.+|.|+||.||.|....+++.||||..-.+.. .-.+|+++|+++.|+|++++.......
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~------------ 89 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSS------------ 89 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEec------------
Confidence 368899999999999999999999999999997654332 346899999999999988875443221
Q ss_pred cCCCcCeeEEeccc-CCeeEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 87 TLGGIPNIKWYGVD-GEDNVLVLDLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 87 ~~~~i~~~~~~~~~-~~~~~lv~e~~g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
... .-+..+||||+..+|...++.- +..++.-.++.+.+||.+||.|||+.||+||||||+|+|+
T Consensus 90 -----------~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLv 158 (364)
T KOG0658|consen 90 -----------TESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLV 158 (364)
T ss_pred -----------CCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEE
Confidence 111 2356789999999999998742 5678999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
. .+.+.+||+|||.|+.......+ .++..|..|+|||.+.|.. |+.++||||.||++.||+-|++.|.|
T Consensus 159 D--~~tg~LKicDFGSAK~L~~~epn--------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 159 D--PDTGVLKICDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred c--CCCCeEEeccCCcceeeccCCCc--------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 6 56799999999999987765432 4667899999999999876 99999999999999999999999999
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHH------------------------HhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIE------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+..+....+.++++ .+..+ ......+++..+|+.+++..+|.+|.+..++.
T Consensus 229 ~s~~dQL~eIik~lG---~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLG---TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred CCHHHHHHHHHHHhC---CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 776655444433322 22111 12234567888888888888888888876653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=336.57 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=213.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+-|++++.||.|+-|.|-+|++-.||+.+|||++.+..+ ...+.+|+-+|+.|.|+|+..++.+.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw---------- 81 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW---------- 81 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee----------
Confidence 679999999999999999999999999999999876522 23488999999999999987776653
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+..++|+|.||+ ||-|.+++.. .+++++.++.++++||+.|+.|+|..+|+||||||+|+
T Consensus 82 -----------------e~~~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENl 143 (786)
T KOG0588|consen 82 -----------------ENKQHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENL 143 (786)
T ss_pred -----------------ccCceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhh
Confidence 4668899999999 9999999886 56799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +..+.+||+|||+|..-..... -.+.||.+.|+|||++.|.+| +.++||||.|+|||.|++|++||
T Consensus 144 LL---d~~~nIKIADFGMAsLe~~gkl--------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF 212 (786)
T KOG0588|consen 144 LL---DVKNNIKIADFGMASLEVPGKL--------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF 212 (786)
T ss_pred hh---hcccCEeeeccceeecccCCcc--------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC
Confidence 99 4677799999999986554432 357899999999999999998 78999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+. .....+.++..+.+..| .+++.+.++|+..|+..||+.|.+.++|..
T Consensus 213 dDd---Nir~LLlKV~~G~f~MP-----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 213 DDD---NIRVLLLKVQRGVFEMP-----SNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CCc---cHHHHHHHHHcCcccCC-----CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 853 34567778888888877 566899999999999999999999887744
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=316.80 Aligned_cols=291 Identities=20% Similarity=0.260 Sum_probs=210.6
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCC-cceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS-KIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l~~~~-~~~~~~~~~~~~~~~~~~~ 82 (449)
.|..+++||+|+||+||+|+++.+|+.||+|.+....+.+ ...+|+.+++.|+|.+ ++.+..+......
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~------ 85 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN------ 85 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc------
Confidence 4778899999999999999999999999999887654322 3689999999999999 6666555432210
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~---~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.......++|+||+.-+|.+++.... ..++...++.+++||+.||+|||+++|+||||||+|
T Consensus 86 ---------------~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQN 150 (323)
T KOG0594|consen 86 ---------------HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQN 150 (323)
T ss_pred ---------------ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcce
Confidence 12234778999999999999999876 468889999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+ +.+.+||+|||+|+.+.-+. +.....++|.+|+|||++.+. .|+..+||||+|||++||+++++.
T Consensus 151 lLi~---~~G~lKlaDFGlAra~~ip~-------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 151 LLIS---SSGVLKLADFGLARAFSIPM-------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred EEEC---CCCcEeeeccchHHHhcCCc-------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 9994 79999999999998554332 234567889999999999998 599999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccc
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI 318 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 318 (449)
|.|..+.+....+.+ .+..|.+..|.+... +-+ +...+.+++....+...+. ....+..+.+. .+
T Consensus 221 FpG~se~~ql~~If~----~lGtP~e~~Wp~v~~----~~~--~k~~f~~~~~~~~l~~~~~----~~~~~~~dll~-~~ 285 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFR----LLGTPNEKDWPGVSS----LPD--YKAPFPKWPGPKDLSSILP----KLDPDGIELLS-KL 285 (323)
T ss_pred CCCCcHHHHHHHHHH----HcCCCCccCCCCccc----ccc--ccccCcCCCCccchHHhcc----ccCccHHHHHH-HH
Confidence 999877544333333 333444443322110 000 0001112221111211111 11111111111 67
Q ss_pred ccccccccccccccCCCCccccCCCC
Q 013125 319 LKYQQTQKTKSQDLLPASRVTNSRVM 344 (449)
Q Consensus 319 l~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (449)
++|++.+|.++..++.|+++......
T Consensus 286 L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 286 LQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred hccCcccCcCHHHHhcChhhcccccc
Confidence 88888888888888999888766543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=321.60 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=192.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.++||.|+||.||+|.+..+++.||+|++.... ....+.+|+++++.++|++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~--------------- 69 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH--------------- 69 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEE---------------
Confidence 57999999999999999999999999999999876432 233577899999999998755543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.++......++|||++.++|.+++..++..++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 70 ------------~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~- 136 (288)
T cd07871 70 ------------DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI- 136 (288)
T ss_pred ------------EEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE-
Confidence 3345567889999999889999888766778999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus 137 --~~~~~~kl~DfG~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 137 --NEKGELKLADFGLARAKSVPTK-------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred --CCCCCEEECcCcceeeccCCCc-------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4788999999999976443221 1134567899999999876 56899999999999999999999999875
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHh--------------------------hccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVL--------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
........+ ... ...+.... ....+.+..+++..|+..||.+||+++++.
T Consensus 208 ~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 208 TVKEELHLI---FRL-LGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred CHHHHHHHH---HHH-hCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 543322222 211 11111111 123355677777777777777777766653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=324.04 Aligned_cols=236 Identities=25% Similarity=0.359 Sum_probs=195.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+++++.++|++++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~-------------- 66 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-------------- 66 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhh--------------
Confidence 47999999999999999999999999999999876431 12347789999999998875543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+..+.+..|+||||+ +++|.+++.. .+.++...++.++.||+.||+|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI 132 (291)
T cd05612 67 -------------FWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132 (291)
T ss_pred -------------HhhhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 22335667899999999 8899998875 45789999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 133 li---~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 133 LL---DKEGHIKLTDFGFAKKLRDRT----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred EE---CCCCCEEEEecCcchhccCCc----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99 478899999999997654321 24578999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
+.... ..+..+.......+ ...+..+++++..||..||.+|++
T Consensus 200 ~~~~~---~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 200 DDNPF---GIYEKILAGKLEFP-----RHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCCHH---HHHHHHHhCCcCCC-----ccCCHHHHHHHHHHcCCCHHHccC
Confidence 75432 33444444443333 234778999999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=328.20 Aligned_cols=260 Identities=20% Similarity=0.271 Sum_probs=199.0
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.++||+|+||.||+|.+..+++.||||++... .....+.+|+++++.++|++++.........
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------- 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP--------- 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc---------
Confidence 699999999999999999999999999999987642 1233578899999999999877654432111
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
........|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 72 -------------~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll- 136 (338)
T cd07859 72 -------------SRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA- 136 (338)
T ss_pred -------------CCCCCceEEEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE-
Confidence 0112245799999999999988875 4569999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+.++.+||+|||+++......... .......||..|+|||++.+ ..++.++|||||||++|||++|++||.+
T Consensus 137 --~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 137 --NADCKLKICDFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred --CCCCcEEEccCccccccccccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 478899999999997654322111 01235678999999999876 5789999999999999999999999987
Q ss_pred ChhhcHHHHHHHH-----------------------HHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKI-----------------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i-----------------------~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+... .......+........++.+.+++..||..+|++||+++++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 211 KNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 5432211111110 1111122223333456788899999999999999999887754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=321.50 Aligned_cols=242 Identities=19% Similarity=0.278 Sum_probs=193.0
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+|+++++.++|++++...
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~-------------- 66 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA-------------- 66 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEE--------------
Confidence 3889999999999999999999999999999876431 122467899999999887655433
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
......+..|+||||+ +++|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05631 67 -------------YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENI 133 (285)
T ss_pred -------------EEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 3335567899999999 88998777543 34689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ ++++.++|+|||++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 134 ll---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 134 LL---DDRGHIRISDLGLAVQIPEGET--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred EE---CCCCCEEEeeCCCcEEcCCCCe--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 99 4778999999999986543221 124578999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
+.........+.... ...........+.++.+|+..||..||.+||+
T Consensus 203 ~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05631 203 KRKERVKREEVDRRV----KEDQEEYSEKFSEDAKSICRMLLTKNPKERLG 249 (285)
T ss_pred CCCcchhHHHHHHHh----hcccccCCccCCHHHHHHHHHHhhcCHHHhcC
Confidence 755432222222211 11122233456889999999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=338.31 Aligned_cols=260 Identities=22% Similarity=0.233 Sum_probs=198.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
...++|+++++||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|++++.+........
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~-------- 132 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTEC-------- 132 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecc--------
Confidence 45678999999999999999999999999999999875432 33567999999999999887654321110
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..........++||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 133 -----------~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NI 201 (440)
T PTZ00036 133 -----------FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNL 201 (440)
T ss_pred -----------cccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHE
Confidence 0001122356799999988988877642 45699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|++ .+.+.+||+|||+|+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||
T Consensus 202 Ll~--~~~~~vkL~DFGla~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 202 LID--PNTHTLKLCDFGSAKNLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred EEc--CCCCceeeeccccchhccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 994 2345799999999986643221 1245789999999998764 5899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCH------------------------HHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPI------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
.+......... +......... ..+....+.++.+|+..||..+|.+||++.++
T Consensus 272 ~~~~~~~~~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~ 348 (440)
T PTZ00036 272 SGQSSVDQLVR---IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348 (440)
T ss_pred CCCChHHHHHH---HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 87654332222 2221111110 11123457889999999999999999999887
Q ss_pred HH
Q 013125 296 KR 297 (449)
Q Consensus 296 ~~ 297 (449)
.+
T Consensus 349 l~ 350 (440)
T PTZ00036 349 LA 350 (440)
T ss_pred hC
Confidence 54
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.02 Aligned_cols=238 Identities=21% Similarity=0.311 Sum_probs=201.6
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGG 90 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (449)
-++.||+|+.|.||+|+. .++.||||.++. ....+++.|++|+|+||+.+.++|
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e-----lkETdIKHLRkLkH~NII~FkGVC------------------- 181 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE-----LKETDIKHLRKLKHPNIITFKGVC------------------- 181 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhh-----hhhhhHHHHHhccCcceeeEeeee-------------------
Confidence 367899999999999987 678899996552 345678999999999999888876
Q ss_pred cCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCC
Q 013125 91 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 169 (449)
Q Consensus 91 i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~ 169 (449)
.....+||||||| .|-|..+++. ++.++......|..+|+.||.|||.+.|||||||.-||||+ .+.
T Consensus 182 --------tqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d 249 (904)
T KOG4721|consen 182 --------TQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDD 249 (904)
T ss_pred --------cCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccc
Confidence 3456789999999 8899998886 77899999999999999999999999999999999999996 678
Q ss_pred eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHH
Q 013125 170 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 249 (449)
Q Consensus 170 ~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~ 249 (449)
.|||+|||.++...+..+. -.++||..|||||+|++.+.++++|||||||+||||+||..||...... .
T Consensus 250 ~VKIsDFGTS~e~~~~STk--------MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---A 318 (904)
T KOG4721|consen 250 VVKISDFGTSKELSDKSTK--------MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---A 318 (904)
T ss_pred eEEeccccchHhhhhhhhh--------hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---e
Confidence 9999999999887766442 4789999999999999999999999999999999999999999864322 2
Q ss_pred HHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 250 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 250 ~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
.+..+....+..|++.. +|+.|+-|+++||...|..||+|.+|+..|.
T Consensus 319 IIwGVGsNsL~LpvPst---cP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 319 IIWGVGSNSLHLPVPST---CPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred eEEeccCCcccccCccc---CchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 22223334444555544 4999999999999999999999999977654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=323.64 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=205.7
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----------------CchhHHHHHHHHHHHcCCCcce
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------------KHPQLLYEAKVYKILQGGSKIR 66 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----------------~~~~~~~E~~~l~~l~~~~~~~ 66 (449)
+..-++|++++.||+|.||.|-+|++..+++.||||++.+.. ..+...+|+.+|++|.|+|+++
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445589999999999999999999999999999999976431 1235789999999999999988
Q ss_pred eeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHH
Q 013125 67 LVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEY 144 (449)
Q Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~-~~~~~~~~i~~qil~~L~~ 144 (449)
++.+.- .++.+.+|||+||| .|.+...- +... ++..+++.|++.++.||+|
T Consensus 173 LiEvLD-------------------------DP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEY 225 (576)
T KOG0585|consen 173 LIEVLD-------------------------DPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEY 225 (576)
T ss_pred EEEeec-------------------------CcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHH
Confidence 876542 24678999999999 55544321 1334 8999999999999999999
Q ss_pred HHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC----CCccc
Q 013125 145 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRD 220 (449)
Q Consensus 145 LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~ 220 (449)
||.+|||||||||+|+|++ ++++|||+|||.+..+........- ..-...+||+.|+|||...+.. .+++.
T Consensus 226 LH~QgiiHRDIKPsNLLl~---~~g~VKIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~ 300 (576)
T KOG0585|consen 226 LHYQGIIHRDIKPSNLLLS---SDGTVKISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFAL 300 (576)
T ss_pred HHhcCeeccccchhheEEc---CCCcEEeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhh
Confidence 9999999999999999995 7899999999999876332111000 0112468999999999887632 47899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 221 DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 221 DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
||||+|++||.|+.|+.||.+... .+.+.+|+...+.+|... ...+.+++||..+|.+||++|.+..+|.
T Consensus 301 DiWalGVTLYCllfG~~PF~~~~~---~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 301 DIWALGVTLYCLLFGQLPFFDDFE---LELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred hhhhhhhhHHHhhhccCCcccchH---HHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhhe
Confidence 999999999999999999987544 467778888877777542 2357899999999999999999987773
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.81 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=198.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC----------------CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCc
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSK 64 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~ 64 (449)
+..++|++.++||+|+||.||+|.+.. ++..||+|++..... ...+.+|++++..++|+++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 557899999999999999999998642 334799999875432 2357889999999998876
Q ss_pred ceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------------------CC
Q 013125 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------RK 125 (449)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------------------~~ 125 (449)
+.+++ +....+..|+||||+ +++|.+++.... ..
T Consensus 82 v~~~~---------------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (304)
T cd05096 82 IRLLG---------------------------VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPA 134 (304)
T ss_pred eEEEE---------------------------EEecCCceEEEEecCCCCcHHHHHHhcccccccccccccccccccccc
Confidence 65543 334556789999999 889998875421 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccc
Q 013125 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205 (449)
Q Consensus 126 ~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y 205 (449)
+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....... +.......++..|
T Consensus 135 ~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y 206 (304)
T cd05096 135 ISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRW 206 (304)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEc---CCccEEECCCccceecccCce-----eEecCcCCCCccc
Confidence 67888999999999999999999999999999999994 778999999999986543321 1112334567889
Q ss_pred cccccccCCCCCccchHHHHHHHHHHHHh--CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhC
Q 013125 206 ASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQS 283 (449)
Q Consensus 206 ~aPE~~~~~~~s~~~DvwSlG~il~el~~--G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 283 (449)
+|||++.+..++.++|||||||++|||++ +..||.+............................+|..+.+++..||.
T Consensus 207 ~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 286 (304)
T cd05096 207 MAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWS 286 (304)
T ss_pred cCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHcc
Confidence 99999998899999999999999999986 6788887654332222211111111000011113457899999999999
Q ss_pred CCCCCCCCHHHHHHHHH
Q 013125 284 LTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 284 ~~p~~Rp~~~~l~~~l~ 300 (449)
.+|.+||++.+|.+.|+
T Consensus 287 ~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 287 RDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCchhCcCHHHHHHHHh
Confidence 99999999999987765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=327.73 Aligned_cols=237 Identities=22% Similarity=0.347 Sum_probs=197.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
-++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+++++.++|++++..+.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~----------- 85 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC----------- 85 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEE-----------
Confidence 478999999999999999999999999999999886431 2335788999999999887665433
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.....+..|+||||+ +++|.+.+.. ...++...+..++.||+.||+|||++||+||||||+|
T Consensus 86 ----------------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 148 (329)
T PTZ00263 86 ----------------SFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPEN 148 (329)
T ss_pred ----------------EEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 335667899999999 8899988875 4578999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ +.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 149 Ill---~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 215 (329)
T PTZ00263 149 LLL---DNKGHVKVTDFGFAKKVPDRT----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215 (329)
T ss_pred EEE---CCCCCEEEeeccCceEcCCCc----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC
Confidence 999 478899999999998654322 2457899999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
.+.... ..+..+.......| ...+..+++++..||..||.+|++
T Consensus 216 ~~~~~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 216 FDDTPF---RIYEKILAGRLKFP-----NWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred CCCCHH---HHHHHHhcCCcCCC-----CCCCHHHHHHHHHHhhcCHHHcCC
Confidence 875432 33444444433332 235788999999999999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=328.90 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=198.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|++++..++|++++.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~-------------- 66 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-------------- 66 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccE--------------
Confidence 57999999999999999999999999999999986431 23346789999998888765544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+....+..|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 132 (333)
T cd05600 67 -------------LYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132 (333)
T ss_pred -------------EEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 33445678899999999 8999998875 45789999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 133 l~---~~~~~~kL~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 133 LI---DASGHIKLTDFGLSKGIVTY----------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred EE---CCCCCEEEEeCcCCcccccc----------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 99 47889999999999765431 235679999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhh--cCCCHH-HhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKK--VSTPIE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~--~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+...... +..+.... ...+.. .....++.++.+++..||..+|.+||+++++.+
T Consensus 200 ~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 200 GSTPNET---WENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred CCCHHHH---HHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 7554322 22222111 111111 001245789999999999999999999887754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.35 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=194.8
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.++|++.++||+|+||+||+|++..+++.||||++..... .....+|+.+++.++|++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~--------------- 68 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLL--------------- 68 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeE---------------
Confidence 4789999999999999999999998999999999865422 2346789999999998875544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..+.......|+||||++++|.+++......++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 69 ------------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 136 (303)
T cd07869 69 ------------HDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI 136 (303)
T ss_pred ------------EEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 33345667899999999999998887666679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++.+.+||+|||+++....... ......+|..|+|||++.+. .++.++|||||||++|||++|..||.+
T Consensus 137 ---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 137 ---SDTGELKLADFGLARAKSVPSH-------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred ---CCCCCEEECCCCcceeccCCCc-------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4788999999999975433221 11345678999999998764 589999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCC-------------------------HHHhhc--cChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTP-------------------------IEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~--~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
.... ...+..+........ ....+. ..+..+.+++..||..||.+||++++
T Consensus 207 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~ 284 (303)
T cd07869 207 MKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284 (303)
T ss_pred CccH--HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence 5432 122222211110000 000011 12456788899999999999998776
Q ss_pred HHH
Q 013125 295 LKR 297 (449)
Q Consensus 295 l~~ 297 (449)
+.+
T Consensus 285 ~l~ 287 (303)
T cd07869 285 ALS 287 (303)
T ss_pred Hhc
Confidence 643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.66 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=196.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+++++.++|++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~------------- 67 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE------------- 67 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhh-------------
Confidence 479999999999999999999999999999998865422 335778999999999987655432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..|+||||+.+++.+.+......++...++.++.||+.||.|||+.||+||||||+||++
T Consensus 68 --------------~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill 133 (287)
T cd07848 68 --------------AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI 133 (287)
T ss_pred --------------hEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 234567889999999666666666556679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.++.+||+|||++......... ......||..|+|||++.+..++.++|||||||++|||++|++||.+.
T Consensus 134 ---~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 134 ---SHNDVLKLCDFGFARNLSEGSNA------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ---cCCCcEEEeeccCcccccccccc------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 47789999999999875432211 112457899999999999989999999999999999999999999875
Q ss_pred hhhcHHHHHHHHHHhhcCCCH---------------------------HHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPI---------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
........+..+ ....+. .......+.++.+++..||..||++||+++++
T Consensus 205 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 205 SEIDQLFTIQKV---LGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred CHHHHHHHHHHh---hCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 543322222111 111110 01112356789999999999999999998876
Q ss_pred H
Q 013125 296 K 296 (449)
Q Consensus 296 ~ 296 (449)
.
T Consensus 282 l 282 (287)
T cd07848 282 L 282 (287)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.03 Aligned_cols=240 Identities=22% Similarity=0.304 Sum_probs=194.7
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+|++++.||+|+||.||+|++..+++.||||++... .....+..|++++..+.|++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~------------------- 61 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP------------------- 61 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCC-------------------
Confidence 589999999999999999999999999999988643 22334677888888877665
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+++.+..+....+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 62 -------~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil 133 (324)
T cd05587 62 -------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133 (324)
T ss_pred -------ceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence 3444555556678899999999 8899888765 456899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ .++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 134 l~---~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 134 LD---AEGHIKIADFGMCKENIFGGK-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred Ec---CCCCEEEeecCcceecCCCCC-------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 94 778999999999875332211 12355789999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.... ..+..+.......+ ...+.++.+++..||..+|.+|++.
T Consensus 204 ~~~~---~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 204 EDED---ELFQSIMEHNVSYP-----KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCHH---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 5432 33444444333322 3457899999999999999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=315.02 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=195.6
Q ss_pred CceEEeeeecccCceeEEEEEEcC-CCceEEEEEecCCCC----chhHHHHHHHHHHH---cCCCcceeeEeecchhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK----HPQLLYEAKVYKIL---QGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l---~~~~~~~~~~~~~~~~~~~ 78 (449)
++|++++.||+|+||.||+|++.. +++.||+|++..... .....+|+.+++.+ .|++++..+..+...
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~---- 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS---- 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc----
Confidence 489999999999999999999864 468899998764322 22466788888776 477766554432110
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
........++|||++.++|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 77 ------------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp 138 (290)
T cd07862 77 ------------------RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 138 (290)
T ss_pred ------------------cCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH
Confidence 01234568999999988999988754 34589999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||++ .++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|.+
T Consensus 139 ~Nil~~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 139 QNILVT---SSGQIKLADFGLARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred HHEEEc---CCCCEEEccccceEeccCCcc--------cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCC
Confidence 999994 788999999999986543311 235678999999999999899999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhc----------------------CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKV----------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
||.+..... .+..+..... ..+.+......++.+.+++..||..||++||++.++
T Consensus 208 ~f~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 208 LFRGSSDVD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred CcCCCCHHH---HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 998765433 2222322111 111223334567788999999999999999998876
Q ss_pred H
Q 013125 296 K 296 (449)
Q Consensus 296 ~ 296 (449)
.
T Consensus 285 l 285 (290)
T cd07862 285 L 285 (290)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=325.75 Aligned_cols=237 Identities=22% Similarity=0.306 Sum_probs=190.8
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
+.||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++|++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~-------------------- 60 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-------------------- 60 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCE--------------------
Confidence 46999999999999999999999999987431 12346788999999888865543
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
..+....+..|+||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +
T Consensus 61 -------~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~ 129 (323)
T cd05571 61 -------KYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---D 129 (323)
T ss_pred -------EEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---C
Confidence 33445677899999999 8889888765 5679999999999999999999999999999999999999 4
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 130 ~~~~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-- 200 (323)
T cd05571 130 KDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-- 200 (323)
T ss_pred CCCCEEEeeCCCCcccccCCC-------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--
Confidence 788999999999875332211 12356799999999999999999999999999999999999999976433
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFL 295 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l 295 (449)
......+.......| ..+++++.+++..||..||.+|| ++.++
T Consensus 201 -~~~~~~~~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 248 (323)
T cd05571 201 -EKLFELILMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI 248 (323)
T ss_pred -HHHHHHHHcCCCCCC-----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence 223333333333322 34578999999999999999999 55554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.07 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=215.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.+.|.+.+.||+|.|+.||++.+..+|+.+|+|+++.. ...+.+.+|+.|-+.|+|++++++...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t--------- 78 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS--------- 78 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh---------
Confidence 5678999999999999999999999999999999987643 345678999999999999998776432
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
..+....|||+|++ |++|..-+.. ..-+++..+-.+.+||+++|.|+|+.||||||+||+
T Consensus 79 ------------------i~~~~~~ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~ 139 (355)
T KOG0033|consen 79 ------------------IQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPE 139 (355)
T ss_pred ------------------hcccceeEEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChh
Confidence 23556789999999 8888765554 244788899999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|+|+...+...-+||+|||+|....... ...+.+||+.|||||++.+.+|+..+|||+.|++||-|+.|.+|
T Consensus 140 nllLASK~~~A~vKL~~FGvAi~l~~g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 140 NLLLASKAKGAAVKLADFGLAIEVNDGE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred heeeeeccCCCceeecccceEEEeCCcc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCC
Confidence 9999887788899999999999887332 24588999999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
|.+.+ ....+..|....+..+.+ .|....++.++|+.+||..||.+|.++.+.
T Consensus 212 F~~~~---~~rlye~I~~g~yd~~~~-~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 212 FWDED---QHRLYEQIKAGAYDYPSP-EWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred CCCcc---HHHHHHHHhccccCCCCc-ccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 99843 335677788888777754 456778999999999999999999987654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=312.66 Aligned_cols=256 Identities=15% Similarity=0.243 Sum_probs=201.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+-..+|++.+.||+|+||.||+|.+. ..+..||+|+++..... ..+.+|+.+++.++|+++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~--------- 72 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE--------- 72 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEE---------
Confidence 45678999999999999999999875 45678999998765332 2477899999888888655543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.+....+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++|++|||||
T Consensus 73 ------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dik 134 (266)
T cd05064 73 ------------------GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA 134 (266)
T ss_pred ------------------EEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 3445667899999999 778888887655679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+|||+ +.++.++++|||.+......... ......++..|+|||++.+..++.++|||||||++||+++ |
T Consensus 135 p~nili---~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g 205 (266)
T cd05064 135 AHKVLV---NSDLVCKISGFRRLQEDKSEAIY------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG 205 (266)
T ss_pred HhhEEE---cCCCcEEECCCcccccccccchh------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCC
Confidence 999999 47889999999987643221110 0113345678999999999999999999999999999775 9
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
..||.+..... ....+ ......+. ...+|..+.+++..||..+|.+||++++|.+.|..+
T Consensus 206 ~~p~~~~~~~~---~~~~~-~~~~~~~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 206 ERPYWDMSGQD---VIKAV-EDGFRLPA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCcCcCCHHH---HHHHH-HCCCCCCC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99998765432 22222 22222222 245688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=328.54 Aligned_cols=196 Identities=20% Similarity=0.203 Sum_probs=166.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
..++|+++++||+|+||.||+|.+..+++.||+|+.. ...+.+|+++++.|+|++++.+..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~--------------- 150 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKG--------------- 150 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeE---------------
Confidence 4578999999999999999999999999999999754 235789999999999987665533
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
++......|+|+|+++++|..++.. ...++...++.++.||+.||+|||++||+||||||+|||+.
T Consensus 151 ------------~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~- 216 (391)
T PHA03212 151 ------------TFTYNKFTCLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN- 216 (391)
T ss_pred ------------EEEECCeeEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc-
Confidence 3345678899999999999888765 45689999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
..+.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 217 --~~~~vkL~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 217 --HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred --CCCCEEEEeCCccccccccccc------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 7789999999999754322211 12356799999999999999999999999999999999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=320.06 Aligned_cols=311 Identities=21% Similarity=0.296 Sum_probs=235.3
Q ss_pred CcccC-CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCc----ceeeEeecchh
Q 013125 2 ERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSK----IRLVVFHVDHV 75 (449)
Q Consensus 2 ~~i~~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~----~~~~~~~~~~~ 75 (449)
|+.+. +||.+.++||.|.|++||+|+|..+.+.||+||.+.... .+..+.|+++|+.++.... ...+..
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~----- 146 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ----- 146 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee-----
Confidence 55666 999999999999999999999999999999999987543 3346889999998865441 111111
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHS-RGFLHR 153 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~-~giiHr 153 (449)
.+..|...|+++.|+|||+|++|.+|+.+|+++. +.+++..++.|++|||.||.|||. +||||.
T Consensus 147 --------------LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 147 --------------LLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred --------------eeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 2333567789999999999999999999999875 559999999999999999999997 699999
Q ss_pred CCCCCcEEeecCC-------------------------------------------------------------------
Q 013125 154 DIKPDNFLMGLGR------------------------------------------------------------------- 166 (449)
Q Consensus 154 DLkp~Nill~~~~------------------------------------------------------------------- 166 (449)
||||+|||+...+
T Consensus 213 DlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~ 292 (590)
T KOG1290|consen 213 DLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLE 292 (590)
T ss_pred CCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccc
Confidence 9999999982100
Q ss_pred --------------------------------------------------------------------------------
Q 013125 167 -------------------------------------------------------------------------------- 166 (449)
Q Consensus 167 -------------------------------------------------------------------------------- 166 (449)
T Consensus 293 ~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~ 372 (590)
T KOG1290|consen 293 GIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPG 372 (590)
T ss_pred cccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcc
Confidence
Q ss_pred ----------------CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHH
Q 013125 167 ----------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 167 ----------------~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~ 230 (449)
.+.+|||+|||.|..+...-+ .-..|..|+|||+++|..|+..+||||++|++|
T Consensus 373 ~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT----------~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~F 442 (590)
T KOG1290|consen 373 TIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFT----------EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAF 442 (590)
T ss_pred ccccccccCCCCCCCccceeEEEeeccchhhhhhhhc----------hhhhhhhccCcceeecCCCCCchhHHHHHHHHH
Confidence 001478888888877655433 335688999999999999999999999999999
Q ss_pred HHHhCCCCCCCChh---hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC
Q 013125 231 YFLRGSLPWQGLKA---ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307 (449)
Q Consensus 231 el~~G~~pf~~~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 307 (449)
||+||..+|....+ ......+..|++.....|...+..+ .--++++..-=.+.--.|..+--|.+.|.+-+.-..
T Consensus 443 ELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~G--k~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~ 520 (590)
T KOG1290|consen 443 ELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGG--KYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSE 520 (590)
T ss_pred HhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcC--cchHhhhccccceecccccCCCcHHHHHHHHhCCCH
Confidence 99999999965433 2244566667777777777665543 234566665555555556555556666655543332
Q ss_pred CCCCccccc--ccccccccccccccccCCCCccccCCC
Q 013125 308 YDFDFVFDW--TILKYQQTQKTKSQDLLPASRVTNSRV 343 (449)
Q Consensus 308 ~~~~~~~dw--~~l~~~~~~~~~~~~~~~~~~~~~~~~ 343 (449)
.+..+.-|| .||+++|++|+++.+++.|||+.....
T Consensus 521 e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 521 EDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 222222233 889999999999999999999876554
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.34 Aligned_cols=209 Identities=22% Similarity=0.335 Sum_probs=168.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
..++|+++++||+|+||+||+|.+..+++.||||+++.... ......|+++++.+++.+.....
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~--------------- 191 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRF--------------- 191 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCc---------------
Confidence 35789999999999999999999999999999999865322 33467799999998876533211
Q ss_pred hcccCCCcCee-EEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~-~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nil 161 (449)
++..+ .++.....+.|+|||++|++|.+++.. ...+++..++.++.||+.||+|||+ .|||||||||+|||
T Consensus 192 ------~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NIL 264 (467)
T PTZ00284 192 ------PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264 (467)
T ss_pred ------ceeeeEEEEEcCCceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence 23333 233345568899999999999998875 4579999999999999999999998 59999999999999
Q ss_pred eecCC-------------CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHH
Q 013125 162 MGLGR-------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228 (449)
Q Consensus 162 l~~~~-------------~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 228 (449)
+...+ +...+||+|||++...... ....+||..|+|||++.+..|+.++|||||||+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 334 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHH
Confidence 95321 1235999999987543221 235689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCChhh
Q 013125 229 LLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~ 245 (449)
+|||++|++||.+....
T Consensus 335 l~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 335 IYELYTGKLLYDTHDNL 351 (467)
T ss_pred HHHHHhCCCCCCCCChH
Confidence 99999999999876543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=324.73 Aligned_cols=260 Identities=21% Similarity=0.348 Sum_probs=223.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
....+.++||-|-||+||.|.|++..-.||||.++.+.. .++|+.|+.+|+.++|+|.+.++++|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-------------- 332 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-------------- 332 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh--------------
Confidence 456778999999999999999999999999999987654 55799999999999999999888776
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~-~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..+-.+|||+||| .|+|++++..|.+. ++.-..+.++.||..||+||..+++|||||...|+|++
T Consensus 333 -------------T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg 399 (1157)
T KOG4278|consen 333 -------------THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 399 (1157)
T ss_pred -------------ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc
Confidence 3456789999999 99999999988764 56666788899999999999999999999999999996
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
++..||++||||++.+..+++..| .+..-...|.|||.+....++.++|||+||++|||+.| |..||.|.
T Consensus 400 ---EnhiVKvADFGLsRlMtgDTYTAH------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 400 ---ENHIVKVADFGLSRLMTGDTYTAH------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred ---ccceEEeeccchhhhhcCCceecc------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 889999999999999988876543 34555788999999999999999999999999999998 99999997
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCC
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 309 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 309 (449)
.-.. +..++++.+...-+ ++||+.+.+||..||+++|.+||+|.+|-+.|+.+|....+.
T Consensus 471 dlSq----VY~LLEkgyRM~~P---eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 471 DLSQ----VYGLLEKGYRMDGP---EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred cHHH----HHHHHhccccccCC---CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 5432 33344555544433 566999999999999999999999999999999998876543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=332.19 Aligned_cols=259 Identities=27% Similarity=0.378 Sum_probs=212.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCC----ceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
..++-.+.++||+|+||+||+|.....+ ..||+|..+... ...++++|+++|+.++|+|+++++++.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa---- 230 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA---- 230 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence 4456677899999999999999986432 238999877421 234589999999999999988887765
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
......+||||+| ||+|.++++..+..++..+...++.+.++||+|||++++||||
T Consensus 231 -----------------------~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRD 287 (474)
T KOG0194|consen 231 -----------------------VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRD 287 (474)
T ss_pred -----------------------cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchh
Confidence 4567889999999 9999999998777799999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCC-CCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
|..+|+|++ .++.+||+|||+|+.... |.... ...-+.+|+|||++....|+.++|||||||++||++
T Consensus 288 IAARNcL~~---~~~~vKISDFGLs~~~~~--------~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 288 IAARNCLYS---KKGVVKISDFGLSRAGSQ--------YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred HhHHHheec---CCCeEEeCccccccCCcc--------eeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 999999995 667789999999875431 11112 224578999999999999999999999999999999
Q ss_pred h-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC
Q 013125 234 R-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307 (449)
Q Consensus 234 ~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 307 (449)
+ |..||.++..... ..+|.......+.+. ..|.++..++..||..+|++||++.++.+.|+.+.....
T Consensus 357 ~~g~~Py~g~~~~~v---~~kI~~~~~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYEV---KAKIVKNGYRMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ccCCCCCCCCCHHHH---HHHHHhcCccCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 8 8999999877643 334434444444443 458999999999999999999999999999998866543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=320.88 Aligned_cols=240 Identities=21% Similarity=0.305 Sum_probs=192.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+|.+++.||+|+||.||+|++..+++.||||++..... ......|..++..+.+..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~------------------- 61 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP------------------- 61 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCC-------------------
Confidence 58999999999999999999999999999999875321 123455666666654433
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++..+..+....+..|+||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 62 -------~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil 133 (323)
T cd05616 62 -------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133 (323)
T ss_pred -------eEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeE
Confidence 3444555556778899999999 8899888765 456999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ +.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 134 l---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 134 L---DSEGHIKIADFGMCKENMWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred E---CCCCcEEEccCCCceecCCCCC-------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 9 4788999999999975432221 12356789999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.... ..+..+.......| ...+.++.+++..|+..+|.+|++.
T Consensus 204 ~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 204 EDED---ELFQSIMEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCHH---HHHHHHHhCCCCCC-----CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 5443 34444444443333 3457899999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=326.44 Aligned_cols=257 Identities=20% Similarity=0.334 Sum_probs=199.9
Q ss_pred CCceEEeeeecccCceeEEEEEEcCC-----CceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecchhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~ 76 (449)
.++|++++.||+|+||.||+|.+... ...||||+++.... ...+.+|+++++.+ +|++++..++
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~------- 109 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLG------- 109 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEee-------
Confidence 46799999999999999999986443 35799999875432 23477899999998 7777555443
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--------------------------------
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-------------------------------- 123 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-------------------------------- 123 (449)
++......|+||||+ +++|.+++....
T Consensus 110 --------------------~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (374)
T cd05106 110 --------------------ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRS 169 (374)
T ss_pred --------------------EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccc
Confidence 345667889999999 899998875421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 124 -------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 124 -------------------------------------~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~--- 246 (374)
T cd05106 170 DSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT--- 246 (374)
T ss_pred cccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---
Confidence 2478889999999999999999999999999999999994
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhh
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAA 245 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~ 245 (449)
+++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 247 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 247 DGRVAKICDFGLARDIMNDSNY-----VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred CCCeEEEeeceeeeeccCCcce-----eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 7789999999999865433211 11123345678999999999899999999999999999997 99999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
. .+..+......... ....++++.+++..||..+|.+||++.+|.+.|++++
T Consensus 322 ~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 322 S---KFYKMVKRGYQMSR---PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred H---HHHHHHHcccCccC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2 22222222222211 1234789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=294.86 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=210.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
--++|.+++.||+|-||.||+|+..+++-.||+||+.+. ....++.+|++|...|+|+|+.++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrl------------ 87 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRL------------ 87 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhh------------
Confidence 347899999999999999999999999999999986543 234467888888888888876654
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+.++.+....||++||. .|.+...+... ..+|++.....++.|++.||.|+|.++||||||||
T Consensus 88 ---------------Y~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp 152 (281)
T KOG0580|consen 88 ---------------YGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP 152 (281)
T ss_pred ---------------hhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCH
Confidence 34456778899999999 77777777633 45699999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|+|++ ..+.+||+|||-+...... ...+++||..|.+||+..+...+..+|+|++|++.||++.|.+
T Consensus 153 enlLlg---~~~~lkiAdfGwsV~~p~~---------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~p 220 (281)
T KOG0580|consen 153 ENLLLG---SAGELKIADFGWSVHAPSN---------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLP 220 (281)
T ss_pred HHhccC---CCCCeeccCCCceeecCCC---------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCC
Confidence 999995 7899999999998754422 2368999999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.... ..+.+.+|....+..| ...+.+.+++|.+|+..+|.+|....++.+
T Consensus 221 pFes~~---~~etYkrI~k~~~~~p-----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 221 PFESQS---HSETYKRIRKVDLKFP-----STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred chhhhh---hHHHHHHHHHccccCC-----cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 998755 5577888888888777 455789999999999999999999777654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=323.09 Aligned_cols=238 Identities=24% Similarity=0.333 Sum_probs=194.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCC-ceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+.-++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+|+++++.++|++++.++
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~--------- 97 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY--------- 97 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceE---------
Confidence 44578999999999999999999976554 68999987532 2234577899999999988755543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.+....+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+|||||
T Consensus 98 ------------------~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 158 (340)
T PTZ00426 98 ------------------GSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK 158 (340)
T ss_pred ------------------EEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC
Confidence 3345667899999999 8899998875 5579999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ +.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 159 p~NILl---~~~~~ikL~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~ 225 (340)
T PTZ00426 159 PENLLL---DKDGFIKMTDFGFAKVVDTRT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225 (340)
T ss_pred HHHEEE---CCCCCEEEecCCCCeecCCCc----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCC
Confidence 999999 478899999999998654221 2567899999999999988999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
.||.+.... ..+..+.......| ...+..+.+++..||..+|.+|+
T Consensus 226 ~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 226 PPFYANEPL---LIYQKILEGIIYFP-----KFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCCCCCCHH---HHHHHHhcCCCCCC-----CCCCHHHHHHHHHHcccCHHHcC
Confidence 999875432 33444444333332 34578899999999999999996
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=325.03 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=191.8
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.++..++|++++..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~-------------- 66 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM-------------- 66 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceE--------------
Confidence 47999999999999999999999999999999986431 12346778888888887765443
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.....+....|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 67 -------------FYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred -------------EEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 34445677899999999 8899998875 46799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCc-------ccc---------------------ccCCCCCCCCcccccccccc
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNR-------HIP---------------------YRENKNLTGTARYASCNTHL 212 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~-------~~~---------------------~~~~~~~~gt~~y~aPE~~~ 212 (449)
|+ +.++.+||+|||+++......... ..| .......+||+.|+|||++.
T Consensus 133 Li---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 133 LL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred EE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 99 478899999999997653221100 000 00012457999999999999
Q ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhh--cCCCHHHhhccChHHHHHHHHHHhCCCCC---
Q 013125 213 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFD--- 287 (449)
Q Consensus 213 ~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~l~~~~l~~~p~--- 287 (449)
+..++.++|||||||++|||++|+.||.+.... ..+..+.... ...|.. ...++++.+++..++. ++.
T Consensus 210 ~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~-~~~~r~ 282 (363)
T cd05628 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ---ETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCC-EWEHRI 282 (363)
T ss_pred CCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcC-ChhhcC
Confidence 999999999999999999999999999875433 3334443322 112211 1246788888887654 444
Q ss_pred CCCCHHHHH
Q 013125 288 QRPDYGFLK 296 (449)
Q Consensus 288 ~Rp~~~~l~ 296 (449)
.||++++|.
T Consensus 283 ~r~~~~ei~ 291 (363)
T cd05628 283 GAPGVEEIK 291 (363)
T ss_pred CCCCHHHHh
Confidence 457777663
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=319.56 Aligned_cols=273 Identities=20% Similarity=0.296 Sum_probs=209.2
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
++..++|++.++||+|+||.||+|.+..++..||+|++..... ...+.+|+++++.++|++++..++
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~---------- 70 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG---------- 70 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeE----------
Confidence 3567899999999999999999999999999999998765422 235789999999999887655443
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKP 157 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp 157 (449)
++...+..|+||||+ +++|.+++.. ...++...+..++.|++.||.|||+. +|+||||||
T Consensus 71 -----------------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp 132 (333)
T cd06650 71 -----------------AFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 132 (333)
T ss_pred -----------------EEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh
Confidence 345567899999999 8899998875 45689999999999999999999985 799999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+. ..+.+||+|||++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 133 ~Nili~---~~~~~kL~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 200 (333)
T cd06650 133 SNILVN---SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY 200 (333)
T ss_pred hhEEEc---CCCCEEEeeCCcchhhhhhc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999994 67889999999987654322 134578999999999999889999999999999999999999
Q ss_pred CCCCChhhcHHHHHH-------------------------------------HHHHhhcCCCHHHhh-ccChHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYD-------------------------------------KICEKKVSTPIEVLC-KSHPAEFASYFH 279 (449)
Q Consensus 238 pf~~~~~~~~~~~~~-------------------------------------~i~~~~~~~~~~~~~-~~~~~~~~~l~~ 279 (449)
||...........+. .+.........+... ...+.++.+|+.
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 280 (333)
T cd06650 201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVN 280 (333)
T ss_pred CCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHH
Confidence 997643321111000 000000000001111 124678999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCcccccc
Q 013125 280 YCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 317 (449)
Q Consensus 280 ~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~ 317 (449)
+||..||.+||++.++.. ..+++....+..+...|.
T Consensus 281 ~~L~~~P~~Rpt~~ell~--h~~~~~~~~~~~~~~~~~ 316 (333)
T cd06650 281 KCLIKNPAERADLKQLMV--HAFIKRSEAEEVDFAGWL 316 (333)
T ss_pred HhccCCcccCcCHHHHhh--CHHHhcCccccccHHHHH
Confidence 999999999999998843 666766555555555663
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.94 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=217.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
|.+=|.+.+.||+|.|+.|-+|++.-||++|||||+.+..- ...++.|+++|+..+|+|+++++.+.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--------- 86 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--------- 86 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh---------
Confidence 45789999999999999999999999999999999987532 23589999999999999988876542
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
..+...|||+|+- +|+|.|++.+....+.+..+++|+.||+.||.|+|...+|||||||+|
T Consensus 87 ------------------DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPEN 148 (864)
T KOG4717|consen 87 ------------------DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPEN 148 (864)
T ss_pred ------------------cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcce
Confidence 4567889999999 889999999888889999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCC-ccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwSlG~il~el~~G~~p 238 (449)
+++- .+-|.|||.|||++-.+.... .-.+.+|+..|-|||+++|..|+ +++||||||+|||-|++|++|
T Consensus 149 VVFF--EKlGlVKLTDFGFSNkf~PG~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P 218 (864)
T KOG4717|consen 149 VVFF--EKLGLVKLTDFGFSNKFQPGK--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP 218 (864)
T ss_pred eEEe--eecCceEeeeccccccCCCcc--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc
Confidence 9886 578999999999997665433 23578999999999999999984 689999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+..++. +.+-.|+.+++..|... +.+.++||..||..||.+|.+.++|..
T Consensus 219 FqeANDS---ETLTmImDCKYtvPshv-----S~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 219 FQEANDS---ETLTMIMDCKYTVPSHV-----SKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccccch---hhhhhhhcccccCchhh-----hHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 9976554 45566788999988665 679999999999999999999988754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=320.55 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=192.1
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.++|++++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~---------------------- 58 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL---------------------- 58 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEece----------------------
Confidence 79999999999999999999999987642 122346789999999988875544
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
..+....+..|+||||+ +++|.+++.. ...++...++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 59 -----~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~ 129 (312)
T cd05585 59 -----KFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQ 129 (312)
T ss_pred -----eeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCC
Confidence 33335667899999999 8999988875 5579999999999999999999999999999999999999 478
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 248 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~ 248 (449)
+.++|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 130 ~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--- 199 (312)
T cd05585 130 GHIALCDFGLCKLNMKDDD-------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--- 199 (312)
T ss_pred CcEEEEECcccccCccCCC-------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---
Confidence 8999999999875432221 123567999999999999999999999999999999999999999875432
Q ss_pred HHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 249 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
+.+..+.......+ ...++++.+++..||..||.+||++..+.+.+
T Consensus 200 ~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 200 EMYRKILQEPLRFP-----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHcCCCCCC-----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 33444443333322 34578999999999999999999765444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=319.17 Aligned_cols=303 Identities=19% Similarity=0.272 Sum_probs=226.7
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++++.+||.++..+|+|.||.|-.+.|..++..|||||++.-.. .+...-|+++++++.+.......
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~------------ 151 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKF------------ 151 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCce------------
Confidence 67889999999999999999999999999999999999886543 44567899999998544322111
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.+..+..++...++.|||+|++|.++.++++.. -.+|+..+++.+++||+.+++|||+.+++|.||||+|
T Consensus 152 ---------rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 152 ---------RCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN 222 (415)
T ss_pred ---------EEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence 122334455677899999999999999999863 3569999999999999999999999999999999999
Q ss_pred EEeecCC-----------------CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchH
Q 013125 160 FLMGLGR-----------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDL 222 (449)
Q Consensus 160 ill~~~~-----------------~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 222 (449)
||+...+ +...|+|+|||.|+.-.... ...+.|..|+|||++++..|+..+||
T Consensus 223 ILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDv 292 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDV 292 (415)
T ss_pred EEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCc
Confidence 9984211 24468999999998665544 36788999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHH-HHhCCC--CCCC--CCHHHHHH
Q 013125 223 ESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH-YCQSLT--FDQR--PDYGFLKR 297 (449)
Q Consensus 223 wSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~-~~l~~~--p~~R--p~~~~l~~ 297 (449)
||+||||+|+.+|...|++..+.+...+++.|++ +.|...+.+.. ..+++. .++.++ ...| -...+...
T Consensus 293 WSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG---p~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ck 366 (415)
T KOG0671|consen 293 WSIGCILVELYTGETLFQTHENLEHLAMMERILG---PIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCK 366 (415)
T ss_pred eeeeeEEEEeeccceecccCCcHHHHHHHHHhhC---CCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCc
Confidence 9999999999999999999887766666666544 44444333211 222222 223221 1112 11111222
Q ss_pred HHHHHHHhcCCCCCccccc--ccccccccccccccccCCCCccccC
Q 013125 298 LFHDLFSREGYDFDFVFDW--TILKYQQTQKTKSQDLLPASRVTNS 341 (449)
Q Consensus 298 ~l~~~~~~~~~~~~~~~dw--~~l~~~~~~~~~~~~~~~~~~~~~~ 341 (449)
.|+..+...+.+....||- .|+.++|++|.++.+++.|++|...
T Consensus 367 pl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 367 PLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred cHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 4445555555555555554 7899999999999999999998654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=309.41 Aligned_cols=256 Identities=20% Similarity=0.244 Sum_probs=195.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHH---cCCCcceeeEeecchhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKIL---QGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l---~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+|++.+.||+|+||+||+|++..+++.||+|++..... .....+|+++++.+ .|++++..+......
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~------ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS------ 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc------
Confidence 69999999999999999999999999999998765322 22466788888776 466655554322110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
........++|||++.++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|
T Consensus 75 ----------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N 138 (288)
T cd07863 75 ----------------RTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN 138 (288)
T ss_pred ----------------cCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 012345679999999889988887543 458999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ +.++.+||+|||+++....... .....+|..|+|||++.+..++.++|||||||++|||++|.+||
T Consensus 139 ili---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 139 ILV---TSGGQVKLADFGLARIYSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred EEE---CCCCCEEECccCccccccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence 999 4788999999999976543221 12456789999999999989999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHh-------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKICEK-------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~-------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+.........+...... ....+........+..+.+++..|+..||.+||++.++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 208 CGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 875543322222221110 001112233345678899999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.26 Aligned_cols=254 Identities=18% Similarity=0.289 Sum_probs=198.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+..++|+++++||+|+||.||+|++..++..||+|++..... ...+.+|+++++.++|++++..+.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~----------- 70 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG----------- 70 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEE-----------
Confidence 557899999999999999999999999999999998875422 235789999999999887655543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPD 158 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp~ 158 (449)
+....+..++||||+ +++|.+++.. ...++...+..++.|++.||.|||++ +|+||||||+
T Consensus 71 ----------------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~ 133 (331)
T cd06649 71 ----------------AFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 133 (331)
T ss_pred ----------------EEEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChh
Confidence 334567889999999 8899998875 45689999999999999999999986 6999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+. .++.++|+|||++....... .....||..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 134 Nil~~---~~~~~kl~Dfg~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 201 (331)
T cd06649 134 NILVN---SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201 (331)
T ss_pred hEEEc---CCCcEEEccCcccccccccc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99994 77899999999987654322 1345789999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHH---------------------------------------HHHHhhcCCCHHH-hhccChHHHHHHH
Q 013125 239 WQGLKAATKKQKYD---------------------------------------KICEKKVSTPIEV-LCKSHPAEFASYF 278 (449)
Q Consensus 239 f~~~~~~~~~~~~~---------------------------------------~i~~~~~~~~~~~-~~~~~~~~~~~l~ 278 (449)
|...........+. ...........+. .....++++.+|+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 281 (331)
T cd06649 202 IPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFV 281 (331)
T ss_pred CCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHH
Confidence 97543321111000 0000000000000 0123567899999
Q ss_pred HHHhCCCCCCCCCHHHHHH
Q 013125 279 HYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 279 ~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+||..||++||++++|.+
T Consensus 282 ~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 282 NKCLIKNPAERADLKMLMN 300 (331)
T ss_pred HHHccCCcccCCCHHHHhc
Confidence 9999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.24 Aligned_cols=238 Identities=22% Similarity=0.325 Sum_probs=189.3
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHH---cCCCcceeeEeecchhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKIL---QGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l---~~~~~~~~~~~~~~~~~~~~~ 80 (449)
|++++.||+|+||.||+|.+..+++.||||+++... ....+.+|++++..+ +|++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~----------------- 63 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF----------------- 63 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCC-----------------
Confidence 789999999999999999999999999999986431 123456676666543 3444
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+..+..+....+..|+||||+ +++|...+. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 64 ----------i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~N 131 (324)
T cd05589 64 ----------LVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131 (324)
T ss_pred ----------hhceeeEEEcCCEEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHH
Confidence 444555556778899999999 888877765 4579999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ +.++.+||+|||+++....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 132 ill---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf 201 (324)
T cd05589 132 LLL---DTEGFVKIADFGLCKEGMGFGD-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201 (324)
T ss_pred eEE---CCCCcEEeCcccCCccCCCCCC-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 999 4788999999999875332211 123567999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+.... ..+..+.......| ..++.++.+++..||..||.+||+..
T Consensus 202 ~~~~~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 202 PGDDEE---EVFDSIVNDEVRYP-----RFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CCCCHH---HHHHHHHhCCCCCC-----CCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 875433 23333433333222 34578999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.22 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=193.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+|.+.+.||+|+||+||+|++..+++.||||++... .....+..|+.++..+.|.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~------------------- 61 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP------------------- 61 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCC-------------------
Confidence 478999999999999999999999999999988643 11234667888887776655
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++..+..+....+..|+||||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 62 -------~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nil 133 (323)
T cd05615 62 -------FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM 133 (323)
T ss_pred -------chhheeeEEecCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 3444444556677899999999 8899888765 456999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ +.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 134 l---~~~~~ikL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 134 L---DSEGHIKIADFGMCKEHMVDGV-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred E---CCCCCEEEeccccccccCCCCc-------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 9 4788999999999875432221 12356789999999999998999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.... ..+..+.......| ...+.++.+++..||..+|.+|++.
T Consensus 204 ~~~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 204 EDED---ELFQSIMEHNVSYP-----KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCHH---HHHHHHHhCCCCCC-----ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 5432 34444444443333 3457889999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=325.61 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=193.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~--------------- 65 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK--------------- 65 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcc---------------
Confidence 47999999999999999999999999999999986431 1234677999999988876544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.++...+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 66 ------------~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI 132 (364)
T cd05599 66 ------------LYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132 (364)
T ss_pred ------------eEEEEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 344456778899999999 8899998875 45799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccc-----------------c---------cc-----CCCCCCCCccccccc
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-----------------P---------YR-----ENKNLTGTARYASCN 209 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~-----------------~---------~~-----~~~~~~gt~~y~aPE 209 (449)
|+ +.++.++|+|||+++.+......... + +. .....+||+.|+|||
T Consensus 133 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 133 LL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred EE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 99 47889999999999765432110000 0 00 011357999999999
Q ss_pred cccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCC
Q 013125 210 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 289 (449)
Q Consensus 210 ~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 289 (449)
++.+..++.++|||||||++|||++|..||.+.... +.+..+.........+. ...+++++.+++..|+. +|.+|
T Consensus 210 ~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R 284 (364)
T cd05599 210 VFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ---ETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERR 284 (364)
T ss_pred HHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH---HHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhc
Confidence 999999999999999999999999999999875543 23333332221111111 12457889999999996 89999
Q ss_pred CC
Q 013125 290 PD 291 (449)
Q Consensus 290 p~ 291 (449)
++
T Consensus 285 ~~ 286 (364)
T cd05599 285 LG 286 (364)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.52 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=196.8
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.++||+|+||.||+|++..+++.||+|+++... ....+.+|+++++.++|++++....
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-------------- 71 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD-------------- 71 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEE--------------
Confidence 68999999999999999999999999999999876432 2235678999999999887655433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+....+..|+||||+.++|.+.+...+..++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 72 -------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill- 137 (309)
T cd07872 72 -------------IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI- 137 (309)
T ss_pred -------------EEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE-
Confidence 335567889999999889998887766778999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+..+.+||+|||+++........ .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 138 --~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 138 --NERGELKLADFGLARAKSVPTKT-------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred --CCCCCEEECccccceecCCCccc-------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 47789999999999764433211 123467899999998875 45899999999999999999999999876
Q ss_pred hhhcHHHHHHHHHHhhcC----------------------CCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVS----------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...+....+......... .+........++++.+++..||..||.+||++.++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 544333222221110000 0001112235677888999999999999998877644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=318.42 Aligned_cols=232 Identities=23% Similarity=0.323 Sum_probs=186.9
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
+.||+|+||.||+|++..+++.||+|++.... ....+.+|+++++.++|++++.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~-------------------- 60 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-------------------- 60 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcce--------------------
Confidence 47999999999999999999999999886431 22345678999999988865543
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
..++...+..|+||||+ +++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +
T Consensus 61 -------~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~ 129 (323)
T cd05595 61 -------KYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---D 129 (323)
T ss_pred -------eeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---c
Confidence 33345667899999999 8888877764 5579999999999999999999999999999999999999 4
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 130 ~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~- 201 (323)
T cd05595 130 KDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE- 201 (323)
T ss_pred CCCCEEecccHHhccccCCCC-------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-
Confidence 788999999999875332221 113467899999999999999999999999999999999999999865432
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
..+..+.......| ..+++++.+++..||..||.+|+
T Consensus 202 --~~~~~~~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 202 --RLFELILMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred --HHHHHHhcCCCCCC-----CCCCHHHHHHHHHHccCCHHHhC
Confidence 23333333333333 34578999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.54 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=199.3
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+.+.-++|+++++||.|+||+||+|++..+++.||+|++..... ...+..|+.+++.|+|++++.++...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f------ 81 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF------ 81 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE------
Confidence 44566899999999999999999999999999999998865322 23578899999999999877665432
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-----
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR----- 148 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~----- 148 (449)
+......+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+.
T Consensus 82 -------------------~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~ 142 (1021)
T PTZ00266 82 -------------------LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN 142 (1021)
T ss_pred -------------------EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccc
Confidence 123446789999999 88999988753 35699999999999999999999984
Q ss_pred --CccccCCCCCcEEeecC--------------CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc
Q 013125 149 --GFLHRDIKPDNFLMGLG--------------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 212 (449)
Q Consensus 149 --giiHrDLkp~Nill~~~--------------~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (449)
+||||||||+||||..+ +....+||+|||++........ .....||+.|+|||++.
T Consensus 143 ~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ 214 (1021)
T PTZ00266 143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLL 214 (1021)
T ss_pred cCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHh
Confidence 49999999999999531 1234599999999976543321 13557899999999986
Q ss_pred C--CCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 213 G--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 213 ~--~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
+ ..++.++||||||||||||++|..||....... ..+ ..+......+ ....+.++.+||..||..+|.+||
T Consensus 215 ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~--qli-~~lk~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRP 287 (1021)
T PTZ00266 215 HETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS--QLI-SELKRGPDLP----IKGKSKELNILIKNLLNLSAKERP 287 (1021)
T ss_pred ccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH--HHH-HHHhcCCCCC----cCCCCHHHHHHHHHHhcCChhHCc
Confidence 5 348899999999999999999999997643321 222 2222221211 134578999999999999999999
Q ss_pred CHHHHHH
Q 013125 291 DYGFLKR 297 (449)
Q Consensus 291 ~~~~l~~ 297 (449)
++.++..
T Consensus 288 Sa~QlL~ 294 (1021)
T PTZ00266 288 SALQCLG 294 (1021)
T ss_pred CHHHHhc
Confidence 9988754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=294.48 Aligned_cols=271 Identities=20% Similarity=0.228 Sum_probs=209.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.|-++||+|.++||+|||+-||+++...+++.+|+|.+.... ..+..++|++..+++++++.++.+.......
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~----- 91 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE----- 91 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh-----
Confidence 366899999999999999999999999999999999766443 3456899999999999998776644322110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRD 154 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHrD 154 (449)
.......||++.|+ .|+|.+.+..+ +..+++.+++.|+.+|+.||++||+.. +.|||
T Consensus 92 -----------------~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~D 154 (302)
T KOG2345|consen 92 -----------------KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRD 154 (302)
T ss_pred -----------------ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccC
Confidence 11335679999999 89999998755 346899999999999999999999998 99999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCc--cccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR--HIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVL 229 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 229 (449)
|||.|||++ +.+.++|.|||.+....-.-.+. ....+.+..-..|..|+|||.+. +...++++|||||||+|
T Consensus 155 iKP~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 155 IKPANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred CCcceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 999999996 68999999999987654322211 11222334556789999999876 45679999999999999
Q ss_pred HHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 230 LYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 230 ~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
|+|++|..||..... ........++...+.+|... .+++.+.+++..|++.||.+||+..+|...+.++
T Consensus 232 Ya~mf~~sPfe~~~~-~GgSlaLAv~n~q~s~P~~~---~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQ-QGGSLALAVQNAQISIPNSS---RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHHHHcCCcchHHhh-cCCeEEEeeeccccccCCCC---CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 999999999964322 11111112333444555332 2688999999999999999999999998877654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.33 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=198.4
Q ss_pred CCceEEeeeecccCceeEEEEEE-----cCCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecchhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~ 76 (449)
.++|++.++||+|+||.||+|++ ..++..||||+++.... ...+.+|+++++.+ +|++++..+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~-------- 105 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLL-------- 105 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeee--------
Confidence 45899999999999999999975 34567899999875422 33578899999999 777655543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--------------------------------
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-------------------------------- 123 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-------------------------------- 123 (449)
.++..+...++||||+ +|+|.+++....
T Consensus 106 -------------------~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (375)
T cd05104 106 -------------------GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLN 166 (375)
T ss_pred -------------------eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhh
Confidence 3445667889999999 899988886421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 124 ------------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 124 ------------------------------------------~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 246 (375)
T cd05104 167 EYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNIL 246 (375)
T ss_pred hhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEE
Confidence 14678889999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
++ +.+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 247 l~---~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 247 LT---HGRITKICDFGLARDIRNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred EE---CCCcEEEecCccceeccCcccc-----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 94 6788999999999866443211 11223445678999999999999999999999999999998 899998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
+..... .+.+.......... ....+.++.+++..||..||++||++.+|.+.|++.
T Consensus 319 ~~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 319 GMPVDS---KFYKMIKEGYRMLS---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCchH---HHHHHHHhCccCCC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 754322 11222222222111 123478999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.97 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=199.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+++.||||++... .....+..|++++..++|++++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~-------------- 66 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL-------------- 66 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccch--------------
Confidence 5799999999999999999999999999999998643 223346789999999888765543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.....++++.|+||||+ +++|.+++... ..++...++.++.||+.||+|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI 132 (350)
T cd05573 67 -------------YYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132 (350)
T ss_pred -------------hhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 33345677899999999 88999998763 6799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCc----------------------cccccCCCCCCCCccccccccccCCCCCc
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNR----------------------HIPYRENKNLTGTARYASCNTHLGIEQSR 218 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ 218 (449)
|+ +.++.+||+|||++.......... ...........||+.|+|||++.+..++.
T Consensus 133 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 209 (350)
T cd05573 133 LI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL 209 (350)
T ss_pred EE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC
Confidence 99 478899999999998655433000 00001123567999999999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHH--hhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC-HHHH
Q 013125 219 RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE--KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFL 295 (449)
Q Consensus 219 ~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~-~~~l 295 (449)
++|||||||++|||++|+.||.+.... .....+.. .....|.. ..+++++.+++..|+. +|.+|++ ++++
T Consensus 210 ~~DiwSlG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 210 ECDWWSLGVILYEMLYGFPPFYSDTLQ---ETYNKIINWKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred ceeeEecchhhhhhccCCCCCCCCCHH---HHHHHHhccCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 999999999999999999999876533 23333333 12222211 2257899999999997 9999999 8877
Q ss_pred HH
Q 013125 296 KR 297 (449)
Q Consensus 296 ~~ 297 (449)
.+
T Consensus 283 l~ 284 (350)
T cd05573 283 KS 284 (350)
T ss_pred hc
Confidence 44
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=310.62 Aligned_cols=242 Identities=19% Similarity=0.268 Sum_probs=192.2
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+|+.+++.++|++++...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~-------------- 66 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-------------- 66 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeee--------------
Confidence 5899999999999999999999899999999876432 123467899999999988755443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+..++..|+||||+ +++|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 67 -------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (285)
T cd05605 67 -------------YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENI 133 (285)
T ss_pred -------------eeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHE
Confidence 3335567899999999 88998877543 34699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ ++.+.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 134 l~---~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 134 LL---DDYGHIRISDLGLAVEIPEGET--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred EE---CCCCCEEEeeCCCceecCCCCc--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence 99 4778999999999976543221 124578999999999999899999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
+.........+....... ........+..+.+++..||..||.+||+
T Consensus 203 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 203 QRKEKVKREEVERRVKED----QEEYSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred CCchhhHHHHHHHHhhhc----ccccCcccCHHHHHHHHHHccCCHHHhcC
Confidence 754432222222211111 11122446789999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=319.31 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=188.8
Q ss_pred ceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+|+++++||+|+||.||+|++. .+++.||+|++.... ....+..|+++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--------------- 65 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP--------------- 65 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCC---------------
Confidence 5899999999999999999874 478899999876421 1234667888888885332
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++..+..+....+..++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 66 -----------~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp 133 (332)
T cd05614 66 -----------FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKL 133 (332)
T ss_pred -----------CcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH
Confidence 3444555556778899999999 8899888765 56799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~ 236 (449)
+|||+ +.++.+||+|||+++.+....... .....||..|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 134 ~Nili---~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 134 ENILL---DSEGHVVLTDFGLSKEFLSEEKER------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred HHeEE---CCCCCEEEeeCcCCccccccCCCc------cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 99999 477899999999998654332211 12467999999999998754 789999999999999999999
Q ss_pred CCCCCChhhcHHHHH-HHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 237 LPWQGLKAATKKQKY-DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.||...........+ ..+...... .....+..+.+++..||..||++||+.
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 205 SPFTLEGERNTQSEVSRRILKCDPP-----FPSFIGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred CCCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 999754332222222 222222111 123457899999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=317.69 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=212.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHc-CCCcceeeEeecchhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~ 78 (449)
+...|++.+.||.|.||.||+|+++.||+.+|+|++.+... .....+|+++|+.+. |++++.+.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~---------- 102 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLK---------- 102 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEE----------
Confidence 55789999999999999999999999999999999876532 246899999999998 77655543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.........++|||++ ||.|.+.+... .+++..+..++.|++.+++|||+.||+||||||
T Consensus 103 -----------------~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKp 163 (382)
T KOG0032|consen 103 -----------------DAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKP 163 (382)
T ss_pred -----------------EEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCH
Confidence 3446667899999999 89999998865 399999999999999999999999999999999
Q ss_pred CcEEeecCCC-CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 158 DNFLMGLGRK-ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 158 ~Nill~~~~~-~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
+|+|+...++ .+.+|++|||+|........ ....+||+.|+|||++.+..|+..+||||+|+++|.|++|.
T Consensus 164 EN~L~~~~~~~~~~ik~~DFGla~~~~~~~~--------~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~ 235 (382)
T KOG0032|consen 164 ENLLLASKDEGSGRIKLIDFGLAKFIKPGER--------LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGV 235 (382)
T ss_pred HHeeeccccCCCCcEEEeeCCCceEccCCce--------EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCC
Confidence 9999975433 45899999999998776221 34779999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+||.+.... .....|........ ...|...+..+++++..++..||..|+++.++.+
T Consensus 236 ~PF~~~~~~---~~~~~i~~~~~~f~-~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 236 PPFWGETEF---EIFLAILRGDFDFT-SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCcCCChh---HHHHHHHcCCCCCC-CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 999986643 33345555555433 4456777899999999999999999999887655
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=318.60 Aligned_cols=238 Identities=21% Similarity=0.313 Sum_probs=189.8
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
+.||+|+||.||+|++..+++.||+|++.... ....+.+|+++++.++|++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~--------------------- 59 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS--------------------- 59 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcc---------------------
Confidence 46899999999999999999999999987531 1234678889999888876544
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
+..+....+..|+||||+ +++|.+.+.. ...+++.+++.++.||+.||+|||++||+||||||+|||+ +
T Consensus 60 ------~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~ 129 (328)
T cd05593 60 ------LKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---D 129 (328)
T ss_pred ------eEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---C
Confidence 333445678899999999 8888877764 5679999999999999999999999999999999999999 4
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 130 ~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~- 201 (328)
T cd05593 130 KDGHIKITDFGLCKEGITDAA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE- 201 (328)
T ss_pred CCCcEEEecCcCCccCCCccc-------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-
Confidence 788999999999875432211 113457999999999999999999999999999999999999999864432
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 296 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~ 296 (449)
.....+.......| ..++.++.+++..||..||.+|+ ++.++.
T Consensus 202 --~~~~~~~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 202 --KLFELILMEDIKFP-----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred --HHHHHhccCCccCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 22223322222222 34578999999999999999997 555553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=313.86 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=203.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+-..+|++.+.||+|+||.||+|.+..+++ .||+|+++.... ..++.+|+.+++.++|++++..++.+
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~----- 78 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC----- 78 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 456789999999999999999999866555 389998864432 33577899999999999877665533
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
.. ...++++|++ +++|.+++......++...++.++.||+.||+|||++||+||||
T Consensus 79 ----------------------~~-~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dl 135 (316)
T cd05108 79 ----------------------LT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDL 135 (316)
T ss_pred ----------------------cC-CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence 22 3457889988 89999998876667899999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+|||++ +++.+||+|||+++......... ......++..|++||++.+..++.++|||||||++|||++
T Consensus 136 kp~Nill~---~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~ 207 (316)
T cd05108 136 AARNVLVK---TPQHVKITDFGLAKLLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 207 (316)
T ss_pred chhheEec---CCCcEEEccccccccccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcC
Confidence 99999994 77899999999998765432211 0122344678999999999999999999999999999997
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
|..||.+.... .+..+.......+.+ ..++.++.+++..||..+|.+||++.++...|..+..
T Consensus 208 g~~p~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 208 GSKPYDGIPAS----EISSILEKGERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCCHH----HHHHHHhCCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 99999875432 222333333333322 2346789999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=332.89 Aligned_cols=261 Identities=23% Similarity=0.228 Sum_probs=201.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+..+++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.++..++|.+++..........
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~--- 104 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD--- 104 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc---
Confidence 3457899999999999999999999999999999999865422 224677888888888887665432111000
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
..........++||||+ +++|.+++... ...++...+..++.|++.||.|||++||+|||
T Consensus 105 ----------------~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrD 168 (496)
T PTZ00283 105 ----------------PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168 (496)
T ss_pred ----------------ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 00001112468999999 89999988643 34689999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 169 LKP~NILl~---~~~~vkL~DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt 240 (496)
T PTZ00283 169 IKSANILLC---SNGLVKLGDFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240 (496)
T ss_pred CCHHHEEEe---CCCCEEEEecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999994 78899999999998765432111 1235679999999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+.||.+.... ..+..+...... .+....++++.+++..||..+|.+||++.++.+
T Consensus 241 G~~Pf~~~~~~---~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 241 LKRPFDGENME---EVMHKTLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCCCCCHH---HHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 99999875432 233333322221 123456889999999999999999999998765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=343.62 Aligned_cols=260 Identities=20% Similarity=0.308 Sum_probs=214.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCC-----ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+-..+-++.+.||+|+||+||.|...... ..||||.++...+ ...|++|+.+|..++|+|++++++++++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-- 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-- 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--
Confidence 33567789999999999999999875332 2499998876644 3458999999999999999999988743
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~------~~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
....+|++||| ||+|+.+++.. ...++....+.++.||+.|++||+++
T Consensus 767 -------------------------~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~ 821 (1025)
T KOG1095|consen 767 -------------------------SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK 821 (1025)
T ss_pred -------------------------CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC
Confidence 45678999999 99999999987 56799999999999999999999999
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHH
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 228 (449)
++|||||.++|+|++ ....|||+|||+|+......+ |+......-..+|||||.+....++.++|||||||+
T Consensus 822 ~fvHRDLAaRNCLL~---~~r~VKIaDFGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVl 893 (1025)
T KOG1095|consen 822 HFVHRDLAARNCLLD---ERRVVKIADFGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVL 893 (1025)
T ss_pred CCcCcchhhhheeec---ccCcEEEcccchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHH
Confidence 999999999999995 779999999999995444433 333333345679999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 229 LLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 229 l~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|||+++ |..||.+..+.+....+.+ +.++..| ..+|..+.++|..||..+|++||+|..|.+.+..++..
T Consensus 894 lWEifslG~~PY~~~~n~~v~~~~~~--ggRL~~P-----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 894 LWEIFSLGATPYPSRSNFEVLLDVLE--GGRLDPP-----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHHhCCCCCCCCcchHHHHHHHHh--CCccCCC-----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 999999 9999998777644433322 3344433 44599999999999999999999999998877666543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=320.66 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=196.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|.+.++||+|+||+||+|++..+++.||+|+++... ....+..|+.+++.++|++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~--------------- 65 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ--------------- 65 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcc---------------
Confidence 47999999999999999999999999999999987532 1234677888888887776443
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+..+..+.+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 66 ------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 66 ------------LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred ------------eeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 334445677899999999 9999999987667899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc------CCCCCccchHHHHHHHHHHHHh
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSlG~il~el~~ 234 (449)
|+ +..+.+||+|||++......... ......||+.|+|||++. +..++.++|||||||++|||++
T Consensus 134 ll---~~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~ 204 (330)
T cd05601 134 LI---DRTGHIKLADFGSAARLTANKMV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204 (330)
T ss_pred EE---CCCCCEEeccCCCCeECCCCCce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc
Confidence 99 47889999999999876543221 112347899999999987 4567899999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhh--cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
|..||...... ..+..+.... ...+. ....+.++.+++..||. +|.+||+++++.
T Consensus 205 g~~Pf~~~~~~---~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 205 GRSPFHEGTSA---KTYNNIMNFQRFLKFPE---DPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CCCCCCCCCHH---HHHHHHHcCCCccCCCC---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 99999875433 2333333221 11111 12357889999999997 999999988764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=320.39 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=194.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+-++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+.+++.++|++++..+.......
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK----- 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----
Confidence 458999999999999999999999999999999988643 22345778999999999999877655432110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+||||++++|.+.+. ..++...+..++.||+.||+|||++||+||||||+||
T Consensus 94 ----------------~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI 154 (359)
T cd07876 94 ----------------SLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 154 (359)
T ss_pred ----------------CccccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 001224579999999888877663 3588999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 155 l~---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 155 VV---KSDCTLKILDFGLARTACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred EE---CCCCCEEEecCCCccccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 99 4788999999999975432211 134578999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCC-------------------------HHH------------hhccChHHHHHHHHHHhC
Q 013125 241 GLKAATKKQKYDKICEKKVSTP-------------------------IEV------------LCKSHPAEFASYFHYCQS 283 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~------------~~~~~~~~~~~l~~~~l~ 283 (449)
+...... +..+.......+ ... .....+.++++++..||.
T Consensus 224 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 300 (359)
T cd07876 224 GTDHIDQ---WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300 (359)
T ss_pred CCCHHHH---HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhc
Confidence 7543221 111111110000 000 001124678899999999
Q ss_pred CCCCCCCCHHHHHH
Q 013125 284 LTFDQRPDYGFLKR 297 (449)
Q Consensus 284 ~~p~~Rp~~~~l~~ 297 (449)
.||.+||++.++.+
T Consensus 301 ~dP~~R~t~~e~l~ 314 (359)
T cd07876 301 IDPDKRISVDEALR 314 (359)
T ss_pred cCcccCCCHHHHhc
Confidence 99999999887744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=314.30 Aligned_cols=235 Identities=23% Similarity=0.334 Sum_probs=185.4
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|++..+++.||||+++... .......|..++..+ +|++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~----------------------- 57 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF----------------------- 57 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCC-----------------------
Confidence 47999999999999999999999999886431 122345566665543 4554
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++.+.......+..|+||||+ |++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+
T Consensus 58 ----i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill--- 129 (316)
T cd05592 58 ----LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL--- 129 (316)
T ss_pred ----ccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---
Confidence 444444455677899999999 8899888875 4579999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 130 ~~~~~~kL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 130 DKDGHIKIADFGMCKENMNGEG-------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred CCCCCEEEccCcCCeECCCCCC-------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 4788999999999976433221 123567999999999999999999999999999999999999999875442
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
+.+..+.......+ ..++.++.+++..||..+|.+||+..
T Consensus 203 ---~~~~~i~~~~~~~~-----~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 203 ---ELFDSILNDRPHFP-----RWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred ---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 33333333222222 34578899999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=323.64 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=192.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
..|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|++++.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l-------------- 66 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL-------------- 66 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeee--------------
Confidence 36999999999999999999999999999999986432 12346789999999988865544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.+..+.+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Ni 132 (381)
T cd05626 67 -------------YYSFQDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNI 132 (381)
T ss_pred -------------EEEEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHE
Confidence 34445678899999999 8899988875 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCcc----------------------------------------ccccCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRH----------------------------------------IPYRENKNLT 200 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~----------------------------------------~~~~~~~~~~ 200 (449)
|+ +..+.+||+|||+++.+........ .........+
T Consensus 133 li---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (381)
T cd05626 133 LI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209 (381)
T ss_pred EE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccccccc
Confidence 99 4788999999999864321110000 0000112467
Q ss_pred CCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHh--hcCCCHHHhhccChHHHHHHH
Q 013125 201 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYF 278 (449)
Q Consensus 201 gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~l~ 278 (449)
||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+... ....+. ...+++++.+++
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~---~~~~s~~~~dli 283 (381)
T cd05626 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE---TQLKVINWENTLHIPP---QVKLSPEAVDLI 283 (381)
T ss_pred CCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH---HHHHHHccccccCCCC---CCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999998754322 22222221 111111 123578899999
Q ss_pred HHHh--CCCCCCCCCHHHHHH
Q 013125 279 HYCQ--SLTFDQRPDYGFLKR 297 (449)
Q Consensus 279 ~~~l--~~~p~~Rp~~~~l~~ 297 (449)
.+++ ..++..|+++.++..
T Consensus 284 ~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 284 TKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHccCcccccCCCCHHHHhc
Confidence 8854 445556999887744
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=308.28 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=202.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCC-----ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+.-++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+.+|++++..++|++++..+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~------- 74 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLL------- 74 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEE-------
Confidence 34568999999999999999999986554 6799998865432 23478899999999888755543
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHH
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMI 139 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qil 139 (449)
.+.......|++|||+ +++|.+++.... ..++...++.++.||+
T Consensus 75 --------------------~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 134 (283)
T cd05048 75 --------------------GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA 134 (283)
T ss_pred --------------------EEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHH
Confidence 3344567789999999 889999887531 4578899999999999
Q ss_pred HHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCcc
Q 013125 140 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR 219 (449)
Q Consensus 140 ~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 219 (449)
.||.|||++|++||||||+||+++ +++.++|+|||+++....... +.......++..|+|||.+.+..++.+
T Consensus 135 ~al~~lH~~~i~H~dlkp~Nil~~---~~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (283)
T cd05048 135 AGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTE 206 (283)
T ss_pred HHHHHHHhCCeeccccccceEEEc---CCCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchh
Confidence 999999999999999999999994 778999999999986543322 112234456788999999998899999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 013125 220 DDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 298 (449)
Q Consensus 220 ~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~ 298 (449)
+|||||||++|||++ |..||.+..... ....+.... .. .....+|.++.+++..||+.+|.+||++.+|.+.
T Consensus 207 sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~i~~~~-~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 207 SDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEMIRSRQ-LL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHcCC-cC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999998 999998765432 222222221 11 1234568999999999999999999999999988
Q ss_pred HHH
Q 013125 299 FHD 301 (449)
Q Consensus 299 l~~ 301 (449)
|+.
T Consensus 280 l~~ 282 (283)
T cd05048 280 LRS 282 (283)
T ss_pred Hhc
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=315.41 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=192.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+++.||+|++... .....+..|+.++..++|+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i----------------- 63 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI----------------- 63 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----------------
Confidence 4799999999999999999999999999999998642 122346778888888777654
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.+..+....++.|+||||+ |++|.+++......++...++.++.||+.||+|||++||+||||||+||
T Consensus 64 ----------~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (331)
T cd05597 64 ----------TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133 (331)
T ss_pred ----------CceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHE
Confidence 44444556778899999999 9999999876667899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----CCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il~el~~G 235 (449)
|+ +.++.+||+|||++.......... .....||+.|+|||++.. ..++.++|||||||++|||++|
T Consensus 134 ll---~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g 204 (331)
T cd05597 134 LL---DKNGHIRLADFGSCLRLLADGTVQ------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204 (331)
T ss_pred EE---CCCCCEEEEECCceeecCCCCCcc------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhC
Confidence 99 478899999999997654432211 123468999999999873 4578899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCC--CCCHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFL 295 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~--Rp~~~~l 295 (449)
+.||.+.... +.+..+.........+......+.++++++..|+..++.+ |++++++
T Consensus 205 ~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~ 263 (331)
T cd05597 205 ETPFYAESLV---ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDF 263 (331)
T ss_pred CCCCCCCCHH---HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999875432 3333333322222222223346788999999988653332 5565544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=304.12 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=203.6
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecc
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVD 73 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 73 (449)
|+-+...+|++.++||+|+||+||+|++..+++ .||+|+...... ...+.+|+.+++.+.|++++..++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~--- 77 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGI--- 77 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEE---
Confidence 677888999999999999999999999876665 489998865433 2346788888888888775554432
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
+. ....++++|++ +++|.+++......++...++.++.||+.||+|||++||+|
T Consensus 78 ------------------------~~-~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH 132 (279)
T cd05109 78 ------------------------CL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132 (279)
T ss_pred ------------------------Ec-CCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 22 23467899998 88999988765567999999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el 232 (449)
|||||+|||++ +++.+||+|||+++.......... .....++..|++||.+.+..++.++|||||||++|||
T Consensus 133 ~dlkp~Nil~~---~~~~~kL~dfG~~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05109 133 RDLAARNVLVK---SPNHVKITDFGLARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204 (279)
T ss_pred cccccceEEEc---CCCcEEECCCCceeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 99999999994 678899999999987654322110 1123346789999999998999999999999999999
Q ss_pred Hh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 233 LR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 233 ~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
++ |..||....... +..........+.+ ..++.++.+++..||..||++||++.++.+.|+++..
T Consensus 205 ~t~g~~p~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 205 MTFGAKPYDGIPARE----IPDLLEKGERLPQP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HcCCCCCCCCCCHHH----HHHHHHCCCcCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 98 999997654322 22222222222221 3457899999999999999999999999888876644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.08 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=199.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEE-EecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK-v~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
|-+..|+++++||+||.+.||++...+.+- +|+| +.....+ ...+.+|+.+|.+|++..
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~---------------- 420 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHD---------------- 420 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCc----------------
Confidence 457789999999999999999998755444 5555 4322222 335899999999998765
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.|..++.|...+.+.|||||+-..+|..+++........-.++.|..|||.++.++|..||||.||||.|
T Consensus 421 ----------~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPAN 490 (677)
T KOG0596|consen 421 ----------KIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPAN 490 (677)
T ss_pred ----------eEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCccc
Confidence 3444566667789999999999999999998766666666899999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-----------CCccchHHHHHHH
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-----------QSRRDDLESLGYV 228 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~~DvwSlG~i 228 (449)
+|+ =.|.+||+|||+|.....+++... ...-+||+.||+||.+.... .++++||||||||
T Consensus 491 FLl----VkG~LKLIDFGIA~aI~~DTTsI~-----kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCI 561 (677)
T KOG0596|consen 491 FLL----VKGRLKLIDFGIANAIQPDTTSIV-----KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCI 561 (677)
T ss_pred EEE----EeeeEEeeeechhcccCcccccee-----eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhH
Confidence 999 579999999999998887766432 34679999999999887433 4678999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||+|++|++||...... ..++..|..-.-.++.+...++ .++.++|..||..||.+||+..+|++
T Consensus 562 LYqMvYgktPf~~~~n~--~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 562 LYQMVYGKTPFGQIINQ--IAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHhcCCchHHHHHH--HHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 99999999999865432 2334444333233333333322 34999999999999999999877654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.85 Aligned_cols=234 Identities=20% Similarity=0.294 Sum_probs=186.5
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|++..+++.||||++... .....+..|.+++..+ +|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp------------------------ 56 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP------------------------ 56 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCC------------------------
Confidence 4699999999999999999999999998643 1123356777777765 344
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++..+..+....+..|+||||+ +++|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 57 ---~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill--- 129 (321)
T cd05591 57 ---FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL--- 129 (321)
T ss_pred ---CccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---
Confidence 3444555556678899999999 8899887765 5679999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 202 (321)
T cd05591 130 DAEGHCKLADFGMCKEGILNGVT-------TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202 (321)
T ss_pred CCCCCEEEeecccceecccCCcc-------ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH
Confidence 47889999999998764332211 23567899999999999999999999999999999999999999875543
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
..+..+.......| ..++.++.+++..||..+|++|++.
T Consensus 203 ---~~~~~i~~~~~~~p-----~~~~~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 203 ---DLFESILHDDVLYP-----VWLSKEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred ---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 33444444333222 2347899999999999999999943
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.04 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=191.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|+++++||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.++|++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~--------------- 65 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS--------------- 65 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcce---------------
Confidence 47999999999999999999999999999999875421 1234677899998888876544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.++.+.++.|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 66 ------------~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI 132 (377)
T cd05629 66 ------------LYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132 (377)
T ss_pred ------------EEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 444456678899999999 8999998875 46789999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCcc-------cc----------------------------c-----cCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRH-------IP----------------------------Y-----RENKNLT 200 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~-------~~----------------------------~-----~~~~~~~ 200 (449)
|++ .++.+||+|||+|+.+........ .. + ......+
T Consensus 133 ll~---~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 133 LID---RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred EEC---CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 994 788999999999974432110000 00 0 0011357
Q ss_pred CCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHH
Q 013125 201 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY 280 (449)
Q Consensus 201 gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~ 280 (449)
||+.|+|||++.+..++.++|||||||++|||++|.+||.+.... ..+..+.........+. ....+.++.+++..
T Consensus 210 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~ 285 (377)
T cd05629 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH---ETYRKIINWRETLYFPD-DIHLSVEAEDLIRR 285 (377)
T ss_pred CCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHH---HHHHHHHccCCccCCCC-CCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999875442 23333332111111111 11346789999999
Q ss_pred HhCCCCCCCC---CHHHH
Q 013125 281 CQSLTFDQRP---DYGFL 295 (449)
Q Consensus 281 ~l~~~p~~Rp---~~~~l 295 (449)
|+. +|.+|+ ++.++
T Consensus 286 lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 286 LIT-NAENRLGRGGAHEI 302 (377)
T ss_pred Hhc-CHhhcCCCCCHHHH
Confidence 997 777764 65554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=318.58 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=210.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.++|..+++||+|+||.+++++++..+..||+|.+.-..- ......|+.++.+++|++++.+...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds----------- 71 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS----------- 71 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----------
Confidence 3689999999999999999999999999999998764422 2246889999999999987765432
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
|-.++...||||+|| ||++.+.++... ..|+++.+..|+.||+.|+.|||+++|+|||||+.|
T Consensus 72 ---------------~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~N 136 (426)
T KOG0589|consen 72 ---------------FEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCAN 136 (426)
T ss_pred ---------------hhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhh
Confidence 223445599999999 999999998654 679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+++ .++.|+|.|||+|+....... ...+++||+.|++||++.+.+|+.++|||||||++|||++-+++|
T Consensus 137 iflt---k~~~VkLgDfGlaK~l~~~~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF 206 (426)
T KOG0589|consen 137 IFLT---KDKKVKLGDFGLAKILNPEDS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAF 206 (426)
T ss_pred hhcc---ccCceeecchhhhhhcCCchh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccccc
Confidence 9996 778889999999998876652 135889999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 298 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~ 298 (449)
.+.+- ...+.+|+...+.+. + ..+..+++.++..|+..+|..||++.+|...
T Consensus 207 ~a~~m---~~Li~ki~~~~~~Pl-p---~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 207 KASNM---SELILKINRGLYSPL-P---SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Cccch---HHHHHHHhhccCCCC-C---ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 87544 355666666553322 2 3447899999999999999999999988664
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=315.09 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=201.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+-+++|++.+.||.|+||.||+|.+.. +++.||+|++..... .+.+..|+++++.+ +|++++..+..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~---- 79 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGA---- 79 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeee----
Confidence 456799999999999999999997543 457899998875332 23467899999988 66765554332
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------------------------------
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------------------ 123 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------------------------------ 123 (449)
+...+...+++|||+ +++|.+++....
T Consensus 80 ----------------------~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (337)
T cd05054 80 ----------------------CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVS 137 (337)
T ss_pred ----------------------EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCC
Confidence 223456788999999 889988875321
Q ss_pred ------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEE
Q 013125 124 ------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173 (449)
Q Consensus 124 ------------------------------~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL 173 (449)
..+++..+..++.||+.||+|||++||+||||||+|||+. +++.++|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL 214 (337)
T cd05054 138 SSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKI 214 (337)
T ss_pred ccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEE
Confidence 2578899999999999999999999999999999999994 6789999
Q ss_pred EeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHH
Q 013125 174 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD 252 (449)
Q Consensus 174 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~ 252 (449)
+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+.
T Consensus 215 ~DfG~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~ 286 (337)
T cd05054 215 CDFGLARDIYKDPDY-----VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFC 286 (337)
T ss_pred eccccchhcccCcch-----hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHH
Confidence 999999865432211 11234456778999999999999999999999999999997 999998744322 122
Q ss_pred HHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 253 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 253 ~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
........... ....++++.+++..||+.+|++||++.+|.+.|++++.
T Consensus 287 ~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 287 RRLKEGTRMRA---PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHhccCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22222211111 13457889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=307.55 Aligned_cols=246 Identities=21% Similarity=0.217 Sum_probs=197.3
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCC-c----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-H----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
..||+|++|.||+|.+ +++.||||++..... . +.+.+|+.+++.++|++++++++...+.
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------------- 90 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI------------- 90 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-------------
Confidence 6789999999999988 788999999875432 2 3466999999999999877766543221
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeecC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nill~~~ 165 (449)
.......++||||+ +++|.+++.. .+.+++.....++.|++.||.|||+ .+++||||||+|||+
T Consensus 91 ----------~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill--- 156 (283)
T PHA02988 91 ----------VDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV--- 156 (283)
T ss_pred ----------ccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---
Confidence 01235679999999 8899999875 4578999999999999999999998 499999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
++++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred CCCCcEEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 478899999999997654322 13467899999999976 679999999999999999999999998764
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
.. +.+..+.......+.+ ..+++++.+++.+||+.||.+||++.++.+.|+.+.
T Consensus 227 ~~---~~~~~i~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 227 TK---EIYDLIINKNNSLKLP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HH---HHHHHHHhcCCCCCCC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 32 3333343333332222 245889999999999999999999999999888663
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=321.20 Aligned_cols=255 Identities=18% Similarity=0.225 Sum_probs=196.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc--CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++..+|+++++||+|+||.||+|... .+++.||+|.+... ....+|+++++.++|+++++++.
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~------------ 153 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIH------------ 153 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceee------------
Confidence 56678999999999999999999764 45678999987643 34578999999999988665533
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+.......|+|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 154 ---------------~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil 217 (392)
T PHA03207 154 ---------------AYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217 (392)
T ss_pred ---------------eEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 2345578899999999999988843 567999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ +..+.++|+|||+++......... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 218 l---~~~~~~~l~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 218 L---DEPENAVLGDFGAACKLDAHPDTP-----QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred E---cCCCCEEEccCccccccCcccccc-----cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9 478899999999997655432211 12356799999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHH---------------------------H--hhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIE---------------------------V--LCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~---------------------------~--~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.........+..+.......+.. . ....++.++.+++..||..+|.+||++
T Consensus 290 ~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa 369 (392)
T PHA03207 290 KQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA 369 (392)
T ss_pred CCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH
Confidence 65443333333333322111110 0 012335567777788888888888887
Q ss_pred HHHHH
Q 013125 293 GFLKR 297 (449)
Q Consensus 293 ~~l~~ 297 (449)
.++..
T Consensus 370 ~e~l~ 374 (392)
T PHA03207 370 QDILS 374 (392)
T ss_pred HHHhh
Confidence 76643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=306.99 Aligned_cols=287 Identities=42% Similarity=0.676 Sum_probs=236.6
Q ss_pred ceEEeeeecccCceeEEEEEEcCCC-ceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+|++.++||+|+||.||+|.+..++ ..+|+|++..... ...+..|..++..+....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~--------------------- 77 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKN--------------------- 77 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhc---------------------
Confidence 8999999999999999999997664 6799999876433 226889999999988410
Q ss_pred cccCCCcCeeEEec-ccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYG-VDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~-~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
...+++.+...| ....+.||||+++|.+|.++..... +.|+..++..++.|++.+|++||+.|++||||||+|+++
T Consensus 78 --~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~ 155 (322)
T KOG1164|consen 78 --GPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVV 155 (322)
T ss_pred --CCCCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeee
Confidence 011788888899 5888999999999999999997655 789999999999999999999999999999999999999
Q ss_pred ecCC--CCCeEEEEeeccee--eecCCCCCccccccC-CCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 163 GLGR--KANQVYIIDFGLAK--KYRDPTTNRHIPYRE-NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 163 ~~~~--~~~~vkL~DfGla~--~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+... +...++|+|||+|+ .+.........+.+. ...+.||.+|++++++.+.+.++++|+||+++++.|+..|.+
T Consensus 156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 8543 22689999999999 443333222344444 456779999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCcccccc
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 317 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~ 317 (449)
||.+.........+........... .+...|.++.+++..+-..++.++|+|..+...|++.+...+......+||.
T Consensus 236 PW~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~ 312 (322)
T KOG1164|consen 236 PWEALEMTDLKSKFEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE 312 (322)
T ss_pred CCccccccchHHHHHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence 9988776555555544443333322 4445578999999999999999999999999999999999999999999997
Q ss_pred ccc
Q 013125 318 ILK 320 (449)
Q Consensus 318 ~l~ 320 (449)
...
T Consensus 313 ~~~ 315 (322)
T KOG1164|consen 313 VKL 315 (322)
T ss_pred ccc
Confidence 644
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.96 Aligned_cols=235 Identities=18% Similarity=0.282 Sum_probs=187.0
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||||++... .....+..|..++..+ +|++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~----------------------- 57 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF----------------------- 57 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCc-----------------------
Confidence 4799999999999999999999999987643 1223456677777655 3544
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++.+..+....+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 ----iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli--- 129 (320)
T cd05590 58 ----LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL--- 129 (320)
T ss_pred ----hhceeeEEEcCCEEEEEEcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---
Confidence 444445556778899999999 8899887765 4679999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (320)
T cd05590 130 DHEGHCKLADFGMCKEGIFNGK-------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202 (320)
T ss_pred CCCCcEEEeeCCCCeecCcCCC-------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 4788999999999875432211 123567899999999999999999999999999999999999999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
..+..+.......+ ...+.++.+++..||..||.+|++..
T Consensus 203 ---~~~~~i~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 203 ---DLFEAILNDEVVYP-----TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ---HHHHHHhcCCCCCC-----CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 33344443333222 23578999999999999999999973
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=303.34 Aligned_cols=256 Identities=20% Similarity=0.344 Sum_probs=205.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+....|.+.++||+|+||.||+|.+.++++.||+|+...... ...+.+|+++++.++|++++..+.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------- 69 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG------------- 69 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEE-------------
Confidence 445679999999999999999999999999999998775432 345788999999999887665543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.......+++|||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 70 --------------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ni 135 (263)
T cd05052 70 --------------VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135 (263)
T ss_pred --------------EEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 334566789999999 889999887543 4589999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
+++ +++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 136 l~~---~~~~~kl~df~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 136 LVG---ENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred EEc---CCCcEEeCCCccccccccceee------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 994 7889999999999866543221 1122334678999999999999999999999999999998 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
.+..... ....+ ...... ......|.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 207 ~~~~~~~---~~~~~-~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 207 PGIDLSQ---VYELL-EKGYRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHH---HHHHH-HCCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 8754322 22222 211111 22345689999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=314.85 Aligned_cols=238 Identities=19% Similarity=0.295 Sum_probs=186.7
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.++..+. |+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~------------------------ 56 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNP------------------------ 56 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCC------------------------
Confidence 47999999999999999999999999987532 1223667888887774 44
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++..+..+....+..|+||||+ +++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 57 ---~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~-- 130 (327)
T cd05617 57 ---FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD-- 130 (327)
T ss_pred ---CEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe--
Confidence 3444555556778899999999 8899887764 45799999999999999999999999999999999999994
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 131 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~ 202 (327)
T cd05617 131 -ADGHIKLTDYGMCKEGLGPGD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202 (327)
T ss_pred -CCCCEEEeccccceeccCCCC-------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC
Confidence 788999999999875332221 123567999999999999999999999999999999999999999653221
Q ss_pred c----HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 246 T----KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 246 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
. .......+.......| ...+..+.+++..||..||.+|++..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 203 PDMNTEDYLFQVILEKPIRIP-----RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred cccccHHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1 1122223333222222 34578899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=312.59 Aligned_cols=235 Identities=21% Similarity=0.303 Sum_probs=184.7
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|++..+++.||+|+++.. ........|..++..+ .|++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~----------------------- 57 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF----------------------- 57 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCC-----------------------
Confidence 4799999999999999999999999988643 1223456666666543 4544
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
+..+..+....++.|+||||+ +++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+
T Consensus 58 ----i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~--- 129 (316)
T cd05620 58 ----LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML--- 129 (316)
T ss_pred ----ccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---
Confidence 444444556678899999999 8899888765 4578999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.++|+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 130 DRDGHIKIADFGMCKENVFGDN-------RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred CCCCCEEeCccCCCeecccCCC-------ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 4778999999999874322111 123567899999999999999999999999999999999999999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.....+....... ....+.++++++..||..||.+|++..
T Consensus 203 ---~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 203 ---ELFESIRVDTPHY-----PRWITKESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred ---HHHHHHHhCCCCC-----CCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 2232222222111 123578899999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.55 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=192.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.|+++++||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~------------- 67 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY------------- 67 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEE-------------
Confidence 4799999999999999999999999999999987542 1233467899999999888755543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
......+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 68 --------------~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 132 (376)
T cd05598 68 --------------YSFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132 (376)
T ss_pred --------------EEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence 3345677899999999 8999998875 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCcc------------------------------------ccccCCCCCCCCcc
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRH------------------------------------IPYRENKNLTGTAR 204 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~------------------------------------~~~~~~~~~~gt~~ 204 (449)
|+ +.++.+||+|||+|..+........ .........+||+.
T Consensus 133 ll---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 133 LI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred EE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 99 4788999999999854321100000 00001124579999
Q ss_pred ccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCC
Q 013125 205 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSL 284 (449)
Q Consensus 205 y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 284 (449)
|+|||++.+..++.++|||||||++|||++|+.||.+..... ....+.........+ ....+++++.+++..|+ .
T Consensus 210 y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~ 284 (376)
T cd05598 210 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE---TQLKVINWETTLHIP-SQAKLSREASDLILRLC-C 284 (376)
T ss_pred ccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHH---HHHHHhccCccccCC-CCCCCCHHHHHHHHHHh-c
Confidence 999999999999999999999999999999999998765432 222222211111111 11345778899999876 5
Q ss_pred CCCCCC---CHHHH
Q 013125 285 TFDQRP---DYGFL 295 (449)
Q Consensus 285 ~p~~Rp---~~~~l 295 (449)
+|.+|+ ++.++
T Consensus 285 ~p~~R~~~~t~~el 298 (376)
T cd05598 285 GAEDRLGKNGADEI 298 (376)
T ss_pred CHhhcCCCCCHHHH
Confidence 999999 55555
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=316.67 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=194.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++++.||.|+||+||+|.+..+++.||||++.... ....+.+|+++++.++|++++..+......
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 86 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA------ 86 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc------
Confidence 5689999999999999999999999999999999876432 123467899999999999877654322110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+......|+++++++++|.+++. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 87 ---------------~~~~~~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Ni 149 (343)
T cd07878 87 ---------------TSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV 149 (343)
T ss_pred ---------------ccccccCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhE
Confidence 0112335679999999999988775 35699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|++ .++.+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 150 l~~---~~~~~kl~Dfg~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 150 AVN---EDCELRILDFGLARQADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred EEC---CCCCEEEcCCccceecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 994 78899999999998654322 24578999999999887 56899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCC--------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+....... ..+.......+ ......+.++.+.+++..|+..||.+||++.
T Consensus 217 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ 293 (343)
T cd07878 217 PGNDYIDQL---KRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293 (343)
T ss_pred CCCCHHHHH---HHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 875432222 22111111111 0111223455678888999999999999887
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 294 ell~ 297 (343)
T cd07878 294 EALA 297 (343)
T ss_pred HHhc
Confidence 7643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.61 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=197.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
-.++|++.++||+|+||.||+|++..+++.||+|++... .....+..|+.+++.++|++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~------------ 108 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL------------ 108 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceE------------
Confidence 346899999999999999999999999999999998642 122336688999998888765443
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
..+....+..|+||||+ |++|.+++.. ..++...+..++.||+.||+|||++||+||||||+
T Consensus 109 ---------------~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~ 171 (370)
T cd05596 109 ---------------HYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 171 (370)
T ss_pred ---------------EEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 34445678899999999 8999988764 46899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC----CCCccchHHHHHHHHHHHHh
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlG~il~el~~ 234 (449)
|||+ +.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 172 NILl---~~~~~~kL~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt 242 (370)
T cd05596 172 NMLL---DKSGHLKLADFGTCMKMDANGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (370)
T ss_pred HEEE---cCCCCEEEEeccceeeccCCCcc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence 9999 47899999999999865433211 12356799999999998754 37899999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCC--CCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~--Rp~~~~l~~ 297 (449)
|+.||.+.... ..+..+.........+. ....+.++.+++..||..+|.+ |++++++.+
T Consensus 243 G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 243 GDTPFYADSLV---GTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCcCCCCHH---HHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 99999875432 33444443222111111 1235789999999999988887 999887644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.14 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=201.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..++|++.++||+|+||.||+|.+..++ .||+|++..... ...+.+|+++++.++|++++..+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~------------ 69 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV------------ 69 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEE------------
Confidence 45689999999999999999999986554 599998875332 3468899999999998876554332
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
. .....|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||
T Consensus 70 ---------------~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Ni 133 (262)
T cd05071 70 ---------------V-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 133 (262)
T ss_pred ---------------E-CCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccE
Confidence 1 335579999999 78999998753 34589999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
+++ +++.++|+|||++......... ......++..|++||+..+..++.++|||||||++|||++ |..||
T Consensus 134 ll~---~~~~~~L~dfg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~ 204 (262)
T cd05071 134 LVG---ENLVCKVADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204 (262)
T ss_pred EEc---CCCcEEeccCCceeeccccccc------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 994 6788999999999766433211 1123456778999999998899999999999999999999 89999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
.+.... .....+.. ....+. ....+..+.+++..||..+|.+||++.++.+.|+++|
T Consensus 205 ~~~~~~---~~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 205 PGMVNR---EVLDQVER-GYRMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCChH---HHHHHHhc-CCCCCC---ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 775432 22222221 111111 2345789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=318.46 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=189.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|++++..+.
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-------------- 139 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD-------------- 139 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeee--------------
Confidence 578899999999999999999999999999999865432 235788999999999887655433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..++||||+ +++|.+. .......+..++.||+.||+|||++||+||||||+|||+
T Consensus 140 -------------~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 201 (353)
T PLN00034 140 -------------MFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201 (353)
T ss_pred -------------EeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 335567889999999 7777542 335677888999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
++++.+||+|||+++....... ......||..|+|||++.. ...+.++|||||||++|||++|+.
T Consensus 202 ---~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 202 ---NSAKNVKIADFGVSRILAQTMD-------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred ---cCCCCEEEcccccceecccccc-------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 4788999999999987643221 1235578999999998743 234678999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||..............+.... .......++.++.+++..||..+|++||++.++.+
T Consensus 272 pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 272 PFGVGRQGDWASLMCAICMSQ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCCCccHHHHHHHHhccC----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 998433322222222221111 11122355789999999999999999999888754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.08 Aligned_cols=238 Identities=22% Similarity=0.310 Sum_probs=188.6
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
+.||+|+||.||+|++..+++.||+|++.... ....+..|+++++.++|++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~--------------------- 59 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA--------------------- 59 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCc---------------------
Confidence 46999999999999999999999999986431 1234567888888888776443
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeecC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nill~~~ 165 (449)
+..+....+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 60 ------~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll--- 129 (325)
T cd05594 60 ------LKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML--- 129 (325)
T ss_pred ------eEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---
Confidence 344445677899999999 8888877654 5579999999999999999999998 799999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~ 202 (325)
T cd05594 130 DKDGHIKITDFGLCKEGIKDGAT-------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202 (325)
T ss_pred CCCCCEEEecCCCCeecCCCCcc-------cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH
Confidence 47889999999998754322211 13457999999999999999999999999999999999999999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 296 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~ 296 (449)
.....+.......| ...++++.+++..||..||.+|+ ++.++.
T Consensus 203 ---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 203 ---KLFELILMEEIRFP-----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred ---HHHHHHhcCCCCCC-----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 22333333332222 34578999999999999999997 655553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=317.32 Aligned_cols=205 Identities=22% Similarity=0.302 Sum_probs=169.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+......
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ------ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc------
Confidence 4589999999999999999999999999999999886432 233577899999999999877665432111
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.........|+||||++++|.+.+. ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 96 ---------------~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI 157 (364)
T cd07875 96 ---------------KSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157 (364)
T ss_pred ---------------ccccccCeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHE
Confidence 0112335679999999888887764 3588999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+++....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ll---~~~~~~kL~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 158 VV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred EE---CCCCcEEEEeCCCccccCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 99 4788999999999976543221 134578999999999999999999999999999999999999998
Q ss_pred CChh
Q 013125 241 GLKA 244 (449)
Q Consensus 241 ~~~~ 244 (449)
+...
T Consensus 227 ~~~~ 230 (364)
T cd07875 227 GTDH 230 (364)
T ss_pred CCCH
Confidence 7554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=318.88 Aligned_cols=242 Identities=22% Similarity=0.314 Sum_probs=201.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.|.-++.||.|+||.||-|++..|.+.||||.+.-. .++..+++|+++|+.|.|+|.+.+-
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYk-------------- 92 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYK-------------- 92 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccc--------------
Confidence 466788999999999999999999999999986533 2345689999999999999866543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.|...+...|||||||-|+..|++.-..+++.+-.+..|..+.+.||.|||+.+.||||||+.|||+
T Consensus 93 -------------gCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 93 -------------GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred -------------ceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 3444556779999999999999998778889999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+ +.+.|||+|||.|..... .++++|||.|||||+|+ .+.|+-++||||||+++.||...++|+
T Consensus 160 s---e~g~VKLaDFGSAsi~~P-----------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 160 S---EPGLVKLADFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred c---CCCeeeeccccchhhcCc-----------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 6 899999999999865432 35899999999999987 356999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
..++...-.. .|....-+... ...++..|+.+++.||+.-|.+||+.+++.
T Consensus 226 FnMNAMSALY---HIAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 226 FNMNAMSALY---HIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred cCchHHHHHH---HHHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 9887764332 23332222222 344578999999999999999999988754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=315.92 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=190.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.++||+|+||+||+|++..+++.||+|++.... ....+..|+.++..+.|++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~------------------ 62 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW------------------ 62 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCC------------------
Confidence 57999999999999999999999999999999876421 1223566777777777665
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+..+..+....+..|+||||+ |++|.+++......++...++.++.||+.||+|||++||+||||||+||
T Consensus 63 ---------i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni 133 (331)
T cd05624 63 ---------ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133 (331)
T ss_pred ---------EeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence 344444556778899999999 9999999987667899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----CCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il~el~~G 235 (449)
|+ +.++.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 134 ll---~~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g 204 (331)
T cd05624 134 LL---DMNGHIRLADFGSCLKMNQDGTV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204 (331)
T ss_pred EE---cCCCCEEEEeccceeeccCCCce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhC
Confidence 99 47789999999999876543221 1124579999999999876 4578899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
+.||.+.... +.+..+.......+.+......+.++++++..|+..++ +|+
T Consensus 205 ~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~ 255 (331)
T cd05624 205 ETPFYAESLV---ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRL 255 (331)
T ss_pred CCCccCCCHH---HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhc
Confidence 9999865432 33334433322222233334567899999999998644 443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=322.83 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=191.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+|+++++||+|+||+||+|++..+++.||+|++.... ....+.+|+++++.++|++++.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~-------------- 66 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-------------- 66 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeE--------------
Confidence 47999999999999999999999999999999876432 12346789999999988765544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+..+...+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NI 132 (382)
T cd05625 67 -------------YYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132 (382)
T ss_pred -------------EEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 33445677899999999 8899988865 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCcc----------------------------------------ccccCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRH----------------------------------------IPYRENKNLT 200 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~----------------------------------------~~~~~~~~~~ 200 (449)
|+ +.++.+||+|||+|..+........ ..-......+
T Consensus 133 Ll---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (382)
T cd05625 133 LI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV 209 (382)
T ss_pred EE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 99 4788999999999864321100000 0000112457
Q ss_pred CCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHH
Q 013125 201 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY 280 (449)
Q Consensus 201 gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~ 280 (449)
||+.|+|||++.+..++.++|||||||++|||++|++||.+.... +....+.........+. ....+++..+++..
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~ 285 (382)
T cd05625 210 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL---ETQMKVINWQTSLHIPP-QAKLSPEASDLIIK 285 (382)
T ss_pred cCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHH---HHHHHHHccCCCcCCCC-cccCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999875443 22223332111111111 12346788888888
Q ss_pred HhCCCCCCCCC---HHHH
Q 013125 281 CQSLTFDQRPD---YGFL 295 (449)
Q Consensus 281 ~l~~~p~~Rp~---~~~l 295 (449)
++ .+|.+|++ ++++
T Consensus 286 l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 286 LC-RGPEDRLGKNGADEI 302 (382)
T ss_pred Hc-cCHhHcCCCCCHHHH
Confidence 76 59999987 5544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.78 Aligned_cols=265 Identities=17% Similarity=0.219 Sum_probs=205.1
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.-+++|.+.|.+|||+.||+|++...+..||+|.+-..+. .....+|+++|+.|+ |+|+|.+++.+...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~-------- 107 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN-------- 107 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc--------
Confidence 4578999999999999999999988889999997654422 224789999999998 77777766532111
Q ss_pred hhcccCCCcCeeEEeccc-CCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVD-GEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKP 157 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHrDLkp 157 (449)
-.+.. .-.++|.|||| |++|.|++... ...|++.++++|++|+++|+.+||.+. |||||||-
T Consensus 108 -------------~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKi 174 (738)
T KOG1989|consen 108 -------------RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKI 174 (738)
T ss_pred -------------ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhh
Confidence 01222 35678999999 68999999843 455999999999999999999999998 99999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCC-CCcccccc-CCCCCCCCccccccccc---cCCCCCccchHHHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRHIPYR-ENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~-~~~~~~~~-~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlG~il~el 232 (449)
||||++ .++..||||||.|....... ....+.+- ..-....|+.|+|||++ .+.+.++|+|||+|||+||-|
T Consensus 175 ENvLls---~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 175 ENVLLS---ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred hheEEc---CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 999995 88899999999986432222 11111111 11234569999999965 578899999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
++...||.+... ..|+...+.+|.. ..++..+.+||..||+.||++||+.-++...+.++..
T Consensus 252 Cy~t~PFe~sg~-------laIlng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 252 CYFTTPFEESGK-------LAILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HHhCCCcCcCcc-------eeEEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 999999987422 2466777777764 3457899999999999999999996666555554433
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.97 Aligned_cols=258 Identities=19% Similarity=0.261 Sum_probs=200.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCC-----CceEEEEEecCCCC---chhHHHHHHHHHHHc-CCCcceeeEeecchhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVI 76 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~ 76 (449)
.++|+++++||+|+||.||+|.+... ...||||++..... ...+.+|+++++.+. |+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~-------- 107 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLL-------- 107 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEE--------
Confidence 57888999999999999999987433 34699999865432 235788999999996 77655544
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--------------------------------
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-------------------------------- 123 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-------------------------------- 123 (449)
.++......||||||+ +++|.+++....
T Consensus 108 -------------------~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (400)
T cd05105 108 -------------------GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVI 168 (400)
T ss_pred -------------------EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhh
Confidence 3445667889999999 899988875421
Q ss_pred ---------------------------------------------------------------CCCCHHHHHHHHHHHHH
Q 013125 124 ---------------------------------------------------------------RKFSLKTVLMLADQMIA 140 (449)
Q Consensus 124 ---------------------------------------------------------------~~~~~~~~~~i~~qil~ 140 (449)
..+++..++.++.||+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~ 248 (400)
T cd05105 169 LSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVAR 248 (400)
T ss_pred hhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHH
Confidence 24778888999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccc
Q 013125 141 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD 220 (449)
Q Consensus 141 ~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 220 (449)
||+|||+.||+||||||+|||++ +++.+||+|||+++........ .......++..|+|||++.+..++.++
T Consensus 249 aL~~LH~~~ivH~dikp~Nill~---~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~ 320 (400)
T cd05105 249 GMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLS 320 (400)
T ss_pred HHHHHHhCCeeCCCCChHhEEEe---CCCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchh
Confidence 99999999999999999999994 6788999999999865433211 112344567889999999998999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 221 DLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 221 DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
|||||||++|||++ |..||....... .+...+......+ ....++.++.+++..||..+|++||++.+|.+.|
T Consensus 321 DiwSlGvil~ellt~g~~P~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 321 DVWSYGILLWEIFSLGGTPYPGMIVDS---TFYNKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred hHHHHHHHHHHHHHCCCCCCcccchhH---HHHHHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 99999999999997 999998754321 1111122222222 1234588999999999999999999999999999
Q ss_pred HHHHH
Q 013125 300 HDLFS 304 (449)
Q Consensus 300 ~~~~~ 304 (449)
+.+++
T Consensus 395 ~~l~~ 399 (400)
T cd05105 395 ESLLP 399 (400)
T ss_pred HHHcC
Confidence 87653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=315.37 Aligned_cols=255 Identities=20% Similarity=0.232 Sum_probs=194.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+-++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+.......
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK----- 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc-----
Confidence 45899999999999999999999999999999998864321 234678999999999999887765432110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+||||+.++|.+.+. ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 90 ----------------~~~~~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Ni 150 (355)
T cd07874 90 ----------------SLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150 (355)
T ss_pred ----------------cccccceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 011234679999999888877764 3588999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 151 ll---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 151 VV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred EE---CCCCCEEEeeCcccccCCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99 4788999999999976543221 134578999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHH-------------------------------------HhhccChHHHHHHHHHHhC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIE-------------------------------------VLCKSHPAEFASYFHYCQS 283 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~-------------------------------------~~~~~~~~~~~~l~~~~l~ 283 (449)
+....... ..++........+ ......+.++++++..||.
T Consensus 220 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 220 GRDYIDQW---NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCHHHHH---HHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 75432221 1111111000000 0001123567889999999
Q ss_pred CCCCCCCCHHHHHH
Q 013125 284 LTFDQRPDYGFLKR 297 (449)
Q Consensus 284 ~~p~~Rp~~~~l~~ 297 (449)
.||.+||++.++.+
T Consensus 297 ~dP~~Rps~~ell~ 310 (355)
T cd07874 297 IDPAKRISVDEALQ 310 (355)
T ss_pred CCchhcCCHHHHhc
Confidence 99999999887644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=312.56 Aligned_cols=237 Identities=21% Similarity=0.310 Sum_probs=185.0
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||+|+++... ....+..|+.++..+ +|+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i---------------------- 58 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL---------------------- 58 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcC----------------------
Confidence 47999999999999999999999999987531 122356777777665 55554
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
+.+..+....+..|+||||+ +++|...+.. ...++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 59 -----v~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili--- 129 (329)
T cd05618 59 -----VGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--- 129 (329)
T ss_pred -----CceeeEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---
Confidence 44444456678899999999 8888877764 5679999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (329)
T cd05618 130 DSEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202 (329)
T ss_pred CCCCCEEEeeCCccccccCCCC-------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCc
Confidence 4788999999999875432221 123567899999999999999999999999999999999999999632111
Q ss_pred ------cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 246 ------TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 246 ------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
........+.......| ...+.++.+++..||..||.+||+.
T Consensus 203 ~~~~~~~~~~~~~~i~~~~~~~p-----~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 203 DNPDQNTEDYLFQVILEKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCcccccHHHHHHHHhcCCCCCC-----CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11122223333333333 3457889999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=307.22 Aligned_cols=202 Identities=22% Similarity=0.310 Sum_probs=163.4
Q ss_pred eeeecccCceeEEEEEEc--CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
+++||+|+||+||+|++. .+++.||+|++..........+|+++++.++|++++.+.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------------- 68 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL----------------- 68 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEe-----------------
Confidence 578999999999999975 4678899999876555566889999999999998776543321
Q ss_pred CcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~--------~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
...+...|+||||++++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||
T Consensus 69 --------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil 140 (317)
T cd07868 69 --------SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 140 (317)
T ss_pred --------cCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEE
Confidence 12345789999999999988876431 24889999999999999999999999999999999999
Q ss_pred eecC-CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013125 162 MGLG-RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 162 l~~~-~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+... +..+.+||+|||+|+....... +........||+.|+|||++.+. .++.++||||+||++|||++|++||
T Consensus 141 ~~~~~~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 141 VMGEGPERGRVKIADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred EecCCCCcCcEEEeecCceeccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 9532 3567899999999987643321 11122356789999999999874 5899999999999999999999999
Q ss_pred CCC
Q 013125 240 QGL 242 (449)
Q Consensus 240 ~~~ 242 (449)
.+.
T Consensus 217 ~~~ 219 (317)
T cd07868 217 HCR 219 (317)
T ss_pred cCC
Confidence 753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=312.00 Aligned_cols=233 Identities=23% Similarity=0.337 Sum_probs=186.7
Q ss_pred eeeecccCceeEEEEEEc---CCCceEEEEEecCC------CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+++||+|+||.||+|++. .+++.||+|++... .....+..|+.+++.++|++++..+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~-------------- 66 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLI-------------- 66 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhcee--------------
Confidence 468999999999999874 46889999987642 1123457899999999988755543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.....++..|+||||+ +++|.+.+.. ...+....++.++.||+.||+|||++||+||||||+|||
T Consensus 67 -------------~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 132 (323)
T cd05584 67 -------------YAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENIL 132 (323)
T ss_pred -------------eEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 2334567889999999 8899888765 556889999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ +.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 133 ~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 133 L---DAQGHVKLTDFGLCKESIHEGT-------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred E---CCCCCEEEeeCcCCeecccCCC-------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 9 4788999999999875433221 12346789999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
.... ..+..+.......+ ..+++++.+++..||..+|++||
T Consensus 203 ~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~ 243 (323)
T cd05584 203 ENRK---KTIDKILKGKLNLP-----PYLTPEARDLLKKLLKRNPSSRL 243 (323)
T ss_pred CCHH---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHcccCHhHcC
Confidence 5432 33334444333322 34578999999999999999999
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=320.05 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=199.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.++..++|++++..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~-------------- 66 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM-------------- 66 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeE--------------
Confidence 4799999999999999999999999999999998642 123346778888888887764443
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.......+..|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 67 -------------~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI 132 (360)
T cd05627 67 -------------FYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132 (360)
T ss_pred -------------EEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 33445678899999999 8899998875 45699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccc----------------------------cccCCCCCCCCcccccccccc
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHI----------------------------PYRENKNLTGTARYASCNTHL 212 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~ 212 (449)
|+ +.++.++|+|||++............ ........+||+.|+|||++.
T Consensus 133 li---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 133 LL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred EE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 99 47889999999998754322110000 000012457999999999999
Q ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhh--cCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 213 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 213 ~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
+..++.++|||||||++|||++|..||.+.... ..+..+.... ...|.. ...++++.+++..++ .+|.+|+
T Consensus 210 ~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~ 282 (360)
T cd05627 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ---ETYRKVMNWKETLVFPPE---VPISEKAKDLILRFC-TDSENRI 282 (360)
T ss_pred CCCCCCcceeccccceeeecccCCCCCCCCCHH---HHHHHHHcCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcC
Confidence 999999999999999999999999999875543 2333333211 111211 124678999998876 4999998
Q ss_pred CHHHHHHHHHHHHHhcCCCCCccccccc
Q 013125 291 DYGFLKRLFHDLFSREGYDFDFVFDWTI 318 (449)
Q Consensus 291 ~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 318 (449)
+...+.+.+ ...|....+|..
T Consensus 283 ~~~~~~ei~-------~hp~f~~~~~~~ 303 (360)
T cd05627 283 GSNGVEEIK-------SHPFFEGVDWGH 303 (360)
T ss_pred CCCCHHHHh-------cCCCCCCCCHHH
Confidence 643332222 234444566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=301.09 Aligned_cols=241 Identities=21% Similarity=0.322 Sum_probs=200.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+.-+.|..++.||+|.||.|.+++.+.+++.+||||+++.- .....+.|-++|+..+|+-
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPF--------------- 229 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPF--------------- 229 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcH---------------
Confidence 34467899999999999999999999999999999987642 2223566777777766653
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+-.+++.+...+..|+||||. ||.|.-.+.. .+.|++...+.+..+|+.||.|||+++||+||||.
T Consensus 230 ------------Lt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKL 296 (516)
T KOG0690|consen 230 ------------LTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKL 296 (516)
T ss_pred ------------HHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechh
Confidence 333455566778999999999 8888777654 56799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|+|+ |++|++||+|||+++....... ..+++|||+.|+|||++....|++++|+|.+|+++|||++|++
T Consensus 297 ENLlL---DkDGHIKitDFGLCKE~I~~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRL 366 (516)
T KOG0690|consen 297 ENLLL---DKDGHIKITDFGLCKEEIKYGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRL 366 (516)
T ss_pred hhhee---ccCCceEeeecccchhcccccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccC
Confidence 99999 6999999999999986443322 1368999999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
||..... ...+..|+...+..| ..+.++.+.|+.-.|..||.+|.
T Consensus 367 PFyn~dh---~kLFeLIl~ed~kFP-----r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 367 PFYNKDH---EKLFELILMEDLKFP-----RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cccccch---hHHHHHHHhhhccCC-----ccCCHHHHHHHHHHhhcChHhhc
Confidence 9987433 345555666666666 34478999999999999999997
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=310.59 Aligned_cols=234 Identities=22% Similarity=0.318 Sum_probs=187.3
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||||++... .....+.+|+++++.+ +|++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~----------------------- 57 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF----------------------- 57 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCC-----------------------
Confidence 4799999999999999999999999988743 1233456788888776 3554
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++.+..+....+..|+||||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 58 ----i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--- 129 (318)
T cd05570 58 ----LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL--- 129 (318)
T ss_pred ----ccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---
Confidence 444444456677899999999 8899888765 4579999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
++++.++|+|||+++....... .....+||..|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~ 202 (318)
T cd05570 130 DSEGHIKIADFGMCKEGILGGV-------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202 (318)
T ss_pred CCCCcEEecccCCCeecCcCCC-------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH
Confidence 4788999999999875332221 113457899999999999999999999999999999999999999865432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
..+..+.......+ ...+.++.+++..||..||.+||++
T Consensus 203 ---~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 203 ---ELFQSILEDEVRYP-----RWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred ---HHHHHHHcCCCCCC-----CcCCHHHHHHHHHHccCCHHHcCCC
Confidence 33333333333222 3457899999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=314.02 Aligned_cols=250 Identities=21% Similarity=0.266 Sum_probs=192.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.++||+|+||+||+|++..+++.||+|++... .....+..|+.++..++|+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i----------------- 63 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWI----------------- 63 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCE-----------------
Confidence 4799999999999999999999999999999987532 112235667777777766653
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+..+....+..|+||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+||
T Consensus 64 ----------~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Ni 133 (332)
T cd05623 64 ----------TTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133 (332)
T ss_pred ----------eeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 33444556778899999999 8999999987667799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G 235 (449)
|+ +.++.+||+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 134 li---~~~~~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g 204 (332)
T cd05623 134 LM---DMNGHIRLADFGSCLKLMEDGTV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204 (332)
T ss_pred EE---CCCCCEEEeecchheecccCCcc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcC
Confidence 99 47889999999999765432221 112457999999999986 34588999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCC--CCCHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFL 295 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~--Rp~~~~l 295 (449)
+.||.+.... +.+..+.......+.+..+...+.++.+++..|+..++.+ |+++.++
T Consensus 205 ~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~ 263 (332)
T cd05623 205 ETPFYAESLV---ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF 263 (332)
T ss_pred CCCCCCCCHH---HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHH
Confidence 9999875432 3444444433333333333456889999999988764433 4555544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.72 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=192.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+|+++++.++|.+++.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~---------------- 64 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN---------------- 64 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCcee----------------
Confidence 4889999999999999999999999999999876432 1223678999999998876443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+..+...++..|+||||+ +++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 65 -----------~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05632 65 -----------LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133 (285)
T ss_pred -----------EEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 333445677899999999 78888777643 34699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ ++.+.++|+|||++........ .....|+..|+|||++.+..++.++|+|||||++|||++|..||.
T Consensus 134 li---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 134 LL---DDYGHIRISDLGLAVKIPEGES--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred EE---CCCCCEEEecCCcceecCCCCc--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99 4678999999999976533211 124578999999999999899999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
+.......+..... ............+.++.+++..||..+|++||+.
T Consensus 203 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 203 GRKEKVKREEVDRR----VLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred CCCHHHHHHHHHHh----hhccccccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 75443222222111 1111122334567889999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=272.50 Aligned_cols=283 Identities=22% Similarity=0.309 Sum_probs=212.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+|...++||+|.||+||+|+...+++.||+|.+..+.+.+ ..++|+.+++.|+|.|++++..+.
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl----------- 70 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL----------- 70 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----------
Confidence 46788899999999999999999999999999877654433 479999999999999998876543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..++...+|+|+|..+|..++..+++.++.+.++.++.|++.||.|+|+++++||||||+|+||
T Consensus 71 ----------------hsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli 134 (292)
T KOG0662|consen 71 ----------------HSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI 134 (292)
T ss_pred ----------------ccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe
Confidence 3457889999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
+.++.+||+|||+|+-+.- |.+.....+.|.+|++|.++.+.. |+...|+||.||++.|+.. |++.|.
T Consensus 135 ---n~ngelkladfglarafgi-------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 135 ---NRNGELKLADFGLARAFGI-------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ---ccCCcEEecccchhhhcCC-------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 5899999999999986643 445556677899999999999987 8999999999999999997 899999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccc
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
|....+....+..++ ..|.+..|.++. .+ .|..--|.|.....+ -++....+..-.+.+. +.++
T Consensus 205 g~dvddqlkrif~~l----g~p~ed~wps~t----~l------pdyk~yp~ypattsw-sqivp~lns~grdllq-kll~ 268 (292)
T KOG0662|consen 205 GNDVDDQLKRIFRLL----GTPTEDQWPSMT----KL------PDYKPYPIYPATTSW-SQIVPKLNSTGRDLLQ-KLLK 268 (292)
T ss_pred CCcHHHHHHHHHHHh----CCCccccCCccc----cC------CCCcccCCccccchH-HHHhhhhcchhHHHHH-HHhc
Confidence 866554444333322 333333332211 00 111222222111110 1111111111111111 5677
Q ss_pred ccccccccccccCCCCccccCC
Q 013125 321 YQQTQKTKSQDLLPASRVTNSR 342 (449)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~ 342 (449)
.+|.++.++..+++|++++...
T Consensus 269 cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 269 CNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred cCcccccCHHHHhcCccccccC
Confidence 8888888888888888886543
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.51 Aligned_cols=257 Identities=18% Similarity=0.225 Sum_probs=199.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
-.++|++.+.||+|+||+||+|.+..+++ .|++|.+...... .++..|+.++..+.|++++..++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~------- 77 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGI------- 77 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEE-------
Confidence 45789999999999999999999977766 4777776543221 235566667777778776655442
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.. +...++++|++ +++|.+++......+++..++.++.||+.||+|||++|++|||||
T Consensus 78 --------------------~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlk 136 (279)
T cd05111 78 --------------------CP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLA 136 (279)
T ss_pred --------------------EC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccC
Confidence 22 34467889988 899999998767789999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+|||+ +.++.+||+|||+++......... ......++..|++||.+.+..++.++|||||||++|||++ |
T Consensus 137 p~nili---~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g 208 (279)
T cd05111 137 ARNILL---KSDSIVQIADFGVADLLYPDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG 208 (279)
T ss_pred cceEEE---cCCCcEEEcCCccceeccCCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999 478899999999998664332111 0123456778999999998899999999999999999998 9
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
..||.+..... +..+.......+.+. .++..+.+++..||..+|.+||++.++.+.|..+..
T Consensus 209 ~~p~~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 209 AEPYAGMRPHE----VPDLLEKGERLAQPQ---ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCCCHHH----HHHHHHCCCcCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 99998765432 223333333222222 246789999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.41 Aligned_cols=235 Identities=23% Similarity=0.339 Sum_probs=185.2
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||||+++.. ........|..++..+ +|++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~----------------------- 57 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF----------------------- 57 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCc-----------------------
Confidence 4799999999999999999999999988653 1223455676666643 5555
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++.+..+....+..|+||||+ +++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 58 ----iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~--- 129 (316)
T cd05619 58 ----LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL--- 129 (316)
T ss_pred ----CcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---
Confidence 444444456677899999999 8899988875 4568999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 130 DTDGHIKIADFGMCKENMLGDA-------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred CCCCCEEEccCCcceECCCCCC-------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 4778999999999875332211 123567899999999999999999999999999999999999999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
+.+..+.......+ ...+.++.+++..||..+|.+||++.
T Consensus 203 ---~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 203 ---ELFQSIRMDNPCYP-----RWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred ---HHHHHHHhCCCCCC-----ccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 23333322221111 23578899999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=305.20 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=209.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+.-||++.+.||+|.||.|-+|+....|+.||||.+.++.-. -.+.+|++||..|+|++++..+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyE---------- 120 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYE---------- 120 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhh----------
Confidence 346899999999999999999999999999999987765322 23789999999999998665433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
-+.+.+..+|||||. +|.|.|++..+ +.+++.+++.+++||..|+.|+|..+++|||||.+
T Consensus 121 -----------------VFENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLE 182 (668)
T KOG0611|consen 121 -----------------VFENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLE 182 (668)
T ss_pred -----------------hhcCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchh
Confidence 246778899999999 99999999874 56999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G~~ 237 (449)
|||+ |.++++||+|||++-.+....- -.++||++-|.+||++.|.+| +..+|-||||++||-|++|..
T Consensus 183 NILL---D~N~NiKIADFGLSNly~~~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtM 251 (668)
T KOG0611|consen 183 NILL---DQNNNIKIADFGLSNLYADKKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTM 251 (668)
T ss_pred heee---cCCCCeeeeccchhhhhccccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccc
Confidence 9999 6899999999999987766543 258899999999999999997 789999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.|.+ ....+..|..+.+..|. -|.+..-||..+|..||++|.+.++|..
T Consensus 252 PFDG~D---hk~lvrQIs~GaYrEP~------~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 252 PFDGRD---HKRLVRQISRGAYREPE------TPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ccCCch---HHHHHHHhhcccccCCC------CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 998843 34556666666555542 2667889999999999999999888765
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=317.75 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=194.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+..++|++.+.||+|+||.||+|++..+++.||+|++... .....+..|+.+++.++|++++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~---------- 109 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF---------- 109 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEE----------
Confidence 3457899999999999999999999999999999987642 1223467889999998888755543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.+...+...|+||||+ +++|.+++.. ..++..+++.++.||+.||+|||++||+||||||
T Consensus 110 -----------------~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp 170 (370)
T cd05621 110 -----------------CAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 170 (370)
T ss_pred -----------------EEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 3345677899999999 8999998864 4689999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC----CCccchHHHHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlG~il~el~ 233 (449)
+|||+ ++.+.+||+|||+|......... ......||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 171 ~NILl---~~~~~~kL~DFG~a~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell 241 (370)
T cd05621 171 DNMLL---DKHGHLKLADFGTCMKMDETGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241 (370)
T ss_pred HHEEE---CCCCCEEEEecccceecccCCce------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence 99999 47899999999999876432211 123567999999999987643 789999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCC--CCCHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 297 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~--Rp~~~~l~~ 297 (449)
+|..||.+.... ..+..+.........+. ....+..+++++..|+..++.+ |+++.++.+
T Consensus 242 ~G~~Pf~~~~~~---~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 242 VGDTPFYADSLV---GTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred hCCCCCCCCCHH---HHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 999999875432 33444443222111111 1234678899999999744432 667665533
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=311.60 Aligned_cols=237 Identities=20% Similarity=0.308 Sum_probs=186.1
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|++..+++.||+|+++... ....+..|..+++.+ +|++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~----------------------- 57 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF----------------------- 57 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCC-----------------------
Confidence 46899999999999999999999999987531 122366788888777 4554
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++.+..+....+..|+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 ----Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili--- 129 (329)
T cd05588 58 ----LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL--- 129 (329)
T ss_pred ----CCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---
Confidence 444444556678899999999 8899887764 5679999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+..+.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 202 (329)
T cd05588 130 DAEGHIKLTDYGMCKEGIRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202 (329)
T ss_pred CCCCCEEECcCccccccccCCC-------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccc
Confidence 4788999999999874322211 123567899999999999999999999999999999999999999642211
Q ss_pred ------cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 246 ------TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 246 ------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
........+.......| ..++.++.+++..||..||.+|++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 203 DNPDQNTEDYLFQVILEKQIRIP-----RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ccccccchHHHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122233333333322 3457889999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=303.73 Aligned_cols=236 Identities=21% Similarity=0.289 Sum_probs=185.3
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||+|+||+||+|.+..+++.||+|++.... ....+..|+++++.++|++++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~---------------------- 58 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL---------------------- 58 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeee----------------------
Confidence 799999999999999999999999876432 12345779999999988765543
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
..+.......|+||||+ +++|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 59 -----~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--- 130 (280)
T cd05608 59 -----AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL--- 130 (280)
T ss_pred -----eEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---
Confidence 23334567789999999 88998776432 3468999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.++|+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 203 (280)
T cd05608 131 DNDGNVRISDLGLAVELKDGQSK-------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 203 (280)
T ss_pred CCCCCEEEeeCccceecCCCCcc-------ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 47789999999999766543221 23557899999999999999999999999999999999999999864332
Q ss_pred cH-HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 246 TK-KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 246 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.. ......+... + .......+.++.+++..||..||++||++
T Consensus 204 ~~~~~~~~~~~~~----~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 204 VENKELKQRILND----S-VTYPDKFSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred hhHHHHHHhhccc----C-CCCcccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 11 1111122111 1 11223468899999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.11 Aligned_cols=248 Identities=19% Similarity=0.324 Sum_probs=194.2
Q ss_pred eecccCceeEEEEEEc--CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccC
Q 013125 14 KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTL 88 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (449)
.||+|+||.||+|.+. .++..||+|+...... .+.+.+|+.+++.++|++++..++.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~----------------- 64 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC----------------- 64 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----------------
Confidence 4899999999999875 4456799998875433 23578999999999999877665432
Q ss_pred CCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCC
Q 013125 89 GGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167 (449)
Q Consensus 89 ~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~ 167 (449)
.....++||||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+. .
T Consensus 65 -----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~ 130 (257)
T cd05115 65 -----------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---N 130 (257)
T ss_pred -----------cCCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---C
Confidence 234678999999 8899998876566799999999999999999999999999999999999994 7
Q ss_pred CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhc
Q 013125 168 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 246 (449)
Q Consensus 168 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~ 246 (449)
++.+||+|||++.......... .......++..|+|||++.+..++.++|||||||++||+++ |..||.+.....
T Consensus 131 ~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 206 (257)
T cd05115 131 QHYAKISDFGLSKALGADDSYY----KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206 (257)
T ss_pred CCcEEeccCCccccccCCccce----eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 7899999999997654332210 11112234578999999998889999999999999999996 999998765432
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
. ...+ ......+ .....++++.+++..||..+|++||++.+|.+.|+.++
T Consensus 207 ~---~~~~-~~~~~~~---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 207 V---MSFI-EQGKRLD---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred H---HHHH-HCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 2 2222 2222212 12345789999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=298.59 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=200.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|++..+++.||||.+..... ...+.+|+++++.++|++++..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------ 69 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD------------ 69 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeee------------
Confidence 689999999999999999999999999999997654211 224678999999999887554432
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++...+..++|+||+ +++|.+++... ...++...++.++.||+.||+|||++|++|+||||
T Consensus 70 ---------------~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~ 134 (267)
T cd08228 70 ---------------SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKP 134 (267)
T ss_pred ---------------eEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCH
Confidence 334567889999999 78998887642 34588999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+||+++ .++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 135 ~nil~~---~~~~~~l~d~g~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 204 (267)
T cd08228 135 ANVFIT---ATGVVKLGDLGLGRFFSSKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred HHEEEc---CCCCEEECccccceeccchhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCC
Confidence 999994 6788999999999876433211 124568889999999998889999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||...... .......+.. ....+ ......+..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 205 p~~~~~~~-~~~~~~~~~~-~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 205 PFYGDKMN-LFSLCQKIEQ-CDYPP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCcccccc-HHHHHHHHhc-CCCCC--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99754321 1222222221 11111 11233468899999999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.56 Aligned_cols=258 Identities=20% Similarity=0.240 Sum_probs=193.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+++++.++|++++..+.......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 72 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPH-------- 72 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCC--------
Confidence 4789999999999999999999999999999876432 1235788999999999998776544321110
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.......|+|+||++++|.+.+.. ...++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 73 --------------~~~~~~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili- 136 (372)
T cd07853 73 --------------IDPFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV- 136 (372)
T ss_pred --------------ccccceEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE-
Confidence 001136799999998888887754 5679999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.++.+||+|||+++........ ......+|..|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 137 --~~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 137 --NSNCVLKICDFGLARVEEPDESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred --CCCCCEEeccccceeecccCccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 47889999999999865433211 11234678999999999875 4799999999999999999999999876
Q ss_pred hhhcHHHHHHHHHH--------------------hhcCCC-HH---HhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICE--------------------KKVSTP-IE---VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~--------------------~~~~~~-~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
........+..... .....+ .. ......++++.+++..||..||.+||++.++.+
T Consensus 209 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 209 SPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 54432222211100 000001 00 011234678889999999999999999877643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=302.08 Aligned_cols=256 Identities=20% Similarity=0.281 Sum_probs=199.6
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
|.+...++|++.++||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++|++++....
T Consensus 3 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~--------- 73 (267)
T cd06646 3 LRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG--------- 73 (267)
T ss_pred cccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeE---------
Confidence 345567889999999999999999999998999999999865432 334678999999998887555433
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.+...+..++||||+ +++|.+++.. ...++...+..++.|++.||+|||+.||+||||||
T Consensus 74 ------------------~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 134 (267)
T cd06646 74 ------------------SYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKG 134 (267)
T ss_pred ------------------EEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH
Confidence 334567889999999 7889888765 45789999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHh
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~ 234 (449)
+||++ ++.+.++|+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++
T Consensus 135 ~nill---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~ 204 (267)
T cd06646 135 ANILL---TDNGDVKLADFGVAAKITATIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred HHEEE---CCCCCEEECcCccceeeccccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh
Confidence 99999 4778899999999987643221 123456889999999875 3447889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|..||....... ....+.......+........+..+.+++..||..+|++||++++|.+
T Consensus 205 g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 205 LQPPMFDLHPMR---ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCCCccccchhh---hheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 999997544321 111111122222221122345789999999999999999999988754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.99 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=194.7
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
++..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.++|++++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~---------- 108 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL---------- 108 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE----------
Confidence 345689999999999999999999999999999999875321 12236678888888888765544
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
......+...|+||||+ +++|.+++.. ..++...++.++.||+.||+|||++||+|||||
T Consensus 109 -----------------~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 169 (371)
T cd05622 109 -----------------FYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169 (371)
T ss_pred -----------------EEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 33445678899999999 8899998864 458999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC----CCccchHHHHHHHHHHH
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYF 232 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlG~il~el 232 (449)
|+|||++ .++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 170 p~NIll~---~~~~ikL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyel 240 (371)
T cd05622 170 PDNMLLD---KSGHLKLADFGTCMKMNKEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (371)
T ss_pred HHHEEEC---CCCCEEEEeCCceeEcCcCCcc------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHH
Confidence 9999994 7889999999999876433211 123567999999999987643 78999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCC---CCCHHHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQ---RPDYGFLKR 297 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~---Rp~~~~l~~ 297 (449)
++|..||.+.... ..+..+.........+. ....+.++++++..|+. ++.. |++++++.+
T Consensus 241 l~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 241 LVGDTPFYADSLV---GTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 303 (371)
T ss_pred HhCCCCCCCCCHH---HHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhc
Confidence 9999999875432 33444443221111111 13457899999999998 5554 566665543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=302.27 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=191.6
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.|++.+.||+|+||+||+|.+..+++.||+|.+..... ...+.+|+.+++.++|.+++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~--------------- 65 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL--------------- 65 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeee---------------
Confidence 48899999999999999999999999999998754321 2246789999999988765443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
...+...+..|+||||+ +++|.+++... ...++...++.++.|++.||.|||++||+||||||+||
T Consensus 66 ------------~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05630 66 ------------AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133 (285)
T ss_pred ------------eEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 33334567899999999 88998887543 34689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ ++.+.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 134 l~---~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 134 LL---DDHGHIRISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred EE---CCCCCEEEeeccceeecCCCcc--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 99 4778899999999876433221 124578999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
.............+... .........++++.+++..||..||.+||+
T Consensus 203 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 203 QRKKKIKREEVERLVKE----VQEEYSEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CCCccchHHHHHhhhhh----hhhhcCccCCHHHHHHHHHHhhcCHHHccC
Confidence 75432222222222111 111223456788999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=307.96 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=204.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+-.+.|+.-+.||+||||+||-++...||+.+|+|.+.+. ......++|.+++.+++.+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~---------------- 245 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP---------------- 245 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC----------------
Confidence 3456789999999999999999999999999999965432 3333468899999888765
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.|+.+-+.....+..|+|+.+| ||+|.-.+-..+ ..|+++.++.++.+|++||++||..+||+||||
T Consensus 246 -----------FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLK 314 (591)
T KOG0986|consen 246 -----------FIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLK 314 (591)
T ss_pred -----------cEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCC
Confidence 3445556667889999999999 899887765444 469999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ |+.|+|+|+|+|+|..+...... ...+||..|||||++.+..|+...|+|||||++|||+.|+
T Consensus 315 PeNILL---Dd~GhvRISDLGLAvei~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~ 383 (591)
T KOG0986|consen 315 PENILL---DDHGHVRISDLGLAVEIPEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGH 383 (591)
T ss_pred hhheee---ccCCCeEeeccceEEecCCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHccc
Confidence 999999 69999999999999987765432 3669999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.||.........+.+.+ .......++...++++.+++.+..|..||.+|...
T Consensus 384 sPFr~~KeKvk~eEvdr----r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 384 SPFRQRKEKVKREEVDR----RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred CchhhhhhhhhHHHHHH----HHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 99987665444433322 22333455557788999999999999999999854
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=301.22 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=197.4
Q ss_pred CCce-EEeeeecccCceeEEEEEE----cCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 6 GVKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 6 ~~~y-~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
.+|| ++.+.||+|+||+||++.. ..+++.||+|++..... ...+.+|+++++.++|++++...+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 76 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCS----- 76 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----
Confidence 4566 9999999999999988753 35677899999875432 345788999999999988666544321
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.......++||||+ +++|.+++.. ..+++.+++.++.|++.||+|||++||+|||||
T Consensus 77 --------------------~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlk 134 (283)
T cd05080 77 --------------------EQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLA 134 (283)
T ss_pred --------------------cCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC
Confidence 12345679999999 8899988864 459999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||++ .++.++|+|||+++........ +.......++..|++||.+.+..++.++|||||||++|||++|.
T Consensus 135 p~Nili~---~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 135 ARNVLLD---NDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred hheEEEc---CCCcEEEeecccccccCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 9999994 6789999999999866543211 11112334567799999999888999999999999999999999
Q ss_pred CCCCCChhhcH-----------HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 237 LPWQGLKAATK-----------KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 237 ~pf~~~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
.||........ ...+..........+ ....+|.++.+++..||..+|++||+++++.+.|+++
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 99865321100 001111111111111 1234578999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.47 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=200.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
-.++|.+.+.||+|+||.||+|.+.. +++.||+|+++..... ..+.+|+++++.++|++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-------- 74 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFY-------- 74 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchhee--------
Confidence 35789999999999999999998743 3578999998765433 4688999999999988755443
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-------------RKFSLKTVLMLADQMIARI 142 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-------------~~~~~~~~~~i~~qil~~L 142 (449)
.+.......++||||+ +++|.+++...+ ..+++..+..++.||+.||
T Consensus 75 -------------------~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l 135 (280)
T cd05049 75 -------------------GVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135 (280)
T ss_pred -------------------eEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHH
Confidence 3345567889999999 899999886432 3478889999999999999
Q ss_pred HHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchH
Q 013125 143 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDL 222 (449)
Q Consensus 143 ~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 222 (449)
.|||++|++||||||+||+++ .++.++|+|||++......... .......++..|+|||++.+..++.++||
T Consensus 136 ~~lH~~~i~h~dlkp~nili~---~~~~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 207 (280)
T cd05049 136 VYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDV 207 (280)
T ss_pred HHHhhCCeeccccccceEEEc---CCCeEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhH
Confidence 999999999999999999994 7799999999999765332211 11233456788999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 223 ESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 223 wSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
|||||++|||++ |..||.+..... ....+.......+ ....+..+.+++..||..+|.+||++.++.+.|+
T Consensus 208 ~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 208 WSFGVVLWEIFTYGKQPWYGLSNEE---VIECITQGRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 999999999998 999998755432 2222322222221 1345789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=296.79 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=202.2
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+|..+.|+++++||+|+||.||+|.+. +++.||+|.+..... ...+.+|+.+++.++|++++.....
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~----------- 69 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV----------- 69 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEE-----------
Confidence 467889999999999999999999864 567899998875433 3468899999999999876554322
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
. ..+..+++||++ +++|.+++... +..++..+++.++.|++.||+|||+.|++||||||+|
T Consensus 70 ----------------~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~n 132 (260)
T cd05067 70 ----------------V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAAN 132 (260)
T ss_pred ----------------E-ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHh
Confidence 1 235679999999 88999987643 3568999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
|+++ +++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ |.+|
T Consensus 133 i~i~---~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p 203 (260)
T cd05067 133 ILVS---ETLCCKIADFGLARLIEDNEYT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203 (260)
T ss_pred EEEc---CCCCEEEccCcceeecCCCCcc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCC
Confidence 9994 7889999999999766532211 1123456778999999998889999999999999999999 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|.+...... ...+ ......+ .....+.++.+++.+||..+|++||++++|.+.|+.
T Consensus 204 ~~~~~~~~~---~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 204 YPGMTNPEV---IQNL-ERGYRMP---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCChHHH---HHHH-HcCCCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 987554322 2222 2222222 224457899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=303.17 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=196.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.++||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++|++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~--------------- 70 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH--------------- 70 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEE---------------
Confidence 679999999999999999999999999999998764322 23467899999999988755543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.+....+..|+||||+.++|.+++......++...++.++.||+.||+|||+.||+||||||+|||+
T Consensus 71 ------------~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~- 137 (301)
T cd07873 71 ------------DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI- 137 (301)
T ss_pred ------------EEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE-
Confidence 3345667899999999889999887766779999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.++.++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|||++|++||.+.
T Consensus 138 --~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 138 --NERGELKLADFGLARAKSIPTK-------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred --CCCCcEEECcCcchhccCCCCC-------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4778999999999875433221 11234568899999998764 4789999999999999999999999875
Q ss_pred hhhcHHHHHHHHHHhhc----------------CCC------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKV----------------STP------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~----------------~~~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
........+..+..... ..+ ........+..+++++.+|+..||.+||+++++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 209 TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 54322222211111000 000 11122345778899999999999999999887744
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=300.96 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=204.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
|-...|.+.+.||+|+||+||+|.+. .++..||+|.+..... ...+.+|+++++.++|++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-------- 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFY-------- 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEE--------
Confidence 34678999999999999999999863 3456699998765432 33578899999999988755443
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIE 143 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------------~~~~~~~~~~i~~qil~~L~ 143 (449)
.++...+..++||||+ +++|.+++.... ..+++.+++.++.||+.||+
T Consensus 74 -------------------~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~ 134 (288)
T cd05093 74 -------------------GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMV 134 (288)
T ss_pred -------------------EEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHH
Confidence 3445667889999999 899999886432 24899999999999999999
Q ss_pred HHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHH
Q 013125 144 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLE 223 (449)
Q Consensus 144 ~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw 223 (449)
|||++|++||||||+|||+ ++++.++|+|||+++....... +.......++..|+|||++.+..++.++|||
T Consensus 135 ~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiw 206 (288)
T cd05093 135 YLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206 (288)
T ss_pred HHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHH
Confidence 9999999999999999999 4788999999999976543221 1112234457789999999998899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 224 SLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 224 SlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||||++|+|++ |..||....... ....+....... .....+.++.+++..||..+|.+||++.++...|+++
T Consensus 207 slG~il~~l~t~g~~p~~~~~~~~---~~~~i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 207 SLGVVLWEIFTYGKQPWYQLSNNE---VIECITQGRVLQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCcCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 99999999998 999998765432 233333322111 1234578999999999999999999999999999888
Q ss_pred HHhc
Q 013125 303 FSRE 306 (449)
Q Consensus 303 ~~~~ 306 (449)
.+..
T Consensus 280 ~~~~ 283 (288)
T cd05093 280 AKAS 283 (288)
T ss_pred HHhc
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.14 Aligned_cols=258 Identities=20% Similarity=0.304 Sum_probs=199.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+-+++|++.+.||+|+||.||+|.+.. ++..||+|....... ...+.+|+.+++.++|+++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~------ 76 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIG------ 76 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE------
Confidence 456889999999999999999999976 678899998764432 234788999999999887655443
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
++......++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++
T Consensus 77 ---------------------~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 135 (277)
T cd05036 77 ---------------------VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135 (277)
T ss_pred ---------------------EEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 334556779999999 899999987543 2589999999999999999999999
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHH
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 228 (449)
+++||||||+||++........+||+|||+++........ ........+..|+|||++.+..++.++|||||||+
T Consensus 136 ~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 210 (277)
T cd05036 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210 (277)
T ss_pred CEeecccchheEEEeccCCCcceEeccCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHH
Confidence 9999999999999964333457999999999866332211 11122234568999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 229 LLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 229 l~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
+|||++ |..||.+..... ....+.. .... .....+|..+.+++..||..+|++||++.+|.+.|.
T Consensus 211 l~el~~~g~~pf~~~~~~~---~~~~~~~-~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 211 LWEIFSLGYMPYPGRTNQE---VMEFVTG-GGRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHcCCCCCCCCCCHHH---HHHHHHc-CCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 999997 999998754432 2222221 1111 112455889999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.44 Aligned_cols=250 Identities=19% Similarity=0.211 Sum_probs=199.7
Q ss_pred CCceEEeeeecccCceeEEEEEEcCC-CceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+..... ...+.+|+.+++.++|+++++.+.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~------------- 132 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD------------- 132 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEE-------------
Confidence 34599999999999999999998777 78899997654322 224677999999999987665543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
++...+..||||||+ +++|.+++... ...++...+..++.||+.||+|||++||+||||||+
T Consensus 133 --------------~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~ 198 (478)
T PTZ00267 133 --------------DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSA 198 (478)
T ss_pred --------------EEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHH
Confidence 345667899999999 89999887542 345899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+ +..+.+||+|||+++.+...... ......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 199 NIll---~~~~~~kL~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~P 270 (478)
T PTZ00267 199 NIFL---MPTGIIKLGDFGFSKQYSDSVSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270 (478)
T ss_pred hEEE---CCCCcEEEEeCcCceecCCcccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 9999 47889999999999876543211 112456799999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|.+.... +.+..+....... ....++.++.+++..||..+|.+||++.++..
T Consensus 271 f~~~~~~---~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 271 FKGPSQR---EIMQQVLYGKYDP----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCHH---HHHHHHHhCCCCC----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 9875432 3333333332221 11345789999999999999999999988754
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.70 Aligned_cols=198 Identities=25% Similarity=0.310 Sum_probs=167.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.+..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++++.|+|++++.++.
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~-------------- 227 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLD-------------- 227 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEE--------------
Confidence 35678999999999999999999999999999999632 234678999999999988666543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++..+...|+|||++.++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 228 -------------~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 228 -------------VRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred -------------EEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 3345678899999998899988876566799999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
..+.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus 295 ---~~~~vkL~DFGla~~~~~~~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 295 ---GPEDICLGDFGAACFARGSWSTP-----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ---CCCCEEEcccCCceecccccccc-----cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 77899999999998654322110 1135679999999999999999999999999999999999876554
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=311.40 Aligned_cols=236 Identities=23% Similarity=0.308 Sum_probs=184.7
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||+|++.... ....+..|.. +++.++|+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~I---------------------- 58 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL---------------------- 58 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCC----------------------
Confidence 47999999999999999999999999986431 1112333333 3455666654
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
..+..++...+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 59 -----v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili--- 129 (325)
T cd05602 59 -----VGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL--- 129 (325)
T ss_pred -----CceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---
Confidence 44444556678899999999 8899888765 5668899999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 130 ~~~~~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (325)
T cd05602 130 DSQGHIVLTDFGLCKENIEHNG-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202 (325)
T ss_pred CCCCCEEEccCCCCcccccCCC-------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH
Confidence 4788999999999975432221 123567999999999999999999999999999999999999999875433
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
..+..+....... ....+..+.+++..||..+|.+|++..+
T Consensus 203 ---~~~~~i~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 203 ---EMYDNILNKPLQL-----KPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred ---HHHHHHHhCCcCC-----CCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 3333333332222 2356789999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=295.10 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=202.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+|+++++.++|++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~------------- 67 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLY------------- 67 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCcccee-------------
Confidence 356689999999999999999999975 456799998875432 34588899999999988755433
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.+....+..|+|||++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|
T Consensus 68 --------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 133 (261)
T cd05068 68 --------------AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARN 133 (261)
T ss_pred --------------EEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcce
Confidence 3345667789999999 999999987543 568999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
|+++ +++.++|+|||+++........ .......+..|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 134 il~~---~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 204 (261)
T cd05068 134 VLVG---ENNICKVADFGLARVIKEDIYE------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204 (261)
T ss_pred EEEc---CCCCEEECCcceEEEccCCccc------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 9994 7889999999999877533211 1112233467999999999899999999999999999999 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|.+..... .+..+. .....+. ....+..+.+++..||..+|.+||++++|.+.|++
T Consensus 205 ~~~~~~~~---~~~~~~-~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 205 YPGMTNAE---VLQQVD-QGYRMPC---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCHHH---HHHHHH-cCCCCCC---CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 98755432 222222 2222221 13457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=297.63 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=201.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
|-.++|+++++||+|+||.||+|.+. ++..||+|.+.... ..+.+.+|+.+++.++|++++..+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------- 68 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA------------- 68 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEE-------------
Confidence 44678999999999999999999974 45679999876533 2446788999999999887655433
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.....+..+++||++ +++|.+++... ...+++..++.++.|++.||+|||+.+++||||||+||
T Consensus 69 --------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 134 (261)
T cd05072 69 --------------VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV 134 (261)
T ss_pred --------------EEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 334567789999999 88999988753 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
+++ +++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 135 li~---~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 135 LVS---ESLMCKIADFGLARVIEDNEYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred Eec---CCCcEEECCCccceecCCCcee------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 994 7889999999999876443211 1123345678999999998889999999999999999998 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
.+..... ....+.. ....+ .....+.++.+++.+||..+|++||+++++.+.|++
T Consensus 206 ~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 206 PGMSNSD---VMSALQR-GYRMP---RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHH---HHHHHHc-CCCCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 8754432 2222221 22222 123467899999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.70 Aligned_cols=235 Identities=23% Similarity=0.329 Sum_probs=185.0
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||||++.... ....+..|.. +++.++|++++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv--------------------- 59 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV--------------------- 59 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCC---------------------
Confidence 47999999999999999999999999976431 1122344443 34556666544
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
.+.......+..|+||||+ +++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 60 ------~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll--- 129 (323)
T cd05575 60 ------GLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL--- 129 (323)
T ss_pred ------CeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---
Confidence 4444456678899999999 8899888765 5679999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 130 DSQGHVVLTDFGLCKEGIEHSK-------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred CCCCcEEEeccCCCcccccCCC-------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence 4788999999999875332211 123567899999999999999999999999999999999999999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
+.+..+....... ....+.++.+++..||..+|.+||+..
T Consensus 203 ---~~~~~i~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 203 ---EMYDNILNKPLRL-----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---HHHHHHHcCCCCC-----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 3333443333222 234588999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=303.13 Aligned_cols=261 Identities=20% Similarity=0.310 Sum_probs=196.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCC--------------ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCccee
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN--------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRL 67 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--------------~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~ 67 (449)
-.++|++.++||+|+||.||+|++..++ ..||+|++..... ...+.+|+++++.++|++++..
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4579999999999999999999875432 3599998875422 2357889999999998865544
Q ss_pred eEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----------CCCCHHHHHHHH
Q 013125 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------RKFSLKTVLMLA 135 (449)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-----------~~~~~~~~~~i~ 135 (449)
..++...+..++||||+ +++|.+++.... ..+++..++.++
T Consensus 83 ---------------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~ 135 (295)
T cd05097 83 ---------------------------LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMA 135 (295)
T ss_pred ---------------------------EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHH
Confidence 33445667889999999 889999885421 136888999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC
Q 013125 136 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 215 (449)
Q Consensus 136 ~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (449)
.|++.||.|||++|++||||||+||+++ +++.+||+|||++........ +.......++..|+|||++.+..
T Consensus 136 ~~i~~al~~lH~~~i~H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~ 207 (295)
T cd05097 136 VQIASGMKYLASLNFVHRDLATRNCLVG---NHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGK 207 (295)
T ss_pred HHHHHHHHHHHhcCeeccccChhhEEEc---CCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCC
Confidence 9999999999999999999999999994 677899999999976543221 11123345577899999999888
Q ss_pred CCccchHHHHHHHHHHHHh--CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 216 QSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 216 ~s~~~DvwSlG~il~el~~--G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
++.++|||||||++|+|++ |..||...............................|+.+.+++..||..+|++||+++
T Consensus 208 ~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 287 (295)
T cd05097 208 FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287 (295)
T ss_pred cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 9999999999999999988 67888765443222221111111111000111234578999999999999999999999
Q ss_pred HHHHHHH
Q 013125 294 FLKRLFH 300 (449)
Q Consensus 294 ~l~~~l~ 300 (449)
+|.+.|+
T Consensus 288 ~i~~~l~ 294 (295)
T cd05097 288 KIHHFLR 294 (295)
T ss_pred HHHHHHh
Confidence 9988765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=313.33 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=190.8
Q ss_pred eeeecccCceeEEEEEEc---CCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
++.||+|+||.||++++. .+++.||+|++.... ....+.+|+++++.++|++++..
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~----------------- 63 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL----------------- 63 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccE-----------------
Confidence 368999999999999873 578899999987432 22346779999999988875554
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..+.......|+||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 64 ----------~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~- 131 (318)
T cd05582 64 ----------HYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL- 131 (318)
T ss_pred ----------EEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE-
Confidence 33345667899999999 8899888764 4568999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 132 --~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 132 --DEEGHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred --CCCCcEEEeeccCCcccCCCCC-------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 4788999999999876543321 1235678999999999999889999999999999999999999998754
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
.. ..+..+.......| ..+++++.+++..||..||.+||++.+
T Consensus 203 ~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 203 RK---ETMTMILKAKLGMP-----QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HH---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 32 33334444333333 345789999999999999999999765
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=295.38 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=199.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..++|++.++||+|+||.||+|.+..+ ..||+|++..... ...+.+|+++++.++|++++..+..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~------------ 69 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV------------ 69 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEE------------
Confidence 4568899999999999999999988654 4599998765433 3457889999999999886554322
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
. ..+..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 70 ---------------~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni 133 (260)
T cd05069 70 ---------------V-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133 (260)
T ss_pred ---------------E-cCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 1 235578999999 77999988753 34589999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
++ ++++.++|+|||++......... ......++..|++||.+.+..++.++|||||||++|||++ |..||
T Consensus 134 ll---~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 204 (260)
T cd05069 134 LV---GDNLVCKIADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred EE---cCCCeEEECCCccceEccCCccc------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99 47889999999999765432211 1123446678999999998889999999999999999999 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
.+..... ....+.. ....+ .....+..+.+++..||..+|.+||++++|.+.|++
T Consensus 205 ~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 205 PGMVNRE---VLEQVER-GYRMP---CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCHHH---HHHHHHc-CCCCC---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 8755432 2222222 22222 124568899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=299.74 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=197.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+..++|++.++||+|+||.||+|.+.. ++..||+|++..... ...+.+|+.+++.++|++++..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~------- 75 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL------- 75 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEE-------
Confidence 567899999999999999999998742 356799998764322 23477899999999888755543
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHH
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYV 145 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------~~~~~~~~~~i~~qil~~L~~L 145 (449)
.+...+...++||||+ +++|.+++.... ..+++..++.++.|++.||+||
T Consensus 76 --------------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 135 (277)
T cd05062 76 --------------------GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL 135 (277)
T ss_pred --------------------EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 3335667889999999 889999886532 2357788999999999999999
Q ss_pred HhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHH
Q 013125 146 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL 225 (449)
Q Consensus 146 H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 225 (449)
|+.|++||||||+||+++ +++.++|+|||+++........ .......++..|+|||++.+..++.++|||||
T Consensus 136 H~~~~vH~dlkp~Nil~~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05062 136 NANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 207 (277)
T ss_pred HHCCcccCCcchheEEEc---CCCCEEECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence 999999999999999994 7889999999998765432221 11123345788999999999889999999999
Q ss_pred HHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 226 GYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 226 G~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
||++|||++ |..||.+.... .....+...... + .....+..+.+++.+||..+|++||++.++.+.|+
T Consensus 208 G~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 208 GVVLWEIATLAEQPYQGMSNE---QVLRFVMEGGLL-D---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCCcC-C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 999999999 78999875443 222222222211 1 12345789999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=330.19 Aligned_cols=263 Identities=27% Similarity=0.362 Sum_probs=202.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.++||+|+||.||+|.+..+++.||||++..... ..++.+|+++++.++|++++..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~------------- 68 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY------------- 68 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEE-------------
Confidence 689999999999999999999999999999998865322 23578899999999988755543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC----------RRKFSLKTVLMLADQMIARIEYVHSRGF 150 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~----------~~~~~~~~~~~i~~qil~~L~~LH~~gi 150 (449)
.++...+..|+||||+ |++|.+++... ...++...++.++.||+.||+|||++||
T Consensus 69 --------------~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GI 134 (932)
T PRK13184 69 --------------SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGV 134 (932)
T ss_pred --------------EEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3345667889999999 89999988642 1235677889999999999999999999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCc-----------cccccCCCCCCCCccccccccccCCCCCcc
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR-----------HIPYRENKNLTGTARYASCNTHLGIEQSRR 219 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 219 (449)
+||||||+|||+ +..+.++|+|||+++......... ..........+||+.|+|||++.+..++.+
T Consensus 135 IHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k 211 (932)
T PRK13184 135 LHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES 211 (932)
T ss_pred cccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence 999999999999 477899999999998762211000 000111234679999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHH-hhccChHHHHHHHHHHhCCCCCCCC-CHHHHHH
Q 013125 220 DDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKR 297 (449)
Q Consensus 220 ~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~l~~~~l~~~p~~Rp-~~~~l~~ 297 (449)
+|||||||++|||++|..||........ .. ......+... .....|+.+.+++.+||..||.+|+ +++++.+
T Consensus 212 SDIWSLGVILyELLTG~~PF~~~~~~ki--~~----~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 212 TDIYALGVILYQMLTLSFPYRRKKGRKI--SY----RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hHHHHHHHHHHHHHHCCCCCCCcchhhh--hh----hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999987433211 11 1111112111 1235688999999999999999996 4677777
Q ss_pred HHHHHHHh
Q 013125 298 LFHDLFSR 305 (449)
Q Consensus 298 ~l~~~~~~ 305 (449)
.|+..+..
T Consensus 286 ~Le~~lq~ 293 (932)
T PRK13184 286 DLEPHLQG 293 (932)
T ss_pred HHHHHHhc
Confidence 77777653
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=310.71 Aligned_cols=192 Identities=23% Similarity=0.321 Sum_probs=162.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
..+|++++.||+|+||.||+|++..+++.||+|+... .....|+.+++.++|+++++++.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----~~~~~E~~~l~~l~h~~iv~~~~---------------- 124 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLIEAMLLQNVNHPSVIRMKD---------------- 124 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----cccHHHHHHHHhCCCCCCcChhh----------------
Confidence 4579999999999999999999999999999998543 23467999999999987665433
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
+.......|+|+|++.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 125 -----------~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill--- 190 (357)
T PHA03209 125 -----------TLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI--- 190 (357)
T ss_pred -----------eEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---
Confidence 334567789999999999999887767789999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+..+.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 191 ~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 191 NDVDQVCIGDLGAAQFPVVAPA--------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCCCCEEEecCccccccccCcc--------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 4788999999999974332211 13567899999999999999999999999999999999854444
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=299.43 Aligned_cols=252 Identities=19% Similarity=0.291 Sum_probs=197.1
Q ss_pred CceEEeeeecccCceeEEEEEEc----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..|++.++||+|+||.||+|.+. .+++.||+|.+...... ..+.+|+++++.++|++++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~---------- 74 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLG---------- 74 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEE----------
Confidence 57899999999999999999863 35578999988643322 34778999999999887655433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh----------------cCCCCHHHHHHHHHHHHHHH
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC----------------RRKFSLKTVLMLADQMIARI 142 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~----------------~~~~~~~~~~~i~~qil~~L 142 (449)
+...+...|+||||+ +++|.+++... ...++..+++.++.||+.||
T Consensus 75 -----------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 137 (283)
T cd05090 75 -----------------VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGM 137 (283)
T ss_pred -----------------EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 334567789999999 78999887532 12478889999999999999
Q ss_pred HHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchH
Q 013125 143 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDL 222 (449)
Q Consensus 143 ~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 222 (449)
+|||++|++||||||+|||++ +++.+||+|||+++......... ......++..|+|||++.+..++.++||
T Consensus 138 ~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 209 (283)
T cd05090 138 EYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSREIYSADYYR-----VQPKSLLPIRWMPPEAIMYGKFSSDSDI 209 (283)
T ss_pred HHHHhcCeehhccccceEEEc---CCCcEEeccccccccccCCccee-----cccCCCccceecChHHhccCCCCchhhh
Confidence 999999999999999999994 77889999999998664332211 1234456778999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 223 ESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 223 wSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
|||||++|||++ |..||.+..... ....+ ...... .....+++.+.+++.+||..+|.+||++.+|.+.|+
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~~~---~~~~~-~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 210 WSFGVVLWEIFSFGLQPYYGFSNQE---VIEMV-RKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-HcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 999999999998 999998754322 12222 222211 133456889999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=294.78 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=192.5
Q ss_pred eeecccCceeEEEEEE--cCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASH--VDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~--~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
++||+|+||.||+|.+ ..++..||+|+++..... ..+..|+.+++.+.|++++..++.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--------------- 65 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC--------------- 65 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE---------------
Confidence 3689999999999965 456789999998754332 3577889999999998866654321
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
..+..++|||++ +++|.+++.. ...++...+..++.||+.||+|||++||+||||||+||++.
T Consensus 66 -------------~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~-- 129 (257)
T cd05116 66 -------------EAESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV-- 129 (257)
T ss_pred -------------cCCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc--
Confidence 234678999999 7889888865 45799999999999999999999999999999999999994
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 244 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~ 244 (449)
.++.++|+|||++......... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 130 -~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 130 -TQHYAKISDFGLSKALGADENY----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred -CCCeEEECCCccccccCCCCCe----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 6788999999999765433221 011122334678999999988889999999999999999998 9999987554
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
.. ....+.. ....+ ....+++++.+++..||..||++||++.+|...|+++
T Consensus 205 ~~---~~~~i~~-~~~~~---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 205 NE---VTQMIES-GERME---CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HH---HHHHHHC-CCCCC---CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 32 2222222 11112 2235688999999999999999999999998888754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.89 Aligned_cols=255 Identities=17% Similarity=0.283 Sum_probs=201.8
Q ss_pred CCceEEeeeecccCceeEEEEEEcCC---CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.++|++.+.||+|+||.||+|.+..+ ...||+|++..... ...+.+|+.+++.++|++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~---------- 72 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEG---------- 72 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeE----------
Confidence 46899999999999999999998643 45799998875432 234778999999998887555433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+....+..++||||+ +++|.+++......+++..++.++.|++.||.|||+.||+||||||+
T Consensus 73 -----------------~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ 135 (266)
T cd05033 73 -----------------VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAAR 135 (266)
T ss_pred -----------------EEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc
Confidence 345567789999999 88999998766667999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~ 237 (449)
||+++ +++.++|+|||+++......... ......++..|++||.+.+..++.++|||||||++|||++ |..
T Consensus 136 nili~---~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~ 207 (266)
T cd05033 136 NILVN---SNLVCKVSDFGLSRRLEDSEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred eEEEc---CCCCEEECccchhhcccccccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCC
Confidence 99994 78899999999998775222110 0112345678999999998899999999999999999998 999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||...... .....+.. ....+.+ ...+..+.+++..||+.+|++||++.+|.+.|.++
T Consensus 208 p~~~~~~~---~~~~~~~~-~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 208 PYWDMSNQ---DVIKAVED-GYRLPPP---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCHH---HHHHHHHc-CCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99765433 22222222 2122221 34578999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=297.04 Aligned_cols=258 Identities=20% Similarity=0.354 Sum_probs=197.7
Q ss_pred eEEeeeecccCceeEEEEEEcCCCc--eEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
|.++++||+|+||.||+|++..++. .||+|.++... ....+..|+++++.++|++++..++.+....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV------- 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC-------
Confidence 4578999999999999999876665 69999876532 2334778999999999998877765442110
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-----~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
........+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 74 --------------~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 139 (272)
T cd05075 74 --------------ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLA 139 (272)
T ss_pred --------------cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 001223568999999 78998877532 2348899999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+|||+ ++++.++|+|||+++....... +.......++..|++||.+.+..++.++|||||||++|||++ |
T Consensus 140 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 140 ARNCML---NENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred hhheEE---cCCCCEEECCCCcccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 999999 4788999999999987643321 111223456778999999999999999999999999999999 8
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
..||.+.... .....+..... .+ .....+..+.+++..||..+|++||++.+|.+.|+++
T Consensus 212 ~~p~~~~~~~---~~~~~~~~~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 212 QTPYPGVENS---EIYDYLRQGNR-LK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCHH---HHHHHHHcCCC-CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999875432 22222222111 11 1234578899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=293.90 Aligned_cols=249 Identities=19% Similarity=0.273 Sum_probs=196.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... ....+.+|+++++.++|++++..+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~----------------- 65 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY----------------- 65 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEE-----------------
Confidence 579999999999999999998754 5579999876543 244688899999999988755443
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
.++......++||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++.
T Consensus 66 ----------~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~- 134 (256)
T cd05114 66 ----------GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS- 134 (256)
T ss_pred ----------EEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc-
Confidence 3445667889999999 8999998876555689999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 243 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~ 243 (449)
+++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 135 --~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 135 --STGVVKVSDFGMTRYVLDDEYT------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred --CCCeEEECCCCCccccCCCcee------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 7889999999998765432211 1123345678999999998889999999999999999999 999997754
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
.. +.+..+.... ....+ ...+..+.+++..||..+|++||++.++.+.|
T Consensus 207 ~~---~~~~~i~~~~-~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 207 NY---EVVEMISRGF-RLYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HH---HHHHHHHCCC-CCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 33 2233332221 11111 23467899999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=299.44 Aligned_cols=240 Identities=20% Similarity=0.256 Sum_probs=187.9
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||+|+||+||+|.+..+++.||+|.+.... .......|+++++.++|++++...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~--------------------- 59 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA--------------------- 59 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEE---------------------
Confidence 799999999999999999999999875321 122356799999999888755433
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~ 167 (449)
.....+.+.|+||||+ |++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+||++. +
T Consensus 60 ------~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~ 130 (277)
T cd05607 60 ------YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---D 130 (277)
T ss_pred ------EEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---C
Confidence 3335667899999999 88998877643 34589999999999999999999999999999999999994 7
Q ss_pred CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc-
Q 013125 168 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT- 246 (449)
Q Consensus 168 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~- 246 (449)
++.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus 131 ~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~ 202 (277)
T cd05607 131 QGNCRLSDLGLAVELKDGKT--------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202 (277)
T ss_pred CCCEEEeeceeeeecCCCce--------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 88999999999987654321 123468899999999999889999999999999999999999997643321
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.......+....... ....++.++.+++..||+.||.+||++.++.
T Consensus 203 ~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 203 KEELKRRTLEDEVKF----EHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHhhcccccc----ccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 112222222211111 1235688999999999999999999986653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=295.37 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=198.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
..+|++.+.||+|+||.||+|.. .+..||+|..........+.+|+.+++.++|++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~--------------- 67 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV--------------- 67 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEE---------------
Confidence 46899999999999999999976 4778999998766555678899999999998876654432
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~-~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+.......++|+||+ +++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 68 -----------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 68 -----------IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred -----------EEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 123445689999999 7899998875433 488999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
+++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 137 ---~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 137 ---EDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ---CCCcEEecCCccceeccccC----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 78899999999987654322 12344568999999998889999999999999999997 99999764
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
.... ....+ ...... .....+|+.+.+++.+||..+|++||++.++.+.|++
T Consensus 204 ~~~~---~~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 204 PLKD---VVPRV-EKGYKM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CHHH---HHHHH-hcCCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 3321 22222 111111 1224568899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=301.35 Aligned_cols=259 Identities=20% Similarity=0.318 Sum_probs=195.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC----------------CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCc
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSK 64 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~ 64 (449)
+..++|++.++||+|+||.||+|.+.. +...||+|++..... ...+.+|+++++.++|+++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 346789999999999999999986532 344699999875432 2357889999999998875
Q ss_pred ceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc----------CCCCHHHHHH
Q 013125 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLM 133 (449)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~----------~~~~~~~~~~ 133 (449)
+.. ..++...+..++||||+ +++|.+++.... ..+++.++..
T Consensus 82 ~~~---------------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (296)
T cd05095 82 IRL---------------------------LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIF 134 (296)
T ss_pred ceE---------------------------EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHH
Confidence 544 33445567789999999 889998886532 2367889999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC
Q 013125 134 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 213 (449)
Q Consensus 134 i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (449)
++.||+.||+|||++|++||||||+|||++ +++.++|+|||+++.+...... .......++..|++||++.+
T Consensus 135 ~~~~i~~al~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 135 MATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred HHHHHHHHHHHHHHCCeecccCChheEEEc---CCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhc
Confidence 999999999999999999999999999994 6789999999999765433211 11123344678999999888
Q ss_pred CCCCccchHHHHHHHHHHHHh--CCCCCCCChhhcHHHHHHHHHHh---hcCCCHHHhhccChHHHHHHHHHHhCCCCCC
Q 013125 214 IEQSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEK---KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQ 288 (449)
Q Consensus 214 ~~~s~~~DvwSlG~il~el~~--G~~pf~~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~ 288 (449)
..++.++|||||||++|||++ |..||.................. ....+. ...++..+.+++..||..||.+
T Consensus 207 ~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~ 283 (296)
T cd05095 207 GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPK---PALCPDSLYKLMLSCWRRNAKE 283 (296)
T ss_pred CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCC---CCCCCHHHHHHHHHHcCCCccc
Confidence 889999999999999999998 78899765443222111111100 111111 1235789999999999999999
Q ss_pred CCCHHHHHHHHH
Q 013125 289 RPDYGFLKRLFH 300 (449)
Q Consensus 289 Rp~~~~l~~~l~ 300 (449)
||++.+|.+.|+
T Consensus 284 Rp~~~~i~~~l~ 295 (296)
T cd05095 284 RPSFQEIHATLL 295 (296)
T ss_pred CCCHHHHHHHHh
Confidence 999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.85 Aligned_cols=300 Identities=21% Similarity=0.330 Sum_probs=217.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
..|+++.+||+|.||.||+|...+++. .+|||.++.. .-.....+|+.+++.|+|+|++.+..++.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl------ 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL------ 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh------
Confidence 469999999999999999996654433 6899988765 22446899999999999999877654432
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~----~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
..+..+++++||...+|..+++.. .+.++...++.|++||+.|+.|||+.-|+|||
T Consensus 98 --------------------~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRD 157 (438)
T KOG0666|consen 98 --------------------SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRD 157 (438)
T ss_pred --------------------ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeecc
Confidence 336788999999999999999754 34589999999999999999999999999999
Q ss_pred CCCCcEEeec-CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHH
Q 013125 155 IKPDNFLMGL-GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYF 232 (449)
Q Consensus 155 Lkp~Nill~~-~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el 232 (449)
|||.|||+.. +...|.|||+|||+|+.+.++.. |......++.|.+|+|||+++|.. |+.++|||+.|||+.||
T Consensus 158 LKPaNIlvmgdgperG~VKIaDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl 233 (438)
T KOG0666|consen 158 LKPANILVMGDGPERGRVKIADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL 233 (438)
T ss_pred CCcceEEEeccCCccCeeEeecccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence 9999999953 34569999999999999887643 333446778899999999999876 99999999999999999
Q ss_pred HhCCCCCCCChhhc------HHHHHHHHHHhhcCCCHHHhhc---cChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 233 LRGSLPWQGLKAAT------KKQKYDKICEKKVSTPIEVLCK---SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 233 ~~G~~pf~~~~~~~------~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
++-++.|.+..... ....+.+|.+.. ..|...-|. ++| +...++...-.. .+..+ -|...+
T Consensus 234 Ltl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL-G~Pt~~~Wp~lkk~P-e~q~~ls~f~~~------~~~n~--sL~~~~ 303 (438)
T KOG0666|consen 234 LTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL-GTPTDKDWPDLKKMP-EYQTLLSDFRRH------YYDNV--SLHKYY 303 (438)
T ss_pred HccCccccchhhhcccCCCchHHHHHHHHHHc-CCCccccchhhhhCc-chHHHHHHhHHh------hcCcc--hHHHHH
Confidence 99999998754321 122334443322 223222221 112 222222211110 00000 123333
Q ss_pred HhcCCCCCccccc--ccccccccccccccccCCCCccccCCCCcc
Q 013125 304 SREGYDFDFVFDW--TILKYQQTQKTKSQDLLPASRVTNSRVMPM 346 (449)
Q Consensus 304 ~~~~~~~~~~~dw--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (449)
...+......+|. ++|.|+|.+|.++.+++.|++|++....+.
T Consensus 304 ~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp~ 348 (438)
T KOG0666|consen 304 HKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPPL 348 (438)
T ss_pred HHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCCC
Confidence 3333333333332 889999999999999999999998865543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=311.61 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=200.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHc-CCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQ-GGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~-~~~~~~~~~~~~~~ 74 (449)
+-.++|.++++||+|+||.||+|++. .+++.||+|+++..... ..+.+|++++..+. |++++.+++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~---- 109 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA---- 109 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE----
Confidence 34567899999999999999999863 34568999998754322 25778999999997 8776655443
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------------------------------
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------------------ 123 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------------------------------ 123 (449)
.......++||||+ +++|.+++....
T Consensus 110 -----------------------~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (401)
T cd05107 110 -----------------------CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKS 166 (401)
T ss_pred -----------------------EccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccccc
Confidence 34556789999999 899999886431
Q ss_pred -------------------------------------------------------------------CCCCHHHHHHHHH
Q 013125 124 -------------------------------------------------------------------RKFSLKTVLMLAD 136 (449)
Q Consensus 124 -------------------------------------------------------------------~~~~~~~~~~i~~ 136 (449)
..+++..++.++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 246 (401)
T cd05107 167 HVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSY 246 (401)
T ss_pred chhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHH
Confidence 1367778899999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||+|||+.+|+||||||+|||+. +.+.++|+|||+++........ .......++..|+|||++.+..+
T Consensus 247 qi~~aL~~LH~~~ivHrdlkp~NiLl~---~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 247 QVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred HHHHHHHHHhcCCcCcccCCcceEEEe---CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCC
Confidence 999999999999999999999999994 6789999999999865432211 11223456789999999999889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |..||....... ............+. ....+.++.+++..||..+|.+||++.+|
T Consensus 319 ~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 319 TTLSDVWSFGILLWEIFTLGGTPYPELPMNE---QFYNAIKRGYRMAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---HHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999998 899997654322 22222222221111 13357899999999999999999999999
Q ss_pred HHHHHHHH
Q 013125 296 KRLFHDLF 303 (449)
Q Consensus 296 ~~~l~~~~ 303 (449)
.+.|+.++
T Consensus 393 l~~L~~~~ 400 (401)
T cd05107 393 VHLVGDLL 400 (401)
T ss_pred HHHHHHHh
Confidence 99998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=301.79 Aligned_cols=261 Identities=20% Similarity=0.310 Sum_probs=200.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-------CCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeec
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHV 72 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~ 72 (449)
+..++|.++++||+|+||.||+|++.. +...||+|++..... ...+.+|+++++.+ +|++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~------ 88 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN------ 88 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEee------
Confidence 345799999999999999999998743 234699999875422 23477799999888 5665444
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLAD 136 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~ 136 (449)
+..++...+..|+||||+ +++|.+++.... ..+++.+++.++.
T Consensus 89 ---------------------~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 147 (307)
T cd05098 89 ---------------------LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY 147 (307)
T ss_pred ---------------------EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence 333445667889999999 789999987532 2478899999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||+|||++|++||||||+||+++ .++.++|+|||+++......... ......++..|+|||++.+..+
T Consensus 148 qi~~aL~~lH~~gi~H~dlkp~Nill~---~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~ 219 (307)
T cd05098 148 QVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIY 219 (307)
T ss_pred HHHHHHHHHHHCCcccccccHHheEEc---CCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCC
Confidence 999999999999999999999999994 77899999999987654322111 0112234568999999999889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |..||.+.... +... .+...... ......+.++.+++..||..+|.+||++.++
T Consensus 220 ~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~~~~-~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFK-LLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH-HHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999999999999998 88999764332 2222 22222111 1223457899999999999999999999999
Q ss_pred HHHHHHHHHhc
Q 013125 296 KRLFHDLFSRE 306 (449)
Q Consensus 296 ~~~l~~~~~~~ 306 (449)
.+.|++++...
T Consensus 293 l~~l~~~~~~~ 303 (307)
T cd05098 293 VEDLDRILALT 303 (307)
T ss_pred HHHHHHHHHHh
Confidence 99999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=296.32 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=196.7
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh----HHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~----~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
|++++.||+|+||+||+|.+..+++.||+|++........ ..+|+.+++.++|++++..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~----------------- 63 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQI----------------- 63 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHE-----------------
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccc-----------------
Confidence 8999999999999999999999999999999887643322 2458899999988765443
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..+.......++|||++ +++|.+++. ....++...++.++.||+.||++||++|++|+||||+||++
T Consensus 64 ----------~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~- 131 (260)
T PF00069_consen 64 ----------LDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL- 131 (260)
T ss_dssp ----------EEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE-
T ss_pred ----------ccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc-
Confidence 33445578899999999 459999887 35678999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.++.++|+|||.+........ ......++..|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 132 --~~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 132 --DENGEVKLIDFGSSVKLSENNE-------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp --STTSEEEESSGTTTEESTSTTS-------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred --cccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4789999999999986522111 124567899999999998 888999999999999999999999999986
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
........+............. .....+.++.+++..||..||++||++.++.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 203 NSDDQLEIIEKILKRPLPSSSQ-QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHHHTHHHHHTT-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhhhhhhhhccccccccccc-ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3333333333322211111100 00112478999999999999999999887753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.33 Aligned_cols=258 Identities=20% Similarity=0.349 Sum_probs=198.9
Q ss_pred eEEeeeecccCceeEEEEEEcC---CCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
|++++.||+|+||.||+|.+.. ++..||+|++..... ...+.+|+++++.++|++++..++......
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS------ 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC------
Confidence 6789999999999999998764 347899998875432 235788999999999998776655432110
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-----~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
........++++||+ +++|..++... ...+++..++.++.|++.||+|||++|++||||
T Consensus 75 ---------------~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 139 (273)
T cd05035 75 ---------------SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDL 139 (273)
T ss_pred ---------------ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 001223579999999 88998887543 235899999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+||++ ++++.+||+|||+++........ .......++..|++||++.+..++.++|||||||++|||++
T Consensus 140 kp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 140 AARNCML---REDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred chheEEE---CCCCeEEECCccceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence 9999999 47789999999999876544321 11223345678999999998889999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
|..||.+.... +.+..+.... ... ....++.++.+++.+||..||.+||++.++.+.|+++
T Consensus 212 g~~p~~~~~~~---~~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 212 GQTPYPGVENH---EIYDYLRHGN-RLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCHH---HHHHHHHcCC-CCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999875443 2232322221 111 2245688999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=306.72 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=198.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecchh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHV 75 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~ 75 (449)
-.++|++++.||+|+||.||+|.+. .+++.||||+++.... ...+.+|+.++..+ +|++++..+..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~----- 79 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA----- 79 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcce-----
Confidence 4579999999999999999999853 4577899999875432 23477899999998 45665444322
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-------------------------------
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------------------- 123 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------------------------------- 123 (449)
+...+...++||||+ +++|.+++....
T Consensus 80 ---------------------~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (343)
T cd05103 80 ---------------------CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRL 138 (343)
T ss_pred ---------------------eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhc
Confidence 223445679999999 899998876421
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 124 -----------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 124 -----------------------------------~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
..+++..+..++.||+.||+|||++||+||||||+|||+. .+
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~ 215 (343)
T cd05103 139 DSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EN 215 (343)
T ss_pred cccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CC
Confidence 2367888899999999999999999999999999999994 77
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 247 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~ 247 (449)
+.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 216 ~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 289 (343)
T cd05103 216 NVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 289 (343)
T ss_pred CcEEEEecccccccccCcch-----hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-
Confidence 89999999999765432211 11223345678999999999899999999999999999997 999998754321
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.+..........+.+ ...++++.+++..||..+|.+||++.+|.+.|+.++..
T Consensus 290 --~~~~~~~~~~~~~~~---~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 290 --EFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred --HHHHHHhccCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111112211111111 23467899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=308.49 Aligned_cols=235 Identities=23% Similarity=0.299 Sum_probs=184.2
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||+||+|++..+++.||+|++.... ....+..|.. +++.++|++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv--------------------- 59 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV--------------------- 59 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCc---------------------
Confidence 46999999999999999999999999986431 1223444444 34556666544
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
.+.......+..|+||||+ +++|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 60 ------~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll--- 129 (325)
T cd05604 60 ------GLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL--- 129 (325)
T ss_pred ------cEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---
Confidence 3444456678899999999 8888877764 5679999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
++++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (325)
T cd05604 130 DSQGHVVLTDFGLCKEGIAQSD-------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202 (325)
T ss_pred CCCCCEEEeecCCcccCCCCCC-------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH
Confidence 4788999999999875332211 123567999999999999999999999999999999999999999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
+.+..+.......+ ...+..+.+++..|+..+|.+||++.
T Consensus 203 ---~~~~~~~~~~~~~~-----~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 203 ---EMYDNILHKPLVLR-----PGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred ---HHHHHHHcCCccCC-----CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 33333333322221 34578899999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=294.53 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=200.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++..++|++.++||+|+||.||+|.+. .+..||+|.+..... ...+.+|+.+++.++|++++..+..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~----------- 69 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAV----------- 69 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeE-----------
Confidence 356789999999999999999999875 456699998875433 3468899999999999886655432
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
. .....+++||++ +++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 70 ----------------~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~N 132 (260)
T cd05070 70 ----------------V-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSAN 132 (260)
T ss_pred ----------------E-CCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccce
Confidence 1 234578999999 88999988753 3458999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
|+++ +++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 133 ili~---~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p 203 (260)
T cd05070 133 ILVG---DGLVCKIADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred EEEe---CCceEEeCCceeeeeccCcccc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCC
Confidence 9995 6789999999999865433211 1123345678999999998889999999999999999999 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|.+..... ....+. .....+. ....+..+.+++..||..+|.+||++.++.+.|++
T Consensus 204 ~~~~~~~~---~~~~~~-~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 204 YPGMNNRE---VLEQVE-RGYRMPC---PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCHHH---HHHHHH-cCCCCCC---CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 98754332 222222 1222221 24557899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.07 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=192.6
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
++||+|+||.||+|.+..+++.||+|....... ...+.+|+++++.++|++++..+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------------- 60 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG-------------------- 60 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEE--------------------
Confidence 479999999999999998999999998764322 235788999999999887655443
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
++......++||||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .+
T Consensus 61 -------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~ 130 (252)
T cd05084 61 -------VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EK 130 (252)
T ss_pred -------EEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CC
Confidence 344567789999999 8899998876556789999999999999999999999999999999999994 77
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 247 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~ 247 (449)
+.+||+|||++.......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 131 ~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~ 205 (252)
T cd05084 131 NVLKISDFGMSREEEDGVYAS-----TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT 205 (252)
T ss_pred CcEEECccccCcccccccccc-----cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH
Confidence 889999999987543321100 0111223457999999998889999999999999999997 9999976544321
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
..........+. ....+..+.+++.+||..+|++||++.++.+.|+
T Consensus 206 ----~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 206 ----REAIEQGVRLPC---PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----HHHHHcCCCCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 112222222222 2345789999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=311.60 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=215.1
Q ss_pred CCceEEeeeecccCceeEEEEEEcC--CCc--eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVD--TNE--IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~~--~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
.+..++.++||.|-||.||.|.... .|+ -||||..+.++. .+.|+.|+-+|+.+.|++++++++++.
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------ 461 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------ 461 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee------
Confidence 3455677899999999999998742 233 499999887643 445899999999999999999998764
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+...+||||++ -|-|..+++.....++..+...+++||..+|.|||++++|||||..
T Consensus 462 ----------------------e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAa 519 (974)
T KOG4257|consen 462 ----------------------EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAA 519 (974)
T ss_pred ----------------------ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhh
Confidence 45679999999 8899999998778899999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~ 236 (449)
.|||+. ....|||+|||+++...+... |. .....-+..|||||.+.-..++.++|||-||+++||++. |.
T Consensus 520 RNiLVs---Sp~CVKLaDFGLSR~~ed~~y-----Yk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 520 RNILVS---SPQCVKLADFGLSRYLEDDAY-----YK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred hheeec---Ccceeeecccchhhhccccch-----hh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 999995 788999999999998776654 22 223344678999999999999999999999999999987 99
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCC
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 308 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~ 308 (449)
-||++..+.+..-.+ +.....|.+ .++|+.+..|+.+||+.+|.+||.|.+|...|.+++..+..
T Consensus 591 kPfqgvkNsDVI~~i----EnGeRlP~P---~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 591 KPFQGVKNSDVIGHI----ENGERLPCP---PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred CccccccccceEEEe----cCCCCCCCC---CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 999998775433222 223333333 45699999999999999999999999999999999875544
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=300.86 Aligned_cols=261 Identities=19% Similarity=0.294 Sum_probs=197.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCC----------------ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcc
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN----------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKI 65 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----------------~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~ 65 (449)
..++|+++++||+|+||.||+|.+..++ ..||+|++..... ...+.+|+++++.++|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999999886543 4589998875432 33577899999999988755
Q ss_pred eeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc----------CCCCHHHHHHH
Q 013125 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLML 134 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~----------~~~~~~~~~~i 134 (449)
..+ .++..+...++|||++ +++|.+++.... ..+++..++.+
T Consensus 83 ~~~---------------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (296)
T cd05051 83 RLL---------------------------GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYM 135 (296)
T ss_pred EEE---------------------------EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHH
Confidence 443 3334557889999999 889999887543 26899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC
Q 013125 135 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 214 (449)
Q Consensus 135 ~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 214 (449)
+.|++.||+|||++||+||||||+||+++ +.+.++|+|||+++........ .......++..|+|||++.+.
T Consensus 136 ~~~i~~al~~LH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~ 207 (296)
T cd05051 136 ATQIASGMRYLESLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLG 207 (296)
T ss_pred HHHHHHHHHHHHHcCccccccchhceeec---CCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcC
Confidence 99999999999999999999999999994 6789999999999765433221 112344567889999999988
Q ss_pred CCCccchHHHHHHHHHHHHh--CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 215 EQSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 215 ~~s~~~DvwSlG~il~el~~--G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.++.++|||||||++|||++ |..||...............................|.++.+++..||+.+|.+||++
T Consensus 208 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 287 (296)
T cd05051 208 KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287 (296)
T ss_pred CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence 89999999999999999998 7788876543322111111100000000011123457899999999999999999999
Q ss_pred HHHHHHHH
Q 013125 293 GFLKRLFH 300 (449)
Q Consensus 293 ~~l~~~l~ 300 (449)
.+|.+.|+
T Consensus 288 ~el~~~L~ 295 (296)
T cd05051 288 REIHLFLQ 295 (296)
T ss_pred HHHHHHhc
Confidence 99987764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.26 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=204.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+-.++|.+.+.||+|+||.||+|++. .++..|++|.+..... ...+.+|+++++.++|++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~--------- 72 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF--------- 72 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceE---------
Confidence 34578999999999999999999864 2455699998765433 2357889999999988865544
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIA 140 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qil~ 140 (449)
..++...+..++||||+ +++|.+++.... ..+++..++.++.||+.
T Consensus 73 ------------------~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 134 (291)
T cd05094 73 ------------------YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIAS 134 (291)
T ss_pred ------------------EEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHH
Confidence 33445667889999999 899999886422 34889999999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccc
Q 013125 141 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD 220 (449)
Q Consensus 141 ~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 220 (449)
||+|||++||+||||||+|||++ +++.++|+|||++......... .......++..|+|||++.+..++.++
T Consensus 135 al~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (291)
T cd05094 135 GMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTES 206 (291)
T ss_pred HHHHHHhCCeeecccCcceEEEc---cCCcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchh
Confidence 99999999999999999999994 7889999999999765433211 112344567889999999998999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 221 DLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 221 DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
|||||||++|||++ |..||....... ....+...... ......|..+.+++.+||..+|.+||++.++.+.|
T Consensus 207 Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 207 DVWSFGVILWEIFTYGKQPWFQLSNTE---VIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99999999999998 999997754432 22222222211 11234578999999999999999999999999999
Q ss_pred HHHHHh
Q 013125 300 HDLFSR 305 (449)
Q Consensus 300 ~~~~~~ 305 (449)
+++.+.
T Consensus 280 ~~~~~~ 285 (291)
T cd05094 280 HALGKA 285 (291)
T ss_pred HHHHhh
Confidence 888654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.79 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=199.3
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.|.+.+.||+|+||.||+|.+..+++.|++|.+... .....+.+|+++++.++|++++..+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------- 66 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE-------------- 66 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehhee--------------
Confidence 489999999999999999999999999999987643 22345778999999999887555433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++...+..|+||||+ +++|.+++... ...++...+..++.|++.||.|||++|++|+||||+||+
T Consensus 67 -------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nil 133 (256)
T cd08529 67 -------------SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133 (256)
T ss_pred -------------eeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 334567889999999 89999998764 467899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ .++.++|+|||+++....... ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 134 i~---~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 203 (256)
T cd08529 134 LD---AYDNVKIGDLGVAKLLSDNTN-------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203 (256)
T ss_pred Ee---CCCCEEEcccccceeccCccc-------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 94 678999999999886654322 12345688999999999998999999999999999999999999986
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... .....+....... .....+.++.+++..||..+|++||++.++.+
T Consensus 204 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 204 NNQG---ALILKIIRGVFPP----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCHH---HHHHHHHcCCCCC----CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 5432 2333333322221 11245789999999999999999999987754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=292.77 Aligned_cols=252 Identities=20% Similarity=0.311 Sum_probs=200.9
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+|+++++.++|++++..+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~--------------- 66 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF--------------- 66 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceE---------------
Confidence 368999999999999999999999889999999887543 234578899999999988755543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+.......|++||++ +++|.+++......++...+..++.|++.||.|||++|++|+||+|+||++
T Consensus 67 ------------~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i 134 (262)
T cd06613 67 ------------GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL 134 (262)
T ss_pred ------------EEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE
Confidence 3345677899999999 778988887655789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC---CCCccchHHHHHHHHHHHHhCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
++++.++|+|||++........ ......++..|++||.+.+. .++.++|||||||++|||++|..||
T Consensus 135 ---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~ 204 (262)
T cd06613 135 ---TEDGDVKLADFGVSAQLTATIA-------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204 (262)
T ss_pred ---CCCCCEEECccccchhhhhhhh-------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 4788999999999876543221 12345788899999999877 7899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+...... ...+.......+........+.++.+++..||..+|.+||++.+|..
T Consensus 205 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 205 FDLHPMRA---LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCCHHHH---HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 87553322 22222221222221222345678999999999999999999987743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.34 Aligned_cols=256 Identities=18% Similarity=0.306 Sum_probs=199.8
Q ss_pred ceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+|++.+.||+|+||.||+|.+.. ....||+|++..... ...+.+|+++++.++|++++..+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~---------- 70 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYG---------- 70 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEE----------
Confidence 58899999999999999998753 235699998765433 235778999999999887655433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----------------------CCCCHHHHHHHH
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLA 135 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-----------------------~~~~~~~~~~i~ 135 (449)
++...+..++|+||+ +++|.+++.... ..+++.+++.++
T Consensus 71 -----------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 133 (290)
T cd05045 71 -----------------ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFA 133 (290)
T ss_pred -----------------EEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHH
Confidence 334566789999999 799998876421 247889999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC
Q 013125 136 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 215 (449)
Q Consensus 136 ~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (449)
.|++.||+|||++|++||||||+|||+. +++.++|+|||+++........ .......++..|++||.+.+..
T Consensus 134 ~~i~~~l~~LH~~~ivH~dikp~nill~---~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~ 205 (290)
T cd05045 134 WQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHI 205 (290)
T ss_pred HHHHHHHHHHHHCCeehhhhhhheEEEc---CCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCC
Confidence 9999999999999999999999999994 7789999999999765432211 1112334567899999999888
Q ss_pred CCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 216 QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 216 ~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
++.++|||||||++|||++ |..||.+..... +..........+. ...++.++.+++..||+.+|.+||++.+
T Consensus 206 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 206 YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER----LFNLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 9999999999999999998 999998754332 2222222222221 2445789999999999999999999999
Q ss_pred HHHHHHHHHHh
Q 013125 295 LKRLFHDLFSR 305 (449)
Q Consensus 295 l~~~l~~~~~~ 305 (449)
+.+.|++++..
T Consensus 279 i~~~l~~~~~~ 289 (290)
T cd05045 279 ISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHHhc
Confidence 99999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=301.38 Aligned_cols=254 Identities=18% Similarity=0.219 Sum_probs=198.1
Q ss_pred CCceEEeeeecccCceeEEEEEEcCC-----CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
..+|++.++||+|+||.||+|.+..+ ++.||||+++..... ..+.+|+.++..++|++++.+++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~-------- 75 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLG-------- 75 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEE--------
Confidence 35688999999999999999987543 578999998754332 34678888999888887665543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHH
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIAR 141 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---------------~~~~~~~~~~~i~~qil~~ 141 (449)
+.......++++||+ +++|.+++... ...+++..++.++.|++.|
T Consensus 76 -------------------~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~a 136 (283)
T cd05091 76 -------------------VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136 (283)
T ss_pred -------------------EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHH
Confidence 334556789999999 78888887531 2347888999999999999
Q ss_pred HHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccch
Q 013125 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 221 (449)
Q Consensus 142 L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D 221 (449)
|+|||++||+||||||+|||+. +++.+||+|||+++........ .......+++.|+|||++.+..++.++|
T Consensus 137 L~~lH~~gi~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~D 208 (283)
T cd05091 137 MEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSD 208 (283)
T ss_pred HHHHHHcCccccccchhheEec---CCCceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchh
Confidence 9999999999999999999994 6788999999998765432211 1123345678899999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 222 LESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 222 vwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
||||||++|||++ |..||.+.... ..+..+...... .....+|..+.+++..||+.+|.+||++.+|.+.|+
T Consensus 209 v~slG~~l~el~~~g~~p~~~~~~~---~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 209 IWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 9999999999998 88999875443 233333322211 123456899999999999999999999999988876
Q ss_pred H
Q 013125 301 D 301 (449)
Q Consensus 301 ~ 301 (449)
.
T Consensus 282 ~ 282 (283)
T cd05091 282 T 282 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.84 Aligned_cols=253 Identities=21% Similarity=0.231 Sum_probs=194.2
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.|+++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------- 66 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD-------------- 66 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEE--------------
Confidence 58999999999999999999998999999998764322 245788999999999887555433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~--~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+...++..|+||||+.++|.+++.... ..++...++.++.||+.||+|||++|++||||||+||+
T Consensus 67 -------------~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil 133 (285)
T cd07861 67 -------------VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL 133 (285)
T ss_pred -------------EEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEE
Confidence 334567889999999889988876533 56899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+. .++.++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||.
T Consensus 134 ~~---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 134 ID---NKGVIKLADFGLARAFGIPVR-------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred Ec---CCCcEEECcccceeecCCCcc-------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 94 788999999999975533211 12234568899999988754 47899999999999999999999998
Q ss_pred CChhhcHHHHHHHHHH---------------------hhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICE---------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~---------------------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+............... ..............++++.+++..||..||.+||++++|..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 204 GDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 7543221111111000 00000011122346788999999999999999999887743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.23 Aligned_cols=263 Identities=25% Similarity=0.348 Sum_probs=209.7
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
|+-.+.|.|++.||+|+||+|.+++++.|++.||+|++++ .....-|..|..+|-.-...
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~--------------- 135 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSE--------------- 135 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcH---------------
Confidence 4556789999999999999999999999999999999875 22233355666666432211
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
=|..+.+.+.+.++.|+||||+ ||+|..++.... ++++..++.|+.+|+.||.-||+.|+||||||
T Consensus 136 ------------Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiK 202 (1317)
T KOG0612|consen 136 ------------WIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIK 202 (1317)
T ss_pred ------------HHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCC
Confidence 1233445567889999999999 999999998766 89999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc----C-CCCCccchHHHHHHHHHH
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL----G-IEQSRRDDLESLGYVLLY 231 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~DvwSlG~il~e 231 (449)
|+|||+ |..|++||+|||.+..+....... ....+|||.|.|||++. + +.|++.||+||+||++||
T Consensus 203 PDNvLl---d~~GHikLADFGsClkm~~dG~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YE 273 (1317)
T KOG0612|consen 203 PDNVLL---DKSGHIKLADFGSCLKMDADGTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYE 273 (1317)
T ss_pred cceeEe---cccCcEeeccchhHHhcCCCCcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHH
Confidence 999999 589999999999998887665533 35778999999999886 2 568999999999999999
Q ss_pred HHhCCCCCCCChhhcHHHHHHHHHHh--hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHHhc
Q 013125 232 FLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKRLFHDLFSRE 306 (449)
Q Consensus 232 l~~G~~pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~l~~~l~~~~~~~ 306 (449)
|++|..||+..+- ...|.+|+.. .+.+| ... ..+++.++||...+. +|+.|.. +++|..
T Consensus 274 MlyG~TPFYadsl---veTY~KIm~hk~~l~FP-~~~--~VSeeakdLI~~ll~-~~e~RLgrngiedik~--------- 337 (1317)
T KOG0612|consen 274 MLYGETPFYADSL---VETYGKIMNHKESLSFP-DET--DVSEEAKDLIEALLC-DREVRLGRNGIEDIKN--------- 337 (1317)
T ss_pred HHcCCCcchHHHH---HHHHHHHhchhhhcCCC-ccc--ccCHHHHHHHHHHhc-ChhhhcccccHHHHHh---------
Confidence 9999999987443 4566777665 45555 221 258899999999885 7888877 665533
Q ss_pred CCCCCcccccccc
Q 013125 307 GYDFDFVFDWTIL 319 (449)
Q Consensus 307 ~~~~~~~~dw~~l 319 (449)
+.|....||..+
T Consensus 338 -HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 338 -HPFFEGIDWDNI 349 (1317)
T ss_pred -CccccCCChhhh
Confidence 455566788543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=291.14 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=201.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+|+++++.++|++++..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~------------ 69 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA------------ 69 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeee------------
Confidence 68999999999999999999999899999999875321 2345788999999998887554433
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++...+..++||||+ +++|.+++... ...++..+++.++.|++.||.|||+.||+||||+|
T Consensus 70 ---------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p 134 (267)
T cd08224 70 ---------------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKP 134 (267)
T ss_pred ---------------eeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcCh
Confidence 334567789999999 78999888643 34589999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+||+++ .++.++|+|||++......... .....++..|+|||.+.+..++.++|||||||++|+|++|..
T Consensus 135 ~nil~~---~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~ 204 (267)
T cd08224 135 ANVFIT---ATGVVKLGDLGLGRFFSSKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred hhEEEC---CCCcEEEeccceeeeccCCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCC
Confidence 999994 7789999999998765443221 124567889999999999889999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||..... ........+..... .+.+ ....+..+.+++..||..+|++||++.+|.+.|+++
T Consensus 205 p~~~~~~-~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 205 PFYGDKM-NLYSLCKKIEKCDY-PPLP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CcccCCc-cHHHHHhhhhcCCC-CCCC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 9975432 11122222222111 1111 124578999999999999999999999998888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=307.27 Aligned_cols=234 Identities=26% Similarity=0.345 Sum_probs=183.8
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|++..+++.||+|++.... ....+..|.. +++.++|++++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~-------------------- 60 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-------------------- 60 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccc--------------------
Confidence 47999999999999999999999999876431 1222444443 456677766444
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
+.......+..|+||||+ +++|...+.. ...++...+..++.||+.||+|||++||+||||||+|||+
T Consensus 61 -------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll--- 129 (321)
T cd05603 61 -------LHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL--- 129 (321)
T ss_pred -------eeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---
Confidence 444445677899999999 8888877764 5678999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (321)
T cd05603 130 DSQGHVVLTDFGLCKEGVEPEE-------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202 (321)
T ss_pred CCCCCEEEccCCCCccCCCCCC-------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH
Confidence 4788999999999875332221 123567899999999999989999999999999999999999999875432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
..+..+.......+ ...+.++.+++..||+.+|.+|++.
T Consensus 203 ---~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~ 241 (321)
T cd05603 203 ---QMYDNILHKPLQLP-----GGKTVAACDLLVGLLHKDQRRRLGA 241 (321)
T ss_pred ---HHHHHHhcCCCCCC-----CCCCHHHHHHHHHHccCCHhhcCCC
Confidence 33344443333222 3447789999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=292.87 Aligned_cols=250 Identities=18% Similarity=0.269 Sum_probs=197.0
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ..+.+.+|+.+++.++|++++..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~----------------- 64 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL----------------- 64 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeE-----------------
Confidence 4679999999999999999998753 4459999876543 24568899999999988865544
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+.++......++||||+ +++|.+++......+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus 65 ----------~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili- 133 (256)
T cd05113 65 ----------YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV- 133 (256)
T ss_pred ----------EEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE-
Confidence 33445566789999999 889999887655679999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
++++.+||+|||+++........ ......++..|++||++.+..++.++|||||||++|||++ |..||...
T Consensus 134 --~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 134 --DDQGCVKVSDFGLSRYVLDDEYT------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred --cCCCCEEECCCccceecCCCcee------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 47789999999998765433211 1123345678999999998889999999999999999998 99999765
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
.... ....+...... +. ....+..+.+++..||..+|.+||++.+|...+
T Consensus 206 ~~~~---~~~~~~~~~~~-~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 206 NNSE---TVEKVSQGLRL-YR---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CHHH---HHHHHhcCCCC-CC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4422 22233222211 11 123478999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.86 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=202.5
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.+-.++|++.+.||+|+||.||+|.+..+++ .||+|++..... ...+.+|+.+++.++|++++..++.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~---- 78 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVC---- 78 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE----
Confidence 3556789999999999999999999877776 478898765433 22467899999999998877665432
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
. ....++++|++ +++|.+++......++...++.++.||+.||+|||++||+|||
T Consensus 79 -----------------------~-~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~d 134 (303)
T cd05110 79 -----------------------L-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 134 (303)
T ss_pred -----------------------c-CCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccc
Confidence 1 23457899999 7899999876666789999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+||++. +++.+||+|||+++......... ......++..|++||++.+..++.++|||||||++|||++
T Consensus 135 ikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 135 LAARNVLVK---SPNHVKITDFGLARLLEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred cccceeeec---CCCceEEccccccccccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 999999994 67889999999998654322110 1123345678999999999899999999999999999997
Q ss_pred -CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 235 -GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 235 -G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
|..||.+..... ...+.......+.+ ...+..+.+++..||..+|++||++.++.+.|+++..
T Consensus 207 ~g~~p~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 207 FGGKPYDGIPTRE----IPDLLEKGERLPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCCCCCCCHHH----HHHHHHCCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999998754322 22223333222222 2346789999999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=297.84 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=194.1
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~-------------- 66 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD-------------- 66 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHH--------------
Confidence 69999999999999999999999999999998764322 235678999999999987655432
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+..+....++|+||++++|.+.+......+++..++.++.||+.||.|||++||+||||||+||++.
T Consensus 67 -------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~ 133 (284)
T cd07839 67 -------------VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN 133 (284)
T ss_pred -------------HhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc
Confidence 2345677899999998899988876667799999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
.++.++|+|||+++....... ......++..|+|||++.+.. ++.++|||||||++|||++|..||...
T Consensus 134 ---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 134 ---KNGELKLADFGLARAFGIPVR-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred ---CCCcEEECccchhhccCCCCC-------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 778999999999976543221 112446788999999987754 789999999999999999998886432
Q ss_pred hhhcHHHHHHHHHHhhcCCC------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTP------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ...+..+........ ........++++.+++..||..||.+||+++++..
T Consensus 204 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 204 NDV--DDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCH--HHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 221 122222211110000 01122345788999999999999999999887743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=310.54 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=200.1
Q ss_pred eecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCc
Q 013125 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI 91 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 91 (449)
.||+|.||+||-|+|..|+..+|||-+..... ...+-.|+.+-+.|+|.|+++.++.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-------------------- 641 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-------------------- 641 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc--------------------
Confidence 68999999999999999999999997765433 33477899999999999988876643
Q ss_pred CeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 92 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 92 ~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~--~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
.++.++-|.||-. ||+|.+++...=+++ .+.++-.+..||++||+|||+..|||||||-+|+||. .-.
T Consensus 642 -------senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TyS 712 (1226)
T KOG4279|consen 642 -------SENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYS 712 (1226)
T ss_pred -------CCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--ecc
Confidence 3445778899998 999999998655556 7888999999999999999999999999999999996 357
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
|.+||+|||.+++...-.. +..++.||..|||||++..++ |+.++|||||||++.||.||++||..+...
T Consensus 713 GvlKISDFGTsKRLAginP-------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp- 784 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAGINP-------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP- 784 (1226)
T ss_pred ceEEecccccchhhccCCc-------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-
Confidence 8999999999987654322 236889999999999998764 899999999999999999999999865432
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...+.++..-+..+|+++ .+..+.+.++..|+..+|.+||++++|..
T Consensus 785 -qAAMFkVGmyKvHP~iPe---elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 785 -QAAMFKVGMYKVHPPIPE---ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -hHhhhhhcceecCCCCcH---HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 234444444455555544 33788999999999999999999887643
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.73 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=201.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCc---eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
|..++|+..+.||+|+||.||+|.+..++. .||+|.+..... ...+..|+++++.++|++++...
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~--------- 72 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE--------- 72 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEE---------
Confidence 556789999999999999999999875554 699998765422 23477899999988888755543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.++...+..++|||++ +++|.+++......+++.++..++.|++.||+|||+.|++|||||
T Consensus 73 ------------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlk 134 (268)
T cd05063 73 ------------------GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA 134 (268)
T ss_pred ------------------EEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 3345567789999999 789999887656679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+||+++ +++.++|+|||++........... .......+..|++||++.+..++.++|||||||++|||++ |
T Consensus 135 p~Nili~---~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g 207 (268)
T cd05063 135 ARNILVN---SNLECKVSDFGLSRVLEDDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFG 207 (268)
T ss_pred hhhEEEc---CCCcEEECCCccceecccccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCC
Confidence 9999994 778999999999976654322110 0112223457999999998889999999999999999997 9
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
..||...... .....+.. ....+. ....+.++.+++.+||..+|.+||++.++.+.|+++
T Consensus 208 ~~p~~~~~~~---~~~~~i~~-~~~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 208 ERPYWDMSNH---EVMKAIND-GFRLPA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCcCCHH---HHHHHHhc-CCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999765432 22222222 222221 124578999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.81 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=197.4
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+|++.++||.|+||.||+|.+..+++.||+|.++... ..+.+..|+.+++.++|++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~----------------- 63 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF----------------- 63 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceE-----------------
Confidence 5899999999999999999999999999999875432 23457789999999988865443
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
...+...+..|+||||+ +++|.+++... ...++...++.++.||+.||.|||++||+|+||||+||++
T Consensus 64 ----------~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili 133 (255)
T cd08219 64 ----------KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL 133 (255)
T ss_pred ----------EEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE
Confidence 33445677899999999 88998887643 4568999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
++++.++|+|||++......... .....++..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 134 ---~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 134 ---TQNGKVKLGDFGSARLLTSPGAY-------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred ---CCCCcEEEcccCcceeecccccc-------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 47889999999999766543221 13456889999999999988999999999999999999999999864
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .....+...... +. ....+..+.+++..||..+|++||++.+|..
T Consensus 204 ~~~---~~~~~~~~~~~~-~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 204 SWK---NLILKVCQGSYK-PL---PSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CHH---HHHHHHhcCCCC-CC---CcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 332 222222222221 11 1335778999999999999999999988755
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=293.79 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=205.9
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
-.+..++|++.+.||+|+||.||+|.+..+++ .||+|+...... ...+.+|+.+++.++|++++..++.+
T Consensus 2 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--- 78 (279)
T cd05057 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGIC--- 78 (279)
T ss_pred cccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE---
Confidence 45677899999999999999999999876654 589998765533 23577899999999998866655432
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.. ...++|+||+ +++|.+++......+++..++.++.||+.||+|||++|++||
T Consensus 79 ------------------------~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~ 133 (279)
T cd05057 79 ------------------------LS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133 (279)
T ss_pred ------------------------ec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence 22 5778999999 899999988766679999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+||++ ++++.+||+|||+++......... ......++..|++||.+....++.++|+|||||++||++
T Consensus 134 di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~ 205 (279)
T cd05057 134 DLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205 (279)
T ss_pred ccCcceEEE---cCCCeEEECCCcccccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHh
Confidence 999999999 477899999999998665322110 011223456899999998888999999999999999999
Q ss_pred h-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 234 R-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 234 ~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
+ |..||.+....... ..+ ......+.+ ...+..+.+++..||..+|.+||++.++.+.|.++++.
T Consensus 206 ~~g~~p~~~~~~~~~~---~~~-~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 206 TFGAKPYEGIPAVEIP---DLL-EKGERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred cCCCCCCCCCCHHHHH---HHH-hCCCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 8 99999876543222 222 222222222 22367899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=301.48 Aligned_cols=262 Identities=19% Similarity=0.312 Sum_probs=201.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCC-------CceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeec
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHV 72 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~ 72 (449)
+...+|++++.||+|+||.||+|++... ...||+|++..... ...+.+|+++++.+ +|++++..+
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~---- 84 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL---- 84 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee----
Confidence 4567899999999999999999986432 23699998775432 23578899999998 677655443
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---------------cCCCCHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLAD 136 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---------------~~~~~~~~~~~i~~ 136 (449)
.++...+..++++||+ +++|.+++... ...+++.+++.++.
T Consensus 85 -----------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 141 (334)
T cd05100 85 -----------------------GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY 141 (334)
T ss_pred -----------------------EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence 3344567789999999 88999988642 12478889999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||.|||++|++||||||+|||++ .++.+||+|||+++........ .......++..|+|||++.+..+
T Consensus 142 qi~~al~~LH~~givH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 213 (334)
T cd05100 142 QVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVY 213 (334)
T ss_pred HHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCc
Confidence 999999999999999999999999994 6789999999999865443211 11122334567999999999999
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |..||.+.... .....+.. ....+ .....+.++.+++..||..+|.+||++.+|
T Consensus 214 ~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 214 THQSDVWSFGVLLWEIFTLGGSPYPGIPVE---ELFKLLKE-GHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred CchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999999999999998 89999875432 22222222 11111 123457899999999999999999999999
Q ss_pred HHHHHHHHHhcC
Q 013125 296 KRLFHDLFSREG 307 (449)
Q Consensus 296 ~~~l~~~~~~~~ 307 (449)
.+.|++++....
T Consensus 287 l~~l~~~~~~~~ 298 (334)
T cd05100 287 VEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHhhhcC
Confidence 999998876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=294.59 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=199.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCC-----CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
++..++|++.+.||+|+||.||+|.+... +..||+|....... ...+.+|+++++.++|++++..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~----- 76 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLG----- 76 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEE-----
Confidence 35678999999999999999999998643 47899999765432 224678899999888887555433
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEY 144 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------~~~~~~~~~~i~~qil~~L~~ 144 (449)
+.......++||||+ +++|.+++.... ..+++..++.++.||+.||.|
T Consensus 77 ----------------------~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 134 (277)
T cd05032 77 ----------------------VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134 (277)
T ss_pred ----------------------EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 345567889999999 889999886421 236788999999999999999
Q ss_pred HHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHH
Q 013125 145 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLES 224 (449)
Q Consensus 145 LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS 224 (449)
||+.||+||||||+|||++ .++.+||+|||+++....... +.......++..|+|||.+.+..++.++||||
T Consensus 135 lH~~~i~H~di~p~nill~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 206 (277)
T cd05032 135 LAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWS 206 (277)
T ss_pred HHhCCccccccChheEEEc---CCCCEEECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHH
Confidence 9999999999999999994 788999999999876543321 11223445678999999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 225 LGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 225 lG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
|||++||+++ |..||.+..... ....+.. ...... ....+.++.+++..||..+|++||++.+|.+.|+
T Consensus 207 lG~il~el~t~g~~p~~~~~~~~---~~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 207 FGVVLWEMATLAEQPYQGLSNEE---VLKFVID-GGHLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHhhccCCCCCccCCHHH---HHHHHhc-CCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 9999999998 999998754432 2222221 111111 1334789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.35 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=200.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+..++|.+.+.||+|+||.||+|.+. .++..||+|+++.... .+.+.+|+++++.+ +|++++..+.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~----- 106 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG----- 106 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEE-----
Confidence 45678999999999999999999863 3455799998765422 23478899999999 6877655543
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
++...+..++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++|+|
T Consensus 107 ----------------------~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH 164 (302)
T cd05055 107 ----------------------ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH 164 (302)
T ss_pred ----------------------EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeh
Confidence 334556789999999 889999887533 34899999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el 232 (449)
+||||+|||++ +++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||
T Consensus 165 ~dlkp~Nil~~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el 236 (302)
T cd05055 165 RDLAARNVLLT---HGKIVKICDFGLARDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236 (302)
T ss_pred hhhccceEEEc---CCCeEEECCCcccccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHH
Confidence 99999999994 7789999999999765433211 011234567889999999998999999999999999999
Q ss_pred Hh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 233 LR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 233 ~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
++ |..||.+..... .+.+........+ .....++++.+++.+||..+|++||++.++.+.|.++
T Consensus 237 ~t~g~~p~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 237 FSLGSNPYPGMPVDS---KFYKLIKEGYRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HhCCCCCcCCCCchH---HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 98 999998754322 2222222222111 1234478999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=292.94 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=201.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCC---ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
..++|++.+.||+|+||.||+|.+..++ ..||+|.++.... ...+.+|+.+++.++|++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~---------- 71 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE---------- 71 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEE----------
Confidence 3578999999999999999999986444 3699998765432 23578899999999888755543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.++...+..|+||||+ +++|.+++......++..+++.++.|++.||.|||++|++||||||
T Consensus 72 -----------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp 134 (267)
T cd05066 72 -----------------GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 134 (267)
T ss_pred -----------------EEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhch
Confidence 3345667889999999 8899999876666789999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~ 236 (449)
+|||++ .++.++|+|||++........... ......++..|++||++.+..++.++|+|||||++||+++ |.
T Consensus 135 ~nili~---~~~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 135 RNILVN---SNLVCKVSDFGLSRVLEDDPEAAY----TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred hcEEEC---CCCeEEeCCCCcccccccccceee----ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCC
Confidence 999994 778999999999987654322110 0112233568999999998889999999999999999886 99
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
.||.+..... ....+.. ....+. ....|+.+.+++.+||..+|.+||++.++.+.|.++
T Consensus 208 ~p~~~~~~~~---~~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 208 RPYWEMSNQD---VIKAIEE-GYRLPA---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcccCCHHH---HHHHHhC-CCcCCC---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9998765432 2222222 222222 134578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=296.11 Aligned_cols=252 Identities=18% Similarity=0.276 Sum_probs=197.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..++|++.++||+|+||.||+|++..+++.||+|+++.... ...+.+|+.+++.++|++++..+.
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~------------- 73 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG------------- 73 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEE-------------
Confidence 45689999999999999999999999999999999875432 234678899999998887655543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.....+..|+||||+ +++|.+++.. ...++..+++.++.|++.||.|||+.|++|+||||+||+
T Consensus 74 --------------~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 138 (267)
T cd06645 74 --------------SYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANIL 138 (267)
T ss_pred --------------EEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 334567889999999 7899998865 457999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
+ +..+.++|+|||++........ ......|+..|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 139 i---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p 208 (267)
T cd06645 139 L---TDNGHVKLADFGVSAQITATIA-------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208 (267)
T ss_pred E---CCCCCEEECcceeeeEccCccc-------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence 9 4778999999999876543221 123557899999999874 44588999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|....... ............+.......++..+.+++..||..+|++||++++|.+
T Consensus 209 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 209 MFDLHPMR---ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccccchh---hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 97644321 111111222222211111235778999999999999999999887643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.42 Aligned_cols=257 Identities=19% Similarity=0.242 Sum_probs=197.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCce--EEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 79 (449)
-++|++.+.||+|+||.||+|.+..++.. +|+|....... ...+.+|++++..+ +|++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~---------------- 69 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN---------------- 69 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCC----------------
Confidence 46899999999999999999998777654 57776553221 23467899999888 6665
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHH
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIE 143 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qil~~L~ 143 (449)
++.+..++..++..|+||||+ +++|.+++.... ..++..+++.++.||+.||+
T Consensus 70 -----------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 138 (303)
T cd05088 70 -----------IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 138 (303)
T ss_pred -----------cceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHH
Confidence 444444556677899999999 899999886532 25789999999999999999
Q ss_pred HHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHH
Q 013125 144 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLE 223 (449)
Q Consensus 144 ~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw 223 (449)
|||++||+||||||+|||++ .++.+||+|||++....... ......++..|+|||++.+..++.++|||
T Consensus 139 ~LH~~gi~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 207 (303)
T cd05088 139 YLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVW 207 (303)
T ss_pred HHHhCCccccccchheEEec---CCCcEEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccch
Confidence 99999999999999999994 77899999999986322110 01122346679999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 224 SLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 224 SlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||||++|||++ |..||.+..... ....+.. .... ......++++.+++..||..+|++||++.++...|+.+
T Consensus 208 slG~il~ellt~g~~p~~~~~~~~---~~~~~~~-~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 208 SYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQ-GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred hhhhHHHHHHhcCCCCcccCChHH---HHHHHhc-CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999998 999998754432 2222211 1111 11234578899999999999999999999999988887
Q ss_pred HHhcC
Q 013125 303 FSREG 307 (449)
Q Consensus 303 ~~~~~ 307 (449)
+....
T Consensus 281 ~~~~~ 285 (303)
T cd05088 281 LEERK 285 (303)
T ss_pred HHhhh
Confidence 66543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=298.78 Aligned_cols=202 Identities=21% Similarity=0.298 Sum_probs=162.4
Q ss_pred eeeecccCceeEEEEEEcC--CCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 12 GRKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~--~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
+.+||+|+||+||+|++.. ++..||+|.+........+.+|+++++.++|++++.......
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------------- 68 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL----------------- 68 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEe-----------------
Confidence 4689999999999999753 567899998876555567889999999999998776544321
Q ss_pred CcCeeEEecccCCeeEEEEecCCCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC--------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~--------~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.......|+|+||++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 69 --------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil 140 (317)
T cd07867 69 --------SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 140 (317)
T ss_pred --------ccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEE
Confidence 1245678999999999998887532 124788999999999999999999999999999999999
Q ss_pred eecC-CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013125 162 MGLG-RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 162 l~~~-~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+... +..+.+||+|||+++........ ........+|..|+|||++.+. .++.++|||||||++|||++|.+||
T Consensus 141 ~~~~~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 141 VMGEGPERGRVKIADMGFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred EccCCCCCCcEEEeeccceeccCCCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 9432 35678999999999876543221 1122356789999999998874 5899999999999999999999999
Q ss_pred CCC
Q 013125 240 QGL 242 (449)
Q Consensus 240 ~~~ 242 (449)
...
T Consensus 217 ~~~ 219 (317)
T cd07867 217 HCR 219 (317)
T ss_pred ccc
Confidence 753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.09 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=191.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-------------- 66 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG-------------- 66 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEE--------------
Confidence 468999999999999999999999999999998865422 234778999999999887655443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..++||||+ +++|..+ ..++...+..++.|++.||.|||+.||+|+||||+|||+
T Consensus 67 -------------~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill 128 (279)
T cd06619 67 -------------AFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV 128 (279)
T ss_pred -------------EEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE
Confidence 334567789999999 6666432 347888999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+ .++.++|+|||++....... .....+|..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 129 ~---~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 129 N---TRGQVKLCDFGVSTQLVNSI---------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred C---CCCCEEEeeCCcceeccccc---------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 4 78899999999997654332 13457899999999999999999999999999999999999999753
Q ss_pred hhhcH----HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATK----KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... ......+... .+........++++.+++..||..+|.+||+++++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 197 QKNQGSLMPLQLLQCIVDE---DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cccccccchHHHHHHHhcc---CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 32211 1111111111 1111112335678999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.46 Aligned_cols=247 Identities=19% Similarity=0.296 Sum_probs=205.9
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
-|.++++||+|+||.||+|.+..+|+.||||.+.-+.+..++.+|+.+++....+..+++++.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGS----------------- 96 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGS----------------- 96 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhh-----------------
Confidence 467889999999999999999999999999998888888899999999999887765544332
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
.-.....+|||||| .|+..+++...++++++.++..+++..+.||+|||...-||||||..|||+ +
T Consensus 97 ----------YFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---N 163 (502)
T KOG0574|consen 97 ----------YFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---N 163 (502)
T ss_pred ----------hccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---c
Confidence 22446789999999 789999999888999999999999999999999999999999999999999 5
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
..+..||+|||.|-.+++.... .+++.||+.|||||++....|+.++||||||++..||..|++||....+.
T Consensus 164 T~G~AKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM- 235 (502)
T KOG0574|consen 164 TDGIAKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM- 235 (502)
T ss_pred ccchhhhhhccccchhhhhHHh-------hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-
Confidence 8899999999999776654332 36889999999999999999999999999999999999999999876543
Q ss_pred HHHHHHHHHHhhcCCCH-HHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 247 KKQKYDKICEKKVSTPI-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.|......+|+ -.-.+.++.+|.+++..||-.+|++|.++.+|.+
T Consensus 236 -----RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 236 -----RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -----ceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 222211112221 1111234788999999999999999998776644
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.72 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=201.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+.+|+++++.++|++++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~-------------- 67 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY-------------- 67 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhh--------------
Confidence 57899999999999999999998899999999765421 12357789999999988875543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
..++...+..+++||++ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||
T Consensus 68 -------------~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p 134 (267)
T cd08229 68 -------------YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKP 134 (267)
T ss_pred -------------hheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 33345567889999999 78999888642 34589999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+||++. .++.++|+|||++......... .....++..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 135 ~nili~---~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~ 204 (267)
T cd08229 135 ANVFIT---ATGVVKLGDLGLGRFFSSKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred HHEEEc---CCCCEEECcchhhhccccCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCC
Confidence 999994 7789999999998765433221 124568899999999999889999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||.+.... .......+...... +......+.++.+++.+||..+|.+||++.+|.+.++++
T Consensus 205 p~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 205 PFYGDKMN-LYSLCKKIEQCDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred Ccccccch-HHHHhhhhhcCCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 99764321 11222222111111 111234578999999999999999999999999888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=298.15 Aligned_cols=252 Identities=17% Similarity=0.297 Sum_probs=196.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
..++.|+++++||.|+||.||+|++..+++.||+|++..... ...+.+|+++++.++|++++....
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------ 76 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG------------ 76 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEE------------
Confidence 356789999999999999999999999999999999865432 234678999999999887555433
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++..+...|+||||+ +++|..++......++...++.++.||+.+|.|||+.|++||||||+||
T Consensus 77 ---------------~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni 141 (292)
T cd06644 77 ---------------AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141 (292)
T ss_pred ---------------EEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceE
Confidence 334556889999999 7788777766566799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G 235 (449)
+++ .++.++|+|||++........ ......++..|+|||++. ...++.++|||||||++|||++|
T Consensus 142 li~---~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g 211 (292)
T cd06644 142 LLT---LDGDIKLADFGVSAKNVKTLQ-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 211 (292)
T ss_pred EEc---CCCCEEEccCccceecccccc-------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcC
Confidence 994 688999999999875433211 123456788999999885 34478899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||...... ..+..+... ..+.......++.++.+++..||..+|++||+++++.+
T Consensus 212 ~~p~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 212 EPPHHELNPM---RVLLKIAKS--EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCCccccHH---HHHHHHhcC--CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9999765432 222222111 11111112345678999999999999999999887743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.29 Aligned_cols=258 Identities=19% Similarity=0.301 Sum_probs=200.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCc---eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.|++.+.||+|+||.||+|.+..+++ .||||+++.... ...+..|+.+++.++|++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~----------- 71 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE----------- 71 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEE-----------
Confidence 4679999999999999999999876554 599999875422 23578899999999988755543
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.+...+...++||||+ +++|.+++......++..+++.++.|++.||+|||++|++||||||+
T Consensus 72 ----------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ 135 (269)
T cd05065 72 ----------------GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAAR 135 (269)
T ss_pred ----------------EEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChh
Confidence 3345667789999999 78999988766667999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~ 237 (449)
||++ +.++.++|+|||++.......... .+........+..|++||.+.+..++.++|||||||++|||++ |..
T Consensus 136 nili---~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 136 NILV---NSNLVCKVSDFGLSRFLEDDTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred eEEE---cCCCcEEECCCccccccccCcccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence 9999 477899999999987654322111 0000111122457999999999899999999999999999886 999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||....... ....+ ......+.. ..+|..+.+++..||..+|.+||++++|...|+.+
T Consensus 211 p~~~~~~~~---~~~~i-~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 211 PYWDMSNQD---VINAI-EQDYRLPPP---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCCCHHH---HHHHH-HcCCcCCCc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 998755432 22222 222222222 34578999999999999999999999998887754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=295.73 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=201.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
..+|+++++||.|+||.||+|.+.. ++.||+|++..... ...+..|+.+++.++|++++..
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~---------------- 67 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL---------------- 67 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhhe----------------
Confidence 4679999999999999999999977 88899999876533 4467889999999988765543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..+....+..++||||+ +++|.+++... +..++...++.++.||+.||.|||+.|++||||||+||+
T Consensus 68 -----------~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nil 136 (261)
T cd05148 68 -----------FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136 (261)
T ss_pred -----------eeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEE
Confidence 33345667889999999 88999998753 456899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
++ +++.++|+|||++......... .....++..|++||++.+..++.++||||||+++|+|++ |+.||.
T Consensus 137 v~---~~~~~kl~d~g~~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 137 VG---EDLVCKVADFGLARLIKEDVYL-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred Ec---CCceEEEccccchhhcCCcccc-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 94 7889999999999765432211 123345678999999998889999999999999999998 899998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
+.... +.+..+.. ....+. ...+++.+.+++..||..+|.+||++.+|.+.|+.
T Consensus 207 ~~~~~---~~~~~~~~-~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 207 GMNNH---EVYDQITA-GYRMPC---PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCHH---HHHHHHHh-CCcCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 75532 23333322 222222 23457899999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.21 Aligned_cols=256 Identities=18% Similarity=0.285 Sum_probs=196.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..++|++.+.||+|+||+||+|.+..+++.||+|+...... ...+..|+.+++.+ +|++++...+......
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~------- 76 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN------- 76 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC-------
Confidence 46789999999999999999999999999999999865432 34578899999888 5777666554332110
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+||||+ +++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 77 --------------~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ni 142 (272)
T cd06637 77 --------------PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 142 (272)
T ss_pred --------------CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHE
Confidence 001135689999999 78999988753 35689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G 235 (449)
++. +++.++|+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|
T Consensus 143 li~---~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 143 LLT---ENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred EEC---CCCCEEEccCCCceecccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 994 778999999999976543221 123567899999999986 34588899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||......... ..+.... ........++.++.+++..||..+|.+||++.++..
T Consensus 213 ~~p~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 213 APPLCDMHPMRAL---FLIPRNP---APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCccccCHHHHH---HHHhcCC---CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 9999764432211 1111111 111122345789999999999999999999887743
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=295.22 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=198.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+..++|++.++||+|+||.||+|.+.. .+..||+|+++.... ...+.+|+.+++.++|++++.++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~------ 76 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLG------ 76 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEE------
Confidence 556899999999999999999997642 345799998764432 224677888999998887555433
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHH
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYV 145 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------~~~~~~~~~~i~~qil~~L~~L 145 (449)
+....+..|+||||+ +++|.+++.... ..++...+..++.||+.||.||
T Consensus 77 ---------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 135 (288)
T cd05061 77 ---------------------VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 135 (288)
T ss_pred ---------------------EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334556789999999 899999987532 2356778899999999999999
Q ss_pred HhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHH
Q 013125 146 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL 225 (449)
Q Consensus 146 H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 225 (449)
|++||+||||||+||+++ +++.++|+|||+++........ .......++..|+|||.+.+..++.++|||||
T Consensus 136 H~~~i~H~dikp~nili~---~~~~~~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvwsl 207 (288)
T cd05061 136 NAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSF 207 (288)
T ss_pred HhCCCcCCCCChheEEEc---CCCcEEECcCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHH
Confidence 999999999999999994 7889999999998765432211 11223345678999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 226 GYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 226 G~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
||++|||++ |..||.+..... ....+...... . .....++.+.+++..||..+|.+||++.++.+.|++.+
T Consensus 208 G~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 208 GVVLWEITSLAEQPYQGLSNEQ---VLKFVMDGGYL-D---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCC-C---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 999999998 789998754432 22222222111 1 12345789999999999999999999999988887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=314.68 Aligned_cols=248 Identities=18% Similarity=0.333 Sum_probs=200.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|.|+..||.|+||.||+|..+.++-..|-|++.... ..+.++-|++||....|++++.++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~--------------- 96 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLS--------------- 96 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHH---------------
Confidence 45788899999999999999999898889999876543 3445788999999888887665432
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
....++.++|+.||| ||-...++...++.++..++..+++|++.||.|||+++|||||||+.|||++
T Consensus 97 ------------ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T 164 (1187)
T KOG0579|consen 97 ------------AYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT 164 (1187)
T ss_pred ------------HHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE
Confidence 234567899999999 6777777778899999999999999999999999999999999999999997
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
-+|.|+|+|||.+....... ....++.||+.|||||+.. +.+|++++||||||++|.||..+.+|
T Consensus 165 ---ldGdirLADFGVSAKn~~t~-------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP 234 (1187)
T KOG0579|consen 165 ---LDGDIRLADFGVSAKNKSTR-------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP 234 (1187)
T ss_pred ---ecCcEeeecccccccchhHH-------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence 67899999999986443322 1235889999999999764 67899999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHh-hccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....++....- +| .-+.|+..+ ...+...|.+++..||..||..||+..+|.+
T Consensus 235 HhelnpMRVll---Ki---aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 235 HHELNPMRVLL---KI---AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccccchHHHHH---HH---hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 88766542222 22 222333322 3456789999999999999999999887643
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=294.72 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=198.2
Q ss_pred CCceEEeeeecccCceeEEEEEE----cCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..+|++.+.||+|+||.||+|.. ..+++.||+|.+..... ...+.+|+++++.++|++++...+.+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------- 75 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCY------- 75 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEc-------
Confidence 56899999999999999999974 45788999999765432 235788999999999988766544321
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.......++|+||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+
T Consensus 76 ------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 76 ------------------SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred ------------------cCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 12345689999999 89999998765667899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++ ++++.++|+|||++......... +.......++..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 138 nili---~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 210 (284)
T cd05081 138 NILV---ESENRVKIGDFGLTKVLPQDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210 (284)
T ss_pred hEEE---CCCCeEEECCCcccccccCCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence 9999 47789999999999866433221 0111122344569999999988899999999999999999998777
Q ss_pred CCCChhhc------------HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 239 WQGLKAAT------------KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 239 f~~~~~~~------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
+....... ....+..++......+ ....++.++.+++..||..+|++||++.+|...|+.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 211 SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCCcchhhhhhcccccccccchHHHHHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 64322110 0000111111111111 1234578999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=291.26 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=196.4
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
..+|++.+.||+|+||.||+|.+. ++..+|+|++.... ....+.+|+++++.++|++++..
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~----------------- 64 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL----------------- 64 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEE-----------------
Confidence 357999999999999999999875 46679999876543 23467889999999988875543
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..++...+..|+|||++ +++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++
T Consensus 65 ----------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i- 133 (256)
T cd05059 65 ----------YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV- 133 (256)
T ss_pred ----------EEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE-
Confidence 33345567789999999 889999887655678999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 134 --~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 134 --GEDNVVKVSDFGLARYVLDDQYT------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred --CCCCcEEECCcccceeccccccc------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 47889999999998765432211 0112234567999999998899999999999999999999 89999865
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
.... ....+. .....+. ....+.++.+++.+||..+|++||++.++.+.|
T Consensus 206 ~~~~---~~~~~~-~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 206 SNSE---VVESVS-AGYRLYR---PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHH---HHHHHH-cCCcCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 4432 222221 1211111 134588999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.56 Aligned_cols=262 Identities=20% Similarity=0.227 Sum_probs=197.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++.........
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 75 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPP------- 75 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecc-------
Confidence 56899999999999999999999999999999998764322 23467899999999998877654332111
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
........|+|+|+++++|.+++. ...++...++.++.|++.||.|||+.||+||||||+|||
T Consensus 76 ---------------~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nil 138 (336)
T cd07849 76 ---------------SFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLL 138 (336)
T ss_pred ---------------cccccceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 011235679999999888888775 457999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+ +..+.++|+|||++........... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 139 l---~~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 139 L---NTNCDLKICDFGLARIADPEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred E---CCCCCEEECcccceeeccccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9 4788999999999987544322111 1234578999999998765 468999999999999999999999997
Q ss_pred CChhhcHHHHHHHHHH-----------------------hhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICE-----------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.........+..+.. .....+........+.++.+++..||..+|++||++.++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 212 GKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 6433221111111000 00011112223445678999999999999999999988755
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=290.35 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=197.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+.|++.+.||+|+||.||.|.+..+++.||+|++..... ...+.+|+++++.++|++++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~---------- 71 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG---------- 71 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEE----------
Confidence 579999999999999999999999999999998764321 224677999999998887554433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+....+..++|+|++ +++|.+++.. ...++...++.++.|++.||.|||+.||+||||+|+
T Consensus 72 -----------------~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 133 (263)
T cd06625 72 -----------------CLRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGA 133 (263)
T ss_pred -----------------EEccCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 345567899999999 8899988875 456899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||+++ +++.++|+|||+++.......... ......++..|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 134 nilv~---~~~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 206 (263)
T cd06625 134 NILRD---SAGNVKLGDFGASKRLQTICSSGT----GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206 (263)
T ss_pred HEEEc---CCCCEEEeecccceeccccccccc----cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99994 778999999999976543221100 01245678899999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|...... .....+...... .......+..+.+++..||..+|.+||++.++.+
T Consensus 207 ~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 207 WAEFEAM---AAIFKIATQPTN---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ccccchH---HHHHHHhccCCC---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 9765332 222222222111 1223456789999999999999999999887754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.41 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=198.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
|-..+|++.++||+|+||.||+|... .++..||+|.+..... ...+.+|+++++.++|++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-------- 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFY-------- 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEE--------
Confidence 45678999999999999999999753 3466799998764432 33588899999999988755543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIAR 141 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--------------~~~~~~~~~~i~~qil~~ 141 (449)
.++......+++|||+ +++|.+++.... ..+++..++.++.||+.|
T Consensus 74 -------------------~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 134 (280)
T cd05092 74 -------------------GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASG 134 (280)
T ss_pred -------------------EEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHH
Confidence 3345567789999999 889999886532 247899999999999999
Q ss_pred HHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccch
Q 013125 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 221 (449)
Q Consensus 142 L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D 221 (449)
|+|||++|++||||||+|||++ +++.++|+|||++........ ++......++..|+|||++.+..++.++|
T Consensus 135 l~~LH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (280)
T cd05092 135 MVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESD 206 (280)
T ss_pred HHHHHHCCeecccccHhhEEEc---CCCCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhh
Confidence 9999999999999999999994 788999999999976543221 11223344578899999999989999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 222 LESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 222 vwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
||||||++|||++ |.+||....... ....+.... ... ....+|+.+.+++..||..+|.+||++++|.+.|+
T Consensus 207 i~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~~-~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 207 IWSFGVVLWEIFTYGKQPWYQLSNTE---AIECITQGR-ELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHHHHHHcCCCCCCccCCHHH---HHHHHHcCc-cCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 9999999999998 999997654332 222222211 111 11345789999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=296.67 Aligned_cols=255 Identities=19% Similarity=0.252 Sum_probs=197.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCc--eEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++|++.+.||+|+||.||+|.+..++. .+++|.++.... ...+.+|++++..+ +|++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~------------- 68 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL------------- 68 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhhe-------------
Confidence 579999999999999999999876654 478887764222 23577899999888 56665443
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHH
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEY 144 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qil~~L~~ 144 (449)
..+.......|+|+||+ +++|.+++.... ..+++..++.++.||+.||+|
T Consensus 69 --------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 134 (297)
T cd05089 69 --------------LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQY 134 (297)
T ss_pred --------------EEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHH
Confidence 33345566789999999 889999886432 348899999999999999999
Q ss_pred HHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHH
Q 013125 145 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLES 224 (449)
Q Consensus 145 LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS 224 (449)
||++||+||||||+|||++ +++.+||+|||++........ ......+..|+|||++.+..++.++||||
T Consensus 135 lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 203 (297)
T cd05089 135 LSEKQFIHRDLAARNVLVG---ENLASKIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWS 203 (297)
T ss_pred HHHCCcccCcCCcceEEEC---CCCeEEECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHH
Confidence 9999999999999999994 678999999999864321110 11223355799999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 225 LGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 225 lG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
|||++|||++ |..||.+..... ....+... ...+ ....++..+.+++..||..+|.+||++.++.+.|+.++
T Consensus 204 lG~il~el~t~g~~pf~~~~~~~---~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 204 FGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQG-YRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHH---HHHHHhcC-CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999997 999998754432 22222221 1111 12345789999999999999999999999999998887
Q ss_pred Hhc
Q 013125 304 SRE 306 (449)
Q Consensus 304 ~~~ 306 (449)
...
T Consensus 277 ~~~ 279 (297)
T cd05089 277 EAR 279 (297)
T ss_pred Hhh
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=292.92 Aligned_cols=260 Identities=21% Similarity=0.304 Sum_probs=204.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+-+++|++.+.||+|+||.||+|.+.. ++..|++|++..... ...+.+|+.+++.++|++++..++.+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~----- 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC----- 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 557899999999999999999999875 357899998765432 23467899999999999876654432
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-------~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
.......+++++++ +++|.+++.... ..++..+++.++.||+.||+|||+.
T Consensus 78 ---------------------~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 136 (280)
T cd05043 78 ---------------------IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136 (280)
T ss_pred ---------------------ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 12346678999998 789999887542 4589999999999999999999999
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHH
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 228 (449)
+++||||||+||+++ +++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||+
T Consensus 137 ~i~H~di~p~nil~~---~~~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~ 208 (280)
T cd05043 137 GVIHKDIAARNCVID---EELQVKITDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVL 208 (280)
T ss_pred CEeecccCHhhEEEc---CCCcEEECCCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHH
Confidence 999999999999994 77899999999998654332110 0123345678999999999899999999999999
Q ss_pred HHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 229 LLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 229 l~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
+||+++ |+.||....... .... ......... ...+|+++.+++.+||..+|++||++.++.+.|+++.+
T Consensus 209 l~el~~~g~~p~~~~~~~~---~~~~-~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 209 LWELMTLGQTPYVEIDPFE---MAAY-LKDGYRLAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHhcCCCCCcCcCCHHH---HHHH-HHcCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999998 999998754432 2211 222222221 13357899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=297.47 Aligned_cols=260 Identities=19% Similarity=0.306 Sum_probs=201.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-------CCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeec
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHV 72 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~ 72 (449)
+..++|.+.+.||+|+||.||+|++. ..+..||+|+...... ...+.+|+.+++.+ +|++++..
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~----- 86 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL----- 86 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhe-----
Confidence 45688999999999999999999753 2345799998764322 23578899999998 67765544
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLAD 136 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~ 136 (449)
..+.......++||||+ +++|.+++.... ..+++.+++.++.
T Consensus 87 ----------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (304)
T cd05101 87 ----------------------LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY 144 (304)
T ss_pred ----------------------eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence 33345567789999999 889999887532 2478889999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||.|||++||+||||||+||+++ +++.+||+|||+++......... ......++..|+|||++.+..+
T Consensus 145 qi~~al~~LH~~givH~dlkp~Nili~---~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~ 216 (304)
T cd05101 145 QVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVY 216 (304)
T ss_pred HHHHHHHHHHHCCeeecccccceEEEc---CCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCC
Confidence 999999999999999999999999994 77899999999998765432211 1123345678999999998889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++||||||+++|||++ |..||.+.... +....+.. ..... ....++.++.+++..||..+|.+||++.++
T Consensus 217 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~-~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 217 THQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFKLLKE-GHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc-CCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 999999999999999998 88899775432 22222221 11111 123557899999999999999999999999
Q ss_pred HHHHHHHHHh
Q 013125 296 KRLFHDLFSR 305 (449)
Q Consensus 296 ~~~l~~~~~~ 305 (449)
.+.|++++..
T Consensus 290 l~~l~~~~~~ 299 (304)
T cd05101 290 VEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHh
Confidence 9999888664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=295.89 Aligned_cols=258 Identities=20% Similarity=0.321 Sum_probs=199.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCC-----CceEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvKv~~~~~~~---~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+-.++|++.+.||+|+||.||+|.+... ...||+|+....... ..+.+|+++++.+ +|++++..+.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~----- 83 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG----- 83 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE-----
Confidence 4568999999999999999999998643 368999988754322 2477899999988 6776554433
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQM 138 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---------------~~~~~~~~~~~i~~qi 138 (449)
+.......+++|||+ +++|.+++... ...+++..++.++.||
T Consensus 84 ----------------------~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 141 (293)
T cd05053 84 ----------------------VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141 (293)
T ss_pred ----------------------EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence 334566789999999 88999988632 3468999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCc
Q 013125 139 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR 218 (449)
Q Consensus 139 l~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ 218 (449)
+.||+|||++||+||||||+||+++ +++.+||+|||+++........ .......++..|+|||++.+..++.
T Consensus 142 ~~al~~LH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~ 213 (293)
T cd05053 142 ARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTH 213 (293)
T ss_pred HHHHHHHHHCCccccccceeeEEEc---CCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCc
Confidence 9999999999999999999999994 7889999999999866543211 1112234567899999999889999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 219 RDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 219 ~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|||||||++|||++ |..||.+..... ....+ ....... .....+..+.+++..||..+|.+||++.++.+
T Consensus 214 ~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 214 QSDVWSFGVLLWEIFTLGGSPYPGIPVEE---LFKLL-KEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred ccceeehhhHHHHHhcCCCCCCCCCCHHH---HHHHH-HcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999997 999998754322 22222 1111111 12344789999999999999999999999999
Q ss_pred HHHHHH
Q 013125 298 LFHDLF 303 (449)
Q Consensus 298 ~l~~~~ 303 (449)
.|++++
T Consensus 287 ~l~~~~ 292 (293)
T cd05053 287 DLDRML 292 (293)
T ss_pred HHHHhh
Confidence 888664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=291.80 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=194.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~------------- 67 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE------------- 67 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeee-------------
Confidence 589999999999999999999998999999998754321 234678999999999887555433
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+.......++||||+.+++.+.+......+++..++.++.||+.||+|||+.|++||||||+||++
T Consensus 68 --------------~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~ 133 (286)
T cd07847 68 --------------VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI 133 (286)
T ss_pred --------------EEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE
Confidence 334567889999999555544444345579999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ .++.++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 134 ~---~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 134 T---KQGQIKLCDFGFARILTGPGDD-------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred c---CCCcEEECccccceecCCCccc-------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 4 7789999999999876543211 124467889999999876 4578999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhh-----------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 242 LKAATKKQKYDKICEKK-----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
....+............ ...+........+..+.+++..||..+|++||++.++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 65433222221111100 00112223345678899999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=290.74 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=201.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..++|++.++||+|+||.||+|.+. +++.||||.+.... ....+.+|+.+++.++|++++..+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-------------- 67 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY-------------- 67 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeee--------------
Confidence 66789999999999999999999975 45779999887543 345688999999999988755443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+.......++|||++ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||
T Consensus 68 -------------~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni 134 (261)
T cd05034 68 -------------AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134 (261)
T ss_pred -------------eeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence 3344557789999999 88999988753 35689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
+++ +++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 135 li~---~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 205 (261)
T cd05034 135 LVG---ENLVCKIADFGLARLIEDDEY------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205 (261)
T ss_pred EEc---CCCCEEECccccceeccchhh------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 994 779999999999986653211 11123334678999999998889999999999999999998 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
.+.... ..+..+.. ....+.+ ...|.++.+++.+||..+|++||+++++.+.|+.
T Consensus 206 ~~~~~~---~~~~~~~~-~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 206 PGMTNR---EVLEQVER-GYRMPRP---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHH---HHHHHHHc-CCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 875443 22333222 2222211 3347899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.73 Aligned_cols=248 Identities=26% Similarity=0.440 Sum_probs=191.8
Q ss_pred EEeeeecccCceeEEEEEEc----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++.+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+|++.++.++|++++.+++.+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~----------- 70 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFC----------- 70 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEE-----------
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccc-----------
Confidence 57899999999999999987 3466799999965433 34688999999999999877665544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
...+..++|+||+ +++|.+++... ...++..++..++.||+.||.|||+++++|+||+++||
T Consensus 71 ----------------~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~ni 134 (259)
T PF07714_consen 71 ----------------IENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNI 134 (259)
T ss_dssp ----------------ESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGE
T ss_pred ----------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3456689999999 78999999876 56799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
+++ +++.+||+|||++......... ...........|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 135 ll~---~~~~~Kl~~f~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~ 206 (259)
T PF07714_consen 135 LLD---SNGQVKLSDFGLSRPISEKSKY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPF 206 (259)
T ss_dssp EEE---TTTEEEEESTTTGEETTTSSSE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTT
T ss_pred ccc---cccccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 994 7889999999999876322111 11234456788999999999889999999999999999999 78999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
....... ....+... ...+. ...++..+.+++..||..+|++||++.+|.+.|
T Consensus 207 ~~~~~~~---~~~~~~~~-~~~~~---~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 207 SDYDNEE---IIEKLKQG-QRLPI---PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSCHHH---HHHHHHTT-EETTS---BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccc---cccccccc-cccee---ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 8764432 22333222 22221 234588999999999999999999999987754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=308.12 Aligned_cols=236 Identities=22% Similarity=0.281 Sum_probs=180.5
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||+|+||+||+|++..+++.||||++..... ......|..++..+. ...++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~------------------------~~~~p 56 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL------------------------LDESP 56 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc------------------------cCCCC
Confidence 7999999999999999999999999754211 112333444444332 00123
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
++..+.......+..|+||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~ 132 (330)
T cd05586 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DAT 132 (330)
T ss_pred cCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCC
Confidence 5556666667778899999999 8899888765 5679999999999999999999999999999999999999 478
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCChhhcH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 247 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~ 247 (449)
+.++|+|||++........ .....+||..|+|||++.+. .++.++|||||||++|||++|..||.+....
T Consensus 133 ~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-- 203 (330)
T cd05586 133 GHIALCDFGLSKANLTDNK-------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-- 203 (330)
T ss_pred CCEEEecCCcCcCCCCCCC-------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--
Confidence 8999999999875332211 12356799999999998765 4899999999999999999999999875432
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
+.+..+.......+. ...+.++.+++..||..+|.+||+.
T Consensus 204 -~~~~~i~~~~~~~~~----~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 204 -QMYRNIAFGKVRFPK----NVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred -HHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 333344333333332 2347889999999999999999953
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=296.66 Aligned_cols=257 Identities=20% Similarity=0.310 Sum_probs=197.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.++||+|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.++|++++..+.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-------------- 66 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYG-------------- 66 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEE--------------
Confidence 479999999999999999999999999999998765432 234778999999999887665543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nil 161 (449)
+...++..|+||||+ +++|.+++.. ...++...+..++.|++.||.|||+ .+++||||||+|||
T Consensus 67 -------------~~~~~~~~~lv~ey~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil 132 (308)
T cd06615 67 -------------AFYSDGEISICMEHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNIL 132 (308)
T ss_pred -------------EEeeCCEEEEEeeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEE
Confidence 334567899999999 8899999876 3668999999999999999999998 59999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ .++.++|+|||++....... .....++..|++||++.+..++.++|||||||++|+|++|+.||..
T Consensus 133 ~~---~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 133 VN---SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred Ee---cCCcEEEccCCCcccccccc---------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 94 67889999999986543322 1355788999999999888899999999999999999999999975
Q ss_pred ChhhcHHHHHH-----------------------------HHHHhhcCCCHHHh-hccChHHHHHHHHHHhCCCCCCCCC
Q 013125 242 LKAATKKQKYD-----------------------------KICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 242 ~~~~~~~~~~~-----------------------------~i~~~~~~~~~~~~-~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
.........+. .+.........+.. ....+.++++++.+||..+|++||+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 280 (308)
T cd06615 201 PDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD 280 (308)
T ss_pred cchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC
Confidence 43221111110 00000000000011 1124678999999999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 013125 292 YGFLKRLFHDLFSR 305 (449)
Q Consensus 292 ~~~l~~~l~~~~~~ 305 (449)
+.++.+ ..++..
T Consensus 281 ~~~ll~--~~~~~~ 292 (308)
T cd06615 281 LKELTK--HPFIKR 292 (308)
T ss_pred HHHHhc--Chhhhh
Confidence 988754 344443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=297.63 Aligned_cols=261 Identities=20% Similarity=0.319 Sum_probs=200.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-------CCceEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCcceeeEeec
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKIL-QGGSKIRLVVFHV 72 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l-~~~~~~~~~~~~~ 72 (449)
+-.++|+++++||+|+||.||+|++.. ....||+|++...... ..+..|+++++.+ +|++++..+.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~--- 85 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG--- 85 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE---
Confidence 456799999999999999999998642 3456999987754322 2467899999888 4776555433
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLAD 136 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~ 136 (449)
++......|+||||+ +++|.+++.... ..+++.+++.++.
T Consensus 86 ------------------------~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 141 (314)
T cd05099 86 ------------------------VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141 (314)
T ss_pred ------------------------EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHH
Confidence 334556789999999 889999886532 3488899999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||.|||++|++||||||+|||+. .++.+||+|||+++......... ......++..|+|||++.+..+
T Consensus 142 qi~~aL~~lH~~gi~H~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~ 213 (314)
T cd05099 142 QVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVY 213 (314)
T ss_pred HHHHHHHHHHHCCeeeccccceeEEEc---CCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCc
Confidence 999999999999999999999999994 67899999999998654322110 0112234567999999999889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |..||.+.... ..+..+... ... .....++.++.+++..||..+|++||++.++
T Consensus 214 ~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 214 THQSDVWSFGILMWEIFTLGGSPYPGIPVE---ELFKLLREG-HRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred CccchhhHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-CCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 999999999999999999 89999775432 222222221 111 1123457899999999999999999999999
Q ss_pred HHHHHHHHHhc
Q 013125 296 KRLFHDLFSRE 306 (449)
Q Consensus 296 ~~~l~~~~~~~ 306 (449)
.+.|.++....
T Consensus 287 l~~l~~~~~~~ 297 (314)
T cd05099 287 VEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHHh
Confidence 99998886644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=287.82 Aligned_cols=247 Identities=19% Similarity=0.245 Sum_probs=196.7
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.++|++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------------- 67 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES------------- 67 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeee-------------
Confidence 59999999999999999999998899999998764322 2347789999999998875554321
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+.......|++||++ +++|.+.+... ...+++.+++.++.|++.||+|||++|++||||||+||+
T Consensus 68 -------------~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil 134 (257)
T cd08223 68 -------------WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134 (257)
T ss_pred -------------ecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEE
Confidence 112345679999999 78998888753 446899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ ..+.++|+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 135 ~~---~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 135 LT---RTNIIKVGDLGIARVLENQCD-------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred Ee---cCCcEEEecccceEEecccCC-------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 94 788999999999987654322 12355688999999999999999999999999999999999999976
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... .....+....... .....++++.+++.+||..+|.+||++.++..
T Consensus 205 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 205 KDMN---SLVYRIIEGKLPP----MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCHH---HHHHHHHhcCCCC----CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 4332 2222233322211 22456789999999999999999999887743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=294.71 Aligned_cols=256 Identities=18% Similarity=0.303 Sum_probs=196.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+ +|++++...+......
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~------- 86 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS------- 86 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc-------
Confidence 3578999999999999999999999999999999876542 334577888888888 5776665544322110
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|++|||+ +++|.+++... ...++...++.++.||+.||.|||+.||+||||||+||
T Consensus 87 --------------~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ni 152 (282)
T cd06636 87 --------------PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152 (282)
T ss_pred --------------ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 002356789999999 67999888753 34588899999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G 235 (449)
+++ +++.++|+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|
T Consensus 153 li~---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g 222 (282)
T cd06636 153 LLT---ENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222 (282)
T ss_pred EEC---CCCCEEEeeCcchhhhhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence 994 778899999999875543221 123567899999999876 34688899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||....... .+..+.. ..+.......++.++.+++.+||..+|.+||++.+|..
T Consensus 223 ~~p~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 223 APPLCDMHPMR---ALFLIPR---NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCccccCHHh---hhhhHhh---CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 99997654321 1111111 12222223456889999999999999999999988743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=295.87 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=197.0
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.+.|++++...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~-------------- 84 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-------------- 84 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEE--------------
Confidence 479999999999999999999999899999999876543 2345788999999998887555433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+...+...|+||||+ +++|.+++.. ..++..++..++.|++.||.|||+.||+||||||+|||+
T Consensus 85 -------------~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill 149 (296)
T cd06654 85 -------------SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (296)
T ss_pred -------------EEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 334567899999999 8899998753 468999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+ .++.++|+|||++......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 150 ~---~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 150 G---MDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred c---CCCCEEECccccchhccccccc-------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 4 7789999999998764332211 12456889999999999888999999999999999999999999865
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... . .+.... .+........+..+.+++.+||..+|++||++.+|.+
T Consensus 220 ~~~~~~--~-~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 220 NPLRAL--Y-LIATNG--TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CHHHhH--H-HHhcCC--CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 432211 1 111111 1111112345788999999999999999999988755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.68 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=202.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCC---CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+-..+|.+.+.||.|+||.||+|.+... ...||||....... ...+.+|+.+++.+.|++++..++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~------ 76 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI------ 76 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE------
Confidence 4567899999999999999999987543 34689998765432 23578899999999998876654432
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.....++|||++ +++|.+++......+++..++.++.||+.||+|||+.|++|||||
T Consensus 77 ----------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~ 134 (270)
T cd05056 77 ----------------------TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134 (270)
T ss_pred ----------------------cCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 224568999999 889999997656678999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+||+++ ..+.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |
T Consensus 135 p~nili~---~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 205 (270)
T cd05056 135 ARNVLVS---SPDCVKLGDFGLSRYLEDESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLG 205 (270)
T ss_pred hheEEEe---cCCCeEEccCceeeecccccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcC
Confidence 9999995 6789999999999866543211 1122334567999999988889999999999999999886 9
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
..||.+..... ....+.. ....+ ....+|.++.+++..||..+|++||++.++.+.|.++..
T Consensus 206 ~~pf~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 206 VKPFQGVKNND---VIGRIEN-GERLP---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCCHHH---HHHHHHc-CCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99998765432 2222211 11111 224568899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=288.03 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=193.0
Q ss_pred eeecccCceeEEEEEEcCCC---ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~---~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
++||+|+||.||+|.+..++ ..||+|++..... ...+.+|+++++.+.|++++..+..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~---------------- 64 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV---------------- 64 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEE----------------
Confidence 57999999999999876554 7899998875543 3457889999999998876654432
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
...+..++|||++ +++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+|||++
T Consensus 65 ------------~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~-- 129 (257)
T cd05060 65 ------------CKGEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV-- 129 (257)
T ss_pred ------------EcCCceEEEEEeCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc--
Confidence 1245679999998 8899998875 34789999999999999999999999999999999999994
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 244 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~ 244 (449)
.++.+||+|||+++........ +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 130 -~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 130 -NRHQAKISDFGMSRALGAGSDY----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred -CCCcEEeccccccceeecCCcc----cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 7889999999999866433221 111122234568999999998899999999999999999998 9999987554
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
.. ....+.. ....+ ....++..+.+++..||..+|.+||++.+|.+.|+.+
T Consensus 205 ~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 205 AE---VIAMLES-GERLP---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HH---HHHHHHc-CCcCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 32 2222222 11111 1234578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=290.74 Aligned_cols=249 Identities=20% Similarity=0.333 Sum_probs=200.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
++|++.++||+|+||.||+|.+..+++.||+|.+........+.+|+++++.++|++++...
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~------------------ 64 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY------------------ 64 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeee------------------
Confidence 68999999999999999999998889999999987654456788999999999888755443
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
.+.......|+++|++ +++|.+++......+++..++.++.|++.||.|||+.|++||||+|+||+++
T Consensus 65 ---------~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~-- 133 (256)
T cd06612 65 ---------GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN-- 133 (256)
T ss_pred ---------eeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC--
Confidence 3334567889999999 7899999877677899999999999999999999999999999999999994
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
.++.++|+|||++........ ......++..|++||++.+..++.++||||||+++|+|++|+.||......
T Consensus 134 -~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 134 -EEGQAKLADFGVSGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred -CCCcEEEcccccchhcccCcc-------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 778999999999986654321 123455788999999999989999999999999999999999999865432
Q ss_pred cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ..+.. ...+.......++.++.+++..||..+|++||+++++..
T Consensus 206 ~~~---~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 206 RAI---FMIPN--KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhh---hhhcc--CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 211 11111 111111111234678999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=294.63 Aligned_cols=255 Identities=17% Similarity=0.252 Sum_probs=197.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++++.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.++|++++.++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~-------------- 66 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG-------------- 66 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhh--------------
Confidence 478999999999999999999998999999998764322 235788999999999887655432
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDN 159 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~--~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~N 159 (449)
++...+..++||||+ +++|..++... ...+++..+..++.||+.||+|||+ .||+||||||+|
T Consensus 67 -------------~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n 133 (286)
T cd06622 67 -------------AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133 (286)
T ss_pred -------------heecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHH
Confidence 234567889999999 88898887653 2368999999999999999999997 599999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC------CCCccchHHHHHHHHHHHH
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlG~il~el~ 233 (449)
|+++ ..+.++|+|||++........ ....++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 134 il~~---~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~ 201 (286)
T cd06622 134 VLVN---GNGQVKLCDFGVSGNLVASLA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201 (286)
T ss_pred EEEC---CCCCEEEeecCCcccccCCcc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence 9994 678999999999876543221 234678899999988544 3588999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
+|..||...........+..+.... .......++.++.+++..||..+|++||+++++.+ ..++...
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~ 268 (286)
T cd06622 202 LGRYPYPPETYANIFAQLSAIVDGD----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKY 268 (286)
T ss_pred hCCCCCCCcchhhHHHHHHHHhhcC----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--Chhhhhc
Confidence 9999997644332222222222211 11222346789999999999999999999988865 3444433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=288.02 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=200.0
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+..++|++.++||+|+||.||+|.+. .+..||+|.+..... ...+.+|+++++.++|++++.....
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~----------- 69 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV----------- 69 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEE-----------
Confidence 367899999999999999999999864 455699998765432 3467889999999999886665332
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
... ...+++|||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+|
T Consensus 70 ----------------~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n 132 (260)
T cd05073 70 ----------------VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 132 (260)
T ss_pred ----------------EcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcce
Confidence 222 5679999999 78999998753 4458889999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
|+++ ..+.++|+|||++......... ......++..|++||++....++.++|+|||||++|++++ |..|
T Consensus 133 i~i~---~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p 203 (260)
T cd05073 133 ILVS---ASLVCKIADFGLARVIEDNEYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203 (260)
T ss_pred EEEc---CCCcEEECCCcceeeccCCCcc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCC
Confidence 9994 7889999999999765432211 1123345678999999998889999999999999999998 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|.+...... ...+ ......+ .....+.++.+++.+||..+|.+||++.++.+.|+.
T Consensus 204 ~~~~~~~~~---~~~~-~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 204 YPGMSNPEV---IRAL-ERGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCHHHH---HHHH-hCCCCCC---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 987544322 2222 1122211 124567899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=289.22 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=196.4
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
-++|++.+.||+|+||.||++.. +++.||+|+.........+.+|+.+++.++|++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-------------- 68 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI-------------- 68 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEE--------------
Confidence 46899999999999999999864 77889999987655556788999999999998866654321
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
. .+..++||||+ +++|.+++.... ..++...++.++.|++.||.|||+.|++||||||+||+++
T Consensus 69 -------------~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~ 134 (254)
T cd05083 69 -------------L-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134 (254)
T ss_pred -------------c-CCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc
Confidence 2 23468999999 789999987543 3589999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
.++.++|+|||++....... .....+..|+|||.+.+..++.++|+|||||++|||++ |+.||...
T Consensus 135 ---~~~~~kl~Dfg~~~~~~~~~----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 135 ---EDGVAKVSDFGLARVGSMGV----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred ---CCCcEEECCCccceeccccC----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 67899999999997643321 12234567999999998889999999999999999997 99999875
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
..... ...+ ....... .....|..+.+++..||..+|.+||++++|...|+
T Consensus 202 ~~~~~---~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 202 SLKEV---KECV-EKGYRME---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CHHHH---HHHH-hCCCCCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 54322 2222 2222211 12456889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=294.97 Aligned_cols=257 Identities=20% Similarity=0.235 Sum_probs=197.4
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+|+.+++.++|++++.......
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------- 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV--------- 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe---------
Confidence 4689999999999999999999999999999998764322 223568999999999998666543321
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+...+..++|||+++++|.+++......+++.+++.++.||+.||.|||+.|++||||||+||+
T Consensus 77 ----------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 140 (309)
T cd07845 77 ----------------GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140 (309)
T ss_pred ----------------cCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 1233567999999988999998876677999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+. ..+.++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 141 ~~---~~~~~kL~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 141 LT---DKGCLKIADFGLARTYGLPAKP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred EC---CCCCEEECccceeeecCCccCC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 94 7789999999999876543211 123345788999999876 458999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhh----------------cCC---C---HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKK----------------VST---P---IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~----------------~~~---~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.........+....... ... + ........++++.+++..||..||.+||+++++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 765543222222111100 000 0 00111224678899999999999999999887744
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=294.22 Aligned_cols=249 Identities=17% Similarity=0.315 Sum_probs=194.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+-|++.+.||.|+||.||+|.+..++..+++|.+..... ...+.+|+++++.+.|++++....
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~--------------- 69 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD--------------- 69 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEE---------------
Confidence 346889999999999999999999999999998865432 234778999999999887555433
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++..++..++|+||+ +++|..++......+++..+..++.|++.||+|||+.|++||||||+|||+
T Consensus 70 ------------~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili- 136 (282)
T cd06643 70 ------------AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF- 136 (282)
T ss_pred ------------EEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE-
Confidence 334567889999999 778877776555679999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
+.++.++|+|||++........ ......++..|+|||++. +..++.++|||||||++|||++|.+|
T Consensus 137 --~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 137 --TLDGDIKLADFGVSAKNTRTIQ-------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred --ccCCCEEEcccccccccccccc-------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 4788999999999876543221 123456889999999874 44578899999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|...... ..+..+.... .+.......++.++.+++..||..+|.+||++.++.+
T Consensus 208 ~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 208 HHELNPM---RVLLKIAKSE--PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ccccCHH---HHHHHHhhcC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9865432 2222222211 1111112345789999999999999999999887643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=289.37 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=197.2
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----------~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ..+.+|+++++.++|++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~--------- 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY--------- 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE---------
Confidence 588999999999999999999888999999987643221 246788999999988865544
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
..++...+..++|+||+ +++|.+++.. ...++...+..++.|++.||+|||++|++||||
T Consensus 72 ------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di 132 (267)
T cd06628 72 ------------------LGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDI 132 (267)
T ss_pred ------------------EEEEEeCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccC
Confidence 33445667889999999 8899988875 456899999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
+|+||++ ++++.++|+|||+++.......... .........|+..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 133 ~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 133 KGANILV---DNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred CHHHEEE---cCCCCEEecccCCCcccccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhC
Confidence 9999999 4788999999999987653221110 01112245688999999999988899999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||...... ..+..+.... .+......+..+.+++.+||..+|.+||++.++.+
T Consensus 209 ~~p~~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 209 KHPFPDCTQL---QAIFKIGENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCCCCccHH---HHHHHHhccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 9999875432 2222222211 11222456789999999999999999999887754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=292.25 Aligned_cols=235 Identities=25% Similarity=0.377 Sum_probs=193.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+++++.+.|++++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-------------- 66 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL-------------- 66 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccce--------------
Confidence 4799999999999999999999999999999987642 123457789999999988865543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+...++..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++|++||||+|+||
T Consensus 67 -------------~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni 132 (290)
T cd05580 67 -------------YGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132 (290)
T ss_pred -------------eeEEEcCCeEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 33445677899999999 9999998876 46799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ +.++.+||+|||++....... ....+++.|++||.+.+..++.++||||||+++|+|++|..||.
T Consensus 133 li---~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 133 LL---DSDGYIKITDFGFAKRVKGRT----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred EE---CCCCCEEEeeCCCccccCCCC----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99 477899999999987654431 24568899999999988889999999999999999999999997
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
.... ......+.......+ ...+..+++++..||..+|.+|+
T Consensus 200 ~~~~---~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 200 DDNP---IQIYEKILEGKVRFP-----SFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred CCCH---HHHHHHHhcCCccCC-----ccCCHHHHHHHHHHccCCHHHcc
Confidence 6542 233333333332222 34478999999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=289.96 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=192.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~---------------- 68 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---------------- 68 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEE----------------
Confidence 689999999999999999999998999999998865432 2246789999999998875543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..++..++..|+|+||+++++.+.+......+....++.++.|++.||+|||++||+||||||+|||++
T Consensus 69 -----------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~ 137 (291)
T cd07870 69 -----------HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS 137 (291)
T ss_pred -----------EEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc
Confidence 334456678899999998888887765455688899999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
.++.++|+|||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|..||.+.
T Consensus 138 ---~~~~~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 138 ---YLGELKLADFGLARAKSIPSQT-------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ---CCCcEEEeccccccccCCCCCC-------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 7789999999998754332211 1234568899999998764 5788999999999999999999999865
Q ss_pred hhhcHHHHHHHHHHhhc-------------------------CCCHHHhhc--cChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 243 KAATKKQKYDKICEKKV-------------------------STPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~-------------------------~~~~~~~~~--~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
... .+.+..+..... .......+. ..+.++.+++..|+..||.+||+++++
T Consensus 208 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~ 285 (291)
T cd07870 208 SDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285 (291)
T ss_pred hhH--HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence 432 122222111000 000111111 125678899999999999999998776
Q ss_pred H
Q 013125 296 K 296 (449)
Q Consensus 296 ~ 296 (449)
.
T Consensus 286 l 286 (291)
T cd07870 286 L 286 (291)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=293.14 Aligned_cols=261 Identities=22% Similarity=0.273 Sum_probs=197.4
Q ss_pred CceEEeeeecccCceeEEEEEE----cCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.-|+++++||+|+||.||+|+. ..+++.||+|.+..... ...+.+|+++++.++|++++.....+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------- 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT------- 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe-------
Confidence 3469999999999999999985 35678899998764422 235788999999999988665543321
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.......++||||+ |++|.+++......+++.+++.++.||+.||+|||++|++||||||+
T Consensus 77 ------------------~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~ 138 (284)
T cd05079 77 ------------------EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 138 (284)
T ss_pred ------------------cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence 11235679999999 89999988765556899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||+++ .++.++|+|||+++........ +.......++..|+|||++.+..++.++|||||||++|||+++..|
T Consensus 139 Nil~~---~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~ 211 (284)
T cd05079 139 NVLVE---SEHQVKIGDFGLTKAIETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211 (284)
T ss_pred eEEEc---CCCCEEECCCccccccccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence 99994 6788999999999866443221 1112345677789999999988899999999999999999998766
Q ss_pred CCCChh-----------hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 239 WQGLKA-----------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 239 f~~~~~-----------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
+..... .................+ ....++..+.+++..||+.+|.+||+++++.+.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 212 ESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CccccchhhhhcccccccccHHHHHHHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 532110 000011111111111111 1234678999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.21 Aligned_cols=250 Identities=19% Similarity=0.320 Sum_probs=197.8
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|++.++||.|+||.||+|.+..+++.||+|+...... ...+..|+++++.++|++++...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------- 69 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE-------------- 69 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEE--------------
Confidence 3689999999999999999999988899999998865422 235778999999999887655544
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
........|+||||+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 70 -------------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili 136 (280)
T cd06611 70 -------------AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL 136 (280)
T ss_pred -------------EEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 334567889999999 889999887766789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+.++.++|+|||++........ ......++..|++||++. ...++.++|||||||++|||++|..
T Consensus 137 ---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 137 ---TLDGDVKLADFGVSAKNKSTLQ-------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred ---CCCCCEEEccCccchhhccccc-------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 4788999999999875433221 123456889999999875 3457889999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||...... ..+..+... ..+.-.....++.++.+++..||..+|.+||++.++.+
T Consensus 207 p~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 207 PHHELNPM---RVLLKILKS--EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CcccCCHH---HHHHHHhcC--CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 99875432 222222211 11111112345789999999999999999999887744
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.86 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=192.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+++++.++|++++..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~---------------- 68 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL---------------- 68 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeE----------------
Confidence 689999999999999999999988899999998764322 2346789999999998875543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..+....+..|+||||++++|.+++......++...++.++.|++.||+|||+.||+||||||+||++
T Consensus 69 -----------~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~- 136 (291)
T cd07844 69 -----------HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI- 136 (291)
T ss_pred -----------EEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE-
Confidence 33445677899999999889999887766678999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.++.++|+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 137 --~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 137 --SERGELKLADFGLARAKSVPSK-------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred --cCCCCEEECccccccccCCCCc-------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4778999999999875432211 1123346788999999876 45899999999999999999999999765
Q ss_pred hhhcHHHHHHHHHHhhc-------------------------CCCHHHhhccCh--HHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 243 KAATKKQKYDKICEKKV-------------------------STPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~-------------------------~~~~~~~~~~~~--~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
.... +.+..+..... ..+......... .++.+++..|+..+|++||++.++
T Consensus 208 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~ 285 (291)
T cd07844 208 TDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA 285 (291)
T ss_pred ccHH--HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence 4211 11111111000 001111111223 678899999999999999998876
Q ss_pred H
Q 013125 296 K 296 (449)
Q Consensus 296 ~ 296 (449)
.
T Consensus 286 l 286 (291)
T cd07844 286 M 286 (291)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=294.48 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=203.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+|-...|.++..||+|+||.|.+|..+.+.+.+|||+++++ .+.+-...|.++|.....+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kpp-------------- 410 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP-------------- 410 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCc--------------
Confidence 45567899999999999999999999999999999998865 22333566777665544333
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.+..+..++..-+..|+||||+ ||+|-..++. -++|.+..+..++.+|+-||-|||++|||+||||
T Consensus 411 ------------FL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK 477 (683)
T KOG0696|consen 411 ------------FLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK 477 (683)
T ss_pred ------------hHHHHHHHhhhhhheeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeecc
Confidence 3333444556678899999999 8888877775 5679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
.+|||+ +..+++||+|||+++.-.-.... ..+++||+.|+|||++...+|+.++|+||||++||||+.|+
T Consensus 478 LDNvmL---d~eGHiKi~DFGmcKEni~~~~T-------TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQ 547 (683)
T KOG0696|consen 478 LDNVML---DSEGHIKIADFGMCKENIFDGVT-------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 547 (683)
T ss_pred ccceEe---ccCCceEeeecccccccccCCcc-------eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCC
Confidence 999999 68999999999999854333221 35899999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
+||.|... .+.+..|.+.....| +.++.+..++....+...|.+|..
T Consensus 548 pPFdGeDE---~elF~aI~ehnvsyP-----KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 548 PPFDGEDE---DELFQAIMEHNVSYP-----KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CCCCCCCH---HHHHHHHHHccCcCc-----ccccHHHHHHHHHHhhcCCccccC
Confidence 99998654 467777888777776 555789999999999999999974
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.25 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=196.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+++++.++|++++..+.......
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 88 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK---- 88 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC----
Confidence 45789999999999999999999999999999999876431 1235678999999999998777654321110
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
........|+||||+.++|.+.+.. .++...+..++.||+.||+|||++||+||||||+|
T Consensus 89 -----------------~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 89 -----------------SLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred -----------------CccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 0122346799999998899887753 28999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|++ +.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 149 il~---~~~~~~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 217 (353)
T cd07850 149 IVV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217 (353)
T ss_pred EEE---CCCCCEEEccCccceeCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence 999 4778999999999986543221 12446788999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCC-------------------------HHHh-------------hccChHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTP-------------------------IEVL-------------CKSHPAEFASYFHYC 281 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~-------------~~~~~~~~~~l~~~~ 281 (449)
....... .+..+.......+ .... ....+..+.+++..|
T Consensus 218 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 294 (353)
T cd07850 218 PGTDHID---QWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294 (353)
T ss_pred CCCCHHH---HHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHH
Confidence 8654322 1222211111100 0000 112355688999999
Q ss_pred hCCCCCCCCCHHHHHH
Q 013125 282 QSLTFDQRPDYGFLKR 297 (449)
Q Consensus 282 l~~~p~~Rp~~~~l~~ 297 (449)
|..||.+||++.++..
T Consensus 295 L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 295 LVIDPEKRISVDDALQ 310 (353)
T ss_pred cCCChhhCcCHHHHhc
Confidence 9999999999888744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.63 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=197.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.+|++.++||.|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++|++++..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~--------------- 83 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD--------------- 83 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeee---------------
Confidence 57999999999999999999999999999999876432 2345788999999999887655433
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+...++..|+|+||+ +++|..++.. ..+++.+++.++.|++.||+|||+.|++||||||+||+++
T Consensus 84 ------------~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 84 ------------SFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred ------------eEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 334567889999999 8899888763 4689999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
.++.++|+|||++......... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+..
T Consensus 150 ---~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 150 ---MDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred ---CCCCEEEccCccchhccccccc-------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7889999999998765433211 124568889999999998889999999999999999999999998754
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... ..+.... .+........++.+.+++.+||..+|.+||++.+|..
T Consensus 220 ~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 220 PLRAL---YLIATNG--TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHH---HHHHhcC--CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 43221 1121111 1111122446788999999999999999999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=294.21 Aligned_cols=254 Identities=19% Similarity=0.310 Sum_probs=197.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+-..+|++.++||+|+||+||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+.
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~----------- 70 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG----------- 70 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEee-----------
Confidence 345789999999999999999999998999999998765422 345788999999999887655543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPD 158 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~ 158 (449)
+....+..|+||||+ +++|.+++.. .+.+++..+..++.|++.+|.|||+ .|++||||||+
T Consensus 71 ----------------~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ 133 (284)
T cd06620 71 ----------------AFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPS 133 (284)
T ss_pred ----------------eEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHH
Confidence 334557889999999 7888888765 4568999999999999999999997 69999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++ ++++.++|+|||++........ ....|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 134 nil~---~~~~~~~l~d~gl~~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p 201 (284)
T cd06620 134 NILV---NSRGQIKLCDFGVSGELINSIA---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201 (284)
T ss_pred HEEE---CCCCcEEEccCCcccchhhhcc---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCC
Confidence 9999 4778999999999865433221 245789999999999888999999999999999999999999
Q ss_pred CCCChhhc----HHHHHHHHHHhhcCCCHHHh-hccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAAT----KKQKYDKICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~----~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|....... ....+............... ....+.++.+++..||..||++||+++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 202 FAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred CcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 98644310 00111111111111111111 1125788999999999999999999988755
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=289.84 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=197.9
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~--------------- 65 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL--------------- 65 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCccee---------------
Confidence 69999999999999999999998999999998765432 34578899999999888755443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.+...+...++|+|+++++|.+++......+++.+++.++.||+.||+|||+.|++|+||||+||++.
T Consensus 66 ------------~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~ 133 (286)
T cd07832 66 ------------DVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS 133 (286)
T ss_pred ------------eEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc
Confidence 33355778899999999999999887667799999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
..+.++|+|||++........ +......++..|+|||++.+.. ++.++|||||||++|||++|.+||.+.
T Consensus 134 ---~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 134 ---ADGVLKIADFGLARLFSEEEP------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred ---CCCcEEEeeeeecccccCCCC------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 688999999999986654321 1123456889999999987544 689999999999999999999888765
Q ss_pred hhhcHHHHHHHHHHhhc-------------------------CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKV-------------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... +..+..... ..+........+..+.+++..||..+|.+||+++++.+
T Consensus 205 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 205 NDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CHHHH---HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 43322 222211110 00112233455788999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=287.25 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+-.+.|++.+.||.|+||.||+|.+ .++.||+|.+..... ..++.+|+.+++.++|++++..++
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~------------- 67 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG------------- 67 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEE-------------
Confidence 4467899999999999999999987 478899999876544 456889999999999887655433
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.......++|||++ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 68 --------------~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Ni 133 (256)
T cd05039 68 --------------VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNV 133 (256)
T ss_pred --------------EEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceE
Confidence 234467789999999 689999887543 3689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
+++ .++.++|+|||.++....... ....+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 134 li~---~~~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 200 (256)
T cd05039 134 LVS---EDLVAKVSDFGLAKEASQGQD----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200 (256)
T ss_pred EEe---CCCCEEEcccccccccccccc----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCC
Confidence 994 788999999999976632221 2234567999999998889999999999999999997 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
....... ....+ ...... ......|+.+.+++..||..+|++||+++++...|+.
T Consensus 201 ~~~~~~~---~~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 201 PRIPLKD---VVPHV-EKGYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCHHH---HHHHH-hcCCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 7654322 11111 111111 1123458899999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.37 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=195.0
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-------hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-------~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+|++.+.||+|+||.||+|.+..+++.||||.+...... ..+..|+++++.++|++++..+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~------------ 68 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLL------------ 68 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhh------------
Confidence 699999999999999999999989999999988654322 2356789999999888755443
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+....+..++||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 69 ---------------~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni 133 (298)
T cd07841 69 ---------------DVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133 (298)
T ss_pred ---------------heeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhE
Confidence 33345678899999999999999875444799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
++. .++.++|+|||++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|.++|
T Consensus 134 ll~---~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~ 203 (298)
T cd07841 134 LIA---SDGVLKLADFGLARSFGSPNRK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203 (298)
T ss_pred EEc---CCCCEEEccceeeeeccCCCcc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence 994 7889999999999876543211 123356788999998865 45789999999999999999998888
Q ss_pred CCChhhcHHHHHHHHHHh--------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEK--------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~--------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+................ ....+........+..+.+++..||..+|++||++.++..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 204 PGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 765543222221111000 0011112223445678999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=288.50 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=197.3
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+++++.++|++++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~---------- 70 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG---------- 70 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhc----------
Confidence 5889999999999999999999999999999886432 1235788999999999987655433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+....+..++|+|++ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+
T Consensus 71 -----------------~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ 132 (268)
T cd06630 71 -----------------ATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGA 132 (268)
T ss_pred -----------------eeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 334567889999999 8899998875 456899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++. ..+..++|+|||++........... .......++..|+|||.+.+..++.++||||+||++|+|++|..|
T Consensus 133 nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 207 (268)
T cd06630 133 NLLID--STGQRLRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207 (268)
T ss_pred HEEEc--CCCCEEEEcccccccccccccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 99994 2334799999999987654322111 012345688999999999988899999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|..............+...... .......++++.+++..||..+|++||++.++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 208 WNAEKHSNHLALIFKIASATTA---PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCcchHHHHHHHhccCCC---CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 9754433222222222111111 2222345788999999999999999999887743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=283.18 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=199.9
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++++.||.|+||.||.+++..+++.|++|.+.... ....+.+|+++++.++|++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~---------------- 64 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY---------------- 64 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEE----------------
Confidence 6999999999999999999999999999999866432 23357889999999988765544
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..++.+.+..+++|||+ +++|.+++... ...++...+..++.|++.||.|||+.|++||||+|+||+
T Consensus 65 -----------~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~ 133 (256)
T cd08221 65 -----------YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF 133 (256)
T ss_pred -----------EeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEE
Confidence 33445667889999999 88999988754 456899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+. +++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 134 ~~---~~~~~kl~d~~~~~~~~~~~~-------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 134 LT---KAGLIKLGDFGISKILGSEYS-------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred Ee---CCCCEEECcCcceEEcccccc-------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 94 678899999999987654332 12355789999999999988899999999999999999999999976
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .+....+........ ....+.++.+++..||..+|.+||+++++.+
T Consensus 204 ~~~---~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 204 TNP---LNLVVKIVQGNYTPV----VSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CCH---HHHHHHHHcCCCCCC----ccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 433 233333333222211 1455789999999999999999999888755
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=289.88 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=196.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..++|++.+.||+|+||.||+|.+..+++.||+|+...... ...+.+|+.+++.+ +|++++..+......
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-------- 87 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK-------- 87 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec--------
Confidence 45799999999999999999999999999999998765332 34578899999998 588766654432110
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
-...++..++||||+ +++|.+++.. ....++...+..++.|++.||.|||+.+++||||||+
T Consensus 88 --------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 153 (286)
T cd06638 88 --------------DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGN 153 (286)
T ss_pred --------------ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHH
Confidence 013456789999999 8899887753 2356889999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----CCCCccchHHHHHHHHHHHH
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il~el~ 233 (449)
||+++ +.+.++|+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||+
T Consensus 154 nili~---~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~ 223 (286)
T cd06638 154 NILLT---TEGGVKLVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223 (286)
T ss_pred hEEEC---CCCCEEEccCCceeecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence 99994 678899999999987643221 1234568999999998853 44788999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|+.||....... .+..+... ..+.......++.++.+++..||..+|++||++.+|.+
T Consensus 224 ~g~~p~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 224 DGDPPLADLHPMR---ALFKIPRN--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cCCCCCCCCchhH---HHhhcccc--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9999998654321 11111111 11111112234678999999999999999999988755
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=290.20 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=191.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcC-CCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQG-GSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~-~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|.+..+++.||||+..... ....+.+|+.+++.+.+ ++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~------ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE------ 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC------
Confidence 47999999999999999999999999999999876432 22457889999999965 56554433221100
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~----~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.......|+||||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 75 ----------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~ 138 (295)
T cd07837 75 ----------------KNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKP 138 (295)
T ss_pred ----------------CCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence 0012237999999987998887643 23589999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~ 236 (449)
+||+++ .+++.++|+|||++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 139 ~nil~~--~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 209 (295)
T cd07837 139 QNLLVD--KQKGLLKIADLGLGRAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209 (295)
T ss_pred HHEEEe--cCCCeEEEeecccceecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCC
Confidence 999995 2278999999999976543221 1123356788999998865 45789999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhh--------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKK--------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~--------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.||.+.........+....... ............+.++.+++..||..+|.+||+++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 210 PLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 9998755432222111100000 00011122245678899999999999999999988764
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
.
T Consensus 290 ~ 290 (295)
T cd07837 290 T 290 (295)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=289.78 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=192.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.++||+|+||.||+|.+..+++.||+|+...... ...+.+|+++++.++|++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~--------------- 65 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL--------------- 65 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhH---------------
Confidence 579999999999999999999988899999998654322 2346789999999988875443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..+...++..|+|+||+ +++|..+.. ....+++..++.++.||+.||.|||+.|++||||+|+||+
T Consensus 66 ------------~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~ 132 (286)
T cd07846 66 ------------IEVFRRKKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENIL 132 (286)
T ss_pred ------------HHhcccCCeEEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 23345677899999999 445554443 3456899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+ ++++.++|+|||++......... .....++..|+|||++.+. .++.++|||||||++|||++|.+||.
T Consensus 133 ~---~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 133 V---SQSGVVKLCDFGFARTLAAPGEV-------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred E---CCCCcEEEEeeeeeeeccCCccc-------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 9 47889999999999865443211 1245678899999998763 47889999999999999999999997
Q ss_pred CChhhcHHHHHHHHHHh-----------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEK-----------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.........+...... ....+......+++..+.+++..||..+|++||++.++.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 203 GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 65432211111111000 0001112233466889999999999999999999987744
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.58 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=197.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
-.++|++.++||.|+||.||+|.+. .++..||+|++..... ...+.+|+++++.+.|++++..++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~------- 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLG------- 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEE-------
Confidence 3578999999999999999999874 3577899998875432 235778999999998887655433
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------------CCCCHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------------RKFSLKTVLML 134 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------------~~~~~~~~~~i 134 (449)
+...+...|+|+|++ +++|.+++.... ..++...++.+
T Consensus 76 --------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 135 (288)
T cd05050 76 --------------------VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCI 135 (288)
T ss_pred --------------------EEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHH
Confidence 334566789999999 789998886421 24778889999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC
Q 013125 135 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 214 (449)
Q Consensus 135 ~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 214 (449)
+.||+.||+|||++|++||||||+||++. +++.++|+|||++......... ........+..|+|||++.+.
T Consensus 136 ~~~i~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~ 207 (288)
T cd05050 136 AKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYN 207 (288)
T ss_pred HHHHHHHHHHHHhCCeecccccHhheEec---CCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcC
Confidence 99999999999999999999999999994 7889999999998765432211 111233446779999999988
Q ss_pred CCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 215 EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 215 ~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.++.++|||||||++|||++ |..||.+.... +....+...... + .....+.++.+++.+||..+|++||++.
T Consensus 208 ~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---~~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 280 (288)
T cd05050 208 RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---EVIYYVRDGNVL-S---CPDNCPLELYNLMRLCWSKLPSDRPSFA 280 (288)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCCC-C---CCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 99999999999999999997 88899875443 222222222211 1 1234578999999999999999999999
Q ss_pred HHHHHHH
Q 013125 294 FLKRLFH 300 (449)
Q Consensus 294 ~l~~~l~ 300 (449)
++.+.|+
T Consensus 281 el~~~l~ 287 (288)
T cd05050 281 SINRILQ 287 (288)
T ss_pred HHHHHhh
Confidence 9988775
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.74 Aligned_cols=248 Identities=21% Similarity=0.372 Sum_probs=188.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHH-HHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKV-YKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~-l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.+.||+|+||.||+|.+..+++.||||.++.... ...+..|+.+ ++.+.|+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~---------------- 64 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVT---------------- 64 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeee----------------
Confidence 479999999999999999999999999999998865432 2234555554 44455665444
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPD 158 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp~ 158 (449)
+..+....+..|+||||+.++|.+++... ...+++..++.++.||+.||+|||++ +++||||||+
T Consensus 65 -----------~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ 133 (283)
T cd06617 65 -----------FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133 (283)
T ss_pred -----------eeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 33344556788999999999998887643 34689999999999999999999997 9999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC----CCCCccchHHHHHHHHHHHHh
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG----IEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwSlG~il~el~~ 234 (449)
||++ +.++.+||+|||++........ .....++..|+|||++.+ ..++.++|+|||||++|||++
T Consensus 134 nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 202 (283)
T cd06617 134 NVLI---NRNGQVKLCDFGISGYLVDSVA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202 (283)
T ss_pred HEEE---CCCCCEEEeecccccccccccc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh
Confidence 9999 4788999999999876543221 123467889999998865 456889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+.||...... .+.+..+.... .. ......++.++.+++..||..+|++||++++|..
T Consensus 203 g~~p~~~~~~~--~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 203 GRFPYDSWKTP--FQQLKQVVEEP-SP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCccccC--HHHHHHHHhcC-CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999753221 12222222211 11 1111235789999999999999999999988755
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=289.74 Aligned_cols=246 Identities=21% Similarity=0.320 Sum_probs=198.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------- 66 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-------------- 66 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeE--------------
Confidence 579999999999999999999999999999998875432 235788999999999887655433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+...+...|+|+|++ +++|.+++... .++...++.++.|++.||.|||+++++||||+|+||++
T Consensus 67 -------------~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i 131 (274)
T cd06609 67 -------------SFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL 131 (274)
T ss_pred -------------EEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 334567889999999 88999988753 78999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
++++.++|+|||+++........ .....++..|++||.+.+..++.++|||||||++|+|++|..||...
T Consensus 132 ---~~~~~~~l~d~g~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 132 ---SEEGDVKLADFGVSGQLTSTMSK-------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred ---CCCCCEEEcccccceeecccccc-------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 47889999999999877644221 23456888999999999988999999999999999999999999765
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .....+.... ... ......+.++.+++..||..+|++||+++++.+
T Consensus 202 ~~~---~~~~~~~~~~-~~~--~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 202 HPM---RVLFLIPKNN-PPS--LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred chH---HHHHHhhhcC-CCC--CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 432 2222222211 111 111226789999999999999999999888744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.95 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=187.3
Q ss_pred eeecccCceeEEEEEEc--CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
+.||+|+||.||+|.+. .++..+|+|.+..... ...+.+|+.+++.++|++++..++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~------------------ 62 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG------------------ 62 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEE------------------
Confidence 46899999999999864 3456799998765432 235778999999999988665543
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~----~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++......++||||+ +++|.+++.... ..++...++.++.|++.||+|||++|++||||||+||++
T Consensus 63 ---------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~ 133 (269)
T cd05087 63 ---------QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL 133 (269)
T ss_pred ---------EEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE
Confidence 234456789999999 789999886532 245677888999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-------CCCccchHHHHHHHHHHHHh-
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-------EQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DvwSlG~il~el~~- 234 (449)
. ..+.++|+|||+++....... +.......++..|+|||++.+. .++.++|||||||++|||++
T Consensus 134 ~---~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 134 T---ADLTVKIGDYGLSHNKYKEDY-----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred c---CCCcEEECCccccccccCcce-----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhC
Confidence 4 678999999999865432221 1112345678889999988642 35889999999999999996
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
|..||......... ...+.......+.+......+..+.+++.+|| .+|++||++++|...|
T Consensus 206 g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 206 GSQPYRHLSDEQVL--TYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CCCCCCCCChHHHH--HHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 99999765443221 11222233333333444456788999999999 6899999999997765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=285.28 Aligned_cols=253 Identities=20% Similarity=0.278 Sum_probs=192.2
Q ss_pred eeecccCceeEEEEEEcC---CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~---~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|.+.. ....||+|.+..... ...+.+|+.+++.++|++++..++.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--------------- 65 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGIC--------------- 65 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEe---------------
Confidence 468999999999998753 345799998754322 23567899999999998866654422
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
...+...++||||+ +++|.+++......++...++.++.|++.||.|||+.+++||||||+|||++
T Consensus 66 -----------~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~-- 132 (262)
T cd05058 66 -----------LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD-- 132 (262)
T ss_pred -----------ecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc--
Confidence 12345578999999 8999999876556678888999999999999999999999999999999994
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 244 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~ 244 (449)
+++.+||+|||+++......... ........++..|+|||.+.+..++.++|||||||++|||++ |.+||.....
T Consensus 133 -~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 208 (262)
T cd05058 133 -ESFTVKVADFGLARDIYDKEYYS---VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208 (262)
T ss_pred -CCCcEEECCccccccccCCccee---ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 77899999999997654322110 111224456778999999998899999999999999999999 5667766443
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
.. ....+.. ....+.+ ...|..+.+++..||..+|++||++.+|...|++++.
T Consensus 209 ~~---~~~~~~~-~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 209 FD---ITVYLLQ-GRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HH---HHHHHhc-CCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 22 2222221 1111111 3357899999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=293.31 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=195.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+..|+++++.++|++++.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~--------------- 65 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT--------------- 65 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchh---------------
Confidence 479999999999999999999999999999998875432 234778899999888776444
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+.......+..|+|||++ +++|.+++... ...++...++.++.||+.||+|||+.|++||||||+|
T Consensus 66 ------------~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 133 (316)
T cd05574 66 ------------LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133 (316)
T ss_pred ------------heeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHH
Confidence 344445677899999999 88999988753 3568999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccc----------------------cccCCCCCCCCccccccccccCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI----------------------PYRENKNLTGTARYASCNTHLGIEQS 217 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~s 217 (449)
|+++ .++.++|+|||++............ +-.......||..|+|||++.+..++
T Consensus 134 ili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 210 (316)
T cd05574 134 ILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG 210 (316)
T ss_pred eEEc---CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC
Confidence 9994 6789999999998754332111000 00011245789999999999998899
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 218 RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 218 ~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
.++|||||||++|+|++|..||.+.... ..+..+.......+.. ...+.++.+++..||..+|++||+
T Consensus 211 ~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 211 SAVDWWTLGILLYEMLYGTTPFKGSNRD---ETFSNILKKEVTFPGS---PPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred chHHHHHHHHHHHHHhhCCCCCCCCchH---HHHHHHhcCCccCCCc---cccCHHHHHHHHHHccCCHhHCCC
Confidence 9999999999999999999999875443 2333333333222211 125789999999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=287.44 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=189.8
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
|++.++||+|+||.||+|.+..+++.||+|+++.... .....+|+.++..+. |++++...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~--------------- 65 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE--------------- 65 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEE---------------
Confidence 7899999999999999999999999999998765322 223457888887775 665444332
Q ss_pred cccCCCcCeeEEecccC--CeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYGVDG--EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~--~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++.+. +..++||||+.++|.+.+......+++..++.++.||+.||+|||++|++||||||+||++
T Consensus 66 ------------~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l 133 (282)
T cd07831 66 ------------VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI 133 (282)
T ss_pred ------------EEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 33333 6789999999889998887655679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
. . +.+||+|||++........ .....++..|+|||++.. ..++.++|||||||++|||++|..||.+
T Consensus 134 ~---~-~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 134 K---D-DILKLADFGSCRGIYSKPP--------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred c---C-CCeEEEecccccccccCCC--------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 4 4 9999999999976543321 123457889999997654 4578899999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHh---------------hcCC------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEK---------------KVST------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~---------------~~~~------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....+.......+... .... .........+.++.+++..||..+|++||+++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 202 TNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 5443221111111100 0000 011222356789999999999999999999887754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=291.09 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=201.7
Q ss_pred CCceEEeeeecccCceeEEEEEEc----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
...|++.++||+|+||.||+|.+. .+++.||+|++..... ...+.+|+++++.+.|++++.....+
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~------- 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVC------- 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeee-------
Confidence 467899999999999999999864 3478899999876544 34688999999999988765543321
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
........++||||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||
T Consensus 76 ------------------~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p 137 (284)
T cd05038 76 ------------------EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAA 137 (284)
T ss_pred ------------------ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 112356789999999 8899999986555799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+||++. .++.++|+|||++......... +.......++..|++||.+.+..++.++|||||||++|||++|..
T Consensus 138 ~nil~~---~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 138 RNILVE---SEDLVKISDFGLAKVLPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred HhEEEc---CCCCEEEcccccccccccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence 999994 6789999999999876532211 111123345567999999998899999999999999999999999
Q ss_pred CCCCChhhc-----------HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 238 PWQGLKAAT-----------KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 238 pf~~~~~~~-----------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||....... ....+...+......+. ...+|.++.+++.+||..+|.+||++.+|.+.|+.+
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CcccccchhccccccccccccHHHHHHHHHcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 987533211 01112222222222221 234578999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=283.97 Aligned_cols=246 Identities=21% Similarity=0.280 Sum_probs=197.1
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+++++.++|++++...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~--------------- 65 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY--------------- 65 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhhee---------------
Confidence 6999999999999999999999999999999876532 233578899999999888755433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
......+..++|||++ +++|.+++... ...+++..++.++.|++.+|+|||++|++|+||+|+||+
T Consensus 66 ------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 133 (256)
T cd08220 66 ------------ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133 (256)
T ss_pred ------------eeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 2234567889999999 88999998754 345899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+. +++..++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||.+
T Consensus 134 ~~--~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 134 LD--KHKMVVKIGDFGISKILSSKSK--------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred Ec--CCCCEEEEccCCCceecCCCcc--------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 94 3456789999999987654321 1245688899999999988899999999999999999999999977
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... .....+...... ......+.++.+++..||..+|.+||++.++.+
T Consensus 204 ~~~~---~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 204 ANLP---ALVLKIMSGTFA----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CchH---HHHHHHHhcCCC----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 5432 222222222111 122345789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=293.85 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=196.7
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|++.++||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++|++++..+.
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~-------------- 83 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-------------- 83 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEE--------------
Confidence 479999999999999999999999899999999876543 2345778999999998887555433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+...++..|+||||+ +++|.+++.. ..++..++..++.|++.||.|||+.|++||||||+|||+
T Consensus 84 -------------~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili 148 (297)
T cd06656 84 -------------SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148 (297)
T ss_pred -------------EEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 334567889999999 8899988763 468899999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+ .++.++|+|||++......... .....+++.|++||.+.+..++.++|+|||||++|+|++|..||.+.
T Consensus 149 ~---~~~~~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 149 G---MDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred C---CCCCEEECcCccceEccCCccC-------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4 7889999999998765433211 12456888999999999988999999999999999999999999764
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... ....+... ..+........+..+.+++.+||..+|++||+++++..
T Consensus 219 ~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 219 NPLR---ALYLIATN--GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred Ccch---heeeeccC--CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4321 11111111 11111112345788999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=313.76 Aligned_cols=262 Identities=18% Similarity=0.290 Sum_probs=219.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCc---eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
|-....+|.+.||.|.||+|++|+.+..++ .||||.++..... ..|+.|+.||-.+.|+|++++.++.
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV------ 699 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV------ 699 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE------
Confidence 344567899999999999999999876554 5999999876432 2489999999999999999988765
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
...+..+||+||| .|+|..+++...+.|+..++..+++.|+.||+||-+.|+|||||.
T Consensus 700 ---------------------Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLA 758 (996)
T KOG0196|consen 700 ---------------------TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLA 758 (996)
T ss_pred ---------------------ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhh
Confidence 4567889999999 999999999888889999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
+.|||+ +.+-.+|++|||+++...++.... | ...+-.-+.+|.|||.|...+++.++||||||++|||.+. |
T Consensus 759 ARNILV---NsnLvCKVsDFGLSRvledd~~~~---y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 759 ARNILV---NSNLVCKVSDFGLSRVLEDDPEAA---Y-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred hhheee---ccceEEEeccccceeecccCCCcc---c-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 999999 588899999999999876554211 1 1112223579999999999999999999999999999886 9
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
..||..+++.+....+ +..+..|.+. .+|..+.+||..||+.|-.+||.|.+|...|.+++++.
T Consensus 832 ERPYWdmSNQdVIkaI----e~gyRLPpPm---DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 832 ERPYWDMSNQDVIKAI----EQGYRLPPPM---DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCcccccchHHHHHHH----HhccCCCCCC---CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999886544333 4455555444 34999999999999999999999999999999998765
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=280.94 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=205.7
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCch--hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP--QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~--~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
.+.||+|+|+.|--+....++..+||||+.+...+. +.++|++++...++..
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~-------------------------- 136 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHK-------------------------- 136 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCc--------------------------
Confidence 467999999999999999999999999998876544 5899999998887654
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
+|..+..|+.++..+|||||-+ ||+|+..+.. .+.|++.++.++...|+.||.|||.+||.||||||+|||-...+.-
T Consensus 137 nilqLiefFEdd~~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 137 NILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV 215 (463)
T ss_pred cHHHHHHHhcccceEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc
Confidence 5555566778899999999999 9999998886 6679999999999999999999999999999999999999655555
Q ss_pred CeEEEEeecceeeec--CCCCCccccccCCCCCCCCcccccccccc---CC--CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 169 NQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARYASCNTHL---GI--EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 169 ~~vkL~DfGla~~~~--~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~--~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
.-|||+||.+..-.. .+......| .-.+-+|++.|||||+.. +. .|+.++|+||||+|+|.|+.|.+||.|
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP--~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTP--ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCc--cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 679999998875432 222211111 223568999999999653 32 489999999999999999999999998
Q ss_pred Chhhc------------HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 242 LKAAT------------KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 242 ~~~~~------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
..+.+ ....+..|.++++.+| +.-|..++.+.++++...+..++.+|.++.++
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFP-dkdWahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFP-DKDWAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCC-hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 65432 4566777888888877 44466778889999999999999888776554
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=297.71 Aligned_cols=254 Identities=18% Similarity=0.214 Sum_probs=187.9
Q ss_pred Eeeeeccc--CceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 11 LGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 11 i~~~LG~G--~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
++++||+| +|++||++.+..+++.||+|+++.... ...+.+|+++++.++|++++..+.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~--------------- 66 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRA--------------- 66 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEE---------------
Confidence 57889999 789999999999999999999875422 224677999999999987665443
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++...+..|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 67 ------------~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~ 134 (327)
T cd08227 67 ------------TFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134 (327)
T ss_pred ------------EEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE
Confidence 335567889999999 88999998753 3458999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
. .++.++++||+.+.............-.......++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 135 ~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 135 S---VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred e---cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 4 77899999998765433211110000001123356778999999976 458999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcC-------CCH----------------------------------HHhhccChHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVS-------TPI----------------------------------EVLCKSHPAEFASYFH 279 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~-------~~~----------------------------------~~~~~~~~~~~~~l~~ 279 (449)
....... .......... .+. .......++.+.+++.
T Consensus 212 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 288 (327)
T cd08227 212 DMPATQM---LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVE 288 (327)
T ss_pred CcchhHH---HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHH
Confidence 6543211 1111110000 000 0011234568999999
Q ss_pred HHhCCCCCCCCCHHHHHH
Q 013125 280 YCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 280 ~~l~~~p~~Rp~~~~l~~ 297 (449)
.||..||++||++.++.+
T Consensus 289 ~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 289 QCLQRNPDARPSASTLLN 306 (327)
T ss_pred HHHhhCchhcCCHHHHhc
Confidence 999999999999988754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.48 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=198.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++.+|++.+.||+|+||+||+|++..+++.||||.+... .....+.+|+.+++.++|++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP------ 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc------
Confidence 568999999999999999999999999999999987642 1233567899999999999877654322110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+|+||++++|.+++.. ...++...++.++.||+.||+|||+++++||||||+||
T Consensus 77 ----------------~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Ni 139 (337)
T cd07858 77 ----------------HREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 139 (337)
T ss_pred ----------------cccccCcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 0012245799999999999888775 45799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
++ +.++.+||+|||+++....... ......++..|+|||++.. ..++.++|||||||++|+|++|+.||
T Consensus 140 l~---~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 209 (337)
T cd07858 140 LL---NANCDLKICDFGLARTTSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209 (337)
T ss_pred EE---cCCCCEEECcCccccccCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC
Confidence 99 4678999999999986543321 1124567889999998875 45899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHH-----------------------hhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKICE-----------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+.........+....+ .....+.......+++++.+++..||..+|.+||+++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell 289 (337)
T cd07858 210 PGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289 (337)
T ss_pred CCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHH
Confidence 76543221111111100 0001112223345678899999999999999999988875
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 290 ~ 290 (337)
T cd07858 290 A 290 (337)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.57 Aligned_cols=249 Identities=22% Similarity=0.234 Sum_probs=202.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----------chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
.+|.=.+.||.|..+.|-++.+..+++.+|+|++..... .+....|+.||+.+.++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP------------- 83 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHP------------- 83 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCC-------------
Confidence 567778899999999999999999999999998753311 112467888998876443
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+|-.+..+.......++|+|+| .|-|.|++.. .-.++++..+.|++|+++|++|||.++|+||||
T Consensus 84 -------------~II~l~D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDL 149 (411)
T KOG0599|consen 84 -------------YIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDL 149 (411)
T ss_pred -------------cEEEeeeeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhccc
Confidence 2333333445667789999999 8899998875 446899999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC------CCCCccchHHHHHHHH
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVL 229 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwSlG~il 229 (449)
||+|||+ +++.+++|+|||+|+....... -..+|||+.|+|||.+.- ..|+..+|+|++|+++
T Consensus 150 KpENILl---ddn~~i~isDFGFa~~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 150 KPENILL---DDNMNIKISDFGFACQLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred Chhheee---ccccceEEeccceeeccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 9999999 6899999999999987765432 247899999999998862 3589999999999999
Q ss_pred HHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 230 LYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 230 ~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|-|+.|.+||..-. ..-++.-|+++++..-.++ |.+++.+.++|+.+||+.||++|.+.++..+
T Consensus 219 yTLLaGcpPFwHRk---QmlMLR~ImeGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 219 YTLLAGCPPFWHRK---QMLMLRMIMEGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHcCCCchhHHH---HHHHHHHHHhcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 99999999998633 2344555777777665443 6677889999999999999999999887754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=308.03 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=207.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCC-C--ceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDT-N--EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~--~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+..++.++||+|+||.||+|.|..- | ..||||.+..+. ..+.|++|+.+|..|+|++.++++++..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------ 182 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------ 182 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------
Confidence 35667889999999999999998632 2 359999987653 34579999999999999999998876532
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
....||+|++ .|+|.+.+.+ ....|-......|+.||+.||.||.++++|||||..
T Consensus 183 ----------------------qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAA 240 (1039)
T KOG0199|consen 183 ----------------------QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAA 240 (1039)
T ss_pred ----------------------chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 4567999999 9999998886 345689999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~ 236 (449)
.|+|+. ....|||+||||.+-+...... |.+.....-...|.|||.+.-..++.++|||+|||++|||++ |.
T Consensus 241 RNllla---sprtVKI~DFGLmRaLg~ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGE 313 (1039)
T KOG0199|consen 241 RNLLLA---SPRTVKICDFGLMRALGENEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGE 313 (1039)
T ss_pred hhheec---ccceeeeecccceeccCCCCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCC
Confidence 999995 6889999999999876654321 223334455678999999999999999999999999999998 99
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
.||.|..+....+.++ .+...+.+.. +++++.+++..||..+|.+||+|..|.+.+
T Consensus 314 ePW~G~~g~qIL~~iD----~~erLpRPk~---csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 314 EPWVGCRGIQILKNID----AGERLPRPKY---CSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCCCHHHHHHhcc----ccccCCCCCC---ChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999988764444433 3444444444 489999999999999999999999987533
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=290.81 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=193.5
Q ss_pred ceEEeeeecccCceeEEEEEEcC--CCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVD--TNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+|.+.++||+|+||.||+|.+.. +++.||+|++... .......+|+.++..++|++++.....+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------- 72 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFL-------- 72 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEe--------
Confidence 68999999999999999999987 8899999988762 22445788999999999987665544321
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~----~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.......|+|||+++++|.+++.... ..++...++.++.||+.||.|||+++|+|||||
T Consensus 73 -----------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk 135 (316)
T cd07842 73 -----------------EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK 135 (316)
T ss_pred -----------------CCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 11237789999999889988876432 268899999999999999999999999999999
Q ss_pred CCcEEeec-CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHh
Q 013125 157 PDNFLMGL-GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 157 p~Nill~~-~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~ 234 (449)
|+|||++. ++..+.+||+|||++......... ........++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 136 p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 136 PANILVMGEGPERGVVKIGDLGLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred HHHEEEcCCCCccceEEECCCccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999952 112789999999999866443221 1123455788999999988764 57999999999999999999
Q ss_pred CCCCCCCChhhc------HHHHHHHHHHhhcCC--------------------------C----HHHh--hccChHHHHH
Q 013125 235 GSLPWQGLKAAT------KKQKYDKICEKKVST--------------------------P----IEVL--CKSHPAEFAS 276 (449)
Q Consensus 235 G~~pf~~~~~~~------~~~~~~~i~~~~~~~--------------------------~----~~~~--~~~~~~~~~~ 276 (449)
|.+||.+..... ....+..++...... + .... ....+.++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (316)
T cd07842 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291 (316)
T ss_pred cCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHH
Confidence 999998654322 111111111111000 0 0000 0134567888
Q ss_pred HHHHHhCCCCCCCCCHHHHHH
Q 013125 277 YFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 277 l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++..||..||++||++.++..
T Consensus 292 ~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 292 LLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhcCCcccCcCHHHHhc
Confidence 999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=314.79 Aligned_cols=201 Identities=19% Similarity=0.250 Sum_probs=153.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCC-CceEEEE------------------EecCC-CCchhHHHHHHHHHHHcCCC
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVK------------------IENSG-TKHPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK------------------v~~~~-~~~~~~~~E~~~l~~l~~~~ 63 (449)
.+.++|+++++||+|+||+||+|..... ++.+++| .+... .....+.+|+++++.++|++
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999876432 2122222 11111 11234678999999999887
Q ss_pred cceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh----cCCCCHHHHHHHHHHHH
Q 013125 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMI 139 (449)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~----~~~~~~~~~~~i~~qil 139 (449)
++.++ .+....+..|+|+++++++|..++... ........++.++.||+
T Consensus 225 Iv~l~---------------------------~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~ 277 (501)
T PHA03210 225 ILKIE---------------------------EILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLL 277 (501)
T ss_pred cCcEe---------------------------EEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHH
Confidence 55543 344566788999999988888776532 12345677889999999
Q ss_pred HHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCcc
Q 013125 140 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR 219 (449)
Q Consensus 140 ~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 219 (449)
.||+|||++|||||||||+|||+ +.++.+||+|||+++.+...... ......||..|+|||++.+..++.+
T Consensus 278 ~aL~yLH~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~ 348 (501)
T PHA03210 278 CAVEYIHDKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEI 348 (501)
T ss_pred HHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcH
Confidence 99999999999999999999999 47889999999999876543221 1235679999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCCC
Q 013125 220 DDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 220 ~DvwSlG~il~el~~G~~pf~ 240 (449)
+|||||||++|||++|..++.
T Consensus 349 ~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 349 TDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred HHHHHHHHHHHHHHHCCCCCc
Confidence 999999999999999876543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=289.30 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=197.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+.|+..++||.|+||.||+|.+..++..||+|++..... ...+.+|+++++.+.|++++..
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~--------------- 67 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY--------------- 67 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeE---------------
Confidence 3578899999999999999999988999999998775432 2347789999998888765444
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..++......|+||||+ +++|.+++.. ..++..++..++.|++.||+|||+.+++|+||+|+||+
T Consensus 68 ------------~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil 133 (277)
T cd06640 68 ------------YGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVL 133 (277)
T ss_pred ------------EEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEE
Confidence 44445677899999999 8899988763 56899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ +++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|||++|..||..
T Consensus 134 ~~---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 134 LS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred Ec---CCCCEEEcccccceeccCCcc-------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 94 778899999999976643321 12345678899999999988899999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....... ..+ .... .+......+..+.+++..||..+|++||++.++..
T Consensus 204 ~~~~~~~---~~~-~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 204 MHPMRVL---FLI-PKNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred cChHhHh---hhh-hcCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 5543211 111 1111 12233345788999999999999999999998854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=284.51 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=196.8
Q ss_pred eeecccCceeEEEEEEcCC---CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~---~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|.+... +..||+|++..... ...+.+|+++++.++|++++..+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~----------------- 63 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLG----------------- 63 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeee-----------------
Confidence 4799999999999999765 88999999876544 346788999999998876554433
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC--------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~--------~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+.......++||||+ +++|.+++... ...+++..++.++.||+.||+|||++|++||||||
T Consensus 64 ----------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p 133 (262)
T cd00192 64 ----------VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAA 133 (262)
T ss_pred ----------eecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCc
Confidence 334567889999999 99999998865 46799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~ 236 (449)
+||+++ .++.++|+|||.+........ +.......++..|+|||.+....++.++|||||||++|||++ |.
T Consensus 134 ~nili~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 205 (262)
T cd00192 134 RNCLVG---EDLVVKISDFGLSRDVYDDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA 205 (262)
T ss_pred ceEEEC---CCCcEEEcccccccccccccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCC
Confidence 999994 779999999999987654332 112335567889999999998889999999999999999999 69
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
.||....... ....+.. ..... .....+.++.+++..||..+|.+||++.++.+.|
T Consensus 206 ~p~~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 206 TPYPGLSNEE---VLEYLRK-GYRLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCHHH---HHHHHHc-CCCCC---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 9998864432 2222222 11111 1234478999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=286.59 Aligned_cols=248 Identities=18% Similarity=0.266 Sum_probs=185.9
Q ss_pred eeecccCceeEEEEEEcC--CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~--~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
++||+|+||.||+|.... ....+|+|.+..... ...+.+|+++++.++|++++.+++.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~----------------- 63 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQ----------------- 63 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEE-----------------
Confidence 469999999999997543 345788887654322 2246789999999998876665443
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~----~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+......|+||||+ +++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 64 ----------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill 133 (269)
T cd05042 64 ----------CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133 (269)
T ss_pred ----------ECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe
Confidence 34567789999999 889999887532 235678889999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-------CCCCCccchHHHHHHHHHHHHh-
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-------GIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwSlG~il~el~~- 234 (449)
++++.+||+|||++......... .......++..|+|||++. ...++.++|||||||++|||++
T Consensus 134 ---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 134 ---TADLSVKIGDYGLALEQYPEDYY-----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred ---cCCCcEEEeccccccccccchhe-----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhC
Confidence 47889999999998653322110 0112345577899999874 3457889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHH-HHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDK-ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
|..||....... .+.. +.......+.+.....++..+.+++..|| .||++||++++|.+.|
T Consensus 206 ~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 206 ADQPYPDLSDEQ---VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCCCcCCHHH---HHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 888997654432 2222 22233333444455667889999999999 5999999999988765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=291.98 Aligned_cols=269 Identities=23% Similarity=0.261 Sum_probs=199.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-++|++.++||+|+||.||+|.+..+++.||||++..... .....+|+++++.++|++++..........
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP------ 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc------
Confidence 4799999999999999999999999999999998754322 234678999999999998776544321110
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
...+......++|+||+++++...+......+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 81 -------------~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil 147 (311)
T cd07866 81 -------------DKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANIL 147 (311)
T ss_pred -------------ccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 0001334567999999988888887765667999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccc----cccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHI----PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~ 236 (449)
+ ++++.++|+|||++............ .........++..|+|||++.+. .++.++|||||||++|||++|+
T Consensus 148 ~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~ 224 (311)
T cd07866 148 I---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224 (311)
T ss_pred E---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCC
Confidence 9 47889999999999865443221110 00112344678889999988764 4789999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhh----------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKK----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~----------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
+||.+.......+.+....... .............+.+.+++..||..+|.+||+..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 225 PILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 9998765543333222211100 000111112234467889999999999999999877
Q ss_pred HH
Q 013125 295 LK 296 (449)
Q Consensus 295 l~ 296 (449)
+.
T Consensus 305 ll 306 (311)
T cd07866 305 AL 306 (311)
T ss_pred Hh
Confidence 64
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=298.17 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=196.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|.-...||+|+||.||+|...+ +..||||.+..... ..+|.+|+.++..++|+|++++++.|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC------------- 140 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC------------- 140 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE-------------
Confidence 467777899999999999999754 48899998876554 46699999999999999877666554
Q ss_pred cccCCCcCeeEEecccCC-eeEEEEecC-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCC
Q 013125 85 SSTLGGIPNIKWYGVDGE-DNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPD 158 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~-~~~lv~e~~-g~sL~~~~~~~~~-~~~~~~~~~i~~qil~~L~~LH~~g---iiHrDLkp~ 158 (449)
.+.+ +.+||+||+ .|+|.+.+..... .++|...++|+.+++.||+|||+.. |||||||++
T Consensus 141 --------------~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss 206 (361)
T KOG1187|consen 141 --------------LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS 206 (361)
T ss_pred --------------ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence 4555 599999999 8899999886555 8899999999999999999999943 999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecC-CCCCccccccCCCCC-CCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRD-PTTNRHIPYRENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~-~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|||+ |++...||+|||+|+.... .... ... .||..|++||.+.....+.++||||||++|.||++|+
T Consensus 207 NILL---D~~~~aKlsDFGLa~~~~~~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr 275 (361)
T KOG1187|consen 207 NILL---DEDFNAKLSDFGLAKLGPEGDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGR 275 (361)
T ss_pred HeeE---CCCCCEEccCccCcccCCccccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCC
Confidence 9999 6899999999999965543 2211 122 7999999999999888999999999999999999999
Q ss_pred CCCCCChhhcH---HHH---------HHHHHHhhcC-CCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 237 LPWQGLKAATK---KQK---------YDKICEKKVS-TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 237 ~pf~~~~~~~~---~~~---------~~~i~~~~~~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
.+.....+... ... +..+++..+. ..... ...-..+..+...|++.+|.+||++.++.+.|+.+
T Consensus 276 ~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 276 KAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD--EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred cccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCCh--HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 88775331111 111 1111111111 00000 00123477788899999999999999987777544
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.23 Aligned_cols=263 Identities=20% Similarity=0.273 Sum_probs=200.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.++|++++......
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--------- 73 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDIL--------- 73 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhc---------
Confidence 4689999999999999999999999999999999876532 233567899999999998866542211
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..........|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 74 --------------~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Ni 138 (334)
T cd07855 74 --------------RPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138 (334)
T ss_pred --------------cccCCCCceEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 111134567899999998899888764 45699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+++ +++.+||+|||++.......... . .......++..|++||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 139 l~~---~~~~~kl~dfg~~~~~~~~~~~~-~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf 212 (334)
T cd07855 139 LVN---EDCELRIGDFGMARGLSSSPTEH-K--YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212 (334)
T ss_pred EEc---CCCcEEecccccceeecccCcCC-C--cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc
Confidence 994 78899999999998764432211 0 01124578899999999876 45899999999999999999999999
Q ss_pred CCChhhcHHHHHHHH-----------------------HHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKI-----------------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i-----------------------~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+.........+... .......+...+....+.++.+++..||+.+|.+||++.++.
T Consensus 213 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 213 PGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred CCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 775432211111110 011112223334456688999999999999999999988774
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
.
T Consensus 293 ~ 293 (334)
T cd07855 293 Q 293 (334)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=286.78 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=195.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|+..++||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..++.+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----------- 69 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL----------- 69 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEE-----------
Confidence 579999999999999999999999999999998875432 335789999999999988666544321
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
....+..|+||||+ +++|.+++.. ....++...+..++.||+.||.|||+.|++|+||+|+|
T Consensus 70 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~n 135 (287)
T cd06621 70 --------------DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135 (287)
T ss_pred --------------ccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 12345689999999 8899887653 24568999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|++. .++.++|+|||++........ ....++..|++||.+.+..++.++|||||||++|+|++|..||
T Consensus 136 il~~---~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 203 (287)
T cd06621 136 ILLT---RKGQVKLCDFGVSGELVNSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203 (287)
T ss_pred EEEe---cCCeEEEeecccccccccccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9994 678899999999865443221 2345788999999999989999999999999999999999999
Q ss_pred CCChh--hcHHHHHHHHHHhhcCCCHHHhh--ccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKA--ATKKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~--~~~~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... ....+....+............. ...++.+.+++..||..+|.+||++.++.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 204 PPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 86522 11122222222111110000000 123578999999999999999999987755
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=290.32 Aligned_cols=263 Identities=24% Similarity=0.284 Sum_probs=198.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.++||+|+||.||+|.+..+++.||||++..... .....+|+++++.++|++++.....+.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT------ 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc------
Confidence 579999999999999999999999999999998754322 2235689999999999998877665432210
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+.......++||||++++|.+++......+++.+++.++.||+.||+|||++|++|+||||+||++
T Consensus 86 -------------~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~ 152 (310)
T cd07865 86 -------------PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI 152 (310)
T ss_pred -------------cccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 0122345679999999989998887655579999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+..+.+||+|||++..+........ .......++..|+|||.+.+.. ++.++||||||+++|||++|..||.+
T Consensus 153 ---~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 153 ---TKDGILKLADFGLARAFSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred ---CCCCcEEECcCCCcccccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 4788999999999987654322110 1113456788999999887654 78899999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHH--------------------------Hh-hccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIE--------------------------VL-CKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~--------------------------~~-~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
.........+..+.. ..+.. .+ .......+.+++..||..||.+||++++
T Consensus 227 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 227 NTEQHQLTLISQLCG---SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCHHHHHHHHHHHhC---CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 654333332222221 11100 00 0012356778999999999999999887
Q ss_pred HHH
Q 013125 295 LKR 297 (449)
Q Consensus 295 l~~ 297 (449)
+.+
T Consensus 304 ~l~ 306 (310)
T cd07865 304 ALN 306 (310)
T ss_pred Hhc
Confidence 643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=306.79 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=205.3
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEec------CCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN------SGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+....||+|+|-+||+|.|..+|..||.-.++ .....+++..|+.+|+.|+|+|+++++....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~----------- 111 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV----------- 111 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee-----------
Confidence 56788999999999999999999988864322 2223457899999999999999988865443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNF 160 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHrDLkp~Ni 160 (449)
........+|+|++ .|+|..+++. .++.+.+.++.|++||+.||.|||++. |||||||.+||
T Consensus 112 --------------d~~n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNI 176 (632)
T KOG0584|consen 112 --------------DTDNKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNI 176 (632)
T ss_pred --------------cCCCceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceE
Confidence 23446678999999 9999999886 567899999999999999999999985 99999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+|. ...|.|||+|+|||...+.... +.+.|||.|||||++. ..|++.+||||||+++.||+|+..||.
T Consensus 177 Fin--G~~G~VKIGDLGLAtl~r~s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 177 FVN--GNLGEVKIGDLGLATLLRKSHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred EEc--CCcCceeecchhHHHHhhcccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 996 5779999999999998876654 4679999999999998 689999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.... ..+.|.++..+..+ ..+.+-..++++++|..|+.. .++||++.+|+. ..+|..
T Consensus 245 EC~n--~AQIYKKV~SGiKP---~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~ 301 (632)
T KOG0584|consen 245 ECTN--PAQIYKKVTSGIKP---AALSKVKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDE 301 (632)
T ss_pred hhCC--HHHHHHHHHcCCCH---HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhcc
Confidence 6543 35677777665433 333344478999999999998 999999877633 444444
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=290.52 Aligned_cols=258 Identities=20% Similarity=0.287 Sum_probs=198.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.++|++++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~--------------- 65 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVS--------------- 65 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeee---------------
Confidence 479999999999999999999999999999998765421 234668888998888876444
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+...+...++.|+||||+ |++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 66 ------------~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI 132 (305)
T cd05609 66 ------------MFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132 (305)
T ss_pred ------------eEEEEecCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence 334445677889999999 8899998875 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCcc--------ccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHH
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRH--------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el 232 (449)
+++ ..+.++|+|||+++.......... ..........++..|+|||.+.+..++.++|+|||||++|||
T Consensus 133 ll~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el 209 (305)
T cd05609 133 LIT---SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEF 209 (305)
T ss_pred EEC---CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHH
Confidence 994 788999999999874321111100 000011234678899999999988899999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
++|..||.+.... +.+..+.......+.. ....+.++.+++.+||..+|++||+...+.+++.
T Consensus 210 ~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 210 LVGCVPFFGDTPE---ELFGQVISDDIEWPEG--DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HhCCCCCCCCCHH---HHHHHHHhcccCCCCc--cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 9999999865432 2333333322222221 1246889999999999999999999765555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=291.31 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=196.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
....+|++.++||+|+||+||+|.+..+++.||+|++..... ...+.+|+++++.++|++++...+.
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~-------- 83 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGC-------- 83 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEE--------
Confidence 345789999999999999999999988999999998764322 1347789999999999876655443
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+...+..|+|+||+.+++.+++......+++..+..++.||+.||.|||+.||+||||+|+
T Consensus 84 -------------------~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~ 144 (307)
T cd06607 84 -------------------YLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAG 144 (307)
T ss_pred -------------------EEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcc
Confidence 3455678999999988998888766677999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G 235 (449)
||++ ++++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++|||++|
T Consensus 145 nIl~---~~~~~~kL~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg 210 (307)
T cd06607 145 NILL---TEPGTVKLADFGSASLVSPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (307)
T ss_pred cEEE---CCCCCEEEeecCcceecCCC-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence 9999 47889999999998754322 2456788999999875 34588899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||.+..... ....+.... +.......++..+.+++..||..+|++||++.+|..
T Consensus 211 ~~p~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 211 KPPLFNMNAMS---ALYHIAQND---SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCCCCccHHH---HHHHHhcCC---CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 99998754322 111121111 111111235778999999999999999999888854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=287.76 Aligned_cols=255 Identities=18% Similarity=0.304 Sum_probs=194.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+ +|++++..+.......
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~-------- 92 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD-------- 92 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc--------
Confidence 4789999999999999999999999999999998865432 34577899999888 6777666544321110
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.......|+||||+ +++|.+++.. ....+++..++.++.|++.||+|||++|++||||||+|
T Consensus 93 --------------~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~n 158 (291)
T cd06639 93 --------------KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158 (291)
T ss_pred --------------ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 01235689999999 8899988763 34578999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-----CCCccchHHHHHHHHHHHHh
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwSlG~il~el~~ 234 (449)
|++. +++.++|+|||++......... .....|+..|+|||++... .++.++|||||||++|||++
T Consensus 159 ili~---~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~ 228 (291)
T cd06639 159 ILLT---TEGGVKLVDFGVSAQLTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228 (291)
T ss_pred EEEc---CCCCEEEeecccchhccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh
Confidence 9994 6788999999998765432211 1244688999999987643 36889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+.||...... ..+..+...... .. ......+..+.+++..||..+|++||++.+|.+
T Consensus 229 g~~p~~~~~~~---~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 229 GDPPLFDMHPV---KTLFKIPRNPPP-TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCCCCcHH---HHHHHHhcCCCC-CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999875432 222222211110 00 011234578999999999999999999888754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=286.12 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=194.2
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+|++.++||.|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~----------------- 63 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL----------------- 63 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeee-----------------
Confidence 5899999999999999999999999999999876542 23457789999999998865443
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~--~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..++...+..++||||+.++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 64 ----------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~ 133 (284)
T cd07836 64 ----------HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI 133 (284)
T ss_pred ----------eeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 33445667889999999889988887543 458999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++++.++|+|||++........ ......++..|++||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 134 ---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 134 ---NKRGELKLADFGLARAFGIPVN-------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred ---CCCCcEEEeecchhhhhcCCcc-------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4778999999999975433211 12234568899999988664 578999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcC---------------------CCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVS---------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~---------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
................... .....+....+..+.+++..||+.+|.+||++.++.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 204 TNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 5443222211111000000 0011112234678899999999999999999887743
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=287.65 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=196.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.++||+|+||.||+|.+..+++.||+|+++... ....+.+|+++++.++|++++..+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~------------- 67 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE------------- 67 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhh-------------
Confidence 58999999999999999999999999999999876432 2346789999999999887554432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++...+..++||||+++++.+.+......++...+..++.||+.||.|||+.|++||||+|+||++
T Consensus 68 --------------~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~ 133 (288)
T cd07833 68 --------------AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV 133 (288)
T ss_pred --------------eEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 234567899999999767766665555679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++++.++|+|||++......... ......++..|+|||++.+. .++.++||||||+++|+|++|.+||.+
T Consensus 134 ---~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 134 ---SESGVLKLCDFGFARALRARPAS------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred ---CCCCCEEEEeeecccccCCCccc------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 47899999999998776544321 11345678899999999888 789999999999999999999999986
Q ss_pred ChhhcHHHHHHHHHHhh------------------cCC---C--HHH-hhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKK------------------VST---P--IEV-LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~------------------~~~---~--~~~-~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....+.......+.... ... + ... .....+.++.+++..||..+|++||+++++..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 205 DSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 54432221111111000 000 0 000 11223788999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=286.06 Aligned_cols=252 Identities=22% Similarity=0.260 Sum_probs=193.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.++||.|+||+||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~--------------- 66 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL--------------- 66 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeE---------------
Confidence 579999999999999999999998999999998754322 2357789999999998875544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..+.......|+||||++++|.+.+.... ..++...+..++.||+.||+|||++|++||||+|+||+
T Consensus 67 ------------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nil 134 (294)
T PLN00009 67 ------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLL 134 (294)
T ss_pred ------------EEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEE
Confidence 33445667899999999888888876533 23688899999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+. ..++.+||+|||++........ ......++..|++||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 135 l~--~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 135 ID--RRTNALKLADFGLARAFGIPVR-------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred EE--CCCCEEEEcccccccccCCCcc-------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 95 2456799999999975433211 11234568899999988764 57899999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcC------------------------CCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVS------------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~------------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
...... .+.++...... ..........++++.+++..|+..+|++||++.++.
T Consensus 206 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 206 GDSEID---ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred CCCHHH---HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 754322 12121111000 001112234578899999999999999999988875
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 283 ~ 283 (294)
T PLN00009 283 E 283 (294)
T ss_pred c
Confidence 4
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.20 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=191.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+|+..+.||+|+||.||++.+..+++.||+|.+..... ...+.+|+.++..+. |++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~--------------- 68 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF--------------- 68 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeee---------------
Confidence 467788999999999999999999999999998764322 234678888888886 6665443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKP 157 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~----~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp 157 (449)
+.+.......+++||+++.++.++... ....++...+..++.|++.||+|||+ .|++||||||
T Consensus 69 ------------~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp 136 (288)
T cd06616 69 ------------YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKP 136 (288)
T ss_pred ------------eeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCH
Confidence 333445677899999998888776542 23569999999999999999999997 5999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC---CCCccchHHHHHHHHHHHHh
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlG~il~el~~ 234 (449)
+||+++ ..+.++|+|||++........ .....|+..|+|||++.+. .++.++|||||||++|||++
T Consensus 137 ~Nil~~---~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 205 (288)
T cd06616 137 SNILLD---RNGNIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205 (288)
T ss_pred HHEEEc---cCCcEEEeecchhHHhccCCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh
Confidence 999994 678999999999976543321 1234678899999998876 68999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+.||..... ..+.+..+...............++.++.+|+..||..+|++||++++|..
T Consensus 206 g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 206 GKFPYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCCchhcch--HHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999976431 112222222111111111122346789999999999999999999998855
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=284.19 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=192.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.++|++++.......
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------- 74 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLR------- 74 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEE-------
Confidence 468999999999999999999999999999998754321 124678999999999988665443211
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.......++++|++ +++|.+.+.. ...++...++.++.||+.||+|||+++|+||||||+
T Consensus 75 ------------------~~~~~~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ 135 (266)
T cd06651 75 ------------------DRAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGA 135 (266)
T ss_pred ------------------cCCCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 12346778999999 7899988875 456899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++ +.++.++|+|||++.......... .......++..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 136 nil~---~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~p 208 (266)
T cd06651 136 NILR---DSAGNVKLGDFGASKRLQTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208 (266)
T ss_pred HEEE---CCCCCEEEccCCCccccccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCC
Confidence 9999 477889999999997654322110 011234678899999999998899999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|...... .....+..... .+......++.+++++ .||..+|++||++++|.+
T Consensus 209 f~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 209 WAEYEAM---AAIFKIATQPT---NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ccccchH---HHHHHHhcCCC---CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 9865322 22222211111 1122233467888888 688889999999988744
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=280.79 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=189.6
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
+.||+|+||.||+|... ++..||+|++..... ...+.+|+++++.++|++++....
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------------- 59 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG-------------------- 59 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEE--------------------
Confidence 47899999999999864 678899998775432 224778999999998887555433
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
++...+..++||||+ +++|.+++......+++..++.++.|++.+|.|||++|++||||||+||+++ ++
T Consensus 60 -------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~ 129 (250)
T cd05085 60 -------VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---EN 129 (250)
T ss_pred -------EEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CC
Confidence 334556789999999 8999988876556689999999999999999999999999999999999994 78
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 247 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~ 247 (449)
+.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|++++ |..||.+......
T Consensus 130 ~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~ 203 (250)
T cd05085 130 NVLKISDFGMSRQEDDGIYS------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA 203 (250)
T ss_pred CeEEECCCccceeccccccc------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 89999999998754332211 1122344567999999998889999999999999999998 9999987644322
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
. ..+ ...... ......+..+.+++.+||..+|++||++.++.+.|
T Consensus 204 ~---~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 204 R---EQV-EKGYRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred H---HHH-HcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 1 122 111111 11234578999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=283.41 Aligned_cols=252 Identities=19% Similarity=0.284 Sum_probs=195.0
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+|++.+.||.|+||+||+|.+ .+++.||+|++..... ...+.+|+++++.++|++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~----------- 68 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYL----------- 68 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEe-----------
Confidence 588999999999999999987 4788999998764321 12467899999999887655443
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.++...+..++|+||+ +++|.+++.. ...++...+..++.|++.||+|||+.||+|+||+|+
T Consensus 69 ----------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 131 (265)
T cd06631 69 ----------------GTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGN 131 (265)
T ss_pred ----------------eEeecCCeEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHH
Confidence 3345568899999999 8899998865 456899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++ ++.+.++|+|||++........... .........++..|++||++.+..++.++|||||||++|+|++|..|
T Consensus 132 nil~---~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 207 (265)
T cd06631 132 NVML---MPNGIIKLIDFGCARRLAWVGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207 (265)
T ss_pred hEEE---CCCCeEEeccchhhHhhhhcccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCc
Confidence 9999 4788999999999876532211100 00112345689999999999998899999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|....... ....+... ....+......+.++.+++..||..+|.+||++.++..
T Consensus 208 ~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 208 LASMDRLA---AMFYIGAH--RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cccCChHH---HHHHhhhc--cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 98654322 11111111 11222234556889999999999999999999887743
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=282.43 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=192.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+++++.+.|++++...+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------- 74 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR------- 74 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec-------
Confidence 579999999999999999999999999999998753211 124677999999999887665443211
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.......++||||+ +++|.+++.. ...++...++.++.|++.||+|||++|++|+||||+
T Consensus 75 ------------------~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (265)
T cd06652 75 ------------------DPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135 (265)
T ss_pred ------------------cCCCceEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 11235678999999 8899988775 356899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||+++ .++.++|+|||++.......... .......++..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 136 nil~~---~~~~~~l~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 208 (265)
T cd06652 136 NILRD---SVGNVKLGDFGASKRLQTICLSG----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208 (265)
T ss_pred HEEec---CCCCEEECcCccccccccccccc----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence 99994 77899999999998654321110 112345688899999999988899999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|...... ..+..+...... .......+..+.+++..|| .+|.+||++++|.+
T Consensus 209 ~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 209 WAEFEAM---AAIFKIATQPTN---PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred CCccchH---HHHHHHhcCCCC---CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 9865332 222222211111 1112234577899999999 49999999887754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=286.52 Aligned_cols=246 Identities=20% Similarity=0.243 Sum_probs=188.3
Q ss_pred eeecccCceeEEEEEEcCCCc--eEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~--~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.||+|+||.||+|++.+++. .+|+|..+.... ...+.+|++++..+ +|++++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~------------------- 61 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL------------------- 61 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeE-------------------
Confidence 468999999999999987765 468887764322 23577899999998 66664443
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGF 150 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qil~~L~~LH~~gi 150 (449)
..++......++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||++|+
T Consensus 62 --------~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i 133 (270)
T cd05047 62 --------LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 133 (270)
T ss_pred --------EEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 33445566789999999 889999886432 247899999999999999999999999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHH
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~ 230 (449)
+||||||+||++ ++++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|
T Consensus 134 ~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 134 IHRDLAARNILV---GENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred eecccccceEEE---cCCCeEEECCCCCccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 999999999999 478899999999985322110 011223356799999999888999999999999999
Q ss_pred HHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 231 YFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 231 el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
||++ |..||.+..... .+..+.. ..... .....+.++.+++.+||..+|.+||++.++...|++++
T Consensus 203 el~~~g~~pf~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 203 EIVSLGGTPYCGMTCAE---LYEKLPQ-GYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHcCCCCCccccCHHH---HHHHHhC-CCCCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9997 999997754322 2222211 11111 11335788999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=285.24 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=193.4
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++++.||.|+||.||+|++..+++.||||++..... ...+.+|+++++.++|+++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-------------- 66 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD-------------- 66 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhh--------------
Confidence 48999999999999999999999999999998764322 235788999999999987665433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+..+.+..++||||+.++|..++... ...+++..++.++.|++.||+|||+.|++||||+|+||++
T Consensus 67 -------------~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill 133 (284)
T cd07860 67 -------------VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 133 (284)
T ss_pred -------------hcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 23456788999999988888887654 3568999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++++.++|+|||++........ ......++..|+|||++.+.. ++.++|||||||++|||++|+.||.+
T Consensus 134 ---~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 134 ---NTEGAIKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred ---CCCCCEEEeeccchhhcccCcc-------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4788999999999875533211 112335678899999887654 68899999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhh---------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 242 LKAATKKQKYDKICEKK---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~---------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
................. ............+.++.+++.+||..||.+||+++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 54332211111100000 00011122234567889999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=286.43 Aligned_cols=253 Identities=19% Similarity=0.313 Sum_probs=198.1
Q ss_pred CCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
.++|++++.||+|+||+||+|+... +.+.|++|........ ..+.+|+++++.++|++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~---------- 73 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRL---------- 73 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeee----------
Confidence 4789999999999999999999753 3467999987654332 458899999999998865443
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--------~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
..+.......|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++
T Consensus 74 -----------------~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~ 136 (275)
T cd05046 74 -----------------LGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA 136 (275)
T ss_pred -----------------EEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 33445567789999999 789999987533 1589999999999999999999999
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHH
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 228 (449)
||+||||||+||+++ ..+.++|+|||++........ .......++..|++||.+.+..++.++||||||++
T Consensus 137 ~i~H~dlkp~Nili~---~~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 207 (275)
T cd05046 137 RFVHRDLAARNCLVS---SQREVKVSLLSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207 (275)
T ss_pred CcccCcCccceEEEe---CCCcEEEcccccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence 999999999999994 678999999999875432211 11234456778999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 229 LLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 229 l~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
+|+|++ |..||...... ..+..+.......+. ...+|..+.+++.+||..+|.+||++.++...|.
T Consensus 208 l~~l~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 208 MWEVFTQGELPFYGLSDE---EVLNRLQAGKLELPV---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHhCCCCCccccchH---HHHHHHHcCCcCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 999998 88999765432 222222222222221 2345889999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=280.24 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=196.1
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
..+|++.+.||.|+||.||+|.+. ++..+|+|++.... ....+..|+++++.++|++++..+.
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~--------------- 66 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG--------------- 66 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEE---------------
Confidence 358999999999999999999885 46789999876543 2456889999999999887554433
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+.......|+|+||+ +++|.+++......+++..++.++.|++.+|+|||+.|++||||||+||+++
T Consensus 67 ------------~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~ 134 (256)
T cd05112 67 ------------VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG 134 (256)
T ss_pred ------------EEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc
Confidence 334556789999999 8899988876566789999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 135 ---~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 135 ---ENQVVKVSDFGMTRFVLDDQYT------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred ---CCCeEEECCCcceeecccCccc------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 7789999999999765432211 1123345678999999998889999999999999999998 99999764
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
... .....+... .....+ ...+..+.+++..||..+|++||++.++.+.|
T Consensus 206 ~~~---~~~~~~~~~-~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 206 SNS---EVVETINAG-FRLYKP---RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CHH---HHHHHHhCC-CCCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 432 222222111 111111 22478899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=294.25 Aligned_cols=272 Identities=19% Similarity=0.196 Sum_probs=197.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+.......
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~------- 75 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG------- 75 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc-------
Confidence 46899999999999999999999999999999998765432 345788999999999998776543221110
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
................|+||||++++|.+++. ...++...++.++.||+.||+|||+.||+||||||+||++
T Consensus 76 ------~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili 147 (342)
T cd07854 76 ------SDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147 (342)
T ss_pred ------cccccccccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 00000001122345689999999888888775 3568999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ .++..++|+|||++........... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 148 ~--~~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 148 N--TEDLVLKIGDFGLARIVDPHYSHKG----YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred c--CCCceEEECCcccceecCCcccccc----ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5 3456899999999976543221110 0123357889999998754 5588999999999999999999999986
Q ss_pred ChhhcHHHHHHHH-------------------H---HhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKI-------------------C---EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i-------------------~---~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
............. . ......+........+.++.+++..||..||.+||++.++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 222 AHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 5432211111000 0 001111222333456788999999999999999999887743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=287.50 Aligned_cols=269 Identities=25% Similarity=0.328 Sum_probs=215.9
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHH--HcCCCcceeeEeecchhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~--l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.|.++...++.+.||+|.||+||+|.+ .|+.||||++... +...+.+|.+|++. |+|+|+..++....-.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~----- 277 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-DERSWFRETEIYQTVMLRHENILGFIAADNKD----- 277 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-chhhhhhHHHHHHHHHhccchhhhhhhccccC-----
Confidence 466788999999999999999999998 6888999999863 45578999999976 7999987765533111
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----C---Cc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-----R---GF 150 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-----~---gi 150 (449)
.-.-...+||++|. .|+|.|++.. ..++....++++.-+++||++||. + .|
T Consensus 278 ------------------~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaI 337 (513)
T KOG2052|consen 278 ------------------NGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAI 337 (513)
T ss_pred ------------------CCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchh
Confidence 01235679999999 9999999974 779999999999999999999995 2 39
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC------CCccchHHH
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLES 224 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwS 224 (449)
.|||||..|||| .+++.+.|+|+|||...........++ .+..+||.+|||||++...- .-..+||||
T Consensus 338 AHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 338 AHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred hccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 999999999999 489999999999998887765444443 46789999999999987431 234689999
Q ss_pred HHHHHHHHHhC----------CCCCCCChhhc-HHHHHHH-HHHhhcCCCHHHhhccCh--HHHHHHHHHHhCCCCCCCC
Q 013125 225 LGYVLLYFLRG----------SLPWQGLKAAT-KKQKYDK-ICEKKVSTPIEVLCKSHP--AEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 225 lG~il~el~~G----------~~pf~~~~~~~-~~~~~~~-i~~~~~~~~~~~~~~~~~--~~~~~l~~~~l~~~p~~Rp 290 (449)
||.++||++.. ++||.+..+.+ ..+.+.+ ++..++.+.++..|+..| ..+.++|+.||..+|.-|.
T Consensus 412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl 491 (513)
T KOG2052|consen 412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL 491 (513)
T ss_pred HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence 99999999862 68998765543 2233333 456777777787787766 4688999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q 013125 291 DYGFLKRLFHDLFS 304 (449)
Q Consensus 291 ~~~~l~~~l~~~~~ 304 (449)
++-.|+..|.++..
T Consensus 492 tALriKKtl~~l~~ 505 (513)
T KOG2052|consen 492 TALRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHHHhc
Confidence 98888888877653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.93 Aligned_cols=263 Identities=18% Similarity=0.274 Sum_probs=213.2
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
++-.++..++++||+|-||+|.+|+.. ...+||+|+++..... ..|.+|+++|..|+|+|+++++++|.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~------- 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV------- 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-------
Confidence 455677889999999999999999863 3689999999876442 35899999999999999999998874
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~-~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.++..|+++||+ .|+|.+++.....+ ..-.....|+.||+.||+||.+.++|||||.+
T Consensus 606 --------------------~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~ 665 (807)
T KOG1094|consen 606 --------------------QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLAT 665 (807)
T ss_pred --------------------cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccc
Confidence 557889999999 99999999875333 35566678999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh--C
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--G 235 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~--G 235 (449)
.|+|+ +..+++||+|||+++.+-.... |+.....+-+.+|||+|.+.-.+++.++|||+||+++||+++ .
T Consensus 666 rNcLv---~~e~~iKiadfgmsR~lysg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~ 737 (807)
T KOG1094|consen 666 RNCLV---DGEFTIKIADFGMSRNLYSGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR 737 (807)
T ss_pred cceee---cCcccEEecCcccccccccCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh
Confidence 99999 5899999999999997665544 344556667889999999999999999999999999999875 7
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
..||..+.+....+....+..............-+|..+.++|..||..+-.+||+|++|...|.+
T Consensus 738 e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 738 EQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred hCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 899988776554444433333222211112223458999999999999999999999998776654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=285.72 Aligned_cols=236 Identities=25% Similarity=0.351 Sum_probs=177.5
Q ss_pred eecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccC
Q 013125 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTL 88 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (449)
.||+|+||.||+|.+..+++.||+|++..... .....+|..+++.+.... +
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~ 56 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD------------------------C 56 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCC------------------------C
Confidence 48999999999999999999999998764321 112344554444443211 1
Q ss_pred CCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCC
Q 013125 89 GGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167 (449)
Q Consensus 89 ~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~ 167 (449)
+++..+......++..++||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.
T Consensus 57 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~ 132 (279)
T cd05633 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DE 132 (279)
T ss_pred CcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CC
Confidence 23444444555677899999999 8889887764 4569999999999999999999999999999999999999 47
Q ss_pred CCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 168 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 168 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
++.++|+|||++........ ....|+..|+|||.+. +..++.++|||||||++|||++|..||.......
T Consensus 133 ~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 203 (279)
T cd05633 133 HGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203 (279)
T ss_pred CCCEEEccCCcceeccccCc---------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC
Confidence 88999999999875543221 2346899999999987 4568999999999999999999999998654332
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
... ..... ...+ ..+....+.++.+++..||..||.+||+
T Consensus 204 ~~~-~~~~~---~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 204 KHE-IDRMT---LTVN-VELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred HHH-HHHHh---hcCC-cCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 221 21111 1111 1223456789999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=282.28 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=198.3
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.++|++++..+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~------------ 68 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRI------------ 68 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeee------------
Confidence 58999999999999999999999999999998764322 23467799999999998866554321
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccC
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVH-----SRGFLHRD 154 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH-----~~giiHrD 154 (449)
....+...+++|||+ +++|.+++... ...+++..++.++.||+.||.||| +.+++|+|
T Consensus 69 -------------~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 69 -------------IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred -------------ecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 112455679999999 88999998754 457899999999999999999999 89999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+||+++ ..+.++|+|||++......... .....++..|++||++.+..++.++|+||||+++|+|++
T Consensus 136 l~p~nili~---~~~~~kl~d~g~~~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 205 (265)
T cd08217 136 LKPANIFLD---ANNNVKLGDFGLAKILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205 (265)
T ss_pred CCHHHEEEe---cCCCEEEecccccccccCCccc-------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH
Confidence 999999994 7799999999999876543221 124568899999999999889999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|..||...... .....+..... +......+..+.+++..||..+|.+||++++|.+
T Consensus 206 g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 206 LSPPFTARNQL---QLASKIKEGKF----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCcccCcCHH---HHHHHHhcCCC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 99999875422 22222222211 1223456789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=287.83 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=197.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~-------------- 66 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG-------------- 66 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhhe--------------
Confidence 468899999999999999999999999999998775432 235788999999988887554332
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nil 161 (449)
.....+..++++|++ +++|.+++......++...+..++.|++.||+|||+ .|++|+||||+||+
T Consensus 67 -------------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~ 133 (265)
T cd06605 67 -------------AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNIL 133 (265)
T ss_pred -------------eeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEE
Confidence 234557889999999 689999988655789999999999999999999999 99999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ +++.++|+|||.+........ ....++..|++||.+.+..++.++|||||||++|+|++|..||..
T Consensus 134 ~~---~~~~~~l~d~g~~~~~~~~~~---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 134 VN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred EC---CCCCEEEeecccchhhHHHHh---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 94 678999999999875543221 125678899999999998999999999999999999999999976
Q ss_pred Chh--hcHHHHHHHHHHhhcCCCHHHhhcc-ChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKA--ATKKQKYDKICEKKVSTPIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~--~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .........+... ....+... .+.++.+++..||..+|.+||++.++..
T Consensus 202 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 202 ENDPPDGIFELLQYIVNE----PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cccccccHHHHHHHHhcC----CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 421 1111222222221 11111111 5788999999999999999999888754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=282.93 Aligned_cols=246 Identities=20% Similarity=0.224 Sum_probs=197.5
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.++||+|+||.||++.+..+++.||+|.+.... ....+.+|+.+++.++|++++..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~---------------- 64 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY---------------- 64 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeee----------------
Confidence 6999999999999999999999999999999876421 23357889999999988765443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..+....++.|+|+|++ +++|.+.+... ...++..+++.++.|++.||.|||++|++|+||+|+||+
T Consensus 65 -----------~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil 133 (256)
T cd08218 65 -----------QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 133 (256)
T ss_pred -----------EeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 33345667899999999 88999888753 346899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ .++.++|+|||++......... .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 134 ~~---~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 134 LT---KDGTIKLGDFGIARVLNSTVEL-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred Ec---CCCCEEEeeccceeecCcchhh-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 94 6788999999999866443211 1234578899999999988899999999999999999999999975
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ...+..+....... .....+.++.+++..||..+|.+||++.++.+
T Consensus 204 ~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 204 GNM---KNLVLKIIRGSYPP----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCH---HHHHHHHhcCCCCC----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 432 23333333322211 22345789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=283.66 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=199.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.||.|+||+||+|.+..++..||+|++.... ....+.+|+++++.++|++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-------------- 66 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT-------------- 66 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEE--------------
Confidence 47999999999999999999998889999999986532 2345788999999998887555432
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.....+..++|+|++ +++|.+++.... ..+++..+..++.||+.||+|||+.|++||||+|+||
T Consensus 67 -------------~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni 133 (267)
T cd06610 67 -------------SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNI 133 (267)
T ss_pred -------------EEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 334567889999999 889999987542 4689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+++ +++.++|+|||++..+....... ........|+..|++||++... .++.++|+|||||++|+|++|+.||
T Consensus 134 ~~~---~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~ 207 (267)
T cd06610 134 LLG---EDGSVKIADFGVSASLADGGDRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207 (267)
T ss_pred EEc---CCCCEEEcccchHHHhccCcccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence 994 67899999999997766543221 0112355789999999998877 7899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCC-CHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVST-PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... ..+.++....... +.......+++.+.+++..||..+|++||++.+|..
T Consensus 208 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 208 SKYPPM---KVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccChh---hhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 765442 2222222221111 111112356789999999999999999999887754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=282.09 Aligned_cols=247 Identities=24% Similarity=0.323 Sum_probs=193.4
Q ss_pred eeecccCceeEEEEEEcC-CC--ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~-~~--~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
++||+|+||.||+|.+.. ++ ..||||.+..... ...+.+|+++++.++|++++..+..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~---------------- 64 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV---------------- 64 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEE----------------
Confidence 478999999999999865 33 3699998876533 3357889999999999886654332
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
... ...++|+|++ +++|.+.+.... ..+++..+..++.|++.||.|||++|++||||||+||++.
T Consensus 65 -----------~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~- 131 (257)
T cd05040 65 -----------VLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA- 131 (257)
T ss_pred -----------EcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe-
Confidence 223 6789999999 899999887644 5689999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 243 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~ 243 (449)
.++.+||+|||++......... +.......++..|++||.+.+..++.++|||||||++|||++ |..||....
T Consensus 132 --~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 132 --SDDKVKIGDFGLMRALPQNEDH----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred --cCCEEEeccccccccccccccc----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 6789999999999876543221 122234567788999999999899999999999999999998 999997654
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
... ....+.......+ .....|..+.+++..||..+|++||++.++.+.|.
T Consensus 206 ~~~---~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 206 GSQ---ILKKIDKEGERLE---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHH---HHHHHHhcCCcCC---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 432 2222222111111 12345789999999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=289.47 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=204.2
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+....++|++.++||+|+||.||+|.+..+++.||+|+++.... ...+.+|+++++.++|++++.......+...
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~- 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD- 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch-
Confidence 45567899999999999999999999998999999998865322 2346789999999999988776554322110
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
...+.......|+|+||+++++.+++......+++..++.++.||+.||.|||+.||+||||||
T Consensus 81 ----------------~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p 144 (302)
T cd07864 81 ----------------ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144 (302)
T ss_pred ----------------hhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 0011123347899999998888888776556799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~ 236 (449)
+||++ ++.+.+||+|||++......... + .....++..|++||.+.+. .++.++|||||||++|||++|+
T Consensus 145 ~nili---~~~~~~kl~dfg~~~~~~~~~~~---~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 145 SNILL---NNKGQIKLADFGLARLYNSEESR---P---YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred HHEEE---CCCCcEEeCcccccccccCCccc---c---cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999 47889999999999866543321 1 1233567889999988654 4788999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCC----------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVST----------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
+||...........+...+...... .....+...|..+.+++..||..+|.+||++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9998655443333333322111100 011223456889999999999999999999887
Q ss_pred HHH
Q 013125 295 LKR 297 (449)
Q Consensus 295 l~~ 297 (449)
+..
T Consensus 296 il~ 298 (302)
T cd07864 296 ALN 298 (302)
T ss_pred Hhc
Confidence 743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=284.12 Aligned_cols=241 Identities=28% Similarity=0.350 Sum_probs=195.1
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+|++.++||.|+||.||+|.+..+++.||+|++.... ....+.+|+++++.++|++++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~--------------- 65 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--------------- 65 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHH---------------
Confidence 5999999999999999999999899999999886432 23457889999999998875443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..+....+..|+|+||+ +++|.+.+... ..++...++.++.||+.||.|||++|++|+||+|+||+
T Consensus 66 ------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 132 (258)
T cd05578 66 ------------WYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132 (258)
T ss_pred ------------HHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 22335677899999999 88999888753 57899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ ++++.++|+|||++........ .....|+..|++||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 133 ~---~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 133 L---DEQGHVHITDFNIATKVTPDTL--------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred E---cCCCCEEEeecccccccCCCcc--------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 9 4788999999999876544321 1345678899999999988899999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
............... .........+..+.+++..||..+|.+||++
T Consensus 202 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 202 HSRTIRDQIRAKQET-----ADVLYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred CCccHHHHHHHHhcc-----ccccCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 654322222221111 1122224567899999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=279.59 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=192.1
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
++||.|+||.||+|.+.. ++.||+|+...... ...+.+|+++++.+.|++++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~---------------------- 57 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---------------------- 57 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEE----------------------
Confidence 479999999999999977 89999998765433 2357889999999988765443
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
..++......++|||++ +++|.+++......++...++.++.|++.+|.|||++|++||||||+||++ +.+
T Consensus 58 -----~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~ 129 (251)
T cd05041 58 -----IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GEN 129 (251)
T ss_pred -----EEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCC
Confidence 33445667889999999 889999887656678999999999999999999999999999999999999 478
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 247 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~ 247 (449)
+.++|+|||++.......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 130 ~~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~ 204 (251)
T cd05041 130 NVLKISDFGMSREEEGGIYTV-----SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204 (251)
T ss_pred CcEEEeeccccccccCCccee-----ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH
Confidence 899999999997654221110 0112234567999999998889999999999999999999 8999977654322
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
... .......+. ....|.++.+++.+||..+|.+||++.+|.+.|+
T Consensus 205 ~~~----~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 205 RER----IESGYRMPA---PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHH----HhcCCCCCC---CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 222 111111111 2345789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=288.71 Aligned_cols=256 Identities=21% Similarity=0.247 Sum_probs=196.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++.+.||.|+||.||+|.+..+++.||+|.++..... ..+.+|+.+++.++|++++......
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~----------- 73 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV----------- 73 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEE-----------
Confidence 5799999999999999999999989999999988654322 2356899999999988766544322
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+.+....|+|+||++++|.+++......+++..++.++.||+.||+|||++|++||||||+||++
T Consensus 74 --------------~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 74 --------------VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred --------------EecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 122337899999999889999887766679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+..+.++|+|||++......... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 140 ---~~~~~~~l~d~g~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 140 ---NNRGILKICDFGLAREYGSPLKP-------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred ---CCCCcEEEeecCceeeccCCccc-------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 47789999999999876554211 12345688999999987654 68999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcC-------------------C---CHHHhhcc--ChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVS-------------------T---PIEVLCKS--HPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~-------------------~---~~~~~~~~--~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+...+..... . ........ .++.+.+++..||..+|++||++.++..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 210 KSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 5543322222111110000 0 00001111 3677999999999999999999887743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=283.54 Aligned_cols=240 Identities=15% Similarity=0.188 Sum_probs=179.0
Q ss_pred eeecccCceeEEEEEEcC------------CCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 13 RKIGSGSFGEIFLASHVD------------TNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~------------~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+.||+|+||.||+|+... ....||+|++..... ...+..|+.+++.++|++++..++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~--------- 71 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYG--------- 71 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEE---------
Confidence 468999999999998532 223589998765422 224677888889898887655443
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++......++||||+ +++|..++......++...++.++.||+.||+|||++||+||||||
T Consensus 72 ------------------~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 133 (262)
T cd05077 72 ------------------VCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCT 133 (262)
T ss_pred ------------------EEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCc
Confidence 344556779999999 6777777665556799999999999999999999999999999999
Q ss_pred CcEEeecCC----CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-CCCCCccchHHHHHHHHHHH
Q 013125 158 DNFLMGLGR----KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 158 ~Nill~~~~----~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il~el 232 (449)
+|||+.... ....++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||
T Consensus 134 ~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el 202 (262)
T cd05077 134 KNILLAREGIDGECGPFIKLSDPGIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202 (262)
T ss_pred ccEEEecCCccCCCCceeEeCCCCCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence 999995211 1124899999998654321 2345788899999887 46689999999999999999
Q ss_pred H-hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 233 L-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 233 ~-~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
+ .|..||......... ......... ....+.++.+++..||..||.+||++.+|.+.|
T Consensus 203 ~~~~~~p~~~~~~~~~~----~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 203 CYNGEIPLKDKTLAEKE----RFYEGQCML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhCCCCCCCCcchhHHH----HHHhcCccC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 8 588988764432211 111111111 112357899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.79 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=197.3
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++++|++.+.||.|+||.||+|.+..+++.||+|.+... .....+..|+++++.++|++++.....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~---------- 77 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI---------- 77 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee----------
Confidence 678999999999999999999999999999999976532 123457789999999999886654332
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.......|+++|+++++|..++. ...++...+..++.||+.||.|||++||+||||+|+||
T Consensus 78 ----------------~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Ni 139 (328)
T cd07856 78 ----------------FISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNI 139 (328)
T ss_pred ----------------EecCCCcEEEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 122345789999999999988775 35688899999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
++ ++.+.++|+|||++....... ....++..|++||.+.+ ..++.++|||||||++|+|++|..||
T Consensus 140 li---~~~~~~~l~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f 206 (328)
T cd07856 140 LI---NENCDLKICDFGLARIQDPQM----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206 (328)
T ss_pred eE---CCCCCEEeCccccccccCCCc----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99 478899999999987543211 24467889999998876 56899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHH-----------------------HhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKIC-----------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+.........+.+.. ......+........+.++.+++..||..+|++||++.++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 8754322211111110 01112233444556788999999999999999999988774
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
.
T Consensus 287 ~ 287 (328)
T cd07856 287 A 287 (328)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=283.71 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=196.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|++.+.||.|+||.||+|.+..+++.|++|++..... .+.+.+|+.+++.+ .|++++..+........
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~------- 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP------- 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC-------
Confidence 5899999999999999999999988899999999875433 34678899999998 58876666554322100
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
...+...|+||||+ +++|.+++... ...++...++.++.|++.||+|||++|++|+||+|+|
T Consensus 78 --------------~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~n 143 (275)
T cd06608 78 --------------PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQN 143 (275)
T ss_pred --------------CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHH
Confidence 02356689999999 78999887653 3679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----CCCCccchHHHHHHHHHHHHh
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il~el~~ 234 (449)
|+++ +++.++|+|||++........ ......++..|+|||++.. ..++.++|||||||++|+|++
T Consensus 144 i~~~---~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 144 ILLT---KNAEVKLVDFGVSAQLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred EEEc---cCCeEEECCCccceecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 9994 678999999999876543221 1234568899999998754 346889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|..||...... .....+...... .. .....++.++.+++..||..||.+||++.+|.+
T Consensus 214 g~~p~~~~~~~---~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 214 GKPPLCDMHPM---RALFKIPRNPPP-TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCccccchH---HHHHHhhccCCC-CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999764332 122222211111 00 011235678999999999999999999988754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=283.02 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=195.2
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----C--------chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----K--------HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~--------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+|.+.+.||.|+||.||+|.+..+++.||+|.+.... . .+.+..|+++++.++|++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-------- 73 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQY-------- 73 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceE--------
Confidence 6999999999999999999998899999999765321 0 1235678888888888765443
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
..++...+..++||||+ +++|.+++... ..++...++.++.||+.||.|||++|++|||
T Consensus 74 -------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 133 (272)
T cd06629 74 -------------------LGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRD 133 (272)
T ss_pred -------------------EEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecC
Confidence 34445667889999999 89999988764 5789999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC--CCccchHHHHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYF 232 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il~el 232 (449)
|+|+||++ +.++.++|+|||++......... .......++..|+|||++.... ++.++|+||||+++||+
T Consensus 134 l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 134 LKADNLLV---DADGICKISDFGISKKSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred CChhhEEE---cCCCeEEEeeccccccccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHH
Confidence 99999999 47889999999998764332111 0123456889999999988655 78999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhh-cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKK-VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|..||...... .....+.... ...........++.++.+++..||..+|++||+++++.+
T Consensus 206 ~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 206 FAGRRPWSDEEAI---AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HhCCCCCcCcchH---HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 9999999654322 2222221111 111123344566889999999999999999999888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=293.50 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=200.6
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~ 76 (449)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+|+.+++.+ +|++++..++.+.
T Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~---- 77 (337)
T cd07852 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK---- 77 (337)
T ss_pred CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeec----
Confidence 456779999999999999999999999888999999976432 2233467899999999 8887666543221
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
..+....|+|||++.++|..++.. ..+++..++.++.||+.||+|||++||+|||||
T Consensus 78 ---------------------~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~ 134 (337)
T cd07852 78 ---------------------AENDKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLK 134 (337)
T ss_pred ---------------------cCCCceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 123456899999998899888764 378899999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G 235 (449)
|+||++ +.++.++|+|||++........... ........|+..|++||++.+ ..++.++|||||||++|+|++|
T Consensus 135 p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg 209 (337)
T cd07852 135 PSNILL---NSDCRVKLADFGLARSLSELEENPE--NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209 (337)
T ss_pred HHHEEE---cCCCcEEEeeccchhcccccccccc--CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhC
Confidence 999999 4788999999999987654332110 011234568999999998765 4578999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHH-----------------------HhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 236 SLPWQGLKAATKKQKYDKIC-----------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
+.||.+.........+.... ......+.......++.++.+++..||..+|++||++
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~ 289 (337)
T cd07852 210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289 (337)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH
Confidence 99997654332211111110 0011112233344568899999999999999999998
Q ss_pred HHHHH
Q 013125 293 GFLKR 297 (449)
Q Consensus 293 ~~l~~ 297 (449)
.++.+
T Consensus 290 ~~il~ 294 (337)
T cd07852 290 EEALE 294 (337)
T ss_pred HHHhh
Confidence 88755
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=305.06 Aligned_cols=209 Identities=23% Similarity=0.378 Sum_probs=175.4
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC---CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+.-|...+.||+|+||.||+++++.+|+.||||.++.. ...+...+|++++++|+|+|++..+++-...
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~-------- 83 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK-------- 83 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc--------
Confidence 35577889999999999999999999999999998763 4456789999999999999998876543221
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~--~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
..+.-...-++||||| ||+|...+... ...+++.+++.++..+..||.|||++||+||||||.|
T Consensus 84 -------------~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~N 150 (732)
T KOG4250|consen 84 -------------FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGN 150 (732)
T ss_pred -------------ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Confidence 1112345668999999 99999998753 2459999999999999999999999999999999999
Q ss_pred EEeecCCCC-CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCC
Q 013125 160 FLMGLGRKA-NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 160 ill~~~~~~-~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
|++-.+.+. -.-||+|||.|+...+... ..+++||..|++||++.. ..|+..+|.|||||++|+++||..
T Consensus 151 Ivl~~Gedgq~IyKLtDfG~Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l 222 (732)
T KOG4250|consen 151 IVLQIGEDGQSIYKLTDFGAARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL 222 (732)
T ss_pred EEEeecCCCceEEeeecccccccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence 998665433 3457999999998876653 358999999999999884 789999999999999999999999
Q ss_pred CCCCCh
Q 013125 238 PWQGLK 243 (449)
Q Consensus 238 pf~~~~ 243 (449)
||....
T Consensus 223 PF~p~~ 228 (732)
T KOG4250|consen 223 PFIPFG 228 (732)
T ss_pred CCCcCC
Confidence 996543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=289.62 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=195.7
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+.|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.+.|++++....
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------- 69 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG------------- 69 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhc-------------
Confidence 3568888999999999999999988899999998764332 234778999999998887555433
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++...+..|+||||+ +++|.+++. ...++...++.++.||+.||.|||++|++|+||+|+||+
T Consensus 70 --------------~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~ 133 (277)
T cd06642 70 --------------SYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVL 133 (277)
T ss_pred --------------ccccCCceEEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEE
Confidence 334567789999999 788888775 456899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+. +++.++|+|||++........ ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 134 i~---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 134 LS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred Ee---CCCCEEEccccccccccCcch-------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 94 678999999999876543221 11345678899999999998899999999999999999999999976
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... ...+.. .. ........+.++.+++..||..+|++||++.++..
T Consensus 204 ~~~~~~---~~~~~~-~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 204 LHPMRV---LFLIPK-NS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cchhhH---Hhhhhc-CC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 543221 111111 11 11222345788999999999999999999998865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.89 Aligned_cols=231 Identities=23% Similarity=0.279 Sum_probs=186.9
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+|+++.+||.+....|+|-|++|..|.|..-+..|||||+.+.. .+..-+.|++||++|+.......+
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~----------- 494 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKF----------- 494 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhh-----------
Confidence 47889999999999999999999999999888899999998754 355578999999999866532211
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~--~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++..+.-.+...+|+|||+|.+..+|.++++..++. +.+..+..|+.||..||..|-.+||+|.||||
T Consensus 495 ----------Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKP 564 (752)
T KOG0670|consen 495 ----------HCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKP 564 (752)
T ss_pred ----------HHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCc
Confidence 111121123456899999999999999999976654 78899999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+||||. .....+||||||.|........ . .+..+..|.|||+++|.+|+...|+||.||+||||.||+.
T Consensus 565 DNiLVN--E~k~iLKLCDfGSA~~~~enei---t------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkI 633 (752)
T KOG0670|consen 565 DNILVN--ESKNILKLCDFGSASFASENEI---T------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKI 633 (752)
T ss_pred cceEec--cCcceeeeccCccccccccccc---c------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccce
Confidence 999996 4567899999999976654332 2 3345678999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHh
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVL 266 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 266 (449)
.|.|..+. +++...++.+..+|-..+
T Consensus 634 lFpG~TNN---~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 634 LFPGRTNN---QMLRLFMELKGKFPNKML 659 (752)
T ss_pred ecCCCCcH---HHHHHHHHhcCCCcHHHh
Confidence 99997665 344444555555654433
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.15 Aligned_cols=247 Identities=19% Similarity=0.307 Sum_probs=193.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|....+||.|+||.||+|.+..++..||||.+.... ....+.+|+.+++.++|++++..+.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~--------------- 86 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--------------- 86 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHH---------------
Confidence 45666788999999999999998899999999876432 2335778999999999887655432
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
....++..|+||||+ +++|.+++. ...++...++.++.||+.||+|||++||+||||||+||+++
T Consensus 87 ------------~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~ 152 (292)
T cd06658 87 ------------SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152 (292)
T ss_pred ------------heecCCeEEEEEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 224567889999999 778888765 34689999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
+++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 153 ---~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 153 ---SDGRIKLSDFGFCAQVSKEVP-------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred ---CCCCEEEccCcchhhcccccc-------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999875433221 1234568899999999998889999999999999999999999998654
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .+..+.. ....... .....+..+.+++..||..+|.+||+++++.+
T Consensus 223 ~~~---~~~~~~~-~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 223 PLQ---AMRRIRD-NLPPRVK-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred HHH---HHHHHHh-cCCCccc-cccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 322 2222211 1111111 11234678999999999999999999988755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=286.64 Aligned_cols=240 Identities=18% Similarity=0.246 Sum_probs=181.7
Q ss_pred eeecccCceeEEEEEEcCCCc-------eEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 13 RKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~-------~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.||+|+||.||+|.+...+. .||+|+...... ...+..|+.+++.+.|++++...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~-------------- 66 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYG-------------- 66 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheee--------------
Confidence 479999999999998865443 488888754322 235778889999998887655443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+...+...++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 67 -------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili 133 (258)
T cd05078 67 -------------VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLL 133 (258)
T ss_pred -------------EEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 334456789999999 889999987666678999999999999999999999999999999999999
Q ss_pred ecCC-----CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhC-
Q 013125 163 GLGR-----KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRG- 235 (449)
Q Consensus 163 ~~~~-----~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G- 235 (449)
+..+ ....++++|||++...... ....++..|+|||++.+. .++.++|||||||++|||++|
T Consensus 134 ~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 202 (258)
T cd05078 134 IREEDRKTGNPPFIKLSDPGISITVLPK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG 202 (258)
T ss_pred ecccccccCCCceEEecccccccccCCc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCC
Confidence 6321 1124799999998654321 245678899999999874 479999999999999999998
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
..||......... .+.......| .....++.+++..||+.+|++||++++|.+.|
T Consensus 203 ~~~~~~~~~~~~~----~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 203 DKPLSALDSQKKL----QFYEDRHQLP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCChhhccHHHHH----HHHHccccCC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 4666554332211 1222222222 22346899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=279.49 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=202.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|++.+..++|++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~--------------- 65 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY--------------- 65 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEE---------------
Confidence 478999999999999999999999999999998876533 44688899999999888655543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nil 161 (449)
.+....+..++|+||+ +++|.+++.. ...++...++.++.|++.||+|||+ .|++||||+|+||+
T Consensus 66 ------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~ 132 (264)
T cd06623 66 ------------GAFYKEGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132 (264)
T ss_pred ------------EEEccCCeEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEE
Confidence 3345567899999999 7999999876 3679999999999999999999999 99999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ +.++.++|+|||++......... .....++..|++||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 133 ~---~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 202 (264)
T cd06623 133 I---NSKGEVKIADFGISKVLENTLDQ-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP 202 (264)
T ss_pred E---CCCCCEEEccCccceecccCCCc-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9 47889999999999866543321 1244678899999999998899999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhcc-ChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.......+....+.... ....... ++..+.+++..||..+|++||++.++.+
T Consensus 203 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 203 PGQPSFFELMQAICDGP----PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ccccCHHHHHHHHhcCC----CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 64322233333333221 1222233 6889999999999999999999988865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=284.19 Aligned_cols=249 Identities=20% Similarity=0.315 Sum_probs=189.7
Q ss_pred eeecccCceeEEEEEEcCCC------ceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 13 RKIGSGSFGEIFLASHVDTN------EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~------~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.||+|+||.||+|++.... +.||+|.+.... ....+.+|+++++.++|++++..++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------- 66 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLG-------------- 66 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEee--------------
Confidence 46899999999999986544 679999876432 2345788999999999987665443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~------~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
++......++|||++ +++|.+++... ...+++.+++.++.||+.||+|||+++++|+|||
T Consensus 67 -------------~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 133 (269)
T cd05044 67 -------------VCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133 (269)
T ss_pred -------------eecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 234456789999999 89999888642 1347889999999999999999999999999999
Q ss_pred CCcEEeecCC--CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 157 PDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 157 p~Nill~~~~--~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|+||++...+ ....++|+|||++......... .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 134 p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 208 (269)
T cd05044 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208 (269)
T ss_pred hheEEEecCCCCCCcceEECCccccccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHH
Confidence 9999995221 1238999999999765433211 11223455788999999999999999999999999999998
Q ss_pred -CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 235 -GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 235 -G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
|..||....... ....+... .... .....|..+.+++.+||..+|.+||+++++.+.|+
T Consensus 209 ~g~~p~~~~~~~~---~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 209 LGQQPYPALNNQE---VLQHVTAG-GRLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCCCCcccCHHH---HHHHHhcC-CccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 999997654432 22222111 1111 12345789999999999999999999999988765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=283.72 Aligned_cols=227 Identities=25% Similarity=0.332 Sum_probs=182.3
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecC---CCCc-hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKH-PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~---~~~~-~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
..+.|.-..+||+|.||+||+|+...+++.||+|+.-- .+.. ....+|+++|+.|+|++.+.++..|....
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~----- 89 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA----- 89 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc-----
Confidence 35678889999999999999999999999999985432 2222 23689999999999999877655443221
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+. ..+...+|+|+++|..+|.-++.....+|+..++..++.+++.||.|+|...|+|||+|++|+
T Consensus 90 ----------Tp~----~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNv 155 (376)
T KOG0669|consen 90 ----------TPT----NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANV 155 (376)
T ss_pred ----------CCc----ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhE
Confidence 000 013345899999999999999877667899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ .++.+||+|||+++.+.........- ....+.|.+|++||.++|. .|+...|||..||++.||++|++.+
T Consensus 156 LIt---~dgilklADFGlar~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 156 LIT---KDGILKLADFGLARAFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred EEc---CCceEEeeccccccceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence 994 78999999999998776554332211 2456779999999998876 4899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICE 256 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~ 256 (449)
++.........+..+++
T Consensus 230 qgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 230 QGNTEQQQLHLISQLCG 246 (376)
T ss_pred cCChHHHHHHHHHHHhc
Confidence 99877655555554443
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.73 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=195.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
....|...+.||+|+||.||+|++..++..||+|++..... ...+.+|+++++.++|++++...+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~---------- 92 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG---------- 92 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEE----------
Confidence 34568899999999999999999998999999998764322 124778999999999887655443
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+....+..++||||+.++|.+++......+++.++..++.||+.||.|||++||+||||+|+|
T Consensus 93 -----------------~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~N 155 (317)
T cd06635 93 -----------------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGN 155 (317)
T ss_pred -----------------EEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCccc
Confidence 334566789999999889988887667779999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|++ +.++.++|+|||++...... ....++..|+|||++. ...++.++|||||||++|||++|.
T Consensus 156 il~---~~~~~~kl~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 221 (317)
T cd06635 156 ILL---TEPGQVKLADFGSASIASPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221 (317)
T ss_pred EEE---CCCCCEEEecCCCccccCCc-----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC
Confidence 999 47789999999998643321 2456788999999874 345889999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||...... .....+........ .....+..+.+++.+||..+|.+||++.++.+
T Consensus 222 ~p~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 222 PPLFNMNAM---SALYHIAQNESPTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred CCCCCccHH---HHHHHHHhccCCCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 999875332 22222222222111 12334678999999999999999999988765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=274.04 Aligned_cols=265 Identities=21% Similarity=0.340 Sum_probs=203.6
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh---HHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~---~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
.+++.-||.|+.|+||+++...+|...|||.+....+.++ ++..+.++-+-
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s-------------------------- 147 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKS-------------------------- 147 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhc--------------------------
Confidence 3467789999999999999999999999998876555433 33333333221
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp~Nill~~ 164 (449)
.+.++|+....|+.....+++.||+|+.-+..+++...+++++..+-++..-++.||.||.++ ||||||+||+|||+
T Consensus 148 ~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl-- 225 (391)
T KOG0983|consen 148 HDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL-- 225 (391)
T ss_pred cCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE--
Confidence 123356666677777888899999998888888887778899999999999999999999985 89999999999999
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
|+.|.+||+|||+|-++.+.... ..-.|-+.|||||.+. ...|+.++||||||++++||+||+.||.+
T Consensus 226 -De~GniKlCDFGIsGrlvdSkAh--------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 226 -DERGNIKLCDFGISGRLVDSKAH--------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred -ccCCCEEeecccccceeeccccc--------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 69999999999999887765442 3557889999999876 34599999999999999999999999998
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccc
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 316 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw 316 (449)
.+. ..+.+.++++. .+ |.-....++++.|.+++..||..|+.+||.|.+|.+ +.++...+....+.-+|
T Consensus 297 c~t--dFe~ltkvln~-eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~a~~dVa~W 365 (391)
T KOG0983|consen 297 CKT--DFEVLTKVLNE-EP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYETAEVDVASW 365 (391)
T ss_pred CCc--cHHHHHHHHhc-CC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc--CcceeecchhhccHHHH
Confidence 543 23455555552 22 221122347899999999999999999999998755 34433333333444555
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=279.43 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=195.1
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-------CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+|+..+.||+|+||.||+|.+..+++.|++|++.... ....+.+|+++++.++|++++...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~------------ 68 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYL------------ 68 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchhee------------
Confidence 6889999999999999999998889999999876432 223577899999999888755443
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.+...+...++++||+ +++|.+++.. ...++...++.++.||+.||.|||+.|++|+||+|+|
T Consensus 69 ---------------~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~n 132 (258)
T cd06632 69 ---------------GTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGAN 132 (258)
T ss_pred ---------------eeEecCCeEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 3345667889999999 7899988875 3468999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~p 238 (449)
|++. .++.+||+|||++........ .....++..|++||.+.... ++.++|+|||||++|+|++|..|
T Consensus 133 i~~~---~~~~~kl~d~~~~~~~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p 201 (258)
T cd06632 133 ILVD---TNGVVKLADFGMAKQVVEFSF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201 (258)
T ss_pred EEEC---CCCCEEEccCccceecccccc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 9994 788999999999876543321 23556889999999988766 89999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|...... .....+.... .........++.+.+++.+||..+|.+||+++++..
T Consensus 202 f~~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 202 WSQLEGV---AAVFKIGRSK---ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cccCcHH---HHHHHHHhcc---cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 9765422 2222221111 111223445788999999999999999999887743
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=283.09 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=193.6
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
|++.++||.|++|+||+|.+..++..||+|++..... ...+.+|+++++.++|++++..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~---------------- 64 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL---------------- 64 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHh----------------
Confidence 6889999999999999999998999999998764421 23577899999999988755433
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.++..++..|+++||++++|.+++.... ..+++..++.++.|++.||+|||+++++||||+|+||+++
T Consensus 65 -----------~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~ 133 (283)
T cd07835 65 -----------DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID 133 (283)
T ss_pred -----------heeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc
Confidence 3345668899999999889998887543 3689999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+++.++|+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|++|.+||.+.
T Consensus 134 ---~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 134 ---REGALKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred ---CCCcEEEeecccccccCCCcc-------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 688999999999975432211 11233568899999988764 4789999999999999999999999875
Q ss_pred hhhcHHHHHHHHHHhh------------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKK------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~------------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....... .+.... ............+..+.+++.+||+.+|.+||+++++..
T Consensus 204 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 204 SEIDQLF---RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CHHHHHH---HHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 4432111 111110 011122233456788999999999999999999887743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=281.94 Aligned_cols=239 Identities=18% Similarity=0.246 Sum_probs=183.7
Q ss_pred eeecccCceeEEEEEEcCCC----------ceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 13 RKIGSGSFGEIFLASHVDTN----------EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~----------~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.||+|+||.||+|.+..++ ..|++|+...... ...+.+|+.+++.++|++++..++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~----------- 69 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGV----------- 69 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeE-----------
Confidence 47899999999999997766 3588888765443 4568889999999998876655432
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.. ...++||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+||
T Consensus 70 ----------------~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 70 ----------------CVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred ----------------Eec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 223 5568999999 8899988876555799999999999999999999999999999999999
Q ss_pred EeecCC----CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC--CCCccchHHHHHHHHHHHHh
Q 013125 161 LMGLGR----KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 161 ll~~~~----~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlG~il~el~~ 234 (449)
|++... ....++|+|||++...... ....++..|+|||++.+. .++.++|||||||++|||++
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~ 201 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201 (259)
T ss_pred EEecCccccCCceeEEeCCCCcccccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence 996221 1127999999999765431 234566789999999876 78999999999999999999
Q ss_pred -CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 235 -GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 235 -G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
|..||...........+ ......+.+ ....+.+++..||..+|.+||++.++.+.|
T Consensus 202 ~~~~p~~~~~~~~~~~~~----~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 202 NGEEPLSTLSSSEKERFY----QDQHRLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCcccCCchhHHHHH----hcCCCCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 68888775432222111 111111111 126899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=298.75 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=206.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-+.|.+.++||+|.|+.|.+|++..++..||||++++..... .+.+|+++|+.|+|+++++++.+.
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~---------- 124 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI---------- 124 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee----------
Confidence 467999999999999999999999999999999988764332 368999999999999988776543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
......|+||||+ ++.+.+++...++. ....+..+..|++.+++|||+++|+|||||++||
T Consensus 125 -----------------~t~~~lylV~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNi 186 (596)
T KOG0586|consen 125 -----------------ETEATLYLVMEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENI 186 (596)
T ss_pred -----------------eecceeEEEEEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHhhcceeccccchhhc
Confidence 4567889999999 99999999885554 4499999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +.+..+||+|||++..+..... ..+.+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|.+||
T Consensus 187 lL---~~~mnikIaDfgfS~~~~~~~~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 187 LL---DENMNIKIADFGFSTFFDYGLM--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred cc---ccccceeeeccccceeeccccc--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 99 4778899999999998875433 358899999999999999986 78999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.|..-. ..-.+++..++.+|... ..+..++|..++.++|.+|++.++|..
T Consensus 256 DG~~lk---~Lr~rvl~gk~rIp~~m-----s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 256 DGQNLK---ELRPRVLRGKYRIPFYM-----SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred CCcccc---cccchheeeeeccccee-----echhHHHHHHhhccCccccCCHHHhhh
Confidence 975432 22233445555555433 457889999999999999999888755
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=278.26 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=194.9
Q ss_pred eEEeeeecccCceeEEEEEEcCCC----ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+++.+.||.|+||.||+|.+...+ ..||+|++..... ...+..|+.+++.+.|++++..+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~------------ 68 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLG------------ 68 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEE------------
Confidence 467899999999999999998766 8899999876543 346788999999998876554433
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~-~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+....+..+++||++ +++|.+++...... +++..+..++.||+.||.|||+.|++||||||+|
T Consensus 69 ---------------~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~n 133 (258)
T smart00219 69 ---------------VCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 133 (258)
T ss_pred ---------------EEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccce
Confidence 334557889999999 88999998754434 9999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
|++ ++++.++|+|||++.......... .....++..|++||.+.+..++.++|||||||++|+|++ |.+|
T Consensus 134 il~---~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p 204 (258)
T smart00219 134 CLV---GENLVVKISDFGLSRDLYDDDYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESP 204 (258)
T ss_pred EEE---ccCCeEEEcccCCceecccccccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 999 477899999999998765442211 112236789999999988889999999999999999998 8899
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 298 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~ 298 (449)
|...... .....+..... .+ .....+.++.+++.+||..+|++||++.++.+.
T Consensus 205 ~~~~~~~---~~~~~~~~~~~-~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 205 YPGMSNE---EVLEYLKKGYR-LP---KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCCCCHH---HHHHHHhcCCC-CC---CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 9874432 22222222221 11 113358899999999999999999999988664
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=284.33 Aligned_cols=245 Identities=21% Similarity=0.314 Sum_probs=193.0
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHc---CCCcceeeEeecchhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQ---GGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~---~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++ |++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~--------------- 66 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK--------------- 66 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeee---------------
Confidence 58899999999999999999999999999998765322 345778999999987 554433
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+..+...+...|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||
T Consensus 67 ------------~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni 132 (277)
T cd06917 67 ------------YYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANI 132 (277)
T ss_pred ------------EeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHE
Confidence 333345667889999999 8899988764 4789999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+++ +.+.++|+|||++......... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||
T Consensus 133 ~i~---~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~ 202 (277)
T cd06917 133 LVT---NTGNVKLCDFGVAALLNQNSSK-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202 (277)
T ss_pred EEc---CCCCEEEccCCceeecCCCccc-------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence 994 6889999999999876544321 234568899999998875 45789999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+..... ....+ ... .+........+.++.+++..||..+|++||++.++..
T Consensus 203 ~~~~~~~---~~~~~-~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 203 SDVDAFR---AMMLI-PKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCChhh---hhhcc-ccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 8654321 11111 111 1111111236789999999999999999999988855
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=289.80 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=195.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++..........
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL----- 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc-----
Confidence 57899999999999999999999999999999998754322 234778999999999998776654322110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+|||+++++|.+++. ...+++..++.++.||+.||+|||+.||+||||||+||
T Consensus 88 ----------------~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Ni 149 (343)
T cd07880 88 ----------------SLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL 149 (343)
T ss_pred ----------------cccccceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 001123568999999999988876 35799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+++ ..+.++|+|||++....... ....++..|++||++.+ ..++.++|+|||||++|+|++|..||
T Consensus 150 ll~---~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 216 (343)
T cd07880 150 AVN---EDCELKILDFGLARQTDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216 (343)
T ss_pred EEc---CCCCEEEeecccccccccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 994 67889999999987543221 24467889999999876 45889999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCC--------------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+..... .+..++...... .........++.+.+++..|+..||.+||++.
T Consensus 217 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~ 293 (343)
T cd07880 217 KGHDHLD---QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293 (343)
T ss_pred CCCCHHH---HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence 8654322 122211111110 11222345677899999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++..
T Consensus 294 ~~l~ 297 (343)
T cd07880 294 EALA 297 (343)
T ss_pred HHhc
Confidence 7753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=286.23 Aligned_cols=260 Identities=21% Similarity=0.337 Sum_probs=196.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~ 79 (449)
+..+.|++.+.||+|+||+||+|.+..+++.||||+++.... ...+..|+.++..+. |++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---------------- 75 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPY---------------- 75 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCc----------------
Confidence 345789999999999999999999988899999999875432 223555666555544 454
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~ 158 (449)
++.+..++......|+|||++++++.+++......+++..+..++.||+.||.|||+ .||+||||+|+
T Consensus 76 -----------i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ 144 (296)
T cd06618 76 -----------IVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPS 144 (296)
T ss_pred -----------hHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHH
Confidence 334444456677899999999889988887766789999999999999999999997 69999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC----CCccchHHHHHHHHHHHHh
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlG~il~el~~ 234 (449)
||++ ++++.++|+|||++......... ....++..|+|||.+.+.. ++.++||||||+++|+|++
T Consensus 145 nill---~~~~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~ 213 (296)
T cd06618 145 NILL---DASGNVKLCDFGISGRLVDSKAK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213 (296)
T ss_pred HEEE---cCCCCEEECccccchhccCCCcc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh
Confidence 9999 47889999999998765432221 1235678899999987654 7889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 307 (449)
|+.||...... .+.+..+........ + ....++.++.+++.+||..+|.+||+++++.+ ..++....
T Consensus 214 g~~p~~~~~~~--~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~ 280 (296)
T cd06618 214 GQFPYKNCKTE--FEVLTKILQEEPPSL-P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIRRYE 280 (296)
T ss_pred CCCCCCcchhH--HHHHHHHhcCCCCCC-C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhhccc
Confidence 99999753221 222333322221111 1 11235789999999999999999999988854 34444333
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.69 Aligned_cols=255 Identities=21% Similarity=0.270 Sum_probs=194.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..........
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~---- 89 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR---- 89 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc----
Confidence 356899999999999999999999998999999998864321 234678999999999998777654322110
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
........|+++++++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 90 -----------------~~~~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 150 (345)
T cd07877 90 -----------------SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 150 (345)
T ss_pred -----------------cccccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHH
Confidence 011234578999999999988775 3469999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|+++ +++.++|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 151 Ill~---~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 217 (345)
T cd07877 151 LAVN---EDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217 (345)
T ss_pred EEEc---CCCCEEEeccccccccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9994 7789999999998754322 124567889999999876 4688999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCC--------------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 239 WQGLKAATKKQKYDKICEKKVST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
|.+..... .+..+....... .........++++.+++..|+..+|.+||+.
T Consensus 218 f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 294 (345)
T cd07877 218 FPGTDHID---QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 294 (345)
T ss_pred CCCCCHHH---HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence 97644322 112221111110 0111112346778899999999999999998
Q ss_pred HHHHH
Q 013125 293 GFLKR 297 (449)
Q Consensus 293 ~~l~~ 297 (449)
.++.+
T Consensus 295 ~e~l~ 299 (345)
T cd07877 295 AQALA 299 (345)
T ss_pred HHHhc
Confidence 87744
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.87 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=197.2
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+|+++++.++|++++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~--------------- 65 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD--------------- 65 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHH---------------
Confidence 6788999999999999999998999999998765432 235778999999998876554332
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
+...++..++|+||+.++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||++.
T Consensus 66 ------------~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~- 132 (283)
T cd05118 66 ------------VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN- 132 (283)
T ss_pred ------------hhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC-
Confidence 2345578899999998899998887667899999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
+++.++|+|||.+........ ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||.+..
T Consensus 133 --~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 133 --TEGVLKLADFGLARSFGSPVR-------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred --CCCcEEEeeeeeeEecCCCcc-------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 778999999999987654331 11234578899999998876 68999999999999999999999997755
Q ss_pred hhcHHHHHHHHHHh----------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEK----------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~----------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..+........... .............+.++.+++..||..+|.+||++.++..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 204 EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 43221111111000 0111122333456789999999999999999999887743
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=287.78 Aligned_cols=260 Identities=19% Similarity=0.257 Sum_probs=194.3
Q ss_pred ceEEeeeecccCceeEEEEEEcCC--CceEEEEEecCCCC----chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTK----HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~--~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~ 80 (449)
+|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+|+.+++.+. |++++..+.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------- 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV------- 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee-------
Confidence 689999999999999999999877 88999998764321 335678999999884 7776665442210
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.......|+++++++++|.+.+.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 74 ----------------~~~~~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Ni 136 (332)
T cd07857 74 ----------------FPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNL 136 (332)
T ss_pred ----------------ccccCCcEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHe
Confidence 1123356789999999999988864 56799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ ++++.++|+|||+++.......... .......||..|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 137 li---~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf 210 (332)
T cd07857 137 LV---NADCELKICDFGLARGFSENPGENA---GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210 (332)
T ss_pred EE---cCCCCEEeCcCCCceeccccccccc---ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence 99 4778999999999987654322110 11234578999999998766 46899999999999999999999999
Q ss_pred CCChhhcHHHHHHH------------HH-----------HhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDK------------IC-----------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~------------i~-----------~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+............ +. ......+........+..+.+++..||..+|.+||++.++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 211 KGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 76442211111100 00 00011122233344577899999999999999999988774
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
.
T Consensus 291 ~ 291 (332)
T cd07857 291 E 291 (332)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=280.43 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=191.1
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHc---CCCcceeeEeecchhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQ---GGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~---~~~~~~~~~~~~~~~~~~~~~ 81 (449)
|++.+.||.|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++ |++++..++......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~------ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR------ 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc------
Confidence 78999999999999999999888999999998743222 23567888887774 665554443321110
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.......+++||++.++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 75 ----------------~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ni 138 (287)
T cd07838 75 ----------------TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNI 138 (287)
T ss_pred ----------------CCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhE
Confidence 00122489999999889998887643 3689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++. +++.++|+|||++........ .....++..|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 139 li~---~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 139 LVT---SDGQVKIADFGLARIYSFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred EEc---cCCCEEEeccCcceeccCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 994 678999999999987644322 123357889999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHH-------------------hhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 241 GLKAATKKQKYDKICE-------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~-------------------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
+.........+..... .....+........+..+.+++..||..||.+||++.++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 208 GTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred CCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 7654332222211100 0001111222234467889999999999999999988774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.62 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=198.0
Q ss_pred CCcccCCceEE-eeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----------------hhHHHHHHHHHHHcCCC
Q 013125 1 MERIIGVKYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------PQLLYEAKVYKILQGGS 63 (449)
Q Consensus 1 ~~~i~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----------------~~~~~E~~~l~~l~~~~ 63 (449)
|..-+.+||.. .+.||.|+||+||+|.+..+++.||||++...... ..+.+|+++++.++|++
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 44556788975 57799999999999999989999999987643221 14678999999999887
Q ss_pred cceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 013125 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 143 (449)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~ 143 (449)
++..+ .++..++..|+|||++.++|.+++.. ...++...+..++.|++.||+
T Consensus 82 iv~~~---------------------------~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~ 133 (335)
T PTZ00024 82 IMGLV---------------------------DVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLN 133 (335)
T ss_pred eeeee---------------------------EEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence 55443 33456678999999998899988864 556999999999999999999
Q ss_pred HHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCcccc-------ccCCCCCCCCccccccccccCCC-
Q 013125 144 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP-------YRENKNLTGTARYASCNTHLGIE- 215 (449)
Q Consensus 144 ~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~- 215 (449)
|||++||+||||+|+||++ +..+.++|+|||++............. ........++..|++||.+.+..
T Consensus 134 ~LH~~~i~H~dl~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 210 (335)
T PTZ00024 134 VLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK 210 (335)
T ss_pred HHHhCCeecccccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCC
Confidence 9999999999999999999 477899999999998765221110000 00112335688899999987654
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCC-----------------------CHHHhhccChH
Q 013125 216 QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST-----------------------PIEVLCKSHPA 272 (449)
Q Consensus 216 ~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~-----------------------~~~~~~~~~~~ 272 (449)
++.++|||||||++|||++|.+||.+...... +..+....... .........+.
T Consensus 211 ~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (335)
T PTZ00024 211 YHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASD 287 (335)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCCh
Confidence 68999999999999999999999987654322 22222211100 01112234577
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 273 EFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 273 ~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++.+++..||..+|++||+++++..
T Consensus 288 ~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 288 DAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHcCCCchhccCHHHHhc
Confidence 8999999999999999999887744
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=279.08 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=194.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-------CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+++++.++|++++..++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~------- 74 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR------- 74 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEE-------
Confidence 57999999999999999999999999999999864321 1124678999999999988665543221
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.......++|+|++ +++|.+.+.. ...++...++.++.|++.||.|||++|++|+||||+
T Consensus 75 ------------------~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ 135 (264)
T cd06653 75 ------------------DPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135 (264)
T ss_pred ------------------cCCCCEEEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 12345678999999 8899988865 345889999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++ +.++.++|+|||+++......... .......++..|+|||++.+..++.++|+|||||++|+|++|+.|
T Consensus 136 ni~i---~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 208 (264)
T cd06653 136 NILR---DSAGNVKLGDFGASKRIQTICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208 (264)
T ss_pred HEEE---cCCCCEEECccccccccccccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 9999 467889999999998654321110 011245688999999999998899999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
|...... ..+..+. .....+......++.+.+++.+||. ++..||+..++.
T Consensus 209 ~~~~~~~---~~~~~~~---~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 209 WAEYEAM---AAIFKIA---TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCccCHH---HHHHHHH---cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 9865322 2222221 1222233445667899999999998 579999988664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=281.61 Aligned_cols=241 Identities=24% Similarity=0.289 Sum_probs=181.4
Q ss_pred eecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccC
Q 013125 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTL 88 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (449)
.||+|+||.||+|.+..+++.||+|++..... ......|..+++.+++.. +
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~ 56 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD------------------------C 56 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCC------------------------C
Confidence 48999999999999999999999998764321 112344544444443211 1
Q ss_pred CCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCC
Q 013125 89 GGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167 (449)
Q Consensus 89 ~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~ 167 (449)
+++..+..+....+..|+||||+ |++|.+++.. ...+++..++.++.|++.||+|||+.+|+||||||+||++ +.
T Consensus 57 ~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~ 132 (278)
T cd05606 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DE 132 (278)
T ss_pred CcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CC
Confidence 23444555556678899999999 8899887764 4579999999999999999999999999999999999999 47
Q ss_pred CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 168 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 168 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
++.++|+|||++....... .....|+..|+|||++.+. .++.++||||+||++|||++|..||.+.....
T Consensus 133 ~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~ 203 (278)
T cd05606 133 HGHVRISDLGLACDFSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203 (278)
T ss_pred CCCEEEccCcCccccCccC---------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc
Confidence 7899999999987553321 1245789999999998754 68999999999999999999999998753322
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 296 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~ 296 (449)
.......+.... ..+....+.++.+++..|+..+|.+|| ++.++.
T Consensus 204 ~~~~~~~~~~~~-----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 204 KHEIDRMTLTMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred hHHHHHHhhccC-----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 222211111111 112234578999999999999999999 766664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.43 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=193.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++..........
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV----- 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc-----
Confidence 45799999999999999999999988999999998764321 234778999999999998776554322110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+|+|++..+|..++ ...++...+..++.|++.||+|||+.|++||||||+||
T Consensus 88 ----------------~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NI 148 (342)
T cd07879 88 ----------------SGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL 148 (342)
T ss_pred ----------------cCCCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 01223456899999987776654 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
++. .++.++|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 149 ll~---~~~~~kL~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf 215 (342)
T cd07879 149 AVN---EDCELKILDFGLARHADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215 (342)
T ss_pred EEC---CCCCEEEeeCCCCcCCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence 994 7889999999998754321 124567889999999876 45899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhc--------------------------CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKV--------------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+...... +..+..... ...........+..+.+++..||..||.+||++.
T Consensus 216 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 216 KGKDYLDQ---LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred CCCCHHHH---HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 87543221 111111000 0011112234567899999999999999999998
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++..
T Consensus 293 e~l~ 296 (342)
T cd07879 293 EALE 296 (342)
T ss_pred HHhc
Confidence 8754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=278.45 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=190.0
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.....||+|+||.||+|.+..++..||+|.+..... ...+.+|+++++.++|++++..++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~----------------- 72 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG----------------- 72 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeee-----------------
Confidence 3445689999999999999988999999998765432 335788999999999887665433
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~--~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+...++..++|+|++ +++|.+++......+ +...++.++.||+.||.|||++||+||||||+||+++
T Consensus 73 ----------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~ 142 (268)
T cd06624 73 ----------SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN 142 (268)
T ss_pred ----------eeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 334567889999999 889999887644445 8888999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
.+.+.++|+|||++......... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 143 --~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 143 --TYSGVVKISDFGTSKRLAGINPC-------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred --CCCCeEEEecchhheecccCCCc-------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 23678999999998765432211 12346788999999987644 78899999999999999999999976
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... ....+...... ..+....++++.+++..||..+|.+||++.++..
T Consensus 214 ~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 214 LGEPQA--AMFKVGMFKIH---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccChhh--hHhhhhhhccC---CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 432211 11111100111 1122445789999999999999999999988754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.30 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=198.6
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
||++.++||.|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++...+......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPS-------- 72 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccC--------
Confidence 6999999999999999999998889999999876532 2346888999999999887665443221100
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.......|+|||+++++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||+.
T Consensus 73 --------------~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~ 137 (330)
T cd07834 73 --------------PEDFNDVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN 137 (330)
T ss_pred --------------cccccceEEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 012246799999998888888764 44799999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
.++.++|+|||++.......... .......++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.
T Consensus 138 ---~~~~~~L~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 138 ---SNCDLKICDFGLARGVDPDEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ---CCCCEEEcccCceEeeccccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 67899999999998765543110 012345678899999999888 7899999999999999999999999876
Q ss_pred hhhcHHHHHHHHHHhhcCC--------------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 243 KAATKKQKYDKICEKKVST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
..... +..+....... +........+.++.+++..||..+|.+||+++++.
T Consensus 211 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 211 DYIDQ---LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred CHHHH---HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 54322 22222211111 11112234578899999999999999999988875
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
.
T Consensus 288 ~ 288 (330)
T cd07834 288 A 288 (330)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=283.82 Aligned_cols=239 Identities=17% Similarity=0.224 Sum_probs=179.7
Q ss_pred eecccCceeEEEEEEcCC------------------------CceEEEEEecCCCC--chhHHHHHHHHHHHcCCCccee
Q 013125 14 KIGSGSFGEIFLASHVDT------------------------NEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRL 67 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~------------------------~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~ 67 (449)
.||+|+||.||+|....+ ...||+|++..... ...+..|+.+++.++|+++++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999975321 13588998764322 2246778888888888875554
Q ss_pred eEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013125 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 146 (449)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH 146 (449)
+ .++......++||||+ +++|..++......+++..++.++.||+.||+|||
T Consensus 82 ~---------------------------~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH 134 (274)
T cd05076 82 H---------------------------GVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134 (274)
T ss_pred E---------------------------EEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4 4445667889999999 88888887665667999999999999999999999
Q ss_pred hCCccccCCCCCcEEeecC----CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccch
Q 013125 147 SRGFLHRDIKPDNFLMGLG----RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDD 221 (449)
Q Consensus 147 ~~giiHrDLkp~Nill~~~----~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~D 221 (449)
++||+||||||+|||++.. .....++++|||++...... ....++..|+|||.+.+ ..++.++|
T Consensus 135 ~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~D 203 (274)
T cd05076 135 DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAAD 203 (274)
T ss_pred cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHH
Confidence 9999999999999999531 12235899999988643221 12356788999998875 56899999
Q ss_pred HHHHHHHHHHHH-hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 222 LESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 222 vwSlG~il~el~-~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
||||||++|||+ +|..||.+........ ........+ ...++.+.+++..||..+|++||++.+|.+.|
T Consensus 204 v~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 204 KWSFGTTLLEICFDGEVPLKERTPSEKER----FYEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHHHHHhCCCCCccccChHHHHH----HHHhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 999999999995 6999998754432211 122222222 12246799999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.91 Aligned_cols=255 Identities=17% Similarity=0.199 Sum_probs=201.5
Q ss_pred CCceEEe-eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
-+.|+|- ++||-|-.|.|-.+.++.|++++|+|++. +.+...+|+++--.. .|++++..+.+...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeN---------- 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYEN---------- 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhh----------
Confidence 3566664 57999999999999999999999999975 334567787765433 45554443322111
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
...+.....+|||.+ ||.|..-++..+ ..|++.++..|+.||..|+.|||+.+|.||||||+|+|
T Consensus 127 -------------s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 127 -------------SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL 193 (400)
T ss_pred -------------hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence 112346678999999 999999888654 46999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
.+....+..+||+|||+|+....... -.+-+-|+.|.|||++....|+..+|+||+|+++|.|++|.+||..
T Consensus 194 yt~t~~na~lKLtDfGFAK~t~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 194 YTTTSPNAPLKLTDFGFAKETQEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred eecCCCCcceEecccccccccCCCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 98777788999999999987654322 1355779999999999999999999999999999999999999987
Q ss_pred Chhhc-HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 242 LKAAT-KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 242 ~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
..... ....-.+|....+.+|.++ |...++..+++++.+|..+|++|.+.+++
T Consensus 266 ~hg~aispgMk~rI~~gqy~FP~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 266 NHGLAISPGMKRRIRTGQYEFPEPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred cCCccCChhHHhHhhccCccCCChh-HhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 65432 2233455666677777544 55668889999999999999999987655
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=278.58 Aligned_cols=247 Identities=22% Similarity=0.288 Sum_probs=195.4
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||.|+||.||+|.+..++..||+|.+... .....+.+|+++++.++|++++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~--------------- 65 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF--------------- 65 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhh---------------
Confidence 699999999999999999999999999999987643 2334678899999999988755433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.........++|+||+ +++|.+++... ...+++..++.++.|++.||.|||+.+++|+||||+||+
T Consensus 66 ------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil 133 (257)
T cd08225 66 ------------ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133 (257)
T ss_pred ------------heeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence 2334567889999999 88999988653 335899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ ++...++|+|||.+......... .....|+..|+|||++.+..++.++|+||||+++|||++|..||..
T Consensus 134 ~~--~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 134 LS--KNGMVAKLGDFGIARQLNDSMEL-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred Ec--CCCCeEEecccccchhccCCccc-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 95 23346799999998765433211 1234688899999999888899999999999999999999999976
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... .....+...... ......+.++.+++.+||..+|++||++.++..
T Consensus 205 ~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 205 NNLH---QLVLKICQGYFA----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ccHH---HHHHHHhcccCC----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 4332 222222222211 122345789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=287.44 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=193.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
-|....+||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.|++++..+.
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~---------------- 85 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK---------------- 85 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhh----------------
Confidence 3555678999999999999998889999999876432 2345778999999888887554432
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
++..++..|+|+||+ +++|..++. ...+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus 86 -----------~~~~~~~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill-- 150 (297)
T cd06659 86 -----------SYLVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL-- 150 (297)
T ss_pred -----------heeeCCeEEEEEecCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE--
Confidence 234567889999999 788888765 3568999999999999999999999999999999999999
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~ 244 (449)
+.++.++|+|||++........ ......++..|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 151 -~~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 222 (297)
T cd06659 151 -TLDGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222 (297)
T ss_pred -ccCCcEEEeechhHhhcccccc-------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4788999999999875443221 12345788999999999988899999999999999999999999986443
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
. ..+..+... ..+........+..+.+++..||..+|.+||+++++.+
T Consensus 223 ~---~~~~~~~~~--~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 223 V---QAMKRLRDS--PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred H---HHHHHHhcc--CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 2 222222111 11112223456788999999999999999999988755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=278.65 Aligned_cols=248 Identities=19% Similarity=0.275 Sum_probs=182.8
Q ss_pred eeecccCceeEEEEEEcCC--CceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 13 RKIGSGSFGEIFLASHVDT--NEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~--~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
++||+|+||.||+|..... ...+++|...... ....+.+|+.+++.++|+++++.++.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~----------------- 63 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQ----------------- 63 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEE-----------------
Confidence 3699999999999976432 3346677665432 23458889999999999886665543
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+......|+||||+ +++|.+++... ...++...++.++.||+.||+|||+++++||||||+|||+
T Consensus 64 ----------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~- 132 (268)
T cd05086 64 ----------CVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL- 132 (268)
T ss_pred ----------ecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE-
Confidence 34456789999999 78999988753 2346777889999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-------CCCCccchHHHHHHHHHHHHh-C
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwSlG~il~el~~-G 235 (449)
+.++.++|+|||++......... .......++..|+|||++.. ..++.++|||||||++|||++ |
T Consensus 133 --~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 133 --TSDLTVKVGDYGIGPSRYKEDYI-----ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred --cCCccEEecccccccccCcchhh-----hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 47789999999998643221110 11234567889999998753 346789999999999999997 6
Q ss_pred CCCCCCChhhcHHHHHHHHH-HhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKIC-EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
..||....... .+..+. ......+.+......++.+.+++..|| .+|++||++++|.+.|
T Consensus 206 ~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 206 AQPYSHLSDRE---VLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCCCCCCHHH---HHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 78887654432 222222 222222233334456788999999999 6899999999987765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=276.12 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=196.5
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
||++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.++|++++..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~-------------- 66 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG-------------- 66 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheee--------------
Confidence 69999999999999999999988999999999876533 235788999999998887555433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..++|+||+ +++|.+++.. ...++...++.++.|++.||+|||+.||+|+||+|+||++
T Consensus 67 -------------~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~ 132 (264)
T cd06626 67 -------------VEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132 (264)
T ss_pred -------------eEecCCEEEEEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 335567889999999 8899998875 4558899999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC---CCccchHHHHHHHHHHHHhCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+ +.+.+||+|||++............ ......++..|++||++.+.. .+.++||||||+++|++++|..||
T Consensus 133 ~---~~~~~kl~d~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf 206 (264)
T cd06626 133 D---HNGVIKLGDFGCAVKLKNNTTTMGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206 (264)
T ss_pred C---CCCCEEEcccccccccCCCCCcccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 4 6889999999999876544321100 012456788999999998766 889999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... ......+.. ......+ .....+..+.+++..||..+|.+||++.++..
T Consensus 207 ~~~~~~--~~~~~~~~~-~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 207 SELDNE--FQIMFHVGA-GHKPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cCCcch--HHHHHHHhc-CCCCCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 765321 111112221 1111111 11234788999999999999999999887743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=286.15 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=194.9
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++|++++...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~-------------- 83 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD-------------- 83 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhh--------------
Confidence 479999999999999999999998889999999875432 2345788999999998887554332
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..|+|+||+ +++|.+++.. ..++...+..++.|++.||.|||++|++||||||+||++
T Consensus 84 -------------~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili 148 (293)
T cd06647 84 -------------SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148 (293)
T ss_pred -------------eeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence 234567789999999 8899988763 458899999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
. .++.++|+|||++......... .....++..|++||.+.+..++.++|||||||++|++++|..||...
T Consensus 149 ~---~~~~~kL~dfg~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 149 G---MDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred c---CCCCEEEccCcceecccccccc-------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4 6789999999998755433221 13456888999999999888999999999999999999999999765
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... .+..+... ..+........+..+.+++..||..+|++||++.++..
T Consensus 219 ~~~~---~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 219 NPLR---ALYLIATN--GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred Chhh---heeehhcC--CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4321 11111111 11111112234678999999999999999999988744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=280.51 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=195.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+-|++.++||.|+||.||+|.+..+++.||||+...... ...+.+|++++..++|++++..+.
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-------------- 69 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-------------- 69 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEE--------------
Confidence 347889999999999999999988899999998764322 234778999999998887555433
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+...+...|+||||+ +++|.+++. ...++...+..++.|++.+|.|||+.|++|+||+|+||++
T Consensus 70 -------------~~~~~~~~~lv~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i 134 (277)
T cd06641 70 -------------SYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 134 (277)
T ss_pred -------------EEEeCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE
Confidence 345667889999999 778888875 3568999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+ .++.++|+|||++......... .....++..|++||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 135 ~---~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 135 S---EHGEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred C---CCCCEEEeecccceecccchhh-------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 4 7788999999998765432211 13456788999999998888999999999999999999999999765
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .....+... ..+......+.++.+++..||..+|.+||++.++..
T Consensus 205 ~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 205 HPM---KVLFLIPKN----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred chH---HHHHHHhcC----CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 432 122222111 111223445789999999999999999999998866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=285.31 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=193.9
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.+.|...++||+|+||+||+|++..+++.||+|++..... ...+.+|+++++.++|++++...
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~------------ 87 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK------------ 87 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEE------------
Confidence 3457888999999999999999999999999998764322 12467899999999888755443
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.++...+..|+||||+.+++.+++......++..+++.++.||+.+|.|||++|++||||+|+||
T Consensus 88 ---------------~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni 152 (313)
T cd06633 88 ---------------GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 152 (313)
T ss_pred ---------------EEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence 33456678899999998899888877667799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
++. +++.++|+|||++..... .....|+..|+|||++. +..++.++|||||||++|||++|..
T Consensus 153 li~---~~~~~kL~dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~ 218 (313)
T cd06633 153 LLT---EPGQVKLADFGSASKSSP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218 (313)
T ss_pred EEC---CCCCEEEeecCCCcccCC-----------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 994 778999999999853221 23457888999999984 3568889999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||....... ....+..... .......++..+.+++..||+.+|.+||++.++..
T Consensus 219 p~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 219 PLFNMNAMS---ALYHIAQNDS---PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCCCChHH---HHHHHHhcCC---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 998754332 2222222111 11122345678999999999999999999887743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=275.41 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=198.9
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|.+.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+++++.++|++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~-------------- 66 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE-------------- 66 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEE--------------
Confidence 6999999999999999999999899999999887542 2345788999999999887554432
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
....+...++|+|++ +++|.+.+... ...++...++.++.|++.||.|||++|++|+||+|+|
T Consensus 67 -------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n 133 (258)
T cd08215 67 -------------SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133 (258)
T ss_pred -------------EEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence 234457889999999 78999988764 3679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+++ +++.++|+|||++........ ......|++.|++||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 134 il~~---~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 203 (258)
T cd08215 134 IFLT---SNGLVKLGDFGISKVLSSTVD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF 203 (258)
T ss_pred eEEc---CCCcEEECCccceeecccCcc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCC
Confidence 9994 678999999999987654431 123456888999999999988999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... .....+..... ..+....+..+.+++..||..+|++||++.++.+
T Consensus 204 ~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 204 EGENLL---ELALKILKGQY----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCcHH---HHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 765422 22222222221 1222356789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=294.91 Aligned_cols=241 Identities=21% Similarity=0.324 Sum_probs=198.2
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
.+.||+|-||+||-|++.++|+.||||++.+. ....++.+|+.||+.+.|+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPG------------------------ 624 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPG------------------------ 624 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCC------------------------
Confidence 46899999999999999999999999998754 23456889999999999884
Q ss_pred CCCcCeeEEecccCCeeEEEEecCCCCHHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~-~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
++.+...++..+..++|||-+.|+..+.+. ...+++++...+.++.||+.||.|||.++|+|+||||+|||+...+
T Consensus 625 ---iV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~ 701 (888)
T KOG4236|consen 625 ---IVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS 701 (888)
T ss_pred ---eeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC
Confidence 555666677888999999999777666554 4467899999999999999999999999999999999999997665
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
.-.++||+|||+|+...+..- ..+++||+.|+|||+++...|++.-|+||.|+|+|--+.|-.||....+.
T Consensus 702 ~FPQvKlCDFGfARiIgEksF--------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI- 772 (888)
T KOG4236|consen 702 PFPQVKLCDFGFARIIGEKSF--------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI- 772 (888)
T ss_pred CCCceeeccccceeecchhhh--------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-
Confidence 667999999999998776542 25889999999999999999999999999999999999999999754322
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
-..|....+..| +.-|+.+.++..+||+..|+..-.+|-+.+
T Consensus 773 ----ndQIQNAaFMyP-p~PW~eis~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 773 ----NDQIQNAAFMYP-PNPWSEISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred ----hHHhhccccccC-CCchhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence 222333333333 334566678899999999988888887654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=279.12 Aligned_cols=257 Identities=20% Similarity=0.337 Sum_probs=193.2
Q ss_pred eEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
|++.+.||+|+||.||+|.+. .+++.||||++..... .+.+.+|+++++.++|++++..++.......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRA----- 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCC-----
Confidence 678999999999999999864 3578899998865422 2347789999999999987766554321100
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-----~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
.......+++++|+ +++|.+++... ...++...++.++.||+.||+|||++||+||||
T Consensus 76 ----------------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~di 139 (273)
T cd05074 76 ----------------KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDL 139 (273)
T ss_pred ----------------CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 00012347888998 88888776432 124788999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+||++ +.++.+||+|||+++....... +.......++..|++||.+.+..++.++|||||||++|||++
T Consensus 140 kp~nili---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 140 AARNCML---NENMTVCVADFGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred chhhEEE---cCCCCEEECcccccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence 9999999 4788999999999986543221 111123345678999999998889999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhh-cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKK-VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
|++||.+..... ....+.... ...+ ...+..+.+++..||..+|++||++.++.+.|+.+
T Consensus 212 g~~p~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 212 GQTPYAGVENSE---IYNYLIKGNRLKQP-----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCHHH---HHHHHHcCCcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 899998754322 222222211 1111 24578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=291.75 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=203.4
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---------chhHHHHHHHHHHHcCCCcceeeEeecc
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------HPQLLYEAKVYKILQGGSKIRLVVFHVD 73 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---------~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 73 (449)
+.+++||-+++.||+|||++||+|.|...++.||+||-....+ +....+|.+|-+.|.|+.++.++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD---- 534 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD---- 534 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee----
Confidence 5678999999999999999999999999999999998543322 223577888888888887666533
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--Ccc
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--GFL 151 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--gii 151 (449)
+|..+.+.+|-|+|||.|+.+|++.+..+.+++++++.|+.||+.||.||.+. -||
T Consensus 535 ----------------------yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPII 592 (775)
T KOG1151|consen 535 ----------------------YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPII 592 (775)
T ss_pred ----------------------eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCee
Confidence 34457788999999996666666665577899999999999999999999986 499
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC----CCCccchHHHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGY 227 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlG~ 227 (449)
|-||||.|||+-.+...|.+||+|||+++.+.+...+...-..-.....||.+|++||.+.-. ..+.++||||.|+
T Consensus 593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV 672 (775)
T KOG1151|consen 593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV 672 (775)
T ss_pred eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence 999999999997777889999999999999887765432222224567899999999987643 3789999999999
Q ss_pred HHHHHHhCCCCCCCChhhcHHHHHHHHHH-hhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 228 VLLYFLRGSLPWQGLKAATKKQKYDKICE-KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 228 il~el~~G~~pf~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
|+|.+++|+-||...-.....-....|+. ....+|.. .....+.+++|.+||+..-++|.+..+|
T Consensus 673 IFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 673 IFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 99999999999986433222222222222 12222221 1235789999999999999999775544
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=277.11 Aligned_cols=240 Identities=21% Similarity=0.280 Sum_probs=189.8
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+.
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------------------- 60 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR-------------------- 60 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeee--------------------
Confidence 7999999999999998899999998764321 235788999999999887555433
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
+...++..|+|+||+ +++|.+++.. ...++...++.++.||+.||+|||++|++|+||+|+||+++ .+
T Consensus 61 -------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~ 129 (262)
T cd05572 61 -------TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SN 129 (262)
T ss_pred -------eEEcCCccEEEEecCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CC
Confidence 335667889999998 8999998875 35689999999999999999999999999999999999994 77
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 248 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~ 248 (449)
+.++|+|||++........ .....++..|++||.+.+..++.++|+||||+++|+|++|..||..... +..
T Consensus 130 ~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~ 200 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQK--------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPM 200 (262)
T ss_pred CCEEEeeCCcccccCcccc--------cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHH
Confidence 8999999999986654321 1245678899999999888899999999999999999999999987552 122
Q ss_pred HHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC-----HHHHHH
Q 013125 249 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 297 (449)
Q Consensus 249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~-----~~~l~~ 297 (449)
..+..+.........+ ...+.++.+++..||..+|.+||+ ++++.+
T Consensus 201 ~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 201 EIYNDILKGNGKLEFP---NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHhccCCCCCCC---cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3333333111111111 223789999999999999999999 555543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=279.62 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=194.3
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
|++.++||+|+||.||+|.+..+++.||+|++.... ....+.+|+++++.++|++++......
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~------------- 67 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIV------------- 67 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeE-------------
Confidence 789999999999999999999889999999987642 123477899999999988766544332
Q ss_pred cccCCCcCeeEEeccc--CCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYGVD--GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~--~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.. .+..++|+||+.++|.+++......+++..++.++.||+.||+|||+.|++|+||||+||++
T Consensus 68 --------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~ 133 (287)
T cd07840 68 --------------TSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133 (287)
T ss_pred --------------ecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence 22 36889999999889998887655679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ +++.++|+|||++.......... .....++..|+|||.+.+. .++.++||||||+++|||++|..||..
T Consensus 134 ~---~~~~~~l~d~g~~~~~~~~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 134 N---NDGVLKLADFGLARPYTKRNSAD------YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred c---CCCCEEEccccceeeccCCCccc------ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4 78899999999998765543211 1234567889999987754 578999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhc----------------------CCCHHHhhcc-ChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKV----------------------STPIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~----------------------~~~~~~~~~~-~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+...+.... .......... .+..+.+++..||..+|.+||+++++.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 205 STELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 554322222211110000 0000111122 3788999999999999999999887744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=276.86 Aligned_cols=240 Identities=20% Similarity=0.300 Sum_probs=184.4
Q ss_pred CceEEeeee--cccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKI--GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~L--G~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|++.+.+ |.|+||.||++.+..+++.+|+|+....... ..|+.+...+ +|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~e~~~~~~~~~h~--------------------- 69 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AIEPMVHQLMKDNP--------------------- 69 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hhhHHHHHHhhcCC---------------------
Confidence 567777777 9999999999999999999999987643211 1133333222 344
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++..+...+...+..|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||++
T Consensus 70 ------~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 70 ------NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142 (267)
T ss_pred ------CEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 4555555556677899999999 89999998764 489999999999999999999999999999999999999
Q ss_pred ecCCCCC-eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~-~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
. ..+ .++|+|||++...... ....++..|+|||++.+..++.++||||||+++|||++|..||..
T Consensus 143 ~---~~~~~~~l~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 143 D---RAKDRIYLCDYGLCKIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred e---CCCCeEEEecCccceecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 5 455 8999999998765422 234678999999999998999999999999999999999999985
Q ss_pred ChhhcH-HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC-HHHHH
Q 013125 242 LKAATK-KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLK 296 (449)
Q Consensus 242 ~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~-~~~l~ 296 (449)
...... ...+.. .. ..+. ...+..++.+.+++..||+.+|.+||+ ++++.
T Consensus 209 ~~~~~~~~~~~~~---~~-~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 209 DEDEELDLESLLK---RQ-QKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred CCcchhhHHHHHH---hh-cccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 433221 111111 11 1111 222356889999999999999999995 57664
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=279.48 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=196.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~ 80 (449)
++|.+.+.||+|+||.||+|.+..+++.||+|+..... ....+.+|+++++.++ |++++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~-------------- 66 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK-------------- 66 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchh--------------
Confidence 47999999999999999999999999999999986531 1335778888888887 665443
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+.......+..++|||++ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+|
T Consensus 67 -------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~n 132 (280)
T cd05581 67 -------------LYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132 (280)
T ss_pred -------------HHHHhcCCceEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 333345667889999999 9999998876 4479999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccc-------------cccCCCCCCCCccccccccccCCCCCccchHHHHH
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG 226 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG 226 (449)
|+++ .++.++|+|||++............ .........++..|++||++.+..++.++||||||
T Consensus 133 i~i~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG 209 (280)
T cd05581 133 ILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG 209 (280)
T ss_pred eEEC---CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHH
Confidence 9994 7789999999999866543321100 01223456688999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 227 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 227 ~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
+++|++++|..||...... ..+..+.......+ ...++.+.+++..||..+|.+||++
T Consensus 210 ~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 210 CIIYQMLTGKPPFRGSNEY---LTFQKILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHHHHHHhCCCCCCCccHH---HHHHHHHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCc
Confidence 9999999999999875432 22333333222222 3447899999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=278.76 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=191.7
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
|++.+.||.|+||+||+|.+..+++.||||.+..... .....+|+..++.++ |++++...
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~---------------- 64 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK---------------- 64 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHH----------------
Confidence 7899999999999999999988899999998764322 123456888888887 76644432
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.+...++..|+|||+++++|.+.+.... ..+++..++.++.|++.+|.|||++|++|+||+|+||+++
T Consensus 65 -----------~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~ 133 (283)
T cd07830 65 -----------EVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133 (283)
T ss_pred -----------HHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc
Confidence 2234567889999999999998887643 4689999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+.+.++|+|||++........ .....++..|+|||++.+ ..++.++|+||||+++|||++|.+||...
T Consensus 134 ---~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 134 ---GPEVVKIADFGLAREIRSRPP--------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred ---CCCCEEEeecccceeccCCCC--------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 789999999999986544321 124567889999998854 45789999999999999999999999876
Q ss_pred hhhcHHHHHHHHHHhh----------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKK----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~----------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...........+.... ............+..+.+++..||..+|.+||+++++..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 5433222221111100 001111222233678999999999999999999887743
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.73 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=203.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.-||.-+.+||.|.||.||-|.+..||+..|+|-++... ..+.+.+|..++..|+|+|+++.+++-
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE--------- 1303 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE--------- 1303 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee---------
Confidence 3467888999999999999999999999999999765432 244578899999999999988776543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
...+..+|.|||| ||+|.+++.- ++..++.....+..|++.|+.|||+.|||||||||+|
T Consensus 1304 ------------------vHRekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aN 1364 (1509)
T KOG4645|consen 1304 ------------------VHREKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPAN 1364 (1509)
T ss_pred ------------------ecHHHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccc
Confidence 2446678999999 9999998874 6667888888999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC---CCccchHHHHHHHHHHHHhCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlG~il~el~~G~ 236 (449)
|++ +.++.+|++|||.|........ .+| .+-+...||+.|||||++.+.. -..++||||+||++.||+||+
T Consensus 1365 I~L---d~~g~iK~~DFGsa~ki~~~~~--~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1365 ILL---DFNGLIKYGDFGSAVKIKNNAQ--TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred eee---ecCCcEEeecccceeEecCchh--cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence 999 5788999999999998776531 112 2345789999999999998754 577999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||..++.. .+.+..+..+..+ +++ ..++.+-++++++||..||+.|.++.+|++
T Consensus 1439 rPW~~~dne--~aIMy~V~~gh~P-q~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1439 RPWAELDNE--WAIMYHVAAGHKP-QIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred Cchhhccch--hHHHhHHhccCCC-CCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 999876543 2333333322222 222 235789999999999999999988765533
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=284.21 Aligned_cols=246 Identities=21% Similarity=0.308 Sum_probs=194.3
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
...+|...+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+++++.++|++++...+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~---------- 82 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG---------- 82 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEE----------
Confidence 34568889999999999999999998999999998753211 224678999999998887555433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+.......++||||+.+++.+++......++..++..++.|++.||.|||+++++||||+|+|
T Consensus 83 -----------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~n 145 (308)
T cd06634 83 -----------------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145 (308)
T ss_pred -----------------EEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHh
Confidence 334567789999999889988887666779999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|++. .++.++|+|||++...... ....++..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 146 il~~---~~~~~kl~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 211 (308)
T cd06634 146 ILLS---EPGLVKLGDFGSASIMAPA-----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (308)
T ss_pred EEEC---CCCcEEECCcccceeecCc-----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence 9994 6789999999998765422 2456788999999975 345788999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||....... ....+....... ......+..+.+++.+||..+|.+||+++++..
T Consensus 212 ~p~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 212 PPLFNMNAMS---ALYHIAQNESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred CCCccccHHH---HHHHHhhcCCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 9997754322 111222211111 112345788999999999999999999988754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=276.29 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=186.2
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----hhHHHHHHHHHH-HcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKI-LQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----~~~~~E~~~l~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
++.||.|+||.||+|.+..+++.||+|++...... ..+..|..++.. +.|+
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~----------------------- 57 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP----------------------- 57 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCC-----------------------
Confidence 36799999999999999989999999987643211 112333333222 2333
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
++..+..+....+..|+|+||+ +++|.+++.. ...++...+..++.||+.||.|||+.|++||||+|+||++.
T Consensus 58 ----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~- 131 (260)
T cd05611 58 ----YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID- 131 (260)
T ss_pred ----CeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-
Confidence 4555555566778899999999 8899998875 35689999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~ 244 (449)
..+.++|+|||++..... .....++..|++||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 132 --~~~~~~l~dfg~~~~~~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 132 --QTGHLKLTDFGLSRNGLE-----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred --CCCcEEEeecccceeccc-----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 778999999999875432 1245678899999999988899999999999999999999999976543
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
. ..+..+.......+ ......++.++.+++..||..+|++||++..+.+++.
T Consensus 199 ~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 199 D---AVFDNILSRRINWP-EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred H---HHHHHHHhcccCCC-CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 2 23333333222222 1222356889999999999999999998766655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.44 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=194.3
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.|++++.........
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA------ 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc------
Confidence 5789999999999999999999999999999999876431 123467899999999988865543211100
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.........|+|+|+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 87 ---------------~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni 149 (343)
T cd07851 87 ---------------SSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149 (343)
T ss_pred ---------------ccccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 00012345899999999999998863 5699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+++ .++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 150 ll~---~~~~~kL~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 216 (343)
T cd07851 150 AVN---EDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216 (343)
T ss_pred EEC---CCCCEEEcccccccccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 994 6789999999999765432 124467889999998865 36789999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCC--------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+..... .+..+.......+ ........++.+.+++..||..+|.+||++.
T Consensus 217 ~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 217 PGSDHID---QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred CCCChHH---HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 8654432 2222222111000 1112234577899999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
+|..
T Consensus 294 ell~ 297 (343)
T cd07851 294 EALA 297 (343)
T ss_pred HHhc
Confidence 7744
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=280.36 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=200.0
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.+.|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++....
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~--------------- 82 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD--------------- 82 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEE---------------
Confidence 4679999999999999999999988899999999876543 456788999999999887555433
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++......|+|+||+ +++|.+++......++...+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 83 ------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i- 149 (286)
T cd06614 83 ------------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL- 149 (286)
T ss_pred ------------EEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE-
Confidence 334557889999999 699999998655479999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
+.++.++|+|||++......... .....++..|++||++.+..++.++|+||||+++|+|++|..||....
T Consensus 150 --~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 150 --SKDGSVKLADFGFAAQLTKEKSK-------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred --cCCCCEEECccchhhhhccchhh-------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 47789999999998654432211 124457889999999998889999999999999999999999998654
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ....+...... +. .....++..+.+++..||+.+|.+||++.++.+
T Consensus 221 ~~~---~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 221 PLR---ALFLITTKGIP-PL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHH---HHHHHHhcCCC-CC-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 332 22222221111 11 112336789999999999999999999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=280.12 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=194.2
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
+|.-.++||.|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.|++++..+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~---------------- 83 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS---------------- 83 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEE----------------
Confidence 5677789999999999999998889999999876432 2334778999999998887555443
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
+....+..|+|+||+ +++|.+++.. .+++...+..++.|++.||+|||++|++||||+|+||++
T Consensus 84 -----------~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~-- 148 (285)
T cd06648 84 -----------SYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL-- 148 (285)
T ss_pred -----------EEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE--
Confidence 334567889999999 8899988875 568999999999999999999999999999999999999
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~ 244 (449)
+.++.++|+|||++........ ......|+..|++||++.+..++.++|||||||++|||++|..||.....
T Consensus 149 -~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~ 220 (285)
T cd06648 149 -TSDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220 (285)
T ss_pred -cCCCcEEEcccccchhhccCCc-------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence 4788999999998865433211 11345688999999999988899999999999999999999999976433
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
. ..+..+.... .+........+..+.+++..||..+|++||++.++.+
T Consensus 221 ~---~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 221 L---QAMKRIRDNL--PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred H---HHHHHHHhcC--CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2 2222222221 1111111235789999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=276.42 Aligned_cols=249 Identities=21% Similarity=0.366 Sum_probs=191.7
Q ss_pred ceEEeeeecccCceeEEEEEEcC-CCceEEEEEecCCCC------------chhHHHHHHHHHH-HcCCCcceeeEeecc
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK------------HPQLLYEAKVYKI-LQGGSKIRLVVFHVD 73 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvKv~~~~~~------------~~~~~~E~~~l~~-l~~~~~~~~~~~~~~ 73 (449)
.|++.+.||+|+||.||+|.+.. +++.||+|.+..... ...+..|+.++.. ++|++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~------- 73 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVR------- 73 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeee-------
Confidence 48899999999999999999987 678999997653211 1124556666654 56665443
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHS-R 148 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~-~ 148 (449)
+..+....+..+++|||+ +++|.+++.. ....++...++.++.|++.||.|||+ .
T Consensus 74 --------------------~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 133 (269)
T cd08528 74 --------------------YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK 133 (269)
T ss_pred --------------------EEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence 333445677899999999 8899888753 24568999999999999999999996 7
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHH
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 228 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 228 (449)
|++|+||+|+||+++ ..+.++|+|||++........ .....++..|++||.+.+..++.++||||||++
T Consensus 134 ~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~l 202 (269)
T cd08528 134 RIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCI 202 (269)
T ss_pred ceeecCCCHHHEEEC---CCCcEEEecccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHH
Confidence 899999999999994 788999999999986544321 134568889999999998889999999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
+|||++|..||...... .....+...... +.. ....++.+.+++.+||..||++||++.++...++
T Consensus 203 l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 203 LYQMCTLQPPFYSTNML---SLATKIVEAVYE-PLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHhCCCcccccCHH---HHHHHHhhccCC-cCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 99999999999764332 222222222222 111 1245789999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=279.47 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=191.1
Q ss_pred ceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCC------CchhHHHHHHHHHHHc-CCCcceeeEeecchhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVII 77 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~------~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~ 77 (449)
+|++.+.||+|+||.||+|++. .+++.||||++.... ....+.+|++++..++ |++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~------------ 68 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV------------ 68 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchh------------
Confidence 4899999999999999999864 467889999876421 1234678999998885 44433
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.+......+...|+||||+ +++|.+.+.. ...++...++.++.|++.+|+|||+.|++|||||
T Consensus 69 ---------------~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~ 132 (288)
T cd05583 69 ---------------TLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIK 132 (288)
T ss_pred ---------------hhheeeecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 3333345667889999999 7899888764 4568999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC--CCccchHHHHHHHHHHHHh
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il~el~~ 234 (449)
|+||++. .++.++|+|||+++........ ......|+..|++||.+.+.. .+.++||||||+++|||++
T Consensus 133 p~nil~~---~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 133 LENILLD---SEGHVVLTDFGLSKEFLAEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred HHHeEEC---CCCCEEEEECcccccccccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence 9999994 6788999999998765433221 122456889999999987765 7889999999999999999
Q ss_pred CCCCCCCChhhcH-HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 235 GSLPWQGLKAATK-KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 235 G~~pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
|..||........ ......+....... ...++..+.+++.+||+.+|++||++..+.+.|+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 204 GASPFTVDGEQNSQSEISRRILKSKPPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCCcccCcccchHHHHHHHHHccCCCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 9999964322211 11222222222111 2335788999999999999999999887766654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=271.28 Aligned_cols=247 Identities=24% Similarity=0.406 Sum_probs=196.7
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
.|.+.+.||+|+||.||+|.+..+++.|++|++.... ....+.+|+++++.++|++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~----------------- 63 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY----------------- 63 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEE-----------------
Confidence 4889999999999999999998889999999987654 345688999999999887655443
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
.+.......++++|++ +++|.+++......++...+..++.|++.+|.|||++|++||||+|+||+++
T Consensus 64 ----------~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~- 132 (253)
T cd05122 64 ----------GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT- 132 (253)
T ss_pred ----------EEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc-
Confidence 3334557889999999 6999998876556799999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~ 244 (449)
+++.++|+|||.+........ .....++..|++||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 133 --~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 202 (253)
T cd05122 133 --SDGEVKLIDFGLSAQLSDTKA--------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202 (253)
T ss_pred --cCCeEEEeecccccccccccc--------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence 688999999999876554321 1345678899999999988899999999999999999999999986533
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... .+....... ......++..+.+++..||..+|++||++.++.+
T Consensus 203 ~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 203 MKALF---KIATNGPPG--LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHH---HHHhcCCCC--cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22111 111111111 0011123688999999999999999999887743
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=277.42 Aligned_cols=238 Identities=22% Similarity=0.282 Sum_probs=184.5
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||+|+||+||+|.+..+++.||+|++.... ....+..|+++++.++|++++..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~---------------------- 58 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL---------------------- 58 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeee----------------------
Confidence 699999999999999999999999875421 12235789999999988765443
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~ 167 (449)
.......+..|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||++ ++
T Consensus 59 -----~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~ 130 (277)
T cd05577 59 -----AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DD 130 (277)
T ss_pred -----eeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CC
Confidence 23334567889999999 789998886543 369999999999999999999999999999999999999 47
Q ss_pred CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcH
Q 013125 168 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 247 (449)
Q Consensus 168 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~ 247 (449)
++.++|+|||++........ .....++..|++||++.+..++.++|||||||++|+|++|+.||........
T Consensus 131 ~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 202 (277)
T cd05577 131 HGNVRISDLGLAVELKGGKK--------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202 (277)
T ss_pred CCCEEEccCcchhhhccCCc--------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc
Confidence 78999999999875543111 1345678899999999888899999999999999999999999987544222
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
...+.. .....+ .......++.+.+++..||..+|.+||++.+
T Consensus 203 ~~~~~~---~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 203 KEELKR---RTLEMA-VEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHh---cccccc-ccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 222111 111111 1122345789999999999999999995433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=276.84 Aligned_cols=252 Identities=21% Similarity=0.242 Sum_probs=195.1
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
|++.++||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.++|++++..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~----------------- 63 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL----------------- 63 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHH-----------------
Confidence 678899999999999999999999999999887642 23456789999999988765443
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
..+.......++|+|+++++|.+++......++...++.++.|++.||+|||+.||+||||+|+||++.
T Consensus 64 ----------~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~- 132 (282)
T cd07829 64 ----------LDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN- 132 (282)
T ss_pred ----------HhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc-
Confidence 233345578999999998899999987556799999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
+++.++|+|||++........ ......++..|+|||.+.+. .++.++|||||||++|||++|..||.+..
T Consensus 133 --~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 133 --RDGVLKLADFGLARAFGIPLR-------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred --CCCCEEEecCCcccccCCCcc-------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 678999999999976543321 11234557789999998776 78999999999999999999999998754
Q ss_pred hhcHHHHHHHHHHhh---------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKK---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~---------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.......+....... ............+..+.+++..||..+|++||+++++..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 204 EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 332222211111000 000111222344678999999999999999999887743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=276.36 Aligned_cols=245 Identities=21% Similarity=0.272 Sum_probs=190.9
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-------CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
||.+.++||+|+||.||+|.+..++..+++|+.+.. ........|+.+++.++|+++++..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~------------ 68 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFH------------ 68 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHH------------
Confidence 799999999999999999999877777777775532 1122456788899999888755432
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.+.......++|+||+ +++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+
T Consensus 69 ---------------~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~ 133 (260)
T cd08222 69 ---------------ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK 133 (260)
T ss_pred ---------------HHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Confidence 2234556789999999 88998887642 4568999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+||++. .+.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|.
T Consensus 134 ~~nili~----~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 134 AKNIFLK----NNLLKIGDFGVSRLLMGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred hhheEee----cCCEeecccCceeecCCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999993 46799999999977644322 123456788999999998888999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||..... ......+... +.+......+.++.+++..||..+|++||++.++.+
T Consensus 203 ~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 203 HAFEGQNF---LSVVLRIVEG----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCccH---HHHHHHHHcC----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 99975332 2222222221 111223455789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=284.59 Aligned_cols=253 Identities=16% Similarity=0.194 Sum_probs=184.8
Q ss_pred eeeeccc--CceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 12 GRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 12 ~~~LG~G--~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
...||.| +||+||+|++..+++.||+|+...... .+.+.+|+.+++.++|++++..+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~---------------- 66 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWT---------------- 66 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEee----------------
Confidence 3566766 999999999999999999999875432 234678888888888887655433
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++..++..|+|+||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+.
T Consensus 67 -----------~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~ 135 (328)
T cd08226 67 -----------VFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135 (328)
T ss_pred -----------eEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe
Confidence 334567889999999 78999888753 34589999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC--CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
..+.++++||+.+.............+.......++..|++||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 136 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 136 ---GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ---CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 678999999986543322211111111112223456789999998764 478999999999999999999999986
Q ss_pred ChhhcHHHHHHHHHHhhcCCC------------------------------------------HHHhhccChHHHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTP------------------------------------------IEVLCKSHPAEFASYFH 279 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~------------------------------------------~~~~~~~~~~~~~~l~~ 279 (449)
..... .+..........+ .......++..+.+++.
T Consensus 213 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 289 (328)
T cd08226 213 MLRTQ---MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289 (328)
T ss_pred cChHH---HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHH
Confidence 54321 1111110000000 00011234678999999
Q ss_pred HHhCCCCCCCCCHHHHHH
Q 013125 280 YCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 280 ~~l~~~p~~Rp~~~~l~~ 297 (449)
.||..||++||+++++.+
T Consensus 290 ~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 290 LCLQQDPEKRPSASSLLS 307 (328)
T ss_pred HHccCCcccCCCHHHHhh
Confidence 999999999999998854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=269.96 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=199.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||+|+||.||+|.+..+++.|++|+...... .+.+.+|+++++.++|++++.....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------------- 67 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS------------- 67 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEE-------------
Confidence 58999999999999999999998999999999876543 4467889999999998876554432
Q ss_pred hcccCCCcCeeEEecccC--CeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 84 FSSTLGGIPNIKWYGVDG--EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~--~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.... ...++|+|++ +++|.+++... ..+++..+..++.|++.+|+|||+.|++|+||+|+||
T Consensus 68 --------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni 132 (260)
T cd06606 68 --------------ERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI 132 (260)
T ss_pred --------------EecCCCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 2334 6789999999 89999988764 3899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++. ..+.++|+|||.+.......... ......++..|++||.+.+...+.++||||||+++|+|++|..||.
T Consensus 133 ~i~---~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 133 LVD---SDGVVKLADFGCAKRLGDIETGE-----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred EEc---CCCCEEEcccccEEecccccccc-----cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 994 67899999999998776543210 1134568889999999998889999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... .......+... ..........+..+.+++..|+..+|.+||++.++..
T Consensus 205 ~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 205 ELGN--PMAALYKIGSS---GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCc--hHHHHHhcccc---CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 7551 11222222211 1112223444789999999999999999999887743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=273.55 Aligned_cols=244 Identities=20% Similarity=0.292 Sum_probs=195.5
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.++||.|+||.||+|.+..+++.||+|.+.... ....+.+|+++++.++|++++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~----------------- 63 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIIS----------------- 63 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchh-----------------
Confidence 6899999999999999999999999999999876432 2334678889999988876443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+..++......++|+|++ +++|.+++... ...++...++.++.|++.||.|||+.|++|+||+|+|
T Consensus 64 ----------~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~n 133 (256)
T cd08530 64 ----------YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133 (256)
T ss_pred ----------hhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 333344567889999999 88998887642 3568999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+++ +.+.++|+|||++....... .....++..|++||.+.+..++.++|+||||+++|||++|+.||
T Consensus 134 i~~~---~~~~~kl~d~g~~~~~~~~~---------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~ 201 (256)
T cd08530 134 ILLV---ANDLVKIGDLGISKVLKKNM---------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201 (256)
T ss_pred EEEe---cCCcEEEeeccchhhhccCC---------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9995 67889999999997665431 12346788999999999988999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....... ....+....... .....+.++.+++..||..+|.+||++.++.+
T Consensus 202 ~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 202 EARSMQD---LRYKVQRGKYPP----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCHHH---HHHHHhcCCCCC----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 8754322 222222222221 12345789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.31 Aligned_cols=143 Identities=23% Similarity=0.465 Sum_probs=123.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|+++++||+|+||+||+|++..+++.||||++..... ...+..|+.+++.++|++++.+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~-------------- 69 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-------------- 69 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeE--------------
Confidence 689999999999999999999999999999999875322 2357788889988888765544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.++....+.||||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 70 -------------~~~~~~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NI 135 (669)
T cd05610 70 -------------YYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135 (669)
T ss_pred -------------EEEEEECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHE
Confidence 33445667899999999 8999998875 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeeccee
Q 013125 161 LMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~ 180 (449)
|+. ..+.+||+|||+++
T Consensus 136 Ll~---~~g~vkL~DFGls~ 152 (669)
T cd05610 136 LIS---NEGHIKLTDFGLSK 152 (669)
T ss_pred EEc---CCCCEEEEeCCCCc
Confidence 994 67899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=272.53 Aligned_cols=269 Identities=20% Similarity=0.305 Sum_probs=207.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
-+.|.+++.||+|+|+.|.+++.++|.+.+|+|++++. .+.+....|..+...-. |..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as--n~p--------------- 311 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS--NNP--------------- 311 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc--CCC---------------
Confidence 36899999999999999999999999999999987653 33334556665554332 222
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.++.+..++..+...++|.||. ||+|--.++. .++++++.++.+..+|..||.|||++|||+||||.+|
T Consensus 312 ---------flvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldn 381 (593)
T KOG0695|consen 312 ---------FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDN 381 (593)
T ss_pred ---------eEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccc
Confidence 3344445566778899999999 8888766654 6789999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+|+ +..+++||+|+|+++....+... ..+++||+.|.|||++++..|+..+|+|+||++++||+.|+.||
T Consensus 382 vll---daeghikltdygmcke~l~~gd~-------tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 382 VLL---DAEGHIKLTDYGMCKEGLGPGDT-------TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred eEE---ccCCceeecccchhhcCCCCCcc-------cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 999 68999999999999875554432 36899999999999999999999999999999999999999999
Q ss_pred CC--Chh---hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccc
Q 013125 240 QG--LKA---ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVF 314 (449)
Q Consensus 240 ~~--~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~ 314 (449)
.- +.+ ......++-|+++.+.+|... +-....++...+..||.+|.... ...-|.+ ..+..|....
T Consensus 452 divgm~n~d~ntedylfqvilekqiriprsl-----svkas~vlkgflnkdp~erlgc~-~~~g~~d---ik~h~ffr~i 522 (593)
T KOG0695|consen 452 DIVGMDNPDMNTEDYLFQVILEKQIRIPRSL-----SVKASHVLKGFLNKDPKERLGCR-PQTGFSD---IKSHAFFRSI 522 (593)
T ss_pred ceecCCCcccchhHHHHHHHhhhccccccee-----ehhhHHHHHHhhcCCcHHhcCCC-cccchhh---hhcchhhhhC
Confidence 63 221 223445556777777777433 55677889999999999996432 1011111 1234455568
Q ss_pred cccccc
Q 013125 315 DWTILK 320 (449)
Q Consensus 315 dw~~l~ 320 (449)
||.++.
T Consensus 523 dwd~le 528 (593)
T KOG0695|consen 523 DWDLLE 528 (593)
T ss_pred CHHHHh
Confidence 898764
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=275.23 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=185.7
Q ss_pred ceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
.|++.+.||.|+||.||+|++. .+++.||+|++.... ....+.+|+++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--------------- 65 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--------------- 65 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCC---------------
Confidence 4899999999999999999985 478899999876431 1234677999998885322
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+++.+..+...+...|+|+||+ +++|.+.+.. ...++...+..++.|++.||.|||+.|++||||+|
T Consensus 66 -----------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p 133 (290)
T cd05613 66 -----------FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133 (290)
T ss_pred -----------ChhceeeEeecCCeEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 3444444455667889999999 8899988875 45689999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC--CCCccchHHHHHHHHHHHHhC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlG~il~el~~G 235 (449)
+|||++ .++.++|+|||++.......... .....|+..|++||.+.+. .++.++||||||+++|+|++|
T Consensus 134 ~nil~~---~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g 204 (290)
T cd05613 134 ENILLD---SNGHVVLTDFGLSKEFHEDEVER------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204 (290)
T ss_pred HHeEEC---CCCCEEEeeCccceecccccccc------cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence 999994 77899999999997654332211 1245688999999998753 468899999999999999999
Q ss_pred CCCCCCChhhcHHHHH-HHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 236 SLPWQGLKAATKKQKY-DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
..||...........+ ..+....... ...+++.+.+++.+||..+|++||+
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 205 ASPFTVDGEKNSQAEISRRILKSEPPY-----PQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred CCCCCcCCccccHHHHHHHhhccCCCC-----CccCCHHHHHHHHHHhcCCHHHhcC
Confidence 9999753222211222 1221111111 2345788999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=274.16 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=192.4
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||.|+||.||+|++..+++.||+|++..... ...+.+|+++++.++|++++...
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~--------------------- 59 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY--------------------- 59 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHH---------------------
Confidence 6899999999999998899999998865422 33577888999999888755432
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
.....+...|+++|++ +++|.+++... ..++...++.++.||+.||.|||++|++||||+|+||++ +++
T Consensus 60 ------~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~ 129 (265)
T cd05579 60 ------YSFQGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSN 129 (265)
T ss_pred ------HheecCcEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCC
Confidence 2234567889999999 78999988763 478999999999999999999999999999999999999 478
Q ss_pred CeEEEEeecceeeecCCCCCc-cccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNR-HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 247 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~ 247 (449)
+.++|+|||++.......... ...........++..|++||.+.+..++.++||||||+++|+|++|..||......
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-- 207 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-- 207 (265)
T ss_pred CCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 899999999987654332100 00001123456788999999999888999999999999999999999999765432
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
..+..+.......+.. ...+..+.+++..||..+|.+||++..+.+.|+
T Consensus 208 -~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 208 -EIFQNILNGKIEWPED---VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -HHHHHHhcCCcCCCcc---ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 2333333323222211 124789999999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=268.97 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=196.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|++++..++|++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~---------------- 64 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY---------------- 64 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEE----------------
Confidence 68999999999999999999998899999998775532 3357889999998888764443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..+...++..+++||++ +++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++
T Consensus 65 -----------~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i 132 (254)
T cd06627 65 -----------IGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT 132 (254)
T ss_pred -----------EEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE
Confidence 33345567889999999 78999888753 678999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+ .++.++|+|||++......... .....++..|++||...+..++.++||||||+++|+|++|..||...
T Consensus 133 ~---~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 133 T---KDGVVKLADFGVATKLNDVSKD-------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred C---CCCCEEEeccccceecCCCccc-------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 4 6789999999999876543321 23456788999999998888899999999999999999999999865
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .....+..... .......+..+.+++..||..+|++||++.++..
T Consensus 203 ~~~---~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 203 NPM---AALFRIVQDDH----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred cHH---HHHHHHhccCC----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 432 12222221111 1223455789999999999999999999887743
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=277.43 Aligned_cols=244 Identities=19% Similarity=0.301 Sum_probs=191.0
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
....+||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~------------------- 83 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY------------------- 83 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhhee-------------------
Confidence 33468999999999999999999999999875432 233578899999999888655443
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
.+....+..++||||+ +++|.+++. ...+++..++.++.|++.+|+|||+.|++||||+|+||++ +
T Consensus 84 --------~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~ 150 (292)
T cd06657 84 --------NSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---T 150 (292)
T ss_pred --------eEEEeCCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---C
Confidence 3345668899999999 778887664 3468999999999999999999999999999999999999 4
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||.+.....
T Consensus 151 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~ 223 (292)
T cd06657 151 HDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223 (292)
T ss_pred CCCCEEEcccccceecccccc-------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 678899999999876543221 1234568899999999988889999999999999999999999998754322
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .+ .......... ....+..+.+++..||..+|.+||++.++..
T Consensus 224 ~~~---~~-~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 224 AMK---MI-RDNLPPKLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHH---HH-HhhCCcccCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 211 11 1112111111 1345788999999999999999999988755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=293.32 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=206.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----C-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----K-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+++++-.||-|+||.|=++........+|+|++++.. + .+....|..||...+.+.+++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvr--------------- 484 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVR--------------- 484 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHH---------------
Confidence 45678889999999999999886555568999887642 1 223677888887766554333
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++--..+.++.|++||-| ||.|...+.. .+.|+..+++.++.-+++|++|||++|||+|||||+|+
T Consensus 485 ------------LYrTfrd~kyvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 485 ------------LYRTFRDSKYVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred ------------HHHHhccchhhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 333345778999999999 9999998876 66799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +..|-+||+|||+|+....... ..+++||+.|.|||++++..-+.++|.||||+++|||++|++||.
T Consensus 552 lL---d~~Gy~KLVDFGFAKki~~g~K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 552 LL---DNRGYLKLVDFGFAKKIGSGRK--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred ee---ccCCceEEeehhhHHHhccCCc--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99 5899999999999998776543 358999999999999999999999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhh--cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHHHhcCCCCCccccc
Q 013125 241 GLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY--GFLKRLFHDLFSREGYDFDFVFDW 316 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~--~~l~~~l~~~~~~~~~~~~~~~dw 316 (449)
+.++. ..+..|+.+. +.+| +.++....+++.+....+|.+|..+ .-|.+ ...+.|...|||
T Consensus 621 ~~dpm---ktYn~ILkGid~i~~P-----r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~D-------IkkH~Wf~gfdw 685 (732)
T KOG0614|consen 621 GVDPM---KTYNLILKGIDKIEFP-----RRITKTATDLIKKLCRDNPTERLGYQKGGIND-------IKKHRWFEGFDW 685 (732)
T ss_pred CCchH---HHHHHHHhhhhhhhcc-----cccchhHHHHHHHHHhcCcHhhhccccCChHH-------HHhhhhhhcCCh
Confidence 87665 4455454432 2333 4457788999999999999999863 22222 123456667899
Q ss_pred cccc
Q 013125 317 TILK 320 (449)
Q Consensus 317 ~~l~ 320 (449)
.-++
T Consensus 686 eglr 689 (732)
T KOG0614|consen 686 EGLR 689 (732)
T ss_pred hhhh
Confidence 7654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=288.50 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=210.6
Q ss_pred eEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+..++||+|+||+||+|.+.-.++ +||+|++..... ..+++.|+-+|..|.|++++++++++..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~-------- 769 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML-------- 769 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc--------
Confidence 4567899999999999999864443 699998765533 4578999999999999999998877632
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
....||++|+ +|+|.++++..+..+-.+..+.|..||+.||.|||+++++||||..+||
T Consensus 770 --------------------s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNV 829 (1177)
T KOG1025|consen 770 --------------------STLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNV 829 (1177)
T ss_pred --------------------chHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhe
Confidence 2266899999 9999999998888899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
||. ....+|+.|||+|+........-.. ......+.|||-|.+....|+.++|||||||++||++| |..||
T Consensus 830 LVk---sP~hvkitdfgla~ll~~d~~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py 901 (1177)
T KOG1025|consen 830 LVK---SPNHVKITDFGLAKLLAPDEKEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPY 901 (1177)
T ss_pred eec---CCCeEEEEecchhhccCcccccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCcc
Confidence 994 8899999999999987665443222 23345678999999999999999999999999999999 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
.++...+....+.+ ..+++.| ..++.++.-+|-.||..|+..||.|+++...|.+..+..
T Consensus 902 ~gi~~~eI~dlle~--geRLsqP-----piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 902 DGIPAEEIPDLLEK--GERLSQP-----PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCHHHhhHHHhc--cccCCCC-----CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 99876544433322 2233333 233789999999999999999999999999998886543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=284.48 Aligned_cols=276 Identities=22% Similarity=0.286 Sum_probs=200.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+-..-|..++.||-|+||+|.+|...+|...+|+|.+.+.+.. .....|..
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERD------------------------ 681 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERD------------------------ 681 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhh------------------------
Confidence 3456799999999999999999999999999999976532110 01122223
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++-+.++.-++++++.+.+.+.+|+||||. ||++-.++.. -+-|.+..++.++.++.+|++++|..|+|||||||
T Consensus 682 ---ILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKP 757 (1034)
T KOG0608|consen 682 ---ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 757 (1034)
T ss_pred ---hHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCc
Confidence 333445556788888889999999999999 9999888875 45699999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccc------------c---------------cc--------CCCCCCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI------------P---------------YR--------ENKNLTGT 202 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~------------~---------------~~--------~~~~~~gt 202 (449)
+|||| |.+|+|||+||||+.-++-......+ | .+ ..-.++||
T Consensus 758 DNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt 834 (1034)
T KOG0608|consen 758 DNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGT 834 (1034)
T ss_pred cceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCC
Confidence 99999 68999999999999754322111000 0 00 12367899
Q ss_pred ccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHh
Q 013125 203 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQ 282 (449)
Q Consensus 203 ~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l 282 (449)
+.|+|||++....|+.-||+||.|+|||||+.|++||-...+.....++.. -+.-+.+ ..|.+++.+..++|.++.
T Consensus 835 ~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n-w~~~l~~---~~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 835 PNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN-WRNFLHI---PYQGNLSKEALDLIQKLC 910 (1034)
T ss_pred CcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee-hhhcccc---ccccccCHHHHHHHHHHh
Confidence 999999999999999999999999999999999999987665433222111 0112222 245666788888887655
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccccc
Q 013125 283 SLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQ 322 (449)
Q Consensus 283 ~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~ 322 (449)
.++++|..-. ..+.+ ....|...+||..+..+
T Consensus 911 -~sad~RLGkn-g~d~v------KaHpfFkgIDfsslRkq 942 (1034)
T KOG0608|consen 911 -CSADSRLGKN-GADQV------KAHPFFKGIDFSSLRKQ 942 (1034)
T ss_pred -cChhhhhccc-chhhh------hcCccccccchHhhhhc
Confidence 3677776422 11111 22455566777655443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.83 Aligned_cols=241 Identities=21% Similarity=0.260 Sum_probs=188.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHH-HcCCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI-LQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.+.|.+...||.|+|+.|-.+.+..+++..++|++.... ....+|+.++.. -+|++++....+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--~~~~~e~~~~~~~~~h~niv~~~~v------------- 384 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--DDNQDEIPISLLVRDHPNIVKSHDV------------- 384 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc--cccccccchhhhhcCCCcceeecce-------------
Confidence 4578999999999999999999999999999999987652 233455544433 455655544333
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..++.+.|+|||++ |+-+.+-+.+ .+.+. ..+..|++||+.++.|||++|||||||||+|||+
T Consensus 385 --------------~~~~~~~~~v~e~l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 385 --------------YEDGKEIYLVMELLDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL 448 (612)
T ss_pred --------------ecCCceeeeeehhccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence 35678899999999 6666665554 33344 7778899999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
. ++.++++|+|||.++...... .+-+-|..|.|||++...+|+++|||||||++||+|++|+.||...
T Consensus 449 ~--~~~g~lrltyFG~a~~~~~~~----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 449 D--GSAGHLRLTYFGFWSELERSC----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred c--CCCCcEEEEEechhhhCchhh----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 4 378899999999998765542 1335588999999999999999999999999999999999999875
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... .+....+....+. ...+++.++|+.+||+.||.+|+++.++..
T Consensus 517 P~~--~ei~~~i~~~~~s-------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 517 PAG--IEIHTRIQMPKFS-------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred Cch--HHHHHhhcCCccc-------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 443 2333332222222 455789999999999999999999998744
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=288.34 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=203.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.+.|+|.+.||.|.+|.||+++..++++.+|+||...+.+ ++++..|.++++.+.+..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hp--------------------- 76 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHP--------------------- 76 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCC---------------------
Confidence 4679999999999999999999999999999999887654 446777888888775433
Q ss_pred cccCCCcCeeEEec-----ccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 85 SSTLGGIPNIKWYG-----VDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 85 ~~~~~~i~~~~~~~-----~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+++.+++++ ..++.+||||||| ||+.-|+++.. +.++.+..+..|++.++.||.+||...+||||||=
T Consensus 77 -----nv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG 151 (953)
T KOG0587|consen 77 -----NVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKG 151 (953)
T ss_pred -----CcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccC
Confidence 444444444 2568899999999 99999999854 66799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-----CCCccchHHHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwSlG~il~el 232 (449)
.|||++ +.+.|||+|||.+...+..-. ..++..||+.|||||++.-. .|+.++|+||||++..||
T Consensus 152 ~NiLLT---~e~~VKLvDFGvSaQldsT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEl 221 (953)
T KOG0587|consen 152 QNVLLT---ENAEVKLVDFGVSAQLDSTVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEM 221 (953)
T ss_pred ceEEEe---ccCcEEEeeeeeeeeeecccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehh
Confidence 999996 889999999999987765432 24688999999999999743 478899999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHh-hccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.-|.+|+.++.+.. .+ ....-.+|+... ++.+..+|.++|..||..|.++||+..++.
T Consensus 222 adG~PPl~DmHPmr---aL---F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 222 AEGAPPLCDMHPMR---AL---FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred cCCCCCccCcchhh---hh---ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 99999999876542 11 111222222222 456688999999999999999999977653
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=273.99 Aligned_cols=247 Identities=19% Similarity=0.244 Sum_probs=180.1
Q ss_pred CceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCee
Q 013125 19 SFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI 94 (449)
Q Consensus 19 ~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 94 (449)
++|.||.+++..+++.||||++.... ....+..|+++++.++|++++..+.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~------------------------- 66 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT------------------------- 66 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhh-------------------------
Confidence 44566666777789999999986541 2335889999999999987665433
Q ss_pred EEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEE
Q 013125 95 KWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 172 (449)
Q Consensus 95 ~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vk 172 (449)
+....+..+++|||+ +++|.+++... ...++...+..++.|++.||+|||++||+||||||+||+++ .++.++
T Consensus 67 --~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~k 141 (314)
T cd08216 67 --SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVV 141 (314)
T ss_pred --eeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceE
Confidence 234567789999999 78898888753 45689999999999999999999999999999999999994 678999
Q ss_pred EEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHH
Q 013125 173 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 250 (449)
Q Consensus 173 L~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~ 250 (449)
|+|||.+............+........++..|+|||++.+. .++.++|||||||++|||++|..||....... ..
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~ 219 (314)
T cd08216 142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--ML 219 (314)
T ss_pred EecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence 999999876643322111111112345677889999998763 58899999999999999999999998644321 11
Q ss_pred HHHHHHhh---------------cC-------C------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 251 YDKICEKK---------------VS-------T------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 251 ~~~i~~~~---------------~~-------~------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...+.... .. . ...........++.+++..||..+|++||+++++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 220 LEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 11110000 00 0 000011223467889999999999999999988755
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=261.34 Aligned_cols=234 Identities=26% Similarity=0.380 Sum_probs=188.4
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.++|++++..
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~---------------------- 58 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL---------------------- 58 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHH----------------------
Confidence 6999999999999988899999998765422 2357889999999988764433
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
......+...|+|||++ +++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++ ..
T Consensus 59 -----~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~ 129 (250)
T cd05123 59 -----HYAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---AD 129 (250)
T ss_pred -----HHHeecCCeeEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CC
Confidence 22335677889999999 9999998875 34689999999999999999999999999999999999994 77
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 248 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~ 248 (449)
+.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|..||..... .
T Consensus 130 ~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~ 199 (250)
T cd05123 130 GHIKLTDFGLAKELSSEGS-------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---K 199 (250)
T ss_pred CcEEEeecCcceecccCCC-------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H
Confidence 8999999999977654321 12355678899999999988899999999999999999999999976443 2
Q ss_pred HHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 249 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
.....+.......+ ...+..+.+++..||..+|++||++.+
T Consensus 200 ~~~~~~~~~~~~~~-----~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 200 EIYEKILKDPLRFP-----EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCCCCC-----CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 33333333222222 334789999999999999999999843
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.94 Aligned_cols=282 Identities=20% Similarity=0.239 Sum_probs=193.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh-h
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT-I 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~ 82 (449)
..|+.++.||+||||.||+|+++-.|+.+|||.+..... ...+.+|+.++.+|+|+|+++++...++........ +
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 568889999999999999999999999999998765532 224789999999999999999885433321110000 0
Q ss_pred h---------h-------------------------cc-----cCCCcC-------------------------eeEEec
Q 013125 83 I---------F-------------------------SS-----TLGGIP-------------------------NIKWYG 98 (449)
Q Consensus 83 ~---------~-------------------------~~-----~~~~i~-------------------------~~~~~~ 98 (449)
+ . .. ...+.+ ....-+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0 0 00 000000 000000
Q ss_pred --------------------cc-------CCeeEEEEecCCCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCc
Q 013125 99 --------------------VD-------GEDNVLVLDLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGF 150 (449)
Q Consensus 99 --------------------~~-------~~~~~lv~e~~g~sL~~~~~~~~~~~-~~~~~~~i~~qil~~L~~LH~~gi 150 (449)
.+ ....||-||||..++...+...+... .....+++.+||++||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 00 03468999999665555544334333 467889999999999999999999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeec----C------CCCCcc-ccccCCCCCCCCccccccccccCCC---C
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----D------PTTNRH-IPYRENKNLTGTARYASCNTHLGIE---Q 216 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~----~------~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~ 216 (449)
|||||||.||++ +.++.|||+|||+|.... . +.+... ..-....+.+||.-|+|||++.+.. |
T Consensus 719 IHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 719 IHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred eeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999 589999999999998621 0 001110 0111345778999999999988665 9
Q ss_pred CccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 217 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
+.|+|+||||+|++||+. ||.. ..+-...+..+....++.+ ..++.+.-+.-+.+|+.+++.||.+||++.+|.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 999999999999999994 5653 2333334444443444444 222222234567899999999999999998875
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
.
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 4
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=291.58 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=202.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEc---C----CCceEEEEEecCCCC---chhHHHHHHHHHHHc-CCCcceeeEeecc
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV---D----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQ-GGSKIRLVVFHVD 73 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~-~~~~~~~~~~~~~ 73 (449)
-.++..+.+.||+|.||.||+|.-. . ....||||..+.... ...+..|+++|+.+. |++++.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l------ 367 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL------ 367 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh------
Confidence 3445577889999999999999753 1 145799999876544 345889999998875 5554444
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHH
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQ 137 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~q 137 (449)
..+.......++|+||+ .|+|..++..++ ..++....+.+++|
T Consensus 368 ---------------------lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~Q 426 (609)
T KOG0200|consen 368 ---------------------LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQ 426 (609)
T ss_pred ---------------------eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHH
Confidence 44445578889999999 999999998765 34889999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCC-CCCccccccccccCCCC
Q 013125 138 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL-TGTARYASCNTHLGIEQ 216 (449)
Q Consensus 138 il~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~ 216 (449)
|+.|++||+++.+|||||.++|||++ .+..+||+|||+|+....... |+...+. .-...|||||.+....|
T Consensus 427 Ia~GMe~L~~~~~vHRDLAaRNVLi~---~~~~~kIaDFGlar~~~~~~~-----y~~~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 427 IANGMEYLASVPCVHRDLAARNVLIT---KNKVIKIADFGLARDHYNKDY-----YRTKSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred HHHHHHHHhhCCccchhhhhhhEEec---CCCEEEEccccceeccCCCCc-----eEecCCCCccceeecCHHHhccCcc
Confidence 99999999999999999999999995 778999999999986544332 2111111 13556999999999999
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++||||||++||||++ |..||.+..... ..+. .+........+. .++.++.++|..||..+|++||+|.++
T Consensus 499 t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--~l~~-~l~~G~r~~~P~---~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 499 TSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--ELLE-FLKEGNRMEQPE---HCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred cccchhhHHHHHHHHHhhCCCCCCCCCCcHH--HHHH-HHhcCCCCCCCC---CCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 999999999999999998 999999844222 1222 223333333333 348899999999999999999999999
Q ss_pred HHHHHHHHHh
Q 013125 296 KRLFHDLFSR 305 (449)
Q Consensus 296 ~~~l~~~~~~ 305 (449)
.+.|...+..
T Consensus 573 ~~~~~~~l~~ 582 (609)
T KOG0200|consen 573 VEFFEKHLQD 582 (609)
T ss_pred HHHHHHHHHH
Confidence 9999886654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=266.98 Aligned_cols=211 Identities=21% Similarity=0.334 Sum_probs=169.0
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
=.+.||.|+||.||.+.|.+.++.||+|.+.+- ....++++|++++-.++|.|....+...
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL--------------- 121 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL--------------- 121 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc---------------
Confidence 357899999999999999999999999965432 2345689999999999999866543321
Q ss_pred cCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
.-+.+.+| ...|+++|++..+|..++.. ...++...++-+++||++||+|||+.||+||||||.|+|+ +
T Consensus 122 ---QPph~dfF----qEiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---N 190 (449)
T KOG0664|consen 122 ---QPANPSFF----QELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---N 190 (449)
T ss_pred ---CCCCchHH----HHHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---c
Confidence 11122222 34688999999999988875 6779999999999999999999999999999999999999 5
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCChhh
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~~~~~ 245 (449)
.++.+||+|||+|+........ .....+.|..|+|||++.|.. |+.++||||.|||+.|++..+..|+...+.
T Consensus 191 SNCvLKICDFGLARvee~d~~~------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 191 SNCILKICDFGLARTWDQRDRL------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred cCceEEecccccccccchhhhh------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 8899999999999876543321 112335688999999999875 999999999999999999999999987766
Q ss_pred cHHHHHHH
Q 013125 246 TKKQKYDK 253 (449)
Q Consensus 246 ~~~~~~~~ 253 (449)
...+.+..
T Consensus 265 qQL~lItd 272 (449)
T KOG0664|consen 265 EQLQMIID 272 (449)
T ss_pred HHHHHHHH
Confidence 55544433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=260.61 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=189.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+.+-+..||.|+||+|++-.++.+|+..|||.+..... ..+++.|.+...+- +.+
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp-------------------- 123 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCP-------------------- 123 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCc--------------------
Confidence 344556789999999999999999999999998876543 33455665543332 233
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKP 157 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~----~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp 157 (449)
+|++++...-.+...||.||+|..++..++++. ...+++..+-.|..-.+.||.||-+ ..|||||+||
T Consensus 124 -------~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKP 196 (361)
T KOG1006|consen 124 -------NIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKP 196 (361)
T ss_pred -------HHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCCh
Confidence 333334344467788999999999998887643 4568888888888889999999997 5899999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHHHHHHHHHHHHhC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el~~G 235 (449)
+|||+ +..|.|||+|||++-.+.+.-. ..--+|-..|||||-+.. ..|+.++||||||++|||++||
T Consensus 197 SNILl---dr~G~vKLCDFGIcGqLv~SiA--------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG 265 (361)
T KOG1006|consen 197 SNILL---DRHGDVKLCDFGICGQLVDSIA--------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG 265 (361)
T ss_pred hheEE---ecCCCEeeecccchHhHHHHHH--------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence 99999 5899999999999865543321 124467889999998863 3589999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHH-HhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||.+... ..+++..++.+..+.... .-+-.+...+..++..|+..|-.+||.|.+|+.
T Consensus 266 ~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 266 NFPYRKWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCcchHHH--HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 999998665 334444444333222211 122345778999999999999999999998865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=286.93 Aligned_cols=263 Identities=19% Similarity=0.210 Sum_probs=169.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCC----CceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDT----NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~----~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
..++|.+.++||+|+||.||+|++..+ +..||+|.+...... |..+...+++....... .. ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e~l~~~~~~~~~----~~--~~~- 197 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNERVRRACPNSCA----DF--VYG- 197 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHHHHHhhchhhHH----HH--HHh-
Confidence 357899999999999999999999888 899999987643222 22222222221100000 00 000
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCC-------------------CCHHHHHHHHHHHHH
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK-------------------FSLKTVLMLADQMIA 140 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~-------------------~~~~~~~~i~~qil~ 140 (449)
...... ...+...++|+||+ +++|.+++...... .....+..++.||+.
T Consensus 198 ---------~~~~~~--~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~ 266 (566)
T PLN03225 198 ---------FLEPVS--SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILF 266 (566)
T ss_pred ---------hhcccc--cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHH
Confidence 000000 24567789999999 78898887643211 123456789999999
Q ss_pred HHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC------
Q 013125 141 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------ 214 (449)
Q Consensus 141 ~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------ 214 (449)
||+|||++||+||||||+|||++ ++.+.+||+|||+|+........ ......+++.|+|||.+...
T Consensus 267 aL~yLH~~gIiHRDLKP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~ 338 (566)
T PLN03225 267 ALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSA 338 (566)
T ss_pred HHHHHHHCCEEeCcCCHHHEEEe--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCC
Confidence 99999999999999999999994 24578999999999865433221 12456789999999976432
Q ss_pred ----------------CCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcC-----------CCHHH--
Q 013125 215 ----------------EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-----------TPIEV-- 265 (449)
Q Consensus 215 ----------------~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~-----------~~~~~-- 265 (449)
.++.++|||||||++|||+++..++.... ..+..++..... .....
T Consensus 339 ~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 413 (566)
T PLN03225 339 PSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL-----IQFNRQLKRNDYDLVAWRKLVEPRASPDLR 413 (566)
T ss_pred ccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHH-----HHHHHHHHhcCCcHHHHHHhhccccchhhh
Confidence 23456799999999999999876654311 111111111000 00000
Q ss_pred ----hhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 266 ----LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 266 ----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
..........+|+..|+..||.+||++.++.+ +.++..
T Consensus 414 ~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~--Hpff~~ 455 (566)
T PLN03225 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA--HPYFDR 455 (566)
T ss_pred hhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC--CcCcCC
Confidence 00011233558999999999999999887754 344433
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=266.73 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=198.3
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHH--HcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
..++.+.||+|.||.||+|+. +++.||||++.. .....+.+|..|+.. ++|++++.++......
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~----------- 276 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG----------- 276 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCH-HHHHHHHhHHHHHhccCccchhHHHhhchhccC-----------
Confidence 356788999999999999987 679999999875 344568888888876 5777766655432111
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCC
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDI 155 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---------giiHrDL 155 (449)
......++||++|. .|+|.++++ ...+++....+++.-|+.||+|||+. .|+||||
T Consensus 277 ------------t~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDl 342 (534)
T KOG3653|consen 277 ------------TADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDL 342 (534)
T ss_pred ------------CccccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccc
Confidence 01244789999999 999999998 46799999999999999999999962 3999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-C-----CccchHHHHHHHH
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-Q-----SRRDDLESLGYVL 229 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----s~~~DvwSlG~il 229 (449)
|..|||| ..+.++.|+|||+|.++....... ..-.-+||.+|||||++.+.- + -.+.||||+|.+|
T Consensus 343 kSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~-----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 343 KSKNVLV---KNDLTCCIADFGLALRLEPGKPQG-----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred cccceEE---ccCCcEEeeccceeEEecCCCCCc-----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 9999999 488999999999999887433221 123578999999999998753 2 2368999999999
Q ss_pred HHHHhCC------------CCCCCChh--hcHHHHHHHHHHhhcCCCHHHhhccC--hHHHHHHHHHHhCCCCCCCCCHH
Q 013125 230 LYFLRGS------------LPWQGLKA--ATKKQKYDKICEKKVSTPIEVLCKSH--PAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 230 ~el~~G~------------~pf~~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
|||++.- +||+..-+ ....+....++.++..+.++..|... ..-+++.++.||..|++.|.++.
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 9999742 33431111 11233334456677777777766544 46789999999999999999999
Q ss_pred HHHHHHHHHH
Q 013125 294 FLKRLFHDLF 303 (449)
Q Consensus 294 ~l~~~l~~~~ 303 (449)
-+.+++.++.
T Consensus 495 Cv~eR~~~l~ 504 (534)
T KOG3653|consen 495 CVEERMAELM 504 (534)
T ss_pred HHHHHHHHHh
Confidence 9988887663
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=257.06 Aligned_cols=220 Identities=17% Similarity=0.182 Sum_probs=169.5
Q ss_pred cCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEe
Q 013125 18 GSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWY 97 (449)
Q Consensus 18 G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 97 (449)
|.||.||+|++..+++.||+|++.... ....|...+....|+ +++.+..+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~---------------------------~i~~~~~~ 53 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCVP---------------------------NMVCLHKY 53 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCCC---------------------------ceeehhhh
Confidence 899999999999999999999886543 223343333333333 44445555
Q ss_pred cccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEee
Q 013125 98 GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176 (449)
Q Consensus 98 ~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~Df 176 (449)
+...+..|+||||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||++. .++.++|+||
T Consensus 54 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df 129 (237)
T cd05576 54 IVSEDSVFLVLQHAEGGKLWSHISK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYF 129 (237)
T ss_pred eecCCeEEEEEecCCCCCHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecc
Confidence 56778899999999 8899988865 34689999999999999999999999999999999999994 7788999999
Q ss_pred cceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHH
Q 013125 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 256 (449)
Q Consensus 177 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~ 256 (449)
|.+....... ....++..|+|||.+.+..++.++||||+||++|||++|..||...... ... .
T Consensus 130 ~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~--~ 192 (237)
T cd05576 130 SRWSEVEDSC----------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT--H 192 (237)
T ss_pred cchhcccccc----------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc--c
Confidence 9876544321 1334567899999998888999999999999999999999887642211 000 0
Q ss_pred hhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 257 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.....| ...++.+++++..||+.||.+|++..
T Consensus 193 ~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 193 TTLNIP-----EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cccCCc-----ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 011111 33578899999999999999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=245.25 Aligned_cols=281 Identities=19% Similarity=0.320 Sum_probs=197.7
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.++|++.+++|+|-|++||.|....++++++||+++.- +...+.+|++||+.|. |+|++.++....+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~D----------- 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKD----------- 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcC-----------
Confidence 46899999999999999999999999999999999863 3456899999999998 7777766544322
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+......|++|+. ..+...++ ..++...++.++.|++.||.|+|+.||+|||+||.|+||.
T Consensus 105 --------------p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId 166 (338)
T KOG0668|consen 105 --------------PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID 166 (338)
T ss_pred --------------ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec
Confidence 3445567899998 56666554 3578889999999999999999999999999999999995
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCC-C
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ-G 241 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~-~ 241 (449)
.....++|+|+|+|..+..... .+-.+.+..|-.||.+.... |+..-|+|||||++..|+..+.||. |
T Consensus 167 --h~~rkLrlIDWGLAEFYHp~~e--------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 167 --HELRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred --hhhceeeeeecchHhhcCCCce--------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 4567899999999987654332 23445567788999888765 8999999999999999999887775 5
Q ss_pred ChhhcHHHHHHHHHHhhc-CCCHHHhhccChHHHHHHHHHHhCC------CCCCCCCH-HHHHHHHHHHHHhcCCCCCcc
Q 013125 242 LKAATKKQKYDKICEKKV-STPIEVLCKSHPAEFASYFHYCQSL------TFDQRPDY-GFLKRLFHDLFSREGYDFDFV 313 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~------~p~~Rp~~-~~l~~~l~~~~~~~~~~~~~~ 313 (449)
.++.+...++.++++... ..-.....-.+++++.+++..--.. +++.+--. .+..++|
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDll-------------- 302 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLL-------------- 302 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHH--------------
Confidence 555544444444433210 0000111112234444443221110 11111000 1122222
Q ss_pred cccccccccccccccccccCCCCccccCC
Q 013125 314 FDWTILKYQQTQKTKSQDLLPASRVTNSR 342 (449)
Q Consensus 314 ~dw~~l~~~~~~~~~~~~~~~~~~~~~~~ 342 (449)
| ++|.|+...|.++++++.|++|....
T Consensus 303 -d-klLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 303 -D-KLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred -H-HHHhhccccccchHHHhcCchHHHHH
Confidence 2 66788888999999999999886544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=299.49 Aligned_cols=251 Identities=14% Similarity=0.196 Sum_probs=184.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
..|...+.||+|+||.||+|++..++..||+|.+..... ....|+++++.++|++++.+++.
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~---------------- 751 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGL---------------- 751 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEE----------------
Confidence 346677899999999999999988999999998764332 23456888898988876665443
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEe
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH---SRGFLHRDIKPDNFLM 162 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH---~~giiHrDLkp~Nill 162 (449)
+...+..|+||||+ +++|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 752 -----------~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 752 -----------CRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred -----------EEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 34566789999999 899999885 3889999999999999999999 6799999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
. ..+..++. ||.+..... .....+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 817 ~---~~~~~~~~-~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 817 D---GKDEPHLR-LSLPGLLCT-----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred C---CCCceEEE-ecccccccc-----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 3 55555554 665433211 12336789999999999999999999999999999999999999543
Q ss_pred hhhc-HHHHHHHHH------HhhcCCCHH---HhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 243 KAAT-KKQKYDKIC------EKKVSTPIE---VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 243 ~~~~-~~~~~~~i~------~~~~~~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.... ......... ......... ........++.+++..||..+|++||++.++.+.|+++.+.
T Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 2211 000000000 000000000 00001134678899999999999999999999999877553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=249.25 Aligned_cols=285 Identities=22% Similarity=0.307 Sum_probs=211.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecC----CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+..||.-+..+|.|.- .|..|.|.-+++.||+|.... ....++..+|..++..++|.++++.+.........
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l--- 90 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL--- 90 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH---
Confidence 3468999999999999 899999999999999996442 23455689999999999999998877654433221
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.....+|+|||++..+|...+. -.++-.++..+++|+++|++|||+.||+||||||+||
T Consensus 91 ------------------~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsni 149 (369)
T KOG0665|consen 91 ------------------EEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNI 149 (369)
T ss_pred ------------------HHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccc
Confidence 2335679999999999998886 3467789999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ +.++.+||.|||+|+.....- .....+.|..|+|||++.+-.|.+.+||||+||++.||++|...|.
T Consensus 150 vv---~~~~~lKi~dfg~ar~e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 150 VV---NSDCTLKILDFGLARTEDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ee---cchhheeeccchhhcccCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 99 588999999999997543321 1345688999999999999999999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC---------CCCC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG---------YDFD 311 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~---------~~~~ 311 (449)
|..- ...+.++.+.... |-+.....+.+..+.++. .||.+.. -.+.+.+.... .+..
T Consensus 219 g~d~---idQ~~ki~~~lgt-pd~~F~~qL~~~~r~yv~--------~~~~y~~--~~f~~~fpD~~f~~~~e~~~~~~~ 284 (369)
T KOG0665|consen 219 GKDH---IDQWNKIIEQLGT-PDPSFMKQLQPTVRNYVE--------NRPQYQA--ISFSELFPDSLFPVVLEGSKLDCS 284 (369)
T ss_pred CchH---HHHHHHHHHHhcC-CCHHHHHHhhHHHHHHhh--------cChHhhc--cchhhhCCcccccccccCCccchH
Confidence 7443 3445555544433 333333344444444443 2222221 11222221110 1111
Q ss_pred --cccccccccccccccccccccCCCCccc
Q 013125 312 --FVFDWTILKYQQTQKTKSQDLLPASRVT 339 (449)
Q Consensus 312 --~~~dw~~l~~~~~~~~~~~~~~~~~~~~ 339 (449)
..+-++||..+|+.|.+.++++.||++.
T Consensus 285 ~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 285 LARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1122488999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=247.52 Aligned_cols=261 Identities=18% Similarity=0.286 Sum_probs=197.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCC-----ceEEEEEecCCCCch---hHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKHP---QLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvKv~~~~~~~~---~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+-..|+++...+-+|.||.||.|.+.+.. +.|-+|.++.....- .++.|.-.+..+.|+|+....+++
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~---- 356 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS---- 356 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE----
Confidence 45678999999999999999999775432 345566555433222 245555555555666644443332
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHS 147 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-------~~~~~~~~~~i~~qil~~L~~LH~ 147 (449)
..+....++++.+. -++|..++..|+ +.++..+...++.|++.|++|||+
T Consensus 357 ----------------------ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~ 414 (563)
T KOG1024|consen 357 ----------------------IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN 414 (563)
T ss_pred ----------------------eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 23456667778888 789999888553 357778889999999999999999
Q ss_pred CCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHH
Q 013125 148 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY 227 (449)
Q Consensus 148 ~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 227 (449)
+||||.||...|++| ++.-+|||+|=.+++.....++..- ......+..||++|.+.+..|+.++||||||+
T Consensus 415 ~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGV 486 (563)
T KOG1024|consen 415 HGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGV 486 (563)
T ss_pred cCcccchhhhhccee---hhheeEEeccchhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHH
Confidence 999999999999999 5889999999999997665543211 12333467899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 228 VLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 228 il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
+||||+| |+.||...++.+....+.+ +.++..| -++|+++..+|..||.+.|++||+++++...|.++..+
T Consensus 487 llWELmtlg~~PyaeIDPfEm~~ylkd--GyRlaQP-----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 487 LLWELMTLGKLPYAEIDPFEMEHYLKD--GYRLAQP-----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHHhcCCCCccccCHHHHHHHHhc--cceecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 9999999 9999988766543322211 2222333 45699999999999999999999999999999887554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=238.16 Aligned_cols=236 Identities=26% Similarity=0.348 Sum_probs=184.7
Q ss_pred CceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeE
Q 013125 19 SFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIK 95 (449)
Q Consensus 19 ~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 95 (449)
+||.||+|.+..+++.||+|+...... .+.+.+|++.++.++|.+++...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~--------------------------- 53 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLY--------------------------- 53 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHH---------------------------
Confidence 689999999988899999999876544 45788999999999887654432
Q ss_pred EecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEE
Q 013125 96 WYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174 (449)
Q Consensus 96 ~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~ 174 (449)
.++......++++|++ +++|.+++.... .++...+..++.+++.+|.|||+.+++|+||+|+||++. +.+.++|+
T Consensus 54 ~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~ 129 (244)
T smart00220 54 DVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLA 129 (244)
T ss_pred hheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEc
Confidence 2334457889999999 559999887533 389999999999999999999999999999999999994 67899999
Q ss_pred eecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHH
Q 013125 175 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 254 (449)
Q Consensus 175 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i 254 (449)
|||.+........ .....++..|++||.+.+..++.++||||||+++|+|++|..||...... ......
T Consensus 130 d~~~~~~~~~~~~--------~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~- 198 (244)
T smart00220 130 DFGLARQLDPGGL--------LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKK- 198 (244)
T ss_pred cccceeeeccccc--------cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH-
Confidence 9999987655421 23556788999999999888999999999999999999999999763221 112221
Q ss_pred HHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 255 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
........ ......++.++.+++..||..+|.+||++.++.+
T Consensus 199 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 199 IGKPKPPF-PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HhccCCCC-ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11111111 1111115789999999999999999999888754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=258.96 Aligned_cols=208 Identities=22% Similarity=0.246 Sum_probs=144.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc----------------CCCceEEEEEecCCCC--chhH--------------H
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV----------------DTNEIVAVKIENSGTK--HPQL--------------L 50 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~~~~vAvKv~~~~~~--~~~~--------------~ 50 (449)
++-.++|++.++||+|+||.||+|.+. ..++.||||.++.... ...+ .
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999752 2345799998764321 1122 2
Q ss_pred HHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEec--------ccCCeeEEEEecC-CCCHHHHHHH
Q 013125 51 YEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYG--------VDGEDNVLVLDLL-GPSLEDLFVY 121 (449)
Q Consensus 51 ~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--------~~~~~~~lv~e~~-g~sL~~~~~~ 121 (449)
.|+.++..+++.++... .+..+..+. ......+||+||+ +++|.+++..
T Consensus 221 vE~~~l~~l~~~~l~~~----------------------~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~ 278 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAA----------------------SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDG 278 (507)
T ss_pred HHHHHHHHhhcccchhh----------------------hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhh
Confidence 34555555555432111 011111111 1235679999999 8899888763
Q ss_pred hc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecc
Q 013125 122 CR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178 (449)
Q Consensus 122 ~~-----------------------~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGl 178 (449)
.. ..+++..++.++.|++.+|.|||+++|+||||||+|||+. .++.+||+|||+
T Consensus 279 ~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGl 355 (507)
T PLN03224 279 KLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGA 355 (507)
T ss_pred ccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcC
Confidence 21 1245678899999999999999999999999999999994 678999999999
Q ss_pred eeeecCCCCCccccccCCCCCCCCccccccccccCCCC----------------------CccchHHHHHHHHHHHHhCC
Q 013125 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ----------------------SRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 179 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----------------------s~~~DvwSlG~il~el~~G~ 236 (449)
+.......... .....+|+.|++||++..... ..+.||||+||++|+|++|.
T Consensus 356 a~~~~~~~~~~------~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~ 429 (507)
T PLN03224 356 AVDMCTGINFN------PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPE 429 (507)
T ss_pred ccccccCCccC------ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCC
Confidence 97554322110 112234789999998764321 23479999999999999987
Q ss_pred C-CCCC
Q 013125 237 L-PWQG 241 (449)
Q Consensus 237 ~-pf~~ 241 (449)
+ ||.+
T Consensus 430 l~p~~~ 435 (507)
T PLN03224 430 LRPVAN 435 (507)
T ss_pred CCCccc
Confidence 5 7754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=257.04 Aligned_cols=194 Identities=23% Similarity=0.352 Sum_probs=166.0
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----------CchhHHHHHHHHHHHc---CCCcceeeEeecch
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQ---GGSKIRLVVFHVDH 74 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----------~~~~~~~E~~~l~~l~---~~~~~~~~~~~~~~ 74 (449)
.|..++.||+|+||.||+|.+++++..|+||.+.+.. +.-..-.|++||..|+ |+|++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl--------- 632 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL--------- 632 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh---------
Confidence 5999999999999999999999999999999876541 1112457999999998 65544
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC--CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~--g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
++..|+++++++||+||-. |.+|.+++.. ...+++..++.|..|++.|+++||+.||||
T Consensus 633 ------------------KlLdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivh 693 (772)
T KOG1152|consen 633 ------------------KLLDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVH 693 (772)
T ss_pred ------------------hhhheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCcee
Confidence 4455668889999999999 6678888875 567999999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLY 231 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~e 231 (449)
||||-+|+++ +.+|.+||+|||.|....... ...++||..|+|||++.|..| +..-|||++|++||-
T Consensus 694 rdikdenviv---d~~g~~klidfgsaa~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillyt 761 (772)
T KOG1152|consen 694 RDIKDENVIV---DSNGFVKLIDFGSAAYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYT 761 (772)
T ss_pred cccccccEEE---ecCCeEEEeeccchhhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeE
Confidence 9999999999 589999999999986554332 247899999999999999987 778899999999999
Q ss_pred HHhCCCCCCC
Q 013125 232 FLRGSLPWQG 241 (449)
Q Consensus 232 l~~G~~pf~~ 241 (449)
+++...||..
T Consensus 762 ivykenpyyn 771 (772)
T KOG1152|consen 762 IVYKENPYYN 771 (772)
T ss_pred EEeccCCCcC
Confidence 9999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=266.63 Aligned_cols=245 Identities=22% Similarity=0.206 Sum_probs=180.3
Q ss_pred eeeecccCce-eEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 12 GRKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 12 ~~~LG~G~fg-~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
.+.+|.|+-| .||+|.. .++.||||.+-.. ..+...+|+++++.-. |+|+++
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-~~~~A~rEi~lL~eSD~H~NviR----------------------- 567 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE-FFDFAQREIQLLQESDEHPNVIR----------------------- 567 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH-hHHHHHHHHHHHHhccCCCceEE-----------------------
Confidence 4678899988 5899987 7889999976532 2335688999887653 333332
Q ss_pred CcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS---LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~---~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
++....+..+.||+.|+|..+|.++++.....+. .-..+.++.|++.||++||+.+||||||||.||||...+
T Consensus 568 ----yyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 568 ----YYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred ----EEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 2223345677899999999999999986322211 134577899999999999999999999999999997542
Q ss_pred --CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCh
Q 013125 167 --KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 243 (449)
Q Consensus 167 --~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~ 243 (449)
...+++|+|||+++.+...... ++...+..||-+|+|||++.....+.++||+||||++|+.++ |..||....
T Consensus 644 ~~~~~ra~iSDfglsKkl~~~~sS----~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 644 ADGTLRAKISDFGLSKKLAGGKSS----FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred CCcceeEEecccccccccCCCcch----hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 3457899999999987665432 344568899999999999999998999999999999999998 599998644
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..+. .|+.....- ..+......+..+||..++..+|..||++.++..
T Consensus 720 ~R~~-----NIl~~~~~L--~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 720 ERQA-----NILTGNYTL--VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred Hhhh-----hhhcCccce--eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 3221 122111110 0000000127899999999999999999988743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=222.77 Aligned_cols=209 Identities=21% Similarity=0.279 Sum_probs=158.2
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
..-+..||+|+||.|=+.++..+|...|+|.+...-+. .++++|+.+...-
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~-------------------------- 101 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT-------------------------- 101 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC--------------------------
Confidence 34567899999999999999999999999987654332 2233343332211
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEE
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFL 161 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp~Nil 161 (449)
...+.++.|+.........+|.||.|..+|..+.+. .+..+++..+-+|+..+..||+|||++ .+||||+||+|||
T Consensus 102 ~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiL 181 (282)
T KOG0984|consen 102 VDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNIL 181 (282)
T ss_pred CCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEE
Confidence 111233333333346678899999999999887763 367799999999999999999999996 8999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC----CCCCccchHHHHHHHHHHHHhCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG----IEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+ +..++||++|||++-.+.+.-. ...-.|...|||||.+.. ..|+.++||||||++++||.+++.
T Consensus 182 I---n~~GqVKiCDFGIsG~L~dSiA--------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~ 250 (282)
T KOG0984|consen 182 I---NYDGQVKICDFGISGYLVDSIA--------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF 250 (282)
T ss_pred E---ccCCcEEEcccccceeehhhhH--------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence 9 6899999999999976655432 123567789999998763 368999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICE 256 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~ 256 (449)
||.... ...+++..+++
T Consensus 251 PY~~w~--tpF~qLkqvVe 267 (282)
T KOG0984|consen 251 PYESWG--TPFQQLKQVVE 267 (282)
T ss_pred cccccC--CHHHHHHHHhc
Confidence 998643 33455555444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=246.62 Aligned_cols=294 Identities=23% Similarity=0.303 Sum_probs=207.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcC---CCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.+.|+++++||+|.|+.||+|.+.. .++.||+|-+.....-.++.+|+++|..+.+..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~------------------ 95 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSD------------------ 95 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccch------------------
Confidence 45789999999999999999999976 788999998887777778999999999998876
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.++..+..+.+..++|+||+ -....+++. .++...++.+++.++.||+++|.+|||||||||.||
T Consensus 96 --------ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNF 163 (418)
T KOG1167|consen 96 --------NIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNF 163 (418)
T ss_pred --------hhhcchhhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccc
Confidence 4555666677889999999999 455556543 478999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCC----------------CC---------------------ccccccCCCCCCCCc
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPT----------------TN---------------------RHIPYRENKNLTGTA 203 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~----------------~~---------------------~~~~~~~~~~~~gt~ 203 (449)
|+. ...+.-.|+|||+|....... .+ ......+.....||+
T Consensus 164 L~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~ 241 (418)
T KOG1167|consen 164 LYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTP 241 (418)
T ss_pred ccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCC
Confidence 996 456778899999997211000 00 000111234667999
Q ss_pred cccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHh
Q 013125 204 RYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQ 282 (449)
Q Consensus 204 ~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l 282 (449)
+|+|||++.+.+ .+.++||||.|+|+.-+++++.||....+. ...+.+|+.......+.. .+.+....+
T Consensus 242 GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd--~~al~ei~tifG~~~mrk--------~A~l~g~~~ 311 (418)
T KOG1167|consen 242 GFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDD--ADALAEIATIFGSAEMRK--------CAALPGRIL 311 (418)
T ss_pred CCCchHHHhhccCcCCccceeeccceeehhhccccccccCccc--cchHHHHHHHhChHHHHH--------HhhcCCcee
Confidence 999999999876 799999999999999999999999754332 122223222222222111 122222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHH-HhcC---------CCCCcc-----ccc--ccccccccccccccccCCCCcccc
Q 013125 283 SLTFDQRPDYGFLKRLFHDLF-SREG---------YDFDFV-----FDW--TILKYQQTQKTKSQDLLPASRVTN 340 (449)
Q Consensus 283 ~~~p~~Rp~~~~l~~~l~~~~-~~~~---------~~~~~~-----~dw--~~l~~~~~~~~~~~~~~~~~~~~~ 340 (449)
-+.++.+|+..++...++.+. ..-. ..+.+. +|. +.+..+|.+|.++.+++.|+.+..
T Consensus 312 l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 312 LWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 122244666555555444441 1100 011111 121 557789999999999999999883
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=228.41 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=177.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.+.|.|.+.||+|.||.+-+|++..++..+++|.+... .....|.+|...--.|.++. |
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~----------h--------- 82 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQ----------H--------- 82 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccch----------h---------
Confidence 347899999999999999999999999999999976543 33445666653322222111 0
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
-+-.+...+...+.+++++||+ .|+|..-+.. ..+-+...+.++.|++.||+|||++++||||||.+||||
T Consensus 83 ------Ii~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 83 ------IIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI 154 (378)
T ss_pred ------hhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence 1111223345566888999999 8888876653 457788889999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-----CCCccchHHHHHHHHHHHHhCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwSlG~il~el~~G~~ 237 (449)
-.. +..+|||+|||+++.....- .-+.-+..|.+||+.... ...+..|+|.||+++|.++||.+
T Consensus 155 f~~-df~rvKlcDFG~t~k~g~tV----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~ 223 (378)
T KOG1345|consen 155 FDA-DFYRVKLCDFGLTRKVGTTV----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF 223 (378)
T ss_pred ecC-CccEEEeeecccccccCcee----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence 654 44599999999987543211 122335678888865422 24678999999999999999999
Q ss_pred CCCCChhhcH-HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 238 PWQGLKAATK-KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 238 pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
||+.....+. ...+.+-. .+.....+...+.+.+.+..++.+-+..++.+|--
T Consensus 224 PWQka~~~d~~Y~~~~~w~-~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drck 277 (378)
T KOG1345|consen 224 PWQKASIMDKPYWEWEQWL-KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCK 277 (378)
T ss_pred cchhhhccCchHHHHHHHh-cccCccCchhhcccCHHHHHHHHHhcCCcccccch
Confidence 9995333221 11222222 23333455556667788999999999999999943
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-28 Score=217.04 Aligned_cols=207 Identities=30% Similarity=0.443 Sum_probs=175.2
Q ss_pred ecccCceeEEEEEEcCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCc
Q 013125 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI 91 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 91 (449)
||+|++|.||++.+..+++.+++|+....... ..+.+|++.++.+++.+ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~---------------------------i 53 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPN---------------------------I 53 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCC---------------------------e
Confidence 68999999999999888999999998876543 67899999999998754 4
Q ss_pred CeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCC-CC
Q 013125 92 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-AN 169 (449)
Q Consensus 92 ~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~-~~ 169 (449)
+.+..++......++++|++ +++|.+++......++...+..++.+++.+|.+||++|++|+||+|.||++. . .+
T Consensus 54 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~ 130 (215)
T cd00180 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNG 130 (215)
T ss_pred eeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCC
Confidence 44555555667889999999 5999999876445789999999999999999999999999999999999994 5 68
Q ss_pred eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCChhhcHH
Q 013125 170 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 248 (449)
Q Consensus 170 ~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~ 248 (449)
.++|+|||.+........ ......+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 131 ~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------- 187 (215)
T cd00180 131 KVKLADFGLSKLLTSDKS-------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------- 187 (215)
T ss_pred cEEEecCCceEEccCCcc-------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------
Confidence 999999999987654431 01245577889999999887 788999999999999999
Q ss_pred HHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 249 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..+.+++..|+..+|++||++.++.+
T Consensus 188 -----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 188 -----------------------PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred -----------------------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 46889999999999999999887754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=254.01 Aligned_cols=249 Identities=18% Similarity=0.259 Sum_probs=199.4
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|.++.++|+|.||.||+|+++.+++..|+|+++... +...+..|+-+++..+|+|++-+++..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy------------ 81 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY------------ 81 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh------------
Confidence 578999999999999999999999999999999988653 344567888888888888877655432
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
...+..+++|||| ||+|.++..- ...+++.++....++.+.||+|||++|-+|||||-.|||+
T Consensus 82 ---------------lr~dklwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 82 ---------------LRRDKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred ---------------hhhcCcEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 3456789999999 8888887653 5678999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+ +.+.+||.|||.+-.+...-. ..+.+.||+.|||||+- +...|...+|||++|++..|+..-++|.
T Consensus 146 t---d~gDvklaDfgvsaqitati~-------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 146 T---DEGDVKLADFGVSAQITATIA-------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred c---ccCceeecccCchhhhhhhhh-------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 5 889999999999876654432 24688999999999964 4667999999999999999999988887
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHH-HhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
....+.... .++.+-...|+. .-...+.+.|.++++.|+..+|.+||+.+.+.
T Consensus 216 fdlhpmr~l----~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 216 FDLHPMRAL----FLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cccchHHHH----HHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 665443211 122222222222 22234578899999999999999999987653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=215.23 Aligned_cols=197 Identities=32% Similarity=0.490 Sum_probs=163.0
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
|.+.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|++.++.+++.+++..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~------------------ 62 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKL------------------ 62 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhh------------------
Confidence 678999999999999999998889999999987653 34467889999988877654433
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
..+.......++++|++ +++|.+++......++...+..++.|++.+|.+||+++++|+||+|.||++.
T Consensus 63 ---------~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~- 132 (225)
T smart00221 63 ---------YGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG- 132 (225)
T ss_pred ---------eeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-
Confidence 33344557889999999 5699998876433389999999999999999999999999999999999994
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
..+.++|+|||++......... ......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 133 --~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 133 --MDGLVKLADFGLARFIHRDLAA------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --CCCCEEEeeCceeeEecCcccc------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 6689999999999877654310 11345678889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=203.12 Aligned_cols=166 Identities=17% Similarity=0.183 Sum_probs=127.4
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCcccc
Q 013125 113 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 192 (449)
Q Consensus 113 ~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~ 192 (449)
|+|.+++...+..+++.+++.++.||+.||.|||+++ ||+|||+ +.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence 6888988876677999999999999999999999998 9999999 47788888 9999765432
Q ss_pred ccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHH--HhhccC
Q 013125 193 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE--VLCKSH 270 (449)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~ 270 (449)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+.......... ......
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHH
Confidence 2257899999999999999999999999999999999999997643321 2222222221111000 001112
Q ss_pred hH--HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 271 PA--EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 271 ~~--~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
+. ++.+++..||..+|.+||++.++.+.+....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 23 6999999999999999999999887665543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=249.14 Aligned_cols=187 Identities=14% Similarity=0.173 Sum_probs=134.5
Q ss_pred CeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec----------------C
Q 013125 102 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----------------G 165 (449)
Q Consensus 102 ~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~----------------~ 165 (449)
..+++++|+++++|.+++......++..+++.+++||+.||+|||++||+||||||+||||+. .
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred chhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 457788999999999999765667999999999999999999999999999999999999942 1
Q ss_pred CCCCeEEEEeecceeeecCCC--------CCcccccc-CCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 166 RKANQVYIIDFGLAKKYRDPT--------TNRHIPYR-ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~--------~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
+..+.+|++|||+++...... .....|+. ......||+.|+|||++.+..|+.++|||||||+||||++|.
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 234556777777775422100 00000100 011346899999999999999999999999999999999998
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|+..... .+..+..... +. ..... .+....++..||..+|.+||++.++.+
T Consensus 213 ~~~~~~~~-----~~~~~~~~~~--~~-~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 213 SSREEKSR-----TMSSLRHRVL--PP-QILLN-WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CchhhHHH-----HHHHHHHhhc--Ch-hhhhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88754211 1111211111 11 11111 345678889999999999999998854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=212.61 Aligned_cols=171 Identities=18% Similarity=0.197 Sum_probs=128.7
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcC-CCceEEEEEecCCC-----C--chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT-----K--HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvKv~~~~~-----~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
+.+.++|++.+.||+|+||+||+|++.. +++.||||+..... . ...+.+|+++++.++|++++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~-------- 85 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP-------- 85 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc--------
Confidence 5678899999999999999999999876 67778999865321 1 234789999999999887443
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.+..+ ...||||||+ |++|.. +. ... ...++.|++.+|.|||++||+||
T Consensus 86 ------------------~l~~~----~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHr 135 (365)
T PRK09188 86 ------------------QLLAT----GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHN 135 (365)
T ss_pred ------------------EEEEc----CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeC
Confidence 22222 3469999999 777752 21 111 14678999999999999999999
Q ss_pred CC-CCCcEEeecCCCCCeEEEEeecceeeecCCCCCcccc-ccCCCCCCCCccccccccccCC
Q 013125 154 DI-KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP-YRENKNLTGTARYASCNTHLGI 214 (449)
Q Consensus 154 DL-kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 214 (449)
|| ||+|||++ .++.+||+|||+|+.+........+. +..-....++..|++||.+...
T Consensus 136 DL~KP~NILv~---~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 136 DLAKPQNWLMG---PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCCcceEEEc---CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99 99999994 66789999999999876654332221 1222466788899999988743
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=226.58 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=192.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+-+..|.|.+.||+|+||.||+|.+.+ ++.||||+.+....++ ++.=.+++.+|+ +....
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk-~~~~~----------------- 754 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLK-PQMLP----------------- 754 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhc-hhhhc-----------------
Confidence 457889999999999999999999876 9999999998766553 444456777777 22111
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+..+..+-...+..+||+||. .|+|.+++. ..+.+++..++.+..||+..+++||.++|||+||||+|+|+
T Consensus 755 ------~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll 827 (974)
T KOG1166|consen 755 ------SIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLL 827 (974)
T ss_pred ------chHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEe
Confidence 1111112223556779999999 999999988 35668999999999999999999999999999999999999
Q ss_pred ecC----CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 163 GLG----RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 163 ~~~----~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
.+. .+...++|+|||.|..+.--..+.. -+..++|-.+-++|+..|.+|++.+|.|.|+.+++-|+.|+..
T Consensus 828 ~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~-----F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 828 RREICADSDSKGLYLIDFGRSIDMKLFPDGTK-----FKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccCCCCcccceEEEecccceeeeEcCCCcE-----EeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 752 2356799999999987654333221 2467889999999999999999999999999999999998532
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
= ..+.. ........+.+++ -.-+.+++..+|..+-..-|...+|+..|++.+.+.
T Consensus 903 q--~~~g~---------~~~~~~~~~Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 903 E--VKNGS---------SWMVKTNFPRYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred H--hcCCc---------ceeccccchhhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 1 00000 0000111222222 134778888888877777788999999988887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-22 Score=193.18 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=185.4
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCC-cceeeEeecchhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGS-KIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~-~~~~~~~~~~~~~~~~~~~ 82 (449)
|.+.+.||.|+||.||++.+. ..+++|++..... ...+.+|+.++..+.+.. ++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~--------------- 63 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL--------------- 63 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeE---------------
Confidence 789999999999999999986 7789998776533 335788999999888774 3333
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
...+......+++++++ ++++.+++.... ..+....+..++.|++.+++|+|+.+++|||+||+|
T Consensus 64 ------------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~n 131 (384)
T COG0515 64 ------------YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPEN 131 (384)
T ss_pred ------------EEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 22233444579999999 788886666433 268999999999999999999999999999999999
Q ss_pred EEeecCCCCC-eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC---CCCCccchHHHHHHHHHHHHhC
Q 013125 160 FLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 160 ill~~~~~~~-~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il~el~~G 235 (449)
|++. ... .++++|||+++............ .......||..|++||.+.+ ..++...|+||+|++++++++|
T Consensus 132 il~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 132 ILLD---RDGRVVKLIDFGLAKLLPDPGSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred eeec---CCCCeEEEeccCcceecCCCCcccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhC
Confidence 9994 455 79999999998655443211000 12357789999999999988 5789999999999999999999
Q ss_pred CCCCCCChhh-cHHHHHHHHHHhhcCCCHHHhhcc----ChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAA-TKKQKYDKICEKKVSTPIEVLCKS----HPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~----~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||...... ........+............... ....+.+++..++..+|..|.+......
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 9998765431 011122212111111000011111 1257889999999999999988765433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=182.77 Aligned_cols=136 Identities=20% Similarity=0.236 Sum_probs=101.8
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----------chhH-----------------HHHHHHHHHHcCCC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQL-----------------LYEAKVYKILQGGS 63 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----------~~~~-----------------~~E~~~l~~l~~~~ 63 (449)
.+.||+|+||.||+|.+. +|+.||||+++.... ..++ ..|++++..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999986 899999999875421 1111 24888888887653
Q ss_pred cceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013125 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARI 142 (449)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~-sL~~~~~~~~~~~~~~~~~~i~~qil~~L 142 (449)
+. .|.... . ...+|||||+++ ++...... ...++...+..++.|++.+|
T Consensus 81 v~-------------------------~p~~~~--~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L 130 (190)
T cd05147 81 IP-------------------------CPEPIL--L--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIM 130 (190)
T ss_pred CC-------------------------CCcEEE--e--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHH
Confidence 21 111111 1 223899999954 44433222 45789999999999999999
Q ss_pred HHH-HhCCccccCCCCCcEEeecCCCCCeEEEEeecceeee
Q 013125 143 EYV-HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182 (449)
Q Consensus 143 ~~L-H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~ 182 (449)
++| |++||+||||||+|||+. ++.++|+|||+|...
T Consensus 131 ~~l~H~~giiHrDlkP~NIli~----~~~v~LiDFG~a~~~ 167 (190)
T cd05147 131 RILYQDCRLVHADLSEYNLLYH----DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHhCCcccCCCCHHHEEEE----CCcEEEEEccccccC
Confidence 999 799999999999999994 478999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=187.17 Aligned_cols=179 Identities=16% Similarity=0.172 Sum_probs=127.3
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh-----------HHHHHHHHHHHcCCCcceeeEe
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----------LLYEAKVYKILQGGSKIRLVVF 70 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~-----------~~~E~~~l~~l~~~~~~~~~~~ 70 (449)
..+++++|++.+.||.|+||.||++.+ ++..+|||++.......+ +.+|++.+..+.|+++......
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 468899999999999999999999765 466899999875432221 4688889999988865443221
Q ss_pred ecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013125 71 HVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149 (449)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g 149 (449)
... ............+|||||+ |.+|.++.. ++. ....+++.+|..||+.|
T Consensus 104 ~~~-------------------~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g 155 (232)
T PRK10359 104 YLL-------------------AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG 155 (232)
T ss_pred eee-------------------cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC
Confidence 100 0000011234679999999 678877632 232 34669999999999999
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHH
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 229 (449)
++|||+||+||+++ .++ ++|+|||.+........ .-...+...++.++|+|||||++
T Consensus 156 i~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~ 212 (232)
T PRK10359 156 MVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYL 212 (232)
T ss_pred CccCCCChHHEEEe---CCC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEee
Confidence 99999999999995 455 99999998764432211 01134444567799999999998
Q ss_pred HHHH
Q 013125 230 LYFL 233 (449)
Q Consensus 230 ~el~ 233 (449)
..+.
T Consensus 213 ~~~~ 216 (232)
T PRK10359 213 LIYK 216 (232)
T ss_pred hHHH
Confidence 8665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=190.80 Aligned_cols=249 Identities=22% Similarity=0.243 Sum_probs=149.1
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+..++.||.|+|+.||.|+|..|++.+|+|+.....+ .+.+.+|.-....+.+...... ....+..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~--------a~~~~r~ 84 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKE--------AYRHLRF 84 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHH--------HHHHH-B
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHH--------HHHhceE
Confidence 45778999999999999999999999999998654432 1123333322222222110000 0000000
Q ss_pred hhcc---cCCCcCeeEEecccCCe-----eEEEEecCCCCHHHHHHHh---cCC---CCHHHHHHHHHHHHHHHHHHHhC
Q 013125 83 IFSS---TLGGIPNIKWYGVDGED-----NVLVLDLLGPSLEDLFVYC---RRK---FSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 83 ~~~~---~~~~i~~~~~~~~~~~~-----~~lv~e~~g~sL~~~~~~~---~~~---~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
+.-. ...+.+.+..-...... .+++|+.+.++|.+++... ... +.....+.+..|++..+++||+.
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 0000 11122223222222222 3778888899998887632 111 22233355568999999999999
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--------CCCCccc
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRD 220 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~ 220 (449)
|++|+||+|+|+++ +.+|.++|+||+.......... ....+..|.+||.... ..++.+.
T Consensus 165 GlVHgdi~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~ 231 (288)
T PF14531_consen 165 GLVHGDIKPENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFAT 231 (288)
T ss_dssp TEEEST-SGGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred ceEecccceeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeecc
Confidence 99999999999999 4889999999987765432111 1233467889996643 3578999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCC
Q 013125 221 DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 289 (449)
Q Consensus 221 DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 289 (449)
|.|+||+++|.|++|..||........... .-..|.+.|+.++.||..+|+.+|.+|
T Consensus 232 DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 232 DAWQLGITLYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CHHHHHHHHHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999999999999987544321110 122455779999999999999999887
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=215.11 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=179.7
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecC---CCCchh-----HHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQ-----LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~---~~~~~~-----~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
...+.+|.|++|.|+.+......+.++.|.... ...... +..|..+-..|.|++++..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~------------ 388 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLD------------ 388 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHH------------
Confidence 457789999999888888766666566654331 111111 122333333344544322111
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.+ .+.....-+||||..+|..++.. ...++...+..++.|++.|++|||+.||.|||||++|++
T Consensus 389 --------------~~-~~~~~~~~~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll 452 (601)
T KOG0590|consen 389 --------------IV-QEIDGILQSMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL 452 (601)
T ss_pred --------------HH-hhcccchhhhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE
Confidence 01 11112222399995588888764 347899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCc-cchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR-RDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~~DvwSlG~il~el~~G~~pf~ 240 (449)
+. ..+.+||+|||.+..+..+.... .......+|+..|+|||++.+..|.+ .+||||.|++++.|.+|+.||.
T Consensus 453 ~~---~~g~lki~Dfg~~~vf~~~~e~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 453 VT---ENGILKIIDFGAASVFRYPWEKN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred Ee---cCCceEEeecCcceeeccCcchh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 95 77899999999998877655431 12345889999999999999999865 5899999999999999999998
Q ss_pred CChhhcHH-HHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKK-QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.....+.. .................+...+|...+.+|..+|+++|.+|.++++|.+
T Consensus 527 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 527 VAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 65443322 1111112223334445566677899999999999999999999888755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=173.46 Aligned_cols=138 Identities=22% Similarity=0.258 Sum_probs=102.7
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----------------------------hhHHHHHHHHHHHcCC
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------------------PQLLYEAKVYKILQGG 62 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----------------------------~~~~~E~~~l~~l~~~ 62 (449)
+.+.||+|+||.||+|.+. +|+.||||++...... ....+|.+.+..+.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998764211 0124567777777655
Q ss_pred CcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 013125 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIAR 141 (449)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~-sL~~~~~~~~~~~~~~~~~~i~~qil~~ 141 (449)
++ .+|....+. ..||||||+++ ++...... ...++...+..++.|++.+
T Consensus 80 ~i-------------------------~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~ 129 (190)
T cd05145 80 GV-------------------------PVPEPILLK----KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQ 129 (190)
T ss_pred CC-------------------------CCceEEEec----CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHH
Confidence 32 122222221 24899999944 34332221 3467888999999999999
Q ss_pred HHHHHh-CCccccCCCCCcEEeecCCCCCeEEEEeecceeeec
Q 013125 142 IEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183 (449)
Q Consensus 142 L~~LH~-~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~ 183 (449)
|.+||. +||+||||||+|||+. ++.++|+|||+|....
T Consensus 130 l~~lH~~~givHrDlkP~NIll~----~~~~~liDFG~a~~~~ 168 (190)
T cd05145 130 MRRLYQEAGLVHGDLSEYNILYH----DGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHhCCEecCCCChhhEEEE----CCCEEEEEcccceecC
Confidence 999999 9999999999999993 6789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=201.20 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=184.4
Q ss_pred ecccCceeEEEEEEc---CCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 15 IGSGSFGEIFLASHV---DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 15 LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
+|.|+||.|+++... +.+..+|+|+.+.... ......|..++...+.+.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~------------------------ 57 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTP------------------------ 57 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCC------------------------
Confidence 799999999998643 4567799998765422 113455666666665332
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
.+..+.+........++++++. |+.|...... ...+....+..+...++.+++++|..||+|||+|++||++ +
T Consensus 58 --f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d 131 (612)
T KOG0603|consen 58 --FLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---L 131 (612)
T ss_pred --ceeeeeeeeccccchhHhhhhcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---c
Confidence 4455556667778889999999 6677665543 5668888999999999999999999999999999999999 5
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~ 246 (449)
..|++++.|||+++...... ..+||..|||||++. ....++|.||||++++||++|-.||.+
T Consensus 132 ~~Ghi~~tdfglske~v~~~-----------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----- 193 (612)
T KOG0603|consen 132 LEGHIKLTDFGLSKEAVKEK-----------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----- 193 (612)
T ss_pred ccCccccCCchhhhHhHhhh-----------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----
Confidence 88999999999998765543 228999999999999 456789999999999999999999987
Q ss_pred HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHHhcCCCCCccccccccc
Q 013125 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG--FLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~--~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
+....|.......|... ....++++.+++..+|..|.-.. -+.+. ....+....||..++
T Consensus 194 --~~~~~Il~~~~~~p~~l-----~~~a~~~~~~l~~r~p~nrLg~~~~~~~ei-------k~h~f~~~i~~~~l~ 255 (612)
T KOG0603|consen 194 --DTMKRILKAELEMPREL-----SAEARSLFRQLFKRNPENRLGAGPDGVDEI-------KQHEFFQSIDWNELE 255 (612)
T ss_pred --HHHHHHhhhccCCchhh-----hHHHHHHHHHHHhhCHHHHhccCcchhHHH-------hccchheeeeHhhHh
Confidence 34455666566666433 56889999999999999886542 22222 123445566776443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-22 Score=204.12 Aligned_cols=216 Identities=24% Similarity=0.387 Sum_probs=153.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
-..|..++.|..|+||.||+++|..+.+.+|+|+-+. + - |++. +..
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~---l------ilRn-----ilt------------------- 127 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N---L------ILRN-----ILT------------------- 127 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c---h------hhhc-----ccc-------------------
Confidence 3578999999999999999999999999999975321 1 1 1211 000
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
..+..+.| |+-..+++. -+.++. +++.+++|||+.||+|||+||+|.+|+
T Consensus 128 --------------~a~npfvv-----gDc~tllk~-~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT-- 177 (1205)
T KOG0606|consen 128 --------------FAGNPFVV-----GDCATLLKN-IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT-- 177 (1205)
T ss_pred --------------ccCCccee-----chhhhhccc-CCCCcc--------hhhHHhHhhccCCeecCCCCCCcceee--
Confidence 00111122 333333332 122332 237789999999999999999999996
Q ss_pred CCCCeEEEEeecceeeecCCCCC----cccc----ccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTN----RHIP----YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~----~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
.-+++|+.|||+++......+. .+|. --..+.++||+.|.|||++....|+..+|+|++|+|+||++.|..
T Consensus 178 -~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcv 256 (1205)
T KOG0606|consen 178 -SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 256 (1205)
T ss_pred -ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeee
Confidence 7899999999999753222111 1110 012457899999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
||.+..+. +.+..++......|-. ....+++.++++.++|..+|-.|.-
T Consensus 257 pffGdtpe---elfg~visd~i~wpE~--dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 257 PFFGDTPE---ELFGQVISDDIEWPEE--DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred eccCCCHH---HHHhhhhhhhcccccc--CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 99986554 3444444444444322 3455789999999999999999953
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=167.45 Aligned_cols=190 Identities=16% Similarity=0.121 Sum_probs=133.3
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch------hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~------~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
-+...|++|+||+||++.. .+.+|+.+.+....... .+.+|+++|+.|.+..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~-------------------- 62 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLP-------------------- 62 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCC--------------------
Confidence 4577899999999998865 67778877665543322 3678999999997654
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL-kp~Nil 161 (449)
++|.+..+ +..+++|||+ |.+|...... ....++.|++.+|+++|++||+|||| ||+|||
T Consensus 63 ------~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NIL 124 (218)
T PRK12274 63 ------RTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWL 124 (218)
T ss_pred ------CCCEEEEE----cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEE
Confidence 56666544 3469999998 7777543211 12357789999999999999999999 799999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCcc-cccc-----CCCCCCCCccccccccccCC-CCC-ccchHHHHHHHHHHHH
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRH-IPYR-----ENKNLTGTARYASCNTHLGI-EQS-RRDDLESLGYVLLYFL 233 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~-~~~~-----~~~~~~gt~~y~aPE~~~~~-~~s-~~~DvwSlG~il~el~ 233 (449)
++ .++.++|+|||+|........... ..++ ..-....++.|++|+...-. ..+ .+.++++-|+.+|.++
T Consensus 125 v~---~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 125 VQ---EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred Ec---CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHH
Confidence 94 678899999999985443221000 0000 00011246777888754432 223 5679999999999999
Q ss_pred hCCCCCCCC
Q 013125 234 RGSLPWQGL 242 (449)
Q Consensus 234 ~G~~pf~~~ 242 (449)
|+..++.+.
T Consensus 202 ~~~~~~~~~ 210 (218)
T PRK12274 202 TRRVLHWED 210 (218)
T ss_pred hccCCcccc
Confidence 999887653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=173.76 Aligned_cols=188 Identities=18% Similarity=0.269 Sum_probs=138.8
Q ss_pred CCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCC-CCeEEEEeecce
Q 013125 101 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLA 179 (449)
Q Consensus 101 ~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~-~~~vkL~DfGla 179 (449)
....|+||..+..+|..++. .+..+......++.|+++|+.|||.+||.|||||.+|||+.++++ ...+.|+|||++
T Consensus 315 ~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 45679999999999999885 566788888999999999999999999999999999999987543 457889999998
Q ss_pred eeecCCCCCccccccCCC-CCCCCccccccccccCCC------CCccchHHHHHHHHHHHHhCCCCCCCChhhcH-HHHH
Q 013125 180 KKYRDPTTNRHIPYRENK-NLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKY 251 (449)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~------~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~-~~~~ 251 (449)
--... .+...||.... ..-|....||||+....+ --.++|.|+.|.+.||++....||.+-..... ...+
T Consensus 393 LAd~~--hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 393 LADDN--HGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeccc--cccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 53322 22334443322 455788899999876432 13489999999999999999999987322111 1111
Q ss_pred HHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 252 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 252 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
+... .+.+...+|+.+++++...++.||.+|++..-....+
T Consensus 471 ----qe~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 471 ----QESQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ----hhhh---CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 1111 2223345589999999999999999999876333333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.4e-21 Score=196.93 Aligned_cols=248 Identities=18% Similarity=0.135 Sum_probs=167.6
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc------hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~------~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+|...+.||++.|=.|.+|++. +|. |+|||+.+.... .+.+.|++ ...+++++
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn------------------ 82 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPN------------------ 82 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCc------------------
Confidence 7889999999999999999984 344 899998765421 22333444 33344444
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+..+...-...+..|||.+|...+|.|-+.. +.-+..-+.+.|+.||+.||..+|..||.|||||.+|||
T Consensus 83 ---------~lPfqk~~~t~kAAylvRqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENIL 152 (1431)
T KOG1240|consen 83 ---------CLPFQKVLVTDKAAYLVRQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENIL 152 (1431)
T ss_pred ---------ccchHHHHHhhHHHHHHHHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEE
Confidence 2222222345677899999999999887752 222567788899999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCc-cccccCCCCCCCCccccccccccCC----------C-CCccchHHHHHHHH
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNR-HIPYRENKNLTGTARYASCNTHLGI----------E-QSRRDDLESLGYVL 229 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~~~DvwSlG~il 229 (449)
|+ .=+-+.|+||..-+..--+..+. ..-|.-. +-..-.+|.|||-+... . .+++-||+|+||++
T Consensus 153 iT---SWNW~~LtDFAsFKPtYLPeDNPadf~fFFD-TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 153 IT---SWNWLYLTDFASFKPTYLPEDNPADFTFFFD-TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred Ee---eechhhhhcccccCCccCCCCCcccceEEEe-cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 96 77899999997654322221111 0111111 11223479999976541 1 57788999999999
Q ss_pred HHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccC-hHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 013125 230 LYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRL 298 (449)
Q Consensus 230 ~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~l~~~~l~~~p~~Rp~~~~l~~~ 298 (449)
+||++ |++||.-. .+.+-.... ....+...+.+ ...++.++..|++.||++|.++++..+.
T Consensus 229 aELf~Eg~PlF~LS-------QL~aYr~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 229 AELFLEGRPLFTLS-------QLLAYRSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhcCCCcccHH-------HHHhHhccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 99998 89998521 111100110 12222222221 3468999999999999999999887664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=166.26 Aligned_cols=141 Identities=21% Similarity=0.256 Sum_probs=106.3
Q ss_pred ceEEeeeecccCceeEEEEE-EcCCCceEEEEEecCCCCc--------------------------hhHHHHHHHHHHHc
Q 013125 8 KYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKH--------------------------PQLLYEAKVYKILQ 60 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~-~~~~~~~vAvKv~~~~~~~--------------------------~~~~~E~~~l~~l~ 60 (449)
-|.+.+.||+|+||.||+|. +..+++.||||++...... ..+.+|+++++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 6678999999988753210 12457888888886
Q ss_pred CCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHH
Q 013125 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMI 139 (449)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~-sL~~~~~~~~~~~~~~~~~~i~~qil 139 (449)
+..+ .+|.+..+ ...++|||++++ +|...... ...+....+..++.||+
T Consensus 109 ~~~i-------------------------~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~ 158 (237)
T smart00090 109 EAGV-------------------------PVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDIL 158 (237)
T ss_pred hcCC-------------------------CCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHH
Confidence 5311 23333322 234899999944 55544322 33466667889999999
Q ss_pred HHHHHHHhCC-ccccCCCCCcEEeecCCCCCeEEEEeecceeee
Q 013125 140 ARIEYVHSRG-FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182 (449)
Q Consensus 140 ~~L~~LH~~g-iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~ 182 (449)
.+|.+||++| |+||||||+||++. .+.++|+|||+|...
T Consensus 159 ~~l~~LH~~g~iiH~Dikp~NIli~----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 159 EEMRKLYKEGELVHGDLSEYNILVH----DGKVVIIDVSQSVEL 198 (237)
T ss_pred HHHHHHHhcCCEEeCCCChhhEEEE----CCCEEEEEChhhhcc
Confidence 9999999999 99999999999993 678999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-20 Score=163.75 Aligned_cols=242 Identities=12% Similarity=0.125 Sum_probs=174.0
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
..++-+|.+...|+.|+|++..+ .++.|+++-..-. ..|..|.-.++++.|+|+...++
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlg--------------- 254 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLG--------------- 254 (448)
T ss_pred hhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhh---------------
Confidence 34667888999999999999544 4567877654322 23566777777778777554433
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcE
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNF 160 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~-~~~~~~~~~i~~qil~~L~~LH~~g--iiHrDLkp~Ni 160 (449)
.+....+..++..|+ .++|..++..... -.+..++.+++..|+.|+.|||+.. |.--.|....+
T Consensus 255 ------------acnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hv 322 (448)
T KOG0195|consen 255 ------------ACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHV 322 (448)
T ss_pred ------------hccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceE
Confidence 334556778899999 8999998875322 2577889999999999999999964 44557888999
Q ss_pred EeecCCCCCeEE--EEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC---CccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVY--IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ---SRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vk--L~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DvwSlG~il~el~~G 235 (449)
++ |++.+.+ .+|--++.. ..+..-.+.||+||.+...+- -+++|+|||++++||+.|.
T Consensus 323 mi---dedltarismad~kfsfq--------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 323 MI---DEDLTARISMADTKFSFQ--------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTR 385 (448)
T ss_pred Ee---cchhhhheecccceeeee--------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence 99 4555544 455444321 123344789999999987653 3479999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
..||....+.+-. .+|.-..+ ...+..+....+..||.-|...||.+||.|+.|.-.|++.
T Consensus 386 evpfadlspmecg---mkialegl---rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 386 EVPFADLSPMECG---MKIALEGL---RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCchhhh---hhhhhccc---cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 9999987765322 22221121 2223356678899999999999999999999998888754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6e-18 Score=152.77 Aligned_cols=139 Identities=16% Similarity=0.184 Sum_probs=98.2
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
.+.||+|+||.||. +..+... +||++... .....+.+|+++++.+.|... .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~----------------------~h~ 61 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLI----------------------DWS 61 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCC----------------------CCc
Confidence 56899999999995 6666666 68987653 234468999999999954210 011
Q ss_pred CcCeeEEecccC---Ce-eEEEEecCC---CCHHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCcEE
Q 013125 90 GIPNIKWYGVDG---ED-NVLVLDLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARI-EYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 90 ~i~~~~~~~~~~---~~-~~lv~e~~g---~sL~~~~~~~~~~~~~~~~~~i~~qil~~L-~~LH~~giiHrDLkp~Nil 161 (449)
+|+.++.+.... .. +.+|+||.| ++|.++++. ..++.. ..++.|++.++ +|||+++|+||||||+|||
T Consensus 62 nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NIL 137 (210)
T PRK10345 62 GIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNIL 137 (210)
T ss_pred ccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 344443333332 23 337899964 899999964 346655 35678888888 9999999999999999999
Q ss_pred eecCC-CCCeEEEEeecce
Q 013125 162 MGLGR-KANQVYIIDFGLA 179 (449)
Q Consensus 162 l~~~~-~~~~vkL~DfGla 179 (449)
++..+ ....++|+||+.+
T Consensus 138 l~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 138 CQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EeccCCCCCcEEEEECCCC
Confidence 96432 3458999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-18 Score=153.43 Aligned_cols=132 Identities=26% Similarity=0.433 Sum_probs=102.2
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCC-c---------hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-H---------PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~---------~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++.||+|++|.||+|.+ .+..|++|+...... . ..+.+|++++..+.+.++.
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~---------------- 62 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVN---------------- 62 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCC----------------
Confidence 36799999999999987 677899998654321 1 2356788888888765421
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+|.+ +.......++||||+ |++|.+++.... . ....++.+++.+|.+||+.|++|||++|+||
T Consensus 63 ---------~p~~--~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Ni 126 (211)
T PRK14879 63 ---------VPAV--YFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNM 126 (211)
T ss_pred ---------CCeE--EEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccE
Confidence 2222 223445678999999 889998876422 2 7889999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceee
Q 013125 161 LMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~ 181 (449)
|+. .+.++|+|||++..
T Consensus 127 l~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 127 ILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEE----CCCEEEEECCcccC
Confidence 993 67899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=150.32 Aligned_cols=127 Identities=22% Similarity=0.398 Sum_probs=97.2
Q ss_pred eecccCceeEEEEEEcCCCceEEEEEecCCCC----------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.||+|+||.||+|.+ ++..|++|+...... ..++.+|+++++.+.+.++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i------------------- 59 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGV------------------- 59 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCC-------------------
Confidence 389999999999985 567899998543211 1235678999988876531
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+|.+ +....+..++|||++ |++|.+++..... .++.|++.+|.+||+.|++|||++|+||++
T Consensus 60 ------~~p~~--~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~ 123 (199)
T TIGR03724 60 ------NTPVV--YDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV 123 (199)
T ss_pred ------CCCEE--EEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEE
Confidence 12222 233455678999999 8888887653110 789999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceee
Q 013125 163 GLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~ 181 (449)
. .+.++++|||++..
T Consensus 124 ~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 124 R----DDKLYLIDFGLGKY 138 (199)
T ss_pred E----CCcEEEEECCCCcC
Confidence 3 68899999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=150.06 Aligned_cols=136 Identities=23% Similarity=0.310 Sum_probs=100.3
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc------------------------hhHHHHHHHHHHHcCCCc
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------------------------PQLLYEAKVYKILQGGSK 64 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~------------------------~~~~~E~~~l~~l~~~~~ 64 (449)
|.+.+.||+|+||.||+|... +++.||||++...... .....|..++..+.+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 889999999999999999874 7999999986643210 013456666666654421
Q ss_pred ceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 013125 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 143 (449)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~ 143 (449)
.++.... ....++|||++ |++|..+.. ......++.+++.++.
T Consensus 96 -------------------------~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~ 139 (198)
T cd05144 96 -------------------------PVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIV 139 (198)
T ss_pred -------------------------CCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHH
Confidence 1222222 13458999999 667765432 1345678899999999
Q ss_pred HHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecC
Q 013125 144 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184 (449)
Q Consensus 144 ~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~ 184 (449)
++|..||+||||||+||++. +++.++|+|||++.....
T Consensus 140 ~lh~~gi~H~Dl~p~Nill~---~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 140 KAYKHGIIHGDLSEFNILVD---DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred HHHHCCCCcCCCCcccEEEc---CCCcEEEEECCccccCCC
Confidence 99999999999999999994 688999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=168.27 Aligned_cols=133 Identities=22% Similarity=0.352 Sum_probs=100.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-CC---------chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TK---------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-~~---------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
..|...++||+|+||+||+|.+... .+++|+.... .. ...+.+|+++++.+++.++.
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~----------- 399 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVP----------- 399 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCC-----------
Confidence 4456789999999999999987443 3444432211 11 13467899999999876532
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
....+.......++||||+ |++|.+++. ....++.|++.+|.+||+.|++||||
T Consensus 400 ----------------~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDl 454 (535)
T PRK09605 400 ----------------TPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDL 454 (535)
T ss_pred ----------------eeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCC
Confidence 2233334455678999999 889988765 34678999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceee
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~ 181 (449)
||+|||+ +++.++|+|||+++.
T Consensus 455 kp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 455 TTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred ChHHEEE----ECCcEEEEeCccccc
Confidence 9999999 467899999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-18 Score=166.25 Aligned_cols=174 Identities=25% Similarity=0.330 Sum_probs=130.1
Q ss_pred CeeEEEEecC-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecc
Q 013125 102 EDNVLVLDLL-GPSLEDLFVY--CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178 (449)
Q Consensus 102 ~~~~lv~e~~-g~sL~~~~~~--~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGl 178 (449)
.+.||.|++| ..+|.+++.. ....-++...+.+..|++.|++| +|.+|||+||.||++. .+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 4678999999 8899999963 23457888899999999999999 9999999999999995 667899999999
Q ss_pred eeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHh
Q 013125 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK 257 (449)
Q Consensus 179 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~ 257 (449)
........+. ..++.....-+||.+||+||.+.+..|+.++||||||++|+|+++ =...|... ..+..+...
T Consensus 403 ~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATLTDIRDG 475 (516)
T ss_pred eeecccCCcc-cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------HhhhhhhcC
Confidence 9876655411 111223346689999999999999999999999999999999997 22333221 111112111
Q ss_pred hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 258 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.+| +..+...| +-..|+..++...|.+||++
T Consensus 476 --~ip-~~~~~d~p-~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 476 --IIP-PEFLQDYP-EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred --CCC-hHHhhcCc-HHHHHHHHhcCCCcccCchH
Confidence 222 22333333 45689999999999999943
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=161.67 Aligned_cols=211 Identities=14% Similarity=0.196 Sum_probs=156.2
Q ss_pred CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCcEEeecC
Q 013125 88 LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-LHRDIKPDNFLMGLG 165 (449)
Q Consensus 88 ~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gi-iHrDLkp~Nill~~~ 165 (449)
|.++..+.+.+.++...++|.+|| .|+|.|.+......++..-...+.+.|+.||+|||+--| .|+.|+..|+++
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--- 82 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--- 82 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee---
Confidence 345566666667778899999999 899999998766678888888999999999999998644 999999999999
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-------CCccchHHHHHHHHHHHHhCCCC
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-------QSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~~DvwSlG~il~el~~G~~p 238 (449)
+..-.+||+|||+........... ......-..-|.|||.+.+.. .+.+.||||||++++|+++.+.|
T Consensus 83 d~~w~lklt~~Gl~~~~~~~~~~~-----~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 83 DSRWVLKLTDFGLNSLLEETAEPE-----AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeEEEEechhhhccccccccccc-----ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 588899999999987654311000 011112345689999998742 36679999999999999999999
Q ss_pred CCCChhhc-HHHHHHHHHHhhcCCCHHHhh--ccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 239 WQGLKAAT-KKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 239 f~~~~~~~-~~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|....... ..+.+..+.........+.+. ...++++..++..||..+|..||+++.+...++.+....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 97633222 233333333312222222222 145668999999999999999999999999888877654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=140.28 Aligned_cols=158 Identities=22% Similarity=0.238 Sum_probs=93.4
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch-hHHHHH--HHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-QLLYEA--KVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~-~~~~E~--~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
+.+.||+|+||.||+|.+. +++.||||++....... .....+ +.+....+.+......... ...+..+....
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~e~~~l~~l~ 75 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWA----EKEFRNLKRLY 75 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHH----HHHHHHHHHHH
Confidence 3578999999999999986 78999999977542211 111111 1121112111111100000 00001111111
Q ss_pred CC--CcCeeEEecccCCeeEEEEecCCC-CHH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEe
Q 013125 88 LG--GIPNIKWYGVDGEDNVLVLDLLGP-SLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLM 162 (449)
Q Consensus 88 ~~--~i~~~~~~~~~~~~~~lv~e~~g~-sL~-~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nill 162 (449)
.. .++....+ ...++||||+.+ ++. ..+..... ...+..++.|++.++.++|. +||+||||||+||++
T Consensus 76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 11 13333322 235899999943 221 11111111 16678899999999999999 999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRD 184 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~ 184 (449)
+ ++.++|+|||.+.....
T Consensus 149 ~----~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D----DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E----CCcEEEEECcccccccC
Confidence 3 78899999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.4e-15 Score=127.06 Aligned_cols=132 Identities=21% Similarity=0.296 Sum_probs=104.8
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGG 90 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (449)
+++.||.|.++.||++.+.. ..+++|+.........+..|+.+++.+++.. ..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~-------------------------~~ 54 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKG-------------------------LP 54 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcC-------------------------CC
Confidence 46889999999999999843 6799998765443456889999999997651 04
Q ss_pred cCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEeecCC
Q 013125 91 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 91 i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---giiHrDLkp~Nill~~~~ 166 (449)
++.+..+....+..+++||++ |..+..+ +......++.+++.+|++||.. +++|+||+|+||++.
T Consensus 55 ~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~--- 123 (155)
T cd05120 55 VPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD--- 123 (155)
T ss_pred CCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---
Confidence 556666666667899999999 4444432 5566778899999999999984 799999999999995
Q ss_pred CCCeEEEEeeccee
Q 013125 167 KANQVYIIDFGLAK 180 (449)
Q Consensus 167 ~~~~vkL~DfGla~ 180 (449)
+.+.++++|||.+.
T Consensus 124 ~~~~~~l~Df~~~~ 137 (155)
T cd05120 124 DGKILGIIDWEYAG 137 (155)
T ss_pred CCcEEEEEeccccc
Confidence 56899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.5e-15 Score=135.69 Aligned_cols=133 Identities=17% Similarity=0.233 Sum_probs=94.8
Q ss_pred eeec-ccCceeEEEEEEcCCCceEEEEEecCC---------------CCchhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 13 RKIG-SGSFGEIFLASHVDTNEIVAVKIENSG---------------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 13 ~~LG-~G~fg~Vy~a~~~~~~~~vAvKv~~~~---------------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
..|| .||.|+||.++. .+..++||..... .....+.+|++++..|++.++.
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~----------- 103 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLP----------- 103 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCC-----------
Confidence 4577 889999999877 4678899876421 1123467899999999876531
Q ss_pred hhhhhhhhcccCCCcCeeEEeccc-C---CeeEEEEecC-C-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVD-G---EDNVLVLDLL-G-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 150 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~-~---~~~~lv~e~~-g-~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gi 150 (449)
+|....+... . ...++|||++ | .+|.+++.. ..++... +.||+.+|.+||++||
T Consensus 104 --------------vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI 163 (239)
T PRK01723 104 --------------VPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGV 163 (239)
T ss_pred --------------CceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCC
Confidence 1222211111 1 1236999999 4 588887753 3455443 5789999999999999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceee
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~ 181 (449)
+||||||+|||++ .++.++|+|||.+..
T Consensus 164 ~HrDlkp~NILv~---~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 164 YHADLNAHNILLD---PDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCchhEEEc---CCCCEEEEECCCccc
Confidence 9999999999994 566899999998854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-16 Score=161.51 Aligned_cols=252 Identities=26% Similarity=0.312 Sum_probs=178.7
Q ss_pred CCceEEeeeecccCceeEEEEEEcC-CCceEEEEEecCCCC-ch---hHHHHHHHHHHHc-CCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK-HP---QLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvKv~~~~~~-~~---~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~ 79 (449)
...|.+.+.||+|+|+.|-++.... +...+|+|.+..... .. ....|..+-+.+. |.+.+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~-------------- 84 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTV-------------- 84 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccccccccc--------------
Confidence 4578999999999999999998753 344577776554321 11 2233555555554 44332
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIK 156 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~-~~~~~~~~~~~~~~i~~qil~~L~~LH-~~giiHrDLk 156 (449)
.+.....+....++++++. |+++.+.+ .......+...+..++.|+..++.|+| ..++.|||||
T Consensus 85 -------------~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ik 151 (601)
T KOG0590|consen 85 -------------HMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIK 151 (601)
T ss_pred -------------ccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCC
Confidence 2333345667788999998 88888777 332225677788899999999999999 9999999999
Q ss_pred CCcEEeecCCCCC-eEEEEeecceeeecC-CCCCccccccCCCCCCC-CccccccccccCCC-CCccchHHHHHHHHHHH
Q 013125 157 PDNFLMGLGRKAN-QVYIIDFGLAKKYRD-PTTNRHIPYRENKNLTG-TARYASCNTHLGIE-QSRRDDLESLGYVLLYF 232 (449)
Q Consensus 157 p~Nill~~~~~~~-~vkL~DfGla~~~~~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~-~s~~~DvwSlG~il~el 232 (449)
|+|.++. ..+ .+++.|||+|..+.. ..... .....+| ++.|+|||.+.+.. .....|+||.|+++.-+
T Consensus 152 P~n~~l~---~s~~~l~~~df~~At~~~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~ 223 (601)
T KOG0590|consen 152 PSNSLLD---ESGSALKIADFGLATAYRNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAM 223 (601)
T ss_pred Cccchhc---cCCCcccCCCchhhccccccCCcce-----eeecccCCCCCCCCcccccchhhcCCCccccccccccccc
Confidence 9999994 566 899999999998876 33221 2235567 99999999999854 57889999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
++|..||........ .+....... .......+..+.....+++..++..+|..|.+.+++
T Consensus 224 ~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 224 LTGELPWDFPSRKDG--RYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred ccCCCCccccccccc--cceeecccc-cccccCccccCChhhhhcccccccCCchhccccccc
Confidence 999999986543321 111111111 111123345566778888888888888889887665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-13 Score=119.48 Aligned_cols=138 Identities=16% Similarity=0.194 Sum_probs=97.2
Q ss_pred eeeecccCceeEEEEEEcC------CCceEEEEEecCCC------------C------------chh----HHHHHHHHH
Q 013125 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGT------------K------------HPQ----LLYEAKVYK 57 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvKv~~~~~------------~------------~~~----~~~E~~~l~ 57 (449)
...||.|--+.||.|.... .+..+|||+.+... + ... ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 35789999854210 0 001 136777777
Q ss_pred HHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCC-HH-HHHHHhcCCCCHHHHHHHH
Q 013125 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPS-LE-DLFVYCRRKFSLKTVLMLA 135 (449)
Q Consensus 58 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~s-L~-~~~~~~~~~~~~~~~~~i~ 135 (449)
++..... .+|.+..+ ...+|||||++++ +. ..++ ...++.+....+.
T Consensus 82 rl~~~Gv-------------------------~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~ 130 (197)
T cd05146 82 RMQKAGI-------------------------PCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAY 130 (197)
T ss_pred HHHHcCC-------------------------CCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHH
Confidence 7665431 35555543 5678999999654 21 1121 2235556777888
Q ss_pred HHHHHHHHHH-HhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecC
Q 013125 136 DQMIARIEYV-HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184 (449)
Q Consensus 136 ~qil~~L~~L-H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~ 184 (449)
.|++.+|..| |..||+|+||++.|||+ .++.++|+|||.|.....
T Consensus 131 ~~i~~~l~~l~H~~glVHGDLs~~NIL~----~~~~v~iIDF~qav~~~h 176 (197)
T cd05146 131 YQVLSMMKQLYKECNLVHADLSEYNMLW----HDGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEE----ECCcEEEEECCCceeCCC
Confidence 9999999998 89999999999999999 357899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=136.72 Aligned_cols=160 Identities=20% Similarity=0.311 Sum_probs=97.0
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcC----CC----------cceee--------Ee
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG----GS----------KIRLV--------VF 70 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~----~~----------~~~~~--------~~ 70 (449)
+.||+|++|.||+|+.. +|+.||||+.... ....+..++.+++.+.. .. ++..+ ..
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~-i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPG-IEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCC-cHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 57999999999999864 6899999998653 23345555555543310 00 00000 00
Q ss_pred ecchhhhhhhhhhhcccCCC--cCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHH
Q 013125 71 HVDHVIIHALTIIFSSTLGG--IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA-RIEYVH 146 (449)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~--i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~-~L~~LH 146 (449)
..+..+...+...+. ..+. +|.++ .......+|||||+ |.+|.++.......+. ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~-~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFK-NDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcC-CCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 000000000111110 1122 33333 33344579999999 8888877653222232 2345556655 478899
Q ss_pred hCCccccCCCCCcEEeecCCCCCeEEEEeecceeeec
Q 013125 147 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183 (449)
Q Consensus 147 ~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~ 183 (449)
..|++|+|+||.||++. +++.++|+|||++..+.
T Consensus 275 ~~g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVL---KDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCCceeCCCCcccEEEC---CCCcEEEEeCCCeeECC
Confidence 99999999999999994 67899999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.9e-12 Score=129.60 Aligned_cols=165 Identities=17% Similarity=0.315 Sum_probs=90.3
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHc-------CC-Ccce-------------
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-------GG-SKIR------------- 66 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~-------~~-~~~~------------- 66 (449)
.|.. +.||+|++|.||+|+...+|+.||||++...- .+.+...+++++.+. .. ....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i-~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDI-LPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcch-HHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 4665 78999999999999998889999999987531 112222222222210 00 0000
Q ss_pred -eeEeecchhhhhhhhhhhccc-CCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCC-----HHHHHHHHHHH
Q 013125 67 -LVVFHVDHVIIHALTIIFSST-LGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS-----LKTVLMLADQM 138 (449)
Q Consensus 67 -~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~-----~~~~~~i~~qi 138 (449)
.+....+-.+...+...+... .=.+|.+++ ......+|||||+ |+.+.++-.-.....+ ...+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~--d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~--- 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYW--DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF--- 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeec--ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH---
Confidence 000000000111111111100 013444443 3345679999999 8888764321122222 22233333
Q ss_pred HHHHHHHHhCCccccCCCCCcEEeecC-CCCCeEEEEeecceeeec
Q 013125 139 IARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYR 183 (449)
Q Consensus 139 l~~L~~LH~~giiHrDLkp~Nill~~~-~~~~~vkL~DfGla~~~~ 183 (449)
..++..|++|+|+||.||++..+ ...+.++++|||++....
T Consensus 274 ----~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 ----TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34456999999999999999521 112389999999987553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.9e-13 Score=115.36 Aligned_cols=126 Identities=21% Similarity=0.301 Sum_probs=93.2
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGG 90 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (449)
++.|+.|.++.||+++. .++.|++|+..... ....+.+|+++++.+.+.. .
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~--------------------------~ 54 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAG--------------------------I 54 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhC--------------------------C
Confidence 56789999999999987 47789999876543 2334688999999887643 2
Q ss_pred cCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEeec
Q 013125 91 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-----LHRDIKPDNFLMGL 164 (449)
Q Consensus 91 i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gi-----iHrDLkp~Nill~~ 164 (449)
+|.+..+.. ...++|||++ |.++... . .....++.+++.+|..||..++ +|+|++|.||++.
T Consensus 55 ~P~~~~~~~--~~~~lv~e~i~G~~l~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~- 122 (170)
T cd05151 55 GPKLYYFDP--ETGVLITEFIEGSELLTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD- 122 (170)
T ss_pred CCceEEEeC--CCCeEEEEecCCCccccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-
Confidence 344444432 3458999999 6555432 0 1123456889999999999885 9999999999993
Q ss_pred CCCCCeEEEEeeccee
Q 013125 165 GRKANQVYIIDFGLAK 180 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~ 180 (449)
++.++++|||.+.
T Consensus 123 ---~~~~~liDf~~a~ 135 (170)
T cd05151 123 ---DGRLWLIDWEYAG 135 (170)
T ss_pred ---CCeEEEEeccccc
Confidence 5679999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=135.81 Aligned_cols=254 Identities=18% Similarity=0.152 Sum_probs=181.0
Q ss_pred cccCCceEEeeeecc--cCceeEEEEEE--cCCCceEEEEEecCCCC--c--hhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGS--GSFGEIFLASH--VDTNEIVAVKIENSGTK--H--PQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~--G~fg~Vy~a~~--~~~~~~vAvKv~~~~~~--~--~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
.++..+|.+.+.+|. |.+|.||.+.. ......+|+|.-+.... . ..-.+|+.-..++....
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~----------- 178 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHE----------- 178 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccc-----------
Confidence 355678889999999 99999999998 78888999997433211 1 12234443322222111
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHH----HHHHHHhCCc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA----RIEYVHSRGF 150 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~----~L~~LH~~gi 150 (449)
......-.....+..++-+|+|+.+|..+......-++...++.++.+... ||.++|+.++
T Consensus 179 ---------------~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~ 243 (524)
T KOG0601|consen 179 ---------------NPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNI 243 (524)
T ss_pred ---------------cccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcc
Confidence 111112223567888999999999888887655555888889999999999 9999999999
Q ss_pred cccCCCCCcEEeecCCCC-CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHH
Q 013125 151 LHRDIKPDNFLMGLGRKA-NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~-~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 229 (449)
+|-|+||+||++. ++ ..++++|||+...+........ +.......|...|++||+..+. ++...|++++|.++
T Consensus 244 ~~~~~kp~~i~~~---~~~~s~~~~df~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~ 317 (524)
T KOG0601|consen 244 VHDDLKPANIFTT---SDWTSCKLTDFGLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVI 317 (524)
T ss_pred cccccchhheecc---cccceeecCCcceeEEccCCccccc--eeeeecCCCCceEeChhhhccc-cchHhhhcchhhhh
Confidence 9999999999995 55 8999999999988776653221 1112233577889999998874 67899999999999
Q ss_pred HHHHhCCCCCCCC--hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 230 LYFLRGSLPWQGL--KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 230 ~el~~G~~pf~~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+..+|..++..- ...... ... ....++|.+...++...+..+++.++-.|++...+..
T Consensus 318 l~~~l~~~~~~~g~~~~W~~~-------r~~--~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 318 LEAILGSHLPSVGKNSSWSQL-------RQG--YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred HhhHhhcccccCCCCCCcccc-------ccc--cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 9999987766543 111111 111 1335667777778888888999888888887765433
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-11 Score=105.93 Aligned_cols=128 Identities=24% Similarity=0.412 Sum_probs=92.0
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEec-CCCCch---------hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHP---------QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~-~~~~~~---------~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..|++|+-+.||.+.+ -+..+++|.-. +.-.++ +..+|++++..+...
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~-------------------- 59 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA-------------------- 59 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc--------------------
Confidence 4578999999999976 34457888532 222222 356788888877644
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++|.-..+..+.+...|+|||. |..|.+.+... . ..++..+=.-+.-||..||+|+||.++||+
T Consensus 60 -------GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiI 124 (204)
T COG3642 60 -------GVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNII 124 (204)
T ss_pred -------CCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEE
Confidence 4444455556677788999999 66666677642 2 334455555667899999999999999999
Q ss_pred eecCCCCCeEEEEeecceee
Q 013125 162 MGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~ 181 (449)
+ .++.++++||||+..
T Consensus 125 l----~~~~i~~IDfGLg~~ 140 (204)
T COG3642 125 L----SGGRIYFIDFGLGEF 140 (204)
T ss_pred E----eCCcEEEEECCcccc
Confidence 9 455699999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.8e-11 Score=102.68 Aligned_cols=143 Identities=17% Similarity=0.220 Sum_probs=103.4
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEec-CCCCch---------hHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHP---------QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~-~~~~~~---------~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.+..|-+|+-+.|+++.+ .|+.++||.-. +.-.++ +..+|++++.++....+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI---------------- 72 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGI---------------- 72 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCC----------------
Confidence 677888999999999987 67888888522 222222 35778888888764421
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCC--CHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP--SLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~--sL~~~~~~~~~~-~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
..|.++ ..+....+|+|||+.| ++.+++...-.. ...+....++.+|=+.|.-||..+|||+||..
T Consensus 73 ---------~~P~l~--~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTT 141 (229)
T KOG3087|consen 73 ---------PAPRLI--FIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTT 141 (229)
T ss_pred ---------CCceEE--EEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccc
Confidence 233443 3455667899999955 788887754333 33333478888899999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeee
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKY 182 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~ 182 (449)
+||++..++..-.+.|+|||++..-
T Consensus 142 SNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 142 SNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred cceEEecCCCcCceEEEeecchhcc
Confidence 9999964444455699999998643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.7e-12 Score=130.60 Aligned_cols=279 Identities=19% Similarity=0.144 Sum_probs=184.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
--+.+.+.+-+-+|+|+.++.+.-..++...++|+......... .++-......++.. .+.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~----~~~~s~r~~s~~~i----~p~----------- 862 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT----NDYESIRSKSNILI----TPR----------- 862 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhcc----ccccccCCccCccc----cCC-----------
Confidence 44667888899999999999998877787777776443211100 00000011111100 000
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++.+.....-.......+||++|+ +++|...+...+ ..+.+-.+.+...+..++++||+..++|||++|.|+++.
T Consensus 863 ---~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 863 ---SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA 938 (1205)
T ss_pred ---CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhc
Confidence 001111111134567789999999 777777776533 456666777778889999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeee-cCCCC-------Cccc----------------cccCCCCCCCCccccccccccCCCCCcc
Q 013125 164 LGRKANQVYIIDFGLAKKY-RDPTT-------NRHI----------------PYRENKNLTGTARYASCNTHLGIEQSRR 219 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~-~~~~~-------~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 219 (449)
..+..++.|||+.... .-+.. .... ..+......||+.|.+||...+..-...
T Consensus 939 ---~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 939 ---YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred ---ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 7899999999843321 11000 0000 1123446679999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 220 DDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 220 ~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
+|+|++|++++|.++|.+||....+. +.+..|.....+ .+......+.+.++++...+..++.+|..+.--
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na~tpq---~~f~ni~~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~---- 1086 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQ---QIFENILNRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA---- 1086 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCCcchh---hhhhccccCCCC--CCCCccccChhhhhhhhhhhccCchhccCcccc----
Confidence 99999999999999999999876554 334444444333 333334457789999999999999999775411
Q ss_pred HHHHHhcCCCCCcccccccccc
Q 013125 300 HDLFSREGYDFDFVFDWTILKY 321 (449)
Q Consensus 300 ~~~~~~~~~~~~~~~dw~~l~~ 321 (449)
....+..+....||..+..
T Consensus 1087 ---~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1087 ---AEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred ---cccccCCccCCCCcccccc
Confidence 1234566777788876643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.8e-10 Score=100.58 Aligned_cols=139 Identities=20% Similarity=0.313 Sum_probs=94.8
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
+.|+.|.++.||++...+ ++.+++|+..... ....+.+|+++++.+.+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~------------------------- 57 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGV------------------------- 57 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCC-------------------------
Confidence 678999999999998743 5789999876543 24568899999999876421
Q ss_pred CcCeeEEecccC---CeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 013125 90 GIPNIKWYGVDG---EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------ 147 (449)
Q Consensus 90 ~i~~~~~~~~~~---~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~------------------ 147 (449)
.+|.+..+.... +..++|||++ |.++.+.+.. ..++......++.+++..|..||+
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 245554444443 2568999999 6555543210 234555555666666666666663
Q ss_pred --------------------------------------CCccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 148 --------------------------------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 148 --------------------------------------~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
..++|+|+++.|||++.+ ..+.+.|+||+.+.
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~ 205 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccc
Confidence 246899999999999511 14668999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.9e-09 Score=99.04 Aligned_cols=132 Identities=17% Similarity=0.143 Sum_probs=92.9
Q ss_pred eEEEEEEcCCCceEEEEEecCCC-------------CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccC
Q 013125 22 EIFLASHVDTNEIVAVKIENSGT-------------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTL 88 (449)
Q Consensus 22 ~Vy~a~~~~~~~~vAvKv~~~~~-------------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (449)
.|+.+.. .|+.|.||...... ......+|...+..|....+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GI------------------------ 90 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGV------------------------ 90 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCC------------------------
Confidence 3556544 56788899653322 01136788888888865432
Q ss_pred CCcCeeEEeccc-----CCeeEEEEecCCC--CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 89 GGIPNIKWYGVD-----GEDNVLVLDLLGP--SLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 89 ~~i~~~~~~~~~-----~~~~~lv~e~~g~--sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+|....++.. ....+||+|++++ +|.+++... ....+......++.+++..+.-||..||+|+||++.||
T Consensus 91 -ptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~Ni 169 (268)
T PRK15123 91 -DTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHF 169 (268)
T ss_pred -CCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhE
Confidence 23333444432 2357899999954 688887643 34456677889999999999999999999999999999
Q ss_pred Eeec----CCCCCeEEEEeeccee
Q 013125 161 LMGL----GRKANQVYIIDFGLAK 180 (449)
Q Consensus 161 ll~~----~~~~~~vkL~DfGla~ 180 (449)
|+.. .++...++|+||+.+.
T Consensus 170 Ll~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 170 LLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EEeccccCCCCCceEEEEECCccc
Confidence 9953 1235789999999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.9e-09 Score=105.93 Aligned_cols=181 Identities=15% Similarity=0.143 Sum_probs=125.5
Q ss_pred eEEeeeecccCceeEE-EEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 9 YKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy-~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
|.| +..+-++.+ || -|..+.++.+|.|.+.+.... .....+-++-++.|+|++++.++.
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~---------------- 76 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLD---------------- 76 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhh----------------
Confidence 444 333333333 44 355567788899998876655 334677788899999998665432
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-~~giiHrDLkp~Nill~~ 164 (449)
........|||+|.+.. |...++. +....+..-+.||+.||.||| +++++|++|.-+.|+|
T Consensus 77 -----------t~e~~~~~ylvTErV~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV-- 138 (690)
T KOG1243|consen 77 -----------TTEEEGTLYLVTERVRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV-- 138 (690)
T ss_pred -----------hhcccCceEEEeecccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE--
Confidence 23456688999999843 3333433 235677788999999999998 5799999999999999
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
+..|..||++|-++......... .....--..|..|+.+-... -..|.|-|||+++|++.|
T Consensus 139 -n~~GeWkLggle~v~~~~~~~~~-------~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 139 -NESGEWKLGGLELVSKASGFNAP-------AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cCCCcEEEeeeEEEeccccCCcc-------cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 48999999999887654432211 11222233466666555443 257999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.9e-11 Score=117.48 Aligned_cols=241 Identities=18% Similarity=0.114 Sum_probs=156.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEc-CCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
...+|.++.+||.|.|+.|+.+... .++..+++|...+... +..-+.|+.+...+.-..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~---------------- 326 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHL---------------- 326 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccc----------------
Confidence 3467899999999999999998765 6788899996554311 111234444444432111
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+.+............|+-.||| ++++.... .....++....+.+..|++.++.++|++.++|+|+||+
T Consensus 327 ----------~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ps 395 (524)
T KOG0601|consen 327 ----------PSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPS 395 (524)
T ss_pred ----------ccCCCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhccccccc
Confidence 1111111112334556888999 55554433 44566888889999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccc--ccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA--SCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
||++.. +++..++.|||++..+.... .......+++ ++.......+..+.|++|||..+.|.++|.
T Consensus 396 ni~i~~--~~~~~~~~~~~~~t~~~~~~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 396 NILISN--DGFFSKLGDFGCWTRLAFSS----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred ceeecc--chhhhhccccccccccceec----------ccccccccccccchhhccccccccccccccccccccccccCc
Confidence 999952 23888999999986432211 1223344555 455556667899999999999999999985
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
..-.... ....|......-. .+...++..+.......++..||.+.++
T Consensus 464 ~ls~~~~------~~~~i~~~~~p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 464 PLSESGV------QSLTIRSGDTPNL-----PGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred ccCcccc------cceeeecccccCC-----CchHHhhhhhhhhhcCCccccchhhhhh
Confidence 4322111 1111222222211 1223567777777888888888877654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.4e-09 Score=94.78 Aligned_cols=126 Identities=27% Similarity=0.349 Sum_probs=76.9
Q ss_pred eEEEEEEcCCCceEEEEEecCCC-----------------------Cc-----hhHHHHHHHHHHHcCCCcceeeEeecc
Q 013125 22 EIFLASHVDTNEIVAVKIENSGT-----------------------KH-----PQLLYEAKVYKILQGGSKIRLVVFHVD 73 (449)
Q Consensus 22 ~Vy~a~~~~~~~~vAvKv~~~~~-----------------------~~-----~~~~~E~~~l~~l~~~~~~~~~~~~~~ 73 (449)
.||.|... .+..||||+..... .. ....+|.+.|..+....+
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv--------- 70 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV--------- 70 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT----------
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc---------
Confidence 48999874 56789999854220 00 013567777777665431
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCc
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY-VHSRGF 150 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g--~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~-LH~~gi 150 (449)
.+|.++.+. ..+|||||++ |.....+... .++......++.+++..+.. +|..||
T Consensus 71 ----------------~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~gi 128 (188)
T PF01163_consen 71 ----------------PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGI 128 (188)
T ss_dssp ----------------SS--EEEEE----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTE
T ss_pred ----------------cCCcEEEEe----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCc
Confidence 355555442 4589999997 5444333321 12234566777888885555 679999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeec
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~ 183 (449)
+|+||.+.|||+. .+.++|+|||.|....
T Consensus 129 vHGDLs~~NIlv~----~~~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 129 VHGDLSEYNILVD----DGKVYIIDFGQAVDSS 157 (188)
T ss_dssp EESS-STTSEEEE----TTCEEE--GTTEEETT
T ss_pred eecCCChhhEEee----cceEEEEecCcceecC
Confidence 9999999999994 4499999999987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.9e-08 Score=96.43 Aligned_cols=262 Identities=15% Similarity=0.224 Sum_probs=159.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
.-...++.||+|+-+.+|-.-. -+. .+-||......-.+ .+....|-...-..... +.+
T Consensus 11 e~i~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~----------~rv---- 69 (637)
T COG4248 11 EPIPPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQ----AQKVAELAATPDAPLLN----------YRV---- 69 (637)
T ss_pred cccCCCccccCCccceeeecch--hhc-hhheeecCCCchHH----HHHHHHhccCCCCcchh----------hhh----
Confidence 3345678899999999996532 222 34477654432211 11222222211111000 000
Q ss_pred cCCCcCeeEEecccCCe-eEEEEecCC--CCHHHHHHHh--c---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 87 TLGGIPNIKWYGVDGED-NVLVLDLLG--PSLEDLFVYC--R---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~-~~lv~e~~g--~sL~~~~~~~--~---~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
--|.-..+|.++.. .-+.|..+. ....+++.-. . ..+.+...++.++.|+.+...||+.|.+-+|+.++
T Consensus 70 ---aWPqa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~ 146 (637)
T COG4248 70 ---AWPQATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQN 146 (637)
T ss_pred ---cccHHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCcc
Confidence 01111223443333 567777772 2344444311 1 23788999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHH
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~ 233 (449)
|+|++ ++..|.|+|-..-....+... ..+-+|...|.+||.-. +..-+...|.|.||+++++++
T Consensus 147 ~~lVs---d~~~V~LVdsDsfqi~~ng~~--------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL 215 (637)
T COG4248 147 SFLVS---DDSKVVLVDSDSFQINANGTL--------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLL 215 (637)
T ss_pred ceeee---cCceEEEEcccceeeccCCce--------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHH
Confidence 99996 788899988543222222111 23567889999999544 455677899999999999999
Q ss_pred hC-CCCCCCChhhc----HHH-HHH-------H-HHHhhcCCCHHHhhccChHHHHHHHHHHhCCC--CCCCCCHHHHHH
Q 013125 234 RG-SLPWQGLKAAT----KKQ-KYD-------K-ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLT--FDQRPDYGFLKR 297 (449)
Q Consensus 234 ~G-~~pf~~~~~~~----~~~-~~~-------~-i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~--p~~Rp~~~~l~~ 297 (449)
.| +.||.|..... ..+ .+. . -.....+.|.+--+.-+|+.+..++.+|+... +.-||+.+.-..
T Consensus 216 ~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~a 295 (637)
T COG4248 216 FGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVA 295 (637)
T ss_pred hcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHH
Confidence 85 99998743211 111 100 0 01112222333233445889999999999754 568999987776
Q ss_pred HHHHHH
Q 013125 298 LFHDLF 303 (449)
Q Consensus 298 ~l~~~~ 303 (449)
.|..+-
T Consensus 296 Al~al~ 301 (637)
T COG4248 296 ALDALR 301 (637)
T ss_pred HHHHHH
Confidence 666553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-09 Score=101.12 Aligned_cols=177 Identities=12% Similarity=0.160 Sum_probs=117.7
Q ss_pred CeeEEEEecC-CCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeecCCCCCeEEEEe
Q 013125 102 EDNVLVLDLL-GPSLEDLFV---YCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 175 (449)
Q Consensus 102 ~~~~lv~e~~-g~sL~~~~~---~~~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHrDLkp~Nill~~~~~~~~vkL~D 175 (449)
....++.||+ .+++..+++ ++...+......+|+.||+.||.|||++. |+|+++..+-|++. .++.+|+.-
T Consensus 145 ~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig~ 221 (458)
T KOG1266|consen 145 PRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIGS 221 (458)
T ss_pred cceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEecc
Confidence 4467899999 889988886 44566888999999999999999999985 99999999999994 566666532
Q ss_pred ecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCChhhcHHHHHHHH
Q 013125 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKI 254 (449)
Q Consensus 176 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p-f~~~~~~~~~~~~~~i 254 (449)
-.-.. ..+...... -.+..--.+.+.|.+||.-.--+.+-.+|||+||....||..|..- -.+.......+.+..+
T Consensus 222 ~ap~s--~h~s~~~~~-~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~ 298 (458)
T KOG1266|consen 222 VAPDS--THPSVNSTR-EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV 298 (458)
T ss_pred cCccc--cchhhhhhh-HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh
Confidence 21111 000000000 0111223456788999987777778899999999999999987543 2222222222222211
Q ss_pred HHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 255 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
..... ..--+.++..|+.-.|..||++..+
T Consensus 299 i~~le-----------n~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 299 IIGLE-----------NGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred eeecc-----------CccccCcCcccccCCCCCCcchhhh
Confidence 11110 1223567889999999999998865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=9e-08 Score=86.76 Aligned_cols=110 Identities=21% Similarity=0.295 Sum_probs=82.6
Q ss_pred chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccC----CeeEEEEecC-C-CCHHHHH
Q 013125 46 HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDG----EDNVLVLDLL-G-PSLEDLF 119 (449)
Q Consensus 46 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~-g-~sL~~~~ 119 (449)
.....+|...+..|....+ .+|....++... ...+||+|.+ + .+|.+++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi-------------------------~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGI-------------------------PTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred chHHHHHHHHHHHHHHcCC-------------------------CCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 4457889888888875542 344444454432 3458999999 3 3688887
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceee
Q 013125 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 120 ~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~ 181 (449)
..... .+......++.+++..+.-||+.||+|+|+++.|||+..++....+.|+||+.++.
T Consensus 110 ~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 110 QQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred Hhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 75322 66777889999999999999999999999999999996433345899999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.5e-08 Score=83.75 Aligned_cols=127 Identities=25% Similarity=0.456 Sum_probs=95.9
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
+..+.||+|.+|.||++.+ .+..+|+|+...+.....+..|++++.+++...
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~-------------------------- 76 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEG-------------------------- 76 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcC--------------------------
Confidence 3457799999999999988 567899999998888888999999999999876
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC--CcEEeecCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP--DNFLMGLGR 166 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp--~Nill~~~~ 166 (449)
..|.+++|+.+ .+.|||. |..|.++... .+.+++. .+++.---|-..||-|..|.- .||++
T Consensus 77 ~~p~vy~yg~~----~i~me~i~G~~L~~~~~~----~~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv---- 140 (201)
T COG2112 77 VTPEVYFYGED----FIRMEYIDGRPLGKLEIG----GDRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLV---- 140 (201)
T ss_pred CCceEEEechh----hhhhhhhcCcchhhhhhc----ccHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEe----
Confidence 56777777754 3559999 6688776442 1233333 344443344557999999875 57777
Q ss_pred CCCeEEEEeeccee
Q 013125 167 KANQVYIIDFGLAK 180 (449)
Q Consensus 167 ~~~~vkL~DfGla~ 180 (449)
.++.++|+||..|+
T Consensus 141 ~~~~~~iIDFd~At 154 (201)
T COG2112 141 NDRDVYIIDFDSAT 154 (201)
T ss_pred cCCcEEEEEccchh
Confidence 45699999998876
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.6e-08 Score=86.57 Aligned_cols=145 Identities=20% Similarity=0.241 Sum_probs=90.3
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh-----------HHHHHHHHHHHcCCCcceeeEe
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----------LLYEAKVYKILQGGSKIRLVVF 70 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~-----------~~~E~~~l~~l~~~~~~~~~~~ 70 (449)
+.++.++|.+.+.+-.....-|.+-.- +++.+++|.........+ ..+++..+..++.........
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~- 102 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD- 102 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc-
Confidence 457889999999999988888887765 678899998665432211 122222222222211111000
Q ss_pred ecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013125 71 HVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149 (449)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g 149 (449)
..+....--.......+|+|||+ |..|.++.. ++. .++..|..+|..||..|
T Consensus 103 ------------------~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G 155 (229)
T PF06176_consen 103 ------------------PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG 155 (229)
T ss_pred ------------------ceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC
Confidence 00000111112234557899999 766665432 222 34566778899999999
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
+.|+|.+|.|++++ ++.++++||+..+
T Consensus 156 ~~HGD~hpgNFlv~----~~~i~iID~~~k~ 182 (229)
T PF06176_consen 156 FYHGDPHPGNFLVS----NNGIRIIDTQGKR 182 (229)
T ss_pred CccCCCCcCcEEEE----CCcEEEEECcccc
Confidence 99999999999994 5669999997653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.8e-09 Score=108.10 Aligned_cols=154 Identities=14% Similarity=0.190 Sum_probs=109.4
Q ss_pred HHHHHHHHHHh-CCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCC--CCCCCCccccccccccC
Q 013125 137 QMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN--KNLTGTARYASCNTHLG 213 (449)
Q Consensus 137 qil~~L~~LH~-~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~ 213 (449)
+.+.||.|+|. .++||++|.|++|.+ +..+..||+-|+.+.....+.......|... -...-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34489999997 599999999999999 5889999999998765544322111112211 12234567999999999
Q ss_pred CCCCccchHHHHHHHHHHHH-hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 214 IEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 214 ~~~s~~~DvwSlG~il~el~-~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
..-+.++|++|+||++|-+. .|+..+.+........ ............+..++|.++++-+...+..+..-||+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh----hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 87899999999999999988 5777666543322111 112223333333446789999999999999999999976
Q ss_pred HHHHH
Q 013125 293 GFLKR 297 (449)
Q Consensus 293 ~~l~~ 297 (449)
..+..
T Consensus 260 ~~l~~ 264 (700)
T KOG2137|consen 260 DLLLS 264 (700)
T ss_pred hhhhc
Confidence 65533
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.2e-07 Score=81.19 Aligned_cols=137 Identities=13% Similarity=0.112 Sum_probs=97.8
Q ss_pred cccCceeEEEEEEcCCCceEEEEEecC--------CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhccc
Q 013125 16 GSGSFGEIFLASHVDTNEIVAVKIENS--------GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSST 87 (449)
Q Consensus 16 G~G~fg~Vy~a~~~~~~~~vAvKv~~~--------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (449)
|+||-+-|+.... .|+.+=+|...+ ....+.+.+|...++.|....+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~Gv----------------------- 81 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGV----------------------- 81 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCC-----------------------
Confidence 6799999998765 344577775431 1245668999999999976652
Q ss_pred CCCcCeeEEeccc----CCeeEEEEecCC--CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 88 LGGIPNIKWYGVD----GEDNVLVLDLLG--PSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 88 ~~~i~~~~~~~~~----~~~~~lv~e~~g--~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+|.+.+++.. .-..+||+|-++ .+|.+++.... .+.+......++.+++..|.-||+.|+.|+|+-+.||
T Consensus 82 --PVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khI 159 (216)
T PRK09902 82 --IVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHI 159 (216)
T ss_pred --CCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhhe
Confidence 23344433322 234689999886 68888775422 3457777789999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeeccee
Q 013125 161 LMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~ 180 (449)
++... +...++++||--++
T Consensus 160 ll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 160 YVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred eecCC-CCeeEEEEEhhccc
Confidence 99421 12349999996543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-07 Score=85.21 Aligned_cols=133 Identities=22% Similarity=0.363 Sum_probs=95.3
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----------------CCc--------hhHHHHHHHHHHHcCCCc
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----------------TKH--------PQLLYEAKVYKILQGGSK 64 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----------------~~~--------~~~~~E~~~l~~l~~~~~ 64 (449)
+.++.+||-|--+.||.|.+. .+.++|||.-... ..+ ....+|.++|+.|.....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457899999999999999986 6888999962211 001 124678888888865420
Q ss_pred ceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 013125 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 143 (449)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~ 143 (449)
.+|.. ...+..++|||+. |.-|..+ +++.+....++..|++-+.
T Consensus 172 -------------------------~VP~P----~~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~ 216 (304)
T COG0478 172 -------------------------KVPKP----IAWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVR 216 (304)
T ss_pred -------------------------CCCCc----cccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHH
Confidence 12222 2346789999999 4433332 2245666677778888887
Q ss_pred HHHhCCccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 144 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 144 ~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
-+-..|+||+|+.+=||+++ ++|.++++||-.+.
T Consensus 217 ~~~~~GiVHGDlSefNIlV~---~dg~~~vIDwPQ~v 250 (304)
T COG0478 217 KAYRRGIVHGDLSEFNILVT---EDGDIVVIDWPQAV 250 (304)
T ss_pred HHHHcCccccCCchheEEEe---cCCCEEEEeCcccc
Confidence 77789999999999999995 78899999996553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.2e-06 Score=78.74 Aligned_cols=72 Identities=18% Similarity=0.143 Sum_probs=54.6
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIP 92 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 92 (449)
.+||.|..+.||+. .+..+++|+...........+|.++++.+..... -+|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~gl-------------------------pvP 57 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGI-------------------------PTP 57 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCC-------------------------CCC
Confidence 57899999999984 2446789987765555678999999999875431 356
Q ss_pred eeEEecccCCeeEEEEecCCC
Q 013125 93 NIKWYGVDGEDNVLVLDLLGP 113 (449)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~g~ 113 (449)
.+..++...+...+|||++.|
T Consensus 58 ~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 58 HPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred ceEEEEecCCeeeeeeeecCC
Confidence 677777777778899999944
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.8e-06 Score=78.33 Aligned_cols=77 Identities=22% Similarity=0.352 Sum_probs=57.3
Q ss_pred CeeEEEEecCCCCHH--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeecCCCCCeEEEEeecc
Q 013125 102 EDNVLVLDLLGPSLE--DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178 (449)
Q Consensus 102 ~~~~lv~e~~g~sL~--~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nill~~~~~~~~vkL~DfGl 178 (449)
....|||||+|..-. -.++ .-.+....+..+..+++..++-|-. .|+||+||..=|||+ .++.++++|||.
T Consensus 139 ~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~~~~p~iID~~Q 212 (268)
T COG1718 139 RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----HDGEPYIIDVSQ 212 (268)
T ss_pred cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----ECCeEEEEECcc
Confidence 456899999965411 1111 1123344678888899999998887 899999999999999 478999999999
Q ss_pred eeeecC
Q 013125 179 AKKYRD 184 (449)
Q Consensus 179 a~~~~~ 184 (449)
|.....
T Consensus 213 aV~~~h 218 (268)
T COG1718 213 AVTIDH 218 (268)
T ss_pred ccccCC
Confidence 865543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.1e-07 Score=91.84 Aligned_cols=162 Identities=21% Similarity=0.346 Sum_probs=91.6
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcC----CCc----ceee--------------Ee
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG----GSK----IRLV--------------VF 70 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~----~~~----~~~~--------------~~ 70 (449)
+.|+.++-|.||.|+.. +|+.|||||...+ -.+.+...+++|+.+.. ... .... ..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPg-i~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPG-IRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCC-hHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 57889999999999975 4999999997653 12233333333333210 000 0000 00
Q ss_pred ecchhhhhhhhhhhcc-cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 71 HVDHVIIHALTIIFSS-TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 71 ~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
..+-.+...+...+.. ..=.+|.++| ......+|+|||+ |..+.++.......++.+.+...+.++. +..+-..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~w--e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYW--EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeeh--hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 0000000001111110 0113455544 3345679999999 6666666432234566444444333332 4445558
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeec
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~ 183 (449)
|+.|.|.+|.||++ +.++.+.+.|||+.....
T Consensus 285 gffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILV---RSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEE---ecCCcEEEEcCcceecCC
Confidence 99999999999999 477999999999986543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.2e-05 Score=77.76 Aligned_cols=166 Identities=18% Similarity=0.238 Sum_probs=118.0
Q ss_pred eeEEEEEEcCCCceEEEEEecCCCCc-h-hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEec
Q 013125 21 GEIFLASHVDTNEIVAVKIENSGTKH-P-QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYG 98 (449)
Q Consensus 21 g~Vy~a~~~~~~~~vAvKv~~~~~~~-~-~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 98 (449)
.+.|+|....+|..|++|.+..+... . .-..-++..+++.|.+++.+..+... +.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t-----------------------~t 346 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLT-----------------------YT 346 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhh-----------------------hc
Confidence 47899999999999999988432110 0 12344678889999997766443221 11
Q ss_pred ccCCeeEEEEecC--CCCHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 99 VDGEDNVLVLDLL--GPSLEDLFVYC--------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 99 ~~~~~~~lv~e~~--g~sL~~~~~~~--------------~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
-.+...++|++|+ .++|.++.-.. +.+.++..++.++.||..||.++|+.|+.-+-|.+.+||+
T Consensus 347 F~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv 426 (655)
T KOG3741|consen 347 FGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV 426 (655)
T ss_pred cCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe
Confidence 2346789999999 66777765211 2346788999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
. ...+++|+--|..-......+ +.+. .-.+-|.=-||.++..|.||.
T Consensus 427 ~---G~~RIriS~C~i~Dvl~~d~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 427 T---GKMRIRISGCGIMDVLQEDPT---------------------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred e---CcceEEEecccceeeecCCCC---------------------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 4 445788877766554433221 1111 122579999999999999984
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.4e-06 Score=74.92 Aligned_cols=79 Identities=18% Similarity=0.222 Sum_probs=53.1
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCc
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI 91 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 91 (449)
++.|+.|..+.||++.... ..+++|+.........+.+|..+++.|....+ .+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~-------------------------pv 54 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGI-------------------------PV 54 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTS-------------------------BS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCC-------------------------CC
Confidence 5789999999999998744 58899986654233467889999998875542 13
Q ss_pred CeeEEec---ccCCeeEEEEecC-CCCHHH
Q 013125 92 PNIKWYG---VDGEDNVLVLDLL-GPSLED 117 (449)
Q Consensus 92 ~~~~~~~---~~~~~~~lv~e~~-g~sL~~ 117 (449)
|.+..+. ......+++|+++ |..+..
T Consensus 55 P~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 55 PRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp --EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred ceEEeecccccccccceEEEEEeccccccc
Confidence 3343322 2333468999999 555554
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.1e-06 Score=83.39 Aligned_cols=89 Identities=24% Similarity=0.435 Sum_probs=61.3
Q ss_pred cCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC-CCC
Q 013125 91 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKA 168 (449)
Q Consensus 91 i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~-~~~ 168 (449)
+|.++|.. ....+|+|||+ |..+.|+-.-....++...+...+.++. ++.|-..|++|+|-+|.||++... +.+
T Consensus 266 VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~ 341 (538)
T KOG1235|consen 266 VPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGD 341 (538)
T ss_pred CCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCC
Confidence 67766543 35679999999 6655554332345677776655555443 344455789999999999999632 247
Q ss_pred CeEEEEeecceeeec
Q 013125 169 NQVYIIDFGLAKKYR 183 (449)
Q Consensus 169 ~~vkL~DfGla~~~~ 183 (449)
..+.+.|||+.....
T Consensus 342 ~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 342 EEIVLLDHGLYAVIS 356 (538)
T ss_pred ccEEEEccccccccc
Confidence 789999999986544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.5e-05 Score=74.19 Aligned_cols=75 Identities=23% Similarity=0.311 Sum_probs=53.1
Q ss_pred eeecccCc-eeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCc
Q 013125 13 RKIGSGSF-GEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI 91 (449)
Q Consensus 13 ~~LG~G~f-g~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 91 (449)
..|-.|.. ..||++.. .+..+.||+..... ...+.+|+++++.+.... -+
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~--------------------------~v 54 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKL--------------------------PV 54 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcC--------------------------CC
Confidence 34556666 78999975 34678899875543 345788999999886432 56
Q ss_pred CeeEEecccCCeeEEEEecC-CCCHH
Q 013125 92 PNIKWYGVDGEDNVLVLDLL-GPSLE 116 (449)
Q Consensus 92 ~~~~~~~~~~~~~~lv~e~~-g~sL~ 116 (449)
|.+..++...+..++|||++ |.++.
T Consensus 55 P~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 55 PEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred CeEEEEEecCCccEEEEEeeCCccHh
Confidence 77777776666789999999 65554
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.7e-05 Score=67.11 Aligned_cols=133 Identities=19% Similarity=0.261 Sum_probs=92.3
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCC------------------CchhHHHHHHHHHHHc-CCCcceeeEeec
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------------KHPQLLYEAKVYKILQ-GGSKIRLVVFHV 72 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~------------------~~~~~~~E~~~l~~l~-~~~~~~~~~~~~ 72 (449)
...||+|+.-.||.-- . +....|||..... ...+..+|+..+..+. ......
T Consensus 6 ~~~i~~G~~R~cy~HP--~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~------ 76 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP--D-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW------ 76 (199)
T ss_pred CcccccCCCceEEECC--C-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc------
Confidence 3568999999999543 2 3335789877654 2456788888888877 433221
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-------CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 145 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-------g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~L 145 (449)
.+++.++.+-......-+|+|.. ..+|.+++. ...++. ..... +-+-.+||
T Consensus 77 ----------------~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~---L~~f~~~l 134 (199)
T PF10707_consen 77 ----------------SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQA---LDEFKRYL 134 (199)
T ss_pred ----------------cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHH---HHHHHHHH
Confidence 16777777777777778888887 236777764 334554 33333 33445688
Q ss_pred HhCCccccCCCCCcEEeecCCCCC-eEEEEe
Q 013125 146 HSRGFLHRDIKPDNFLMGLGRKAN-QVYIID 175 (449)
Q Consensus 146 H~~giiHrDLkp~Nill~~~~~~~-~vkL~D 175 (449)
-+.+|+.+||+|.||++...++.. .+.|+|
T Consensus 135 ~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 135 LDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 899999999999999998765555 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.9e-05 Score=71.86 Aligned_cols=45 Identities=16% Similarity=0.141 Sum_probs=31.9
Q ss_pred eeeecccCce-eEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcC
Q 013125 12 GRKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61 (449)
Q Consensus 12 ~~~LG~G~fg-~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~ 61 (449)
++.|+.|+.. .||+.. ..+++|+.........+.+|.++++.|..
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~ 47 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAP 47 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhc
Confidence 3567877777 499762 34678986554344568999999999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00015 Score=64.35 Aligned_cols=145 Identities=17% Similarity=0.175 Sum_probs=89.3
Q ss_pred CceEEeeeecccCc-eeEEEEEEcCCCceEEEEEecC---C--------------------CCchhHHHHHHHHHHHcCC
Q 013125 7 VKYKLGRKIGSGSF-GEIFLASHVDTNEIVAVKIENS---G--------------------TKHPQLLYEAKVYKILQGG 62 (449)
Q Consensus 7 ~~y~i~~~LG~G~f-g~Vy~a~~~~~~~~vAvKv~~~---~--------------------~~~~~~~~E~~~l~~l~~~ 62 (449)
..++.++.||.|.- |.||+++. .|+.+|||+... . ...+.+..|.+.+-+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999987 678999999221 0 0112477899999988877
Q ss_pred CcceeeE-eecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 013125 63 SKIRLVV-FHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 141 (449)
Q Consensus 63 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~ 141 (449)
+...++. .|..-.....-..+.....+ ...+.......||-||....- .++.. -+.+|++-
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~-----~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~d 176 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQR-----GSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRD 176 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcc-----cccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHH
Confidence 7644422 12111111100000000000 000112223467888773221 22322 34567788
Q ss_pred HHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecce
Q 013125 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179 (449)
Q Consensus 142 L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla 179 (449)
|..+|..||+-+|+++.|..= -+|+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 899999999999999999863 279999865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.7e-06 Score=87.48 Aligned_cols=185 Identities=10% Similarity=0.009 Sum_probs=130.6
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccC
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTL 88 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (449)
|...+-+++|+++.+++.+...+...+ .+++... ....-++++|.+.++++..-.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~--------------------- 298 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVR--------------------- 298 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCccc---------------------
Confidence 344556789999999999887666655 6765432 345567889999988871110
Q ss_pred CCcCeeEEecccCCeeEEEEecCCCC--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 89 GGIPNIKWYGVDGEDNVLVLDLLGPS--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 89 ~~i~~~~~~~~~~~~~~lv~e~~g~s--L~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
...-...+.+.+++++++++. ....+.-..-.|..-+...+.+.-+.++++||+.-=+||| ||+.
T Consensus 299 -----~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~---- 365 (829)
T KOG0576|consen 299 -----YLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG---- 365 (829)
T ss_pred -----ccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----
Confidence 011123456778999999332 3222221122244455566777788899999997668888 8887
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
.....++.||+....+.... ..+...+|+.+++||+.....+....|+|++|.-..++.-|-+|-
T Consensus 366 s~~~~~~~~~~v~~~L~~~~--------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 366 SEEEVKLLDFAVPPQLTRTM--------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccccccccccCCcccCccc--------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 56788999999876554432 135778999999999999999999999999998888888776654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00034 Score=76.66 Aligned_cols=78 Identities=14% Similarity=0.198 Sum_probs=51.6
Q ss_pred EeeeecccCceeEEEEEEcCCC--ceEEEEEecCCC---CchhHHHHHHHHHHHcC-CCcceeeEeecchhhhhhhhhhh
Q 013125 11 LGRKIGSGSFGEIFLASHVDTN--EIVAVKIENSGT---KHPQLLYEAKVYKILQG-GSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~--~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
-+++|+.|.+..+|+......+ ..+++|+..... ....+.+|.++++.|.. ..+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~v-------------------- 101 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDV-------------------- 101 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCC--------------------
Confidence 4678899999999998764332 357778654322 22357899999999863 321
Q ss_pred cccCCCcCeeEEecccC---CeeEEEEecCCC
Q 013125 85 SSTLGGIPNIKWYGVDG---EDNVLVLDLLGP 113 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~---~~~~lv~e~~g~ 113 (449)
-+|.++.++.+. ...|+|||++.|
T Consensus 102 -----pVP~v~~~~~d~~v~G~~flVME~v~G 128 (822)
T PLN02876 102 -----PVPKVYCLCTDASVIGTAFYIMEYLEG 128 (822)
T ss_pred -----CCCcEEEEecCCCcCCCceEEEEecCC
Confidence 345555554432 356899999943
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00032 Score=67.26 Aligned_cols=140 Identities=20% Similarity=0.236 Sum_probs=92.7
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCC---------------------CC-ch------hHHHHHHHHHHHcCC
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---------------------TK-HP------QLLYEAKVYKILQGG 62 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~---------------------~~-~~------~~~~E~~~l~~l~~~ 62 (449)
|-..|..|--+.||.|.. .+|..+||||.+.. +. .+ ....|++-|++|+..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344566788889999985 46777999985421 11 11 135677777777665
Q ss_pred CcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013125 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 142 (449)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L 142 (449)
.+.. |.. ..-...+|||+|+|.+-...-+-....++...+..+-.|++.-|
T Consensus 227 GIP~-------------------------PeP----IlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~M 277 (520)
T KOG2270|consen 227 GIPC-------------------------PEP----ILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIM 277 (520)
T ss_pred CCCC-------------------------CCc----eeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHH
Confidence 4211 000 01144689999997542221111133467777878878888888
Q ss_pred HHHH-hCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecC
Q 013125 143 EYVH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184 (449)
Q Consensus 143 ~~LH-~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~ 184 (449)
.-|- .+++||.||.-=|+|+ -.|.++++|.+.|.....
T Consensus 278 R~lY~~c~LVHADLSEfN~Ly----hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 278 RRLYQKCRLVHADLSEFNLLY----HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred HHHHHHhceeccchhhhhheE----ECCEEEEEEccccccCCC
Confidence 7765 4899999999999999 579999999998864433
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00057 Score=67.78 Aligned_cols=75 Identities=25% Similarity=0.265 Sum_probs=52.5
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCC---------CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+.||.|.+..||++.+...++.|+||.-... ...++...|.+.|+.+....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~------------------- 91 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYV------------------- 91 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhC-------------------
Confidence 46899999999999998654468999974311 12345677888888765321
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLG 112 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g 112 (449)
.+.+|.++.++. +..++|||++.
T Consensus 92 -----p~~VPkV~~~D~--~~~~lVME~L~ 114 (401)
T PRK09550 92 -----PDLVPKVYHYDE--ELAVTVMEDLS 114 (401)
T ss_pred -----CCCCCeEEEECC--CCCEEEEecCC
Confidence 115777877754 55789999983
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00063 Score=63.78 Aligned_cols=48 Identities=10% Similarity=0.058 Sum_probs=33.0
Q ss_pred eecccCceeEEEEEEcCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCC
Q 013125 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGS 63 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~--~~~~~E~~~l~~l~~~~ 63 (449)
.+..|-...+|+... +++.+++|+....... -...+|.++++.+....
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g 52 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALG 52 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcC
Confidence 456688889998873 5667889975543222 13578999999887543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0025 Score=61.75 Aligned_cols=48 Identities=10% Similarity=0.070 Sum_probs=33.1
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~ 62 (449)
.+.|+.|....+|++... +..+++|+.. ......+..|..+++.|...
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~ 74 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTAEDLPFFLGLMQHLAAR 74 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec-cCChHHhHHHHHHHHHHHHC
Confidence 456777877899998753 3368899875 33344566788888888644
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0018 Score=59.80 Aligned_cols=52 Identities=15% Similarity=0.190 Sum_probs=35.8
Q ss_pred eeeecccCceeEEEEEEcC-CCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCC
Q 013125 12 GRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGS 63 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~-~~~~vAvKv~~~~~~~-~~~~~E~~~l~~l~~~~ 63 (449)
++.|..|-...||++.... .++.|++|+....... -...+|+.+++.+....
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~g 56 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHG 56 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCC
Confidence 4677888888999997532 3567899986543221 23457899998886544
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0034 Score=60.56 Aligned_cols=51 Identities=14% Similarity=0.079 Sum_probs=35.3
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~ 62 (449)
..++.++.|.-..||++.. . +..+++|+.........+..|.++++.|...
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~ 75 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAAR 75 (307)
T ss_pred eeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHC
Confidence 3456777787789999864 2 3357789876543345677888888888644
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0036 Score=60.92 Aligned_cols=72 Identities=17% Similarity=0.150 Sum_probs=47.7
Q ss_pred eecccCceeEEEEEEcCCCceEEEEEec----C-----CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN----S-----GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~~~~vAvKv~~----~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.||.|....||++.+...++.|+||.-. . .-..++...|...|+......
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~--------------------- 60 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHV--------------------- 60 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccC---------------------
Confidence 5799999999999985444679999521 1 122345677888887654321
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL 111 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~ 111 (449)
.+.+|.++.|. .+..++|||++
T Consensus 61 ---P~~vP~vy~~D--~e~~~~vMEdL 82 (370)
T TIGR01767 61 ---PHLVPRIFHFD--TEMAVTVMEDL 82 (370)
T ss_pred ---ccccCeEEEEc--cccceehHhhC
Confidence 11466666654 45567999998
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0036 Score=59.99 Aligned_cols=50 Identities=8% Similarity=0.050 Sum_probs=36.6
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~ 63 (449)
-.+.|..|....+|++.. .+..+++|+... .....+..|+++++.|.+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g 67 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERG 67 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCC
Confidence 366777888889999865 344688998765 34456788999999986543
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0014 Score=58.28 Aligned_cols=83 Identities=19% Similarity=0.212 Sum_probs=60.5
Q ss_pred CcCeeEEecccCCeeEEEEecCC-CCHHHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCcEE
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLLG-PSLEDL----FVYCRRKFSLKTVLMLADQMIARIEYVHS---RGFLHRDIKPDNFL 161 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~g-~sL~~~----~~~~~~~~~~~~~~~i~~qil~~L~~LH~---~giiHrDLkp~Nil 161 (449)
.+|++.+++ ..++|.|+.+ +++... .. -...++....+++.+++..+++|+. ..+.-.|++++||.
T Consensus 21 ~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfg 94 (188)
T PF12260_consen 21 PFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFG 94 (188)
T ss_pred CCCCeeeEC----CCEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeE
Confidence 455554443 2367889985 344311 11 1236899999999999999999997 34777999999999
Q ss_pred eecCCCCCeEEEEeecceee
Q 013125 162 MGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~ 181 (449)
+. +++.+|++|......
T Consensus 95 v~---~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 95 VN---DDGRLKLIDLDDVFV 111 (188)
T ss_pred Ee---CCCcEEEEechhcch
Confidence 94 778999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0023 Score=69.65 Aligned_cols=200 Identities=16% Similarity=0.121 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCC
Q 013125 49 LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS 127 (449)
Q Consensus 49 ~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~ 127 (449)
.+.|...+..+.|.+....+.......+. +-...+..++| +.++..++.. ...++
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~-----------------------g~~~~v~~~~~s~~~~~~~~q~-v~~i~ 284 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFR-----------------------GIVLDVLQEICSKVELRSLLQS-VGSIP 284 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcc-----------------------hHHHHHHHhhcCccchHHHHhh-ccccC
Confidence 45667777778887766554433222100 00112233555 5566665554 56688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEE--eecceeeecCCCCCccccccCCCCCCCCccc
Q 013125 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII--DFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205 (449)
Q Consensus 128 ~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~--DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y 205 (449)
..+++.+..++++||.|+|+..+.|.-|...-..-...+..+.+.++ ||+.+..+.+.... .....+..+
T Consensus 285 ~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~ 356 (1351)
T KOG1035|consen 285 LETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIR 356 (1351)
T ss_pred HHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--------hhhcCcccc
Confidence 99999999999999999999866665444442211111344555655 88888766554322 123334567
Q ss_pred cccccccCCCCCc--cchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhC
Q 013125 206 ASCNTHLGIEQSR--RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQS 283 (449)
Q Consensus 206 ~aPE~~~~~~~s~--~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 283 (449)
.++|......+.. ..|+|.+|..+..+..|..+-.. ...+...++.....+..+....|+.
T Consensus 357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~-----------------~~~~~~~l~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEK-----------------SAVPVSLLDVLSTSELLDALPKCLD 419 (1351)
T ss_pred ccccccccccchhhhhhHHHHHHHHHhhhhhcCccccc-----------------ccchhhhhccccchhhhhhhhhhcc
Confidence 7888777665544 47999999999999987543211 0111112222222356778888998
Q ss_pred CCCCCCCCHHHHHH
Q 013125 284 LTFDQRPDYGFLKR 297 (449)
Q Consensus 284 ~~p~~Rp~~~~l~~ 297 (449)
.+.++|++..++..
T Consensus 420 ~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 420 EDSEERLSALELLT 433 (1351)
T ss_pred hhhhhccchhhhhh
Confidence 88999998776644
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0083 Score=57.66 Aligned_cols=52 Identities=17% Similarity=0.146 Sum_probs=36.4
Q ss_pred eeeecccCceeEEEEEEcC------CCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC
Q 013125 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~ 63 (449)
++.|..|--..||++.... +++.+++|+...... .....+|.++++.+....
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g 61 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERN 61 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCC
Confidence 4566667777999987533 257899999765432 235688999999987654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.00046 Score=65.15 Aligned_cols=133 Identities=20% Similarity=0.313 Sum_probs=87.9
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----------C---------Cch-----hHHHHHHHHHHHcCCC
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----------T---------KHP-----QLLYEAKVYKILQGGS 63 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----------~---------~~~-----~~~~E~~~l~~l~~~~ 63 (449)
-+.++++||-|--+.||.+-+. .|...++|+-... . .+- ...+|...|+.|....
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3678899999999999999874 5777889962110 0 000 1245666666665432
Q ss_pred cceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013125 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 142 (449)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L 142 (449)
. -+|.. .+.+..|+|||++ |-.|..+.. --. +..+...+..-|
T Consensus 172 f-------------------------pVPkp----iD~~RH~Vvmelv~g~Pl~~v~~----v~d---~~~ly~~lm~~I 215 (465)
T KOG2268|consen 172 F-------------------------PVPKP----IDHNRHCVVMELVDGYPLRQVRH----VED---PPTLYDDLMGLI 215 (465)
T ss_pred C-------------------------CCCCc----ccccceeeHHHhhcccceeeeee----cCC---hHHHHHHHHHHH
Confidence 0 12221 2446779999999 666654421 112 233444555556
Q ss_pred HHHHhCCccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 143 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 143 ~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
.-|-..|+||+|..-=|||+. +++.++++||-...
T Consensus 216 v~la~~GlIHgDFNEFNimv~---dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 216 VRLANHGLIHGDFNEFNIMVK---DDDKIVVIDFPQMV 250 (465)
T ss_pred HHHHHcCceecccchheeEEe---cCCCEEEeechHhh
Confidence 778889999999999999994 68899999996543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0083 Score=57.54 Aligned_cols=110 Identities=16% Similarity=0.106 Sum_probs=74.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
..-.-.+.||.|..+.||.... .+..+.+|+.+.......+..|+..++.|.....+
T Consensus 14 ~~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~v--------------------- 70 (297)
T PRK10593 14 EKLSRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTV--------------------- 70 (297)
T ss_pred hhhheeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCC---------------------
Confidence 3445567899999999999865 23357778854422445789999999999764311
Q ss_pred cCCCcCeeEEeccc---CCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 87 TLGGIPNIKWYGVD---GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 87 ~~~~i~~~~~~~~~---~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
.+|.+...+.. .+..+||||++ |.++.+. .........++.+++.+|.-||..
T Consensus 71 ---pVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 71 ---RMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ---CcCcEEEEeccCCcCCCeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 46666655432 35689999999 6555441 123344556677788888888874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0042 Score=58.90 Aligned_cols=49 Identities=10% Similarity=0.155 Sum_probs=30.7
Q ss_pred eeeecccCce---eEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcC
Q 013125 12 GRKIGSGSFG---EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61 (449)
Q Consensus 12 ~~~LG~G~fg---~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~ 61 (449)
.+.++.|+-| .||.+.+ ..|+.+++|.-........+.+|+++++.|..
T Consensus 13 ~~~~~~~~~g~~~~v~~i~~-~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~ 64 (276)
T cd05152 13 PETLSLNESGLDFQVVFAKD-TDGVPWVLRIPRRPDVSERAAAEKRVLALVRK 64 (276)
T ss_pred CCcceecCCcceeEEEEEEc-CCCCeEEEEecCCHHHHHHHHHHHHHHHHHHh
Confidence 3444444444 5555432 24677888976543334568999999999975
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.016 Score=57.25 Aligned_cols=74 Identities=20% Similarity=0.273 Sum_probs=49.4
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEe----cCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIE----NSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~----~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.+.||.|.-..||++.+...++.|+||.- ... -..++...|.++|+.+....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~-------------------- 93 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELA-------------------- 93 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhC--------------------
Confidence 67899999999999998433567999942 211 22345677888888765321
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL 111 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 111 (449)
.+.+|.++.|. .+..++|||++
T Consensus 94 ----P~~VP~vy~~D--~e~~~~vMEdL 115 (409)
T PRK12396 94 ----PGLVPKVYLFD--SVMNCCVMEDL 115 (409)
T ss_pred ----CCcCCeEEEEC--cHHhhHHHHhC
Confidence 11466666654 34567888887
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.05 Score=54.04 Aligned_cols=75 Identities=12% Similarity=0.238 Sum_probs=49.6
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEec-----CCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~-----~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
..+.||.|....||++.+. +..|+||.-. ... ...+...|+..|+.+....
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~------------------ 95 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC------------------ 95 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC------------------
Confidence 4778899999999999873 4568899643 111 3334566677666554221
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP 113 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~ 113 (449)
...+|.++.++. +..+++||++.+
T Consensus 96 ------p~~VPkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 96 ------PDHVPEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred ------CCCCCeEEEECC--CCCEEEEeecCC
Confidence 115777777766 557889999933
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.048 Score=53.46 Aligned_cols=55 Identities=13% Similarity=0.070 Sum_probs=36.3
Q ss_pred eEEeeeecccCceeEEEEEEcC----CCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC
Q 013125 9 YKLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~ 63 (449)
..-+..|-.|-.-.+|++.... +++.|++|+...... .-....|..+++.+....
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~g 97 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHG 97 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcC
Confidence 3344566558888999987532 346899998765432 112367899998887654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0099 Score=57.25 Aligned_cols=74 Identities=20% Similarity=0.266 Sum_probs=59.4
Q ss_pred ccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeecCCCCCeEEEEeec
Q 013125 99 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFG 177 (449)
Q Consensus 99 ~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp~Nill~~~~~~~~vkL~DfG 177 (449)
.++.+.|++|++.|+++.-. .....+++..++++.+.-+.-+..+ .+-||||.-+|||| +.|.|.|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEee
Confidence 45567788999988887532 2245788889999988877777664 68899999999999 58999999999
Q ss_pred ceee
Q 013125 178 LAKK 181 (449)
Q Consensus 178 la~~ 181 (449)
+|+.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.039 Score=53.80 Aligned_cols=52 Identities=17% Similarity=0.129 Sum_probs=33.7
Q ss_pred eeeecccCceeEEEEEEcCC---CceEEEEEecCCCCc-hhHHHHHHHHHHHcCCC
Q 013125 12 GRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH-PQLLYEAKVYKILQGGS 63 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~---~~~vAvKv~~~~~~~-~~~~~E~~~l~~l~~~~ 63 (449)
++.|..|---.+|++..... +..|++|+....... -...+|..+++.+....
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~g 74 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAG 74 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcC
Confidence 44454477778998875432 337999987654321 12467889999887655
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.038 Score=52.56 Aligned_cols=76 Identities=20% Similarity=0.280 Sum_probs=51.5
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccC
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTL 88 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (449)
.+-.+.|+-|....+|+.. .+++.+.||+-. ......+..|++-|+.|.....+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~----------------------- 72 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPI----------------------- 72 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTS-----------------------
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCC-----------------------
Confidence 4556788999999999987 467788899866 33445689999999999543321
Q ss_pred CCcCeeEEecccCCeeEEEEecC
Q 013125 89 GGIPNIKWYGVDGEDNVLVLDLL 111 (449)
Q Consensus 89 ~~i~~~~~~~~~~~~~~lv~e~~ 111 (449)
.+|.+..++...+..+||||++
T Consensus 73 -~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 73 -RVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -BS--EEEEEE-SSCCEEEEE--
T ss_pred -CCCeEEEEEeecCCceEEEEee
Confidence 5888888888878889999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.00049 Score=76.41 Aligned_cols=131 Identities=11% Similarity=0.003 Sum_probs=96.9
Q ss_pred cCCeeEEEEecC-CCCHHHHHHHhcCCCC--HHHHHHHHHHH-HHHHHHHHhC-C----ccccCCCCCcEEeecCCCCCe
Q 013125 100 DGEDNVLVLDLL-GPSLEDLFVYCRRKFS--LKTVLMLADQM-IARIEYVHSR-G----FLHRDIKPDNFLMGLGRKANQ 170 (449)
Q Consensus 100 ~~~~~~lv~e~~-g~sL~~~~~~~~~~~~--~~~~~~i~~qi-l~~L~~LH~~-g----iiHrDLkp~Nill~~~~~~~~ 170 (449)
.....+.+++++ +|.+.+.+.+....++ ....+...+|+ +.+..-+|+. + .+|++||+-|.+| ..+..
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence 345568889998 8888888876433322 22333444444 7777777764 2 6899999999999 47788
Q ss_pred EEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 171 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 171 vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+|+.++|+.+....... ..+...+++.|+.+++.....++.++|+|..|+.+|+...|..+|-
T Consensus 1379 v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred ccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 99999999983222211 1246678888999999999999999999999999999998877764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.026 Score=56.82 Aligned_cols=79 Identities=19% Similarity=0.121 Sum_probs=50.9
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcC---CCHH-HhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 218 RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS---TPIE-VLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 218 ~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~---~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
+++||||+|.++.|+.-|...|...........+.+....... ...+ .....++..+.++...|+-..|..||.+.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 3899999999999999998888765544333333322110000 0000 11233467888999999999999999665
Q ss_pred HHH
Q 013125 294 FLK 296 (449)
Q Consensus 294 ~l~ 296 (449)
++.
T Consensus 190 ~~~ 192 (725)
T KOG1093|consen 190 ELS 192 (725)
T ss_pred HHh
Confidence 543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.14 Score=49.18 Aligned_cols=29 Identities=24% Similarity=0.555 Sum_probs=24.8
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeecceee
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~ 181 (449)
++|+|+++.|+++. ..+.+-|+||+++..
T Consensus 200 lvHGD~~~gNlii~---~~~~~gVlDwe~~~l 228 (321)
T COG3173 200 LVHGDYRPGNLIID---PGRPTGVLDWELATL 228 (321)
T ss_pred eeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence 89999999999995 455588999998864
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.041 Score=53.93 Aligned_cols=60 Identities=23% Similarity=0.249 Sum_probs=41.0
Q ss_pred CeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEee
Q 013125 102 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 102 ~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~L-H~~giiHrDLkp~Nill~ 163 (449)
...+|+-+|. |.++..+++.. ..+++...+++.-...||-.| --.+++|.|++|.||++.
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3456777777 88888887643 234445556665555554443 346899999999999994
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.37 Score=46.88 Aligned_cols=43 Identities=14% Similarity=0.100 Sum_probs=29.6
Q ss_pred CceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCC
Q 013125 19 SFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGG 62 (449)
Q Consensus 19 ~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~ 62 (449)
.-..||.+.. .++..+++|+..... ....+..|.+++..|...
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~ 80 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA 80 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC
Confidence 3446888875 345679999876432 345677899999888654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.79 Score=45.58 Aligned_cols=28 Identities=36% Similarity=0.475 Sum_probs=23.1
Q ss_pred CCccccCCCCCcEEeecCCCCCeEEEEeecce
Q 013125 148 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179 (449)
Q Consensus 148 ~giiHrDLkp~Nill~~~~~~~~vkL~DfGla 179 (449)
..+.|.||-+.|||. .+..++++||-.|
T Consensus 227 ~VfCHNDL~~gNIL~----~~~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILD----FNQGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEe----cCCCEEEEEeccc
Confidence 457899999999998 4567999999554
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.46 E-value=1 Score=50.76 Aligned_cols=47 Identities=15% Similarity=0.140 Sum_probs=33.0
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~ 61 (449)
+.|+ |..-.+|++.. .+++.+++|+.+..........|.+++..|..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 4564 45678898875 35667999998876555556677778887764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.13 Score=49.46 Aligned_cols=28 Identities=46% Similarity=0.860 Sum_probs=23.8
Q ss_pred CCccccCCCCCcEEeecCCCCCeEEEEeecce
Q 013125 148 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179 (449)
Q Consensus 148 ~giiHrDLkp~Nill~~~~~~~~vkL~DfGla 179 (449)
.+++|+|+++.||++. . +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECccc
Confidence 5789999999999994 3 67899999755
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.91 Score=50.99 Aligned_cols=47 Identities=15% Similarity=0.122 Sum_probs=31.9
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~ 62 (449)
..|+.+. -.+|+++.. +..+++|+.+.......+..|..++..|...
T Consensus 37 ~~L~s~~-d~nf~v~t~--~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~ 83 (972)
T PRK06149 37 TELGSQQ-DRNFRVDSD--GGRFVLKICHAAYAAVELEAQHAALRHLAER 83 (972)
T ss_pred EecCCcC-cceEEEEec--CCcEEEEeCCccCChHHHHHHHHHHHHHHhh
Confidence 4555333 368888753 3468889988655556778888888888654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.75 Score=41.91 Aligned_cols=73 Identities=19% Similarity=0.304 Sum_probs=49.9
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCc
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI 91 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 91 (449)
.+++.-|..-+.|...+ ....|-+|+-. ......+.-|+.=|+.|...+-+ .+
T Consensus 21 r~~v~gG~inea~~v~d--g~~~~FvK~n~-~~~~~~f~AEa~gL~~la~s~ti------------------------~V 73 (286)
T COG3001 21 REEVSGGDINEAWRLRD--GTDPFFVKCNQ-REQLSMFTAEADGLELLARSNTI------------------------TV 73 (286)
T ss_pred ccccCCccccceeEeec--CCcceEEEecc-hhhHHHHHHHHHHHHHHHhcCCc------------------------cc
Confidence 34455555555665554 34567788622 12233477788888888766522 68
Q ss_pred CeeEEecccCCeeEEEEecC
Q 013125 92 PNIKWYGVDGEDNVLVLDLL 111 (449)
Q Consensus 92 ~~~~~~~~~~~~~~lv~e~~ 111 (449)
|++...|....+.|+||||+
T Consensus 74 P~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 74 PKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cceEEecCCCCeeEEEEeec
Confidence 88999999999999999999
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=93.37 E-value=0.47 Score=44.20 Aligned_cols=52 Identities=15% Similarity=0.158 Sum_probs=34.8
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHH---HHHHHHcCCCccee
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA---KVYKILQGGSKIRL 67 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~---~~l~~l~~~~~~~~ 67 (449)
...+..|..+.|+.|+. .+|..+++|+...... ...|. ..|+..++...+++
T Consensus 7 ~~~~~~g~~s~V~pv~~-~dG~~avLKl~~p~~~---~~~E~~g~~~L~~w~G~GaVrl 61 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRR-ADGTPAVLKLAPPHAE---AEHEARGEAALRWWNGRGAVRL 61 (253)
T ss_pred CCCCCCCcceEEEEEEc-CCCCeEEEEecCCccc---chhhhhHHhHhheeCCCCceee
Confidence 34566799999999984 5688999998764332 23333 55777766654444
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.00 E-value=1.6 Score=39.64 Aligned_cols=76 Identities=24% Similarity=0.309 Sum_probs=50.5
Q ss_pred eecccCce-eEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcC
Q 013125 14 KIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIP 92 (449)
Q Consensus 14 ~LG~G~fg-~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 92 (449)
.+..|..| +||+..- ..+--+-+|+... .....+..|+..++.+..... .+|
T Consensus 25 ~v~~geS~~~v~rl~a-~~r~g~~~k~~~~-~~~a~L~~Ea~RlrWla~~~l-------------------------~~P 77 (266)
T COG3231 25 RVTEGESGAGVFRLFA-DSRPGLYLKIASS-GPAAELEGEAARLRWLAGQGL-------------------------GCP 77 (266)
T ss_pred eeeccCCCCeEEEEec-cCCCceEEEEecC-cchhhhhhHHHHHHHhcccCC-------------------------CCC
Confidence 44555444 6776543 2233345565443 345678999999999986531 677
Q ss_pred eeEEecccCCeeEEEEecC-CCCHH
Q 013125 93 NIKWYGVDGEDNVLVLDLL-GPSLE 116 (449)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~-g~sL~ 116 (449)
.+.....+.+..||+|+-+ |.++.
T Consensus 78 ~V~~~~~~~~~~wLl~salpG~~~s 102 (266)
T COG3231 78 RVLGLEDDADQAWLLMSALPGEDAS 102 (266)
T ss_pred ceEeeccCcchhHHhhhhcCCCccc
Confidence 7888888888999999988 65554
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.91 E-value=2.1 Score=43.45 Aligned_cols=53 Identities=21% Similarity=0.155 Sum_probs=36.1
Q ss_pred EeeeecccCceeEEEEEEcC--------CCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~--------~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~ 63 (449)
-++.|..|---.+|++.... +++.|.+++...... .-....|..+++.+....
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~g 170 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYR 170 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCC
Confidence 56667677777899987542 146799998765432 113467888888887655
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 449 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-142 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-123 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-123 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-123 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 9e-93 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 9e-93 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-91 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 6e-91 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 7e-91 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-90 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-89 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 3e-26 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 4e-25 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 4e-25 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 4e-24 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 537 bits (1385), Expect = 0.0
Identities = 245/447 (54%), Positives = 296/447 (66%), Gaps = 27/447 (6%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE VA+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG+ GIPN++W+GV+G+ NVLV+DLLGPSLEDLF
Sbjct: 61 GGT--------------------------GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RK SLKTVLMLADQMI R+E+VHS+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAK
Sbjct: 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD +T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YFLRGSLPWQ
Sbjct: 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKA TKKQKY+KI EKKV+T IE LC+ +P EFASYFHYC+SL FD +PDY +LKRLF
Sbjct: 215 GLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCS 360
DLF REG+ FD+VFDWTILKYQQ+Q + S + P +
Sbjct: 275 DLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGR 334
Query: 361 AEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNAS-IPSASFVLPSTFNRN 419
P A + + +D F K + +AS S +
Sbjct: 335 TSGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVS 394
Query: 420 FQKPEGPDEAANIGRGHGNKTGASSSW 446
+ P + + R +
Sbjct: 395 SSRDVMPIDTSEPSRTRATDASPGAFR 421
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 526 bits (1358), Expect = 0.0
Identities = 165/343 (48%), Positives = 226/343 (65%), Gaps = 29/343 (8%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
++G +++G+KIG G+FGE+ L ++ TNE VA+K+E ++ PQL E + YK L
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS 63
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
G GIP + ++G G+ N +VL+LLGPSLEDLF
Sbjct: 64 GD--------------------------GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDL 97
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLA 179
C R FSLKTVLM+A Q+I+R+EYVHS+ ++RD+KP+NFL+G + ++IIDF LA
Sbjct: 98 CDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239
K+Y DP T +HIPYRE+K+LTGTARY S NTHLG EQSRRDDLE+LG++ +YFLRGSLPW
Sbjct: 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217
Query: 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299
QGLKA T K++Y KI + K +TPIEVLC++ P E A+Y Y + L F ++PDY +L++LF
Sbjct: 218 QGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276
Query: 300 HDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSR 342
DLF R+GY FD+ +DW + QD +S +
Sbjct: 277 TDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQ 319
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 205/320 (64%), Positives = 255/320 (79%), Gaps = 26/320 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF
Sbjct: 63 GGV--------------------------GIPTIRWCGAEGDYNVMVMELLGPSLEDLFN 96
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 97 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276
Query: 301 DLFSREGYDFDFVFDWTILK 320
+LF R+G+ +D+VFDW +LK
Sbjct: 277 NLFHRQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 519 bits (1340), Expect = 0.0
Identities = 166/321 (51%), Positives = 212/321 (66%), Gaps = 28/321 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
G + GIPN+ ++G +G NVLV+DLLGPSLEDL
Sbjct: 64 GCT--------------------------GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD 97
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGL 178
C RKFS+KTV M A QM+AR++ +H + ++RDIKPDNFL+G + AN +Y++DFG+
Sbjct: 98 LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238
K YRDP T +HIPYRE KNL+GTARY S NTHLG EQSRRDDLE+LG+V +YFLRGSLP
Sbjct: 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 298
WQGLKAAT KQKY++I EKK STP+ LC P EF Y HY ++L FD PDY +L+ L
Sbjct: 218 WQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277
Query: 299 FHDLFSREGYDFDFVFDWTIL 319
F + R D FDW +L
Sbjct: 278 FSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 488 bits (1259), Expect = e-173
Identities = 84/342 (24%), Positives = 148/342 (43%), Gaps = 27/342 (7%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKHPQLLYEAKV 55
+ + +K+G IG G FG I+LA V ++ VK+E S + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS--DNGPLFTELKF 86
Query: 56 YKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGED----NVLVLDLL 111
Y+ +I+ G+P G+ ++ +++D
Sbjct: 87 YQRAAKPEQIQ------------KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF 134
Query: 112 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
G L+ ++ ++FS KTVL L+ +++ +EY+H ++H DIK N L+ +QV
Sbjct: 135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQV 193
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 231
Y++D+GLA +Y ++ + GT + S + H G+ SRR DLE LGY ++
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253
Query: 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQ 288
+L G LPW+ K + KI ++ + C + P E A Y + L + +
Sbjct: 254 WLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTE 313
Query: 289 RPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQ 330
+P Y L+ + G D D ++++ +
Sbjct: 314 KPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTIT 355
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 468 bits (1206), Expect = e-165
Identities = 90/328 (27%), Positives = 146/328 (44%), Gaps = 31/328 (9%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQLLYEAKVYK 57
++ + G ++ LG+KIGSG FG I+LA + E A VK+E ++ L E K Y+
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY--QENGPLFSELKFYQ 88
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGV----DGEDNVLVLDLLGP 113
+ I+ + + GIP G+ +V++ LG
Sbjct: 89 RVAKKDCIKKWIERKQLDYL------------GIPLFYGSGLTEFKGRSYRFMVMERLGI 136
Query: 114 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
L+ + F TVL L +M+ +EY+H ++H DIK N L+G +QVY+
Sbjct: 137 DLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYL 194
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233
D+GL+ +Y ++ K GT + S + H G+ SRR D+E LGY +L +L
Sbjct: 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
Query: 234 RGSLPWQGL---KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
G LPW+ A + K + + E S S E A + SL +D++P
Sbjct: 255 CGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP 314
Query: 291 DYGFLKRLFHDLFSREGYDFDFVFDWTI 318
+Y LK++ + G D++
Sbjct: 315 NYQALKKILNPHGIPLGP-----LDFST 337
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-158
Identities = 69/330 (20%), Positives = 129/330 (39%), Gaps = 33/330 (10%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGTKHPQLLYEAKV 55
G ++KL + G ++ A+ T + ++K++ K +L E
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA---KDGRLFNEQNF 95
Query: 56 YKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGED-NVLVLDLLGPS 114
++ + ++ ++S+ L IP +GV + LVL LG S
Sbjct: 96 FQRA------------AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS 143
Query: 115 LEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
L+ + S ++VL +A +++ +E++H ++H ++ +N + + +QV +
Sbjct: 144 LQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTL 202
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 231
+G A +Y + +H+ Y E G + S + H G SRR DL+SLGY +L
Sbjct: 203 AGYGFAFRYCP--SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260
Query: 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK---SHPAEFASYFHYCQSLTFDQ 288
+L G LPW T+ K P C Y +LT+++
Sbjct: 261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEE 320
Query: 289 RPDYGFLKRLFHDLFSREGYDFDFVFDWTI 318
+P Y L+ L +
Sbjct: 321 KPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 37/277 (13%), Positives = 77/277 (27%), Gaps = 29/277 (10%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
G +G A+ +T E V + Q+ E ++L+
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN-----VLVLDLLGPSL 115
G + H+ + L + +D D + + +L
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLV-----KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 116 EDLFVY------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 169
+ + L L Q+I + +H G +H ++P + ++ +
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRG 243
Query: 170 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229
V++ F + + E L S + + D +LG ++
Sbjct: 244 GVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LV 302
Query: 230 LY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 265
+Y LP + I + P V
Sbjct: 303 IYWIWCADLPITK---DAALGGSEWIFRSCKNIPQPV 336
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-31
Identities = 47/275 (17%), Positives = 80/275 (29%), Gaps = 38/275 (13%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
K KL + G +FL V+ E A+K+ ENS ++ +L L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN-----VLVLDLLGPSL 115
G S L + + P +D +L++ L
Sbjct: 121 GESPEEARDRR------RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 116 EDLF------VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 169
E LF R + + +L Q+I + S+G +H PDN +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDG 231
Query: 170 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS--CNTHLGIEQSRRDDLESLGY 227
++ + D K + YA + + LG
Sbjct: 232 RLMLGDVSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 228 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
+ LP+ GL K + + + T
Sbjct: 282 SIYRVWCLFLPF-GLVTPGIKGSWKRPSLRVPGTD 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 36/291 (12%), Positives = 81/291 (27%), Gaps = 45/291 (15%)
Query: 1 MERIIGVKYKL---GRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYE 52
+E +G + + G +G A+ +T E V + Q+ E
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128
Query: 53 AKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN-----VLV 107
++L+G + H+ + L + +D D +
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLV-----KDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 108 LDLLGPSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161
+ +L+ L L Q+I + +H G +H ++P + +
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 162 MGLGRKANQVYIIDFGLAKKYRDPT-TNRHIPYRENKNLTGTARYASCNTHLGIEQ---- 216
+ + V++ F + + + + +
Sbjct: 244 LD---QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTL 293
Query: 217 -SRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 265
+ D +LG + +Y+ LP + I + P V
Sbjct: 294 MTFAFDTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPV 340
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 55/281 (19%), Positives = 94/281 (33%), Gaps = 63/281 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82
Query: 59 LQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN--VLVLDLLGPSLE 116
LQ H D +I + Y + D +V++ L
Sbjct: 83 LQQ---------HSDKII------------------RLYDYEITDQYIYMVMECGNIDLN 115
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
++ M+ + +H G +H D+KP NFL+ G + +IDF
Sbjct: 116 SWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDF 170
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYAS-----------CNTHLGIEQSRRDDLESL 225
G+A + + TT+ + GT Y N + S + D+ SL
Sbjct: 171 GIANQMQPDTTSVVK-----DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 226 G---YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 263
G Y + Y G P+Q + + K I +
Sbjct: 226 GCILYYMTY---GKTPFQQI--INQISKLHAIIDPNHEIEF 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 54/281 (19%), Positives = 93/281 (33%), Gaps = 63/281 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 59 LQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN--VLVLDLLGPSLE 116
LQ H D +I + Y + D +V++ L
Sbjct: 64 LQQ---------HSDKII------------------RLYDYEITDQYIYMVMECGNIDLN 96
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
++ M+ + +H G +H D+KP NFL+ + +IDF
Sbjct: 97 SWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDF 151
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYAS-----------CNTHLGIEQSRRDDLESL 225
G+A + + TT+ + GT Y N + S + D+ SL
Sbjct: 152 GIANQMQPDTTSVVK-----DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 226 G---YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 263
G Y + Y G P+Q + + K I +
Sbjct: 207 GCILYYMTY---GKTPFQQII--NQISKLHAIIDPNHEIEF 242
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 53/281 (18%), Positives = 92/281 (32%), Gaps = 63/281 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 59 LQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDN--VLVLDLLGPSLE 116
LQ H D +I + Y + D +V++ L
Sbjct: 111 LQQ---------HSDKII------------------RLYDYEITDQYIYMVMECGNIDLN 143
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
++ M+ + +H G +H D+KP NFL+ + +IDF
Sbjct: 144 SWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDF 198
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYAS-----------CNTHLGIEQSRRDDLESL 225
G+A + + TT+ + G Y N + S + D+ SL
Sbjct: 199 GIANQMQPDTTSVVK-----DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 226 G---YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 263
G Y + Y G P+Q + + K I +
Sbjct: 254 GCILYYMTY---GKTPFQQI--INQISKLHAIIDPNHEIEF 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 59/299 (19%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE 116
L +H I+ I +T VL+++ SL
Sbjct: 64 L-------------NHKNIVKLFAIEEETTTRHK-------------VLIMEFCPCGSLY 97
Query: 117 DLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-I 173
+ + L L++ ++ + ++ G +HR+IKP N + +G VY +
Sbjct: 98 TVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYAS----CNTHLGIEQSRRDDLE--- 223
DFG A++ D ++ GT Y L + ++
Sbjct: 158 TDFGAARELED-----------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 224 -SLGYVLLY-FLRGSLPWQGLKAA-TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH 279
S+G V Y GSLP++ + K+ KI K S I + K+
Sbjct: 207 WSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 61/327 (18%), Positives = 113/327 (34%), Gaps = 68/327 (20%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE 116
L +H I+ I +T VL+++ SL
Sbjct: 64 L-------------NHKNIVKLFAIEEETTTRHK-------------VLIMEFCPCGSLY 97
Query: 117 DLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-I 173
+ + L L++ ++ + ++ G +HR+IKP N + +G VY +
Sbjct: 98 TVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYAS--------CNTHLGIEQSRRDDL 222
DFG A++ D ++ GT Y + DL
Sbjct: 158 TDFGAARELED-----------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 223 ESLGYVLLY-FLRGSLPWQGLKAA-TKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYF 278
S+G V Y GSLP++ + K+ KI K S I + ++ P +++
Sbjct: 207 WSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265
Query: 279 HYCQSLTFDQRPDYGFLKRLFHDLFSR 305
SL+ L+ L + +
Sbjct: 266 PVSCSLS-------RGLQVLLTPVLAN 285
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 26/209 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIR 66
++ +G G+FG++ A + + A+K I ++ K +L E + L +R
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK 125
++ + + ++ +L DL
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKS------TLF--------IQMEYCENGTLYDLIHSENLN 112
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
L Q++ + Y+HS+G +HRD+KP N + ++ V I DFGLAK
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRS 169
Query: 186 TTNRHIP----YRENKNLT---GTARYAS 207
+ + NLT GTA Y +
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 2e-22
Identities = 52/275 (18%), Positives = 96/275 (34%), Gaps = 49/275 (17%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ G +++ ++G+G FG + H DT E VA+K E S + E ++ K
Sbjct: 10 TQTCG-PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68
Query: 59 LQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE 116
L +H ++ A + + +L ++ G L
Sbjct: 69 L-------------NHPNVVSAREVPDGLQ---------KLAPNDLPLLAMEYCEGGDLR 106
Query: 117 DLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
L + L + + + Y+H +HRD+KP+N ++ G + II
Sbjct: 107 KYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLT---GTARYASCNTHLGIEQSRRDDLESLGYVLLY 231
D G AK+ + T GT +Y + + + D S G L +
Sbjct: 167 DLGYAKELDQ-----------GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG-TLAF 214
Query: 232 FL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 265
G P+ + ++ +K + I V
Sbjct: 215 ECITGFRPFLP---NWQPVQWHGKVREKSNEHIVV 246
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 48/277 (17%), Positives = 91/277 (32%), Gaps = 55/277 (19%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGS 63
Y +K+G G F + L + A+K + + EA ++++
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF---- 83
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-----DGEDNV-LVLDL-LGPSL 115
+H PNI + + L+L +L
Sbjct: 84 ---------NH-----------------PNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117
Query: 116 EDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 172
+ + K + +L L + +E +H++G+ HRD+KP N L+G Q
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPV 174
Query: 173 IIDFGLAKKYRDPTTNRH--IPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGY 227
++D G + + ++ T Y + + R D+ SLG
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG- 233
Query: 228 VLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 263
+LY + G P+ K + ++S P
Sbjct: 234 CVLYAMMFGEGPYDM--VFQKGDSVALAVQNQLSIPQ 268
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 64/289 (22%), Positives = 101/289 (34%), Gaps = 90/289 (31%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVY--- 56
E +Y+LG +G G FG +F + VA+K+ N L
Sbjct: 27 EAFEA-EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 57 KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGP 113
+L V H P + + E +LVL+ P
Sbjct: 86 ALL------WKVGAGGGH-----------------PGVIRLLDWFETQEGFMLVLERPLP 122
Query: 114 SLEDLFVY-----------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162
+ +DLF Y R F Q++A I++ HSRG +HRDIK +N L
Sbjct: 123 A-QDLFDYITEKGPLGEGPSRCFFG---------QVVAAIQHCHSRGVVHRDIKDENIL- 171
Query: 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYA-----SCNTHLGI 214
+ + +IDFG D + T GT Y+ S + + +
Sbjct: 172 -IDLRRGCAKLIDFGSGALLHD------------EPYTDFDGTRVYSPPEWISRHQYHAL 218
Query: 215 EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 262
+ SLG +LLY + G +P++ +I E ++ P
Sbjct: 219 PA----TVWSLG-ILLYDMVCGDIPFER---------DQEILEAELHFP 253
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY---KILQ 60
+Y + + +GSG+ GE+ LA T + VA+KI + + + V +IL+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL--GPSLE 116
++H P I K ++ +VL+L+ G
Sbjct: 71 ----------KLNH-----------------PCIIKIKNFFDAEDYYIVLELMEGG---- 99
Query: 117 DLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+LF V ++ T + QM+ ++Y+H G +HRD+KP+N L+ + + I
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 175 DFGLAKKYRD 184
DFG +K +
Sbjct: 160 DFGHSKILGE 169
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-22
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 60/268 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+K+G +G GSF ++ A + T VA+K+ +G ++ E K++
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHC---- 66
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLED 117
+ H P+I + Y + + V LVL++ +
Sbjct: 67 ---------QLKH-----------------PSILELYNYFEDSNYVYLVLEMCHNGEMNR 100
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
+ FS Q+I + Y+HS G LHRD+ N L+ + + I DFG
Sbjct: 101 YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFG 157
Query: 178 LAKKYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLR 234
LA + + P + T GT Y S D+ SLG + Y L
Sbjct: 158 LATQLKMPHEKHY---------TLCGTPNYISPEIATRSAHGLESDVWSLG-CMFYTLLI 207
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTP 262
G P+ T K +K+ P
Sbjct: 208 GRPPFD---TDTVKNTLNKVVLADYEMP 232
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 63/274 (22%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQ 60
+ Y+ +K+GSG++GE+ L T+ A+KI S + + +LL E V K
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK--- 91
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLE 116
+DH PNI K Y + + N LV++ G L
Sbjct: 92 ----------LLDH-----------------PNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
D ++ R KF+ ++ Q+++ + Y+H +HRD+KP+N L+ K + I+DF
Sbjct: 125 DEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLY 231
GL+ + ++ K GTA Y + E R+ D+ S+G V+L+
Sbjct: 184 GLSAVFE--------NQKKMKERLGTAYYIA------PEVLRKKYDEKCDVWSIG-VILF 228
Query: 232 F-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 264
L G P+ G T ++ K+ + K +
Sbjct: 229 ILLAGYPPFGG---QTDQEILRKVEKGKYTFDSP 259
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 61/267 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+++GR +G G FG ++LA + I+A+K +E +G +H QL E ++
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQS---- 64
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDL 118
H+ H PNI + YG D L+L+ L +
Sbjct: 65 ---------HLRH-----------------PNILRLYGYFHDATRVYLILEYA--PLGTV 96
Query: 119 FVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
+ ++ KF + ++ + Y HS+ +HRDIKP+N L+G A ++ I DF
Sbjct: 97 YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADF 153
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRG 235
G + H P +L GT Y G + DL SLG VL Y FL G
Sbjct: 154 GWSV---------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG-VLCYEFLVG 203
Query: 236 SLPWQGLKAATKKQKYDKICEKKVSTP 262
P++ A T ++ Y +I + + P
Sbjct: 204 KPPFE---ANTYQETYKRISRVEFTFP 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 71/275 (25%), Positives = 110/275 (40%), Gaps = 64/275 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKIL 59
+YK R +G GSFGE+ L T + AVK+ T LL E ++ K
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK-- 81
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL-GPSL 115
+DH PNI K Y + + LV ++ G L
Sbjct: 82 -----------QLDH-----------------PNIMKLYEFFEDKGYFYLVGEVYTGGEL 113
Query: 116 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
D + R++FS + Q+++ I Y+H +HRD+KP+N L+ K + IID
Sbjct: 114 FDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIID 172
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLL 230
FGL+ + ++ K+ GTA Y + E D+ S G V+L
Sbjct: 173 FGLSTHFE--------ASKKMKDKIGTAYYIA------PEVLHGTYDEKCDVWSTG-VIL 217
Query: 231 YF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 264
Y L G P+ G A + K+ + K + +
Sbjct: 218 YILLSGCPPFNG---ANEYDILKKVEKGKYTFELP 249
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 44/190 (23%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY---KILQ 60
+Y + + +GSG+ GE+ LA T + VA++I + + + V +IL+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL--GPSLE 116
++H P I K ++ +VL+L+ G
Sbjct: 196 ----------KLNH-----------------PCIIKIKNFFDAEDYYIVLELMEGG---- 224
Query: 117 DLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+LF V ++ T + QM+ ++Y+H G +HRD+KP+N L+ + + I
Sbjct: 225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 175 DFGLAKKYRD 184
DFG +K +
Sbjct: 285 DFGHSKILGE 294
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 62/273 (22%), Positives = 100/273 (36%), Gaps = 71/273 (26%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLA- 73
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDL-LGPSLED 117
H ++ ++G + D V +VL+L SL +
Sbjct: 74 ----------------H-------------QHVVGFHGFFEDNDFVFVVLELCRRRSLLE 104
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
L R+ + Q++ +Y+H +HRD+K N L V I DFG
Sbjct: 105 LHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFG 160
Query: 178 LAKKYRDPTTNRHIPYRENKNLT--GTARYA-----SCNTHLGIEQSRRDDLESLGYVLL 230
LA K + GT Y S H S D+ S+G ++
Sbjct: 161 LATKVEYDGERKK---------VLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIM 205
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
Y L G P++ + K+ Y +I + + S P
Sbjct: 206 YTLLVGKPPFE---TSCLKETYLRIKKNEYSIP 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 56/277 (20%), Positives = 99/277 (35%), Gaps = 35/277 (12%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYK 57
+ KY L IG GS+G + +A T I A+KI + + ++ E ++ K
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 58 ILQGGSKIRLVVFHVDHVIIHALT-----------IIFSSTLGGIPNIKWYGVDGEDNVL 106
L + RL + D I + +
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 107 VLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164
+ + F K + + Q+ + + Y+H++G HRDIKP+NFL
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF-S 202
Query: 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDD 221
K+ ++ ++DFGL+K++ + GT + + NT + D
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNT-TNESYGPKCD 258
Query: 222 LESLGYVLLYF-LRGSLP-W----QGLKAATKKQKYD 252
S G VLL+ L G++P + +K
Sbjct: 259 AWSAG-VLLHLLLMGAVPFPGVNDADTISQVLNKKLC 294
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 58/280 (20%), Positives = 106/280 (37%), Gaps = 74/280 (26%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVY--- 56
E + +Y++G +GSG FG ++ V N VA+K ++ + +L +V
Sbjct: 39 EPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 57 KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGP 113
+L+ V G + + + VL+L+ P
Sbjct: 98 VLLK----------KVSS---------------GFSGVIRLLDWFERPDSFVLILERPEP 132
Query: 114 SLEDLFVYCRRKFSLKTVL--MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
+DLF + + +L+ L Q++ + + H+ G LHRDIK +N L + ++
Sbjct: 133 V-QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGEL 189
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLE 223
+IDFG +D T GT Y+ + + G +
Sbjct: 190 KLIDFGSGALLKD------------TVYTDFDGTRVYSPPEWIRYHRYHGRSA----AVW 233
Query: 224 SLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 262
SLG +LLY + G +P++ ++I +V
Sbjct: 234 SLG-ILLYDMVCGDIPFEH---------DEEIIRGQVFFR 263
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 35/176 (19%), Positives = 61/176 (34%), Gaps = 31/176 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
++ ++G GS+GE+F + + AVK + +G
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK---------------RSMSPFRGPKDRAR 102
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRR 124
+ V H +G P + E +L +L GPSL+
Sbjct: 103 ---KLAEVGSHE-------KVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA 152
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
V + + ++HS+G +H D+KP N +G + + DFGL
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLV 205
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 42/251 (16%), Positives = 85/251 (33%), Gaps = 46/251 (18%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
+ + + + +G G+ G I + N VAVK E ++ +
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-ECFSFADREVQLLRESD 75
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLLGPSLED 117
+H PN+ +++ + ++L +L++
Sbjct: 76 ------------EH-----------------PNVIRYFCTEKDRQFQYIAIELCAATLQE 106
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIID 175
+ L Q + + ++HS +HRD+KP N L+ + + I D
Sbjct: 107 YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYF 232
FGL KK + + + GT + + + + D+ S G + Y+
Sbjct: 167 FGLCKKLAVGRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG-CVFYY 221
Query: 233 L--RGSLPWQG 241
+ GS P+
Sbjct: 222 VISEGSHPFGK 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 62/275 (22%), Positives = 100/275 (36%), Gaps = 71/275 (25%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKIL 59
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSL 98
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL-GPSL 115
H ++ ++G + D V +VL+L SL
Sbjct: 99 A-----------------H-------------QHVVGFHGFFEDNDFVFVVLELCRRRSL 128
Query: 116 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
+L R+ + Q++ +Y+H +HRD+K N L V I D
Sbjct: 129 LELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGD 184
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLT--GTARYA-----SCNTHLGIEQSRRDDLESLGYV 228
FGLA K + GT Y S H S D+ S+G
Sbjct: 185 FGLATKVEYDGERKK---------VLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-C 229
Query: 229 LLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
++Y L G P++ + K+ Y +I + + S P
Sbjct: 230 IMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIP 261
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 65/273 (23%), Positives = 107/273 (39%), Gaps = 74/273 (27%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
I + RK+GSG+FG++ L + +K + S Q+ E +V K
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK---- 75
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPSLE 116
+DH PNI K + V D + +V++ G
Sbjct: 76 ---------SLDH-----------------PNIIKIFEVFEDYHNMYIVMETCEGG---- 105
Query: 117 DLF------VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 170
+L + S V L QM+ + Y HS+ +H+D+KP+N L +
Sbjct: 106 ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSP 165
Query: 171 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESL 225
+ IIDFGLA+ ++ + N GTA Y + E +RD D+ S
Sbjct: 166 IKIIDFGLAELFK--------SDEHSTNAAGTALYMA------PEVFKRDVTFKCDIWSA 211
Query: 226 GYVLLYF-LRGSLP-W----QGLKAATKKQKYD 252
G V++YF L G LP + ++ ++ +
Sbjct: 212 G-VVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 53/265 (20%), Positives = 91/265 (34%), Gaps = 63/265 (23%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
E+ + + +G GS G + VAVK L E K+
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-FCDIALMEIKLLTES-- 65
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDL 118
DH PN+ ++Y + + + L+L +L+DL
Sbjct: 66 ----------DDH-----------------PNVIRYYCSETTDRFLYIALELCNLNLQDL 98
Query: 119 ------FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL----------M 162
+ + L Q+ + + ++HS +HRD+KP N L
Sbjct: 99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158
Query: 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA-------SCNTHLGIE 215
G + ++ I DFGL KK + N +GT+ + S N
Sbjct: 159 QTGAENLRILISDFGLCKKLDS---GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRR 215
Query: 216 QSRRDDLESLGYVLLYFL--RGSLP 238
+R D+ S+G + Y++ +G P
Sbjct: 216 LTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 69/277 (24%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK--- 76
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLE 116
+DH PNI K + + + + +V +L G L
Sbjct: 77 ----------KLDH-----------------PNIMKLFEILEDSSSFYIVGELYTGGELF 109
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
D + R++FS + Q+ + I Y+H +HRD+KP+N L+ K + IIDF
Sbjct: 110 DEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 177 GLAKKYRDPTTNRHIPYRENKNLT---GTARYASCNTHLGIEQSRRD-----DLESLGYV 228
GL+ +++N + GTA Y + E R D+ S G V
Sbjct: 169 GLSTC-----------FQQNTKMKDRIGTAYYIA------PEVLRGTYDEKCDVWSAG-V 210
Query: 229 LLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 264
+LY L G+ P+ G + ++ K + +
Sbjct: 211 ILYILLSGTPPFYG---KNEYDILKRVETGKYAFDLP 244
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 64/269 (23%), Positives = 105/269 (39%), Gaps = 65/269 (24%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+ +GR +G G FG ++LA I+A+K +E G +H QL E ++
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQS---- 69
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPSLE 116
H+ H PNI + Y D + L+L+ G
Sbjct: 70 ---------HLRH-----------------PNILRMYNYFHDRKRIYLMLEFAPRG---- 99
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+L+ ++ +F + +++ + Y H R +HRDIKP+N LMG ++ I
Sbjct: 100 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIA 156
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FL 233
DFG + H P + + GT Y G + DL G VL Y FL
Sbjct: 157 DFGWSV---------HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAG-VLCYEFL 206
Query: 234 RGSLPWQGLKAATKKQKYDKICEKKVSTP 262
G P+ + + + + +I + P
Sbjct: 207 VGMPPFD---SPSHTETHRRIVNVDLKFP 232
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 45/191 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK--- 76
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSL 115
+DH PNI K + + + + +V +L G
Sbjct: 77 ----------KLDH-----------------PNIMKLFEILEDSSSFYIVGELYTGG--- 106
Query: 116 EDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
+LF + R++FS + Q+ + I Y+H +HRD+KP+N L+ K + I
Sbjct: 107 -ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165
Query: 174 IDFGLAKKYRD 184
IDFGL+ ++
Sbjct: 166 IDFGLSTCFQQ 176
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 68/278 (24%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------ENSGTKHPQLLYEAKV 55
IG Y RK+GSG++GE+ L + + A+K+ S + ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 56 Y---KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLD 109
Y +L+ +DH PNI K + V + + LV +
Sbjct: 94 YNEISLLK----------SLDH-----------------PNIIKLFDVFEDKKYFYLVTE 126
Query: 110 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168
G L + + R KF + Q+++ I Y+H +HRDIKP+N L+
Sbjct: 127 FYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185
Query: 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD-----DLE 223
+ I+DFGL+ + + ++ GTA Y + E ++ D+
Sbjct: 186 LNIKIVDFGLSSFFS--------KDYKLRDRLGTAYYIA------PEVLKKKYNEKCDVW 231
Query: 224 SLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVS 260
S G V++Y L G P+ G + K+ + K
Sbjct: 232 SCG-VIMYILLCGYPPFGG---QNDQDIIKKVEKGKYY 265
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 58/278 (20%), Positives = 97/278 (34%), Gaps = 81/278 (29%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY +GSG+FG ++ A + N+ V VK K ++L + + G K+ L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK---KE-KVLEDCWIEDPKLG--KVTL 78
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY--- 121
+ + + H NI K + + LV++ G L+ LF +
Sbjct: 79 EI-AILSRVEH-------------ANIIKVLDIFENQGFFQLVMEKHGSGLD-LFAFIDR 123
Query: 122 --------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
F Q+++ + Y+ + +HRDIK +N + + + +
Sbjct: 124 HPRLDEPLASYIFR---------QLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKL 171
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESL 225
IDFG A K GT Y N + G E ++ SL
Sbjct: 172 IDFGSAAYLER-----------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSL 216
Query: 226 GYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 262
G V LY L P+ ++ E + P
Sbjct: 217 G-VTLYTLVFEENPFCE---------LEETVEAAIHPP 244
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 6e-20
Identities = 47/189 (24%), Positives = 75/189 (39%), Gaps = 43/189 (22%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
I Y L IG GS+GE+ +A T A K I + E ++ K
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK----- 61
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLED 117
+DH PNI + Y + ++ LV++L G +
Sbjct: 62 --------SLDH-----------------PNIIRLYETFEDNTDIYLVMELCTGG----E 92
Query: 118 LF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
LF V +R F + +++ + Y H HRD+KP+NFL + + +ID
Sbjct: 93 LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLID 152
Query: 176 FGLAKKYRD 184
FGLA +++
Sbjct: 153 FGLAARFKP 161
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 48/188 (25%), Positives = 73/188 (38%), Gaps = 45/188 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
Y + ++G G+F + H T A KI N S +L EA++ +
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR------ 60
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDL 118
+ H PNI + + E LV DL+ G +L
Sbjct: 61 -------KLQH-----------------PNIVRLHDSIQEESFHYLVFDLVTGG----EL 92
Query: 119 F--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
F + R +S Q++ I Y HS G +HR++KP+N L+ K V + DF
Sbjct: 93 FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 152
Query: 177 GLAKKYRD 184
GLA + D
Sbjct: 153 GLAIEVND 160
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 8e-20
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 46/232 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
Y + ++G+G+FG + + T A K + + E +
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS-------- 209
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVY 121
+ H P + + D + V++ + + G L +
Sbjct: 210 -----VLRH-----------------PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 247
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
K S + Q+ + ++H ++H D+KP+N + +++N++ +IDFGL
Sbjct: 248 EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAH 306
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233
P + K TGTA +A+ G D+ S+G VL Y L
Sbjct: 307 LD--------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYIL 349
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 61/279 (21%), Positives = 104/279 (37%), Gaps = 56/279 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKI 65
+Y L +IG GS+G + LA + + N A+K+ + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 66 RLVVFHVDHVI--IHALTIIFSSTLGGIPNI-KWYGV---DGEDNV-LVLDLL------- 111
++ V I L + PN+ K V ED++ +V +L+
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDH------PNVVKLVEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 112 ----GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167
P ED R F +I IEY+H + +HRDIKP N L+G +
Sbjct: 128 VPTLKPLSEDQ---ARFYFQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVG---E 172
Query: 168 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLES 224
+ I DFG++ +++ N GT + + + I + D+ +
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLS-------NTVGTPAFMAPESLSETRKIFSGKALDVWA 225
Query: 225 LGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
+G V LY F+ G P+ + KI + + P
Sbjct: 226 MG-VTLYCFVFGQCPFMD---ERIMCLHSKIKSQALEFP 260
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 35/208 (16%), Positives = 75/208 (36%), Gaps = 44/208 (21%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGS 63
+ KY + +G G FG + + + K ++ GT + E IL
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEI---SILN--- 56
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF 119
H NI + E+ V++ + + G + +
Sbjct: 57 -------IARH-----------------RNILHLHESFESMEELVMIFEFISGLDIFERI 92
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + + ++ Q+ ++++HS H DI+P+N + R+++ + II+FG A
Sbjct: 93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQA 151
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYAS 207
++ + P + L Y +
Sbjct: 152 RQLK--------PGDNFRLLFTAPEYYA 171
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 47/243 (19%), Positives = 90/243 (37%), Gaps = 38/243 (15%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
++ ++ R + G F ++ A V + A+K N K+ ++ E K L G
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-- 84
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVL-DLLGPSLEDLFVYC 122
H +++ ++++G K G+ L+L +L L +
Sbjct: 85 -------H-PNIV----QFCSAASIG-----KEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 123 RRK--FSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ S TVL + Q ++++H + +HRD+K +N L+ + + DFG
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGS 184
Query: 179 AKKYRDPTTNRHIPYR-----ENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLL 230
A R E T Y + + + + D+ +LG +L
Sbjct: 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CIL 243
Query: 231 YFL 233
Y L
Sbjct: 244 YLL 246
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 44/190 (23%), Positives = 74/190 (38%), Gaps = 45/190 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
+Y+L ++G G+F + V + A I N S H +L EA +I +
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA---RICR--- 65
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDL 118
+ H PNI + + E + L+ DL+ G +L
Sbjct: 66 -------LLKH-----------------PNIVRLHDSISEEGHHYLIFDLVTGG----EL 97
Query: 119 F--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
F + R +S Q++ + + H G +HR++KP+N L+ K V + DF
Sbjct: 98 FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157
Query: 177 GLAKKYRDPT 186
GLA +
Sbjct: 158 GLAIEVEGEQ 167
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 66/279 (23%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY---KIL 59
++IG KY +G +G GS+G++ +T AVKI EA V ++L
Sbjct: 2 KLIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDN----VLVLDLLGPS 114
R + H N+ + V + +V++
Sbjct: 61 ------RRL----RH-----------------KNVIQLVDVLYNEEKQKMYMVMEYCVCG 93
Query: 115 LEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
++++ ++F + Q+I +EY+HS+G +H+DIKP N L L + I
Sbjct: 94 MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKI 150
Query: 174 IDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYAS------CNTHLGIEQSRRDDLES 224
G+A P+ + G+ + +T G + D+ S
Sbjct: 151 SALGVA--------EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWS 198
Query: 225 LGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
G V LY G P++G + ++ I + + P
Sbjct: 199 AG-VTLYNITTGLYPFEG---DNIYKLFENIGKGSYAIP 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 77/282 (27%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY 56
+ IG Y+L + IG G+F ++ LA H+ T VA+KI + + T +L E ++
Sbjct: 10 EQPHIG-NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 57 KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE 116
KIL H + I+ +I + Y L+++ S
Sbjct: 69 KILN----------H-PN-IVKLFEVIETEK-------TLY--------LIMEYA--SGG 99
Query: 117 DLFVY-----------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165
++F Y R KF Q+++ ++Y H + +HRD+K +N L L
Sbjct: 100 EVFDYLVAHGRMKEKEARSKFR---------QIVSAVQYCHQKRIVHRDLKAENLL--LD 148
Query: 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYASCNTHLGIE-QSRRDD 221
N + I DFG + ++ L G YA+ G + D
Sbjct: 149 ADMN-IKIADFGFSNEFTV-----------GGKLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 222 LESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 262
+ SLG V+LY L GSLP+ G K+ +++ K P
Sbjct: 197 VWSLG-VILYTLVSGSLPFDG---QNLKELRERVLRGKYRIP 234
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 48/191 (25%), Positives = 73/191 (38%), Gaps = 45/191 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
Y + ++G G+F + H T A KI N S +L EA++ +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR--- 83
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSL 115
+ H PNI + + E LV DL+ G
Sbjct: 84 ----------KLQH-----------------PNIVRLHDSIQEESFHYLVFDLVTGG--- 113
Query: 116 EDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
+LF + R +S Q++ I Y HS G +HR++KP+N L+ K V +
Sbjct: 114 -ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 172
Query: 174 IDFGLAKKYRD 184
DFGLA + D
Sbjct: 173 ADFGLAIEVND 183
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 44/201 (21%), Positives = 64/201 (31%), Gaps = 48/201 (23%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSKI 65
++G GSFGE+ T AVK +E + E L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGL------ 107
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVY 121
P I YG E + ++LL G SL L
Sbjct: 108 -------SS-----------------PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
L Q + +EY+H+R LH D+K DN L L ++ + DFG A
Sbjct: 144 MG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL--LSSDGSRAALCDFGHALC 200
Query: 182 YRDPTTNRHIPYRENKNLTGT 202
+ + + + GT
Sbjct: 201 LQPDGLGKSLLTG--DYIPGT 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 41/186 (22%), Positives = 81/186 (43%), Gaps = 43/186 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
+ +GSG+F E+FL T ++ A+K ++ + L E +L+
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI---AVLK----- 61
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF- 119
+ H NI + + + LV+ L+ G +LF
Sbjct: 62 -----KIKH-----------------ENIVTLEDIYESTTHYYLVMQLVSGG----ELFD 95
Query: 120 -VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ R ++ K ++ Q+++ ++Y+H G +HRD+KP+N L + +++ I DFGL
Sbjct: 96 RILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL 155
Query: 179 AKKYRD 184
+K ++
Sbjct: 156 SKMEQN 161
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 69/287 (24%), Positives = 105/287 (36%), Gaps = 86/287 (29%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+ + L + +G G++GE+ LA + T E VAVKI + + +
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-------------RAVDC 48
Query: 62 GSKI-RLVVFH--VDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLE- 116
I + + + ++H N+ K+YG E N+ L LE
Sbjct: 49 PENIKKEICINKMLNH-----------------ENVVKFYGHRREGNIQYL-----FLEY 86
Query: 117 ----DLFVY-----------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161
+LF +R F Q++A + Y+H G HRDIKP+N L
Sbjct: 87 CSGGELFDRIEPDIGMPEPDAQRFFH---------QLMAGVVYLHGIGITHRDIKPENLL 137
Query: 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA-----SCNTHLGIEQ 216
L + N + I DFGLA +R R + + GT Y
Sbjct: 138 --LDERDN-LKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPELLKRREFHAEPV 189
Query: 217 SRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
D+ S G ++L L G LPW + Q+Y EKK
Sbjct: 190 ----DVWSCG-IVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLN 229
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 42/226 (18%), Positives = 73/226 (32%), Gaps = 59/226 (26%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSK 64
++ + +G G FG +F A + + A+K + N +++ E K L
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL----- 60
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFV--- 120
+H P I +++ E N L++
Sbjct: 61 --------EH-----------------PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ 95
Query: 121 YCRRK--------------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166
CR++ L + Q+ +E++HS+G +HRD+KP N
Sbjct: 96 LCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT--- 152
Query: 167 KANQVYIIDFGLAKK-----YRDPTTNRHIPYRENKNLTGTARYAS 207
+ V + DFGL Y + GT Y S
Sbjct: 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 52/276 (18%), Positives = 89/276 (32%), Gaps = 73/276 (26%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQ 60
Y+L IG G F + + +T + AVKI + G L EA I
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA---SICH 81
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSL 115
+ H P+I + + + +V + +
Sbjct: 82 ----------MLKH-----------------PHIVELLETYSSDGMLYMVFEFMDGA--- 111
Query: 116 EDLF------VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 169
DL +S Q++ + Y H +HRD+KP L+ +
Sbjct: 112 -DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA 170
Query: 170 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS----CNTHLGIEQSRRDDLESL 225
V + FG+A + + GT + + G D+
Sbjct: 171 PVKLGGFGVAIQLGE-------SGLVAGGRVGTPHFMAPEVVKREPYGKPV----DVWGC 219
Query: 226 GYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVS 260
G V+L+ L G LP+ G TK++ ++ I + K
Sbjct: 220 G-VILFILLSGCLPFYG----TKERLFEGIIKGKYK 250
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 52/200 (26%), Positives = 80/200 (40%), Gaps = 44/200 (22%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---- 57
+R V Y + IG+GSFG ++ A D+ E+VA+K ++L + + +K
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---------KVLQDKR-FKNREL 98
Query: 58 -ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE 116
I++ +DH I L F S+ + LVLD + E
Sbjct: 99 QIMR----------KLDHCNIVRLRYFFYSSGEKKDEVYLN--------LVLDYVP---E 137
Query: 117 DLFVYCRRKFSLKTVLMLAD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 170
++ R K L + Q+ + Y+HS G HRDIKP N L L
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAV 195
Query: 171 VYIIDFGLAKKYRDPTTNRH 190
+ + DFG AK+ N
Sbjct: 196 LKLCDFGSAKQLVRGEPNVS 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 58/214 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y++G ++GSG F + T + A K G ++ E IL
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN---IL 62
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPS 114
+ + H PNI + + + D VL+L+L+ G
Sbjct: 63 R----------EIRH-----------------PNIITLHDIFENKTDVVLILELVSGG-- 93
Query: 115 LEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQV 171
+LF + + + Q++ + Y+HS+ H D+KP+N ++ ++
Sbjct: 94 --ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205
+IDFG+A K E KN+ GT +
Sbjct: 152 KLIDFGIAHKIE--------AGNEFKNIFGTPEF 177
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 52/232 (22%), Positives = 86/232 (37%), Gaps = 37/232 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+K IGSG FG++F A H + +K + + E K L
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAEREVKALAKL--------- 61
Query: 69 VFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRK 125
DHV I+H + K + + ++ +LE R +
Sbjct: 62 ----DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 126 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
L L +Q+ ++Y+HS+ ++RD+KP N + QV I DFGL ++
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKN 174
Query: 185 PTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 233
+ GT RY S + + + DL +LG ++L L
Sbjct: 175 DG--------KRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALG-LILAEL 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 39/184 (21%), Positives = 68/184 (36%), Gaps = 32/184 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
Y+ +G G + H T + AVKI + + A+ + L+ + +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIID---VTGGGSFSAEEVQELREATLKEV 74
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--V 120
+ V H PNI + + LV DL+ G +LF +
Sbjct: 75 DILR--KVSGH-------------PNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYL 115
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ S K + ++ I +H +HRD+KP+N L L N + + DFG +
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSC 172
Query: 181 KYRD 184
+
Sbjct: 173 QLDP 176
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 40/199 (20%), Positives = 73/199 (36%), Gaps = 47/199 (23%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKIRLVV 69
+G G++G ++ + +A+K E L E ++K L
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL---------- 76
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDL--FVYCR 123
H NI ++ G E+ + ++ + G SL L +
Sbjct: 77 ---KH-----------------KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
K + +T+ Q++ ++Y+H +HRDIK DN L + + + I DFG +K+
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL--INTYSGVLKISDFGTSKRLA 174
Query: 184 DPTTNRHIPYRENKNLTGT 202
+ TGT
Sbjct: 175 GINPCT-------ETFTGT 186
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 69/287 (24%), Positives = 105/287 (36%), Gaps = 86/287 (29%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+ + L + +G G++GE+ LA + T E VAVKI + + +
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-------------RAVDC 48
Query: 62 GSKI-RLVVFH--VDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLE- 116
I + + + ++H N+ K+YG E N+ L LE
Sbjct: 49 PENIKKEICINKMLNH-----------------ENVVKFYGHRREGNIQYL-----FLEY 86
Query: 117 ----DLFVY-----------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161
+LF +R F Q++A + Y+H G HRDIKP+N L
Sbjct: 87 CSGGELFDRIEPDIGMPEPDAQRFFH---------QLMAGVVYLHGIGITHRDIKPENLL 137
Query: 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA-----SCNTHLGIEQ 216
L + N + I DFGLA +R R + + GT Y
Sbjct: 138 --LDERDN-LKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPELLKRREFHAEPV 189
Query: 217 SRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
D+ S G ++L L G LPW + Q+Y EKK
Sbjct: 190 ----DVWSCG-IVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLN 229
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 52/316 (16%), Positives = 105/316 (33%), Gaps = 66/316 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKILQGGSKIR 66
Y++ R + G F +I L N+ A+K E S + + ++ KI
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 67 L-----VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLED 117
++ + + G+ D V ++ + + S+
Sbjct: 90 FKNELQIITDIKN-----------------EYCLTCEGIITNYDEVYIIYEYMENDSILK 132
Query: 118 LFVYCRR-------KFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKAN 169
Y ++ + + ++ Y+H+ + HRD+KP N LM K
Sbjct: 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNG 189
Query: 170 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLT---GTARYAS---CNTHLGIEQSRRDDLE 223
+V + DFG ++ Y +K + GT + + + D+
Sbjct: 190 RVKLSDFGESE------------YMVDKKIKGSRGTYEFMPPEFFSNESSY-NGAKVDIW 236
Query: 224 SLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQ 282
SLG + LY +P+ + + ++ I K + P++ +P
Sbjct: 237 SLG-ICLYVMFYNVVPFSL--KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 283 SLTFDQRPDYGFLKRL 298
L+ + FLK
Sbjct: 294 FLSNEDI---DFLKLF 306
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 47/214 (21%), Positives = 79/214 (36%), Gaps = 58/214 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E IL
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS---IL 69
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPS 114
+ V H N+ + V + D VL+L+L+ G
Sbjct: 70 R----------QVLH-----------------HNVITLHDVYENRTDVVLILELVSGG-- 100
Query: 115 LEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQV 171
+LF + +K SL + Q++ + Y+H++ H D+KP+N ++ +
Sbjct: 101 --ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205
+IDFGLA + E KN+ GT +
Sbjct: 159 KLIDFGLAHEIE--------DGVEFKNIFGTPEF 184
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 36/199 (18%), Positives = 73/199 (36%), Gaps = 43/199 (21%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKHPQLLYEAKVYK 57
++ + +G G+F +++ A+ D N + +K++ P +E +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-----PANPWEFYIGT 115
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE 116
L + + + H+ + + +VLV +L +L
Sbjct: 116 QL-----MERLKPSMQHMFMKFYSAHLFQN---------------GSVLVGELYSYGTLL 155
Query: 117 DLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-- 170
+ + + V+ A +M+ IE VH +H DIKPDNF++G G
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 171 ------VYIIDFGLAKKYR 183
+ +ID G + +
Sbjct: 216 DDLSAGLALIDLGQSIDMK 234
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 37/203 (18%), Positives = 74/203 (36%), Gaps = 39/203 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVV 69
+ ++IG G FG + V +VA+K G + K + + ++ ++
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR---EVFIMS 78
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS 127
+++H PNI K YG+ +V++ + L +
Sbjct: 79 -NLNH-----------------PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK 120
Query: 128 LKTVLMLADQMIAR-IEYVHSRG--FLHRDIKPDNFLMGLGRKANQVY--IIDFGLAKKY 182
L L IA IEY+ ++ +HRD++ N + + V + DFGL+++
Sbjct: 121 WSVKLRLMLD-IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179
Query: 183 RDPTTNRHIPYRENKNLTGTARY 205
+ G ++
Sbjct: 180 VHSVSGL----------LGNFQW 192
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 44/226 (19%), Positives = 69/226 (30%), Gaps = 65/226 (28%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSK 64
++ KIGSG FG +F I A+K +G+ Q L+
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--------NALR---- 59
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFV 120
V HA LG ++ +++ ED+ + + G SL D
Sbjct: 60 ---------EVYAHA-------VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS 103
Query: 121 YCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYII-- 174
R F + L Q+ + Y+HS +H DIKP N F+
Sbjct: 104 ENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163
Query: 175 -------------DFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 207
D G + P G +R+ +
Sbjct: 164 DDWASNKVMFKIGDLGHVTRISSPQV-----------EEGDSRFLA 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 37/188 (19%), Positives = 65/188 (34%), Gaps = 35/188 (18%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGS 63
KY IG G + H T AVK +E + + E +
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR--- 148
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDL 118
+ I+ + G P+I + + LV DL+ G +L
Sbjct: 149 ETH---------ILRQVA--------GHPHIITLIDSYESSSFMFLVFDLMRKG----EL 187
Query: 119 F--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
F + + S K + ++ + ++H+ +HRD+KP+N L L + + DF
Sbjct: 188 FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDF 244
Query: 177 GLAKKYRD 184
G +
Sbjct: 245 GFSCHLEP 252
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 48/206 (23%), Positives = 74/206 (35%), Gaps = 45/206 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSKI 65
Y + ++GSG+FG + T + K N + E +
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN-------- 103
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVY 121
+ H P + + D + VL+L+ L G L D
Sbjct: 104 -----QLHH-----------------PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 141
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
K S V+ Q ++++H +H DIKP+N + +KA+ V IIDFGLA K
Sbjct: 142 EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATK 200
Query: 182 YRDPTTNRHIPYRENKNLTGTARYAS 207
P K T TA +A+
Sbjct: 201 LN--------PDEIVKVTTATAEFAA 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 39/242 (16%), Positives = 74/242 (30%), Gaps = 46/242 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQ---- 60
++ + +G G FG +F A + + A+K + N +++ E K L+
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 61 ---GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLED 117
+ + + S+ + + ++
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 118 LFV------------YCRRK--------------FSLKTVLMLADQMIARIEYVHSRGFL 151
L CR++ L + Q+ +E++HS+G +
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 152 HRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-----GTARY 205
HRD+KP N F + V + DFGL + + T GT Y
Sbjct: 187 HRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 206 AS 207
S
Sbjct: 243 MS 244
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 57/260 (21%), Positives = 98/260 (37%), Gaps = 73/260 (28%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----------E 52
+II +YK+ K+G G ++LA N VA+K E
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFERE 61
Query: 53 AKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWY--GVDGEDNVLVLD 109
+ +L H NI + + LV++
Sbjct: 62 VH--------NSSQL-----SH-----------------QNIVSMIDVDEEDDCYYLVME 91
Query: 110 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168
+ GP+L + + S+ T + +Q++ I++ H +HRDIKP N L+
Sbjct: 92 YIEGPTLSEY-IESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SN 147
Query: 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDL 222
+ I DFG+AK + + + ++ GT +Y S EQ++ D+
Sbjct: 148 KTLKIFDFGIAKALSETSLT------QTNHVLGTVQYFS------PEQAKGEATDECTDI 195
Query: 223 ESLGYVLLY-FLRGSLPWQG 241
S+G ++LY L G P+ G
Sbjct: 196 YSIG-IVLYEMLVGEPPFNG 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 68/300 (22%), Positives = 114/300 (38%), Gaps = 64/300 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP----QLLYEAKVYKILQGG 62
+++ +KIG G F E++ A+ + VA+K ++ + E + K L
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL--- 89
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDL 118
+H PN+ K+Y EDN L VL+L L +
Sbjct: 90 ----------NH-----------------PNVIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 119 FVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYII 174
+ +++ +TV Q+ + +E++HSR +HRDIKP N F+ V +
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLG 178
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLY 231
D GL + + TT +L GT Y S + + + D+ SLG +L
Sbjct: 179 DLGLGRFFSSKTTAA-------HSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYE 228
Query: 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
P+ G KI + P+ S E + C + ++RPD
Sbjct: 229 MAALQSPFYG-DKMNLYSLCKKIEQCDYP-PLPSDHYS--EELRQLVNMCINPDPEKRPD 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 47/208 (22%), Positives = 77/208 (37%), Gaps = 42/208 (20%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP-QLLYEAKVYKILQGGSKIRL 67
G +G G FG+ +H +T E++ +K + + L E KV + L
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-------- 64
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCR 123
+H PN+ K+ GV +D L + + + G +L +
Sbjct: 65 -----EH-----------------PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD 102
Query: 124 RKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
++ + A IA + Y+HS +HRD+ N L+ + V + DFGLA+
Sbjct: 103 SQYPWSQRVSFAKD-IASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLM 158
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNT 210
D T R K RY
Sbjct: 159 VDEKTQPEGL-RSLKKPDRKKRYTVVGN 185
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 47/301 (15%), Positives = 94/301 (31%), Gaps = 66/301 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSKI 65
++G IG G FG+++ VA+++ + + L E Y+
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQT------ 86
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVY 121
H N+ + G ++ L G +L +
Sbjct: 87 -------RH-----------------ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD 122
Query: 122 CRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ + +A + I + + Y+H++G LH+D+K N G+ V I DFGL
Sbjct: 123 AKIVLDVNKTRQIAQE-IVKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFS 177
Query: 181 -KYRDPTTNRHIPYRENKNLTGTARY---------ASCNTHLGIEQSRRDDLESLGYVLL 230
R R G + + + S+ D+ +LG +
Sbjct: 178 ISGVLQAGRREDKLRIQ---NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
P++ A ++ ++ E + +C + ++RP
Sbjct: 235 ELHAREWPFKTQPAE---AIIWQMGTGMKPNLSQIGM---GKEISDILLFCWAFEQEERP 288
Query: 291 D 291
Sbjct: 289 T 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 55/304 (18%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYKILQGGSKI 65
+G++IGSGSFG ++ + VAVK+ N PQ L E V + +
Sbjct: 27 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR----- 78
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYC 122
H NI + G + +V G SL
Sbjct: 79 ------------H-------------VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHAS 113
Query: 123 RRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
KF +K ++ +A Q AR ++Y+H++ +HRD+K +N + + N V I DFGLA
Sbjct: 114 ETKFEMKKLIDIARQ-TARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT- 168
Query: 182 YRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238
+R + + L+G+ + + S + D+ + G VL + G LP
Sbjct: 169 ----EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 298
+ + Q + + +S + + + P C D+RP + +
Sbjct: 225 YSNINNRD--QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
Query: 299 FHDL 302
+L
Sbjct: 283 IEEL 286
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 47/214 (21%), Positives = 79/214 (36%), Gaps = 58/214 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E + +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR-- 70
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPS 114
V H PNI + V + D VL+L+L+ G
Sbjct: 71 -----------QVLH-----------------PNIITLHDVYENRTDVVLILELVSGG-- 100
Query: 115 LEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQV 171
+LF + +K SL + Q++ + Y+H++ H D+KP+N ++ +
Sbjct: 101 --ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205
+IDFGLA + E KN+ GT +
Sbjct: 159 KLIDFGLAHEIE--------DGVEFKNIFGTPEF 184
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 46/214 (21%), Positives = 76/214 (35%), Gaps = 58/214 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E IL
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS---IL 68
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPS 114
+ + H PN+ + V + D +L+L+L+ G
Sbjct: 69 K----------EIQH-----------------PNVITLHEVYENKTDVILILELVAGG-- 99
Query: 115 LEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQV 171
+LF + + + + Q++ + Y+HS H D+KP+N ++ ++
Sbjct: 100 --ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205
IIDFGLA K E KN+ GT +
Sbjct: 158 KIIDFGLAHKID--------FGNEFKNIFGTPEF 183
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 71/273 (26%), Positives = 109/273 (39%), Gaps = 61/273 (22%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R IG Y + +G GSFG++ LA+H T + VA+K + + L ++ +
Sbjct: 5 KRHIG-PYIIRETLGEGSFGKVKLATHYKTQQKVALKFIS---RQ-LLKKSDMHMRVERE 59
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDL 118
S ++L+ H P+I K Y V D V+V++ G L D
Sbjct: 60 ISYLKLL----RH-----------------PHIIKLYDVITTPTDIVMVIEYAGGELFDY 98
Query: 119 FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
V +++ + Q+I IEY H +HRD+KP+N L L N V I DFGL
Sbjct: 99 IVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGL 154
Query: 179 AKKYRDPTTNRHIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLL 230
+ D L G+ YA + + G E D+ S G ++L
Sbjct: 155 SNIMTD-----------GNFLKTSCGSPNYAAPEVINGKLYAGPEV----DVWSCG-IVL 198
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
Y L G LP+ + K+ P
Sbjct: 199 YVMLVGRLPFDD---EFIPNLFKKVNSCVYVMP 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 56/254 (22%), Positives = 93/254 (36%), Gaps = 62/254 (24%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLY----EAKVYK 57
G Y+L R +G G G+++ A IVA+K+ + + P EA+
Sbjct: 31 TQFG-PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG 89
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE 116
LQ V IH +G + + L+ G L
Sbjct: 90 RLQ----------EPHVVPIHD-----------------FGEIDGQLYVDMRLINGVDLA 122
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
+ + + + + + Q+ + ++ H+ G HRD+KP+N L+ + Y++DF
Sbjct: 123 AM-LRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDF 178
Query: 177 GLAKKYRDPT---TNRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDLESLGY 227
G+A D N GT Y + E+ R D+ +L
Sbjct: 179 GIASATTDEKLTQLG---------NTVGTLYYMA------PERFSESHATYRADIYALTC 223
Query: 228 VLLYFLRGSLPWQG 241
VL L GS P+QG
Sbjct: 224 VLYECLTGSPPYQG 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 67/278 (24%), Positives = 103/278 (37%), Gaps = 84/278 (30%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSK-IR 66
Y++ IG GS+ H TN AVKI + K + ++ I
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---------------IDKSKRDPTEEIE 67
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF-- 119
+++ + H PNI V D V +V +L+ G +L
Sbjct: 68 ILLRYGQH-----------------PNIITLKDVYDDGKYVYVVTELMKGG----ELLDK 106
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGL 178
+ ++ FS + + + +EY+H++G +HRD+KP N L + I DFG
Sbjct: 107 ILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 179 AKKYRDPTTNRHIPYRENKNLT---GTARY------------ASCNTHLGIEQSRRDDLE 223
AK+ R EN L TA + A+C D+
Sbjct: 167 AKQLRA----------ENGLLMTPCYTANFVAPEVLERQGYDAAC------------DIW 204
Query: 224 SLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVS 260
SLG VLLY L G P+ T ++ +I K S
Sbjct: 205 SLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 46/257 (17%), Positives = 87/257 (33%), Gaps = 72/257 (28%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-ENSGTKHPQ--LLYEAKVY 56
I+ +Y++ I G G I+LA +D N V +K +SG Q + E +
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF- 132
Query: 57 KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-----LVLDLL 111
+ V H I I + + + +V++ +
Sbjct: 133 ------------LAEVVHP--------------SIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 112 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 170
G SL+ +K + + +++ + Y+HS G ++ D+KP+N ++ Q
Sbjct: 167 GGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQ 219
Query: 171 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR-----RDDLESL 225
+ +ID G + L GT + + E R D+ ++
Sbjct: 220 LKLIDLGAVSRINSFGY-----------LYGTPGFQA------PEIVRTGPTVATDIYTV 262
Query: 226 GYVLLY-FLRGSLPWQG 241
G L G
Sbjct: 263 G-RTLAALTLDLPTRNG 278
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 18/184 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKILQ 60
E +Y L RK+G G F ++LA + N VA+KI E K+ + +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
+ +H I+ L + G +G V+V ++LG +L L
Sbjct: 74 DADNTKEDSMGANH-ILKLLD-----------HFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 121 YCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRK---ANQVYIID 175
R L V ++ Q++ ++Y+H R G +H DIKP+N LM + Q+ I D
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 176 FGLA 179
G A
Sbjct: 182 LGNA 185
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 37/187 (19%), Positives = 71/187 (37%), Gaps = 41/187 (21%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSK 64
+ +++ ++G G+ ++ T + A+K+ + E +L
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI---GVLL---- 103
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF 119
+ H PNI K + + + LVL+L+ G +LF
Sbjct: 104 ------RLSH-----------------PNIIKLKEIFETPTEISLVLELVTGG----ELF 136
Query: 120 --VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
+ + +S + Q++ + Y+H G +HRD+KP+N L + I DFG
Sbjct: 137 DRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 178 LAKKYRD 184
L+K
Sbjct: 197 LSKIVEH 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 38/185 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG GS+G +F + DT +IVA+K ++ K L E ++ K L+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKHP 62
Query: 63 SKIRLV-VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
+ + L+ VF + + LV + ++
Sbjct: 63 NLVNLLEVFRRKR--------------------RLH--------LVFEYCDHTVLHELDR 94
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+R V + Q + + + H +HRD+KP+N L+ K + + + DFG A+
Sbjct: 95 YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARL 151
Query: 182 YRDPT 186
P+
Sbjct: 152 LTGPS 156
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 49/206 (23%), Positives = 80/206 (38%), Gaps = 47/206 (22%)
Query: 8 KYKLGRK--IGSGSFGEIFLASHVDTNEIVAVK-IENSGTK-HPQLLYEAKVYKILQGGS 63
Y + + +G G FG++ T +A K I+ G K ++ E V
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN------ 141
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF 119
+DH N+ + Y D VLV++ + G L D
Sbjct: 142 -------QLDH-----------------ANLIQLYDAFESKNDIVLVMEYVDGGELFDRI 177
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + ++ Q+ I ++H LH D+KP+N L + R A Q+ IIDFGLA
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLA 236
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARY 205
++Y+ P + K GT +
Sbjct: 237 RRYK--------PREKLKVNFGTPEF 254
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 52/241 (21%), Positives = 94/241 (39%), Gaps = 49/241 (20%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSK 64
Y+L +G G+ + ++ T++ AVKI + G ++ E ++ QG
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG--- 69
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF 119
H N+ + + ED LV + + G +
Sbjct: 70 -------------H-------------RNVLELIEFFEEEDRFYLVFEKMRGG----SIL 99
Query: 120 --VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
++ RR F+ ++ + + ++++H++G HRD+KP+N L + + V I DF
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARYAS-----CNTHLGIEQSRRDDLESLGYVLLYF 232
L + I E G+A Y + + +R DL SLG V+LY
Sbjct: 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYI 218
Query: 233 L 233
L
Sbjct: 219 L 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 63/282 (22%), Positives = 101/282 (35%), Gaps = 70/282 (24%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVY 56
M Y++ IG+GS+G +I+ K + G+ L+ E +
Sbjct: 1 MPSRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 57 KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVL--VLDLL 111
+ L H PNI ++Y +D + L V++
Sbjct: 60 REL-------------KH-----------------PNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 112 -GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGF-----LHRDIKPDNFLM 162
G L + ++ + VL + Q+ ++ H R LHRD+KP N +
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRR 219
V + DFGLA+ T+ K GT Y S N + + +
Sbjct: 150 D---GKQNVKLGDFGLARILNHDTSFA-------KTFVGTPYYMSPEQMN---RMSYNEK 196
Query: 220 DDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVS 260
D+ SLG LLY L P+ A ++K+ KI E K
Sbjct: 197 SDIWSLG-CLLYELCALMPPFT---AFSQKELAGKIREGKFR 234
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 38/184 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ +G GS+G + + DT IVA+K ++ K + E K+ K L+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHE 84
Query: 63 SKIRLV-VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
+ + L+ V +WY LV + + ++ D
Sbjct: 85 NLVNLLEVCKKKK--------------------RWY--------LVFEFVDHTILDDLEL 116
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ V Q+I I + HS +HRDIKP+N L+ ++ V + DFG A+
Sbjct: 117 FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFART 173
Query: 182 YRDP 185
P
Sbjct: 174 LAAP 177
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 44/186 (23%), Positives = 69/186 (37%), Gaps = 45/186 (24%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSKIR 66
+Y + IGSG+FG L T E+VAVK G + + E ++ L
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL------- 73
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFV 120
H PNI ++ V L + +E +L+
Sbjct: 74 ------RH-----------------PNIVRFKEVILTPTHLAI-----IMEYASGGELYE 105
Query: 121 Y--CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+FS Q+++ + Y HS HRD+K +N L+ G A ++ I DFG
Sbjct: 106 RICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGY 164
Query: 179 AKKYRD 184
+K
Sbjct: 165 SKSSVL 170
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 42/188 (22%), Positives = 64/188 (34%), Gaps = 52/188 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
KY +KIG GSFG+ L + +K N + E V +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM---- 80
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----D 117
H PNI ++ E+ L + ++ D
Sbjct: 81 ---------KH-----------------PNIVQYRESFEENGSLYI-----VMDYCEGGD 109
Query: 118 LFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
LF + F +L Q+ +++VH R LHRDIK N + K V +
Sbjct: 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQL 166
Query: 174 IDFGLAKK 181
DFG+A+
Sbjct: 167 GDFGIARV 174
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 70/308 (22%), Positives = 108/308 (35%), Gaps = 79/308 (25%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I L IG G FGE++ E VAVKI +S + EA++Y+
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQ---- 89
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV------LVLDLL-GP 113
+ H NI + D +DN LV D
Sbjct: 90 -------TVMLRH-----------------ENILGFIAADNKDNGTWTQLWLVSDYHEHG 125
Query: 114 SLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSR--------GFLHRDIKPDNFLMGL 164
SL D R +++ ++ LA A + ++H HRD+K N L+
Sbjct: 126 SLFDYL--NRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 180
Query: 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY--------ASCNTHLGIEQ 216
+K I D GLA ++ T I + GT RY + H E
Sbjct: 181 -KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRVGTKRYMAPEVLDDSINMKHF--ES 234
Query: 217 SRRDDLESLGYVLLYFLRGS----------LPWQGLKA--ATKKQKYDKICEKKVSTPIE 264
+R D+ ++G V R LP+ L + ++ +CE+K+ I
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 265 VLCKSHPA 272
+S A
Sbjct: 295 NRWQSCEA 302
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 49/220 (22%), Positives = 82/220 (37%), Gaps = 55/220 (25%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I + ++ ++IG G +GE+++ E VAVK+ + + E ++Y+ +
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTV-- 86
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV------LVLDLL-GP 113
+ H NI + D + L+ D
Sbjct: 87 ---------LMRH-----------------ENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 114 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF--------LHRDIKPDNFLMGLG 165
SL D K++L LA ++ + ++H+ F HRD+K N L+
Sbjct: 121 SLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--- 175
Query: 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205
+K I D GLA K+ T IP GT RY
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRY 212
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 43/215 (20%), Positives = 77/215 (35%), Gaps = 58/215 (26%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV----YKILQGGS 63
KY LG+ +G+GSFG + +++ + A+K ++L + + I++
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK---------KVLQDPRYKNRELDIMK--- 55
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV------------------ 105
+DHV I L F +T P D
Sbjct: 56 -------VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 106 ------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD------QMIARIEYVHSRGFLHR 153
++++ + + L + + + Q+ + ++HS G HR
Sbjct: 109 QNKYLNVIMEYVP---DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165
Query: 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 188
DIKP N L + K N + + DFG AKK +
Sbjct: 166 DIKPQNLL--VNSKDNTLKLCDFGSAKKLIPSEPS 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 45/195 (23%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK-----ILQG 61
+ Y + IG+GSFG +F A V+++E VA+K ++L + + +K I++
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK---------KVLQDKR-FKNRELQIMR- 87
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
V H + L F S + LVL+ + E ++
Sbjct: 88 ---------IVKHPNVVDLKAFFYSNGDKKDEVFLN--------LVLEYVP---ETVYRA 127
Query: 122 CRRKFSLKTVLMLAD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
R LK + + Q++ + Y+HS G HRDIKP N L L + + +ID
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLID 185
Query: 176 FGLAKKYRDPTTNRH 190
FG AK N
Sbjct: 186 FGSAKILIAGEPNVS 200
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 43/204 (21%), Positives = 73/204 (35%), Gaps = 53/204 (25%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVV 69
++ +G G+FG + A + VA+K S ++ + E + +
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV---------- 58
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--K 125
+H PNI K YG LV++ G SL ++
Sbjct: 59 ---NH-----------------PNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPY 98
Query: 126 FSLKTVLMLADQMIAR-IEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
++ + Q ++ + Y+HS +HRD+KP N L L + I DFG A
Sbjct: 99 YTAAHAMSWCLQ-CSQGVAYLHSMQPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACD 155
Query: 182 YRDPTTNRHIPYRENKNLTGTARY 205
+ TN G+A +
Sbjct: 156 IQTHMTNN----------KGSAAW 169
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 62/261 (23%), Positives = 108/261 (41%), Gaps = 52/261 (19%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKI--RLVVF 70
R IG GSFG++ + DT ++ A+K + + K + + + ++
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKY----------MNKQKCVERNEVRNVFKELQIMQ 70
Query: 71 HVDHVIIHALTIIFSSTLGGIPNIKWYGV-DGEDNVLVLDLL--GPSLEDLFVYCRR--K 125
++H + L WY D ED +V+DLL G DL + ++
Sbjct: 71 GLEHPFLVNL---------------WYSFQDEEDMFMVVDLLLGG----DLRYHLQQNVH 111
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
F +TV + +++ ++Y+ ++ +HRD+KPDN L+ + V+I DF +A
Sbjct: 112 FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRE 168
Query: 186 TTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 241
T + GT Y + ++ G S D SLG V Y LRG P+
Sbjct: 169 TQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRRPYHI 219
Query: 242 LKAATKKQKYDKICEKKVSTP 262
+ + K+ V+ P
Sbjct: 220 RSSTSSKEIVHTFETTVVTYP 240
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 38/208 (18%), Positives = 75/208 (36%), Gaps = 47/208 (22%)
Query: 8 KYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIR 66
Y L +++G G F + T + A K + K +G
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKF---------------LKKRRRGQDCRA 73
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVY 121
++ + ++ P + + V + + +L+L+ G ++F
Sbjct: 74 EILHEIA--VLELAK--------SCPRVINLHEVYENTSEIILILEYAAGG----EIFSL 119
Query: 122 CRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
C + S V+ L Q++ + Y+H +H D+KP N L+ + I+DFG
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARY 205
+++K E + + GT Y
Sbjct: 180 MSRKIG--------HACELREIMGTPEY 199
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 57/265 (21%), Positives = 105/265 (39%), Gaps = 55/265 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+K G+ +G GSF + LA + T+ A+KI L + + K +
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKI----------LEKRHIIKENK-------- 73
Query: 69 VFHVDHVII--HALTII---FSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFV 120
V +V ++ + F L ++ ++ + L G +L
Sbjct: 74 ---VPYVTRERDVMSRLDHPFFVKL-------YFTFQDDEKLYFGLSYAKNG----ELLK 119
Query: 121 YCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
Y R+ F ++++ +EY+H +G +HRD+KP+N L+ + + I DFG
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGT 176
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSL 237
AK + + GTA+Y S + DL +LG ++Y + G
Sbjct: 177 AKVLSPESKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLP 230
Query: 238 PWQGLKAATKKQKYDKICEKKVSTP 262
P+ +A + + KI + + P
Sbjct: 231 PF---RAGNEYLIFQKIIKLEYDFP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 36/188 (19%), Positives = 65/188 (34%), Gaps = 41/188 (21%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E +++
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQ 69
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-----DGEDNV-LVLDLL--G 112
P+I + V G + +V++ L G
Sbjct: 70 ----------------C-------------PHIVRIVDVYENLYAGRKCLLIVMECLDGG 100
Query: 113 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 172
+ + F+ + + + I+Y+HS HRD+KP+N L R +
Sbjct: 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 173 IIDFGLAK 180
+ DFG AK
Sbjct: 161 LTDFGFAK 168
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 63/267 (23%), Positives = 100/267 (37%), Gaps = 81/267 (30%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTKHPQLLY--------- 51
+ +Y+LG +G G E+ LA D + VAVK+ L
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLA--RDLRDHRDVAVKV-----LRADLARDPSFYLRFR 60
Query: 52 -EAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV---- 105
EA+ + L +H P I Y GE
Sbjct: 61 REAQ--------NAAAL-----NH-----------------PAIVAVYDT-GEAETPAGP 89
Query: 106 ---LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161
+V++ + G +L D+ V+ + K + + + + H G +HRD+KP N +
Sbjct: 90 LPYIVMEYVDGVTLRDI-VHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR--- 218
+ N V ++DFG+A+ D + + GTA+Y S EQ+R
Sbjct: 149 IS---ATNAVKVMDFGIARAIADSGN----SVTQTAAVIGTAQYLS------PEQARGDS 195
Query: 219 ---RDDLESLGYVLLY-FLRGSLPWQG 241
R D+ SLG +LY L G P+ G
Sbjct: 196 VDARSDVYSLG-CVLYEVLTGEPPFTG 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 39/191 (20%), Positives = 69/191 (36%), Gaps = 46/191 (24%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-KI 65
++++ R G G+FG + L T VA+K K++Q +
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------------------KVIQDPRFRN 64
Query: 66 RLV-----VFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF 119
R + + + H I+ + ++ +I +V++ + + L
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN--------VVMEYVP---DTLH 113
Query: 120 VYCRRKFSLKTVLMLAD------QMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQV 171
CR + + Q+I I +H S HRDIKP N L + +
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTL 171
Query: 172 YIIDFGLAKKY 182
+ DFG AKK
Sbjct: 172 KLCDFGSAKKL 182
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 48/185 (25%), Positives = 73/185 (39%), Gaps = 41/185 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
Y LG +G G+FG++ + H T VAVKI N + ++ V KI + ++L
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQ-KIRSLDVVGKIKREIQNLKL 67
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY 121
H P+I K Y V + +E +LF Y
Sbjct: 68 F----RH-----------------PHIIKLYQVISTPTDFFM-----VMEYVSGGELFDY 101
Query: 122 C--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ L Q+++ ++Y H +HRD+KP+N L L N I DFGL+
Sbjct: 102 ICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLS 158
Query: 180 KKYRD 184
D
Sbjct: 159 NMMSD 163
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 38/179 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+GG
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGG----- 90
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL----FVYCR 123
++I L I + P + + V+ D L +L D ++Y
Sbjct: 91 -----PNII--TLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTDYDIRFYMY-- 137
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+++ ++Y HS G +HRD+KP N + + + ++ +ID+GLA+ Y
Sbjct: 138 -------------EILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFY 181
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 40/228 (17%), Positives = 86/228 (37%), Gaps = 26/228 (11%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGG 62
+ +Y + RK+G G F ++L+ + + VA+K+ S + + L E ++ K ++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93
Query: 63 SKI----RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
+VV +D I GV+G +V ++LG L
Sbjct: 94 DPNDPNREMVVQLLDDFKIS-------------------GVNGTHICMVFEVLGHHLLKW 134
Query: 119 -FVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDF 176
+ L V + Q++ ++Y+H++ +H DIKP+N L+ + + + +
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLES 224
++ P + + + + DL +
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 68/247 (27%)
Query: 5 IGVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
Y L + +G GSF H +N+ AVKI + E K+ +G
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-RMEANTQKEITALKLCEG 64
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLE 116
H PNI K + V + + LV++LL G
Sbjct: 65 ----------------H-------------PNIVKLHEVFHDQLHTFLVMELLNGG---- 91
Query: 117 DLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+LF + ++ FS + ++++ + ++H G +HRD+KP+N L ++ II
Sbjct: 92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLT---GTARYAS-----CNTHLGIEQSRRDDLESLG 226
DFG A+ +N+ L T YA+ N + DL SLG
Sbjct: 152 DFGFARLKPP----------DNQPLKTPCFTLHYAAPELLNQNGY-----DESCDLWSLG 196
Query: 227 YVLLYFL 233
V+LY +
Sbjct: 197 -VILYTM 202
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 50/186 (26%), Positives = 73/186 (39%), Gaps = 49/186 (26%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKI 65
Y+L IGSG+ + A E VA+K E T +LL E +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC------ 70
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVY 121
H PNI +Y V ++ LV+ LL G S+ D+ +
Sbjct: 71 -------HH-----------------PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH 106
Query: 122 CRRKFSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 173
K K+ ++ IA I EY+H G +HRD+K N L+G + V I
Sbjct: 107 IVAKGEHKSGVLDEST-IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQI 162
Query: 174 IDFGLA 179
DFG++
Sbjct: 163 ADFGVS 168
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 9e-15
Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 38/185 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG G++G +F A + +T+EIVA+K ++ G L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHK 61
Query: 63 SKIRLV-VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
+ +RL V H D + LV + L+ F
Sbjct: 62 NIVRLHDVLHSDKKL----------------------------TLVFEFCDQDLKKYFDS 93
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
C + V Q++ + + HSR LHRD+KP N L+ + ++ + +FGLA+
Sbjct: 94 CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARA 150
Query: 182 YRDPT 186
+ P
Sbjct: 151 FGIPV 155
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 52/197 (26%), Positives = 78/197 (39%), Gaps = 60/197 (30%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSK 64
IG Y LG +G G+FG++ + H T VAVKI N + ++ V KI +
Sbjct: 15 IG-HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN---RQ-KIRSLDVVGKIRREIQN 69
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DL 118
++L H P+I K Y V + + + +E +L
Sbjct: 70 LKLF----RH-----------------PHIIKLYQVISTPSDIFM-----VMEYVSGGEL 103
Query: 119 FVY-----------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 167
F Y RR F Q+++ ++Y H +HRD+KP+N L L
Sbjct: 104 FDYICKNGRLDEKESRRLFQ---------QILSGVDYCHRHMVVHRDLKPENVL--LDAH 152
Query: 168 ANQVYIIDFGLAKKYRD 184
N I DFGL+ D
Sbjct: 153 MN-AKIADFGLSNMMSD 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 51/190 (26%), Positives = 80/190 (42%), Gaps = 26/190 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQ-LLYEAKVYKILQGGS 63
KY+ KIG G+FGE+F A H T + VA V +EN P L E K+ ++L+ +
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
+ L I ++ G I Y LV D L L
Sbjct: 78 VVNL------IEICRTKASPYNRCKGSI-----Y--------LVFDFCEHDLAGLLSNVL 118
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
KF+L + + ++ + Y+H LHRD+K N L+ + + + DFGLA+ +
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFS 175
Query: 184 DPTTNRHIPY 193
++ Y
Sbjct: 176 LAKNSQPNRY 185
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 43/247 (17%), Positives = 77/247 (31%), Gaps = 62/247 (25%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVV 69
KL IG G +G ++ S VAVK+ + + + E +Y++
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ-NFINEKNIYRVP---------- 62
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-------LVLDLL-GPSLEDLFV 120
++H NI ++ D LV++ SL
Sbjct: 63 -LMEH-----------------DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL- 103
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHS---------RGFLHRDIKPDNFLMGLGRKANQV 171
+ LA + + Y+H+ HRD+ N L+ +
Sbjct: 104 -SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTC 159
Query: 172 YIIDFGLAKKY-RDPTTNRHIPYRENKNLTGTARY-------ASCNTHLGIEQSRRDDLE 223
I DFGL+ + + + GT RY + N ++ D+
Sbjct: 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 224 SLGYVLL 230
+LG +
Sbjct: 220 ALGLIYW 226
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 47/221 (21%), Positives = 73/221 (33%), Gaps = 55/221 (24%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+R + L +G G +GE++ S E VAVKI +S + E ++Y +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEK-SWFRETELYNTVM 58
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV------LVLDLL-G 112
+ H NI + D L+
Sbjct: 59 -----------LRH-----------------ENILGFIASDMTSRHSSTQLWLITHYHEM 90
Query: 113 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF--------LHRDIKPDNFLMGL 164
SL D + L + + + + ++H F HRD+K N L+
Sbjct: 91 GSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV-- 146
Query: 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205
+K Q I D GLA + T + N GT RY
Sbjct: 147 -KKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRY 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 41/188 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y+ +G G F ++ A +TN+IVA+K KI+L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIK-------------------------KIKL 45
Query: 68 VVFHVDH--VIIHALTIIFSSTLGGI--PNI-KWYGVDGEDN--VLVLDLLGPSLEDLFV 120
+ AL I L + PNI G + LV D + LE +
Sbjct: 46 GHRSEAKDGINRTALREI--KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK 103
Query: 121 YCRRKFSLKTV--LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ + ML + +EY+H LHRD+KP+N L+ + + + DFGL
Sbjct: 104 DNSLVLTPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGL 158
Query: 179 AKKYRDPT 186
AK + P
Sbjct: 159 AKSFGSPN 166
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 34/188 (18%), Positives = 67/188 (35%), Gaps = 42/188 (22%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIR 66
Y+L ++ +G G G++ H T + A+K+ P+ E + G
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQEVDHHWQASG----- 80
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLED 117
P+I V G+ + ++++ + G
Sbjct: 81 -----------G-------------PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
+ + F+ + + + I+++HS HRD+KP+N L K + + DFG
Sbjct: 117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 178 LAKKYRDP 185
AK+
Sbjct: 177 FAKETTQN 184
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 36/192 (18%), Positives = 66/192 (34%), Gaps = 41/192 (21%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E +++
Sbjct: 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQ 113
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-----DGEDNV-LVLDLL--G 112
P+I + V G + +V++ L G
Sbjct: 114 ----------------C-------------PHIVRIVDVYENLYAGRKCLLIVMECLDGG 144
Query: 113 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 172
+ + F+ + + + I+Y+HS HRD+KP+N L R +
Sbjct: 145 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204
Query: 173 IIDFGLAKKYRD 184
+ DFG AK+
Sbjct: 205 LTDFGFAKETTS 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 61/269 (22%), Positives = 95/269 (35%), Gaps = 68/269 (25%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSKI 65
R IG G FGE++ DT ++ A+K G L E +L
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERI---MLS----- 244
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLF--V 120
+V D I ++ F + D + +LDL+ G DL +
Sbjct: 245 --LVSTGDCPFIVCMSYAFHT---------------PDKLSFILDLMNGG----DLHYHL 283
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
FS + A ++I +E++H+R ++RD+KP N L+ + V I D GLA
Sbjct: 284 SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLAC 340
Query: 181 KYRDPTTNRHIPYRENKNLTGTARY------ASCNTHLGIEQSRRDDLESLGYVLLY-FL 233
+ + GT Y + D SLG +L+ L
Sbjct: 341 DFSKKKPH---------ASVGTHGYMAPEVLQKGVAY-----DSSADWFSLG-CMLFKLL 385
Query: 234 RGSLPWQGLKAATKKQKYDKICEKKVSTP 262
RG P++ K K + V P
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTMAVELP 414
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 26/179 (14%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+ +Y++ + IG GSFG++ A ++ VA+K + N H Q E ++ + L+
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 63 SKIRLVVFHVDHVIIHAL-TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
K +IH L F + + + +LL +L +L
Sbjct: 154 DK------DNTMNVIHMLENFTFRNHI----------------CMTFELLSMNLYELIKK 191
Query: 122 CR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + FSL V A ++ ++ +H +H D+KP+N L+ + + + +IDFG +
Sbjct: 192 NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS 249
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 41/184 (22%), Positives = 73/184 (39%), Gaps = 37/184 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
Y K+G G++ ++ T+ +VA+K +IRL
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK-------------------------EIRL 37
Query: 68 VVFHVDHVIIHALTIIFSSTLGGI--PNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYC 122
H + A+ + S L + NI + + + LV + L L+ C
Sbjct: 38 E--HEEGAPCTAIREV--SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC 93
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
++ V + Q++ + Y H + LHRD+KP N L+ + ++ + DFGLA+
Sbjct: 94 GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAK 150
Query: 183 RDPT 186
PT
Sbjct: 151 SIPT 154
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 6e-14
Identities = 37/189 (19%), Positives = 74/189 (39%), Gaps = 32/189 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
+Y+ +IG G++G ++ A + VA V++ N G L + E + + L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 61 GGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF 119
+H ++ + + +S + LV + + L
Sbjct: 70 AF----------EHPNVVRLMDVCATSRTDREIKV----------TLVFEHVDQDLRTYL 109
Query: 120 VYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+T+ L Q + ++++H+ +HRD+KP+N L+ V + DFGL
Sbjct: 110 DKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGL 166
Query: 179 AKKYRDPTT 187
A+ Y
Sbjct: 167 ARIYSYQMA 175
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 56/258 (21%), Positives = 81/258 (31%), Gaps = 66/258 (25%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+L G FG ++ A NE VAVKI K E +VY +
Sbjct: 25 PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQ-SWQNEYEVYSLP-------- 73
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDLL-------GPSLEDLF 119
+ H NI ++ G + + +DL SL D
Sbjct: 74 ---GMKH-----------------ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGF----------LHRDIKPDNFLMGLGRKAN 169
S + +A+ M + Y+H HRDIK N L+ K N
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNN 167
Query: 170 -QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY-----ASCNTHLGIEQSRRDDLE 223
I DFGLA K+ + + GT RY + + R D+
Sbjct: 168 LTACIADFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222
Query: 224 SLGYVLLYFLRGSLPWQG 241
++G VL G
Sbjct: 223 AMGLVLWELASRCTAADG 240
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 46/215 (21%), Positives = 72/215 (33%), Gaps = 63/215 (29%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGS 63
L IG G FG+++ A + VAVK + EAK++ +L+
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLK--- 64
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF 119
H PNI GV + LV++ G L +
Sbjct: 65 --------------H-------------PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 97
Query: 120 VYCRRKFSLKTVLMLADQMIAR-IEYVHSRG---FLHRDIKPDNFLMGLGRKANQVY--- 172
++ ++ A Q IAR + Y+H +HRD+K N L+ + +
Sbjct: 98 S--GKRIPPDILVNWAVQ-IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154
Query: 173 --IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 205
I DFGLA R + G +
Sbjct: 155 LKITDFGLA---------REWHRTTKMSAAGAYAW 180
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 41/200 (20%), Positives = 78/200 (39%), Gaps = 64/200 (32%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGT--------------KHPQ 48
+Y+ K+G G++GE++ A TNE VA+K E G +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 49 LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVL 108
++ ++ ++ ++ L+ + ++ ++K Y +
Sbjct: 95 II---ELKSVIHHNHRLHLIFEYAEN------------------DLKKY----------M 123
Query: 109 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168
D S++ + Q+I + + HSR LHRD+KP N L+ + +
Sbjct: 124 DKNPD------------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAS 171
Query: 169 N--QVYIIDFGLAKKYRDPT 186
+ I DFGLA+ + P
Sbjct: 172 ETPVLKIGDFGLARAFGIPI 191
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 37/175 (21%), Positives = 69/175 (39%), Gaps = 31/175 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+ R+IG GSFG ++ A V +E+VA+K + K ++ + ++
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV--------R 106
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRR 124
+ + H PN ++ G + LV++ S DL ++
Sbjct: 107 FLQKLRH-----------------PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 149
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + + + Y+HS +HRD+K N L+ + V + DFG A
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 39/198 (19%), Positives = 71/198 (35%), Gaps = 63/198 (31%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGT--------------KHPQ 48
++ KIG G++G ++ A + T E+VA+K E G HP
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 49 LLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVL 108
++ K+ ++ +K+ LV + ++K + +
Sbjct: 64 IV---KLLDVIHTENKLYLVFEFLHQ------------------DLKKF----------M 92
Query: 109 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168
D L + Q++ + + HS LHRD+KP N L+
Sbjct: 93 DASAL----------TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TE 139
Query: 169 NQVYIIDFGLAKKYRDPT 186
+ + DFGLA+ + P
Sbjct: 140 GAIKLADFGLARAFGVPV 157
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 57/258 (22%), Positives = 95/258 (36%), Gaps = 49/258 (18%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G+FGE+ L H T ++ A+K+ +++ + + R ++ +
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWEE----RDIMAFANS 128
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRR-KFSLKT 130
+ L +Y + + +V++ + G DL K
Sbjct: 129 PWVVQL---------------FYAFQDDRYLYMVMEYMPGG----DLVNLMSNYDVPEKW 169
Query: 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 190
+++ ++ +HS GF+HRD+KPDN L+ K+ + + DFG K R
Sbjct: 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVR- 225
Query: 191 IPYRENKNLTGTARYAS----CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAA 245
GT Y S + R D S+G V LY L G P+ A
Sbjct: 226 -----CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTPF---YAD 276
Query: 246 TKKQKYDKICEKKVSTPI 263
+ Y KI K S
Sbjct: 277 SLVGTYSKIMNHKNSLTF 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 67/301 (22%), Positives = 107/301 (35%), Gaps = 74/301 (24%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-AKVYKILQGGSKIRLV 68
+ KIG+GSFG + A VAVKI H + + E + I+ ++R
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIM---KRLR-- 92
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF--VYC 122
H PNI + G + +V + L SL L
Sbjct: 93 ---------H-------------PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 123 RRKFSLKTVLMLADQMIAR-IEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
R + + L +A +A+ + Y+H+R +HR++K N L+ K V + DFGL+
Sbjct: 131 REQLDERRRLSMAYD-VAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLS 186
Query: 180 K-KYRDPTTNRHIPYRENKNLTGTARY--------ASCNTHLGIEQSRRDDLESLGYVLL 230
+ K + +K+ GT + N E+S D+ S G +L
Sbjct: 187 RLKASTFLS--------SKSAAGTPEWMAPEVLRDEPSN-----EKS---DVYSFGVILW 230
Query: 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
PW L A Q + K I + A+ C + +RP
Sbjct: 231 ELATLQQPWGNLNPA---QVVAAVGFKCKRLEIPRNL---NPQVAAIIEGCWTNEPWKRP 284
Query: 291 D 291
Sbjct: 285 S 285
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 5e-13
Identities = 51/184 (27%), Positives = 73/184 (39%), Gaps = 37/184 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY KIG G++G ++ A + + E A+K KIRL
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALK-------------------------KIRL 36
Query: 68 VVFHVDHVIIHALTIIFSSTLGGI--PNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYC 122
+ + + I S L + NI K Y V VLV + L L+ L C
Sbjct: 37 EKED-EGIPSTTIREI--SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC 93
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
T Q++ I Y H R LHRD+KP N L+ + ++ I DFGLA+ +
Sbjct: 94 EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAF 150
Query: 183 RDPT 186
P
Sbjct: 151 GIPV 154
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 38/185 (20%), Positives = 70/185 (37%), Gaps = 39/185 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ K+G G++G ++ A IVA+K E+ G + E + K L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHHP 79
Query: 63 SKIRLV-VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
+ + L+ V H + + LV + + L+ +
Sbjct: 80 NIVSLIDVIHSERCL----------------------------TLVFEFMEKDLKKVLDE 111
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ + + Q++ + + H LHRD+KP N L+ + + DFGLA+
Sbjct: 112 NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARA 168
Query: 182 YRDPT 186
+ P
Sbjct: 169 FGIPV 173
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 38/196 (19%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD--TNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
ER+ + G K+G G++G ++ A D ++ A+K IE +G E + +
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRE 74
Query: 59 LQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLD--------L 110
L+ + I L + HA ++ L+ D +
Sbjct: 75 LKHPNVISLQ----KVFLSHADRKVW---------------------LLFDYAEHDLWHI 109
Query: 111 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKAN 169
+ + V L Q++ I Y+H+ LHRD+KP N L MG G +
Sbjct: 110 IKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169
Query: 170 QVYIIDFGLAKKYRDP 185
+V I D G A+ + P
Sbjct: 170 RVKIADMGFARLFNSP 185
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 40/197 (20%), Positives = 73/197 (37%), Gaps = 58/197 (29%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENS-GT--------------KHPQL 49
++K K+G+G++ ++ + T VA+K +++ GT KH +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 50 LYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLD 109
+ ++Y ++ +K+ LV +D+ D
Sbjct: 66 V---RLYDVIHTENKLTLVFEFMDN----------------------------------D 88
Query: 110 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 169
L R L V Q++ + + H LHRD+KP N L+ K
Sbjct: 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRG 145
Query: 170 QVYIIDFGLAKKYRDPT 186
Q+ + DFGLA+ + P
Sbjct: 146 QLKLGDFGLARAFGIPV 162
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 58/264 (21%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+ + +G+GSFG + L H ++ A+KI L + KV K+ Q
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKI----------LDKQKVVKLKQ-------- 84
Query: 69 VFHVDHVII--HALTII---FSSTLGGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVY 121
++H + L + F + +++ D + +V++ + G ++F +
Sbjct: 85 ---IEHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGG----EMFSH 131
Query: 122 CRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
RR +FS A Q++ EY+HS ++RD+KP+N L+ + + + DFG A
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFA 188
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLP 238
K+ + T L GT + L ++ D +LG VL+Y G P
Sbjct: 189 KRVKGRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPP 237
Query: 239 WQGLKAATKKQKYDKICEKKVSTP 262
+ A Q Y+KI KV P
Sbjct: 238 F---FADQPIQIYEKIVSGKVRFP 258
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 41/200 (20%), Positives = 82/200 (41%), Gaps = 56/200 (28%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
++L +G+G++G+++ HV T ++ A+K+ + + + +I Q +I ++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--------VTGDEEEEIKQ---EINML 74
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYG------VDGEDNVL--VLDLL-GPSLEDL 118
+ H NI +YG G D+ L V++ S+ DL
Sbjct: 75 KKYSHH-----------------RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 119 FVYCRRKFSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQ 170
+ L ++ IA I ++H +HRDIK N L+ + +
Sbjct: 118 IKNTKGN-------TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAE 167
Query: 171 VYIIDFGLAKKYRDPTTNRH 190
V ++DFG++ + R+
Sbjct: 168 VKLVDFGVSAQLDRTVGRRN 187
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 40/187 (21%), Positives = 78/187 (41%), Gaps = 37/187 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+ + K+G GS+G ++ A H +T +IVA+K E+ + +I++ +I
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---------VESDLQEIIK---EI-S 76
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR 123
++ D P++ K+YG D +V++ S+ D+
Sbjct: 77 IMQQCDS-----------------PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
+ + + + + +EY+H +HRDIK N L+ + DFG+A +
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLT 176
Query: 184 DPTTNRH 190
D R+
Sbjct: 177 DTMAKRN 183
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 52/261 (19%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74
IG G+FGE+ + + +++ A+KI ++L A+ + R V+ + D
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREE----RDVLVNGDS 133
Query: 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRR---KFSL 128
I L Y ++N+ LV+D G DL + +
Sbjct: 134 KWITTL---------------HYAFQDDNNLYLVMDYYVGG----DLLTLLSKFEDRLPE 174
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 188
+ +M+ I+ VH ++HRDIKPDN LM + + DFG K + T
Sbjct: 175 EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDGTV 231
Query: 189 RHIPYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLY-FLRGSLPWQGL 242
+ + GT Y S +E + D SLG V +Y L G P+
Sbjct: 232 Q------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYGETPFY-- 282
Query: 243 KAATKKQKYDKICEKKVSTPI 263
A + + Y KI K
Sbjct: 283 -AESLVETYGKIMNHKERFQF 302
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 34/187 (18%), Positives = 75/187 (40%), Gaps = 35/187 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+++ ++G G+FG+++ A + +T + A K+ + ++
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----------------TKSEEELED 62
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR 123
+ V I L P I K G ++++ G +++ + +
Sbjct: 63 YI-----VEIEILATCDH------PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD 111
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
R + + ++ QM+ + ++HS+ +HRD+K N LM L + + DFG++ K
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNL 168
Query: 184 DPTTNRH 190
R
Sbjct: 169 KTLQKRD 175
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 57/269 (21%), Positives = 88/269 (32%), Gaps = 66/269 (24%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
IG G+F E+ + T ++ A+K ++ E R
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC--FREE-------------RD 113
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR- 124
V+ + D I L F Y LV++ G DL +
Sbjct: 114 VLVNGDRRWITQLHFAFQD------ENYLY--------LVMEYYVGG----DLLTLLSKF 155
Query: 125 --KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+ + +++ I+ VH G++HRDIKPDN L+ + + + DFG K
Sbjct: 156 GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKL 212
Query: 183 RDPTTNRHIPYRENKNLTGTARY-------ASCNTHLGIEQSRRDDLESLGYVLLY-FLR 234
R T R + GT Y A D +LG V Y
Sbjct: 213 RADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMFY 265
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTPI 263
G P+ A + + Y KI K +
Sbjct: 266 GQTPFY---ADSTAETYGKIVHYKEHLSL 291
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 44/228 (19%), Positives = 75/228 (32%), Gaps = 86/228 (37%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAK-VY--- 56
I ++L +G G++G + A+H T EIVA+K + A
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------PLFALRTLREI 60
Query: 57 KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE 116
KIL+ H H NI + + ++ P
Sbjct: 61 KILK----------HFKH-----------------ENI----------ITIFNIQRPDSF 83
Query: 117 DLF--VYCRRKFSLKTVLMLAD--------------------QMIARIEYVHSRGFLHRD 154
+ F VY + LM D Q + ++ +H +HRD
Sbjct: 84 ENFNEVY------IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 155 IKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 201
+KP N L+ +N + + DFGLA+ + + P + +
Sbjct: 138 LKPSNLLI----NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 42/189 (22%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKI 65
+ KIG GSFGE+F T ++VA+KI E + + + E V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC------ 77
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVY 121
D P + K+YG + ++++ L G S DL
Sbjct: 78 -------DS-----------------PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL--L 111
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ + +++ ++Y+HS +HRDIK N L+ + +V + DFG+A +
Sbjct: 112 EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ 168
Query: 182 YRDPTTNRH 190
D R+
Sbjct: 169 LTDTQIKRN 177
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 50/185 (27%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L ++ T E+VAVK ++G +H E + + L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL--- 90
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV---DGEDNV-LVLDLLGPSLED 117
H +I K+ G G ++ LV++ + L
Sbjct: 91 ----------YH-----------------EHIIKYKGCCEDAGAASLQLVMEYV--PLGS 121
Query: 118 LFVYCRR-KFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
L Y R L +L+ A Q I + Y+H++ ++HRD+ N L+ V I D
Sbjct: 122 LRDYLPRHSIGLAQLLLFAQQ-ICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGD 177
Query: 176 FGLAK 180
FGLAK
Sbjct: 178 FGLAK 182
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 39/192 (20%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP-QLLYEAK-VY---KI 58
+ Y +GSG++G + A + E VA+K + P Q AK Y +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-----PFQSEIFAKRAYRELLL 76
Query: 59 LQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLED 117
L+ H+ H +I L + ++ + D LV+ + D
Sbjct: 77 LK----------HMQHENVIGLLDVFTPASSLR---------NFYDFYLVMPFMQ---TD 114
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDF 176
L KFS + + L QM+ ++Y+HS G +HRD+KP N + + ++ I+DF
Sbjct: 115 LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDF 170
Query: 177 GLAKKYRDPTTN 188
GLA+ T
Sbjct: 171 GLARHADAEMTG 182
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 39/215 (18%), Positives = 67/215 (31%), Gaps = 62/215 (28%)
Query: 8 KYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLY-EAKVYKILQG 61
Y+L IG G + LA + T E V V+ E + L E V K+
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-- 83
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLED 117
+H PNI + + + +V + S +D
Sbjct: 84 -----------NH-----------------PNIVPYRATFIADNELWVVTSFMAYGSAKD 115
Query: 118 LFVYCRRKFSLKTVLM--LADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRK 167
L + T M + + IA I +Y+H G++HR +K + L+
Sbjct: 116 L---------ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---V 163
Query: 168 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 202
+VY+ + + + K
Sbjct: 164 DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 46/197 (23%), Positives = 76/197 (38%), Gaps = 45/197 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGSKIR 66
LG +IG G+FGE+F N +VAVK L EA++ K
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY------- 169
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYC 122
H PNI + GV + +V++L+ G
Sbjct: 170 ------SH-----------------PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 206
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+ +KT+L + A +EY+ S+ +HRD+ N L+ + N + I DFG++++
Sbjct: 207 GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREE 263
Query: 183 RDPTTNRH-----IPYR 194
D +P +
Sbjct: 264 ADGVYAASGGLRQVPVK 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 53/195 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KY KIG G+ G ++ A V T + VA++ N LQ K L
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-----------------LQQQPKKEL 63
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR 123
++ I + + PNI + + G++ +V++ L G SL D+
Sbjct: 64 II-----NEILVMRENKN------PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 124 RKFSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
+ + IA + E++HS +HRDIK DN L+G+ V + D
Sbjct: 113 ----------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTD 159
Query: 176 FGLAKKYRDPTTNRH 190
FG + + R
Sbjct: 160 FGFCAQITPEQSKRS 174
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 6e-12
Identities = 60/274 (21%), Positives = 105/274 (38%), Gaps = 78/274 (28%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+++ R +G+GSFG + L A+K+ L + V ++ Q
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKV----------LKKEIVVRLKQ-------- 49
Query: 69 VFHVDHVII--HALTII---FSSTLGGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVY 121
V+H L+I+ F I + D + +++D + G +LF
Sbjct: 50 ---VEHTNDERLMLSIVTHPF------IIRMWGTFQDAQQIFMIMDYIEGG----ELFSL 96
Query: 122 CRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
R+ +F A ++ +EY+HS+ ++RD+KP+N L+ K + I DFG A
Sbjct: 97 LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFA 153
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY----------VL 229
K D T L GT Y + E + + Y +L
Sbjct: 154 KYVPDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWSFGIL 192
Query: 230 LY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
+Y L G P+ + + Y+KI ++ P
Sbjct: 193 IYEMLAGYTPFY---DSNTMKTYEKILNAELRFP 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 38/205 (18%), Positives = 75/205 (36%), Gaps = 57/205 (27%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY-------- 56
+G +Y + +G G G +F A D ++ VA+K +++
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---------KIVLTDPQSVKHALREI 59
Query: 57 KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE 116
KI++ +DH I + I + + + + +V + + L
Sbjct: 60 KIIR----------RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA 109
Query: 117 DL-------------FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163
++ F+Y Q++ ++Y+HS LHRD+KP N
Sbjct: 110 NVLEQGPLLEEHARLFMY---------------QLLRGLKYIHSANVLHRDLKPANLF-- 152
Query: 164 LGRKANQVYIIDFGLAKKYRDPTTN 188
+ + + I DFGLA+ ++
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSH 177
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 43/196 (21%), Positives = 72/196 (36%), Gaps = 53/196 (27%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSK 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ---- 83
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-----KWYGVDGEDNVL--VLDLL-GPSLE 116
H PNI W + V +L+ +L+
Sbjct: 84 -------------H-------------PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDN-FLMGLGRKANQV 171
Y +R +K + Q++ ++++H+R +HRD+K DN F+ G V
Sbjct: 118 T---YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSV 171
Query: 172 YIIDFGLAKKYRDPTT 187
I D GLA R
Sbjct: 172 KIGDLGLATLKRASFA 187
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 28/181 (15%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+Y++ IG GSFG++ A E VA+K I+N Q E ++ +++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110
Query: 63 SKIRLVVFHVDHVIIHAL-TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF-V 120
+ + I+H +F + L LV ++L +L DL
Sbjct: 111 DT------EMKYYIVHLKRHFMFRNHL----------------CLVFEMLSYNLYDLLRN 148
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
R SL A QM + ++ + +H D+KP+N L+ K + + I+DFG
Sbjct: 149 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGS 207
Query: 179 A 179
+
Sbjct: 208 S 208
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 50/186 (26%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L +T E VAVK SG H L E ++ + L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL--- 80
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV---DGEDNV-LVLDLL--GPSL 115
H NI K+ G+ DG + + L+++ L G SL
Sbjct: 81 ----------YH-----------------ENIVKYKGICTEDGGNGIKLIMEFLPSG-SL 112
Query: 116 EDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
++ + K +LK L A Q I + ++Y+ SR ++HRD+ N L+ +QV I
Sbjct: 113 KEYLPKNKNKINLKQQLKYAVQ-ICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIG 168
Query: 175 DFGLAK 180
DFGL K
Sbjct: 169 DFGLTK 174
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 37/187 (19%), Positives = 75/187 (40%), Gaps = 30/187 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGG 62
+Y+ +IG G++G++F A + + VA V+++ P + E V + L+
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 63 SKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
+H ++ + S + LV + + L
Sbjct: 72 ----------EHPNVVRLFDVCTVSRTDRETKL----------TLVFEHVDQDLTTYLDK 111
Query: 122 CRRKF-SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+T+ + Q++ ++++HS +HRD+KP N L+ + Q+ + DFGLA+
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLAR 168
Query: 181 KYRDPTT 187
Y
Sbjct: 169 IYSFQMA 175
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 52/264 (19%), Positives = 92/264 (34%), Gaps = 62/264 (23%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+G G FGE+ T ++ A K + G L E +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNE-------------KQ 236
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFVY--- 121
++ V+ + +L + + +D + LVL L+ G DL +
Sbjct: 237 ILEKVNSRFVVSLAYAYET---------------KDALCLVLTLMNGG----DLKFHIYH 277
Query: 122 -CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ F + A ++ +E +H ++RD+KP+N L+ + I D GLA
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAV 334
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 239
+ T + GT Y + + D +LG LLY + G P+
Sbjct: 335 HVPEGQTIK--------GRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPF 385
Query: 240 QGLKAATKKQK-YDKICEKKVSTP 262
Q K K+++ + E
Sbjct: 386 QQRKKKIKREEVERLVKEVPEEYS 409
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 49/185 (26%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK ++ E ++ K L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL---- 68
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV---DGEDNV-LVLDLL--GPSLE 116
H NI K+ GV G N+ L+++ L G SL
Sbjct: 69 ---------QH-----------------DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLR 101
Query: 117 DLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
D + + +L Q I + +EY+ ++ ++HRD+ N L+ N+V I D
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ-ICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGD 157
Query: 176 FGLAK 180
FGL K
Sbjct: 158 FGLTK 162
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 45/187 (24%), Positives = 81/187 (43%), Gaps = 41/187 (21%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAK-VY---K 57
+ +Y+ + IGSG+ G + A + VA+K K Q AK Y
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK------KLSRPFQNQTHAKRAYRELV 113
Query: 58 ILQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE 116
+++ V+H II L + + +D LV++L+
Sbjct: 114 LMK----------CVNHKNIISLLNVFTPQKTLE---------EFQDVYLVMELMD---A 151
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIID 175
+L + + + + L QM+ I+++HS G +HRD+KP N ++ K++ + I+D
Sbjct: 152 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD 207
Query: 176 FGLAKKY 182
FGLA+
Sbjct: 208 FGLARTA 214
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 49/185 (26%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK T+ E ++ K L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL---- 99
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV---DGEDNV-LVLDLL--GPSLE 116
H NI K+ GV G N+ L+++ L G SL
Sbjct: 100 ---------QH-----------------DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLR 132
Query: 117 DLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
D + + +L Q I + +EY+ ++ ++HRD+ N L+ N+V I D
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQ-ICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGD 188
Query: 176 FGLAK 180
FGL K
Sbjct: 189 FGLTK 193
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 53/195 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
KIG GS G + LA + VAVK+ + L+ + L
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD-----------------LRKQQRREL 88
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR 123
+ + + I+ N+ + Y + GE+ ++++ L G +L D+
Sbjct: 89 --------LFNEVVIMRDYQH---FNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---- 133
Query: 124 RKFSLKTVLMLADQMIARI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
+ + L ++ IA + Y+H++G +HRDIK D+ L+ L +V + D
Sbjct: 134 ------SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSD 184
Query: 176 FGLAKKYRDPTTNRH 190
FG + R
Sbjct: 185 FGFCAQISKDVPKRK 199
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 51/274 (18%), Positives = 96/274 (35%), Gaps = 79/274 (28%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+G G FGE+F T ++ A K + G + + E +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG--AMVE-------------KK 237
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLF----- 119
++ V I +L F + + ++ LV+ ++ G D+
Sbjct: 238 ILAKVHSRFIVSLAYAFET---------------KTDLCLVMTIMNGG----DIRYHIYN 278
Query: 120 -VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
F + Q+++ +E++H R ++RD+KP+N L+ V I D GL
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGL 335
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTH--------LGIEQSRRDDLESLGYVLL 230
A + + + T T LG E D +LG V L
Sbjct: 336 AVE-----------LKAGQTKTKG----YAGTPGFMAPELLLGEEYDFSVDYFALG-VTL 379
Query: 231 Y-FLRGSLPWQGLKAATKKQK-YDKICEKKVSTP 262
Y + P++ + ++ ++ E+ V+ P
Sbjct: 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 49/185 (26%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
K ++G G+FG + L +T +VAVK +++SG + E ++ K L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL---- 81
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV---DGEDNV-LVLDLL--GPSLE 116
I K+ GV G ++ LV++ L G L
Sbjct: 82 ---------HS-----------------DFIVKYRGVSYGPGRQSLRLVMEYLPSG-CLR 114
Query: 117 DLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
D R + +L+ + Q I + +EY+ SR +HRD+ N L+ V I D
Sbjct: 115 DFLQRHRARLDASRLLLYSSQ-ICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIAD 170
Query: 176 FGLAK 180
FGLAK
Sbjct: 171 FGLAK 175
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 36/191 (18%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAK-VY---KILQ 60
+ +Y+ +GSG++G + A T VAVK + + AK Y ++L+
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLK 83
Query: 61 GGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF 119
H+ H +I L + P + D LV L+G DL
Sbjct: 84 ----------HMKHENVIGLLDVF-------TPARSL--EEFNDVYLVTHLMG---ADLN 121
Query: 120 VYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFG 177
+ +K + V L Q++ ++Y+HS +HRD+KP N + + ++ I+DFG
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFG 177
Query: 178 LAKKYRDPTTN 188
LA+ D T
Sbjct: 178 LARHTADEMTG 188
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 44/184 (23%), Positives = 79/184 (42%), Gaps = 41/184 (22%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAK-VY---K 57
+ +Y+ + IGSG+ G + A VA+K K Q AK Y
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK------KLSRPFQNQTHAKRAYRELV 76
Query: 58 ILQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE 116
+++ V+H II L + + +D +V++L+
Sbjct: 77 LMK----------CVNHKNIIGLLNVFTPQKSLE---------EFQDVYIVMELMD---A 114
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIID 175
+L + + + + L QM+ I+++HS G +HRD+KP N ++ K++ + I+D
Sbjct: 115 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD 170
Query: 176 FGLA 179
FGLA
Sbjct: 171 FGLA 174
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 41/194 (21%), Positives = 68/194 (35%), Gaps = 47/194 (24%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVV 69
KL + IG G FG++ L + VAVK + L EA V L
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQL---------- 71
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNV-LVLDLLGPSLEDLFVYCR-- 123
H N+ + GV + + + +V + + + L Y R
Sbjct: 72 ---RH-----------------SNLVQLLGVIVEEKGGLYIVTEYM--AKGSLVDYLRSR 109
Query: 124 --RKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+L + + +EY+ F+HRD+ N L+ + N + DFGL K
Sbjct: 110 GRSVLGGDCLLKFSLD-VCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTK 165
Query: 181 KYRDPTTNRHIPYR 194
+ +P +
Sbjct: 166 EASSTQDTGKLPVK 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 69/218 (31%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS- 63
+ KY+L +K+G G++G ++ + T E+VAVK K++ Q +
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---------------KIFDAFQNSTD 51
Query: 64 ------KIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL----- 111
+I ++ H I++ L ++ + + Y LV D +
Sbjct: 52 AQRTFREIMILTELSGHENIVNLLNVLRADNDRDV-----Y--------LVFDYMETDLH 98
Query: 112 ----GPSLEDL----FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163
LE + VY Q+I I+Y+HS G LHRD+KP N L+
Sbjct: 99 AVIRANILEPVHKQYVVY---------------QLIKVIKYLHSGGLLHRDMKPSNILL- 142
Query: 164 LGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 200
A V + DFGL++ + + + T
Sbjct: 143 ---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 44/183 (24%), Positives = 74/183 (40%), Gaps = 43/183 (23%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+ K+G G +GE++ + VAVK T + L EA V K +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI--------- 66
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPN-IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCR 123
H PN ++ GV ++ + + G +L D C
Sbjct: 67 ----KH-----------------PNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECN 104
Query: 124 RK-FSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
R+ S +L +A Q I+ +EY+ + F+HRD+ N L+G + + V + DFGL++
Sbjct: 105 RQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRL 160
Query: 182 YRD 184
Sbjct: 161 MTG 163
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 42/190 (22%), Positives = 72/190 (37%), Gaps = 52/190 (27%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAK-VY---KIL 59
+ Y + IG GS+G ++LA +T + VA+K + L + K + IL
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED----LIDCKRILREITIL 79
Query: 60 QGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
+ II +I L ++ +VL++ L+ L
Sbjct: 80 N----------RLKSDYIIRLYDLIIPDDLL----------KFDELYIVLEIADSDLKKL 119
Query: 119 FVYCRRKFSLKTVLMLAD--------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN- 169
KT + L + ++ ++H G +HRD+KP N L+ +
Sbjct: 120 ---------FKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDC 166
Query: 170 QVYIIDFGLA 179
V + DFGLA
Sbjct: 167 SVKVCDFGLA 176
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 32/175 (18%), Positives = 73/175 (41%), Gaps = 39/175 (22%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKIRLVVF 70
++GSG+ G+++ T ++AVK + ++ ++L + + +V+
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD------------LDVVLK 79
Query: 71 HVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
D P I + +G + D + ++L+G E L +
Sbjct: 80 SHDC-----------------PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP 122
Query: 128 LKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ + + ++ + Y+ G +HRD+KP N L+ + Q+ + DFG++ +
Sbjct: 123 ERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGR 174
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 43/183 (23%), Positives = 68/183 (37%), Gaps = 47/183 (25%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + +I VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV--- 74
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDL 118
D+ P++ + G+ V L+ L G L D
Sbjct: 75 ----------DN-----------------PHVCRLLGICLTSTVQLITQLMPFG-CLLDY 106
Query: 119 FVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
+ + +L Q IA+ + Y+ R +HRD+ N L+ V I DFG
Sbjct: 107 VREHKDNIGSQYLLNWCVQ-IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFG 162
Query: 178 LAK 180
LAK
Sbjct: 163 LAK 165
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 44/192 (22%), Positives = 69/192 (35%), Gaps = 43/192 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVV 69
KL + IG G FG++ L + VAVK + L EA V L+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLR--------- 244
Query: 70 FHVDHVIIHALTIIFSSTLGGIPNI-KWYGV---DGEDNVLVLDLL--GPSLED-LFVYC 122
H N+ + GV + +V + + G SL D L
Sbjct: 245 --------H-------------SNLVQLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRG 282
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
R +L + + +EY+ F+HRD+ N L+ + N + DFGL K+
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA 339
Query: 183 RDPTTNRHIPYR 194
+P +
Sbjct: 340 SSTQDTGKLPVK 351
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAK-VY---KIL 59
I +Y++ IG+GS+G + A +VA+K I + K + IL
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLID---CKRILREIAIL 106
Query: 60 QGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
++H ++ L I+ + + Y +VL++ + L
Sbjct: 107 N----------RLNHDHVVKVLDIVIPKDVEKFDEL--Y--------VVLEIADSDFKKL 146
Query: 119 FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFG 177
F + + L ++ ++YVHS G LHRD+KP N L+ + V + DFG
Sbjct: 147 F-RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCDFG 201
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL-GYV 228
LA R + Y EN N + +L ++ L G+V
Sbjct: 202 LA---------RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 39/180 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
++IGSG FG + L ++ ++ VA+K G + + EA+V L
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKL--------- 60
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRR 124
H P + + YGV + LV + + L D R
Sbjct: 61 ----SH-----------------PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG 99
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
F+ +T+L + + + Y+ +HRD+ N L+G + + + DFG+ + D
Sbjct: 100 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-10
Identities = 37/209 (17%), Positives = 60/209 (28%), Gaps = 27/209 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
K + KIG G FGE+F + VA+KI + ++L E + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPS--- 114
L S + + S + Y D
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 115 --------LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLG 165
DL + SL T + Q+ A + + F HRD+ N L+
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL--- 195
Query: 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYR 194
+K + + K P+ +
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 36/201 (17%), Positives = 64/201 (31%), Gaps = 56/201 (27%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
+ +Y++ +G G+FG++ H VA+K I N G E V K ++
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKE 75
Query: 62 GSK------IRLV--VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP 113
K + + H+ I +LLG
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCI-----------------------------AFELLGK 106
Query: 114 SLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---------- 162
+ + + + L V +A Q+ + ++H H D+KP+N L
Sbjct: 107 NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
Query: 163 ------GLGRKANQVYIIDFG 177
K + + DFG
Sbjct: 167 EHKSCEEKSVKNTSIRVADFG 187
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 39/194 (20%), Positives = 69/194 (35%), Gaps = 43/194 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+++G+G FG + + VA+K+ G+ + EAKV L
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL--------- 76
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRR 124
H + + YGV ++ + + L + R
Sbjct: 77 ----SH-----------------EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH 115
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
+F + +L + + +EY+ S+ FLHRD+ N L+ V + DFGL++ D
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLD 172
Query: 185 PTTNRH----IPYR 194
P R
Sbjct: 173 DEYTSSVGSKFPVR 186
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 45/196 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+ K+G G +GE++ + VAVK T + L EA V K ++
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-------- 274
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPN-IKWYGV--DGEDNVLVLDLL--GPSLED-LFVYC 122
H PN ++ GV ++ + + G +L D L
Sbjct: 275 --H--------------------PNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECN 311
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
R++ S +L +A Q+ + +EY+ + F+HR++ N L+G + + V + DFGL++
Sbjct: 312 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLM 368
Query: 183 RD----PTTNRHIPYR 194
P +
Sbjct: 369 TGDTYTAHAGAKFPIK 384
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 37/205 (18%), Positives = 74/205 (36%), Gaps = 60/205 (29%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG 62
++ + + RK+G G+FG + L H+D + AVK+ + K EA + K +Q
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 63 SK-----IRLV--VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSL 115
++ + DH+ + + + LGPSL
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCL-----------------------------IFEPLGPSL 122
Query: 116 EDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM------------ 162
++ F ++ + + +++ + Y+ H D+KP+N L+
Sbjct: 123 YEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182
Query: 163 ----------GLGRKANQVYIIDFG 177
K+ + +IDFG
Sbjct: 183 RRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 43/216 (19%), Positives = 67/216 (31%), Gaps = 88/216 (40%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY------- 56
+G +Y IG G++G + A VA+K I +E + Y
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLRE 75
Query: 57 -KILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSL 115
KIL H NI + + D++
Sbjct: 76 IKILL----------RFRH-----------------ENI----------IGINDIIRAPT 98
Query: 116 EDLF--VYCRRKFSLKTVLMLAD--------------------QMIARIEYVHSRGFLHR 153
+ VY + LM D Q++ ++Y+HS LHR
Sbjct: 99 IEQMKDVY------IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 152
Query: 154 DIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 188
D+KP N L+ + I DFGLA+ +
Sbjct: 153 DLKPSNLLL----NTTCDLKICDFGLARVADPDHDH 184
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 47/183 (25%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
+ + +GSG FG + ++ +I V +K+ + SG + Q + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL--- 72
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDL--LGPSLEDL 118
DH +I + G+ G LV LG SL D
Sbjct: 73 ----------DH-----------------AHIVRLLGLCPGSSLQLVTQYLPLG-SLLDH 104
Query: 119 FVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
R + +L Q IA+ + Y+ G +HR++ N L+ +QV + DFG
Sbjct: 105 VRQHRGALGPQLLLNWGVQ-IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFG 160
Query: 178 LAK 180
+A
Sbjct: 161 VAD 163
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 19/207 (9%), Positives = 46/207 (22%), Gaps = 56/207 (27%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-AKVYKILQGGSKIRLV 68
K+ GE++ + VK+ + + + L
Sbjct: 13 NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRL---RIFS-- 65
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV----DGEDNVLVLDLL-GPSLED-LFVY 121
H PN+ G L+ + SL + L
Sbjct: 66 ---------H-------------PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG 103
Query: 122 CRRKFSLKTVLMLADQMIAR-IEYVHSRGF--LHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ A +AR + ++H+ + + ++ + I +
Sbjct: 104 TNFVVDQSQAVKFALD-MARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADV 159
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARY 205
++ +
Sbjct: 160 KF------------SFQSPGRMYAPAW 174
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 56/268 (20%), Positives = 100/268 (37%), Gaps = 69/268 (25%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+G G+FG++ L T A+K I H + E
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH--TVTE-------------SR 57
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLF--VYC 122
V+ + H + AL F + D + V++ G +LF +
Sbjct: 58 VLQNTRHPFLTALKYAFQT---------------HDRLCFVMEYANGG----ELFFHLSR 98
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK- 181
R F+ + ++++ +EY+HSR ++RDIK +N ++ K + I DFGL K+
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEG 155
Query: 182 -YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSL 237
T T GT Y + + R D LG V++Y + G L
Sbjct: 156 ISDGATMK-----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRL 203
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEV 265
P+ ++ ++ I +++ P +
Sbjct: 204 PFYN---QDHERLFELILMEEIRFPRTL 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 36/188 (19%), Positives = 60/188 (31%), Gaps = 37/188 (19%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVY----- 56
+ Y + R I SGS+G + VA+K +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 57 ---KILQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLG 112
++L H H I+ I + + Y LV +L+
Sbjct: 78 REIRLLN----------HFHHPNILGLRDIFVHFEEPAMHKL--Y--------LVTELMR 117
Query: 113 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QV 171
L + R S + + ++ + +H G +HRD+ P N L+ N +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDI 173
Query: 172 YIIDFGLA 179
I DF LA
Sbjct: 174 TICDFNLA 181
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 37/194 (19%), Positives = 66/194 (34%), Gaps = 43/194 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
L +++GSG FG + L + VAVK+ G+ EA+ L
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKL--------- 60
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRR 124
H P + K+YGV +V + + L + +
Sbjct: 61 ----SH-----------------PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK 99
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
+L + + + ++ S F+HRD+ N L+ + V + DFG+ + D
Sbjct: 100 GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLD 156
Query: 185 PTTNRH----IPYR 194
P +
Sbjct: 157 DQYVSSVGTKFPVK 170
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 44/185 (23%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
+LGR IG G FG++ S + VA+K + T L EA +
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF---- 73
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFV 120
DH P+I K GV ++++L L
Sbjct: 74 ---------DH-----------------PHIVKLIGVITENPVWIIMELCTLGELRSFLQ 107
Query: 121 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ L ++++ A Q ++ + Y+ S+ F+HRDI N L+ + V + DFGL+
Sbjct: 108 VRKYSLDLASLILYAYQ-LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS 163
Query: 180 KKYRD 184
+ D
Sbjct: 164 RYMED 168
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 48/206 (23%), Positives = 78/206 (37%), Gaps = 66/206 (32%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAK-VY---K 57
+ Y+ + +GSG++G + A T VA+K K Q AK Y +
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK------KLYRPFQSELFAKRAYRELR 76
Query: 58 ILQGGSKIRLVVFHVDHV-IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLE 116
+L+ H+ H +I L + P+ D D LV+ +G L
Sbjct: 77 LLK----------HMRHENVIGLLDVF-------TPDETL--DDFTDFYLVMPFMGTDLG 117
Query: 117 DL-------------FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163
L VY QM+ + Y+H+ G +HRD+KP N +
Sbjct: 118 KLMKHEKLGEDRIQFLVY---------------QMLKGLRYIHAAGIIHRDLKPGNLAV- 161
Query: 164 LGRKAN-QVYIIDFGLAKKYRDPTTN 188
+ ++ I+DFGLA++ T
Sbjct: 162 ---NEDCELKILDFGLARQADSEMTG 184
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 63/268 (23%), Positives = 100/268 (37%), Gaps = 68/268 (25%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
IG GSFG++ LA H AVK ++ KH ++ E V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH--IMSERNV------------ 91
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRR 124
++ +V H + L F + D + VLD + G +LF + +R
Sbjct: 92 LLKNVKHPFLVGLHFSFQT---------------ADKLYFVLDYINGG----ELFYHLQR 132
Query: 125 --KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK- 181
F A ++ + + Y+HS ++RD+KP+N L+ + + DFGL K+
Sbjct: 133 ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKEN 189
Query: 182 -YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSL 237
+ TT+ T GT Y + R D LG +LY L G
Sbjct: 190 IEHNSTTS-----------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLYGLP 237
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEV 265
P+ + YD I K + +
Sbjct: 238 PFYS---RNTAEMYDNILNKPLQLKPNI 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 26/245 (10%), Positives = 50/245 (20%), Gaps = 73/245 (29%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYK 57
RI +Y+L G + + A + VA+ + P L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE 116
+ + ++V + + G SL+
Sbjct: 87 RID----------KPGVARVLD-----------------VVHTRAGGLVVAEWIRGGSLQ 119
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
++ S + + A + H G P + V +
Sbjct: 120 EVA---DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYP 173
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236
+DD+ +G L L
Sbjct: 174 A----TMPDAN------------------------------PQDDIRGIGASLYALLVNR 199
Query: 237 LPWQG 241
P
Sbjct: 200 WPLPE 204
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 33/179 (18%), Positives = 69/179 (38%), Gaps = 51/179 (28%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKIRLVVF 70
+IG G++G + H + +I+AVK + QLL + + +V+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD------------LDVVMR 76
Query: 71 HVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
D P I ++YG D + ++L+ S + + +
Sbjct: 77 SSDC-----------------PYIVQFYGALFREGDCWICMELMSTSFDKFY----KYVY 115
Query: 128 LKTVLMLADQMIARI--------EYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
++ ++++ +I ++ +HRDIKP N L+ ++ + + DFG
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 43/183 (23%), Positives = 67/183 (36%), Gaps = 47/183 (25%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + E VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV--- 74
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDL 118
D+ P++ + G+ V L+ L G L D
Sbjct: 75 ----------DN-----------------PHVCRLLGICLTSTVQLITQLMPFG-CLLDY 106
Query: 119 FVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
+ + +L Q IA+ + Y+ R +HRD+ N L+ V I DFG
Sbjct: 107 VREHKDNIGSQYLLNWCVQ-IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFG 162
Query: 178 LAK 180
LAK
Sbjct: 163 LAK 165
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 55/318 (17%), Positives = 108/318 (33%), Gaps = 64/318 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKI 65
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH-------- 86
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVY 121
+ P I +YG + + ++ + G SL+ +
Sbjct: 87 -----ECNS-----------------PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGF-LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
R + + ++ +I + Y+ + +HRD+KP N L+ ++ + DFG++
Sbjct: 125 AGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 180
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+ D N + GT Y S G S + D+ S+G L+ G P
Sbjct: 181 QLIDSMANSFV---------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTF--------DQRPDY 292
A + + E + + ++ P
Sbjct: 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-- 289
Query: 293 GFLKRLFHDLFSREGYDF 310
+L +FS E DF
Sbjct: 290 ---PKLPSGVFSLEFQDF 304
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 37/183 (20%), Positives = 73/183 (39%), Gaps = 52/183 (28%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSKIRLVVF 70
++G G++G + HV + +I+AVK + + +LL + + + +
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD------------LDISMR 61
Query: 71 HVDHVIIHALTIIFSSTLGGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
VD P +YG D + ++L+ SL+ + K
Sbjct: 62 TVDC-----------------PFTVTFYGALFREGDVWICMELMDTSLDKFY-----KQV 99
Query: 128 LKTVLMLADQMIARI--------EYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ + + ++ +I E++HS +HRD+KP N L+ QV + DFG+
Sbjct: 100 IDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGI 156
Query: 179 AKK 181
+
Sbjct: 157 SGY 159
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 47/196 (23%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
KL ++G+G FGE+++ + + VAVK G+ P L EA + K L
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL--------- 65
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCR--- 123
H + + Y V E ++ + + L + +
Sbjct: 66 ----QH-----------------QRLVRLYAVVTQEPIYIITEYM--ENGSLVDFLKTPS 102
Query: 124 -RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
K ++ +L +A Q+ + ++ R ++HRD++ N L+ I DFGLA+
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLI 159
Query: 183 RDPTTNRH----IPYR 194
D P +
Sbjct: 160 EDNEYTAREGAKFPIK 175
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 70/311 (22%), Positives = 118/311 (37%), Gaps = 69/311 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL--------- 236
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRK 125
H + + Y V E+ + +V + + SL D K
Sbjct: 237 ----RH-----------------EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGK 275
Query: 126 FSLKTVLMLADQMIARI----EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ L+ M A+I YV ++HRD++ N L+G + + DFGLA+
Sbjct: 276 YLRLPQLV---DMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL 329
Query: 182 YRD----PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRG 235
D P + TA A+ + + D+ S G +LL +G
Sbjct: 330 IEDNEYTARQGAKFPIK------WTAPEAALYGRF----TIKSDVWSFG-ILLTELTTKG 378
Query: 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295
+P+ G+ ++ D++ E+ P C P C ++RP + +L
Sbjct: 379 RVPYPGM---VNREVLDQV-ERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYL 431
Query: 296 KRLFHDLFSRE 306
+ D F+
Sbjct: 432 QAFLEDYFTST 442
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 38/201 (18%), Positives = 68/201 (33%), Gaps = 56/201 (27%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLA-SHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
++ +Y++ +G G+FG++ H VAVK ++N E +V + L
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 62 GSK------IRLV--VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP 113
++++ H H+ I V +LLG
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICI-----------------------------VFELLGL 101
Query: 114 SLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---------- 162
S D F L + +A Q+ + ++HS H D+KP+N L
Sbjct: 102 STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161
Query: 163 ------GLGRKANQVYIIDFG 177
+ ++DFG
Sbjct: 162 PKIKRDERTLINPDIKVVDFG 182
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 70/311 (22%), Positives = 118/311 (37%), Gaps = 69/311 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL--------- 319
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRK 125
H + + Y V E+ + +V + + SL D K
Sbjct: 320 ----RH-----------------EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGK 358
Query: 126 FSLKTVLMLADQMIARI----EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ L+ M A+I YV ++HRD++ N L+G + + DFGLA+
Sbjct: 359 YLRLPQLV---DMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL 412
Query: 182 YRD----PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRG 235
D P + TA A+ + + D+ S G +LL +G
Sbjct: 413 IEDNEYTARQGAKFPIK------WTAPEAALYGRF----TIKSDVWSFG-ILLTELTTKG 461
Query: 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295
+P+ G+ ++ D++ E+ P C P C ++RP + +L
Sbjct: 462 RVPYPGM---VNREVLDQV-ERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYL 514
Query: 296 KRLFHDLFSRE 306
+ D F+
Sbjct: 515 QAFLEDYFTST 525
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 35/186 (18%), Positives = 68/186 (36%), Gaps = 44/186 (23%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+ IG+G FGE++ S VA+K +G Q L EA +
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF--- 103
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDL 118
H NI + GV + +++ + + +L+
Sbjct: 104 ----------SH-----------------HNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 119 FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+FS+ ++ + + A ++Y+ + ++HRD+ N L+ + DFGL
Sbjct: 137 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGL 193
Query: 179 AKKYRD 184
++ D
Sbjct: 194 SRVLED 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 39/185 (21%), Positives = 68/185 (36%), Gaps = 43/185 (23%)
Query: 10 KLGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + IGSG GE+ + VA+K +G Q L EA +
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF---- 107
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF 119
DH PNI + GV G ++V + + SL+
Sbjct: 108 ---------DH-----------------PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+F++ ++ + + A + Y+ G++HRD+ N L+ + DFGL+
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLS 198
Query: 180 KKYRD 184
+ D
Sbjct: 199 RVLED 203
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 40/181 (22%), Positives = 68/181 (37%), Gaps = 44/181 (24%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
L R +G G FGE++ + + VAVK + EA + K L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL---- 70
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFV 120
DH P+I K G+ + E ++++L L
Sbjct: 71 ---------DH-----------------PHIVKLIGIIEEEPTWIIMELYPYGELGHYLE 104
Query: 121 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ + T+++ + Q I + + Y+ S +HRDI N L+ V + DFGL+
Sbjct: 105 RNKNSLKVLTLVLYSLQ-ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS 160
Query: 180 K 180
+
Sbjct: 161 R 161
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 45/198 (22%), Positives = 77/198 (38%), Gaps = 46/198 (23%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+LGR IG G FG++ ++ VA+K + T L EA +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR------ 446
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFV 120
DH P+I K GV E+ V ++++L L
Sbjct: 447 -------QFDH-----------------PHIVKLIGVITENPVWIIMELCTLGELRSFLQ 482
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ L ++++ A Q+ + Y+ S+ F+HRDI N L+ + V + DFGL++
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR 539
Query: 181 KYRD----PTTNRHIPYR 194
D + +P +
Sbjct: 540 YMEDSTYYKASKGKLPIK 557
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 53/267 (19%), Positives = 98/267 (36%), Gaps = 66/267 (24%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+G G+FG++ L T A+K + H L E
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH--TLTE-------------NR 200
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRR 124
V+ + H + AL F + D + V++ G +LF + R
Sbjct: 201 VLQNSRHPFLTALKYSFQT---------------HDRLCFVMEYANGG----ELFFHLSR 241
Query: 125 --KFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
FS ++++ ++Y+HS + ++RD+K +N ++ K + I DFGL K+
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKE 298
Query: 182 --YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLP 238
T GT Y + + R D LG V++Y + G LP
Sbjct: 299 GIKDGATMK---------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLP 348
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEV 265
+ ++ ++ I +++ P +
Sbjct: 349 FYN---QDHEKLFELILMEEIRFPRTL 372
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 38/185 (20%), Positives = 69/185 (37%), Gaps = 43/185 (23%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + +G+G FGE+ EI VA+K G Q L EA +
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF---- 103
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF 119
DH PNI + GV + ++V + + SL+
Sbjct: 104 ---------DH-----------------PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+F++ ++ + + + ++Y+ G++HRD+ N L+ + DFGL
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLG 194
Query: 180 KKYRD 184
+ D
Sbjct: 195 RVLED 199
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 45/180 (25%)
Query: 11 LGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKHPQL----LYEAKVYKILQGGSK 64
+++GSG+FG + + + VAVKI + P L L EA V + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL----- 75
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFV 120
D+ P I + G+ + E +LV+++ LG L ++
Sbjct: 76 --------DN-----------------PYIVRMIGICEAESWMLVMEMAELG-PLNK-YL 108
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
R K ++ L Q+ ++Y+ F+HRD+ N L+ + I DFGL+K
Sbjct: 109 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 46/184 (25%), Positives = 67/184 (36%), Gaps = 48/184 (26%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQG 61
+L K+G GSFG + + VAVK + E L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-- 78
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDL--LGPSLED 117
DH N+ + YGV + +V +L LG SL D
Sbjct: 79 -----------DH-----------------RNLIRLYGVVLTPPMKMVTELAPLG-SLLD 109
Query: 118 LFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
+ F L T+ A Q +A + Y+ S+ F+HRD+ N L+ + V I DF
Sbjct: 110 RLRKHQGHFLLGTLSRYAVQ-VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDF 165
Query: 177 GLAK 180
GL +
Sbjct: 166 GLMR 169
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 44/210 (20%), Positives = 75/210 (35%), Gaps = 65/210 (30%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF---- 83
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLE---- 116
H PN+ G+ E + LV+ L
Sbjct: 84 ---------SH-----------------PNVLSLLGICLRSEGSPLVV------LPYMKH 111
Query: 117 -DLFVYCR---RKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
DL + R ++K ++ Q +A+ ++Y+ S+ F+HRD+ N ++ + V
Sbjct: 112 GDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVHRDLAARNCMLD---EKFTV 167
Query: 172 YIIDFGLAKK------YR-DPTTNRHIPYR 194
+ DFGLA+ Y T +P +
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 40/189 (21%), Positives = 72/189 (38%), Gaps = 58/189 (30%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
R IG G FG ++ ++D + A+K + + + L E + + L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL---- 79
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLE---- 116
+H PN+ G+ E VL L
Sbjct: 80 ---------NH-----------------PNVLALIGIMLPPEGLPHVL------LPYMCH 107
Query: 117 -DLFVY---CRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
DL + +R ++K ++ Q +AR +EY+ + F+HRD+ N ++ ++ V
Sbjct: 108 GDLLQFIRSPQRNPTVKDLISFGLQ-VARGMEYLAEQKFVHRDLAARNCMLD---ESFTV 163
Query: 172 YIIDFGLAK 180
+ DFGLA+
Sbjct: 164 KVADFGLAR 172
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 43/221 (19%), Positives = 75/221 (33%), Gaps = 70/221 (31%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
G+ +G+G+FG++ A D VAVK+ ++ + L+ E KV L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG- 84
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL- 111
+H NI G G +++ DLL
Sbjct: 85 -----------NH-----------------MNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 112 -----------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDN 159
+ + L+ +L + Q +A+ + ++ S+ +HRD+ N
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAARN 175
Query: 160 FLMGLGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
L+ I DFGLA+ Y N +P +
Sbjct: 176 ILLT---HGRITKICDFGLARDIKNDSNYV-VKGNARLPVK 212
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 44/208 (21%), Positives = 72/208 (34%), Gaps = 53/208 (25%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-- 90
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLED 117
+H NI + GV ++++L+ G L+
Sbjct: 91 -----------NH-----------------QNIVRCIGVSLQSLPRFILMELMAGGDLKS 122
Query: 118 LFVYCRRKFSLKTVLMLADQM-----IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
R + S + L + D + IA +Y+ F+HRDI N L+
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182
Query: 172 YIIDFGLAKK-----YRDPTTNRHIPYR 194
I DFG+A+ Y +P +
Sbjct: 183 KIGDFGMARDIYRASYYRKGGCAMLPVK 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 43/194 (22%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIRLV 68
KL +K+G+G FGE+++A++ + VAVK G+ + L EA V K L
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTL--------- 240
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPN-IKWYGVDGEDNVLVLDLLGP--SLED-LFVYCRR 124
H +K + V ++ + ++ SL D L
Sbjct: 241 ----QH-----------------DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS 279
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
K L ++ + Q+ + ++ R ++HRD++ N L+ + I DFGLA+ D
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIED 336
Query: 185 PTTNRH----IPYR 194
P +
Sbjct: 337 NEYTAREGAKFPIK 350
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 28/195 (14%), Positives = 62/195 (31%), Gaps = 52/195 (26%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI-------VAVKIENSGTKHPQ--LLYEAKVYKILQ 60
+G G+F +IF + + V +K+ + ++ A + L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLED 117
H ++ YGV G++N+LV + +
Sbjct: 70 ------------SH-----------------KHLVLNYGVCVCGDENILVQEFV--KFGS 98
Query: 118 LFVYCRR---KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL-----MGLGRKAN 169
L Y ++ ++ L +A Q+ A + ++ +H ++ N L
Sbjct: 99 LDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158
Query: 170 QVYIIDFGLAKKYRD 184
+ + D G++
Sbjct: 159 FIKLSDPGISITVLP 173
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 41/203 (20%), Positives = 70/203 (34%), Gaps = 61/203 (30%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK------ 145
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLE---- 116
H PN+ G+ E + LV+ L
Sbjct: 146 -------DFSH-----------------PNVLSLLGICLRSEGSPLVV------LPYMKH 175
Query: 117 -DLFVY---CRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
DL + ++K ++ Q +A+ ++++ S+ F+HRD+ N ++ + V
Sbjct: 176 GDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVHRDLAARNCMLD---EKFTV 231
Query: 172 YIIDFGLAKKYRDPTTNRHIPYR 194
+ DFGLA RD
Sbjct: 232 KVADFGLA---RDMYDKEFDSVH 251
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 64/202 (31%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L R++G G+FG++FLA + + +VAVK T + EA++ L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL--- 74
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL-- 111
H +I K+YGV DG+ ++V DL
Sbjct: 75 ----------QH-----------------EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 107
Query: 112 --------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLM 162
++ + + L +L +A Q IA + Y+ S+ F+HRD+ N L+
Sbjct: 108 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ-IASGMVYLASQHFVHRDLATRNCLV 166
Query: 163 GLGRKANQVYIIDFGLAKKYRD 184
G V I DFG++ RD
Sbjct: 167 G---ANLLVKIGDFGMS---RD 182
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 39/180 (21%), Positives = 73/180 (40%), Gaps = 42/180 (23%)
Query: 10 KLGR-KIGSGSFGEIFLAS-HVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
+ ++G G+FG + + +I VA+K+ + + + ++ EA++ L
Sbjct: 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL---- 67
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFV 120
D+ P I + GV E +LV+++ G L V
Sbjct: 68 ---------DN-----------------PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV 101
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
R + + V L Q+ ++Y+ + F+HRD+ N L+ + I DFGL+K
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 39/178 (21%), Positives = 72/178 (40%), Gaps = 41/178 (23%)
Query: 11 LGRKIGSGSFGEIFLAS-HVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGSKI 65
++G G+FG + + +I VA+K+ GT+ ++ EA++
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH-------- 391
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYC 122
+D+ P I + GV E +LV+++ G L V
Sbjct: 392 -----QLDN-----------------PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK 429
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
R + + V L Q+ ++Y+ + F+HR++ N L+ + I DFGL+K
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 47/217 (21%), Positives = 78/217 (35%), Gaps = 67/217 (30%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L ++G G+FG++FLA +VAVK ++ + EA++ +L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML--- 100
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL-- 111
H +I +++GV +G ++V DL
Sbjct: 101 ----------QH-----------------QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133
Query: 112 -------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMG 163
L L +L +A Q +A + Y+ F+HRD+ N L+G
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ-VAAGMVYLAGLHFVHRDLATRNCLVG 192
Query: 164 LGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
G V I DFG+++ YR +P R
Sbjct: 193 QGL---VVKIGDFGMSRDIYSTDYYR-VGGRTMLPIR 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 45/213 (21%), Positives = 72/213 (33%), Gaps = 63/213 (29%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-- 131
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL--GPSLE 116
+H NI + GV ++L+L+ G
Sbjct: 132 -----------NH-----------------QNIVRCIGVSLQSLPRFILLELMAGG---- 159
Query: 117 DLFVYCRR---------KFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGR 166
DL + R ++ +L +A IA +Y+ F+HRDI N L+
Sbjct: 160 DLKSFLRETRPRPSQPSSLAMLDLLHVARD-IACGCQYLEENHFIHRDIAARNCLLTCPG 218
Query: 167 KANQVYIIDFGLAKK-----YRDPTTNRHIPYR 194
I DFG+A+ Y +P +
Sbjct: 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 25/156 (16%)
Query: 117 DLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DL + KF L A ++I ++++HS+G ++RD+K DN L+ K + I
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIA 160
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
DFG+ K+ D TN T GT Y + LG + + D S G VLL
Sbjct: 161 DFGMCKENMLGDAKTN-----------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLL 208
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 265
Y L G P+ G +++ + I P +
Sbjct: 209 YEMLIGQSPFHG---QDEEELFHSIRMDNPFYPRWL 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 25/156 (16%)
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DL + ++ +F + A ++ + ++ S+G ++RD+K DN ++ + I
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIA 484
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
DFG+ K+ + TT T GT Y + + D + G VLL
Sbjct: 485 DFGMCKENIWDGVTTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLL 532
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 265
Y L G P++G + + + I E V+ P +
Sbjct: 533 YEMLAGQAPFEG---EDEDELFQSIMEHNVAYPKSM 565
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DL + ++ +F + A ++ + ++ S+G ++RD+K DN ++ + I
Sbjct: 107 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIA 163
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
DFG+ K+ + TT T GT Y + + D + G VLL
Sbjct: 164 DFGMCKENIWDGVTTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLL 211
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
Y L G P++G + + + I E V+ P
Sbjct: 212 YEMLAGQAPFEG---EDEDELFQSIMEHNVAYP 241
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 25/156 (16%)
Query: 117 DLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DL + R+F A ++I+ + ++H +G ++RD+K DN L+ +
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLA 166
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
DFG+ K+ TT T GT Y + + D ++G VLL
Sbjct: 167 DFGMCKEGICNGVTTA-----------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLL 214
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 265
Y L G P++ + ++ I +V P +
Sbjct: 215 YEMLCGHAPFEA---ENEDDLFEAILNDEVVYPTWL 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 42/213 (19%), Positives = 63/213 (29%), Gaps = 62/213 (29%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSK 64
K IG G+FG++ A A+K E +V L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG---- 83
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL---- 111
H PNI G L + +LL
Sbjct: 84 --------HH-----------------PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
Query: 112 ------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGL 164
+ S + +L A +AR ++Y+ + F+HRD+ N L+G
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAAD-VARGMDYLSQKQFIHRDLAARNILVGE 177
Query: 165 GRKANQVYIIDFGLAKK---YRDPTTNRHIPYR 194
I DFGL++ Y T +P R
Sbjct: 178 N---YVAKIADFGLSRGQEVYV-KKTMGRLPVR 206
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 44/216 (20%), Positives = 77/216 (35%), Gaps = 64/216 (29%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +G+G+FG++ A+ + VAVK+ S + L+ E K+ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG- 107
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL- 111
H NI G G +++ DLL
Sbjct: 108 -----------QH-----------------ENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 112 -------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMG 163
+ F S + +L + Q +A+ + ++ S+ +HRD+ N L+
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ-VAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 164 LGRKANQVYIIDFGLAKK-YRDP----TTNRHIPYR 194
G + I DFGLA+ D N +P +
Sbjct: 199 NG---HVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 42/215 (19%), Positives = 77/215 (35%), Gaps = 67/215 (31%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R++G GSFG ++ + VA+K N + L EA V K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK---- 83
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL- 111
+ ++ + GV G+ ++++ DL
Sbjct: 84 ---------EFNC-----------------HHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 112 -----GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLG 165
P++ + V SL ++ +A + IA + Y+++ F+HRD+ N ++
Sbjct: 118 YLRSLRPAMANNPV--LAPPSLSKMIQMAGE-IADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 166 RKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
V I DFG+ + YR +P R
Sbjct: 175 FT---VKIGDFGMTRDIYETDYYR-KGGKGLLPVR 205
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 70/221 (31%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ +A VAVK+ L+ E ++ K++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DL 110
H NI G +++ +L
Sbjct: 98 G------------KH-----------------KNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 111 L----------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDN 159
D+ + + K ++ Q +AR +EY+ S+ +HRD+ N
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARN 187
Query: 160 FLMGLGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
L+ + I DFGLA+ Y+ TTN +P +
Sbjct: 188 VLVTENNV---MKIADFGLARDINNIDYYK-KTTNGRLPVK 224
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 25/153 (16%)
Query: 117 DLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DLF + F+ + V ++ ++++HS G ++RD+KP+N L+ + + +
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLT 168
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
DFGL+K+ + + GT Y + ++ D S G VL+
Sbjct: 169 DFGLSKESIDHEKKAY-----------SFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLM 216
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 262
+ L G+LP+QG +K+ I + K+ P
Sbjct: 217 FEMLTGTLPFQG---KDRKETMTMILKAKLGMP 246
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 35/203 (17%), Positives = 61/203 (30%), Gaps = 65/203 (32%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ ++G FG+++ + + + VA+K + P +EA + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-- 69
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL- 111
H PN+ GV + ++ DL
Sbjct: 70 -----------QH-----------------PNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 101
Query: 112 ---------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFL 161
D + + L Q IA +EY+ S +H+D+ N L
Sbjct: 102 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ-IAAGMEYLSSHHVVHKDLATRNVL 160
Query: 162 MGLGRKANQVYIIDFGLAKKYRD 184
+ V I D GL R+
Sbjct: 161 VY---DKLNVKISDLGLF---RE 177
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 36/162 (22%), Positives = 69/162 (42%), Gaps = 28/162 (17%)
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DL + +R K + + ++ + Y+H RG ++RD+K DN L+ + +
Sbjct: 96 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLT 152
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
D+G+ K+ TT+ T GT Y + G + D +LG VL+
Sbjct: 153 DYGMCKEGLRPGDTTS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLM 200
Query: 231 Y-FLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEV 265
+ + G P+ + ++ T+ + I EK++ P +
Sbjct: 201 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 46/221 (20%), Positives = 78/221 (35%), Gaps = 70/221 (31%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ LA + VAVK+ S L+ E ++ K++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DL 110
H NI G +++ +L
Sbjct: 132 G------------KH-----------------KNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 111 L----------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDN 159
+ + S K ++ A Q +AR +EY+ S+ +HRD+ N
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ-VARGMEYLASKKCIHRDLAARN 221
Query: 160 FLMGLGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
L+ + I DFGLA+ Y+ TTN +P +
Sbjct: 222 VLVTEDNV---MKIADFGLARDIHHIDYYK-KTTNGRLPVK 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
+LF+ R F T ++ + ++H +G ++RD+KP+N ++ V +
Sbjct: 107 ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLT 163
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
DFGL K+ + T+ T GT Y + + +R D SLG L+
Sbjct: 164 DFGLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALM 211
Query: 231 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 265
Y L G+ P+ G +K+ DKI + K++ P +
Sbjct: 212 YDMLTGAPPFTG---ENRKKTIDKILKCKLNLPPYL 244
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 36/162 (22%), Positives = 69/162 (42%), Gaps = 28/162 (17%)
Query: 117 DLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 174
DL + +R K + + ++ + Y+H RG ++RD+K DN L+ + +
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLT 195
Query: 175 DFGLAKK--YRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLL 230
D+G+ K+ TT+ T GT Y + G + D +LG VL+
Sbjct: 196 DYGMCKEGLRPGDTTS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLM 243
Query: 231 Y-FLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEV 265
+ + G P+ + ++ T+ + I EK++ P +
Sbjct: 244 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 45/220 (20%), Positives = 79/220 (35%), Gaps = 69/220 (31%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
KLG+ +G G+FG++ A T VAVK+ G H + L+ E K+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG- 88
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL-------DLL 111
H N+ G ++V+ +L
Sbjct: 89 -----------HH-----------------LNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 112 ----------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNF 160
P + +L+ ++ + Q +A+ +E++ SR +HRD+ N
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ-VAKGMEFLASRKCIHRDLAARNI 179
Query: 161 LMGLGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
L+ + N V I DFGLA+ Y + +P +
Sbjct: 180 LLS---EKNVVKICDFGLARDIYKDPDYV-RKGDARLPLK 215
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 50/201 (24%), Positives = 74/201 (36%), Gaps = 39/201 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LG+ +G G FG + + + VAVK + L EA K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 63 SKIRL--VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
+ IRL V + I +I G ++ Y LL LE
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYG--DLHTY------------LLYSRLET--- 139
Query: 121 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
+ L+T+L IA +EY+ +R FLHRD+ N ++ V + DFGL+
Sbjct: 140 -GPKHIPLQTLLKFMVD-IALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLS 194
Query: 180 KK------YRDPTTNRHIPYR 194
KK YR +P +
Sbjct: 195 KKIYSGDYYRQ-GRIAKMPVK 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 43/221 (19%), Positives = 75/221 (33%), Gaps = 70/221 (31%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G FG++ +A VAVK+ L+ E ++ K++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DL 110
H NI G +++ +L
Sbjct: 144 G------------KH-----------------KNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 111 L----------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDN 159
D+ + + K ++ Q +AR +EY+ S+ +HRD+ N
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARN 233
Query: 160 FLMGLGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
L+ + I DFGLA+ Y+ TTN +P +
Sbjct: 234 VLVTENNV---MKIADFGLARDINNIDYYK-KTTNGRLPVK 270
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 117 DLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQV 171
+LF + R +F+ V + +++ +E++H G ++RDIK +N L+ G V
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HV 198
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQ--SRRDDLESLGY 227
+ DFGL+K + + GT Y + + G + + D SLG
Sbjct: 199 VLTDFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG- 249
Query: 228 VLLY-FLRGSLPWQGL-KAATKKQKYDKICEKKVSTPIEV 265
VL+Y L G+ P+ + ++ + +I + + P E+
Sbjct: 250 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 47/218 (21%), Positives = 72/218 (33%), Gaps = 72/218 (33%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LGR +G G FG + A + VAVK+ + L EA K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF--- 82
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-------- 111
DH P++ K GV + +
Sbjct: 83 ----------DH-----------------PHVAKLVGVSLRSRAKGRLPIPMVILPFMKH 115
Query: 112 GPSLEDLFVYCR--------RKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLM 162
G DL + L+T++ IA +EY+ SR F+HRD+ N ++
Sbjct: 116 G----DLHAFLLASRIGENPFNLPLQTLVRFMVD-IACGMEYLSSRNFIHRDLAARNCML 170
Query: 163 GLGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
+ V + DFGL++K YR +P +
Sbjct: 171 A---EDMTVCVADFGLSRKIYSGDYYR-QGCASKLPVK 204
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 52/333 (15%), Positives = 99/333 (29%), Gaps = 126/333 (37%)
Query: 28 HVDT---NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVD-HVIIHALTII 83
HV+ I+ + + +++ L VF H+ L++I
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDR-------------LSVFPPSAHIPTILLSLI 395
Query: 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 143
W+ V D ++V++ L K+SL + Q
Sbjct: 396 ------------WFDVIKSDVMVVVNKL------------HKYSL-----VEKQPKESTI 426
Query: 144 YVHSRGFLHRDI--KPDNFLMGLGRKANQVYIID-FGLAKKY--RDPTTNR-------HI 191
+ S ++ ++ K +N L R I+D + + K + D HI
Sbjct: 427 SIPS---IYLELKVKLEN-EYALHRS-----IVDHYNIPKTFDSDDLIPPYLDQYFYSHI 477
Query: 192 PYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 250
+ HL IE R L + ++ FL +K +
Sbjct: 478 GH-----------------HLKNIEHPERMTLFRMVFLDFRFLE------------QKIR 508
Query: 251 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY--------GFLKRLFHDL 302
+D + + L + Y Y D P Y FL ++ +L
Sbjct: 509 HDSTAWNASGSILNTL-----QQLKFYKPY----ICDNDPKYERLVNAILDFLPKIEENL 559
Query: 303 FSREGYDF---------DFVFDWTILKYQQTQK 326
+ D + +F+ ++Q Q+
Sbjct: 560 ICSKYTDLLRIALMAEDEAIFEEA---HKQVQR 589
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 49/239 (20%), Positives = 85/239 (35%), Gaps = 57/239 (23%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-- 59
KLG+ +G G+FG++ A T VAVK+ G H L+ E K+ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 60 ------------QGGSKIRLVVFHV------DHVIIHALTIIFSSTLGGI--PNIKWYGV 99
+ G + ++V ++ + T G + G
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 100 DGEDNVLVLDLLGPS-------------------LEDLFVYCRRKFSLKTVLMLADQMIA 140
D LD + S E + +L+ ++ + Q+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 141 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDP----TTNRHIPYR 194
+E++ SR +HRD+ N L+ V I DFGLA+ Y+DP + +P +
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRKGDARLPLK 260
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 44/215 (20%), Positives = 73/215 (33%), Gaps = 53/215 (24%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
LG+ +G G FG++ A VAVK+ + LL E V K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 62 GSKIRL--VVFHVDHVIIHALTIIF-------------SSTLGGIPNIKWYGVDGEDNVL 106
I+L L +I S G + G ++
Sbjct: 86 PHVIKLYGACSQDGP-----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 107 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLG 165
D ++ DL + A Q I++ ++Y+ +HRD+ N L+ G
Sbjct: 141 HPDERALTMGDL-------------ISFAWQ-ISQGMQYLAEMKLVHRDLAARNILVAEG 186
Query: 166 RKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
++ I DFGL++ Y + IP +
Sbjct: 187 ---RKMKISDFGLSRDVYEEDSYV-KRSQGRIPVK 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 43/204 (21%), Positives = 73/204 (35%), Gaps = 31/204 (15%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R IG G+FG +F A + +VAVK+ EA +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 62 GSKIRL--VVFHVDHVIIHALTIIFSSTLGGIPNIKWY--GVDGEDNVLVLDLLGPSLED 117
+ ++L V + ++F G ++ + + + +
Sbjct: 110 PNIVKLLGVCAVGKPMC-----LLFEYMAYG--DLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 118 LFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 176
+ S L +A Q +A + Y+ R F+HRD+ N L+G V I DF
Sbjct: 163 VSSPGPPPLSCAEQLCIARQ-VAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADF 218
Query: 177 GLAKK------YRDPTTNRHIPYR 194
GL++ Y+ N IP R
Sbjct: 219 GLSRNIYSADYYK-ADGNDAIPIR 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 44/226 (19%), Positives = 71/226 (31%), Gaps = 75/226 (33%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +GSG+FG++ A S + VAVK+ + L+ E K+ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG- 106
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVL------DLL- 111
H NI G L+ DLL
Sbjct: 107 -----------SH-----------------ENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 112 ----------------GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRD 154
+ + +L A Q +A+ +E++ + +HRD
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ-VAKGMEFLEFKSCVHRD 197
Query: 155 IKPDNFLMGLGRKANQVYIIDFGLAKK------YRDPTTNRHIPYR 194
+ N L+ V I DFGLA+ Y N +P +
Sbjct: 198 LAARNVLVT---HGKVVKICDFGLARDIMSDSNYV-VRGNARLPVK 239
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 15/92 (16%)
Query: 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 148
GIP + VD ++ +++ + G +D+ + +++ ++ H
Sbjct: 400 GIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE------DNLDIAYKIGEIVGKL---HKN 450
Query: 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+H D+ NF+ +YIIDFGL K
Sbjct: 451 DVIHNDLTTSNFIFD-----KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 449 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.8 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.76 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.29 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.66 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=447.71 Aligned_cols=299 Identities=78% Similarity=1.329 Sum_probs=273.3
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
|+.+++++|+++++||+|+||.||+|++..+++.||||++........+.+|+++++.|++.+
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~----------------- 63 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT----------------- 63 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTST-----------------
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCC-----------------
Confidence 788999999999999999999999999999999999999888777778999999999999876
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+++.+.+++...+..||||||++++|.+++..+...+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 64 ---------~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 134 (483)
T 3sv0_A 64 ---------GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134 (483)
T ss_dssp ---------TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ---------CCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceE
Confidence 56667778888899999999999999999998888999999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
||+.++..+.+||+|||+++.+.........+++......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 135 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99655578899999999999988877767777777888999999999999999999999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccc
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
+.......+.+..+.........+.++.++|.++.+++..||..+|.+||++.+|.+.|++++...++.++..+||..++
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~ 294 (483)
T 3sv0_A 215 GLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILK 294 (483)
T ss_dssp SCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHT
T ss_pred cccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhc
Confidence 98877777888888888888888999999999999999999999999999999999999999999999999999999887
Q ss_pred ccccc
Q 013125 321 YQQTQ 325 (449)
Q Consensus 321 ~~~~~ 325 (449)
....+
T Consensus 295 ~~~~~ 299 (483)
T 3sv0_A 295 YQQSQ 299 (483)
T ss_dssp C----
T ss_pred ccccc
Confidence 66543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=418.98 Aligned_cols=267 Identities=22% Similarity=0.329 Sum_probs=220.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.++|++++.||+|+||+||+|++..+++.||||++... .....+.+|+++++.|+|+++++++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~------------ 98 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY------------ 98 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE------------
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEE------------
Confidence 36799999999999999999999999999999998642 3345689999999999998766554
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.++.+.+..||||||| ||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 99 ---------------~~~~~~~~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeN 162 (311)
T 4aw0_A 99 ---------------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162 (311)
T ss_dssp ---------------EEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ---------------EEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 3446778899999999 8999999986 4579999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ +.++.+||+|||+|+.+....... ...+.+||+.|||||++.+..|+.++||||+||++|||++|++||
T Consensus 163 ILl---~~~g~vKl~DFGla~~~~~~~~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 234 (311)
T 4aw0_A 163 ILL---NEDMHIQITDFGTAKVLSPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234 (311)
T ss_dssp EEE---CTTSCEEECCCTTCEECCTTTTCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eEE---cCCCCEEEEEcCCceecCCCCCcc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999 478999999999999875433211 134779999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCcccccccc
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 319 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 319 (449)
.+.+. .+.+..|.......| ..+++++++|+..||..||.+||+++++... .. + ..+.|...+||..+
T Consensus 235 ~~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~-i--~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 235 RAGNE---GLIFAKIIKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GP-L--KAHPFFESVTWENL 302 (311)
T ss_dssp CCSSH---HHHHHHHHHTCCCCC-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HH-H--HTSGGGTTCCCTTG
T ss_pred CCCCH---HHHHHHHHcCCCCCC-----cccCHHHHHHHHHHccCCHhHCcChHHHcCC-HH-H--HCCCCcCCCCHHHh
Confidence 87543 355666666665554 3568899999999999999999998875321 11 1 12455556778655
Q ss_pred c
Q 013125 320 K 320 (449)
Q Consensus 320 ~ 320 (449)
.
T Consensus 303 ~ 303 (311)
T 4aw0_A 303 H 303 (311)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=418.37 Aligned_cols=259 Identities=22% Similarity=0.214 Sum_probs=211.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
+.|++.++||+|+||+||+|++..+++.||||+++.... ..+|+++++.|+|++++.++.
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~----------------- 117 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYG----------------- 117 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEE-----------------
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEE-----------------
Confidence 569999999999999999999999999999999875432 357999999999987666544
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
++.+.+..||||||| |++|.++++. .+.+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 118 ----------~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-- 184 (336)
T 4g3f_A 118 ----------AVREGPWVNIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS-- 184 (336)
T ss_dssp ----------EEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC--
T ss_pred ----------EEEECCEEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe--
Confidence 445678899999999 8999999986 45799999999999999999999999999999999999994
Q ss_pred CCCC-eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChh
Q 013125 166 RKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244 (449)
Q Consensus 166 ~~~~-~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~ 244 (449)
.++ .+||+|||+|+.......... .......+||+.|||||++.+..|+.++|||||||++|||++|++||.+...
T Consensus 185 -~~g~~vKl~DFGla~~~~~~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 185 -SDGSRAALCDFGHALCLQPDGLGKS--LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp -TTSCCEEECCCTTCEEC--------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred -CCCCEEEEeeCCCCeEccCCCcccc--eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 454 699999999987654322111 0112456899999999999999999999999999999999999999987654
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
... +..+... ..+...+...+++++.+++..||..||.+||++.+|.+.|..++...
T Consensus 262 ~~~---~~~i~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 262 GPL---CLKIASE--PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp SCC---HHHHHHS--CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH---HHHHHcC--CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 432 2333332 23344556678999999999999999999999999998887776543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=418.44 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=207.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|+++++||+|+||+||+|++..+|+.||||+++.. .....+.+|+++++.|+|+|++.++.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~--------------- 138 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--------------- 138 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEE---------------
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEE---------------
Confidence 5799999999999999999999999999999998643 33456899999999999998766544
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++.+.+..||||||| ||+|.+++.. ..+++.+++.++.||+.||+|||++|||||||||+|||+
T Consensus 139 ------------~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl- 203 (346)
T 4fih_A 139 ------------SYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL- 203 (346)
T ss_dssp ------------EEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-
T ss_pred ------------EEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE-
Confidence 345678899999999 8899998874 569999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
+.++.+||+|||+|+.+...... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+..
T Consensus 204 --~~~g~vKl~DFGla~~~~~~~~~-------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 204 --THDGRVKLSDFGFCAQVSKEVPR-------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp --CTTCCEEECCCTTCEECCSSSCC-------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --CCCCCEEEecCcCceecCCCCCc-------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 47899999999999877544321 247799999999999999999999999999999999999999998755
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.. +.+..+.... . +....+..+++++.+|+..||..||.+||++.++.
T Consensus 275 ~~---~~~~~i~~~~-~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 275 PL---KAMKMIRDNL-P-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp HH---HHHHHHHHSS-C-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HH---HHHHHHHcCC-C-CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 43 3344443322 1 11223356789999999999999999999988763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=403.50 Aligned_cols=244 Identities=26% Similarity=0.344 Sum_probs=195.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~------------ 80 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD------------ 80 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE------------
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEE------------
Confidence 68999999999999999999999999999999986542 2335889999999999998666544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++.+.+..||||||++|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 81 ---------------~~~~~~~~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL 144 (275)
T 3hyh_A 81 ---------------VIKSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL 144 (275)
T ss_dssp ---------------EEECSSEEEEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred ---------------EEEECCEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence 3456788999999999999999876 567999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+ +.++.+||+|||+|+....... ..+.+||+.|||||++.+..| +.++||||+||++|||++|+.||.
T Consensus 145 l---~~~~~vkl~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 145 L---DEHLNVKIADFGLSNIMTDGNF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp E---CTTCCEEECCSSCC-----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred E---CCCCCEEEeecCCCeecCCCCc--------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence 9 4788999999999986654332 246789999999999999886 689999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+... ...+..+.......| ..+++++++|+..||..||++||+++++.+
T Consensus 214 ~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 214 DESI---PVLFKNISNGVYTLP-----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CSSH---HHHHHHHHHTCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCH---HHHHHHHHcCCCCCC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 7543 344555555554443 456899999999999999999999988755
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=411.20 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=213.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.|-.++|.+.++||+|+||+||+|++. .++..||||+++.... ..++.+|+++++.|+|+|++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~----- 83 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGV----- 83 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-----
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEE-----
Confidence 455678999999999999999999875 3578899999876432 3458899999999999987776654
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHH
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARI 142 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------------~~~~~~~~~~i~~qil~~L 142 (449)
+.+.+..||||||| +|+|.+++...+ ..+++.+++.++.||+.||
T Consensus 84 ----------------------~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl 141 (299)
T 4asz_A 84 ----------------------CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGM 141 (299)
T ss_dssp ----------------------ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHH
T ss_pred ----------------------EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHH
Confidence 35667889999999 999999997532 4699999999999999999
Q ss_pred HHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchH
Q 013125 143 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDL 222 (449)
Q Consensus 143 ~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 222 (449)
+|||+++||||||||+|||+ ++++.+||+|||+|+........ .......||+.|||||++.+..|+.++||
T Consensus 142 ~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DV 213 (299)
T 4asz_A 142 VYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDV 213 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhH
Confidence 99999999999999999999 47889999999999865433221 12234578999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 223 ESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 223 wSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|||||++|||+| |+.||.+.... +.+..+...... +. ...+|+++.+|+..||+.||++||++.+|.+.|++
T Consensus 214 wS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~~~~~~-~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 214 WSLGVVLWEIFTYGKQPWYQLSNN---EVIECITQGRVL-QR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHHTCCC-CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCCCC-CC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 999999999998 99999987654 344444443321 11 24568999999999999999999999999999988
Q ss_pred HHHhc
Q 013125 302 LFSRE 306 (449)
Q Consensus 302 ~~~~~ 306 (449)
+.+..
T Consensus 287 ~~~~~ 291 (299)
T 4asz_A 287 LAKAS 291 (299)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 76643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=419.26 Aligned_cols=247 Identities=21% Similarity=0.215 Sum_probs=201.8
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.|+|+|++.++.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~------------- 90 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE------------- 90 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEE-------------
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEE-------------
Confidence 589999999999999999999999999999999875432 235789999999999998666544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.+.+..||||||| ||+|.+++...+ ..+++.+++.|+.||+.||+|||++|||||||||+||
T Consensus 91 --------------~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 91 --------------SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp --------------EEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred --------------EEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 345678899999999 899999997643 4579999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.
T Consensus 157 Ll---~~~g~vKl~DFGla~~~~~~~~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 157 FL---TKDGTVQLGDFGIARVLNSTVE-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp EE---CTTCCEEECSTTEESCCCHHHH-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EE---CCCCCEEEcccccceeecCCcc-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99 4788999999999986543211 1135679999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.+. .+.+..+.....+. ....+++++.+|+..||..||.+||+++++.+
T Consensus 227 ~~~~---~~~~~~i~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 227 AGSM---KNLVLKIISGSFPP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CSSH---HHHHHHHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcCH---HHHHHHHHcCCCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7544 34555555544332 23456899999999999999999999888744
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=408.98 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=204.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
|-.++|+++++||+|+||+||+|++. ..||||+++.... ...+.+|+++++.|+|+|++.+++.+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-------- 101 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-------- 101 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--------
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--------
Confidence 44578899999999999999999864 3599999875432 23578999999999999987765532
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
..+..||||||| ||+|.+++......+++.+++.|+.||+.||+|||+++||||||||+
T Consensus 102 --------------------~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~ 161 (307)
T 3omv_A 102 --------------------TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSN 161 (307)
T ss_dssp --------------------CSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSS
T ss_pred --------------------ECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHH
Confidence 234579999999 89999999866678999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC---CCCccchHHHHHHHHHHHHhC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlG~il~el~~G 235 (449)
|||++ +++.+||+|||+|+......... .....+||+.|||||++.+. .|+.++|||||||++|||+||
T Consensus 162 NILl~---~~~~~Ki~DFGla~~~~~~~~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg 233 (307)
T 3omv_A 162 NIFLH---EGLTVKIGDFGLATVKSRWSGSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233 (307)
T ss_dssp SEEEE---TTEEEEECCCSSCBC-----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HEEEC---CCCcEEEeeccCceecccCCcce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHC
Confidence 99994 78899999999998654332211 12466899999999999743 589999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhc-CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKV-STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
+.||.+..... .+..++.... .+........+|+++.+|+..||+.||++||++.+|.+.|+.+
T Consensus 234 ~~Pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 234 ELPYSHINNRD---QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTTTCCCHH---HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCChHH---HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99998765432 2223333333 3333445567899999999999999999999999998887644
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=420.84 Aligned_cols=247 Identities=19% Similarity=0.281 Sum_probs=207.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|+++++||+|+||.||+|++..+|+.||||++.... ..+.+.+|+++|+.|+|+|++.++.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~--------------- 215 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--------------- 215 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEE---------------
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEE---------------
Confidence 57999999999999999999999999999999987543 3446889999999999998776554
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++...+..||||||| ||+|.+++.. ..+++.+++.++.||+.||+|||++|||||||||+|||++
T Consensus 216 ------------~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~ 281 (423)
T 4fie_A 216 ------------SYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 281 (423)
T ss_dssp ------------EEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred ------------EEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 345678899999999 8999998864 5699999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
.++.+||+|||+|+.+...... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+..
T Consensus 282 ---~~g~vKl~DFGla~~~~~~~~~-------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 282 ---HDGRVKLSDFGFCAQVSKEVPR-------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp ---TTCCEEECCCTTCEECCSSCCC-------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---CCCCEEEecCccceECCCCCcc-------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 7899999999999876544321 247799999999999999999999999999999999999999998755
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.. +.+..|.... . +....+..+++++++|+..||..||.+||++.++++
T Consensus 352 ~~---~~~~~i~~~~-~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 352 PL---KAMKMIRDNL-P-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HH---HHHHHHHHSC-C-CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HH---HHHHHHHcCC-C-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 43 3333443322 1 112223567899999999999999999999887643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=409.27 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=205.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
|-..+|.+.++||+|+||+||+|++. .+++.||||+++.... ...+.+|++++..|+|+|++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~----- 112 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC----- 112 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 44568999999999999999999874 3678999999875432 34588999999999999877766543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIAR 141 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--------------~~~~~~~~~~i~~qil~~ 141 (449)
.+.+..||||||| +|+|.+++.... ..+++.+++.|+.||+.|
T Consensus 113 ----------------------~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 170 (329)
T 4aoj_A 113 ----------------------TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170 (329)
T ss_dssp ----------------------CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHH
T ss_pred ----------------------EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 5567889999999 999999986432 358999999999999999
Q ss_pred HHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccch
Q 013125 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 221 (449)
Q Consensus 142 L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D 221 (449)
|+|||+++||||||||+|||++ +++.+||+|||+|+........ .......||+.|||||++.+..|+.++|
T Consensus 171 l~yLH~~~iiHRDLKp~NILl~---~~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sD 242 (329)
T 4aoj_A 171 MVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESD 242 (329)
T ss_dssp HHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHH
T ss_pred HHHHhcCCeecccccHhhEEEC---CCCcEEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCcccc
Confidence 9999999999999999999994 7899999999999866443221 1234567999999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 222 LESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 222 vwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
||||||++|||+| |+.||.+.... +.+..+.... ..+.+ ..+|+++.+|+..||+.||++||++.+|.+.|+
T Consensus 243 vwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~~g~-~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 243 VWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCITQGR-ELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHHHHTC-CCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred ccchHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCC-CCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 9999999999998 99999986654 3333443322 22222 456899999999999999999999999999998
Q ss_pred HHHHh
Q 013125 301 DLFSR 305 (449)
Q Consensus 301 ~~~~~ 305 (449)
.+.+.
T Consensus 316 ~l~~~ 320 (329)
T 4aoj_A 316 ALAQA 320 (329)
T ss_dssp HHHHS
T ss_pred HHhhC
Confidence 87653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=399.64 Aligned_cols=294 Identities=70% Similarity=1.243 Sum_probs=255.4
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
|+..++++|++++.||+|+||.||+|++..+++.||||++........+.+|+++++.++|++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~----------------- 65 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV----------------- 65 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTST-----------------
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCC-----------------
Confidence 456688999999999999999999999999999999999887777778999999999999887
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.++.+..++...+..++|||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 66 ---------~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 136 (296)
T 4hgt_A 66 ---------GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 136 (296)
T ss_dssp ---------TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ---------CCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 44555666677889999999999999999987778899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+...++.+.+||+|||+++...........++.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 137 l~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 99544578899999999999887776655566666778899999999999999999999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccc
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
+.........+..+.......+.+..+..+|+++.+++..||..+|.+||++.+|.+.|++++...+..++..+||+.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 4hgt_A 217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp SCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred ccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence 87666555666667777778888888889999999999999999999999999999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=402.45 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=202.3
Q ss_pred cCCce-EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.++|| ++.++||+|+||+||+|.+..+++.||+|++..... ...+.+|+++++.|+|+|++++++.....
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~----- 97 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST----- 97 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-----
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-----
Confidence 45676 788999999999999999999999999998864322 23588999999999999988876643211
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIK 156 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHrDLk 156 (449)
.......||||||| ||+|.+++.. ...+++..++.++.||+.||+|||++| |||||||
T Consensus 98 ------------------~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlK 158 (290)
T 3fpq_A 98 ------------------VKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158 (290)
T ss_dssp ------------------ETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCC
T ss_pred ------------------cCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccC
Confidence 12345689999999 8999999976 567999999999999999999999998 9999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||++ +.++.+||+|||+|+...... ..+.+||+.|||||++.+ .|+.++|||||||++|||+||+
T Consensus 159 p~NILl~--~~~g~vKl~DFGla~~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~ 226 (290)
T 3fpq_A 159 CDNIFIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp GGGEEES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred hhheeEE--CCCCCEEEEeCcCCEeCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCC
Confidence 9999994 246899999999997543221 246789999999999875 6999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||.+.... ...+..+.... .........++++.+|+..||..||.+||++.++.+
T Consensus 227 ~Pf~~~~~~--~~~~~~i~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 227 YPYSECQNA--AQIYRRVTSGV---KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CTTTTCSSH--HHHHHHHTTTC---CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcH--HHHHHHHHcCC---CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999864432 22333332221 122334556789999999999999999999887744
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=397.33 Aligned_cols=294 Identities=70% Similarity=1.243 Sum_probs=261.2
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
|+..++++|++++.||+|+||.||+|++..+++.||||++........+.+|+++++.++|++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~----------------- 65 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV----------------- 65 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTST-----------------
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCC-----------------
Confidence 456788999999999999999999999999999999999887777778999999999999887
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.++.+.+++......++|||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 66 ---------~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI 136 (296)
T 3uzp_A 66 ---------GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 136 (296)
T ss_dssp ---------TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ---------CCCccccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHe
Confidence 44555666677888999999999999999987778899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|++..++++.+||+|||++............+++......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 99654577899999999999887766555556666678899999999999999999999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccc
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
+.......+.+..+.......+.+..+..+|+++.+++..||..||.+||++.+|.+.|++++...+...+..+||+.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 3uzp_A 217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp SCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGCC
T ss_pred CcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 86655555566666677777888888889999999999999999999999999999999999999999999999998763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=404.76 Aligned_cols=257 Identities=18% Similarity=0.232 Sum_probs=209.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
+|--..++++++||+|+||+||+|+.. .+++.||||+++.... ...+.+|+.++..|+|+|++.+++.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~--- 98 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV--- 98 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE---
Confidence 455578999999999999999999863 4678899999875432 34689999999999999887776654
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQM 138 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---------------~~~~~~~~~~~i~~qi 138 (449)
...+..||||||| +|+|.+++... ...+++..++.++.||
T Consensus 99 ------------------------~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 154 (308)
T 4gt4_A 99 ------------------------TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 154 (308)
T ss_dssp ------------------------CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHH
T ss_pred ------------------------EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHH
Confidence 4567789999999 99999998642 2358999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCc
Q 013125 139 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR 218 (449)
Q Consensus 139 l~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ 218 (449)
+.||+|||+++||||||||+|||+ ++++.+||+|||+|+........ ......+||+.|||||++.+..|+.
T Consensus 155 a~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ 226 (308)
T 4gt4_A 155 AAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSI 226 (308)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCc
Confidence 999999999999999999999999 47889999999999865433221 1234668999999999999999999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 219 RDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 219 ~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|||||||++|||+| |..||.+.... +.+..+... ...+. ...+|+++.+|+..||+.||.+||++.+|.+
T Consensus 227 ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~i~~~-~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 227 DSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEMIRNR-QVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHHHHTT-CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-CCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999998 89999987654 333333332 22222 2456899999999999999999999999988
Q ss_pred HHHH
Q 013125 298 LFHD 301 (449)
Q Consensus 298 ~l~~ 301 (449)
.|+.
T Consensus 300 ~L~a 303 (308)
T 4gt4_A 300 RLRA 303 (308)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 8763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-54 Score=407.96 Aligned_cols=242 Identities=23% Similarity=0.347 Sum_probs=196.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
-.++|++++.||+|+||+||+|++. .+++.||||+++... ....+.+|+++++.|+|++++.++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~-------- 93 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHY-------- 93 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEE--------
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEE--------
Confidence 3468999999999999999999984 467899999986532 2335788999999888887666543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
++.+.+..||||||| ||+|.+++.. ...+++.+++.++.||+.||+|||++||+|||||
T Consensus 94 -------------------~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 153 (304)
T 3ubd_A 94 -------------------AFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK 153 (304)
T ss_dssp -------------------EEEETTEEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred -------------------EEEECCEEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 445678899999999 8999999986 4579999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ +.++.+||+|||+|+....... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+
T Consensus 154 p~NILl---~~~g~vKl~DFGla~~~~~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 223 (304)
T 3ubd_A 154 PENILL---DEEGHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223 (304)
T ss_dssp GGGEEE---CTTSCEEEESSEEEEC-----C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred HHHeEE---cCCCCEEecccccceeccCCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCC
Confidence 999999 4788999999999986544332 124678999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
+||.+.+.. +.+..+.......| ..+++++.+|+..||..||.+||++
T Consensus 224 ~PF~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 224 LPFQGKDRK---ETMTMILKAKLGMP-----QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CSSCCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCcCHH---HHHHHHHcCCCCCC-----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 999875543 45555666555544 3468999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=402.01 Aligned_cols=284 Identities=57% Similarity=1.030 Sum_probs=254.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-+++++|++++.||+|+||+||+|++..+++.||||++........+.+|+++++.| +|++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~------------------ 66 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG------------------ 66 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTT------------------
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCC------------------
Confidence 467899999999999999999999999999999999998776667799999999999 6664
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++.+..++...+..++||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 67 ---------i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil 137 (330)
T 2izr_A 67 ---------IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL 137 (330)
T ss_dssp ---------SCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred ---------CCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence 55555566778889999999999999999987788999999999999999999999999999999999999
Q ss_pred eecCCCCCe-----EEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 162 MGLGRKANQ-----VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 162 l~~~~~~~~-----vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
++ .++. +||+|||+|+.+.........+++......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 138 l~---~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 138 IG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214 (330)
T ss_dssp EC---CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ec---cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 95 4444 999999999988777666666666677889999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccc
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 316 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw 316 (449)
.||.+.......+.+..+.......+....+..+| ++.+++..||..+|.+||++++|.+.|++++.+.+...+..+||
T Consensus 215 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 215 LPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp CTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred CCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 99998776666777777777777888888888888 99999999999999999999999999999999999999999999
Q ss_pred c
Q 013125 317 T 317 (449)
Q Consensus 317 ~ 317 (449)
.
T Consensus 294 ~ 294 (330)
T 2izr_A 294 I 294 (330)
T ss_dssp T
T ss_pred C
Confidence 7
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=392.36 Aligned_cols=292 Identities=57% Similarity=0.994 Sum_probs=257.1
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.+++++|++++.||+|+||.||+|.+..+++.||||++........+.+|+++++.+.+..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~------------------ 66 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT------------------ 66 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCT------------------
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCC------------------
Confidence 56899999999999999999999999999999999999887766777999999999985432
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+++.+..++......++|||+++++|.+++...+..++...++.++.||+.||+|||++||+||||||+|||
T Consensus 67 --------~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl 138 (298)
T 1csn_A 67 --------GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFL 138 (298)
T ss_dssp --------TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred --------CCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 466666677788899999999999999999887778999999999999999999999999999999999999
Q ss_pred eecC--CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 162 MGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 162 l~~~--~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
++.. .....+||+|||+++...........+++......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 139 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 139 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence 9532 12334999999999988776665555556667888999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCcccccccc
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 319 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 319 (449)
.+.........+..+.......+....+..+|+++.+++..||..+|.+||++++|.+.|++++...+...+..+||+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 298 (298)
T 1csn_A 219 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298 (298)
T ss_dssp SSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred chhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCCC
Confidence 98766666667777777777778888888899999999999999999999999999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=405.50 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=212.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCC-----CceEEEEEecCCCCc---hhHHHHHHHHHHHcC-CCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQG-GSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~-~~~~~~~~~~~~~ 74 (449)
|-.++|+++++||+|+||+||+|.+..+ ++.||||+++..... ..+.+|++++..+.| +|++++++.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~-- 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-- 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE--
Confidence 4457899999999999999999998654 357999998765432 348899999999977 56666555431
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQM 138 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qi 138 (449)
..++..||||||| +|+|.++++... ..+++..++.++.||
T Consensus 139 ------------------------~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 194 (353)
T 4ase_A 139 ------------------------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 194 (353)
T ss_dssp ------------------------CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHH
T ss_pred ------------------------ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHH
Confidence 2346789999999 999999997532 348999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCc
Q 013125 139 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR 218 (449)
Q Consensus 139 l~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ 218 (449)
+.||+|||+++||||||||+|||++ +++.+||+|||+|+........ ......+||+.|||||++.+..|+.
T Consensus 195 a~gl~yLH~~~iiHRDLK~~NILl~---~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ 266 (353)
T 4ase_A 195 AKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTI 266 (353)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHhHhhCCeecCccCccceeeC---CCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCC
Confidence 9999999999999999999999994 7889999999999866543321 1234567899999999999999999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 219 RDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 219 ~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|||||||++|||+| |+.||.+..... .+..++......+.+ ..+++++.+++..||..||.+||++.+|.+
T Consensus 267 ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~---~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 267 QSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccEeehHHHHHHHHhCCCCCCCCCCHHH---HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999998 999998865432 222333333333322 345899999999999999999999999999
Q ss_pred HHHHHHHhc
Q 013125 298 LFHDLFSRE 306 (449)
Q Consensus 298 ~l~~~~~~~ 306 (449)
.|.++++..
T Consensus 341 ~L~~llq~~ 349 (353)
T 4ase_A 341 HLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=408.23 Aligned_cols=262 Identities=21% Similarity=0.252 Sum_probs=208.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++++|+++++||+|+||+||+|++..+|+.||||+++..... ..+.+|+++|+.|+|+|++.++.+.....
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 126 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV----- 126 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS-----
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc-----
Confidence 568999999999999999999999999999999998765332 24778999999999999888766532110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+.+.+..|||||||+++|.+++.. .+.+++..++.+++||+.||+|||++|||||||||+||
T Consensus 127 ----------------~~~~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI 189 (398)
T 4b99_A 127 ----------------PYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 189 (398)
T ss_dssp ----------------CTTTCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred ----------------ccccCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccc
Confidence 1134567899999998899998875 56799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +.++.+||+|||+|+.+........ ....+.+||+.|+|||++.+.. |+.++||||+||++|||++|++||
T Consensus 190 l~---~~~~~~Ki~DFGla~~~~~~~~~~~---~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 190 LV---NENCELKIGDFGMARGLCTSPAEHQ---YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp EE---CTTCCEEECCCTTCBCC-------C---CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred cc---CCCCCEEEeecceeeecccCccccc---cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 99 4789999999999987644321110 1234779999999999998864 699999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCC--------------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+.+.... +..|....... +......+.++++.+|+..||..||.+||++.
T Consensus 264 ~g~~~~~~---l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 264 PGKNYVHQ---LQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp CCSSHHHH---HHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCHHHH---HHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 98665433 33333322222 23334456678999999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 341 e~L~ 344 (398)
T 4b99_A 341 AALR 344 (398)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 7643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=389.00 Aligned_cols=268 Identities=19% Similarity=0.237 Sum_probs=189.5
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
||.+ ++|++++.||+|+||+||+|++..+++.||||+++.... .+.+.+|+++++.|+|+|+++++.........
T Consensus 1 GR~l-~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~- 78 (299)
T 4g31_A 1 GRYL-TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT- 78 (299)
T ss_dssp CHHH-HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred CCcc-hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc-
Confidence 3444 469999999999999999999999999999999875433 23578999999999999999887765432110
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
..........+.||||||| |++|.+++.... ...+...++.++.||+.||+|||++|||||||
T Consensus 79 --------------~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDl 144 (299)
T 4g31_A 79 --------------EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDL 144 (299)
T ss_dssp ----------------------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred --------------ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccC
Confidence 0001112344679999999 899999987532 12556778999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccc-----cccCCCCCCCCccccccccccCCCCCccchHHHHHHHHH
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~ 230 (449)
||+|||++ .++.+||+|||+|+........... ......+.+||+.|||||++.+..|+.++|||||||++|
T Consensus 145 Kp~NILl~---~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvily 221 (299)
T 4g31_A 145 KPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILF 221 (299)
T ss_dssp CGGGEEEC---TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred cHHHeEEC---CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHH
Confidence 99999994 7889999999999876543321110 111234568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 231 el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||++ ||.+... ....+..+... ..| ......++...+|+..||+.||.+||++.++.+
T Consensus 222 ell~---Pf~~~~~--~~~~~~~~~~~--~~p--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 222 ELLY---PFSTQME--RVRTLTDVRNL--KFP--PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHS---CCSSHHH--HHHHHHHHHTT--CCC--HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcc---CCCCccH--HHHHHHHHhcC--CCC--CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9996 7865321 12222222222 222 122233467789999999999999999887744
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=391.38 Aligned_cols=269 Identities=23% Similarity=0.246 Sum_probs=199.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHH--HHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE--AKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E--~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
|..+|.+.++||+|+||+||+|++ +|+.||||+++... ...+..| +..+..++|+|++.+++.+...
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~-------- 69 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKD-------- 69 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE--------
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEec--------
Confidence 457899999999999999999987 68999999987543 2234444 4444567899888776654321
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------Ccccc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHR 153 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--------giiHr 153 (449)
+......||||||| +|+|.+++.. ..++++.+..++.|++.||+|||++ +||||
T Consensus 70 ---------------~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHR 132 (303)
T 3hmm_A 70 ---------------NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp ---------------CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECS
T ss_pred ---------------CCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeec
Confidence 01123679999999 8999999874 5699999999999999999999987 99999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC------CCCccchHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGY 227 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlG~ 227 (449)
||||+|||+ +.++.+||+|||+|+.......... ......+||+.|||||++.+. .++.++|||||||
T Consensus 133 DlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gv 206 (303)
T 3hmm_A 133 DLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred cCCcccEEE---CCCCCEEEEeCCCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHH
Confidence 999999999 4789999999999987765432211 112356899999999999765 3678999999999
Q ss_pred HHHHHHhCCCCCCC----------Chhh--cHHHHHHHHHHhhcCCCHHHhhc--cChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 228 VLLYFLRGSLPWQG----------LKAA--TKKQKYDKICEKKVSTPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 228 il~el~~G~~pf~~----------~~~~--~~~~~~~~i~~~~~~~~~~~~~~--~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
++|||+||.+||.. .... ........+.......+.+..+. ..+..+.+|+..||..||++||++.
T Consensus 207 vl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 286 (303)
T 3hmm_A 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 99999999776542 2111 11222233334444333332222 2356799999999999999999999
Q ss_pred HHHHHHHHHHHhcC
Q 013125 294 FLKRLFHDLFSREG 307 (449)
Q Consensus 294 ~l~~~l~~~~~~~~ 307 (449)
+|.+.|+++.+.++
T Consensus 287 ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 287 RIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHHHHC--
T ss_pred HHHHHHHHHHHHcC
Confidence 99999998876554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=410.29 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=210.8
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
-++|++++.||+|+||+||+|++..+++.||||++.+. .......+|..++..++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~------------------ 249 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG------------------ 249 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS------------------
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC------------------
Confidence 36899999999999999999999999999999998642 2233355565555554321
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.|++|..++.++.+.+..||||||| ||+|.+++.. ...|++..++.|+.||+.||+|||++|||||||||+|
T Consensus 250 ------~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeN 322 (689)
T 3v5w_A 250 ------DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322 (689)
T ss_dssp ------CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred ------CCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHH
Confidence 1235556666667889999999999 9999999976 4679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||+ +.++.+||+|||+|+.+..... .+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+|
T Consensus 323 ILl---d~~G~vKL~DFGlA~~~~~~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~P 390 (689)
T 3v5w_A 323 ILL---DEHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390 (689)
T ss_dssp EEE---CTTSCEEECCCTTCEECSSCCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eEE---eCCCCEEecccceeeecCCCCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999 5889999999999987654332 46799999999999974 5799999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCcc
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLFSREGYDFDFV 313 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~-----~~~l~~~l~~~~~~~~~~~~~~ 313 (449)
|.+.......+....+.......| ..+++++++|+..||..||.+|++ +++|++ +.|...
T Consensus 391 F~~~~~~~~~~i~~~i~~~~~~~p-----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~----------HpfF~~ 455 (689)
T 3v5w_A 391 FRQHKTKDKHEIDRMTLTMAVELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------SPFFRS 455 (689)
T ss_dssp TCGGGCCCHHHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT----------SGGGTT
T ss_pred CCCCChHHHHHHHHhhcCCCCCCC-----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc----------CccccC
Confidence 987655444445555555444444 456899999999999999999997 455532 455556
Q ss_pred cccccc
Q 013125 314 FDWTIL 319 (449)
Q Consensus 314 ~dw~~l 319 (449)
+||..+
T Consensus 456 idW~~l 461 (689)
T 3v5w_A 456 LDWQMV 461 (689)
T ss_dssp CCHHHH
T ss_pred CCHHHH
Confidence 788654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=386.45 Aligned_cols=205 Identities=22% Similarity=0.367 Sum_probs=167.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|+++++||+|+||+||+|++. .+++.||||++.......++.+|+++++.+. |++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~-------------- 84 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMG-------------- 84 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCC--------------
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCce--------------
Confidence 5689999999999999999999875 4678999999877666667889999999884 565443
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
++.+....++.||||||+ |++|.+++. .+++.+++.+++||+.||+|||++||+||||||+|
T Consensus 85 -------------l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeN 147 (361)
T 4f9c_A 85 -------------VKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSN 147 (361)
T ss_dssp -------------CSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -------------EEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHH
Confidence 444456778999999999 889998873 59999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCcc---------------------ccccCCCCCCCCccccccccccCCC-CC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRH---------------------IPYRENKNLTGTARYASCNTHLGIE-QS 217 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~s 217 (449)
||++ .+.+.+||+|||+|+.......... .........+||+.|+|||++.+.. |+
T Consensus 148 iLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~ 225 (361)
T 4f9c_A 148 FLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225 (361)
T ss_dssp EEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCC
T ss_pred eEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC
Confidence 9995 3447999999999987654321100 0001123568999999999998864 89
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 218 RRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 218 ~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
.++||||+||++|||++|+.||.+.
T Consensus 226 ~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 226 TAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp THHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CccchhhhHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=383.15 Aligned_cols=299 Identities=28% Similarity=0.504 Sum_probs=231.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCC-----CceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+..++|+++++||+|+||.||+|.+..+ ++.||||++... ...+.+|+++++.+.+.+.+.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~~~~~~~~~~~~------------ 97 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAKPEQIQ------------ 97 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETT--CHHHHHHHHHHHHHCCHHHHH------------
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeecc--chhHHHHHHHHHhhhhhHHHH------------
Confidence 4456999999999999999999998754 578999998753 346788888888887644221
Q ss_pred hhhhhhcccCCCcCeeEEecccC----CeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDG----EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
.+.......|++++.++.++... .+.||||||+|++|.+++......+++..++.++.||+.||+|||++||+|||
T Consensus 98 e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrD 177 (364)
T 3op5_A 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177 (364)
T ss_dssp HHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEec
Confidence 12223344566777776665543 56899999999999999988777899999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||++. +..+.+||+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||++
T Consensus 178 lkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 256 (364)
T 3op5_A 178 IKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256 (364)
T ss_dssp CCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999952 257899999999998765443222221222346679999999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHh---h---ccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCC
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL---C---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 308 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~---~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~ 308 (449)
|+.||.+.......... ...........+ | ..+|.++.+++..||..+|.+||++.+|.+.|++++...+.
T Consensus 257 g~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 257 GHLPWEDNLKDPKYVRD---SKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp SCCTTGGGTTCHHHHHH---HHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCccccccCHHHHHH---HHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 99999864332211111 111111122221 1 56689999999999999999999999999999999999999
Q ss_pred CCCccccccccc
Q 013125 309 DFDFVFDWTILK 320 (449)
Q Consensus 309 ~~~~~~dw~~l~ 320 (449)
..+..+||....
T Consensus 334 ~~~~~~dw~~~~ 345 (364)
T 3op5_A 334 KDDGKLDLSVVE 345 (364)
T ss_dssp CCCCCCCC----
T ss_pred CcCCccceEecc
Confidence 999999998654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=400.40 Aligned_cols=251 Identities=18% Similarity=0.258 Sum_probs=211.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+++|+.|+|+++++++.
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~--------------- 221 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD--------------- 221 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEE---------------
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEE---------------
Confidence 689999999999999999999999999999999875432 345789999999999998666544
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++.+.+..||||||| ||+|.+++......|++.+++.+++||+.||+|||++||+||||||+|||+.
T Consensus 222 ------------~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~ 289 (573)
T 3uto_A 222 ------------AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 289 (573)
T ss_dssp ------------EEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred ------------EEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhcccc
Confidence 345678899999999 8999998875566799999999999999999999999999999999999995
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
. +..+.+||+|||+|+.+..... ....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+..
T Consensus 290 ~-~~~~~vKl~DFG~a~~~~~~~~--------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 290 T-KRSNELKLIDFGLTAHLDPKQS--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp S-SSCCCEEECCCSSCEECCTTSE--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C-CCCCCEEEeeccceeEccCCCc--------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2 2347999999999987754322 235689999999999999999999999999999999999999998865
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.. +.+..|.......+ ...+..+++++.+||..||..||.+||++.++++
T Consensus 361 ~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 361 DD---ETLRNVKSCDWNMD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HH---HHHHHHHTTCCCCC-SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HH---HHHHHHHhCCCCCC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 43 44455555444433 3345677899999999999999999999887744
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.26 Aligned_cols=293 Identities=22% Similarity=0.359 Sum_probs=229.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCC--------CceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--------~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+++++.++|++++..+...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~------ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKL------ 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHH------
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhh------
Confidence 68999999999999999999999874 789999998754 4688999999999998876543221
Q ss_pred hhhhhhhcccCCCcCeeEEeccc-CCeeEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVD-GEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
......+++.+..++.. ....|+||||++++|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 112 ------~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Di 185 (352)
T 2jii_A 112 ------YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNV 185 (352)
T ss_dssp ------TTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred ------ccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 11223356666666664 7888999999999999999864 367999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCC--eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 156 KPDNFLMGLGRKAN--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 156 kp~Nill~~~~~~~--~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||+|||++ .++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||+
T Consensus 186 kp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 186 TAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp CGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999995 555 8999999999876543221111111224568999999999999999999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhh--cCCCHH---HhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCC
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKK--VSTPIE---VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 308 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~--~~~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~ 308 (449)
+|+.||.+..... ..+....... ...... ..+..+++++.+++..||..||.+||++.+|.+.|++++...+.
T Consensus 263 ~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 263 YGFLPWTNCLPNT--EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HSCCTTGGGTTCH--HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hCCCCcccCCcCH--HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 9999998754221 1111111111 111111 11235689999999999999999999999999999999999999
Q ss_pred CCCccccccc
Q 013125 309 DFDFVFDWTI 318 (449)
Q Consensus 309 ~~~~~~dw~~ 318 (449)
..+..+||..
T Consensus 341 ~~~~~~dw~~ 350 (352)
T 2jii_A 341 SPYDPIGLPM 350 (352)
T ss_dssp CTTSCCCCCC
T ss_pred CcCccccCcC
Confidence 9999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.20 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=211.6
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+|++++++|++++.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++|++++.
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~--------- 75 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS--------- 75 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCC---------
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCce---------
Confidence 578999999999999999999999999999999999998754322 124678888888888876544
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
+..++...+..|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+|||
T Consensus 76 ------------------~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~D 136 (294)
T 4eqm_A 76 ------------------MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRD 136 (294)
T ss_dssp ------------------EEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ------------------EEEeeeeCCeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 444456778899999999 8899999876 45799999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||+ +.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 137 lkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 207 (294)
T 4eqm_A 137 IKPQNILI---DSNKTLKIFDFGIAKALSETSLT------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207 (294)
T ss_dssp CCGGGEEE---CTTSCEEECCCSSSTTC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEE---CCCCCEEEEeCCCcccccccccc------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 99999999 47889999999999765433211 1235679999999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHHHh
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSR 305 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-~~~~l~~~l~~~~~~ 305 (449)
|+.||.+.... .....................+|+.+.+++..||..||.+|| +++++.+.|..++..
T Consensus 208 g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 208 GEPPFNGETAV---SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SSCSSCSSCHH---HHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CCCCCCCCChH---HHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 99999876543 222233333444444555677899999999999999999998 788888777765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=355.21 Aligned_cols=265 Identities=20% Similarity=0.295 Sum_probs=210.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~ 78 (449)
--++|++++.||+|+||+||+|++..+++.||||+++.. .....+..|..++..+ +|++++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv------------- 116 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV------------- 116 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBC-------------
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcC-------------
Confidence 346899999999999999999999999999999998753 2233578899998877 666544
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.++.++...+..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 117 --------------~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp 181 (396)
T 4dc2_A 117 --------------GLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181 (396)
T ss_dssp --------------CEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred --------------eeEEEEEECCEEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCH
Confidence 4445556778899999999 8899988876 46799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 182 ~NILl---~~~g~ikL~DFGla~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~ 251 (396)
T 4dc2_A 182 DNVLL---DSEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251 (396)
T ss_dssp GGEEE---CTTSCEEECCCTTCBCCCCTTC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEE---CCCCCEEEeecceeeecccCCC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999 4789999999999986433221 1346789999999999999999999999999999999999999
Q ss_pred CCCCChhh------cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHHhcCC
Q 013125 238 PWQGLKAA------TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG---FLKRLFHDLFSREGY 308 (449)
Q Consensus 238 pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~---~l~~~l~~~~~~~~~ 308 (449)
||.+.... ........+.......| ..++.++.+++..||..||.+||++. .+.+.+. .
T Consensus 252 Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~-------H 319 (396)
T 4dc2_A 252 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-------H 319 (396)
T ss_dssp SSTTTTC------CCHHHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH-------S
T ss_pred CCcccccccccchhhHHHHHHHHhccccCCC-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc-------C
Confidence 99753221 12233444555544444 34588999999999999999999862 2222222 4
Q ss_pred CCCcccccccc
Q 013125 309 DFDFVFDWTIL 319 (449)
Q Consensus 309 ~~~~~~dw~~l 319 (449)
.|...+||..+
T Consensus 320 pff~~i~w~~l 330 (396)
T 4dc2_A 320 PFFRNVDWDMM 330 (396)
T ss_dssp TTTTTCCHHHH
T ss_pred ccccCCCHHHH
Confidence 55556788654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=352.05 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=210.2
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
.-+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++.++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~------ 81 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH------ 81 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE------
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE------
Confidence 3467899999999999999999999999999999999875432 24578999999999888755543
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.++......|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||
T Consensus 82 ---------------------~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHr 139 (361)
T 2yab_A 82 ---------------------DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF 139 (361)
T ss_dssp ---------------------EEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ---------------------EEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 3445678899999999 8999998864 5579999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCC----eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKAN----QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229 (449)
Q Consensus 154 DLkp~Nill~~~~~~~----~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 229 (449)
||||+|||+. +.+ .+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 140 Dlkp~NIll~---~~~~~~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 140 DLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp CCSGGGEEES---CTTSSSCCEEECCCSSCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCHHHEEEe---CCCCCccCEEEEecCCceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 9999999995 333 799999999987654322 2356799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 230 LYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 230 ~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+|++|..||.+.... ..+..+.......+ ...+...++++.+++..||..||.+||++.++.+
T Consensus 209 ~~ll~g~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 209 YILLSGASPFLGDTKQ---ETLANITAVSYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHSCCSSCCSSHH---HHHHHHHTTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCCCCCCHH---HHHHHHHhcCCCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999875443 34445555444444 4455677899999999999999999999887644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=345.56 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=203.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..++|+++++||+|+||+||+|.+..+++.||||++... .....+.+|+.+++.++|++++.++.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~------------- 84 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD------------- 84 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEE-------------
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeE-------------
Confidence 347899999999999999999999999999999987643 33445789999999999987665543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
++...+..|+||||+ +++|.+++.. ..++...++.++.||+.||+|||++||+||||||+|||
T Consensus 85 --------------~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil 148 (297)
T 3fxz_A 85 --------------SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148 (297)
T ss_dssp --------------EEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred --------------EEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 345567889999999 9999998874 46999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ .++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 149 ~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 149 LG---MDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp EC---TTCCEEECCCTTCEECCSTTCC-------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EC---CCCCEEEeeCCCceecCCcccc-------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 94 7889999999999876543321 2456899999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... ...+....... ......++..+.+++..||..||.+||++.++.+
T Consensus 219 ~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 219 ENPLRA---LYLIATNGTPE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCHHHH---HHHHHHHCSCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHH---HHHHHhCCCCC--CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 654322 22222222111 1112456889999999999999999999887743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=354.08 Aligned_cols=243 Identities=19% Similarity=0.281 Sum_probs=197.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~ 77 (449)
+--++|++++.||+|+||+||+|++..+++.||||++... .....+.+|..+++.+ +|++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~-------------- 85 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF-------------- 85 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTT--------------
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCc--------------
Confidence 4457899999999999999999999999999999998642 2334577888888887 4654
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
++.++.++...+..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+|||||
T Consensus 86 -------------Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 151 (353)
T 3txo_A 86 -------------LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLK 151 (353)
T ss_dssp -------------BCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred -------------eeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Confidence 444555566778899999999 8899998876 4679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 152 p~NILl---~~~g~ikL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 221 (353)
T 3txo_A 152 LDNVLL---DHEGHCKLADFGMCKEGICNGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221 (353)
T ss_dssp GGGEEE---CTTSCEEECCCTTCBCSCC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSS
T ss_pred HHHEEE---CCCCCEEEccccceeecccCCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCC
Confidence 999999 4789999999999975433221 124678999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.||.+.... ..+..+.......| ..+++++.+++..||..||.+||++
T Consensus 222 ~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 222 APFEAENED---DLFEAILNDEVVYP-----TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CSSCCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCHH---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 999876543 45555666555544 2357899999999999999999997
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=347.99 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=204.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+.-++|++++.||+|+||+||+|++..+++.||||++... .....+.+|+++++.++|++++.
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~------------ 69 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA------------ 69 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCC------------
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcc------------
Confidence 3457999999999999999999999999999999998642 23445788999998888876544
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+..+....+..|+||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||
T Consensus 70 ---------------l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 133 (337)
T 1o6l_A 70 ---------------LKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp ---------------EEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred ---------------eEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCH
Confidence 444456678899999999 8899988875 56799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 134 ~NIll---~~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 203 (337)
T 1o6l_A 134 ENLML---DKDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp GGEEE---CTTSCEEECCCTTCBCSCCTTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred HHEEE---CCCCCEEEeeccchhhcccCCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCC
Confidence 99999 4788999999999986433221 1246789999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~~ 297 (449)
||.+.... ..+..+.......| ..+++++.+++..||..||.+|| ++++|.+
T Consensus 204 Pf~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 204 PFYNQDHE---RLFELILMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSCCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCHH---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 99875432 34444555444443 34588999999999999999999 6666643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=352.35 Aligned_cols=256 Identities=19% Similarity=0.226 Sum_probs=210.2
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-------CCchhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.++.++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+|+++++.++|++++.++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~------ 93 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE------ 93 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE------
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE------
Confidence 45678999999999999999999999999999999987531 13456889999999999987665543
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFL 151 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~gii 151 (449)
+....+..|+||||+ |++|.+.+... +..+++..++.++.||+.||+|||++||+
T Consensus 94 ---------------------~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv 152 (351)
T 3c0i_A 94 ---------------------TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNII 152 (351)
T ss_dssp ---------------------EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------------------EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 335567899999999 79998877643 33589999999999999999999999999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 231 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~e 231 (449)
||||||+|||++..+....+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 153 HrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 225 (351)
T 3c0i_A 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225 (351)
T ss_dssp CSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCB-------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred eccCChHHeEEecCCCCCcEEEecCcceeEecCCCee-------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHH
Confidence 9999999999964444566999999999876543321 235679999999999999999999999999999999
Q ss_pred HHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 232 l~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|++|..||.+... ..+..+.......+ ...+..+++++.+++..||..||.+||++.++.+
T Consensus 226 ll~g~~pf~~~~~----~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 226 LLSGCLPFYGTKE----RLFEGIIKGKYKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHSSCSSCSSHH----HHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCCCCCcHH----HHHHHHHcCCCCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999987532 34444444444443 3445677899999999999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=348.61 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=205.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..-++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++.++.
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~---------- 81 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE---------- 81 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE----------
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEE----------
Confidence 345789999999999999999999999999999999865422 234778999999999987665543
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+....+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+
T Consensus 82 -----------------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 143 (328)
T 3fe3_A 82 -----------------VIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAE 143 (328)
T ss_dssp -----------------EEECSSEEEEEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -----------------EEEECCEEEEEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHH
Confidence 345667899999999 8899998876 467999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCC-ccchHHHHHHHHHHHHhCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwSlG~il~el~~G~~ 237 (449)
|||+ +.++.+||+|||++........ ....+||+.|+|||++.+..+. .++|||||||++|||++|+.
T Consensus 144 NIll---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 212 (328)
T 3fe3_A 144 NLLL---DADMNIKIADFGFSNEFTVGGK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212 (328)
T ss_dssp GEEE---CTTSCEEECSTTCCGGGSSSCG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEE---cCCCCEEEeeccCceecCCCCc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 9999 4788999999999976543321 2356899999999999988875 89999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.+.... .....+.......| ...++++.+++..||..||.+||+++++.+
T Consensus 213 pf~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 213 PFDGQNLK---ELRERVLRGKYRIP-----FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp SSCCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCHH---HHHHHHHhCCCCCC-----CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99886543 34444555554444 235789999999999999999999887744
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=363.37 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=214.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+..++|+++++||+|+||+||+|++..+++.||||++... .....+..|+.++..++|++++.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l----------- 139 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL----------- 139 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE-----------
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE-----------
Confidence 4568999999999999999999999999999999998642 233347889999999888765544
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
..++.+.+..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||
T Consensus 140 ----------------~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp 203 (437)
T 4aw2_A 140 ----------------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203 (437)
T ss_dssp ----------------EEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred ----------------EEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCH
Confidence 44456778899999999 9999999986567899999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el 232 (449)
+|||+ +.++.+||+|||+|+........ .....+||+.|+|||++. +..++.++|||||||++|||
T Consensus 204 ~NILl---~~~g~vkL~DFGla~~~~~~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~el 274 (437)
T 4aw2_A 204 DNILM---DMNGHIRLADFGSCLKLMEDGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274 (437)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECCTTSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHH
T ss_pred HHeeE---cCCCCEEEcchhhhhhcccCCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHH
Confidence 99999 47899999999999876543321 123568999999999987 55689999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHHHhcCCCC
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRLFHDLFSREGYDF 310 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~--Rp~~~~l~~~l~~~~~~~~~~~ 310 (449)
++|+.||.+.... +.+..+.........+.....+++++.+|+..||..+|.+ |++++++.+ ..|
T Consensus 275 ltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~----------Hpf 341 (437)
T 4aw2_A 275 LYGETPFYAESLV---ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK----------HPF 341 (437)
T ss_dssp HHSSCTTCCSSHH---HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT----------SGG
T ss_pred HhCCCCCCCCChh---HHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC----------CCc
Confidence 9999999875543 3444454433222222333456899999999999988887 899887644 344
Q ss_pred Ccccccccc
Q 013125 311 DFVFDWTIL 319 (449)
Q Consensus 311 ~~~~dw~~l 319 (449)
...+||..+
T Consensus 342 f~~i~w~~l 350 (437)
T 4aw2_A 342 FSGIDWDNI 350 (437)
T ss_dssp GTTCCTTTG
T ss_pred cCCCCHHHH
Confidence 455778765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=343.32 Aligned_cols=257 Identities=19% Similarity=0.253 Sum_probs=205.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+-+.++|+++++||+|+||+||+|++. +++.||+|++...... ..+.+|+++++.++|++++.++.
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~--------- 86 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID--------- 86 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEE---------
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeee---------
Confidence 456799999999999999999999985 5889999998654322 35789999999999887665543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+.......|+||||+.++|.+++......++...++.++.||+.||+|||++||+||||||+
T Consensus 87 ------------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~ 148 (311)
T 3niz_A 87 ------------------VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148 (311)
T ss_dssp ------------------EECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred ------------------EEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchH
Confidence 34566788999999988999988866667999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
|||++ .++.+||+|||+|+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 149 NIl~~---~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 149 NLLIN---SDGALKLADFGLARAFGIPVR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp GEEEC---TTCCEEECCCTTCEETTSCCC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hEEEC---CCCCEEEccCcCceecCCCcc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence 99994 778999999999987653322 1235578999999999987 458999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhc----------------------CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKV----------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
||.+.........+..+..... ..+.......+++++.+++..||..||.+||++.++
T Consensus 219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9998766654444433322111 112233344567899999999999999999998877
Q ss_pred HH
Q 013125 296 KR 297 (449)
Q Consensus 296 ~~ 297 (449)
.+
T Consensus 299 l~ 300 (311)
T 3niz_A 299 MN 300 (311)
T ss_dssp HT
T ss_pred hc
Confidence 54
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=348.16 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=211.1
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCc---eEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.++..++|++.+.||+|+||+||+|.+..+++ .||||+++.... ...+.+|+++++.++|++++.++.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~------ 117 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG------ 117 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE------
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEE------
Confidence 35678899999999999999999999976554 499999876433 234788999999998887655443
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
++...+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+|||
T Consensus 118 ---------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D 176 (325)
T 3kul_A 118 ---------------------VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176 (325)
T ss_dssp ---------------------EECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ---------------------EEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence 345567889999999 8899999976667899999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||+ +.++.+||+|||+++.......... ......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 177 lkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 249 (325)
T 3kul_A 177 LAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249 (325)
T ss_dssp CSGGGEEE---CTTCCEEECCCSSCEECC----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CCcceEEE---CCCCCEEECCCCcccccccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 99999999 4788999999999987654432211 1224456788999999998899999999999999999999
Q ss_pred -CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 235 -GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 235 -G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|..||.+..... ....+.. ....+. ...+++++.+++..||..||.+||++.+|.+.|+.++...
T Consensus 250 ~g~~p~~~~~~~~---~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 250 YGERPYWNMTNRD---VISSVEE-GYRLPA---PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TSCCTTTTSCHHH---HHHHHHT-TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCcccCCHHH---HHHHHHc-CCCCCC---CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 999998765532 2222222 222222 2356889999999999999999999999999999887654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=354.28 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=207.1
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+.+.-++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++.+
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l--------- 80 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL--------- 80 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCE---------
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcE---------
Confidence 355668999999999999999999999999999999987542 234467889999999988865554
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+.++......|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+||||
T Consensus 81 ------------------~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl 141 (384)
T 4fr4_A 81 ------------------WYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141 (384)
T ss_dssp ------------------EEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred ------------------EEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 44445677899999999 8899988875 567999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC---CCCCccchHHHHHHHHHHH
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il~el 232 (449)
||+|||+ +.++.+||+|||+|+....... ....+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 142 kp~NIll---~~~g~vkL~DFG~a~~~~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~el 210 (384)
T 4fr4_A 142 KPDNILL---DEHGHVHITDFNIAAMLPRETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210 (384)
T ss_dssp SGGGEEE---CTTSCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHH
T ss_pred cHHHeEE---CCCCCEEEeccceeeeccCCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHH
Confidence 9999999 4789999999999987654322 246789999999999874 4589999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC-HHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFL 295 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~-~~~l 295 (449)
++|..||.+.........+..+.......| ..++.++.+++..||..||.+||+ +++|
T Consensus 211 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 211 LRGRRPYHIRSSTSSKEIVHTFETTVVTYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp HHSSCSSCCCTTSCHHHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred HhCCCCCCCCCCccHHHHHHHHhhcccCCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 999999987665555555555444444433 345789999999999999999998 5544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.82 Aligned_cols=264 Identities=18% Similarity=0.230 Sum_probs=201.9
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-------CchhHHHHHHHHHHHc---CCCcceeeEe
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQ---GGSKIRLVVF 70 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-------~~~~~~~E~~~l~~l~---~~~~~~~~~~ 70 (449)
+|.++.++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++ |++++.++..
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 36788999999999999999999999999999999999876321 1335788998888876 8877666544
Q ss_pred ecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013125 71 HVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRG 149 (449)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~g 149 (449)
+.... .......++|||+++++|.+++.... ..+++..++.++.||+.||+|||++|
T Consensus 83 ~~~~~----------------------~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 140 (308)
T 3g33_A 83 CATSR----------------------TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 140 (308)
T ss_dssp EEECC----------------------SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeccC----------------------CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 32110 01112579999999999999987543 23999999999999999999999999
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHH
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 229 (449)
|+||||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++
T Consensus 141 ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 209 (308)
T 3g33_A 141 IVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209 (308)
T ss_dssp CCCSCCCTTTEEEC---TTSCEEECSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHH
T ss_pred cccCCCCHHHEEEc---CCCCEEEeeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHH
Confidence 99999999999994 788999999999976543322 2356789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCChhhcHHHHHHHHHHh-------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 230 LYFLRGSLPWQGLKAATKKQKYDKICEK-------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 230 ~el~~G~~pf~~~~~~~~~~~~~~i~~~-------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
|||++|+.||.+.........+...... ....+........++++.+++..||..||.+||
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 289 (308)
T 3g33_A 210 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI 289 (308)
T ss_dssp HHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC
Confidence 9999999999886654433332222110 011222334456788999999999999999999
Q ss_pred CHHHHHH
Q 013125 291 DYGFLKR 297 (449)
Q Consensus 291 ~~~~l~~ 297 (449)
++.++.+
T Consensus 290 t~~e~l~ 296 (308)
T 3g33_A 290 SAFRALQ 296 (308)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9887644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=345.06 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=200.5
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
++..++|++.++||+|+||+||+|++ +++.||||++...... ..+.+|+++++.++|++++.++.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~--------- 101 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG--------- 101 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEE---------
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE---------
Confidence 45678999999999999999999987 6888999998765432 24778999999999887655443
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccc
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRG--FLHR 153 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--~~~~~~~~~~i~~qil~~L~~LH~~g--iiHr 153 (449)
++......++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++| |+||
T Consensus 102 ------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~ 163 (309)
T 3p86_A 102 ------------------AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163 (309)
T ss_dssp ------------------EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCT
T ss_pred ------------------EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECC
Confidence 445667789999999 889999987432 23899999999999999999999999 9999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 164 Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 233 (309)
T 3p86_A 164 NLKSPNLLV---DKKYTVKVCDFGLSRLKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233 (309)
T ss_dssp TCCGGGEEE---CTTCCEEECCCC------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred CCChhhEEE---eCCCcEEECCCCCCcccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 999999999 4788999999999975443321 123567999999999999999999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
+|..||.+..... ....+....... .....+++++.+++..||..+|.+||++.+|.+.|+.+++..
T Consensus 234 tg~~Pf~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 234 TLQQPWGNLNPAQ---VVAAVGFKCKRL---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HCCCTTTTSCHHH---HHHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred hCCCCCCCCCHHH---HHHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 9999998765432 222222111111 222456889999999999999999999999999999887643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=359.49 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=210.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+..++|++++.||+|+||+||+|++..+++.||||+++.. .....+.+|..++..++|++++.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~------------ 125 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ------------ 125 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC------------
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee------------
Confidence 4568999999999999999999999999999999998642 12334788999998888776444
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++.++.+.+..|+||||+ |++|.+++...+..+++..++.++.||+.||+|||++||+||||||
T Consensus 126 ---------------l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp 190 (412)
T 2vd5_A 126 ---------------LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190 (412)
T ss_dssp ---------------EEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred ---------------EEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCH
Confidence 444556778899999999 9999999987667899999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-------CCCCCccchHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-------GIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwSlG~il~ 230 (449)
+|||+ +.++.+||+|||+|+........ .....+||+.|+|||++. +..++.++|||||||++|
T Consensus 191 ~NILl---d~~g~vkL~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvily 261 (412)
T 2vd5_A 191 DNILL---DRCGHIRLADFGSCLKLRADGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261 (412)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECCTTSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHH
T ss_pred HHeee---cCCCCEEEeechhheeccCCCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHH
Confidence 99999 47899999999999876543321 123568999999999987 356899999999999999
Q ss_pred HHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHHHhcC
Q 013125 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFLKRLFHDLFSREG 307 (449)
Q Consensus 231 el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp---~~~~l~~~l~~~~~~~~ 307 (449)
||++|+.||.+.... +.+..+.........+.....+++++++++..||. +|.+|+ ++++|.+
T Consensus 262 elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~---------- 327 (412)
T 2vd5_A 262 EMFYGQTPFYADSTA---ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT---------- 327 (412)
T ss_dssp HHHHSSCTTCCSSHH---HHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT----------
T ss_pred HHHhCCCCCCCCCHH---HHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc----------
Confidence 999999999875543 34444444322222222345678999999999999 999984 6666533
Q ss_pred CCCCcccccccc
Q 013125 308 YDFDFVFDWTIL 319 (449)
Q Consensus 308 ~~~~~~~dw~~l 319 (449)
+.|...+||..+
T Consensus 328 Hpff~~i~w~~l 339 (412)
T 2vd5_A 328 HPFFFGLDWDGL 339 (412)
T ss_dssp SGGGTTCCSTTS
T ss_pred CCCcCCCCHHHH
Confidence 344445678655
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=343.89 Aligned_cols=269 Identities=20% Similarity=0.238 Sum_probs=208.1
Q ss_pred CcccCCceEEeeeecccCceeEEEEE----EcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
+.+..++|+++++||+|+||+||+|+ +..+++.||||++..... ...+.+|+++++.++|++++.++..+.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY--- 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 46788999999999999999999998 567889999999875432 235789999999999998777655432
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
.......++||||+ +++|.+++......++...++.++.||+.||+|||++||+|||
T Consensus 82 ----------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 139 (295)
T 3ugc_A 82 ----------------------SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD 139 (295)
T ss_dssp ----------------------HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ----------------------cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence 12345689999999 8899999987666799999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||++ .++.+||+|||+++......... .......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 140 ikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 212 (295)
T 3ugc_A 140 LATRNILVE---NENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212 (295)
T ss_dssp CSGGGEEEE---ETTEEEECCCCSCC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHhhEEEc---CCCeEEEccCcccccccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 999999995 77899999999998765432211 11234567888999999999999999999999999999999
Q ss_pred CCCCCCCChhhcH------------HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 235 GSLPWQGLKAATK------------KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 235 G~~pf~~~~~~~~------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
|..||........ ..............+ ....+|+++.+++..||..||.+||++.++.+.|+++
T Consensus 213 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp TTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 9999875322100 001111111111222 1245689999999999999999999999999999987
Q ss_pred HHh
Q 013125 303 FSR 305 (449)
Q Consensus 303 ~~~ 305 (449)
...
T Consensus 290 ~~~ 292 (295)
T 3ugc_A 290 RDN 292 (295)
T ss_dssp HHC
T ss_pred HHh
Confidence 653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=347.52 Aligned_cols=253 Identities=17% Similarity=0.239 Sum_probs=210.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++.++.
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~-------------- 68 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE-------------- 68 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEE--------------
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeE--------------
Confidence 46899999999999999999999999999999999875432 334788999999999887665543
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..++||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 69 -------------~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~ 135 (321)
T 1tki_A 69 -------------SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135 (321)
T ss_dssp -------------EEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred -------------EEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE
Confidence 345667899999999 789999987655679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+. +.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 136 ~~-~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 136 QT-RRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp SS-SSCCCEEECCCTTCEECCTTCE--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cc-CCCCCEEEEECCCCeECCCCCc--------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 52 1268999999999987654322 12457899999999999988999999999999999999999999875
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ..+..+.......+ ...+..++.++.+++..||..||.+||++.++.+
T Consensus 207 ~~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 207 TNQ---QIIENIMNAEYTFD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SHH---HHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHH---HHHHHHHcCCCCCC-hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 543 34445555544444 4455677899999999999999999999988755
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.60 Aligned_cols=261 Identities=20% Similarity=0.314 Sum_probs=210.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-------CCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeec
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHV 72 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~ 72 (449)
+..++|++++.||+|+||.||+|++. .++..||||+++.... ...+.+|+++++.+ +|++++.++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~---- 153 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL---- 153 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE----
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE----
Confidence 45679999999999999999999975 3456799999876533 23478999999999 787655544
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLAD 136 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~ 136 (449)
.++...+..|+||||+ +++|.+++.... ..+++..++.++.
T Consensus 154 -----------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 210 (370)
T 2psq_A 154 -----------------------GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210 (370)
T ss_dssp -----------------------EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHH
T ss_pred -----------------------EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHH
Confidence 3445667889999999 889999998643 3489999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+........ .......+|+.|+|||++.+..+
T Consensus 211 qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~ 282 (370)
T 2psq_A 211 QLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVY 282 (370)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCC
Confidence 99999999999999999999999999 47889999999999876543321 12235567889999999999999
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |..||.+...... +..+.. ..... ....++.++.+++..||..+|.+||++.+|
T Consensus 283 ~~~~DvwslG~il~ellt~g~~p~~~~~~~~~---~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 283 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---FKLLKE-GHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHT-TCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHhc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999999999999999 9999988654332 222222 21111 123558899999999999999999999999
Q ss_pred HHHHHHHHHhc
Q 013125 296 KRLFHDLFSRE 306 (449)
Q Consensus 296 ~~~l~~~~~~~ 306 (449)
.+.|+.++...
T Consensus 356 l~~L~~il~~~ 366 (370)
T 2psq_A 356 VEDLDRILTLT 366 (370)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999887643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.94 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=205.2
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.+++++|+++++||+|+||+||+|++..+++.||||++..... ......|+.+++.+++...
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~---------------- 93 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI---------------- 93 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCST----------------
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCC----------------
Confidence 57889999999999999999999999999999999999875322 3346779999999874321
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.+++++.+..++...+..|+|||+++++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|
T Consensus 94 ------~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 167 (360)
T 3llt_A 94 ------NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167 (360)
T ss_dssp ------TGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ------CCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCccc
Confidence 1225555666666778999999999999999998654 359999999999999999999999999999999999
Q ss_pred EEeecC----------------------CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCC
Q 013125 160 FLMGLG----------------------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 217 (449)
Q Consensus 160 ill~~~----------------------~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 217 (449)
||+... ...+.+||+|||+|+...... ....||+.|+|||++.+..++
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCC
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCC
Confidence 999421 127889999999998644322 356789999999999999999
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhh------------------------------
Q 013125 218 RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC------------------------------ 267 (449)
Q Consensus 218 ~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~------------------------------ 267 (449)
.++|||||||++|||++|+.||.+......... +.......+.....
T Consensus 238 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM---MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred CccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH---HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 999999999999999999999988655433322 22222222221110
Q ss_pred -----------ccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 268 -----------KSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 268 -----------~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
...++.+.+|+..||..||.+||++.++.
T Consensus 315 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354 (360)
T ss_dssp HHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred hhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 11136788999999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=358.68 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=210.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.++|+++++||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++.++.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~---------- 77 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD---------- 77 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEE----------
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEE----------
Confidence 456899999999999999999999999999999999876532 234789999999999887665443
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+..+.+..|+||||+ |++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 78 -----------------~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~ 139 (444)
T 3soa_A 78 -----------------SISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139 (444)
T ss_dssp -----------------EEECSSEEEEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSST
T ss_pred -----------------EEEECCEEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence 445678899999999 8899998876 567999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||++...+++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~P 212 (444)
T 3soa_A 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQA-------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212 (444)
T ss_dssp TEEESBSSTTCCEEECCCSSCBCCCTTCCB-------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HEEEeccCCCCcEEEccCceeEEecCCCce-------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 999964445689999999999766543321 2356899999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|.+.... ..+..+.......+. ..+..+++++.+++..||..||.+||++.++.+
T Consensus 213 f~~~~~~---~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 213 FWDEDQH---RLYQQIKAGAYDFPS-PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCSSHH---HHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCccHH---HHHHHHHhCCCCCCc-cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9875443 344455555544443 234567899999999999999999999988765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=349.53 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=200.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~ 76 (449)
++.-++|++++.||+|+||.||+|++..+++.||||+++.. .....+..|..++..+ +|+
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp-------------- 81 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP-------------- 81 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCT--------------
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCC--------------
Confidence 34568999999999999999999999999999999998643 2334467777777665 333
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+++.+..+....+..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||
T Consensus 82 -------------~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 147 (353)
T 2i0e_A 82 -------------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147 (353)
T ss_dssp -------------TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred -------------EEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccC
Confidence 4555666667778999999999 8899998876 456999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 148 kp~NIll---~~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 217 (353)
T 2i0e_A 148 KLDNVML---DSEGHIKIADFGMCKENIWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217 (353)
T ss_dssp CGGGEEE---CTTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred CHHHEEE---cCCCcEEEEeCCcccccccCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcC
Confidence 9999999 4788999999999986433221 12467899999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
+.||.+... .+.+..+.......| ..+++++.+++..||..||.+||+.
T Consensus 218 ~~Pf~~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 218 QAPFEGEDE---DELFQSIMEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp SCSSCCSSH---HHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCCCH---HHHHHHHHhCCCCCC-----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 999987543 345555665555444 3568899999999999999999965
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.81 Aligned_cols=254 Identities=25% Similarity=0.297 Sum_probs=209.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++.++.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~---------- 95 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD---------- 95 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEE----------
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE----------
Confidence 356789999999999999999999999999999999876432 234788999999999987665543
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+..+.+..|+||||+ |++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 96 -----------------~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~ 157 (362)
T 2bdw_A 96 -----------------SIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157 (362)
T ss_dssp -----------------EEECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred -----------------EEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchH
Confidence 345667889999999 8899888764 456999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+...+..+.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 158 NIll~~~~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 229 (362)
T 2bdw_A 158 NLLLASKAKGAAVKLADFGLAIEVNDSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229 (362)
T ss_dssp GEEESCSSTTCCEEECCCTTCBCCTTCCS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HEEEecCCCCCCEEEeecCcceEecCCcc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99996444456799999999986654322 2356899999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|.+.... ..+..+.......+. ..+..+++++.+++..||..||.+||++.++.+
T Consensus 230 f~~~~~~---~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 230 FWDEDQH---RLYAQIKAGAYDYPS-PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp SCCSSHH---HHHHHHHHTCCCCCT-TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCHH---HHHHHHHhCCCCCCc-ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9875443 344445454444443 234567899999999999999999999887754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=348.70 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=201.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~ 77 (449)
+.-++|++++.||+|+||.||+|++..+++.||||+++.. .....+..|..++..+ +|++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~----------- 82 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH----------- 82 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCC-----------
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCc-----------
Confidence 4558999999999999999999999999999999998642 3344577888888876 6665444
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
+..+....+..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+|||||
T Consensus 83 ----------------l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 145 (345)
T 1xjd_A 83 ----------------MFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 145 (345)
T ss_dssp ----------------EEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred ----------------EEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence 444556678899999999 8899999876 4579999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 146 p~NIll---~~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 215 (345)
T 1xjd_A 146 LDNILL---DKDGHIKIADFGMCKENMLGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215 (345)
T ss_dssp GGGEEE---CTTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred hhhEEE---CCCCCEEEeEChhhhhcccCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCC
Confidence 999999 4788999999999975433221 124678999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.||.+.... ..+..+.......| ..+++++.+++..||..||.+||++.
T Consensus 216 ~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 216 SPFHGQDEE---ELFHSIRMDNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp CSSCCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCCCCCHH---HHHHHHHhCCCCCC-----cccCHHHHHHHHHHhcCCHhHcCCCh
Confidence 999875443 34444544443333 34578999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=343.55 Aligned_cols=264 Identities=19% Similarity=0.280 Sum_probs=208.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
-.++|+++++||+|+||+||+|.+..+++.||+|++..... ...+.+|+++++.++|++++.++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-------------- 73 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI-------------- 73 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEE--------------
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEE--------------
Confidence 35899999999999999999999999999999998754322 33578999999999888755544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.++......++||||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 74 -------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 140 (310)
T 3s95_A 74 -------------GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140 (310)
T ss_dssp -------------EEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred -------------EEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEE
Confidence 3445667899999999 88999999877778999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccc-------cccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHI-------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
+ +.++.+||+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 141 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 217 (310)
T 3s95_A 141 V---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217 (310)
T ss_dssp E---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred E---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc
Confidence 9 47889999999999876544322100 0011125679999999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHH--HHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 235 GSLPWQGLKAATKK--QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 235 G~~pf~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|..||......... .......... ....+|+++.+++..||..||.+||++.++.+.|+.+...
T Consensus 218 g~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 218 RVNADPDYLPRTMDFGLNVRGFLDRY-------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TCCSSTTTSCBCTTSSBCHHHHHHHT-------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcchhhhHHHHhhhhhcccccc-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99998764332110 0011111111 1245678999999999999999999999999998877543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=351.77 Aligned_cols=283 Identities=29% Similarity=0.467 Sum_probs=200.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcC---CCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
++.+++|++++.||+|+||.||+|.+.. ++..||||+..... .....|+++++.+.+...+ ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~~~~~~~~~~~------------~e 98 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--GPLFSELKFYQRVAKKDCI------------KK 98 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC---CHHHHHHHHHHHHCCHHHH------------HH
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCC--cchHHHHHHHHHHhhhHHH------------HH
Confidence 4567899999999999999999999987 78899999987543 2345566666555433211 11
Q ss_pred hhhhhcccCCCcCeeEEeccc----CCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVD----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+..+....+++++.++.++.. ....|+|||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||
T Consensus 99 ~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 177 (345)
T 2v62_A 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDI 177 (345)
T ss_dssp HHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhhccccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCc
Confidence 122223344556666555544 67889999999999999887533 7999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||++.. ..+.+||+|||+|+.+..................||..|+|||++.+..++.++|||||||++|||++|
T Consensus 178 kp~NIll~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 178 KAANLLLGYK-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp SGGGEEEESS-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CHHHEEEccC-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999521 223999999999987654322111111112466899999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCH--HHhhc--cChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPI--EVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~--~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
..||.+....... ............+. ..... .+++++.+++..||..||.+||++.+|.+.|+++
T Consensus 257 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 257 KLPWEQNLKDPVA-VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp SCTTGGGTTCHHH-HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred CCCccccccccHH-HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 9999653222111 11111111112221 11112 6788999999999999999999999998877643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=345.27 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=201.7
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
|..+--++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+ +|++++
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv--------- 73 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV--------- 73 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBC---------
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccC---------
Confidence 345566899999999999999999999999999999999875421 22367888888877 666544
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.++.+....+..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||
T Consensus 74 ------------------~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 134 (345)
T 3a8x_A 74 ------------------GLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYR 134 (345)
T ss_dssp ------------------CEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred ------------------eEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 4444556678899999999 8899988875 4579999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 135 Dlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 204 (345)
T 3a8x_A 135 DLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204 (345)
T ss_dssp CCCGGGEEE---CTTSCEEECCGGGCBCSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEE---CCCCCEEEEeccccccccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHH
Confidence 999999999 4788999999999986433221 124678999999999999999999999999999999999
Q ss_pred hCCCCCCCChh------hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 234 RGSLPWQGLKA------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 234 ~G~~pf~~~~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
+|..||..... .........+.......| ..++.++.+++..||..||.+||++
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HSSCTTTTTTC-------CHHHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred hCCCCcCCcccccccccccHHHHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 99999975321 112233344444444433 3468899999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=349.08 Aligned_cols=243 Identities=22% Similarity=0.344 Sum_probs=204.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.-++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~------------- 105 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK------------- 105 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCC-------------
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCe-------------
Confidence 447999999999999999999999999999999997542 23345778999988888776444
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+..+.......|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+||||||+
T Consensus 106 --------------~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (350)
T 1rdq_E 106 --------------LEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170 (350)
T ss_dssp --------------EEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred --------------EEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccc
Confidence 444456678899999999 8999999876 456999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+ +.++.+||+|||+++...... ...+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 171 NIll---~~~g~~kL~DFg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 237 (350)
T 1rdq_E 171 NLLI---DQQGYIQVTDFGFAKRVKGRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp GEEE---CTTSCEEECCCTTCEECSSCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEE---CCCCCEEEcccccceeccCCc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCC
Confidence 9999 478899999999998764322 356899999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC-----HHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLK 296 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~-----~~~l~ 296 (449)
|.+... ...+..+.......| ..++.++.+++..||..||.+||+ +++|.
T Consensus 238 f~~~~~---~~~~~~i~~~~~~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~ 292 (350)
T 1rdq_E 238 FFADQP---IQIYEKIVSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp SCCSSH---HHHHHHHHHCCCCCC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCH---HHHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence 987543 344555555554444 346889999999999999999998 56553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.32 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=208.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++.++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~------- 80 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH------- 80 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE-------
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE-------
Confidence 456889999999999999999999999999999999875421 34588999999999988765543
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
.++......++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus 81 --------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 139 (326)
T 2y0a_A 81 --------------------EVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFD 139 (326)
T ss_dssp --------------------EEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --------------------EEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCC
Confidence 3345677899999999 8899998864 56799999999999999999999999999999
Q ss_pred CCCCcEEeecCC-CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 155 IKPDNFLMGLGR-KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 155 Lkp~Nill~~~~-~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
|||+|||+.... ....+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 140 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 211 (326)
T 2y0a_A 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211 (326)
T ss_dssp CCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 999999995211 123899999999987654322 23567999999999999999999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|..||.+.... ..+..+.......+ ...+...+..+.+++..||..||.+||++.++.+
T Consensus 212 ~g~~pf~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 212 SGASPFLGDTKQ---ETLANVSAVNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HSCCSSCCSSHH---HHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HCcCCCCCCCHH---HHHHHHHhcCCCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999875443 33333444343333 4445677899999999999999999999887754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.55 Aligned_cols=251 Identities=23% Similarity=0.280 Sum_probs=201.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|++++.++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~-------------- 67 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-------------- 67 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEE--------------
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEE--------------
Confidence 5899999999999999999999999999999998754332 3577899999999888755543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+....+..|+||||+++++.+.+......++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 -------------~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~ 134 (292)
T 3o0g_A 68 -------------DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134 (292)
T ss_dssp -------------EEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred -------------eEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 3345677899999999889999888777889999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCC-
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ- 240 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~- 240 (449)
+ .++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 135 ~---~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 135 N---RNGELKLANFGLARAFGIPVR-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp C---TTSCEEECCCTTCEECCSCCS-------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred c---CCCCEEEeecccceecCCccc-------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 4 788999999999987654322 124567899999999998776 8999999999999999999877754
Q ss_pred CChhhcHHHHHHHHHHhhcCCCH------------------------HHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPI------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
+.... ..+..+......... .......++++.+++..||..||.+||+++++.
T Consensus 205 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 205 GNDVD---DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp CSSHH---HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCHH---HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 43322 233333322211111 111234578899999999999999999988774
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 282 ~ 282 (292)
T 3o0g_A 282 Q 282 (292)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=351.98 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=193.9
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHc-CCCcceeeEeecchh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHV 75 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~ 75 (449)
+++.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+. |++++.++....
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--- 79 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR--- 79 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE---
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe---
Confidence 355677999999999999999999999999999999998764322 234678999999997 887666544321
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
..+....|+||||++++|.+++.. ..++...+..++.||+.||+|||++||+||||
T Consensus 80 ----------------------~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 135 (388)
T 3oz6_A 80 ----------------------ADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDM 135 (388)
T ss_dssp ----------------------CTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred ----------------------cCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCC
Confidence 123457899999999899998874 57999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCc-ccc-------------ccCCCCCCCCccccccccccC-CCCCccc
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR-HIP-------------YRENKNLTGTARYASCNTHLG-IEQSRRD 220 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~-~~~-------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~ 220 (449)
||+|||+ +.++.+||+|||+|+.+....... ..+ .......+||+.|+|||++.+ ..++.++
T Consensus 136 kp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 212 (388)
T 3oz6_A 136 KPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212 (388)
T ss_dssp CGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHH
T ss_pred CHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChh
Confidence 9999999 478899999999998764321110 000 011235689999999999987 5789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHh----------------------------------
Q 013125 221 DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL---------------------------------- 266 (449)
Q Consensus 221 DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~---------------------------------- 266 (449)
|||||||++|||++|++||.+...... +..+......+..+.+
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQ---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchh
Confidence 999999999999999999998655433 3333322222111110
Q ss_pred --------hccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 267 --------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 267 --------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....++++.+|+..||..||.+||+++++.+
T Consensus 290 ~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 290 NLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp HHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 0145778899999999999999999876643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=348.72 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=194.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.+.++|++.+.||+|+||.||+|++..+++.||||++........+.+|+++++.++|++++.++.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-------------- 115 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKE-------------- 115 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEE--------------
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceee--------------
Confidence 456789999999999999999999999999999999987666667889999999999887655443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++......++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 116 -------------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll 181 (349)
T 2w4o_A 116 -------------IFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLY 181 (349)
T ss_dssp -------------EEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred -------------eEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEE
Confidence 345667899999999 8899998864 4569999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+..+.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 182 ~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 182 ATPAPDAPLKIADFGLSKIVEHQVL--------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp SSSSTTCCEEECCCC------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred ecCCCCCCEEEccCccccccCcccc--------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 6434588999999999986543321 23567899999999999999999999999999999999999999865
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ...+..+.......+ ...+...+.++.+++..||..||.+||++.++.+
T Consensus 254 ~~~--~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 254 RGD--QFMFRRILNCEYYFI-SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TCH--HHHHHHHHTTCCCCC-TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc--HHHHHHHHhCCCccC-CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 432 223344444333322 2334567889999999999999999999887744
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.47 Aligned_cols=266 Identities=20% Similarity=0.254 Sum_probs=208.7
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC---CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+++++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+|+++++.++|++++.++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------- 77 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEE------- 77 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-------
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEee-------
Confidence 46789999999999999999999999999999999998753 22345789999999999988766654321
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~--~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.......|+||||+ +++|.+++..... .+++..++.++.||+.||+|||++||+|||||
T Consensus 78 ------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 139 (319)
T 4euu_A 78 ------------------ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139 (319)
T ss_dssp ------------------CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ------------------cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence 12344789999999 8999999875432 39999999999999999999999999999999
Q ss_pred CCcEEeecC-CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc--------CCCCCccchHHHHHH
Q 013125 157 PDNFLMGLG-RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--------GIEQSRRDDLESLGY 227 (449)
Q Consensus 157 p~Nill~~~-~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DvwSlG~ 227 (449)
|+|||+..+ +..+.+||+|||+|+....... .....||+.|+|||++. +..++.++|||||||
T Consensus 140 p~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 211 (319)
T 4euu_A 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (319)
T ss_dssp GGGEEEEECTTSCEEEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHH
T ss_pred HHHEEEeccCCCCceEEEccCCCceecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHH
Confidence 999998432 3566799999999987655432 23567999999999987 567899999999999
Q ss_pred HHHHHHhCCCCCCCChhh-cHHHHHHHHHHhhcCC-------------------C-HHHhhccChHHHHHHHHHHhCCCC
Q 013125 228 VLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKVST-------------------P-IEVLCKSHPAEFASYFHYCQSLTF 286 (449)
Q Consensus 228 il~el~~G~~pf~~~~~~-~~~~~~~~i~~~~~~~-------------------~-~~~~~~~~~~~~~~l~~~~l~~~p 286 (449)
++|||++|..||...... ...+.+..+....... + ...+....+..+.+++..||..||
T Consensus 212 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 291 (319)
T 4euu_A 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (319)
T ss_dssp HHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCCh
Confidence 999999999999765432 2233444444332210 0 011223446789999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 013125 287 DQRPDYGFLKRLFHD 301 (449)
Q Consensus 287 ~~Rp~~~~l~~~l~~ 301 (449)
.+||+++++.+...+
T Consensus 292 ~~R~s~~ell~h~~d 306 (319)
T 4euu_A 292 EKCWGFDQFFAETSD 306 (319)
T ss_dssp TTSCCHHHHHHHHHH
T ss_pred hhhccHHHhhhccHH
Confidence 999999988775543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=354.37 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=211.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+-.++|++.++||+|+||+||+|++..+++.||||+++.... ...+.+|+++++.++|++++.+++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~----------- 179 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG----------- 179 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEE-----------
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEE-----------
Confidence 346799999999999999999999998999999999875432 235788999999999887666544
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
++...+..|+||||+ +++|.+++...+..++...++.++.||+.||+|||++||+||||||+|
T Consensus 180 ----------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 243 (377)
T 3cbl_A 180 ----------------VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN 243 (377)
T ss_dssp ----------------EECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ----------------EEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHH
Confidence 335567789999999 899999998767779999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
||+ +.++.+||+|||+|+......... ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 244 il~---~~~~~~kl~DfG~s~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p 315 (377)
T 3cbl_A 244 CLV---TEKNVLKISDFGMSREEADGVYAA-----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315 (377)
T ss_dssp EEE---CTTCCEEECCGGGCEECTTSEEEC-----CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEE---cCCCcEEECcCCCceecCCCceee-----cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999 478899999999998644321100 0122345778999999998889999999999999999998 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|.+....... .........+.+ ..+|+++.+++..||..||.+||++.+|.+.|+++.+.
T Consensus 316 ~~~~~~~~~~----~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 316 YPNLSNQQTR----EFVEKGGRLPCP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp STTSCHHHHH----HHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHH----HHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9886654322 222223233322 34588999999999999999999999999999887653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=338.73 Aligned_cols=248 Identities=20% Similarity=0.223 Sum_probs=197.3
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHH-cCCCcceeeEeecchhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKIL-QGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~ 76 (449)
+.++.++|+++++||+|+||+||+|++..+++.||||++....... ....|+..+..+ +|++
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~------------- 118 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC------------- 118 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTT-------------
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCc-------------
Confidence 4566789999999999999999999999999999999876543222 234444444444 5554
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
++.+..++..++..|+|||+++++|.+++...+..+++..++.++.||+.||+|||++||+|||||
T Consensus 119 --------------iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 184 (311)
T 3p1a_A 119 --------------CVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK 184 (311)
T ss_dssp --------------BCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred --------------EEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence 444555556778899999999999999998877789999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus 185 p~NIll---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~ 252 (311)
T 3p1a_A 185 PANIFL---GPRGRCKLGDFGLLVELGTAGA--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM 252 (311)
T ss_dssp GGGEEE---CGGGCEEECCCTTCEECC--------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC
T ss_pred HHHEEE---CCCCCEEEccceeeeecccCCC--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC
Confidence 999999 4778999999999987654332 235569999999999887 7999999999999999999997
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||.+... ...+... .........+++++.+++..||..||.+||++.++.+
T Consensus 253 ~~~~~~~~------~~~~~~~---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 253 ELPHGGEG------WQQLRQG---YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCSSHHH------HHHHTTT---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCccH------HHHHhcc---CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 77665322 2222221 2233455677899999999999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=344.59 Aligned_cols=254 Identities=26% Similarity=0.317 Sum_probs=202.7
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
|..-+-++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.++|++++.++
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~--------- 71 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--------- 71 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEE---------
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEE---------
Confidence 455567999999999999999999999999999999999865422 34588999999999988755543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.++...+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+|||||
T Consensus 72 ------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlk 132 (323)
T 3tki_A 72 ------------------GHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132 (323)
T ss_dssp ------------------EEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ------------------EEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 3446678889999999 7899888764 4569999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G 235 (449)
|+|||+ +.++.+||+|||+++.+...... .......||+.|+|||++.+..+ +.++|||||||++|||++|
T Consensus 133 p~NIll---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 133 PENLLL---DERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp GGGEEE---CTTCCEEECCCTTCEECEETTEE-----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred hHHEEE---eCCCCEEEEEeeccceeccCCcc-----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 999999 47789999999999866433211 11236689999999999988775 7899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
..||.+...... .+..........+ .+..++.++.+++..||..||.+||++.++
T Consensus 205 ~~pf~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 259 (323)
T 3tki_A 205 ELPWDQPSDSCQ--EYSDWKEKKTYLN---PWKKIDSAPLALLHKILVENPSARITIPDI 259 (323)
T ss_dssp SCSCSSSCTTSH--HHHHHHTTCTTST---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCchHHH--HHHHHhcccccCC---ccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999987554322 2222222221111 135568899999999999999999998766
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=341.29 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=203.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.-++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++|++++.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~------------ 71 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM------------ 71 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCE------------
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceE------------
Confidence 347899999999999999999999999999999998643 233456788888888888765544
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+.+..+....|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+||||||+
T Consensus 72 ---------------~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 135 (318)
T 1fot_A 72 ---------------WGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 135 (318)
T ss_dssp ---------------EEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred ---------------eEEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChh
Confidence 44445678899999999 8899999876 567999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+ +.++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 136 NIll---~~~g~~kL~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 202 (318)
T 1fot_A 136 NILL---DKNGHIKITDFGFAKYVPDV----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202 (318)
T ss_dssp GEEE---CTTSCEEECCCSSCEECSSC----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eEEE---cCCCCEEEeecCcceecCCc----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 9999 47889999999999865432 1356899999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 296 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~ 296 (449)
|.+... ...+..+.......| ..+++++.+++..||..||.+|| +++++.
T Consensus 203 f~~~~~---~~~~~~i~~~~~~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 203 FYDSNT---MKTYEKILNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp TCCSSH---HHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCH---HHHHHHHHhCCCCCC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 987543 344555555554444 34578999999999999999999 666553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=351.41 Aligned_cols=265 Identities=18% Similarity=0.272 Sum_probs=210.0
Q ss_pred CcccCCceEEeeeecccCceeEEEEEE-----cCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecc
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVD 73 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 73 (449)
.++..++|+++++||+|+||+||+|++ ..+++.||||++..... ...+.+|+.+++.++|++++.++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~---- 141 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG---- 141 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE----
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEE----
Confidence 356678999999999999999999994 45678899999865433 224788999999999887665544
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVH 146 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------~~~~~~~~~~i~~qil~~L~~LH 146 (449)
++......++||||+ +++|.+++.... ..+++..++.++.||+.||+|||
T Consensus 142 -----------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 198 (367)
T 3l9p_A 142 -----------------------VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198 (367)
T ss_dssp -----------------------EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH
Confidence 345667789999999 889999998654 35899999999999999999999
Q ss_pred hCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHH
Q 013125 147 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG 226 (449)
Q Consensus 147 ~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG 226 (449)
++||+||||||+|||++..+....+||+|||+|+....... +.......||+.|+|||++.+..++.++||||||
T Consensus 199 ~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG 273 (367)
T 3l9p_A 199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273 (367)
T ss_dssp HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence 99999999999999995433456799999999975432221 1122355679999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 227 YVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 227 ~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|++|||++ |..||.+.... ..+..+...... . ....++..+.+++..||..+|.+||++.+|.+.|+.+...
T Consensus 274 ~il~ellt~g~~pf~~~~~~---~~~~~i~~~~~~-~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 274 VLLWEIFSLGYMPYPSKSNQ---EVLEFVTSGGRM-D---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHHHTTSCCSSTTCCHH---HHHHHHHTTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCC-C---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 99999998 99999876543 223333222211 1 1245688999999999999999999999999998877553
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.07 Aligned_cols=255 Identities=24% Similarity=0.253 Sum_probs=207.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+|++++..+ +|++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~----------------- 80 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIIT----------------- 80 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCC-----------------
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCe-----------------
Confidence 46789999999999999999999999999999999876432 356788888887 5665444
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++.++.+.+..|+||||+ |++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 81 ----------~~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~ 149 (342)
T 2qr7_A 81 ----------LKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149 (342)
T ss_dssp ----------EEEEEECSSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ----------EEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEE
Confidence 444556778899999999 8899998865 5579999999999999999999999999999999999998
Q ss_pred ecCC-CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGR-KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~-~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
...+ ..+.+||+|||+++........ ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 150 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 150 VDESGNPESIRICDFGFAKQLRAENGL-------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp SSSSCSGGGEEECCCTTCEECBCTTCC-------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ecCCCCcCeEEEEECCCcccCcCCCCc-------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 5221 2246999999999876544321 2356789999999999988899999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.......+.+..+.......+ ...+..+++++.+++..||..||.+||++.++.+
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 223 GPDDTPEEILARIGSGKFSLS-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp STTSCHHHHHHHHHHCCCCCC-STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcCCHHHHHHHHccCCcccC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 554455555666655544433 2344567899999999999999999999887744
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=337.78 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=199.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|+++++||+|+||+||+|++ .+++.||+|++..... ...+.+|+++++.++|++++.++.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~------------- 67 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD------------- 67 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEE-------------
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeee-------------
Confidence 6899999999999999999998 6789999998865422 345789999999998887655443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..|+|||++.++|.+++..+...++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 --------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 133 (288)
T 1ob3_A 68 --------------VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133 (288)
T ss_dssp --------------EEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --------------EEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 345667899999999889999998767789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+
T Consensus 134 ---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 134 ---NREGELKIADFGLARAFGIPVR-------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp ---CTTSCEEECCTTHHHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ---cCCCCEEEeECccccccCcccc-------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4788999999999976543221 12345789999999999764 589999999999999999999999988
Q ss_pred ChhhcHHHHHHHHHHhhc---------------------CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKV---------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~---------------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+........ ..+........++++.+++..||..||.+||++.++.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 655433332222211100 11122334567899999999999999999999887744
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=341.47 Aligned_cols=268 Identities=21% Similarity=0.275 Sum_probs=206.5
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHH--HcCCCcceeeEeecchhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~--l~~~~~~~~~~~~~~~~~~~ 78 (449)
|++++.++|++++.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++|++++.++......
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~---- 74 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTS---- 74 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE----
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccc----
Confidence 6789999999999999999999999988 6889999998653 33456778888877 7888877665543211
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRG 149 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--------~~g 149 (449)
.......|+||||+ +++|.++++ ...+++..++.++.||+.||+||| ++|
T Consensus 75 -------------------~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 133 (301)
T 3q4u_A 75 -------------------RHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133 (301)
T ss_dssp -------------------ETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE
T ss_pred -------------------cCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC
Confidence 22345689999999 789999985 457999999999999999999999 999
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC------CCCccchHH
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLE 223 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~Dvw 223 (449)
|+||||||+|||++ .++.+||+|||+|+........... ......||+.|+|||++.+. .++.++|||
T Consensus 134 ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvw 207 (301)
T 3q4u_A 134 IAHRDLKSKNILVK---KNGQCCIADLGLAVMHSQSTNQLDV---GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207 (301)
T ss_dssp EECSCCCGGGEEEC---TTSCEEECCCTTCEEEETTTTEEEC---CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHH
T ss_pred eecCCCChHhEEEc---CCCCEEEeeCCCeeecccccccccc---cccccccccceeChhhhcCcCCCCcccCCchhhHH
Confidence 99999999999994 7889999999999876654332111 12355899999999999877 455799999
Q ss_pred HHHHHHHHHHhC----------CCCCCCChhhc-HHHHHHHHHH-hh--cCCCHHHhhccChHHHHHHHHHHhCCCCCCC
Q 013125 224 SLGYVLLYFLRG----------SLPWQGLKAAT-KKQKYDKICE-KK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 289 (449)
Q Consensus 224 SlG~il~el~~G----------~~pf~~~~~~~-~~~~~~~i~~-~~--~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 289 (449)
||||++|||++| ..||....... ....+..+.. .. ...+........+.++.+++..||..||.+|
T Consensus 208 slG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 287 (301)
T 3q4u_A 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287 (301)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhC
Confidence 999999999999 88987643322 1222222221 11 1222222333456889999999999999999
Q ss_pred CCHHHHHHHHHHH
Q 013125 290 PDYGFLKRLFHDL 302 (449)
Q Consensus 290 p~~~~l~~~l~~~ 302 (449)
|++.++.+.|+++
T Consensus 288 ps~~~i~~~L~~i 300 (301)
T 3q4u_A 288 LTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHhcc
Confidence 9999999988764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=339.92 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=200.3
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
++|.+++|++.++||+|+||+||+|++. ..||+|+++..... ..+.+|+++++.++|++++.++..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~------- 88 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY------- 88 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-------
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-------
Confidence 5788999999999999999999999863 35999998755432 347889999999998876654432
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
......++||||+ +++|.+++......+++..++.++.||+.||+|||++||+|||||
T Consensus 89 ---------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlk 147 (289)
T 3og7_A 89 ---------------------STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147 (289)
T ss_dssp ---------------------ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred ---------------------ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 2345679999999 789999887666779999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHH
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~ 233 (449)
|+|||++ .++.+||+|||+++......... ......||+.|+|||++. +..++.++|||||||++|||+
T Consensus 148 p~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 219 (289)
T 3og7_A 148 SNNIFLH---EDNTVKIGDFGLATEKSRWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219 (289)
T ss_dssp GGGEEEE---TTTEEEECCCC-----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH
T ss_pred cceEEEC---CCCCEEEccceeccccccccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH
Confidence 9999995 77899999999997654322111 123567899999999987 566899999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
+|+.||.+..... .....+...............+|+++.+++..||..+|.+||++.++.+.|+++.
T Consensus 220 ~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 220 TGQLPYSNINNRD--QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HSSCTTSSCCCHH--HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HCCCCccccchHH--HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 9999998755432 2223333444444555556677899999999999999999999999999988764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=357.81 Aligned_cols=255 Identities=20% Similarity=0.249 Sum_probs=196.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|++++.++.......
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 134 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK----- 134 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC-----
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC-----
Confidence 4589999999999999999999999999999999987532 1335789999999999999887765432210
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
...+....|+||||+.++|.+.+. ..++...++.++.||+.||+|||++||+||||||+||
T Consensus 135 ----------------~~~~~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI 195 (464)
T 3ttj_A 135 ----------------TLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195 (464)
T ss_dssp ----------------STTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ----------------ccccCCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence 012345789999999888877764 4599999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+|+....... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.
T Consensus 196 ll---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 196 VV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp EE---CTTSCEEECCCCCC-----CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EE---eCCCCEEEEEEEeeeecCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 99 4788999999999986654321 235689999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHh-------------------------h------------ccChHHHHHHHHHHhC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVL-------------------------C------------KSHPAEFASYFHYCQS 283 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~-------------------------~------------~~~~~~~~~l~~~~l~ 283 (449)
+..... .+..+.........+.. . +..++++.+|+..||.
T Consensus 265 g~~~~~---~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~ 341 (464)
T 3ttj_A 265 GRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341 (464)
T ss_dssp CSSHHH---HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCHHH---HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC
Confidence 865443 33333332222211110 0 0014678999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013125 284 LTFDQRPDYGFLKR 297 (449)
Q Consensus 284 ~~p~~Rp~~~~l~~ 297 (449)
.||.+||+++++.+
T Consensus 342 ~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 342 IDPAKRISVDDALQ 355 (464)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999887644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=340.49 Aligned_cols=255 Identities=20% Similarity=0.268 Sum_probs=187.9
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.++|+++++||+|+||+||+|.+..+++.||+|+++... ....+.+|+++++.++|++++.++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~------------- 70 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD------------- 70 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEE-------------
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEE-------------
Confidence 478999999999999999999999999999999987543 2346889999999998887655443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-----~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+....+..|+||||+.++|.+++.... ..++...++.++.||+.||+|||++||+||||||
T Consensus 71 --------------~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp 136 (317)
T 2pmi_A 71 --------------VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP 136 (317)
T ss_dssp --------------EECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred --------------EEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCh
Confidence 445667899999999889999887543 4589999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~ 236 (449)
+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 137 ~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (317)
T 2pmi_A 137 QNLLI---NKRGQLKLGDFGLARAFGIPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206 (317)
T ss_dssp GGEEE---CTTCCEEECCCSSCEETTSCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred HHeEE---cCCCCEEECcCccceecCCCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999 4788999999999987653322 12355789999999999874 5899999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCC---------------------CH-----HHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVST---------------------PI-----EVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~---------------------~~-----~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
.||.+.........+.......... .. .......+.++.+++..||..||.+||
T Consensus 207 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 286 (317)
T 2pmi_A 207 PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286 (317)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC
Confidence 9998866543333332221110000 00 011124678899999999999999999
Q ss_pred CHHHHHH
Q 013125 291 DYGFLKR 297 (449)
Q Consensus 291 ~~~~l~~ 297 (449)
++.++.+
T Consensus 287 t~~e~l~ 293 (317)
T 2pmi_A 287 SAKQALH 293 (317)
T ss_dssp CHHHHTT
T ss_pred CHHHHhC
Confidence 9877643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=352.85 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=205.4
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.+..+|+++++||+|+||+||+|.+..+++.||||++..... ...+.+|+++++.+++....
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~---------------- 156 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD---------------- 156 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTT----------------
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhcccc----------------
Confidence 4577899999999999999999999999999999999875432 34577899999999776421
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.++++..+..++......|+|||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 157 -----~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NI 231 (429)
T 3kvw_A 157 -----NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231 (429)
T ss_dssp -----SCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGE
T ss_pred -----CCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 1225555666667778999999999999999988654 4599999999999999999999999999999999999
Q ss_pred EeecCCCCCe--EEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 161 LMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 161 ll~~~~~~~~--vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|++ .++. +||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 232 Ll~---~~~~~~vkL~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p 298 (429)
T 3kvw_A 232 LLK---QQGRSGIKVIDFGSSCYEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298 (429)
T ss_dssp EES---STTSCCEEECCCTTCEETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEc---cCCCcceEEeecccceecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence 994 4554 9999999997644322 356889999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHH-----------------------------------------------------
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEV----------------------------------------------------- 265 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~----------------------------------------------------- 265 (449)
|.+........ .+.......+...
T Consensus 299 f~~~~~~~~l~---~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (429)
T 3kvw_A 299 LPGEDEGDQLA---CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN 375 (429)
T ss_dssp SCCSSHHHHHH---HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHH
T ss_pred CCCCCHHHHHH---HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHh
Confidence 98866543332 2222221111110
Q ss_pred -hhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 266 -LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 266 -~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+....++++.+|+..||..||.+||++.++.+
T Consensus 376 ~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 376 ALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 11123678899999999999999999887643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=354.19 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=209.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+..++|+++++||+|+||+||+|.+ +++.||||+++.......+.+|+++++.++|++++.+++.+.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------- 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----------- 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEE-----------
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEE-----------
Confidence 4567899999999999999999988 477999999988777778999999999999998777655431
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~-~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
......|+||||+ +++|.+++...+.. ++...++.++.||+.||+|||++||+||||||+|||
T Consensus 257 ---------------~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 321 (450)
T 1k9a_A 257 ---------------EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 321 (450)
T ss_dssp ---------------CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred ---------------cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEE
Confidence 2334789999999 88999999875543 799999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
++ .++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 322 l~---~~~~~kl~DfG~a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 322 VS---EDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp EC---TTSCEEECCCTTCEECC----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EC---CCCCEEEeeCCCcccccccc----------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 94 78899999999998543221 13356889999999999999999999999999999998 999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
+......... +. .....+. ...+|+++.++|..||..||.+||++.+|.+.|+++...
T Consensus 389 ~~~~~~~~~~---i~-~~~~~~~---p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 389 RIPLKDVVPR---VE-KGYKMDA---PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TSCTTTHHHH---HH-TTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHH---HH-cCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 8765443322 22 2222222 245689999999999999999999999999999887654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=351.11 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=205.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+..++|+++++||+|+||+||+|++..+++.||+|++.. ......+.+|+.+++.++|++++.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l----------- 134 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL----------- 134 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCE-----------
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeE-----------
Confidence 446799999999999999999999999999999999764 2334457899999999988875554
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+.++.+....|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 135 ----------------~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp 196 (410)
T 3v8s_A 135 ----------------FYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196 (410)
T ss_dssp ----------------EEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred ----------------EEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH
Confidence 44456778899999999 9999998864 4699999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC----CCccchHHHHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlG~il~el~ 233 (449)
+|||+ +.++.+||+|||+|+........ .....+||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 197 ~NILl---~~~g~ikL~DFG~a~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell 267 (410)
T 3v8s_A 197 DNMLL---DKSGHLKLADFGTCMKMNKEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267 (410)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECCTTSEE------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH
T ss_pred HHeeE---CCCCCEEEeccceeEeeccCCcc------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH
Confidence 99999 47899999999999876543211 124678999999999998766 789999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhh--cCCCHHHhhccChHHHHHHHHHHhCCCCCC--CCCHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 297 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~--Rp~~~~l~~ 297 (449)
+|..||.+.... ..+..+.... ...|. ...++.++++|+..||..+|.+ ||++++|.+
T Consensus 268 ~G~~Pf~~~~~~---~~~~~i~~~~~~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 268 VGDTPFYADSLV---GTYSKIMNHKNSLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HSSCTTCCSSHH---HHHHHHHTHHHHCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred hCCCCCCCCChh---hHHHHHHhccccccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 999999875543 3444444432 22232 1356889999999999988888 999888754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=344.52 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=195.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
..++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|++++.++.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-------------- 83 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKE-------------- 83 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEE--------------
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEE--------------
Confidence 4589999999999999999999999999999999987643 3456889999999999887665443
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++......|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 84 -------------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill 149 (361)
T 3uc3_A 84 -------------VILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL 149 (361)
T ss_dssp -------------EEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE
T ss_pred -------------EEeeCCEEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 345667899999999 8899998875 4569999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCcc-chHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR-DDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwSlG~il~el~~G~~pf~~ 241 (449)
+. +..+.+||+|||+|+....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+
T Consensus 150 ~~-~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 150 DG-SPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp CS-SSSCCEEECCCCCC-----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred cC-CCCceEEEeecCccccccccCC--------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 41 1233599999999974332221 235679999999999998887655 8999999999999999999987
Q ss_pred Chhhc-HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAAT-KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... ....+..+.......+.. ..+++++.+|+..||..||.+||++.++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 221 PEEPRDYRKTIQRILSVKYSIPDD---IRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ---CCCHHHHHHHHHTTCCCCCTT---SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CccHHHHHHHHHHHhcCCCCCCCc---CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 55432 233344444444433322 245789999999999999999999988755
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=332.74 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=199.9
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCC---CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
++..++|++++.||+|+||+||+|.+..+ +..||+|+...... ...+.+|+.+++.++|++++.++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------ 84 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV------ 84 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE------
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEE------
Confidence 46778999999999999999999998653 45699999875433 2347889999999998876665432
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
. .++..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||
T Consensus 85 ---------------------~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 142 (281)
T 1mp8_A 85 ---------------------I-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 142 (281)
T ss_dssp ---------------------E-CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ---------------------E-ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 1 345679999999 77999999876667999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+|||++ .++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++
T Consensus 143 kp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~ 213 (281)
T 1mp8_A 143 AARNVLVS---SNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 213 (281)
T ss_dssp SGGGEEEE---ETTEEEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred cHHHEEEC---CCCCEEECccccccccCccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhc
Confidence 99999995 6789999999999876543221 1224456789999999998899999999999999999997
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|..||.+....... ..+.... ..+ ....+++++.+++..||..||.+||++.++.+.|++++...
T Consensus 214 g~~pf~~~~~~~~~---~~i~~~~-~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 214 GVKPFQGVKNNDVI---GRIENGE-RLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp SCCTTTTCCGGGHH---HHHHTTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHH---HHHHcCC-CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 99999876554322 2222221 111 22456899999999999999999999999999999887653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=338.95 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=197.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
..+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++|++++.++......
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 84 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE--- 84 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE---
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc---
Confidence 45779999999999999999999999999999999998765322 2467788888888888766655432111
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
...+...|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+|||||
T Consensus 85 --------------------~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 143 (311)
T 3ork_A 85 --------------------TPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143 (311)
T ss_dssp --------------------ETTEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred --------------------CCCCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 11223459999999 8899999876 4579999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||++ .++.+||+|||+++......... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 144 p~Nil~~---~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 216 (311)
T 3ork_A 144 PANIMIS---ATNAVKVMDFGIARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216 (311)
T ss_dssp GGGEEEE---TTSCEEECCCSCC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHHEEEc---CCCCEEEeeccCccccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999995 77899999999998665432211 1123567899999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
.||.+..... ....+.. ....+.......++.++.+++..||..||.+||+..++
T Consensus 217 ~pf~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 217 PPFTGDSPVS---VAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp CSCCCSSHHH---HHHHHHH-CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCCCCCChHH---HHHHHhc-CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 9998765432 2222222 33445555667789999999999999999999976543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=356.43 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=190.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|++++.++.......
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 125 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD---- 125 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC----
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC----
Confidence 356899999999999999999999999999999998865422 235789999999999999887766542210
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.......|+|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 126 ------------------~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~N 186 (458)
T 3rp9_A 126 ------------------VEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186 (458)
T ss_dssp ------------------TTTCCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred ------------------cccCceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhh
Confidence 123467899999999999998864 5679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccc-c-------------------ccCCCCCCCCcccccccccc-CCCCCc
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-P-------------------YRENKNLTGTARYASCNTHL-GIEQSR 218 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~-~-------------------~~~~~~~~gt~~y~aPE~~~-~~~~s~ 218 (449)
||+ +.++.+||+|||+|+........... + .+.....+||+.|+|||++. +..++.
T Consensus 187 ILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 263 (458)
T 3rp9_A 187 CLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263 (458)
T ss_dssp EEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCT
T ss_pred EEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCc
Confidence 999 47889999999999876533211100 0 01234568899999999874 566999
Q ss_pred cchHHHHHHHHHHHHh-----------CCCCCCCChhh-----------------cHHHHHHHHHHhhcCCC--------
Q 013125 219 RDDLESLGYVLLYFLR-----------GSLPWQGLKAA-----------------TKKQKYDKICEKKVSTP-------- 262 (449)
Q Consensus 219 ~~DvwSlG~il~el~~-----------G~~pf~~~~~~-----------------~~~~~~~~i~~~~~~~~-------- 262 (449)
++|||||||++|||++ |+++|.+.... .....+..+.......+
T Consensus 264 ~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 343 (458)
T 3rp9_A 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343 (458)
T ss_dssp HHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSS
T ss_pred HhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcC
Confidence 9999999999999998 77777664310 01122222322222221
Q ss_pred ------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 263 ------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 263 ------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
........++++.+|+..||..||.+||+++++.+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp CHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 12223445789999999999999999999887754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.47 Aligned_cols=264 Identities=20% Similarity=0.307 Sum_probs=213.0
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCC-------CceEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCcceeeEee
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTKH---PQLLYEAKVYKIL-QGGSKIRLVVFH 71 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvKv~~~~~~~---~~~~~E~~~l~~l-~~~~~~~~~~~~ 71 (449)
++..++|+++++||+|+||+||+|++..+ +..||||+++..... ..+.+|+++++.+ +|++++.++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~--- 141 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL--- 141 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE---
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe---
Confidence 46678999999999999999999997543 357999998765433 3478999999999 787655544
Q ss_pred cchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHH
Q 013125 72 VDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLA 135 (449)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~ 135 (449)
.++...+..|+||||+ +++|.+++.... ..+++..++.++
T Consensus 142 ------------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 197 (382)
T 3tt0_A 142 ------------------------GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197 (382)
T ss_dssp ------------------------EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHH
T ss_pred ------------------------eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHH
Confidence 3445667889999999 889999998653 359999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC
Q 013125 136 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 215 (449)
Q Consensus 136 ~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (449)
.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+........ .......+|+.|+|||++.+..
T Consensus 198 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~ 269 (382)
T 3tt0_A 198 YQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRI 269 (382)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHhCCEecCCCCcceEEEc---CCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCC
Confidence 9999999999999999999999999994 7889999999999866543321 1223556788999999999999
Q ss_pred CCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 216 QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 216 ~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
++.++|||||||++|||++ |..||.+..... ....+.. ..... ....+++++.+++..||..+|.+||++.+
T Consensus 270 ~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~e 342 (382)
T 3tt0_A 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKE-GHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQ 342 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHT-TCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999999999999 999998765432 2222222 21111 12456889999999999999999999999
Q ss_pred HHHHHHHHHHhcCC
Q 013125 295 LKRLFHDLFSREGY 308 (449)
Q Consensus 295 l~~~l~~~~~~~~~ 308 (449)
|.+.|+.++.....
T Consensus 343 ll~~L~~~~~~~~~ 356 (382)
T 3tt0_A 343 LVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHHhc
Confidence 99999998876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.68 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=198.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++.++.......
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 97 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE----- 97 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS-----
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC-----
Confidence 46899999999999999999999999999999999865432 234678999999999998877655432110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+|||+++++|.+++.. ..++...++.++.||+.||+|||++||+||||||+||
T Consensus 98 ----------------~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NI 159 (367)
T 1cm8_A 98 ----------------TLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 159 (367)
T ss_dssp ----------------STTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ----------------ccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHE
Confidence 0012245799999999999999875 5799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +.++.+||+|||+++...... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 160 ll---~~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 226 (367)
T 1cm8_A 160 AV---NEDCELKILDFGLARQADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226 (367)
T ss_dssp EE---CTTCCEEECCCTTCEECCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EE---cCCCCEEEEeeeccccccccc----------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 99 478899999999998754321 35678999999999987 67999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCH--------------------------HHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPI--------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+..... .+..+.......+. .......++++.+|+..||..||.+||++.
T Consensus 227 ~~~~~~~---~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~ 303 (367)
T 1cm8_A 227 KGSDHLD---QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303 (367)
T ss_dssp CCSSHHH---HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCHHH---HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence 8865443 33333332222221 222345678999999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 304 e~l~ 307 (367)
T 1cm8_A 304 EALA 307 (367)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 7754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=345.80 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=207.5
Q ss_pred ccCCceEEeeeecccCceeEEEEE-----EcCCCceEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKH---PQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+..++|+++++||+|+||.||+|+ +..+++.||||+++..... ..+.+|++++..+ +|++++.+++.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~--- 95 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC--- 95 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee---
Confidence 567899999999999999999999 4456789999999765433 3488999999999 667766554432
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC-----------------------------
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR----------------------------- 124 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~----------------------------- 124 (449)
...+...++||||+ +++|.+++.....
T Consensus 96 -----------------------~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (359)
T 3vhe_A 96 -----------------------TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRR 152 (359)
T ss_dssp -----------------------CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------
T ss_pred -----------------------ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhcc
Confidence 22345689999999 8899999875422
Q ss_pred ------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCC
Q 013125 125 ------------------------------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 168 (449)
Q Consensus 125 ------------------------------------~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~ 168 (449)
.+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~ 229 (359)
T 3vhe_A 153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EK 229 (359)
T ss_dssp -------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GG
T ss_pred ccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CC
Confidence 189999999999999999999999999999999999994 77
Q ss_pred CeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcH
Q 013125 169 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 247 (449)
Q Consensus 169 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~ 247 (449)
+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 230 ~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 303 (359)
T 3vhe_A 230 NVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 303 (359)
T ss_dssp GCEEECCCGGGSCTTSCTTC-----EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred CcEEEEeccceeeecccccc-----hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-
Confidence 89999999999865433221 12245678899999999999999999999999999999998 999998755432
Q ss_pred HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.+............ ....++++.+++..||..||.+||++.++.+.|+.++..
T Consensus 304 --~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 304 --EFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 12222222222221 234578999999999999999999999999999988764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=348.62 Aligned_cols=268 Identities=19% Similarity=0.296 Sum_probs=202.8
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+++++.++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.+++.+... ..
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~-----~~------ 99 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND-----PN------ 99 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTC-----GG------
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCC-----CC------
Confidence 367889999999999999999999999999999999999875422 345789999999997543110 00
Q ss_pred hhhhhcccCCCcCeeEEec----ccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc
Q 013125 80 LTIIFSSTLGGIPNIKWYG----VDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHR 153 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~----~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~-giiHr 153 (449)
++++..+..+. ......|+|||+++++|.+.+.... ..+++..++.++.||+.||+|||++ ||+||
T Consensus 100 --------~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 100 --------REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp --------GGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred --------cceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 11233332222 2567889999999999988887543 5699999999999999999999998 99999
Q ss_pred CCCCCcEEeecCC----------------------------------------------CCCeEEEEeecceeeecCCCC
Q 013125 154 DIKPDNFLMGLGR----------------------------------------------KANQVYIIDFGLAKKYRDPTT 187 (449)
Q Consensus 154 DLkp~Nill~~~~----------------------------------------------~~~~vkL~DfGla~~~~~~~~ 187 (449)
||||+|||++..+ ....+||+|||+|+......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~- 250 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF- 250 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-
Confidence 9999999995211 11379999999998764322
Q ss_pred CccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhc---HHHHHHHHHHhhcCCCHH
Q 013125 188 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT---KKQKYDKICEKKVSTPIE 264 (449)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~---~~~~~~~i~~~~~~~~~~ 264 (449)
....||+.|+|||++.+..++.++|||||||++|||++|..||.+..... ....+..+.......|..
T Consensus 251 ---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 321 (397)
T 1wak_A 251 ---------TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321 (397)
T ss_dssp ---------CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHH
T ss_pred ---------ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChH
Confidence 34578999999999999999999999999999999999999998654322 222233333322232221
Q ss_pred Hh-------------------------------------hccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 265 VL-------------------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 265 ~~-------------------------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.. ....+..+.+|+..||..||.+||++.++.+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred HhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 11 1122467889999999999999999887744
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=334.10 Aligned_cols=256 Identities=17% Similarity=0.273 Sum_probs=203.0
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc---------hhHHHHHHHHHHHcCCCcceeeEeecc
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---------PQLLYEAKVYKILQGGSKIRLVVFHVD 73 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~---------~~~~~E~~~l~~l~~~~~~~~~~~~~~ 73 (449)
.+..++|++.+.||+|+||+||+|++..+++.||+|++...... ..+.+|+++++.++|++++.++...
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-- 92 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM-- 92 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee--
Confidence 46789999999999999999999999999999999998654221 4578899999999988766654432
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--F 150 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g--i 150 (449)
. ...++||||+ +++|.+.+......+++..++.++.||+.||+|||++| |
T Consensus 93 -------------------------~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 93 -------------------------H--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp -------------------------T--TTTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred -------------------------c--CCCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 2 2237999999 79998888766678999999999999999999999999 9
Q ss_pred cccCCCCCcEEeecCC--CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc--CCCCCccchHHHHH
Q 013125 151 LHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLG 226 (449)
Q Consensus 151 iHrDLkp~Nill~~~~--~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwSlG 226 (449)
+||||||+|||++..+ ....+||+|||+++..... .....||+.|+|||++. ...++.++||||||
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG 215 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFA 215 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHH
Confidence 9999999999995211 1123999999999744322 13567899999999984 45578999999999
Q ss_pred HHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 227 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 227 ~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|++|||++|+.||....... ......+........ ....+++++.+++..||..||.+||++.++.+.|++
T Consensus 216 ~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 216 MILYTILTGEGPFDEYSYGK-IKFINMIREEGLRPT---IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHSSCTTTTCCCCH-HHHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHcCCCCCccccccH-HHHHHHHhccCCCCC---CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 99999999999998754432 222222223222222 234568999999999999999999999999888764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.75 Aligned_cols=248 Identities=26% Similarity=0.303 Sum_probs=202.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
...-++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+++++.++|++++.++.
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~-------- 76 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD-------- 76 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEE--------
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEE--------
Confidence 34458999999999999999999999999999999987532 33456889999999999887665543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+....+..++||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 77 -------------------~~~~~~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp 136 (336)
T 3h4j_B 77 -------------------VITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136 (336)
T ss_dssp -------------------EEECSSEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCST
T ss_pred -------------------EEEeCCEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCch
Confidence 3456678999999999999998876 45799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G~ 236 (449)
+|||+ ++++.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 137 ~NIll---~~~~~~kl~DFG~s~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 205 (336)
T 3h4j_B 137 ENLLL---DDNLNVKIADFGLSNIMTDGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205 (336)
T ss_dssp TTEEE---CTTCCEEECCSSCTBTTTTSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred hhEEE---cCCCCEEEEEeccceeccCCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence 99999 4788999999999976544321 235679999999999998876 78999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||.+....... ..+...... .....++++.+++..||..||.+||++.++.+
T Consensus 206 ~Pf~~~~~~~~~---~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 206 LPFDDEFIPNLF---KKVNSCVYV-----MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSSBCSSSTTCB---CCCCSSCCC-----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCCccHHHHH---HHHHcCCCC-----CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999875432111 111111111 12345789999999999999999999988755
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=329.21 Aligned_cols=255 Identities=25% Similarity=0.294 Sum_probs=208.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
..+.++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~---------- 71 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH---------- 71 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEE----------
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEE----------
Confidence 3567999999999999999999999999999999999865432 23467899999999988755543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.+.......++|||++ +++|.+.+.. ...++...+..++.||+.||+|||++||+||||||
T Consensus 72 -----------------~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 133 (284)
T 3kk8_A 72 -----------------DSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133 (284)
T ss_dssp -----------------EEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred -----------------EEEEcCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCH
Confidence 3445677889999999 7899888775 46799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+||+++..+..+.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 134 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (284)
T 3kk8_A 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205 (284)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCSSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEecCCCCCcEEEeeceeeEEcccCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCC
Confidence 999996444456699999999987654322 235679999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.+.... .....+.......+.+ .+...++++.+++..||..||.+||++.++.+
T Consensus 206 pf~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 206 PFWDEDQH---RLYAQIKAGAYDYPSP-EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp SSCCSSHH---HHHHHHHHTCCCCCTT-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCchh---HHHHHHHhccccCCch-hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99875543 3333344444433322 23466889999999999999999999988755
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.99 Aligned_cols=254 Identities=19% Similarity=0.249 Sum_probs=196.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|++++.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~---------------- 65 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL---------------- 65 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCE----------------
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCee----------------
Confidence 589999999999999999999999999999998864422 1235578899988888765544
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..+....+..|+||||++++|.+++...+..++...++.++.||+.||+|||++||+||||||+|||++
T Consensus 66 -----------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 134 (324)
T 3mtl_A 66 -----------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134 (324)
T ss_dssp -----------EEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC
T ss_pred -----------eeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC
Confidence 344456778999999999899999988777899999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 135 ---~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 135 ---ERGELKLADFGLARAKSIPTK-------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ---TTCCEEECSSSEEECC-------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ---CCCCEEEccCcccccccCCcc-------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 778999999999986543322 1235578999999999887 56899999999999999999999999986
Q ss_pred hhhcHHHHHHHHHHhhcCC----------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVST----------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
........+..+....... ........+++++.+|+..||..||.+||++.++.+
T Consensus 205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 205 TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 6554333333322211110 011222345788999999999999999999887643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=369.72 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=204.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+.-++|++++.||+|+||.||+|++..+++.||||+++.. .....+..|..++..+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~--------------- 402 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP--------------- 402 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCT---------------
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCC---------------
Confidence 4457899999999999999999999999999999997642 33445677888777664333
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++..+..+....+..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++|||||||||
T Consensus 403 -----------~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp 470 (674)
T 3pfq_A 403 -----------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 470 (674)
T ss_dssp -----------TBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCS
T ss_pred -----------eEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCCh
Confidence 5566666677788999999999 8899998876 45799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+ +.++.+||+|||+|+........ ....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 471 ~NILl---~~~g~ikL~DFGla~~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~ 540 (674)
T 3pfq_A 471 DNVML---DSEGHIKIADFGMCKENIWDGVT-------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540 (674)
T ss_dssp TTEEE---CSSSCEEECCCTTCEECCCTTCC-------BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred hhEEE---cCCCcEEEeecceeeccccCCcc-------cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCC
Confidence 99999 47889999999999864433221 246789999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
||.+... .+.+..|.......| ..+++++.+|+..||..||.+||++
T Consensus 541 Pf~~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 541 PFEGEDE---DELFQSIMEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SSCCSSH---HHHHHHHHSSCCCCC-----TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCCCCH---HHHHHHHHhCCCCCC-----ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 9988544 355566666555554 3568999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=341.25 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=195.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+.+++|++++.||+|+||.||+|.+ .+++.||||++...... ..+.+|+++++.++|..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~---------------- 68 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS---------------- 68 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTC----------------
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcC----------------
Confidence 5688999999999999999999998 46889999998754332 34788999999998721
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
++++.++.++......|+|||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 69 ---------~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~N 138 (343)
T 3dbq_A 69 ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 138 (343)
T ss_dssp ---------TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ---------CceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 145555556677889999999889999999886 5679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----------CCCCccchHHHHHHH
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYV 228 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlG~i 228 (449)
||+ +++.+||+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 139 Ill----~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i 209 (343)
T 3dbq_A 139 FLI----VDGMLKLIDFGIANQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209 (343)
T ss_dssp EEE----ETTEEEECCCSSSCCC-----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred EEE----ECCcEEEeecccccccCccccc-----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence 999 3678999999999866543221 11235679999999999865 678999999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|||++|+.||.+.... ...+..+........ .....+.++.+++..||..||.+||++.++.+
T Consensus 210 l~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 210 LYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHSSCTTTTCCSH--HHHHHHHHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCcchhhhhH--HHHHHHHhcCCcccC---CcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 99999999999864332 222233332222211 12334678999999999999999999988754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=336.70 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=193.5
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCcceeeEeecc
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSKIRLVVFHVD 73 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 73 (449)
.+..++|++++.||+|+||.||+|++. .+++.||||+++... ....+.+|+++++.++|++++.++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~----- 87 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI----- 87 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEE-----
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCcccee-----
Confidence 466789999999999999999999985 688999999987542 233467899999999988755543
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
.++...+..|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+|
T Consensus 88 ----------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 144 (327)
T 3a62_A 88 ----------------------YAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIY 144 (327)
T ss_dssp ----------------------EEEECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----------------------EEEEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 3445677899999999 8899998875 456999999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el 232 (449)
|||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 145 ~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (327)
T 3a62_A 145 RDLKPENIML---NHQGHVKLTDFGLCKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214 (327)
T ss_dssp CCCCTTTEEE---CTTSCEEECCCSCC-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred ccCCHHHeEE---CCCCcEEEEeCCcccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHH
Confidence 9999999999 4788999999999975433221 12356799999999999999999999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
++|..||.+.... ..+..+.......+ ..++.++.+++..||..||.+||+
T Consensus 215 ~~g~~pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~L~~dp~~R~~ 265 (327)
T 3a62_A 215 LTGAPPFTGENRK---KTIDKILKCKLNLP-----PYLTQEARDLLKKLLKRNAASRLG 265 (327)
T ss_dssp HHSSCSCCCSSHH---HHHHHHHHTCCCCC-----TTSCHHHHHHHHHHSCSCGGGSTT
T ss_pred HHCCCCCCCCCHH---HHHHHHHhCCCCCC-----CCCCHHHHHHHHHHHhcCHhhccC
Confidence 9999999875443 34444555444443 345789999999999999999994
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.56 Aligned_cols=266 Identities=20% Similarity=0.238 Sum_probs=200.7
Q ss_pred cccCCceEEe-eeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHH-cCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~ 78 (449)
..+.++|++. +.||+|+||+||+|++..+++.||||++..... ...+.+|++++..+ +|++++.
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~------------ 75 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE------------ 75 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCC------------
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeee------------
Confidence 3456899996 789999999999999999999999999875432 34688999999885 5665444
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+..+....+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||
T Consensus 76 ---------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 139 (316)
T 2ac3_A 76 ---------------LIEFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKP 139 (316)
T ss_dssp ---------------EEEEEEETTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ---------------EEEEEeeCCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCH
Confidence 444445678899999999 7999999876 45799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----CCCCccchHHHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il~el 232 (449)
+|||++..+....+||+|||++.....................||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 140 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l 219 (316)
T 2ac3_A 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219 (316)
T ss_dssp GGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHH
T ss_pred HHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHH
Confidence 99999633333459999999997654322111111111234569999999999875 4588999999999999999
Q ss_pred HhCCCCCCCChhhc------------HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 233 LRGSLPWQGLKAAT------------KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 233 ~~G~~pf~~~~~~~------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|..||.+..... .......+.......+. ..+...++++.+++..||..||.+||++.++.+
T Consensus 220 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 220 LSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 99999998754321 22334444444444443 334567899999999999999999999887754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=347.56 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=203.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHH-HHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKV-YKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~-l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+..++|++++.||+|+||.||+|++..+++.||||++..... ...+..|..+ ++.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~------------------ 96 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV------------------ 96 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC------------------
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC------------------
Confidence 445789999999999999999999999999999999865321 1122333332 1222
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.|++++.++.++...+..|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+|||||
T Consensus 97 ---------~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 166 (373)
T 2r5t_A 97 ---------KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 166 (373)
T ss_dssp ---------CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred ---------CCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 3446666777777888999999999 8899998876 4679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ +.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 167 p~NIll---~~~g~ikL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 236 (373)
T 2r5t_A 167 PENILL---DSQGHIVLTDFGLCKENIEHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236 (373)
T ss_dssp GGGEEE---CTTSCEEECCCCBCGGGBCCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred HHHEEE---CCCCCEEEeeCccccccccCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCC
Confidence 999999 4788999999999986433221 124678999999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccc
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 316 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw 316 (449)
.||.+... .+.+..+.......+ ..++.++.+++..||..||.+||++.+. +.++ ....|...+||
T Consensus 237 ~Pf~~~~~---~~~~~~i~~~~~~~~-----~~~~~~~~~li~~lL~~dp~~R~~~~~~---~~~i---~~h~~f~~~~w 302 (373)
T 2r5t_A 237 PPFYSRNT---AEMYDNILNKPLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDD---FMEI---KSHVFFSLINW 302 (373)
T ss_dssp CTTCCSBH---HHHHHHHHHSCCCCC-----SSSCHHHHHHHHHHTCSSGGGSTTTTTT---HHHH---HTSGGGTTCCH
T ss_pred CCCCCCCH---HHHHHHHHhcccCCC-----CCCCHHHHHHHHHHcccCHHhCCCCCCC---HHHH---hCCccccCCCH
Confidence 99987543 344555555544433 3568899999999999999999997422 1222 12344455677
Q ss_pred ccc
Q 013125 317 TIL 319 (449)
Q Consensus 317 ~~l 319 (449)
..+
T Consensus 303 ~~l 305 (373)
T 2r5t_A 303 DDL 305 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.07 Aligned_cols=252 Identities=25% Similarity=0.285 Sum_probs=208.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+.++|++.++||+|+||.||+|.+..+++.||+|++... .....+.+|+++++.++|++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~--------------- 71 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL--------------- 71 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCE---------------
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeE---------------
Confidence 568999999999999999999999999999999987653 334568899999999988865544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..++......|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 72 ------------~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil 138 (277)
T 3f3z_A 72 ------------YETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138 (277)
T ss_dssp ------------EEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ------------EEEEecCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence 33445677899999999 8899888875 466999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+..++..+.+||+|||++........ .....||+.|+|||++.+. ++.++|||||||++|||++|..||.+
T Consensus 139 ~~~~~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 139 FLTDSPDSPLKLIDFGLAARFKPGKM--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp ESSSSTTCCEEECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EecCCCCCcEEEEecccceeccCccc--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 95545778999999999987654332 2356799999999998765 89999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.... .....+.......+ ...+...++++.+++..||..||.+||++.++.+
T Consensus 210 ~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 210 PTDS---EVMLKIREGTFTFP-EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp SSHH---HHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHH---HHHHHHHhCCCCCC-chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 5543 33344444444443 3444567899999999999999999999988754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=329.90 Aligned_cols=257 Identities=19% Similarity=0.294 Sum_probs=209.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+-.++|++++.||+|+||.||+|.+. +++.||+|++.... ....+.+|+++++.++|++++..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~--------------- 70 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--------------- 70 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCE---------------
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeE---------------
Confidence 45689999999999999999999986 46779999987654 34568899999999998865554
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..++.+....|+||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+||+
T Consensus 71 ------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil 138 (269)
T 4hcu_A 71 ------------YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 138 (269)
T ss_dssp ------------EEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ------------EEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEE
Confidence 33445667889999999 88999999766677999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
++ .++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 139 ~~---~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 139 VG---ENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp EC---GGGCEEECCTTGGGGBCCHHH------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred Ec---CCCCEEecccccccccccccc------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 94 678999999999976543211 11235567889999999999999999999999999999999 999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
+.... .....+... ..... ....++++.+++..||..+|.+||++.++.+.|+++..
T Consensus 210 ~~~~~---~~~~~~~~~-~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 210 NRSNS---EVVEDISTG-FRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TCCHH---HHHHHHHTT-CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHhcC-ccCCC---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 75543 222333222 11111 13347899999999999999999999999999988765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=329.59 Aligned_cols=256 Identities=16% Similarity=0.221 Sum_probs=209.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++..++|++++.||+|+||.||+|.+. ++..||+|++.... ....+.+|+++++.++|++++.++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~------------- 69 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFY------------- 69 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEE-------------
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEE-------------
Confidence 456789999999999999999999875 56779999987654 345688999999999988755543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.++......++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 70 --------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 135 (268)
T 3sxs_A 70 --------------GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC 135 (268)
T ss_dssp --------------EEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGE
T ss_pred --------------EEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceE
Confidence 3445667889999999 8899999987677799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
++ +.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 136 l~---~~~~~~~l~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (268)
T 3sxs_A 136 LV---DRDLCVKVSDFGMTRYVLDDQYV------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206 (268)
T ss_dssp EE---CTTCCEEECCTTCEEECCTTCEE------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred EE---CCCCCEEEccCccceecchhhhh------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCc
Confidence 99 47889999999999876544321 1234566788999999999899999999999999999999 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
....... ....+..... ...+ ...++++.+++..||..+|.+||++.++.+.|+.+
T Consensus 207 ~~~~~~~---~~~~~~~~~~-~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 207 DLYTNSE---VVLKVSQGHR-LYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp TTSCHHH---HHHHHHTTCC-CCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred cccChHH---HHHHHHcCCC-CCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 8765432 2222222221 1111 33478999999999999999999999998888755
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=341.13 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=201.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCce----EEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.+..++|+++++||+|+||+||+|++..+++. ||+|.+.... ....+.+|+++++.++|++++.+++.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 86 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC---- 86 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEE----
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE----
Confidence 35578999999999999999999999877765 4777765432 234688999999999998866655432
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
.. ...++|+|++ +++|.+++......++...++.++.||+.||+|||++||+|||
T Consensus 87 -----------------------~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~D 142 (327)
T 3poz_A 87 -----------------------LT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142 (327)
T ss_dssp -----------------------ES-SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred -----------------------ec-CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCC
Confidence 23 3467888888 9999999987777899999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||++ .++.+||+|||+|+......... ......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 143 ikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 214 (327)
T 3poz_A 143 LAARNVLVK---TPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp CCGGGEEEE---ETTEEEECCTTHHHHHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CChheEEEC---CCCCEEEccCcceeEccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence 999999995 77899999999998765443221 1234567889999999999999999999999999999999
Q ss_pred -CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 235 -GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 235 -G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
|..||.+........ ++......+.+ ...+.++.+++..||..+|.+||++.++.+.|+.+..
T Consensus 215 ~g~~p~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 215 FGSKPYDGIPASEISS----ILEKGERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TSCCTTTTCCGGGHHH----HHHTTCCCCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCccCCCHHHHHH----HHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999998865543222 22222222222 3347899999999999999999999999998887654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=349.60 Aligned_cols=256 Identities=20% Similarity=0.187 Sum_probs=194.8
Q ss_pred CceEEe-eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHH-HcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI-LQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
++|.+. +.||+|+||+||+|.+..+++.||||++.. ...+.+|++++.. ++|++++.++....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~------------ 125 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYE------------ 125 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEE------------
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEe------------
Confidence 556666 799999999999999999999999999863 3567889888754 46777665544321
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.......+.||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 126 -----------~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill 194 (400)
T 1nxk_A 126 -----------NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194 (400)
T ss_dssp -----------EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred -----------ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEE
Confidence 1122356789999999 889999987532 459999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+..+.++.+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 195 ~~~~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 195 TSKRPNAILKLTDFGFAKETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp SSSSTTCCEEECCCTTCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ecCCCCccEEEEecccccccCCCCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 6333378999999999986553321 23567899999999999999999999999999999999999999875
Q ss_pred hhhcH-HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATK-KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... ......+.......+.. .+..++.++.+|+..||..||.+||++.++.+
T Consensus 267 ~~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 267 HGLAISPGMKTRIRMGQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TTCSSCCSHHHHHHHTCCCCCTT-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccccHHHHHHHHcCcccCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 43321 11222333344433322 33567899999999999999999999988865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.14 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=203.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+++++.++|++++.++..+....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 89 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA------- 89 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc-------
Confidence 799999999999999999999999999999998765432 335789999999999999887766543221
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..++...+..|+||||+.++|.+.+......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 90 ------------~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~ 157 (351)
T 3mi9_A 90 ------------SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 157 (351)
T ss_dssp -------------------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ------------cccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE
Confidence 01123356789999999889998887666789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+.++.+||+|||+|+.+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 158 ---~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 158 ---TRDGVLKLADFGLARAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp ---CTTSCEEECCCTTCEECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ---cCCCCEEEccchhcccccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 4788999999999987654322211 11245678999999999986 4589999999999999999999999998
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHh------------------------hccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVL------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+..+.........+.. ....++++.+|+..||..||.+||++.++.+
T Consensus 232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 232 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 6654433333332221111100000 0012567889999999999999999877644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.61 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=196.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcC--CCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG--GSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~--~~~~~~~~~~~~~~~~ 77 (449)
+.+.+|++++.||+|+||.||+|.+.. ++.||||++...... ..+.+|+++++.|++ +
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~--------------- 116 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD--------------- 116 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCT---------------
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCC---------------
Confidence 345679999999999999999999865 889999998754332 357899999999975 4
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++..++.++...+..|+|||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 117 ------------~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp 183 (390)
T 2zmd_A 117 ------------KIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183 (390)
T ss_dssp ------------TBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCG
T ss_pred ------------eEEEEEEEEecCCEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence 34445555667788999999779999999886 45789999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----------CCCCccchHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLG 226 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlG 226 (449)
+|||+ .++.+||+|||+|+.+....... .....+||+.|+|||++.+ ..++.++||||||
T Consensus 184 ~NIll----~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG 254 (390)
T 2zmd_A 184 ANFLI----VDGMLKLIDFGIANQMQPDTTSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254 (390)
T ss_dssp GGEEE----SSSCEEECCCSSSCCC--------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred HHEEE----ECCeEEEEecCccccccCCCccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence 99999 45789999999998765432211 1235679999999999876 3689999999999
Q ss_pred HHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 227 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 227 ~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|++|||++|..||.+.... ...+..+.........+ ...+.++.+++..||..||.+||++.++.+
T Consensus 255 vil~ell~G~~Pf~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 255 CILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHHHHSSCTTTTCCCH--HHHHHHHHCTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCcchhhhHH--HHHHHHHhCccccCCCC---ccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 9999999999999864322 22333333332222221 233678999999999999999999988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=331.73 Aligned_cols=259 Identities=19% Similarity=0.298 Sum_probs=208.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..++|+++++||+|+||+||+|.+. ++..||+|++.... ....+.+|+++++.++|++++.+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~--------------- 84 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--------------- 84 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCE---------------
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeE---------------
Confidence 55689999999999999999999875 57789999988654 34568899999999988865544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
..++...+..|+||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||
T Consensus 85 ------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 152 (283)
T 3gen_A 85 ------------YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL 152 (283)
T ss_dssp ------------EEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred ------------EEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEE
Confidence 34445677889999999 89999999865677999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
++ .++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 153 i~---~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 153 VN---DQGVVKVSDFGLSRYVLDDEY------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp EC---TTSCEEECSTTGGGGBCCHHH------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred Ec---CCCCEEEcccccccccccccc------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 94 788999999999976543211 11234567889999999998899999999999999999998 999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
...... ....+.... ....+ ...++.+.+++..||..+|.+||++.++.+.|.+++..+
T Consensus 224 ~~~~~~---~~~~~~~~~-~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 224 RFTNSE---TAEHIAQGL-RLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TSCHHH---HHHHHHTTC-CCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccChhH---HHHHHhccc-CCCCC---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 765442 222232221 11111 334789999999999999999999999999999887653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=353.38 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=195.7
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
++..++|+++++||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-------------- 209 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF-------------- 209 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTT--------------
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCe--------------
Confidence 34557899999999999999999999999999999997632 22234566777777666665
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDI 155 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDL 155 (449)
++.+..++...+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||
T Consensus 210 -------------iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDl 275 (446)
T 4ejn_A 210 -------------LTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275 (446)
T ss_dssp -------------SCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCC
T ss_pred -------------EeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCC
Confidence 444455556778899999999 8899888875 4679999999999999999999998 99999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 276 kp~NIll---~~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 345 (446)
T 4ejn_A 276 KLENLML---DKDGHIKITDFGLCKEGIKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345 (446)
T ss_dssp CGGGEEE---CSSSCEEECCCCCCCTTCC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred CHHHEEE---CCCCCEEEccCCCceeccCCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhC
Confidence 9999999 4788999999999975433221 12467899999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~~ 297 (449)
+.||.+.... ..+..+.......| ..+++++.+++..||..||.+|| +++++.+
T Consensus 346 ~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 346 RLPFYNQDHE---KLFELILMEEIRFP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SCSSCCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCHH---HHHHHHHhCCCCCC-----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 9999875443 34444444444433 34588999999999999999999 8776643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.20 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----------------------------chhHHHHHHH
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------------------HPQLLYEAKV 55 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----------------------------~~~~~~E~~~ 55 (449)
+.-++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 445899999999999999999999999999999999865421 2457899999
Q ss_pred HHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHH
Q 013125 56 YKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLML 134 (449)
Q Consensus 56 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i 134 (449)
++.++|++++.++.... .......|+||||+ +++|.+++. ...+++..++.+
T Consensus 90 l~~l~h~~iv~~~~~~~-------------------------~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~ 142 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLD-------------------------DPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFY 142 (298)
T ss_dssp HHTCCCTTBCCEEEEEE-------------------------CSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEE-------------------------cCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHH
Confidence 99999988766554321 12357889999999 778877543 457999999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC
Q 013125 135 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 214 (449)
Q Consensus 135 ~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 214 (449)
+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++........ .....||+.|+|||++.+.
T Consensus 143 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 212 (298)
T 2zv2_A 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSET 212 (298)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTT
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccC
Confidence 99999999999999999999999999994 7789999999999876543221 1355799999999999876
Q ss_pred C---CCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 215 E---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 215 ~---~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
. ++.++|||||||++|||++|..||.+.... .....+.......+. ...+++++.+++..||..||.+||+
T Consensus 213 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s 286 (298)
T 2zv2_A 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM---CLHSKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIV 286 (298)
T ss_dssp CCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred CCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH---HHHHHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCC
Confidence 5 378899999999999999999999875432 222333333333221 2356889999999999999999999
Q ss_pred HHHHHH
Q 013125 292 YGFLKR 297 (449)
Q Consensus 292 ~~~l~~ 297 (449)
+.++.+
T Consensus 287 ~~e~l~ 292 (298)
T 2zv2_A 287 VPEIKL 292 (298)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 988743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=335.27 Aligned_cols=262 Identities=18% Similarity=0.234 Sum_probs=206.5
Q ss_pred CcccCCceEEeeeecccCceeEEEEEE-cCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASH-VDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
|+++.++|++++.||+|+||+||+|.+ ..+++.||||++..... ...+.+|+++++.++|.+...
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~------------- 75 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS------------- 75 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTC-------------
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCC-------------
Confidence 678899999999999999999999998 56789999999875322 345788999999998765321
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+.+++.+..+....+..|+|||+++++|.+++.... ..++...++.++.||+.||+|||++||+||||||+
T Consensus 76 --------~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 147 (339)
T 1z57_A 76 --------TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE 147 (339)
T ss_dssp --------TTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred --------ceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 113555666667778999999999999999988644 36899999999999999999999999999999999
Q ss_pred cEEeecCCC----------------CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchH
Q 013125 159 NFLMGLGRK----------------ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDL 222 (449)
Q Consensus 159 Nill~~~~~----------------~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 222 (449)
|||+...+. ++.+||+|||+++...... ....||+.|+|||++.+..++.++||
T Consensus 148 Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di 217 (339)
T 1z57_A 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDV 217 (339)
T ss_dssp GEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHH
T ss_pred HEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhh
Confidence 999952111 5679999999998644322 35678999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHh------------------------------------
Q 013125 223 ESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL------------------------------------ 266 (449)
Q Consensus 223 wSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~------------------------------------ 266 (449)
|||||++|||++|..||.+.........+..+ ....|....
T Consensus 218 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (339)
T 1z57_A 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERI---LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294 (339)
T ss_dssp HHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH---HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhh
Confidence 99999999999999999876554333333222 122221110
Q ss_pred ---hccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 267 ---CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 267 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
....++++.+++..||..||.+||++.++.+
T Consensus 295 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0112567899999999999999999887643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=348.35 Aligned_cols=252 Identities=23% Similarity=0.222 Sum_probs=205.9
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++.++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~--------------- 114 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH--------------- 114 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEE---------------
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEE---------------
Confidence 4789999999999999999999999999999999875432 23578899999999888755544
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.++......|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 115 ------------~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll 182 (387)
T 1kob_A 115 ------------DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 182 (387)
T ss_dssp ------------EEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ------------EEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEE
Confidence 3445678899999999 889999887555679999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
.. +..+.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 183 ~~-~~~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 183 ET-KKASSVKIIDFGLATKLNPDEI--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp SS-TTCCCEEECCCTTCEECCTTSC--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ec-CCCCceEEEecccceecCCCcc--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 42 1357899999999987654322 12447899999999999999999999999999999999999999876
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ..+..+.......+ ...+..+++++.+++..||..||.+||++.++.+
T Consensus 254 ~~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 254 DDL---ETLQNVKRCDWEFD-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp SHH---HHHHHHHHCCCCCC-SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CHH---HHHHHHHhCCCCCC-ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 543 33333333333222 2234567899999999999999999999887744
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=334.14 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=208.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
..+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~------ 81 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH------ 81 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE------
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE------
Confidence 3456799999999999999999999999999999999875432 34588999999999988755543
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.+.......|+|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+||
T Consensus 82 ---------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~ 139 (321)
T 2a2a_A 82 ---------------------DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF 139 (321)
T ss_dssp ---------------------EEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ---------------------EEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3445677899999999 8899998874 5678999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCC----eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKAN----QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229 (449)
Q Consensus 154 DLkp~Nill~~~~~~~----~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 229 (449)
||||+|||+. .++ .+||+|||++........ .....||+.|+|||++.+..++.++|||||||++
T Consensus 140 dikp~NIl~~---~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 140 DLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (321)
T ss_dssp CCSGGGEEES---CTTSSSCCEEECCCTTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCChHHEEEe---cCCCCcCCEEEccCccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHH
Confidence 9999999995 444 799999999987654322 2355789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 230 LYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 230 ~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+|++|..||.+.... ..+..+.......+ .......+..+.+++..||..||.+||++.++.+
T Consensus 209 ~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQ---ETLANITSVSYDFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHSCCSSCCSSHH---HHHHHHHTTCCCCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCHH---HHHHHHHhcccccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999999999875443 33333433333333 4445677899999999999999999999887754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.26 Aligned_cols=262 Identities=18% Similarity=0.226 Sum_probs=206.0
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCC-ceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+++++.++|++++.||+|+||+||+|.+..++ +.||+|++..... ...+.+|+++++.++|.+.....
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~---------- 82 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF---------- 82 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS----------
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce----------
Confidence 47789999999999999999999999998776 6899999875422 34577899999999876532211
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.+..+..+.......|+|||+++++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 83 -----------~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp 151 (355)
T 2eu9_A 83 -----------LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKP 151 (355)
T ss_dssp -----------CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred -----------eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 2444455556678999999999999988887644 4699999999999999999999999999999999
Q ss_pred CcEEeecC----------------CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccch
Q 013125 158 DNFLMGLG----------------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 221 (449)
Q Consensus 158 ~Nill~~~----------------~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D 221 (449)
+|||+... +..+.+||+|||+++...... ....||+.|+|||++.+..++.++|
T Consensus 152 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~D 221 (355)
T 2eu9_A 152 ENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCD 221 (355)
T ss_dssp GGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHH
T ss_pred HHEEEecccccccccccccccccccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccc
Confidence 99999422 257889999999998644322 3567999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHh-----------------------------------
Q 013125 222 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL----------------------------------- 266 (449)
Q Consensus 222 vwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~----------------------------------- 266 (449)
||||||++|||++|..||.+.........+..+ ....|....
T Consensus 222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (355)
T 2eu9_A 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKI---LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298 (355)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH---HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccc
Confidence 999999999999999999886654433333322 222221110
Q ss_pred ----hccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 267 ----CKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 267 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
....+.++.+|+..||..||.+||++.++.
T Consensus 299 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp GCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred cccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 001145788999999999999999988764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=332.73 Aligned_cols=263 Identities=21% Similarity=0.324 Sum_probs=212.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEE-----cCCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+..++|++++.||+|+||.||+|.+ ..+++.||||++..... ...+.+|+++++.+ +|++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~------ 93 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL------ 93 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE------
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE------
Confidence 5568999999999999999999985 35678999999876543 24578999999999 777655544
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC-----------------CCCHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR-----------------KFSLKTVLMLAD 136 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~-----------------~~~~~~~~~i~~ 136 (449)
.+....+..++|||++ +++|.+++..... .+++..++.++.
T Consensus 94 ---------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (313)
T 1t46_A 94 ---------------------GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152 (313)
T ss_dssp ---------------------EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred ---------------------EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHH
Confidence 3445667889999999 7899999886433 489999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||.|||++||+||||||+|||++ .++.+||+|||+++........ .......+|+.|+|||++.+..+
T Consensus 153 qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 153 QVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHCCeecCCCccceEEEc---CCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCC
Confidence 999999999999999999999999995 7889999999999866543321 11234567889999999999999
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |..||.+..... .+..+.......+. ....+.++.+++..||..||.+||++.++
T Consensus 225 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el 298 (313)
T 1t46_A 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDS---KFYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (313)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---HHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCcccchh---HHHHHhccCCCCCC---cccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 999999999999999999 999998765432 22222232322221 23458899999999999999999999999
Q ss_pred HHHHHHHHHhcC
Q 013125 296 KRLFHDLFSREG 307 (449)
Q Consensus 296 ~~~l~~~~~~~~ 307 (449)
.+.|++++....
T Consensus 299 l~~L~~~~~~~~ 310 (313)
T 1t46_A 299 VQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHHHHTC
T ss_pred HHHHHHHHHHhh
Confidence 999999887643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=339.59 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=185.6
Q ss_pred cCCceEEe---eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~---~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|.+. +.||+|+||.||+|.+..+++.||||++... ......+|+.+++.+. |++++.
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~-------------- 70 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVK-------------- 70 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCC--------------
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeE--------------
Confidence 34688886 8899999999999999999999999998653 3346788999999987 665444
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
++.++.+....|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 71 -------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 136 (325)
T 3kn6_A 71 -------------LHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPEN 136 (325)
T ss_dssp -------------EEEEEECSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred -------------EEEEEEcCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHH
Confidence 444556778899999999 8899998876 5679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+...+....+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 137 Ill~~~~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 209 (325)
T 3kn6_A 137 LLFTDENDNLEIKIIDFGFARLKPPDNQP-------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209 (325)
T ss_dssp EEEEC----CEEEECCCTTCEECCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEEecCCCcccEEEeccccceecCCCCCc-------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 99964334458999999999865543221 23557899999999999999999999999999999999999999
Q ss_pred CCChhh----cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 240 QGLKAA----TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 240 ~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
.+.... ...+.+..+.......+ ...+..+++++.+++..||..||.+||++.++
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 210 QSHDRSLTCTSAVEIMKKIKKGDFSFE-GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp C-------CCCHHHHHHHHTTTCCCCC-SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred CCCccccccccHHHHHHHHHcCCCCCC-cccccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 875431 22334444444333333 34456678999999999999999999997765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=348.11 Aligned_cols=267 Identities=19% Similarity=0.254 Sum_probs=198.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++|++++.++.......
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 98 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD----- 98 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC-----
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC-----
Confidence 678999999999999999999999999999999998754322 35789999999999998877665432110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.......|+|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 99 -----------------~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 160 (432)
T 3n9x_A 99 -----------------LLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANC 160 (432)
T ss_dssp -----------------TTTCCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred -----------------CCcCCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHe
Confidence 012257899999999999998864 56699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCcccc---------------ccCCCCCCCCccccccccc-cCCCCCccchHHH
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP---------------YRENKNLTGTARYASCNTH-LGIEQSRRDDLES 224 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwS 224 (449)
|+ +.++.+||+|||+|+............ .......+||+.|+|||++ .+..++.++||||
T Consensus 161 Ll---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS 237 (432)
T 3n9x_A 161 LL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237 (432)
T ss_dssp EE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred EE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence 99 478899999999998765432210000 0112467899999999986 4556999999999
Q ss_pred HHHHHHHHHhC-----------CCCCCCChh--------------hcHHHHHHHHHHhhcCCC-----------------
Q 013125 225 LGYVLLYFLRG-----------SLPWQGLKA--------------ATKKQKYDKICEKKVSTP----------------- 262 (449)
Q Consensus 225 lG~il~el~~G-----------~~pf~~~~~--------------~~~~~~~~~i~~~~~~~~----------------- 262 (449)
|||++|||++| .++|.+... ......+..+.......+
T Consensus 238 lG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 317 (432)
T 3n9x_A 238 TGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317 (432)
T ss_dssp HHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred HHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence 99999999984 444444321 001222223322222222
Q ss_pred ---------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 263 ---------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 263 ---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
........++++.+|+..||..||.+||+++++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22233557889999999999999999999887644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=344.72 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=200.3
Q ss_pred cCCceEEeeeeccc--CceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 5 IGVKYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 5 ~~~~y~i~~~LG~G--~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
.+++|+++++||+| +||+||+|++..+++.||||++..... ...+.+|+++++.++|++++.++.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~--------- 93 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA--------- 93 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE---------
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeE---------
Confidence 46899999999999 999999999999999999999875432 234677999999999987665543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
+....+..|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+|||||
T Consensus 94 ------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 155 (389)
T 3gni_B 94 ------------------TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK 155 (389)
T ss_dssp ------------------EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred ------------------EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 345667899999999 89999998764 3569999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHHHHHHHHHHHHh
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el~~ 234 (449)
|+|||+ +.++.+||+|||++.....................||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 156 p~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~ 232 (389)
T 3gni_B 156 ASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232 (389)
T ss_dssp GGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH
Confidence 999999 478899999999987654332211111112234578999999999988 578999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhc-----------------------------------------CCCHHHhhccChHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKV-----------------------------------------STPIEVLCKSHPAE 273 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~-----------------------------------------~~~~~~~~~~~~~~ 273 (449)
|+.||.+......... +..... ..+.......++++
T Consensus 233 g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 309 (389)
T 3gni_B 233 GHVPFKDMPATQMLLE---KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309 (389)
T ss_dssp SSCTTTTCCSTTHHHH---C--------------------------------------------------------CCHH
T ss_pred CCCCCCCCCHHHHHHH---HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHH
Confidence 9999987544322111 110000 00111233456788
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 274 FASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 274 ~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.+|+..||..||.+||++.++.+
T Consensus 310 ~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 310 FHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHhhcCcccCCCHHHHhc
Confidence 999999999999999999887643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=338.74 Aligned_cols=261 Identities=20% Similarity=0.221 Sum_probs=205.4
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.++|++++.++.......
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT------- 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS-------
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC-------
Confidence 48999999999999999999999999999999998754332 35789999999999998777654432110
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.......|+|||+++++|.+++.. ..++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 99 ---------------~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 161 (364)
T 3qyz_A 99 ---------------IEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 161 (364)
T ss_dssp ---------------TTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ---------------ccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE
Confidence 022356899999999999998874 569999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+.++.+||+|||+++......... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 162 ---~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 162 ---NTTCDLKICDFGLARVADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp ---CTTCCEEECCCTTCEECCGGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---CCCCCEEEEeCcceEecCCCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 478899999999998765432211 112356899999999987654 489999999999999999999999988
Q ss_pred ChhhcHHHHHHHHHHh-----------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEK-----------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+..+... ....+........+.++.+|+..||..||.+||++.++.+
T Consensus 235 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp SSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7655433333221110 0112233344566889999999999999999999887754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=339.86 Aligned_cols=268 Identities=21% Similarity=0.234 Sum_probs=204.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+-.++|+++++||+|+||+||+|++ .++.||||++..... .....+|+.+++.++|++++.+++.....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-------- 90 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRG-------- 90 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE--------
T ss_pred cchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccC--------
Confidence 3457999999999999999999987 478999999865422 22356688888888888877766543211
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------Ccc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR----------GFL 151 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~----------gii 151 (449)
.......|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++ ||+
T Consensus 91 ---------------~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~iv 153 (322)
T 3soc_A 91 ---------------TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153 (322)
T ss_dssp ---------------CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEE
T ss_pred ---------------CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEE
Confidence 11134579999999 8899999874 4599999999999999999999999 999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-----CCCccchHHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLG 226 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwSlG 226 (449)
||||||+|||+ +.++.+||+|||+|+......... ......||+.|+|||++.+. .++.++||||||
T Consensus 154 H~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 154 HRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCC-----CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred eCCCChHhEEE---CCCCeEEEccCCcccccccccCcc-----ccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 99999999999 478899999999998776543211 12356799999999999873 466788999999
Q ss_pred HHHHHHHhCCCCCCCChhhc-------------HHHHHHHHHHhhcCCCHHHhhc--cChHHHHHHHHHHhCCCCCCCCC
Q 013125 227 YVLLYFLRGSLPWQGLKAAT-------------KKQKYDKICEKKVSTPIEVLCK--SHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 227 ~il~el~~G~~pf~~~~~~~-------------~~~~~~~i~~~~~~~~~~~~~~--~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
|++|||++|+.||.+..... .......+............+. ..+.++.+++..||..||.+||+
T Consensus 226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC
Confidence 99999999999997643211 1111112222222222222211 22567999999999999999999
Q ss_pred HHHHHHHHHHHHHhc
Q 013125 292 YGFLKRLFHDLFSRE 306 (449)
Q Consensus 292 ~~~l~~~l~~~~~~~ 306 (449)
+.++.+.|+++.+..
T Consensus 306 ~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 306 AGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=329.96 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=198.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.++|++.++||+|+||.||+|.+..+++.||+|++.... ....+.+|+++++.++|++++.++.
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~------------ 87 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE------------ 87 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEE------------
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHH------------
Confidence 4589999999999999999999999999999999876543 2356889999999999887555443
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+.......|+||||+ +++|.+.+... ...++...++.++.||+.||+|||++||+||||||
T Consensus 88 ---------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp 152 (285)
T 3is5_A 88 ---------------VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP 152 (285)
T ss_dssp ---------------EEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred ---------------heecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCH
Confidence 345667889999999 78999888643 46799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+...+..+.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|||++|..
T Consensus 153 ~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~ 223 (285)
T 3is5_A 153 ENILFQDTSPHSPIKIIDFGLAELFKSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCL 223 (285)
T ss_dssp GGEEESSSSTTCCEEECCCCCCCC------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEecCCCCCCEEEEeeecceecCCccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCC
Confidence 999996444568899999999976554322 23567899999999886 468999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.+...... ...+....... ...+...++++.+++..||..||.+||++.++.+
T Consensus 224 pf~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 224 PFTGTSLEEV---QQKATYKEPNY--AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp SSCCSSHHHH---HHHHHHCCCCC--CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCCCCHHHH---HhhhccCCccc--ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9988654322 22222222111 2223446789999999999999999999988754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=341.66 Aligned_cols=261 Identities=21% Similarity=0.342 Sum_probs=208.9
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
.+..++|++++.||+|+||.||+|++. .+++.||||+++.... ...+.+|+++++.++|++++.++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~----- 117 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG----- 117 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE-----
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE-----
Confidence 355689999999999999999999986 3458899999876543 234788999999998887555443
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----------------------CCCCHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKT 130 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-----------------------~~~~~~~ 130 (449)
++...+..|+||||+ +++|.+++.... ..+++..
T Consensus 118 ----------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 175 (343)
T 1luf_A 118 ----------------------VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175 (343)
T ss_dssp ----------------------EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred ----------------------EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHH
Confidence 445667889999999 889999987642 5689999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccc
Q 013125 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 210 (449)
Q Consensus 131 ~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 210 (449)
++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....... +.......+|+.|+|||+
T Consensus 176 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~ 247 (343)
T 1luf_A 176 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPES 247 (343)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC---CCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhh
Confidence 999999999999999999999999999999994 778999999999976543221 112235578899999999
Q ss_pred ccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCC
Q 013125 211 HLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 289 (449)
Q Consensus 211 ~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 289 (449)
+.+..++.++|||||||++|||++ |..||.+.... +....+....... ....++.++.+++..||..||.+|
T Consensus 248 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~R 320 (343)
T 1luf_A 248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVIYYVRDGNILA----CPENCPLELYNLMRLCWSKLPADR 320 (343)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH---HHHHHHhCCCcCC----CCCCCCHHHHHHHHHHcccCcccC
Confidence 999899999999999999999999 99999876543 2233333322211 224568899999999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 013125 290 PDYGFLKRLFHDLFSR 305 (449)
Q Consensus 290 p~~~~l~~~l~~~~~~ 305 (449)
|++.++.+.|+++...
T Consensus 321 ps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 321 PSFCSIHRILQRMCER 336 (343)
T ss_dssp CCHHHHHHHHHHTTC-
T ss_pred CCHHHHHHHHHHHHhh
Confidence 9999999999877543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=339.49 Aligned_cols=258 Identities=19% Similarity=0.250 Sum_probs=203.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCce----EEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+..++|++++.||+|+||+||+|.+..+++. ||+|++.... ....+.+|+.+++.++|++++.++..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------ 83 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL------ 83 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEE------
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEE------
Confidence 4468999999999999999999999887776 7777765432 23457789999999999886665442
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+ .+...++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||
T Consensus 84 ---------------------~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Di 141 (325)
T 3kex_A 84 ---------------------C-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNL 141 (325)
T ss_dssp ---------------------E-CBSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ---------------------E-cCCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 2 245688999999 89999998765567999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+|||+ +.++.+||+|||+|+......... ......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 142 kp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 213 (325)
T 3kex_A 142 AARNVLL---KSPSQVQVADFGVADLLPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 213 (325)
T ss_dssp SSTTEEE---SSSSCEEECSCSGGGGSCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred chheEEE---CCCCeEEECCCCcccccCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhC
Confidence 9999999 478899999999998765443211 1235567889999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
|..||.+......... + ......+.+ ..++.++.+++..||..||.+||++.++.+.|+.+..
T Consensus 214 g~~p~~~~~~~~~~~~---~-~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 214 GAEPYAGLRLAEVPDL---L-EKGERLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp SCCTTTTSCTTHHHHH---H-HTTCBCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCccccCHHHHHHH---H-HcCCCCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999988654432222 2 222121111 2346789999999999999999999999999887643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.59 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=187.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++.++.......
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 101 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR----- 101 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS-----
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC-----
Confidence 46899999999999999999999999999999999865422 235779999999999999877665432110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+|+|+++++|.+++.. ..++...++.++.||+.||+|||++||+||||||+||
T Consensus 102 ----------------~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 163 (367)
T 2fst_X 102 ----------------SLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 163 (367)
T ss_dssp ----------------SGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ----------------ccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhE
Confidence 0123456799999999999998864 5799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +.++.+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 164 ll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 230 (367)
T 2fst_X 164 AV---NEDCELKILDFGLARHTADEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230 (367)
T ss_dssp EE---CTTCCEEECC-------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred EE---CCCCCEEEeeccccccccccC----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99 478899999999998654321 35678999999999987 67899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHh-----------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKICEK-----------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+.........+...+.. ....+......+.++++.+|+..||..||.+||++.++.
T Consensus 231 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 231 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 886654333322221110 001122333445678899999999999999999988764
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 311 ~ 311 (367)
T 2fst_X 311 A 311 (367)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=334.33 Aligned_cols=267 Identities=22% Similarity=0.252 Sum_probs=208.9
Q ss_pred CcccCCceEEeeeecccCceeEEEEE----EcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
+.+...+|+++++||+|+||.||+|+ +..+++.||||++.... ....+.+|+++++.++|++++.++....
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT-- 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE--
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe--
Confidence 34567889999999999999999999 56789999999987543 2346889999999999987666544321
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.......++||||+ +++|.+++......++...++.++.||+.||+|||++||+||
T Consensus 94 -----------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 150 (302)
T 4e5w_A 94 -----------------------EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR 150 (302)
T ss_dssp -----------------------C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred -----------------------cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccC
Confidence 12236689999999 889999997777789999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||++ .++.+||+|||++......... +.......||..|+|||++.+..++.++|||||||++|||+
T Consensus 151 dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 223 (302)
T 4e5w_A 151 DLAARNVLVE---SEHQVKIGDFGLTKAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223 (302)
T ss_dssp CCSGGGEEEE---ETTEEEECCCTTCEECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CCchheEEEc---CCCCEEECcccccccccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHH
Confidence 9999999995 6789999999999876654321 11234567888999999999999999999999999999999
Q ss_pred hCCCCCCCChh-----------hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 234 RGSLPWQGLKA-----------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 234 ~G~~pf~~~~~-----------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
+|..||..... ......+..........+ ....+++++.+++..||..||.+||++.++.+.|+++
T Consensus 224 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 224 TYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp TTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 99998754221 111111111112111111 2245688999999999999999999999999999877
Q ss_pred H
Q 013125 303 F 303 (449)
Q Consensus 303 ~ 303 (449)
+
T Consensus 301 l 301 (302)
T 4e5w_A 301 L 301 (302)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=341.08 Aligned_cols=212 Identities=24% Similarity=0.293 Sum_probs=175.7
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++.+.++|++++.||+|+||+||+|.+..+++.||||+++.... ...+..|+++++.+++...+.
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~-------------- 114 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEM-------------- 114 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGG--------------
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhccccc--------------
Confidence 34567899999999999999999999999999999999875322 334678899999886443211
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKP 157 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH--~~giiHrDLkp 157 (449)
+.+++.+..+....+..|+|||+++++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||
T Consensus 115 -------~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp 187 (382)
T 2vx3_A 115 -------KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 187 (382)
T ss_dssp -------GGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSG
T ss_pred -------ceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCc
Confidence 013555555666778999999999889999998654 56999999999999999999999 57999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||++. +..+.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 188 ~NIll~~-~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 188 ENILLCN-PKRSAIKIVDFGSSCQLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp GGEEESS-TTSCCEEECCCTTCEETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccEEEec-CCCCcEEEEeccCceeccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999942 246789999999998764322 35678999999999999999999999999999999999999
Q ss_pred CCCCChhh
Q 013125 238 PWQGLKAA 245 (449)
Q Consensus 238 pf~~~~~~ 245 (449)
||.+....
T Consensus 257 pf~~~~~~ 264 (382)
T 2vx3_A 257 LFSGANEV 264 (382)
T ss_dssp SSCCSSHH
T ss_pred CCCCCCHH
Confidence 99986554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.07 Aligned_cols=261 Identities=18% Similarity=0.284 Sum_probs=210.4
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
++..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+++++.++|++++.++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~----- 93 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG----- 93 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-----
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEE-----
Confidence 456789999999999999999999984 44588999998765432 34778999999998887555443
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----------------------CCCCHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKT 130 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-----------------------~~~~~~~ 130 (449)
+....+..++||||+ +++|.+++.... ..+++..
T Consensus 94 ----------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (314)
T 2ivs_A 94 ----------------------ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151 (314)
T ss_dssp ----------------------EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHH
T ss_pred ----------------------EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHH
Confidence 345667889999999 799999997643 2389999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccc
Q 013125 131 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 210 (449)
Q Consensus 131 ~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 210 (449)
++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++........ .......+|+.|+|||+
T Consensus 152 ~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 152 LISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIES 223 (314)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHCCCcccccchheEEEc---CCCCEEEccccccccccccccc-----eeccCCCCcccccChhh
Confidence 999999999999999999999999999999995 7789999999999876543321 11234567889999999
Q ss_pred ccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCC
Q 013125 211 HLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 289 (449)
Q Consensus 211 ~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 289 (449)
+.+..++.++|||||||++|||++ |..||.+........ .+.. ..... ....+++++.+++..||..||.+|
T Consensus 224 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~~~-~~~~~---~~~~~~~~~~~li~~~l~~dp~~R 296 (314)
T 2ivs_A 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN---LLKT-GHRME---RPDNCSEEMYRLMLQCWKQEPDKR 296 (314)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---Hhhc-CCcCC---CCccCCHHHHHHHHHHccCChhhC
Confidence 999889999999999999999999 999998765543222 2222 21111 224568899999999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 013125 290 PDYGFLKRLFHDLFSR 305 (449)
Q Consensus 290 p~~~~l~~~l~~~~~~ 305 (449)
|++.+|.+.|++++..
T Consensus 297 ps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 297 PVFADISKDLEKMMVK 312 (314)
T ss_dssp CCHHHHHHHHHHHHHT
T ss_pred cCHHHHHHHHHHHHhh
Confidence 9999999999988764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.71 Aligned_cols=257 Identities=24% Similarity=0.253 Sum_probs=200.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
...+|++++.||+|+||.||+|++..+++.||||++.... ....+|+++++.|+|++++.++..+....
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~--------- 120 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSG--------- 120 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEE---------
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccC---------
Confidence 3458999999999999999999999999999999886543 23457999999999999887655432110
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
...+..+.++||||+.++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 121 ------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIL 188 (420)
T 1j1b_A 121 ------------EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188 (420)
T ss_dssp ------------TTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred ------------CCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEE
Confidence 0012334679999998888877653 3567999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ .+.+.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 189 l~--~~~~~~kl~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 189 LD--PDTAVLKLCDFGSAKQLVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp EE--TTTTEEEECCCTTCEECCTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred Ee--CCCCeEEeccchhhhhcccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 95 2456799999999987654322 2356789999999999875 69999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHH------------------------HhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIE------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
+....+. +..++........+ .+....++++.+|+..||..||.+||++.++.
T Consensus 259 ~~~~~~~---l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 259 GDSGVDQ---LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp CSSHHHH---HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCHHHH---HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 8655432 23333222111111 11234578999999999999999999988764
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 336 ~ 336 (420)
T 1j1b_A 336 A 336 (420)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.17 Aligned_cols=262 Identities=19% Similarity=0.272 Sum_probs=207.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCC---CchhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGT---KHPQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+..++|++++.||+|+||.||+|.+. .+++.||||++.... ....+.+|+++++.+ .|++++.++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~----- 116 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG----- 116 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE-----
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE-----
Confidence 45689999999999999999999973 456789999987542 345688999999999 7876555443
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC----------------------CCCHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR----------------------KFSLKTV 131 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~----------------------~~~~~~~ 131 (449)
++...+..++||||+ +++|.+++..... .+++..+
T Consensus 117 ----------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 174 (344)
T 1rjb_A 117 ----------------------ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174 (344)
T ss_dssp ----------------------EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred ----------------------EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHH
Confidence 445567889999999 8899999875432 3789999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccc
Q 013125 132 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 211 (449)
Q Consensus 132 ~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 211 (449)
+.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++......... .......||+.|+|||++
T Consensus 175 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESL 246 (344)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChhhEEEc---CCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHh
Confidence 99999999999999999999999999999995 7889999999999866543221 112345678899999999
Q ss_pred cCCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC
Q 013125 212 LGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290 (449)
Q Consensus 212 ~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 290 (449)
.+..++.++|||||||++|||++ |..||.+..... .+..+.......+.+ ...++++.+++..||..||.+||
T Consensus 247 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rp 320 (344)
T 1rjb_A 247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---NFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRP 320 (344)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH---HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCchhCc
Confidence 99999999999999999999998 999998765432 222333333332222 34588999999999999999999
Q ss_pred CHHHHHHHHHHHHHhc
Q 013125 291 DYGFLKRLFHDLFSRE 306 (449)
Q Consensus 291 ~~~~l~~~l~~~~~~~ 306 (449)
++.+|.+.|+.++...
T Consensus 321 s~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 321 SFPNLTSFLGCQLADA 336 (344)
T ss_dssp CHHHHHHHHHHHC---
T ss_pred CHHHHHHHHHHHHHHH
Confidence 9999999999876654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=350.63 Aligned_cols=270 Identities=19% Similarity=0.250 Sum_probs=211.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC---CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+++++|++.++||+|+||+||+|++..+++.||||++... .....+.+|+++++.++|++++.++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~------- 77 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEE------- 77 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-------
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeec-------
Confidence 46789999999999999999999999999999999998753 22345789999999999998776654321
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.......|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 78 ------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 139 (396)
T 4eut_A 78 ------------------ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139 (396)
T ss_dssp ------------------CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred ------------------cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcC
Confidence 12344779999999 889999987533 239999999999999999999999999999999
Q ss_pred CCcEEeecC-CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--------CCCCccchHHHHHH
Q 013125 157 PDNFLMGLG-RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGY 227 (449)
Q Consensus 157 p~Nill~~~-~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwSlG~ 227 (449)
|+|||+..+ +..+.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 140 p~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~ 211 (396)
T 4eut_A 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (396)
T ss_dssp GGGEEEEECTTSCEEEEECCGGGCEECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHH
T ss_pred HHHEEEeecCCCceeEEEecCCCceEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHH
Confidence 999998432 3556799999999987654321 235679999999999875 46788999999999
Q ss_pred HHHHHHhCCCCCCCChhh-cHHHHHHHHHHhhcCCC--------------------HHHhhccChHHHHHHHHHHhCCCC
Q 013125 228 VLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKVSTP--------------------IEVLCKSHPAEFASYFHYCQSLTF 286 (449)
Q Consensus 228 il~el~~G~~pf~~~~~~-~~~~~~~~i~~~~~~~~--------------------~~~~~~~~~~~~~~l~~~~l~~~p 286 (449)
++|||++|+.||...... ...+.+..+........ ...+....+..+.+++..||..||
T Consensus 212 il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP 291 (396)
T 4eut_A 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (396)
T ss_dssp HHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccCh
Confidence 999999999999764432 22334444443321110 011223446789999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHh
Q 013125 287 DQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 287 ~~Rp~~~~l~~~l~~~~~~ 305 (449)
.+||++.++.+.+.+++..
T Consensus 292 ~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 292 EKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTSCCHHHHHHHHHHHHTC
T ss_pred hhhccHHHHHHHHHHHhhc
Confidence 9999999998888877653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=345.92 Aligned_cols=262 Identities=18% Similarity=0.285 Sum_probs=198.9
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
++..++|++.+.||+|+||+||+|++. .++..||||+++.... ...+.+|+++++.++|++++.+++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~------- 113 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG------- 113 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-------
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEE-------
Confidence 455679999999999999999999886 4577899999876433 234788999999998887655543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
++...+..++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||
T Consensus 114 --------------------~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 173 (373)
T 2qol_A 114 --------------------VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 173 (373)
T ss_dssp --------------------EECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred --------------------EEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCC
Confidence 445667889999999 89999999866667999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+|||+ +.++.+||+|||+++.......... ......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 174 kp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~ 246 (373)
T 2qol_A 174 AARNILI---NSNLVCKVSDFGLGRVLEDDPEAAY----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246 (373)
T ss_dssp CGGGEEE---CTTCCEEECCC--------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CcceEEE---cCCCCEEECcCccccccccCCccce----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhC
Confidence 9999999 4788999999999987654322110 1123345778999999999999999999999999999998
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|..||.+..... ....+.. ....+. ...++..+.+++..||..+|.+||++.+|.+.|+.++..
T Consensus 247 g~~P~~~~~~~~---~~~~i~~-~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 247 GERPYWEMSNQD---VIKAVDE-GYRLPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp C-CTTTTCCHHH---HHHHHHT-TEECCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHH---HHHHHHc-CCCCCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 999998765432 2222222 222222 134588999999999999999999999999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.90 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=200.5
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceE----EEEEecCC---CCchhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV----AVKIENSG---TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AvKv~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.+..++|+++++||+|+||+||+|++..+++.| |+|.+... .....+.+|+++++.++|++++.++..+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 86 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC---- 86 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEE----
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE----
Confidence 355789999999999999999999998887765 66655432 2344688999999999988766554432
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
.. ...++|++++ +++|.+++......++...++.++.||+.||+|||++||+|||
T Consensus 87 -----------------------~~-~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 142 (327)
T 3lzb_A 87 -----------------------LT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142 (327)
T ss_dssp -----------------------ES-SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred -----------------------ec-CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCC
Confidence 22 3467888888 8999999988777899999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||++ .++.+||+|||+++......... ......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 143 ikp~NIl~~---~~~~~kL~DfG~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 214 (327)
T 3lzb_A 143 LAARNVLVK---TPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp CCGGGEEEE---ETTEEEECCTTC---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCHHHEEEc---CCCCEEEccCcceeEccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence 999999995 77899999999998765433211 1234557889999999999999999999999999999999
Q ss_pred -CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 235 -GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 235 -G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
|..||.+......... .......+.+ ..++.++.+++..||..||.+||++.++.+.|..+..
T Consensus 215 ~g~~p~~~~~~~~~~~~----~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 215 FGSKPYDGIPASEISSI----LEKGERLPQP---PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TSCCTTTTCCGGGHHHH----HHTTCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCCCCCHHHHHHH----HHcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9999988655432222 2222222222 3357899999999999999999999999999887754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=329.83 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=195.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-++|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|++++..+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~------------- 68 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL------------- 68 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEE-------------
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchh-------------
Confidence 37899999999999999999999999999999988665433 2367899999999988755544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g-~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+....+..++||||+. ++|.+++. ....++...++.++.||+.||+|||++||+||||||+||
T Consensus 69 --------------~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Ni 133 (311)
T 4agu_A 69 --------------EVFRRKRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133 (311)
T ss_dssp --------------EEEEETTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred --------------heeecCCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhE
Confidence 33456678999999994 55555544 466799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|++ .++.+||+|||++......... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 134 l~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 203 (311)
T 4agu_A 134 LIT---KHSVIKLCDFGFARLLTGPSDY-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203 (311)
T ss_dssp EEC---TTSCEEECCCTTCEECC-------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEc---CCCCEEEeeCCCchhccCcccc-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 994 7889999999999876543321 235578999999999986 56899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhh-----------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKK-----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
.+.........+....... ...+........+.++.+++..||..||.+||+++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 204 PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred CCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 8876554333332221110 00112233356788899999999999999999988775
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 284 ~ 284 (311)
T 4agu_A 284 H 284 (311)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.67 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=202.1
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~----------- 121 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG----------- 121 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEE-----------
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE-----------
Confidence 45799999999999999999999999999999998754322 34788999999999987665543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+....+..++||||+.++|.+++......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 122 ----------------~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 185 (348)
T 1u5q_A 122 ----------------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185 (348)
T ss_dssp ----------------EEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred ----------------EEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 3455678899999998899999887678899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
|++ .++.+||+|||++..... .....||+.|+|||++. +..++.++|||||||++|||++|..
T Consensus 186 ll~---~~~~~kL~DfG~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 251 (348)
T 1u5q_A 186 LLS---EPGLVKLGDFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251 (348)
T ss_dssp EEE---TTTEEEECCCTTCBSSSS-----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEC---CCCCEEEeeccCceecCC-----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 995 788999999999976532 13567999999999985 4568999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.+..... .+..+........ ....+++.+.+++..||..||.+||++.++.+
T Consensus 252 p~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 252 PLFNMNAMS---ALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TTTTSCHHH---HHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCChHH---HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 998765432 2233333222211 12355889999999999999999999988754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.30 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=196.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----------CchhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
+.++|++.++||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.++|++++.++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~---- 208 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF---- 208 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE----
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE----
Confidence 4689999999999999999999999999999999976421 12247899999999999987665332
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
. ..+..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||
T Consensus 209 -----------------------~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr 263 (419)
T 3i6u_A 209 -----------------------F-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263 (419)
T ss_dssp -----------------------E-ESSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -----------------------E-ecCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 1 335579999999 8899887754 5679999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC---CCCCccchHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLL 230 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il~ 230 (449)
||||+|||++..+....+||+|||+|+....... ....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ 335 (419)
T 3i6u_A 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335 (419)
T ss_dssp CCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHH
T ss_pred CCChHhEEEecCCCcceEEEeecccceecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHH
Confidence 9999999996544556799999999986543321 235689999999999864 56888999999999999
Q ss_pred HHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 231 el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|++|..||.+...... ....+..... ...+..+...++.+.+++..||..||.+||++.++.+
T Consensus 336 ~lltg~~pf~~~~~~~~--~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 336 ICLSGYPPFSEHRTQVS--LKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHSSCSSCCCSSSCC--HHHHHHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCcchHH--HHHHHhcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99999999987543321 1122223333 3345556678899999999999999999999887754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.17 Aligned_cols=258 Identities=20% Similarity=0.337 Sum_probs=212.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+-..+|++.++||+|+||.||+|.+..++..||||+++... ....+.+|+++++.++|++++.+++.
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------------ 284 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV------------ 284 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEE------------
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEE------------
Confidence 44578999999999999999999999889999999987653 34568999999999999886665543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+......||||||+ +++|.+++.... ..++...++.++.||+.||+|||++||+||||||+||
T Consensus 285 ---------------~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 349 (495)
T 1opk_A 285 ---------------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNC 349 (495)
T ss_dssp ---------------ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ---------------EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 34567789999999 799999998643 4599999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
|++ .++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 350 ll~---~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~ 420 (495)
T 1opk_A 350 LVG---ENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420 (495)
T ss_dssp EEC---GGGCEEECCTTCEECCTTCCE------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred EEC---CCCcEEEeecccceeccCCce------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence 994 778999999999987654321 12234567889999999998899999999999999999999 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
.+......... +......+. ...+|+++.++|..||..||.+||++.+|.+.|+.++.
T Consensus 421 ~~~~~~~~~~~----~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 421 PGIDLSQVYEL----LEKDYRMER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCGGGHHHH----HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHH----HHcCCCCCC---CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 98765432222 222222222 24568999999999999999999999999998886643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=354.13 Aligned_cols=258 Identities=22% Similarity=0.399 Sum_probs=209.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++..++|++.++||+|+||+||+|.+. ++..||||+++... ....+.+|+++++.++|++++.++..+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~---------- 252 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV---------- 252 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----------
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEE----------
Confidence 355689999999999999999999985 46789999987643 345689999999999999877654432
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
..+..|+||||+ +++|.+++... ...++...++.++.||+.||+|||++||+||||||+|
T Consensus 253 ------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 314 (454)
T 1qcf_A 253 ------------------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 314 (454)
T ss_dssp ------------------CSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGG
T ss_pred ------------------eCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 245689999999 88999998743 3468999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
||++ .++.+||+|||+|+...... +.......+|..|+|||++....++.++|||||||++|||++ |+.|
T Consensus 315 ill~---~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P 385 (454)
T 1qcf_A 315 ILVS---ASLVCKIADFGLARVIEDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385 (454)
T ss_dssp EEEC---TTCCEEECSTTGGGGBCCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEEC---CCCcEEEeeCCCceEcCCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCC
Confidence 9994 78899999999998654321 111234456889999999998899999999999999999999 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|.+..... ....+. .....+.+ ..+|+++.+++..||..||.+||++++|.+.|++++..
T Consensus 386 ~~~~~~~~---~~~~i~-~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 386 YPGMSNPE---VIRALE-RGYRMPRP---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp STTCCHHH---HHHHHH-HTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCHHH---HHHHHH-cCCCCCCC---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 98865543 222222 22222222 45689999999999999999999999999998876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.34 Aligned_cols=261 Identities=20% Similarity=0.335 Sum_probs=214.7
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++..++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~------------- 75 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL------------- 75 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEE-------------
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEE-------------
Confidence 4677899999999999999999999999999999999876543 34688999999999988755543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.++......|+|||++ +++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|
T Consensus 76 --------------~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~N 141 (288)
T 3kfa_A 76 --------------GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141 (288)
T ss_dssp --------------EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGG
T ss_pred --------------EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcce
Confidence 3445667889999999 789999998643 459999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
|+++ .++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 142 il~~---~~~~~~l~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p 212 (288)
T 3kfa_A 142 CLVG---ENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212 (288)
T ss_dssp EEEC---GGGCEEECCCCGGGTSCSSSSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEEc---CCCCEEEccCccceeccCCccc------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9994 6789999999999765543221 1234556889999999999999999999999999999999 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|.+.........+ ....... ....+++++.+++..||..||.+||++.++.+.|+.++...
T Consensus 213 ~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 213 YPGIDLSQVYELL----EKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp STTCCGGGHHHHH----HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHH----hccCCCC---CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9876554322222 2222221 12456889999999999999999999999999999887764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=351.32 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=210.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecC----CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|+++++||+|+||+||+|++..+++.||||++.. ......+.+|+++++.++|++++.++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~----------- 88 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE----------- 88 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEE-----------
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEE-----------
Confidence 45899999999999999999999999999999999753 233456889999999999987665543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+.......|+||||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ----------------~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 151 (486)
T 3mwu_A 89 ----------------ILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151 (486)
T ss_dssp ----------------EEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----------------EEEcCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHH
Confidence 345677899999999 8899988875 4579999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+...+..+.+||+|||+|+.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||
T Consensus 152 il~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 152 ILLESKEKDCDIKIIDFGLSTCFQQNTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp EEESSSSTTCCEEECSCSCTTTBCCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEecCCCCCCEEEEECCcCeECCCCCc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9996544567899999999976544322 235679999999999986 5999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.+.... ..+..+.......+.+ .+..+++++.+++..||..||.+||++.++.+ +.+++.
T Consensus 223 ~~~~~~---~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~ 282 (486)
T 3mwu_A 223 YGKNEY---DILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQK 282 (486)
T ss_dssp CCSSHH---HHHHHHHHTCCCSCSG-GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHH
T ss_pred CCCCHH---HHHHHHHhCCCCCCCc-ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhcc
Confidence 886543 3444444444443332 34567899999999999999999999988865 344443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=340.41 Aligned_cols=279 Identities=19% Similarity=0.228 Sum_probs=204.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh--
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT-- 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-- 81 (449)
...++|++++.||+|+||+||+|++..+++.||||++..+. ....+|+++++.++|++++.++.............
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 45789999999999999999999999999999999887543 23458999999999999998877653321100000
Q ss_pred -----hhh----cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013125 82 -----IIF----SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRG 149 (449)
Q Consensus 82 -----~~~----~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~g 149 (449)
... ....+....+........+.++||||+.++|.+.+.. ....+++..++.++.||+.||+|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 000 0000001111112245567899999998898877763 3567999999999999999999999999
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHH
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYV 228 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~i 228 (449)
|+||||||+|||++ ..++.+||+|||+|+....... .....||+.|+|||++.+.. ++.++|||||||+
T Consensus 162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999994 2578999999999987654332 23567899999999988754 8999999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCH------------------------HHhhccChHHHHHHHHHHhCC
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI------------------------EVLCKSHPAEFASYFHYCQSL 284 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~~l~~~~l~~ 284 (449)
+|||++|+.||.+....+.. ..+......... .......++++.+|+..||..
T Consensus 232 l~ell~g~~pf~~~~~~~~~---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQL---VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999986654333 333322222111 112234678899999999999
Q ss_pred CCCCCCCHHHHHH
Q 013125 285 TFDQRPDYGFLKR 297 (449)
Q Consensus 285 ~p~~Rp~~~~l~~ 297 (449)
||.+||++.++.+
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999988754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=341.62 Aligned_cols=263 Identities=16% Similarity=0.195 Sum_probs=205.0
Q ss_pred ccCCceEEeeeecccCceeEEEEE-----EcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+.+++|++.++||+|+||+||+|. +..+++.||||++... ....+..|+++++.+++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~--------------- 125 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSM--------------- 125 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGG---------------
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhh---------------
Confidence 456889999999999999999994 6678999999998753 4456888999998886321
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~----~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
++++..++.++...+..|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||
T Consensus 126 ---------~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHr 196 (365)
T 3e7e_A 126 ---------QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196 (365)
T ss_dssp ---------GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred ---------hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence 114555566666778899999999 89999999753 4569999999999999999999999999999
Q ss_pred CCCCCcEEeec--------CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHH
Q 013125 154 DIKPDNFLMGL--------GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL 225 (449)
Q Consensus 154 DLkp~Nill~~--------~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 225 (449)
||||+|||++. .+..+.+||+|||+|+.+....... .....+||+.|+|||++.+..++.++|||||
T Consensus 197 DiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 271 (365)
T 3e7e_A 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271 (365)
T ss_dssp CCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHH
T ss_pred CCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHH
Confidence 99999999952 1127899999999998765322211 1246689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHHH
Q 013125 226 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR-PDYGFLKRLFHDLFS 304 (449)
Q Consensus 226 G~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R-p~~~~l~~~l~~~~~ 304 (449)
||++|||++|+.||........ ......... ..++.+.+++..|+..+|.+| |++.++.+.|++++.
T Consensus 272 G~il~elltg~~pf~~~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 272 AATVYCMLFGTYMKVKNEGGEC----------KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHHHHHHHHSSCCCEEEETTEE----------EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCccccCCCCce----------eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 9999999999999975433210 000111110 225789999999999999998 678889999999887
Q ss_pred hcCC
Q 013125 305 REGY 308 (449)
Q Consensus 305 ~~~~ 308 (449)
....
T Consensus 340 ~~~~ 343 (365)
T 3e7e_A 340 QHYT 343 (365)
T ss_dssp HHTT
T ss_pred Hhhh
Confidence 7543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.58 Aligned_cols=246 Identities=20% Similarity=0.245 Sum_probs=201.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
.+..++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l---------- 249 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL---------- 249 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCE----------
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeE----------
Confidence 35678899999999999999999999999999999997542 234457889999999988865544
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
..+....+..|+||||+ |++|.+++...+ ..+++..++.++.||+.||+|||++||+||||
T Consensus 250 -----------------~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDL 312 (576)
T 2acx_A 250 -----------------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312 (576)
T ss_dssp -----------------EEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred -----------------EEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCC
Confidence 34445678899999999 899998887543 34999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||+ +.++.+||+|||+|+....... ....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 313 KPeNILl---d~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG 381 (576)
T 2acx_A 313 KPENILL---DDHGHIRISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381 (576)
T ss_dssp CGGGEEE---CTTSCEEECCCTTCEECCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHS
T ss_pred chheEEE---eCCCCeEEEecccceecccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 9999999 4788999999999987654322 1356899999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHH-HHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 236 SLPWQGLKAATKKQ-KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 236 ~~pf~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
..||.+........ ....+.......+ ..+++++.+++..||..||.+||+
T Consensus 382 ~~PF~~~~~~~~~~~i~~~i~~~~~~~p-----~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 382 QSPFQQRKKKIKREEVERLVKEVPEEYS-----ERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp SCSSSCSSSCCCHHHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred CCCCcccccchhHHHHHHHhhcccccCC-----ccCCHHHHHHHHHhccCCHHHcCC
Confidence 99998764432222 2233333222222 456889999999999999999994
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=331.93 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=201.1
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
.|...++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~---------------- 109 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK---------------- 109 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEE----------------
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEE----------------
Confidence 48999999999999999999998999999999875432 345789999999999887655443
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
+....+..++||||+ +++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 110 -----------~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll-- 174 (321)
T 2c30_A 110 -----------SYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL-- 174 (321)
T ss_dssp -----------EEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred -----------EEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 334567899999999 889999876 4569999999999999999999999999999999999999
Q ss_pred CCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChh
Q 013125 165 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244 (449)
Q Consensus 165 ~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~ 244 (449)
+.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 175 -~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 175 -TLDGRVKLSDFGFCAQISKDVPK-------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp -CTTCCEEECCCTTCEECCSSSCC-------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -CCCCcEEEeeeeeeeecccCccc-------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 47889999999999876543221 2356899999999999999999999999999999999999999987544
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
. ..+..+.... .+........++++.+++..||..||.+||++.++.+
T Consensus 247 ~---~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 247 V---QAMKRLRDSP--PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp H---HHHHHHHHSS--CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H---HHHHHHhcCC--CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3 2223332221 1111123456889999999999999999999887744
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.87 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=203.0
Q ss_pred cccCCceEEe-eeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+.+.++|.+. +.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.+..
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-------------- 89 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP-------------- 89 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT--------------
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC--------------
Confidence 3567889998 89999999999999999999999999987532 2345788999999886522
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+++.+..+.......|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 90 ------------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Di 157 (327)
T 3lm5_A 90 ------------RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDL 157 (327)
T ss_dssp ------------TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ------------CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcC
Confidence 4445555556778899999999 78998887532 356999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||++.....+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 158 kp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp CGGGEEESCBTTBCCEEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ChHHEEEecCCCCCcEEEeeCccccccCCccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999995322368999999999987654322 2356799999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||.+.... ..+..+.......+ ......+++.+.+++..||..||.+||+++++.+
T Consensus 230 ~~pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 230 TSPFVGEDNQ---ETYLNISQVNVDYS-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp SCSSCCSSHH---HHHHHHHHTCCCCC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCch---HHHHHHHhcccccC-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 9999876543 23333333333322 3334567889999999999999999999887743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.96 Aligned_cols=268 Identities=20% Similarity=0.304 Sum_probs=193.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCc---eEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
.+..++|++++.||+|+||.||+|++..+++ .||||++.... ....+.+|+++++.++|++++.++.......
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3567899999999999999999999876665 89999987542 1345789999999999988776654432110
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRG 149 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-----~~~~~~~~~~i~~qil~~L~~LH~~g 149 (449)
. .......++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|
T Consensus 99 ~---------------------~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 157 (323)
T 3qup_A 99 A---------------------KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN 157 (323)
T ss_dssp ---------------------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c---------------------ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC
Confidence 0 00112348999999 889999886532 25899999999999999999999999
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHH
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL 229 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 229 (449)
|+||||||+|||++ .++.+||+|||+|+........ .......+|+.|+|||++.+..++.++|||||||++
T Consensus 158 ivH~Dikp~NIli~---~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 229 (323)
T 3qup_A 158 FIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229 (323)
T ss_dssp CCCSCCSGGGEEEC---TTSCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEc---CCCCEEEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHH
Confidence 99999999999994 7789999999999866443321 112345568899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 230 LYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 230 ~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|||++ |..||.+...... ...+....... ....+++++.+++..||..||.+||++.++.+.|++++...
T Consensus 230 ~ell~~g~~p~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 230 WEIMTRGQTPYAGIENAEI---YNYLIGGNRLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHTTSCCTTTTCCGGGH---HHHHHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhCCCCCccccChHHH---HHHHhcCCCCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 99999 9999988655432 22222222111 12355789999999999999999999999999999887754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.51 Aligned_cols=255 Identities=23% Similarity=0.223 Sum_probs=195.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.-++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|++++.++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~------------ 99 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK------------ 99 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEE------------
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEE------------
Confidence 44799999999999999999999999999999999875432 23467899999999888755543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+....+..|+||||+.++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 100 ---------------~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 100 ---------------SVIHHNHRLHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp ---------------EEEEETTEEEEEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ---------------EEEecCCEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 34456778999999998899998876 45699999999999999999999999999999999999
Q ss_pred EeecC--CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCC
Q 013125 161 LMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 161 ll~~~--~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~ 237 (449)
|+... +..+.+||+|||+++....... ......||..|+|||++.+.. ++.++|||||||++|||++|..
T Consensus 164 ll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 164 LLSVSDASETPVLKIGDFGLARAFGIPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp EEEC-----CCEEEECCTTHHHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEecCCCCccceEEECcCCCccccCCccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99532 2455799999999986643322 123557899999999998754 8999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCC-------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTP-------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
||.+....... ..+.......+ ...+....++++.+|+..||..||.+||++
T Consensus 237 pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 313 (329)
T 3gbz_A 237 LFPGDSEIDQL---FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313 (329)
T ss_dssp SSCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CcCCCCHHHHH---HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH
Confidence 99886554322 22322211111 111223367899999999999999999998
Q ss_pred HHHHH
Q 013125 293 GFLKR 297 (449)
Q Consensus 293 ~~l~~ 297 (449)
.++.+
T Consensus 314 ~e~l~ 318 (329)
T 3gbz_A 314 KNALE 318 (329)
T ss_dssp HHHHT
T ss_pred HHHhC
Confidence 87744
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=329.89 Aligned_cols=253 Identities=19% Similarity=0.293 Sum_probs=201.9
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
....++|++++.||+|+||.||+|.+..+++.||||++........+.+|+++++.++|++++..+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------- 91 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYG------------- 91 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEE-------------
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEE-------------
Confidence 4567899999999999999999999999999999999987777778999999999998887555443
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+....+..|+|||++ +++|.+++......++...++.++.||+.||.|||++||+||||||+||+
T Consensus 92 --------------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil 157 (314)
T 3com_A 92 --------------SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157 (314)
T ss_dssp --------------EEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred --------------EEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence 334567889999999 77999998866778999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
++ .++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 158 ~~---~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 158 LN---TEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp EC---TTCCEEECCCTTCEECBTTBS-------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EC---CCCCEEEeecccchhhhhhcc-------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 94 778999999999987654322 12356789999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... ....+.... .+.......++..+.+++..||..||.+||++.++.+
T Consensus 228 ~~~~~---~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 228 IHPMR---AIFMIPTNP--PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SCHHH---HHHHHHHSC--CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CChHH---HHHHHhcCC--CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 54432 221221111 1111122345889999999999999999999988754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=329.01 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=198.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+-.++|++.+.||+|+||+||+|++ .++.||||++........+.+|+++++.++|++++.+++.
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~------------ 69 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA------------ 69 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEB------------
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEE------------
Confidence 45568999999999999999999987 4788999998766556678999999999999887665432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS---RGFLHRDIK 156 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~--~~~~~~~~~i~~qil~~L~~LH~---~giiHrDLk 156 (449)
..+..|+||||+ +++|.+++..... .++...++.++.||+.||+|||+ +||+|||||
T Consensus 70 -----------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlk 132 (307)
T 2eva_A 70 -----------------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132 (307)
T ss_dssp -----------------CTTTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCS
T ss_pred -----------------EcCCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCC
Confidence 124478999999 8899999875332 47899999999999999999999 899999999
Q ss_pred CCcEEeecCCCCC-eEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 157 PDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 157 p~Nill~~~~~~~-~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
|+|||+. .++ .+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 133 p~NIll~---~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 199 (307)
T 2eva_A 133 PPNLLLV---AGGTVLKICDFGTACDIQTHM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR 199 (307)
T ss_dssp GGGEEEE---TTTTEEEECCCCC----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred hhHEEEe---CCCCEEEEccccccccccccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999995 444 58999999997554322 234689999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
+.||....... ......+.. ... ......+|..+.+++..||..||.+||++.++.+.|+.+...
T Consensus 200 ~~p~~~~~~~~-~~~~~~~~~-~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 200 RKPFDEIGGPA-FRIMWAVHN-GTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCTTTTTCSSH-HHHHHHHHT-TCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CCCchhhCccH-HHHHHHHhc-CCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 99998643322 111111111 111 122355689999999999999999999999999999877543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=350.59 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=207.5
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+++.-++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++.++.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~------- 83 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ------- 83 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEE-------
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEE-------
Confidence 456678999999999999999999999999999999998643 22345789999999999887665543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+....+..|+||||+ |++|.+++.. ...++...++.++.||+.||+|||++||+||||
T Consensus 84 --------------------~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDL 142 (476)
T 2y94_A 84 --------------------VISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142 (476)
T ss_dssp --------------------EEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred --------------------EEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccc
Confidence 335567899999999 8899998864 457999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHh
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~ 234 (449)
||+|||+ +.++.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|||++
T Consensus 143 kp~NIll---~~~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 211 (476)
T 2y94_A 143 KPENVLL---DAHMNAKIADFGLSNMMSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211 (476)
T ss_dssp SGGGEEE---CTTCCEEECCCSSCEECCTTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred cHHHEEE---ecCCCeEEEeccchhhcccccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh
Confidence 9999999 4788999999999987654322 235689999999999998775 789999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|..||.+.... ..+..+.......| ..+++++.+++..||..||.+||++.++.+
T Consensus 212 G~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 212 GTLPFDDDHVP---TLFKKICDGIFYTP-----QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp SSCSSCCSSSH---HHHHHHHTTCCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCHH---HHHHHHhcCCcCCC-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 99999875433 34444554444333 345789999999999999999999998865
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=324.00 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=204.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
++.++|++++.||+|+||.||+|++..+++.||+|+++... ....+.+|+++++.++|++++..+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~------- 74 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH------- 74 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE-------
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh-------
Confidence 56789999999999999999999999999999999876542 134588999999999988755543
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
.+.......++|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+|||
T Consensus 75 --------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 133 (283)
T 3bhy_A 75 --------------------DIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFD 133 (283)
T ss_dssp --------------------EEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred --------------------heecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 3345667889999999 8999998875 45799999999999999999999999999999
Q ss_pred CCCCcEEeecCC-CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 155 IKPDNFLMGLGR-KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 155 Lkp~Nill~~~~-~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
|||+||++.... ....+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 134 l~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CChHHEEEecCCCCCCceEEEecccceeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHH
Confidence 999999995211 123899999999987654322 13456899999999999999999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|..||.+.... .....+....... ........+..+.+++..||..||.+||++.++.+
T Consensus 206 ~g~~p~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 206 SGASPFLGETKQ---ETLTNISAVNYDF-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HSSCTTCCSSHH---HHHHHHHTTCCCC-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HCCCCCCCcchH---HHHHHhHhcccCC-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 999999875543 2333333333333 34455677899999999999999999999988865
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=353.05 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=204.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+..++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++.+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l----------- 250 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL----------- 250 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCE-----------
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeE-----------
Confidence 4458999999999999999999999999999999998642 223457889999999988765543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
..+.......|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+|||
T Consensus 251 ----------------~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrD 314 (543)
T 3c4z_A 251 ----------------AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314 (543)
T ss_dssp ----------------EEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ----------------EEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 44445678899999999 89999888753 24699999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||+ +.++.+||+|||+++........ ....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 315 LKP~NILl---~~~g~vkL~DFGla~~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt 384 (543)
T 3c4z_A 315 LKPENVLL---DDDGNVRISDLGLAVELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384 (543)
T ss_dssp CCGGGEEE---CTTSCEEECCCTTCEECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CChHHEEE---eCCCCEEEeecceeeeccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh
Confidence 99999999 47889999999999876543321 235689999999999999999999999999999999999
Q ss_pred CCCCCCCChhh-cHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 235 GSLPWQGLKAA-TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 235 G~~pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
|..||.+.... ........+.......| ..+++++.+++..||..||.+||++
T Consensus 385 G~~PF~~~~~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 385 ARGPFRARGEKVENKELKQRVLEQAVTYP-----DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp SSCSSCCTTCCCCHHHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCCCCCCCccchhHHHHHHHHhhcccCCC-----cccCHHHHHHHHHhccCCHhHCCCC
Confidence 99999875432 22334444444444433 4568899999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.31 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=208.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---------------CchhHHHHHHHHHHHcCCCcceee
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------------KHPQLLYEAKVYKILQGGSKIRLV 68 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---------------~~~~~~~E~~~l~~l~~~~~~~~~ 68 (449)
-++++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|++++.++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 46789999999999999999999999999999999986532 134578899999999988765544
Q ss_pred EeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 013125 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 147 (449)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~ 147 (449)
.+.......|+||||+ |++|.+.+.. ...+++..++.++.||+.||+|||+
T Consensus 113 ---------------------------~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~ 164 (504)
T 3q5i_A 113 ---------------------------DVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK 164 (504)
T ss_dssp ---------------------------EEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------EEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445678899999999 8899988876 4679999999999999999999999
Q ss_pred CCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHH
Q 013125 148 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY 227 (449)
Q Consensus 148 ~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 227 (449)
+||+||||||+|||+...+....+||+|||+|........ .....||+.|+|||++.+ .++.++|||||||
T Consensus 165 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~ 235 (504)
T 3q5i_A 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGV 235 (504)
T ss_dssp TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHH
T ss_pred CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHH
Confidence 9999999999999996333334799999999987654322 235679999999999875 6899999999999
Q ss_pred HHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 228 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 228 il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
++|+|++|..||.+.... ..+..+.......+. ..+..+++++.+++..||..||.+||++.++.+ +.+++.
T Consensus 236 il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~ 307 (504)
T 3q5i_A 236 IMYILLCGYPPFGGQNDQ---DIIKKVEKGKYYFDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKK 307 (504)
T ss_dssp HHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred HHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCCc-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhh
Confidence 999999999999886543 344445454444443 345677899999999999999999999998855 344443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.25 Aligned_cols=260 Identities=19% Similarity=0.242 Sum_probs=206.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcC---CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
.+..++|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+|+++++.++|++++.++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 82 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII----- 82 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE-----
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence 3556899999999999999999998753 344699999876532 34578899999999998876654431
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
..+..++|||++ +++|.+++......++...++.++.||+.||.|||++||+||||
T Consensus 83 -----------------------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 139 (281)
T 3cc6_A 83 -----------------------EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 139 (281)
T ss_dssp -----------------------CSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred -----------------------cCCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 234568999999 78999999876777999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+|||++ .++.+||+|||++......... ......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 140 kp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~ 210 (281)
T 3cc6_A 140 AVRNILVA---SPECVKLGDFGLSRYIEDEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF 210 (281)
T ss_dssp SGGGEEEE---ETTEEEECCCCGGGCC---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccceEEEC---CCCcEEeCccCCCccccccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhC
Confidence 99999995 6789999999999865543221 1234567889999999998899999999999999999998
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|+.||...........+ .. ....+. ...+++.+.+++..||..+|.+||++.++.+.|++++...
T Consensus 211 g~~p~~~~~~~~~~~~~---~~-~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 211 GKQPFFWLENKDVIGVL---EK-GDRLPK---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp TCCTTTTSCGGGHHHHH---HH-TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcccCChHHHHHHH---hc-CCCCCC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 99999876554332222 22 112221 1345889999999999999999999999999999886643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=332.01 Aligned_cols=263 Identities=18% Similarity=0.258 Sum_probs=203.9
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCC----ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
++..++|++.+.||+|+||+||+|.+..++ ..||||++...... ..+.+|+++++.++|++++.++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~------- 112 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE------- 112 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE-------
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEE-------
Confidence 567789999999999999999999986543 35999998765332 2477899999999888755543
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
.+....+..++|||++ +++|.+++......+++..++.++.||+.||+|||++||+|||
T Consensus 113 --------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 172 (333)
T 1mqb_A 113 --------------------GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRD 172 (333)
T ss_dssp --------------------EEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --------------------EEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 3445667889999999 7799999987667899999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||+ +.++.+||+|||+++.......... ......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 173 ikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 245 (333)
T 1mqb_A 173 LAARNILV---NSNLVCKVSDFGLSRVLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245 (333)
T ss_dssp CCGGGEEE---CTTCCEEECCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CChheEEE---CCCCcEEECCCCcchhhcccccccc----ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHc
Confidence 99999999 4788999999999987654322110 1123456789999999999999999999999999999998
Q ss_pred -CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 235 -GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 235 -G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|..||.+.... .....+.. ....+. ...++..+.+++..||..+|.+||++.++.+.|++++...
T Consensus 246 ~g~~pf~~~~~~---~~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 246 YGERPYWELSNH---EVMKAIND-GFRLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TSCCTTTTCCHH---HHHHHHHT-TCCCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCCCCcccCCHH---HHHHHHHC-CCcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 99999876543 22223322 222221 2356889999999999999999999999999999887643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=351.14 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=205.3
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|+++++||+|+||+||+|++..+++.||||++... .....+.+|+.+++.++|++++.++.
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~----------- 103 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD----------- 103 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEE-----------
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEE-----------
Confidence 346899999999999999999999999999999998753 23456889999999999887665543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+.......|+||||+ +++|.+.+.. ...++...++.++.||+.||.|||++||+||||||+|
T Consensus 104 ----------------~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 166 (494)
T 3lij_A 104 ----------------FFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPEN 166 (494)
T ss_dssp ----------------EEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ----------------EEEeCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhh
Confidence 445677899999999 8899888875 4579999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+...+..+.+||+|||+|..+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||
T Consensus 167 il~~~~~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 167 LLLESKEKDALIKIVDFGLSAVFENQKK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp EEESCSSTTCCEEECCCTTCEECBTTBC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEeCCCCCCcEEEEECCCCeECCCCcc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCC
Confidence 9996444567799999999987664332 235679999999999864 6999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+.... +.+..+.......+. ..+...++++.+++..||..+|.+||++.++.+
T Consensus 238 ~~~~~~---~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 238 GGQTDQ---EILRKVEKGKYTFDS-PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSSHH---HHHHHHHHTCCCCCS-GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHH---HHHHHHHhCCCCCCc-hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 886543 344444444444332 335677899999999999999999999998865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=336.50 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=199.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
..++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+++++.++|++++.++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-------- 79 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD-------- 79 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEE--------
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEE--------
Confidence 35789999999999999999999999999999999864321 235789999999999887665543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
++......++||||+.++|.+++......++...++.++.||+.||+|||++||+||||||
T Consensus 80 -------------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 140 (346)
T 1ua2_A 80 -------------------AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140 (346)
T ss_dssp -------------------EECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred -------------------EEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCH
Confidence 3345678899999998899988876566799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~ 236 (449)
+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 141 ~Nil~---~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 210 (346)
T 1ua2_A 141 NNLLL---DENGVLKLADFGLAKSFGSPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210 (346)
T ss_dssp GGEEE---CTTCCEEECCCGGGSTTTSCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHEEE---cCCCCEEEEecccceeccCCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99999 4788999999999986543322 12356789999999999765 4899999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcC-----------------------CCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVS-----------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
+||.+..... .+..+...... .+........+.++.+++..||..||.+||++.
T Consensus 211 ~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 287 (346)
T 1ua2_A 211 PFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 287 (346)
T ss_dssp CSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred CCCCCCCHHH---HHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHH
Confidence 9998865443 33333332111 122334456678999999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 288 ell~ 291 (346)
T 1ua2_A 288 QALK 291 (346)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 7744
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=332.54 Aligned_cols=262 Identities=19% Similarity=0.314 Sum_probs=208.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-------CCCceEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCcceeeEeec
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKIL-QGGSKIRLVVFHV 72 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l-~~~~~~~~~~~~~ 72 (449)
+..++|++++.||+|+||.||+|++. .+++.||||++...... ..+.+|+++++.+ +|++++.+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~----- 106 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL----- 106 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE-----
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE-----
Confidence 55789999999999999999999985 35678999998765432 3478899999999 77765544
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLAD 136 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~ 136 (449)
..++...+..|+||||+ +++|.+++.... ..+++..++.++.
T Consensus 107 ----------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 164 (334)
T 2pvf_A 107 ----------------------LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164 (334)
T ss_dssp ----------------------EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHH
T ss_pred ----------------------EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHH
Confidence 33445667889999999 889999987533 2489999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ .......+|+.|+|||++.+..+
T Consensus 165 qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 236 (334)
T 2pvf_A 165 QLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVY 236 (334)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCc
Confidence 99999999999999999999999999 47889999999999876543221 11234567889999999998889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |..||.+..... ....+.... ..+ ....++.++.+++..||..+|.+||++.++
T Consensus 237 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKLLKEGH-RMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHHTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---HHHHHhcCC-CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999999999 999998764432 222222221 111 124568899999999999999999999999
Q ss_pred HHHHHHHHHhcC
Q 013125 296 KRLFHDLFSREG 307 (449)
Q Consensus 296 ~~~l~~~~~~~~ 307 (449)
.+.|+.++....
T Consensus 310 l~~L~~l~~~~~ 321 (334)
T 2pvf_A 310 VEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHHHC
T ss_pred HHHHHHHHhccc
Confidence 999999887653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.60 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=209.8
Q ss_pred CCceEEeeeecccCceeEEEEE----EcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.++|+++++||+|+||.||+|+ +..+++.||||++..... ...+.+|+++++.++|++++.++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-------- 93 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS-------- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--------
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEE--------
Confidence 5799999999999999999999 467889999999876533 23478999999999988766654432
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
++......|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+
T Consensus 94 -----------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 156 (327)
T 3lxl_A 94 -----------------YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156 (327)
T ss_dssp -----------------ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -----------------ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh
Confidence 224567789999999 99999999876667999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||++ .++.+||+|||++.......... .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 157 NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 157 NILVE---SEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229 (327)
T ss_dssp GEEEE---ETTEEEECCGGGCEECCTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred hEEEC---CCCCEEEcccccceecccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 99995 78899999999998765433211 122455688899999999998999999999999999999999999
Q ss_pred CCCChhhc-----------HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 239 WQGLKAAT-----------KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 239 f~~~~~~~-----------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|....... ....+..........+ ....+++++.+++..||..||.+||++.++.+.|+.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp GGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred CccccchhhhhcccccccccHHHHHHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 97643211 0111111122222222 1245689999999999999999999999999998877543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=346.30 Aligned_cols=264 Identities=17% Similarity=0.214 Sum_probs=187.4
Q ss_pred ccCCceEE-eeeecccCceeEEEEEEc--CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKL-GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i-~~~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.+.+.|.+ +++||+|+||+||+|++. .+++.||||++........+.+|+++++.|+|++++.++....
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-------- 88 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL-------- 88 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEE--------
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEe--------
Confidence 45577888 568999999999999975 5688999999987666678899999999999998776544321
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~--------~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
.......|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+|
T Consensus 89 -----------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH 151 (405)
T 3rgf_A 89 -----------------SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH 151 (405)
T ss_dssp -----------------ETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred -----------------cCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeC
Confidence 13467889999999999998886432 24999999999999999999999999999
Q ss_pred cCCCCCcEEeecC-CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLL 230 (449)
Q Consensus 153 rDLkp~Nill~~~-~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~ 230 (449)
|||||+|||+... +..+.+||+|||+|+.+...... .......+||+.|+|||++.+. .++.++|||||||++|
T Consensus 152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp CCCCGGGEEECCSSTTTTCEEECCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 9999999999532 35689999999999876543211 1123456899999999999885 4899999999999999
Q ss_pred HHHhCCCCCCCChhh------cHHHHHHHHHHhhcCCCHHHhh----------------------------------ccC
Q 013125 231 YFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVLC----------------------------------KSH 270 (449)
Q Consensus 231 el~~G~~pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~~----------------------------------~~~ 270 (449)
||++|.+||.+.... .....+..+.......+ ...+ ...
T Consensus 228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (405)
T 3rgf_A 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA-DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306 (405)
T ss_dssp HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCC-TTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCT
T ss_pred HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCC-hhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCC
Confidence 999999999764331 11223333332221111 1000 011
Q ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 271 PAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 271 ~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+..+.+|+..||..||.+||++.++.+
T Consensus 307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 307 DSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp TSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 457788888888888888888776643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=323.96 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=194.4
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC------chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
++-.++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+++++.++|++++.++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-------- 72 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR-------- 72 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEE--------
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEE--------
Confidence 45678999999999999999999998 488999999765422 24578899999999988755544
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG---FLH 152 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g---iiH 152 (449)
.++...+..++||||+ +++|.+++. .+.+++..++.++.||+.||+|||++| |+|
T Consensus 73 -------------------~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H 131 (271)
T 3dtc_A 73 -------------------GVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131 (271)
T ss_dssp -------------------EEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCC
T ss_pred -------------------EEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Confidence 3445667789999999 889988875 567999999999999999999999999 899
Q ss_pred cCCCCCcEEeecCC-----CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHH
Q 013125 153 RDIKPDNFLMGLGR-----KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY 227 (449)
Q Consensus 153 rDLkp~Nill~~~~-----~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 227 (449)
|||||+|||++... ..+.+||+|||++........ ....||+.|+|||++.+..++.++|||||||
T Consensus 132 ~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 202 (271)
T 3dtc_A 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202 (271)
T ss_dssp SCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCCchHHEEEecccccccccCcceEEccCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHH
Confidence 99999999995211 267899999999976544322 2457899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 228 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 228 il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
++|+|++|+.||.+..... ....+.......+. ...+++++.+++..||..+|.+||++.++.+.|++
T Consensus 203 ~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 203 LLWELLTGEVPFRGIDGLA---VAYGVAMNKLALPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHHHCCCTTTTSCHHH---HHHHHHTSCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCCCHHH---HHHhhhcCCCCCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999999999998765432 22222222322222 24568899999999999999999999999888764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=329.57 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=205.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+++++.++|++++..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~------------- 72 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE------------- 72 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEE-------------
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehh-------------
Confidence 45689999999999999999999999999999999987543 234578999999999988755543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.+.......|+|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 73 --------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NI 137 (304)
T 2jam_A 73 --------------DIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL 137 (304)
T ss_dssp --------------EEEECSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGC
T ss_pred --------------hhcccCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 3345667899999999 7899998875 45699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++...+..+.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 138 l~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 138 LYLTPEENSKIMITDFGLSKMEQNGI---------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp EESSSSTTCCEEBCSCSTTCCCCCBT---------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEecCCCCCCEEEccCCcceecCCCc---------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99544577899999999986543221 123468999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.... .....+.......+ ...+...++++.+++..||..||.+||++.++.+
T Consensus 209 ~~~~~---~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 209 EETES---KLFEKIKEGYYEFE-SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TSCHH---HHHHHHHHCCCCCC-TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCHH---HHHHHHHcCCCCCC-ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 75443 33334444333322 2334567899999999999999999999988754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.16 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=202.4
Q ss_pred cCCceEE--eeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKL--GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+++.|.+ .+.||+|+||.||+|.+..+++.||+|+++... ....+.+|+++++.++|++++.++
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~------------ 152 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY------------ 152 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEE------------
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEE------------
Confidence 3455666 678999999999999999999999999987643 234578999999999888755543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.++...+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|
T Consensus 153 ---------------~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 217 (373)
T 2x4f_A 153 ---------------DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN 217 (373)
T ss_dssp ---------------EEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ---------------EEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 3445667899999999 889999887666679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+.. ++.+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 218 Ill~~-~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 288 (373)
T 2x4f_A 218 ILCVN-RDAKQIKIIDFGLARRYKPREK--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288 (373)
T ss_dssp EEEEE-TTTTEEEECCCSSCEECCTTCB--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEEec-CCCCcEEEEeCCCceecCCccc--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 99842 2467899999999987654322 23457999999999999989999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+.... ..+..+.......+ ...+..+++++.+++..||..||.+||++.++.+
T Consensus 289 ~~~~~~---~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 289 LGDNDA---ETLNNILACRWDLE-DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CCSSHH---HHHHHHHHTCCCSC-SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCHH---HHHHHHHhccCCCC-hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 876543 34444554444333 2334567899999999999999999999988865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=330.59 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=198.8
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
-++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++.+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~------------- 99 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI------------- 99 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCE-------------
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEE-------------
Confidence 3789999999999999999999999999999999875422 1357789999988888765544
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
..++...+..|+|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|
T Consensus 100 --------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 164 (309)
T 2h34_A 100 --------------HDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPEN 164 (309)
T ss_dssp --------------EEEEEETTEEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred --------------EEEEeeCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHH
Confidence 44445677899999999 7799999876 4579999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||++ .++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 165 Il~~---~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (309)
T 2h34_A 165 ILVS---ADDFAYLVDFGIASATTDEKLT------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY 235 (309)
T ss_dssp EEEC---TTSCEEECSCCC----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred EEEc---CCCCEEEecCccCccccccccc------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCC
Confidence 9994 7789999999999765543221 123557899999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHHHhc
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSRE 306 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-~~~~l~~~l~~~~~~~ 306 (449)
.+.... .+........ .........+|.++.+++..||..||.+|| +++++.+.|+.++...
T Consensus 236 ~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 236 QGDQLS----VMGAHINQAI-PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CSCHHH----HHHHHHHSCC-CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCchHH----HHHHHhccCC-CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 875432 2222222222 223344567789999999999999999999 8999999888765543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=349.02 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=204.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..++|++.++||+|+||+||+|.+.. +..||||+++... ..+.+.+|+++++.++|++++.+++.+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----------- 248 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV----------- 248 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----------
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-----------
Confidence 556889999999999999999999864 4669999988654 345689999999999999877665432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
. .+..|+||||+ +++|.+++... +..++...++.++.||+.||+|||++||+||||||+||
T Consensus 249 ----------------~-~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 249 ----------------S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp ----------------C-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----------------c-CCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 2 25679999999 88999999753 45699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
|++ .++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 312 ll~---~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~ 382 (452)
T 1fmk_A 312 LVG---ENLVCKVADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382 (452)
T ss_dssp EEC---GGGCEEECCCCTTC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred EEC---CCCCEEECCCccceecCCCce------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCC
Confidence 994 778999999999986653321 11234567889999999998899999999999999999999 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
.+..... ....+ ......+.+ ..+|+.+.++|..||..+|.+||++++|.+.|++++...
T Consensus 383 ~~~~~~~---~~~~i-~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 383 PGMVNRE---VLDQV-ERGYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp TTCCHHH---HHHHH-HTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCHHH---HHHHH-HcCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 8865543 22222 222222222 356889999999999999999999999999988776443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=332.64 Aligned_cols=261 Identities=19% Similarity=0.306 Sum_probs=209.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCc-----eEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+..++|++.+.||+|+||.||+|.+..+++ .||+|++..... ...+.+|+++++.+ +|++++.++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~------ 116 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL------ 116 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE------
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEE------
Confidence 456899999999999999999999976654 799999876543 23478999999999 787655543
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-------------cCCCCHHHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-------------RRKFSLKTVLMLADQMIA 140 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-------------~~~~~~~~~~~i~~qil~ 140 (449)
.++...+..|+||||+ +++|.+++... ...++...++.++.||+.
T Consensus 117 ---------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 175 (333)
T 2i1m_A 117 ---------------------GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175 (333)
T ss_dssp ---------------------EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHH
T ss_pred ---------------------EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHH
Confidence 3445667889999999 77999998753 245899999999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccc
Q 013125 141 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRD 220 (449)
Q Consensus 141 ~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 220 (449)
||+|||++||+||||||+|||++ .++.+||+|||+++........ .......+|+.|+|||++.+..++.++
T Consensus 176 ~l~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~ 247 (333)
T 2i1m_A 176 GMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQS 247 (333)
T ss_dssp HHHHHHHTTEECSCCSGGGCEEE---GGGEEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHhcCCcccCCcccceEEEC---CCCeEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHH
Confidence 99999999999999999999995 6789999999999865443221 112345678899999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013125 221 DLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 299 (449)
Q Consensus 221 DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l 299 (449)
|||||||++|||++ |..||.+..... .+..+.......+.+ ...++.+.+++..||..||.+||++.+|.+.|
T Consensus 248 Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 248 DVWSYGILLWEIFSLGLNPYPGILVNS---KFYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCSSH---HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCCcccchhH---HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 99999999999998 999998754432 222333333322222 33478999999999999999999999999999
Q ss_pred HHHHHh
Q 013125 300 HDLFSR 305 (449)
Q Consensus 300 ~~~~~~ 305 (449)
+++...
T Consensus 322 ~~~~~~ 327 (333)
T 2i1m_A 322 QEQAQE 327 (333)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.43 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=210.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
.++.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++.++
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~--------- 92 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY--------- 92 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEE---------
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEE---------
Confidence 45678999999999999999999999999999999998643 2344588999999999988765544
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
.+.......|+|||++ +++|.+.+.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 93 ------------------~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 153 (484)
T 3nyv_A 93 ------------------EFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153 (484)
T ss_dssp ------------------EEEECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred ------------------EEEEeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 3445677899999999 8899988864 5679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+...+..+.+||+|||+|+.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 154 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~ 224 (484)
T 3nyv_A 154 PENLLLESKSKDANIRIIDFGLSTHFEASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 224 (484)
T ss_dssp GGGEEESSSSTTCCEEECCTTHHHHBCCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred HHHEEEecCCCCCcEEEEeeeeeEEcccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCC
Confidence 9999995444678999999999987654322 124578999999999987 6999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+||.+.... ..+..+.......+.+ .+..+++++.+++..||..+|.+||++.++.+
T Consensus 225 ~pf~~~~~~---~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 225 PPFNGANEY---DILKKVEKGKYTFELP-QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CSSCCSSHH---HHHHHHHHCCCCCCSG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCHH---HHHHHHHcCCCCCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 999886543 3444444444443332 34567899999999999999999999998865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=324.59 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=209.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++..++|++++.||+|+||.||+|.+. ++..||+|++.... ....+.+|+++++.++|++++..+...
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---------- 77 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV---------- 77 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE----------
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEE----------
Confidence 356789999999999999999999975 56789999987653 345688999999999998866654321
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
..+..++|||++ +++|.+++... ...++...++.++.||+.||+|||++||+||||||+|
T Consensus 78 ------------------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 139 (279)
T 1qpc_A 78 ------------------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139 (279)
T ss_dssp ------------------CSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ------------------cCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhh
Confidence 234579999999 89999988643 2369999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
||+ +.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 140 il~---~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 210 (279)
T 1qpc_A 140 ILV---SDTLSCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (279)
T ss_dssp EEE---CTTSCEEECCCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred EEE---cCCCCEEECCCcccccccCccc------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 999 4788999999999987654321 11234567889999999998889999999999999999999 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|.+..... ....+.. ..... ....++.++.+++..||..+|.+||++.+|.+.|++++...
T Consensus 211 ~~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 211 YPGMTNPE---VIQNLER-GYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp STTCCHHH---HHHHHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcccCHHH---HHHHHhc-ccCCC---CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 98755432 2222222 21111 12456889999999999999999999999999999988754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=334.92 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=192.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++.++.......
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK----- 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC-----
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc-----
Confidence 45799999999999999999999999999999999875432 234778999999999998877765432210
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
........|+||||+.++|.+.+. ..++...+..++.||+.||+|||++||+||||||+||
T Consensus 98 ----------------~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI 158 (371)
T 2xrw_A 98 ----------------SLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158 (371)
T ss_dssp ----------------STTTCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ----------------ccccccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence 012234789999999888888774 4689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 159 l~---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 159 VV---KSDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp EE---CTTSCEEECCCCC------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EE---cCCCCEEEEEeecccccccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99 4788999999999986543221 235678999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHH-------------------------------------hhccChHHHHHHHHHHhC
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEV-------------------------------------LCKSHPAEFASYFHYCQS 283 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~-------------------------------------~~~~~~~~~~~l~~~~l~ 283 (449)
+..... .+..+........... .....+.++.+|+..||.
T Consensus 228 ~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 304 (371)
T 2xrw_A 228 GTDHID---QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304 (371)
T ss_dssp CSSHHH---HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCHHH---HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCc
Confidence 865432 2333322211111100 001125689999999999
Q ss_pred CCCCCCCCHHHHHH
Q 013125 284 LTFDQRPDYGFLKR 297 (449)
Q Consensus 284 ~~p~~Rp~~~~l~~ 297 (449)
.||.+||+++++.+
T Consensus 305 ~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 305 IDASKRISVDEALQ 318 (371)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCCCHHHHhC
Confidence 99999999988755
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.93 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=200.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
.+.-++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+|+++++.++|++++.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~---------- 74 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL---------- 74 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCE----------
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcch----------
Confidence 34568999999999999999999999999999999987532 223457889999988888765544
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
..++......++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+|||||
T Consensus 75 -----------------~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlk 136 (279)
T 3fdn_A 75 -----------------YGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIK 136 (279)
T ss_dssp -----------------EEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCC
T ss_pred -----------------hheEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence 44446677899999999 7899988876 4569999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|+|||+ +.++.++|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 137 p~Nili---~~~~~~~l~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 204 (279)
T 3fdn_A 137 PENLLL---GSAGELKIADFGWSVHAPSSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204 (279)
T ss_dssp GGGEEE---CTTSCEEECSCCEESCC-----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred hHhEEE---cCCCCEEEEeccccccCCccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCC
Confidence 999999 478899999999986543322 23567899999999999999999999999999999999999
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.||.+.... .....+.......+ ...++.+.+++..||..||.+||++.++.+
T Consensus 205 ~p~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 205 PPFEANTYQ---ETYKRISRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CTTCCSSHH---HHHHHHHHTCCCCC-----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCCcHH---HHHHHHHhCCCCCC-----CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 999875443 23333333333333 345789999999999999999999988865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.69 Aligned_cols=264 Identities=22% Similarity=0.278 Sum_probs=198.5
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
...-++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++.++
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~--------- 98 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY--------- 98 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEE---------
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEE---------
Confidence 3455799999999999999999999999999999999875321 23477899999999888755543
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.+....+..++|||++ +++|.+++... ...++...++.++.||+.||.|||++||+||
T Consensus 99 ------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~ 160 (310)
T 2wqm_A 99 ------------------ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160 (310)
T ss_dssp ------------------EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred ------------------EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence 3345567899999999 77999988742 4569999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+||++ +.++.+||+|||++......... .....|+..|+|||++.+..++.++|||||||++|+|+
T Consensus 161 dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 230 (310)
T 2wqm_A 161 DIKPANVFI---TATGVVKLGDLGLGRFFSSKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230 (310)
T ss_dssp CCCGGGEEE---CTTSCEEECCC-------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcHHHEEE---cCCCCEEEEeccceeeecCCCcc-------ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 999999999 47889999999999765443221 23457899999999999999999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 307 (449)
+|..||.+.... .......+........ ....+++++.+++..||..||.+||++.++.+.|+++.....
T Consensus 231 ~g~~p~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 231 ALQSPFYGDKMN-LYSLCKKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HSSCTTC---CC-HHHHHHHHHTTCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hCCCCCcccchh-HHHHHHHhhcccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 999999864322 2222223322222211 124568899999999999999999999999999998866543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.42 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=201.6
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCC-------ceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeec
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHV 72 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 72 (449)
.++..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+|+++++.++|++++.++.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~--- 79 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYG--- 79 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEE---
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEE---
Confidence 5788899999999999999999999998776 469999986432 2345889999999999887655443
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 151 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gii 151 (449)
++...+..++||||+ +++|.+++......++...++.++.||+.||.|||++||+
T Consensus 80 ------------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 135 (289)
T 4fvq_A 80 ------------------------VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135 (289)
T ss_dssp ------------------------EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ------------------------EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeE
Confidence 445567789999999 7899999987666699999999999999999999999999
Q ss_pred ccCCCCCcEEeecCCCCCe--------EEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchH
Q 013125 152 HRDIKPDNFLMGLGRKANQ--------VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDL 222 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~--------vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv 222 (449)
||||||+|||++ .++. +||+|||++...... ....||..|+|||++.+ ..++.++||
T Consensus 136 H~Dlkp~NIll~---~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di 201 (289)
T 4fvq_A 136 HGNVCAKNILLI---REEDRKTGNPPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDK 201 (289)
T ss_dssp CCCCCGGGEEEE---ECCBGGGTBCCEEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHH
T ss_pred CCCcCcceEEEe---cCCcccccccceeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHH
Confidence 999999999995 3333 999999998643221 23457889999999988 679999999
Q ss_pred HHHHHHHHHHHhC-CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 223 ESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 223 wSlG~il~el~~G-~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
|||||++|||++| .+||....... ...........+ ...+.++.+++..||..||.+||++.++.+.|++
T Consensus 202 wslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 202 WSFGTTLWEICSGGDKPLSALDSQR----KLQFYEDRHQLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHHHcCCCCCccccchHH----HHHHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9999999999995 55555433321 112222222222 2346789999999999999999999999999887
Q ss_pred HHHhc
Q 013125 302 LFSRE 306 (449)
Q Consensus 302 ~~~~~ 306 (449)
++...
T Consensus 273 l~~p~ 277 (289)
T 4fvq_A 273 LFTPD 277 (289)
T ss_dssp CC---
T ss_pred hcCCC
Confidence 65543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=331.33 Aligned_cols=268 Identities=19% Similarity=0.226 Sum_probs=205.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++..+......
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 81 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD----- 81 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS-----
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc-----
Confidence 4567999999999999999999999999999999999865432 22467899999999999887776543211
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
........|+|||+++++|.+++.. ..++...++.++.||+.||+|||++||+||||||+|
T Consensus 82 -----------------~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (353)
T 2b9h_A 82 -----------------SFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN 142 (353)
T ss_dssp -----------------CSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----------------ccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 0123467899999999899998874 579999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCcccc---ccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP---YRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G 235 (449)
||+ +.++.+||+|||+++...........+ ........||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 143 il~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 219 (353)
T 2b9h_A 143 LLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219 (353)
T ss_dssp EEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHS
T ss_pred eEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhC
Confidence 999 478899999999998765432211100 011234578999999998765 6789999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHh------------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 236 SLPWQGLKAATKKQKYDKICEK------------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~------------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
..||.+.........+..+... ....+.......+++++.+++..||..||.+||+
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (353)
T 2b9h_A 220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299 (353)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC
Confidence 9999886543322222221110 0112233444577899999999999999999999
Q ss_pred HHHHHH
Q 013125 292 YGFLKR 297 (449)
Q Consensus 292 ~~~l~~ 297 (449)
+.++.+
T Consensus 300 ~~ell~ 305 (353)
T 2b9h_A 300 AKEALE 305 (353)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 887754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=332.84 Aligned_cols=265 Identities=17% Similarity=0.267 Sum_probs=205.7
Q ss_pred CcccCCceEEeeeecccCceeEEEEE-----EcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecc
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVD 73 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 73 (449)
.++..++|++++.||+|+||.||+|+ +..+++.||||++..... ...+.+|+.+++.++|++++.+++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~---- 100 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG---- 100 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE----
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEE----
Confidence 56788999999999999999999999 456788999999865432 234788999999998887655443
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVH 146 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~------~~~~~~~~~~i~~qil~~L~~LH 146 (449)
++......|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||
T Consensus 101 -----------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH 157 (327)
T 2yfx_A 101 -----------------------VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157 (327)
T ss_dssp -----------------------EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 345567789999999 899999998653 34899999999999999999999
Q ss_pred hCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHH
Q 013125 147 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG 226 (449)
Q Consensus 147 ~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG 226 (449)
++||+||||||+|||+...+....+||+|||++......... .......||+.|+|||++.+..++.++||||||
T Consensus 158 ~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred hCCeecCcCCHhHEEEecCCCcceEEECcccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 999999999999999964445667999999999765433221 112345678999999999998999999999999
Q ss_pred HHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 227 YVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 227 ~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|++|||++ |..||.+.... .....+....... ....++..+.+++..||..||.+||++.++.+.|..+...
T Consensus 233 ~il~ellt~g~~p~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQ---EVLEFVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHH---HHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCCCCCCCcCHH---HHHHHHhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 99999998 99999875443 2222222222111 1245688999999999999999999999999988876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=358.66 Aligned_cols=266 Identities=20% Similarity=0.293 Sum_probs=207.3
Q ss_pred cCCceEEee-eecccCceeEEEEEEc--CCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 5 IGVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 5 ~~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
..++|.+.+ +||+|+||.||+|.+. .++..||||+++... ....+.+|+++++.++|++++.+++.+
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~------- 405 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC------- 405 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEE-------
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEe-------
Confidence 345667776 8999999999999875 356679999987643 234688999999999999877665432
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
. .+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||
T Consensus 406 --------------------~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp 464 (613)
T 2ozo_A 406 --------------------Q-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464 (613)
T ss_dssp --------------------E-SSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred --------------------c-cCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCH
Confidence 2 24589999999 8899999876566799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 236 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~ 236 (449)
+|||++ .++.+||+|||+|+........ +.......+|+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 465 ~NILl~---~~~~vkL~DFGla~~~~~~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 537 (613)
T 2ozo_A 465 RNVLLV---NRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 537 (613)
T ss_dssp GGEEEE---ETTEEEECCCSTTTTCC------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred HHEEEc---CCCcEEEeeccCcccccCCCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999995 7789999999999865432211 111223456789999999999999999999999999999998 99
Q ss_pred CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCc
Q 013125 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDF 312 (449)
Q Consensus 237 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~ 312 (449)
.||.+..... ....+... ...+. ...+|+++.++|..||..+|.+||++.+|.+.|+.++...+...+.
T Consensus 538 ~Pf~~~~~~~---~~~~i~~~-~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~ 606 (613)
T 2ozo_A 538 KPYKKMKGPE---VMAFIEQG-KRMEC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606 (613)
T ss_dssp CTTTTCCSHH---HHHHHHTT-CCCCC---CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred CCCCCCCHHH---HHHHHHcC-CCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence 9999876543 22223222 21111 2356899999999999999999999999999999988776554433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.25 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=207.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
++..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+++++.++|++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~------ 94 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL------ 94 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE------
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE------
Confidence 467789999999999999999999876 35778999998754332 2477899999988888655543
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEY 144 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------~~~~~~~~~~i~~qil~~L~~ 144 (449)
.+....+..++|||++ +++|.+++.... ..+++..++.++.||+.||.|
T Consensus 95 ---------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 153 (322)
T 1p4o_A 95 ---------------------GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153 (322)
T ss_dssp ---------------------EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred ---------------------EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHH
Confidence 3445667889999999 789999987532 457999999999999999999
Q ss_pred HHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHH
Q 013125 145 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLES 224 (449)
Q Consensus 145 LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS 224 (449)
||++||+||||||+|||++ .++.+||+|||+++....... +.......+|+.|+|||++.+..++.++||||
T Consensus 154 lH~~~i~H~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 225 (322)
T 1p4o_A 154 LNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 225 (322)
T ss_dssp HHHTTCBCSCCSGGGEEEC---TTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHCCCccCCCccceEEEc---CCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHH
Confidence 9999999999999999994 778999999999976543221 11123456788999999999989999999999
Q ss_pred HHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 225 LGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 225 lG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
|||++|||++ |..||.+.... .....+....... ....++..+.+++..||..||.+||++.++.+.|++.+
T Consensus 226 lG~il~el~~~g~~p~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 226 FGVVLWEIATLAEQPYQGLSNE---QVLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHHHHHTSCCTTTTSCHH---HHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHHHHhcCCCccccCCHH---HHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 9999999999 89999876543 2233333322211 12456889999999999999999999999988887654
Q ss_pred H
Q 013125 304 S 304 (449)
Q Consensus 304 ~ 304 (449)
.
T Consensus 299 ~ 299 (322)
T 1p4o_A 299 E 299 (322)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.29 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=196.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-++|++++.||+|+||.||+|++..+++.||||++....... .+.+|+++++.++|++++.++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~------------- 90 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL------------- 90 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEE-------------
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEE-------------
Confidence 378999999999999999999999999999999886554332 367899999999988755544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.++...+..|+||||+.+.+...+......++...++.++.||+.||+|||++||+||||||+|||
T Consensus 91 --------------~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil 156 (331)
T 4aaa_A 91 --------------EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156 (331)
T ss_dssp --------------EEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred --------------EEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE
Confidence 344567788999999955555444444667999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ .++.+||+|||+++........ .....||..|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 157 ~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 157 VS---QSGVVKLCDFGFARTLAAPGEV-------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp EC---TTSCEEECCCTTC-------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred Ec---CCCcEEEEeCCCceeecCCccc-------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 94 7789999999999765543221 2355789999999999875 68999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHh-----------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEK-----------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.........+...... ....+.......+++++.+++..||..||.+||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 86554322222111110 0111223334467889999999999999999999988755
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.46 Aligned_cols=257 Identities=19% Similarity=0.291 Sum_probs=208.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+-.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+|+++++.++|++++..+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-------------- 69 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY-------------- 69 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEE--------------
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEE--------------
Confidence 34679999999999999999999986 57789999987654 345688999999999888755543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.++...+..++|||++ +++|.+++......++...++.++.||+.||+|||++||+||||||+||+
T Consensus 70 -------------~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 136 (267)
T 3t9t_A 70 -------------GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136 (267)
T ss_dssp -------------EEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred -------------EEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEE
Confidence 3445667889999999 78999999876677999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
++ .++.+||+|||++........ .......+|..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 137 i~---~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (267)
T 3t9t_A 137 VG---ENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207 (267)
T ss_dssp EC---GGGCEEECCTTGGGGBCCHHH------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EC---CCCCEEEcccccccccccccc------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCC
Confidence 94 778999999999976543211 11234567889999999998899999999999999999999 899998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
+.... .....+... ..... ....+..+.+++..||..+|.+||++.++.+.|+++..
T Consensus 208 ~~~~~---~~~~~i~~~-~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 208 NRSNS---EVVEDISTG-FRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TCCHH---HHHHHHHTT-CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHhcC-CcCCC---CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 75443 222333222 11111 13457899999999999999999999999999988765
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=331.07 Aligned_cols=250 Identities=19% Similarity=0.212 Sum_probs=204.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----------chhHHHHHHHHHHH-cCCCcceeeEeecc
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKIL-QGGSKIRLVVFHVD 73 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----------~~~~~~E~~~l~~l-~~~~~~~~~~~~~~ 73 (449)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +|++++
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv-------- 163 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII-------- 163 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC--------
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe--------
Confidence 34689999999999999999999998999999999875432 22467899999988 576544
Q ss_pred hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 74 HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 74 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
.+..++......|+||||+ |++|.+++.. ...++...++.++.||+.||.|||++||+|
T Consensus 164 -------------------~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H 223 (365)
T 2y7j_A 164 -------------------TLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVH 223 (365)
T ss_dssp -------------------CEEEEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred -------------------EEEEEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4444456678899999999 7899998875 457999999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC------CCCCccchHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLG 226 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwSlG 226 (449)
|||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||
T Consensus 224 ~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 292 (365)
T 2y7j_A 224 RDLKPENILL---DDNMQIRLSDFGFSCHLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292 (365)
T ss_dssp SCCSGGGEEE---CTTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHH
T ss_pred CCCCHHHEEE---CCCCCEEEEecCcccccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHH
Confidence 9999999999 4788999999999987654322 235689999999999863 3588999999999
Q ss_pred HHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 227 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 227 ~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|++|||++|..||.+.... ..+..+.......+.+ .+...+.++.+++..||..||.+||++.++.+
T Consensus 293 ~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 293 VILFTLLAGSPPFWHRRQI---LMLRMIMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999875432 3344444444444433 34567889999999999999999999988754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=329.60 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=207.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEE-----cCCCceEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
+..++|++++.||+|+||+||+|.+ ..+++.||||++...... ..+.+|+++++.+ +|++++.++..+
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--- 100 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC--- 100 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE---
Confidence 5578999999999999999999985 356789999998765432 2478899999999 566655544322
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCC---------------CCHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK---------------FSLKTVLMLADQM 138 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~---------------~~~~~~~~i~~qi 138 (449)
...+...++||||+ +++|.+++...... ++...++.++.||
T Consensus 101 -----------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 157 (316)
T 2xir_A 101 -----------------------TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157 (316)
T ss_dssp -----------------------CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHH
T ss_pred -----------------------ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHH
Confidence 22345689999999 78999998754322 8899999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCc
Q 013125 139 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR 218 (449)
Q Consensus 139 l~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ 218 (449)
+.||.|||++||+||||||+|||++ .++.+||+|||+++......... ......||+.|+|||++.+..++.
T Consensus 158 ~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~ 229 (316)
T 2xir_A 158 AKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTI 229 (316)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTTCTTSE-----EETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHhCCcccccCccceEEEC---CCCCEEECCCccccccccCccce-----eccCCCcceeecCchhhccccccc
Confidence 9999999999999999999999994 67899999999998654432211 123456788999999999999999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 219 RDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 219 ~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|||||||++|||++ |..||.+..... .+............ ....++++.+++..||..||.+||++.++.+
T Consensus 230 ~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 303 (316)
T 2xir_A 230 QSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303 (316)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcccchhH---HHHHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999998 999998754332 11122222221111 2345789999999999999999999999999
Q ss_pred HHHHHHHhc
Q 013125 298 LFHDLFSRE 306 (449)
Q Consensus 298 ~l~~~~~~~ 306 (449)
.|+.++...
T Consensus 304 ~L~~~~~~~ 312 (316)
T 2xir_A 304 HLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhhh
Confidence 999987754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.12 Aligned_cols=272 Identities=18% Similarity=0.201 Sum_probs=203.0
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+..++++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++..+........
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 82 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS--- 82 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC---
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc---
Confidence 45678999999999999999999999999999999998875432 2357899999999999998887765422110
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.+.............|+||||++++|.+++. ...++...++.++.||+.||+|||++||+||||||+|
T Consensus 83 ----------~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 150 (320)
T 2i6l_A 83 ----------QLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 150 (320)
T ss_dssp ----------BCCC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred ----------ccccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 0111112234567889999999889999886 4679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++ .+++.+||+|||+++......... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 151 il~~--~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 151 LFIN--TEDLVLKIGDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp EEEE--TTTTEEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEc--CCCCeEEEccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9995 246799999999998654321111 11234467899999998876 6789999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhh-------------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 239 WQGLKAATKKQKYDKICEKK-------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
|.+...... +..+.... ...+.......++.++.+++..||..||.+||++.
T Consensus 225 f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (320)
T 2i6l_A 225 FAGAHELEQ---MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301 (320)
T ss_dssp SCCSSHHHH---HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CCCCCHHHH---HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH
Confidence 988654322 22222211 12233444566789999999999999999999998
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 302 ell~ 305 (320)
T 2i6l_A 302 EALS 305 (320)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 8755
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=336.87 Aligned_cols=262 Identities=18% Similarity=0.255 Sum_probs=197.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCC---ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.+|++.+.||+|+||+||+|++..++ ..||+|+++.... ...+.+|+.+++.++|++++.++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--------- 159 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--------- 159 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE---------
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE---------
Confidence 35899999999999999999985432 4689998875433 23578899999999888866654432
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
....+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|
T Consensus 160 -----------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 222 (373)
T 3c1x_A 160 -----------------LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222 (373)
T ss_dssp -----------------CCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----------------EcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence 23446779999999 789999998666779999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
||+ +.++.+||+|||+++......... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 223 Ill---~~~~~~kL~DFG~a~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 223 CML---DEKFTVKVADFGLARDMYDKEFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp EEE---CTTCCEEECCC------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEE---CCCCCEEEeecccccccccccccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 999 478899999999998654332111 011234567889999999999999999999999999999999 7888
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 307 (449)
|.+........ .+...... .. ...+|..+.+++..||..+|.+||++.++.+.|++++....
T Consensus 297 ~~~~~~~~~~~---~~~~~~~~-~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 297 YPDVNTFDITV---YLLQGRRL-LQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CTTSCSSCHHH---HHHTTCCC-CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCHHHHHH---HHHcCCCC-CC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 88765443222 22222211 11 13468899999999999999999999999999999887653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=336.54 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=201.3
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
++++..++|+++++||+|+||+||+|.+..+++.||+|++..... ...+.+|+++++.++|++++.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~---------- 96 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF---------- 96 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCE----------
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEE----------
Confidence 367888999999999999999999999999999999999876533 2347788888888887765544
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDI 155 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDL 155 (449)
..++...+..|+||||+ +++|.+++.. ...++...+..++.||+.||+|||++ ||+||||
T Consensus 97 -----------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dl 158 (360)
T 3eqc_A 97 -----------------YGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158 (360)
T ss_dssp -----------------EEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCC
T ss_pred -----------------eEEEEECCEEEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCc
Confidence 34445677899999999 7899999876 45699999999999999999999996 9999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||++ .++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 159 kp~Nil~~---~~~~~kl~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 226 (360)
T 3eqc_A 159 KPSNILVN---SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226 (360)
T ss_dssp SGGGEEEC---TTCCEEECCCCCCHHHHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred cHHHEEEC---CCCCEEEEECCCCccccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999994 78899999999987553321 2356789999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHH---------------------------------------HHHHHhhcCCCHHHhhccChHHHHH
Q 013125 236 SLPWQGLKAATKKQKY---------------------------------------DKICEKKVSTPIEVLCKSHPAEFAS 276 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~---------------------------------------~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (449)
..||...........+ ..+.... +.......++.++.+
T Consensus 227 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 303 (360)
T 3eqc_A 227 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP---PPKLPSGVFSLEFQD 303 (360)
T ss_dssp SCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC---CCCCCTTTSCHHHHH
T ss_pred CCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC---CCCCCcccccHHHHH
Confidence 9999875433211111 1111100 000111235788999
Q ss_pred HHHHHhCCCCCCCCCHHHHHH
Q 013125 277 YFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 277 l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++..||..||.+||++.++.+
T Consensus 304 li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 304 FVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp HHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHhhcChhhCCCHHHHhh
Confidence 999999999999999988855
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=324.52 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=199.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+..++|++.+.||+|+||.||+|.+ +++.||||++........+.+|+++++.++|++++..+...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------------ 83 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI------------ 83 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEE------------
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEE------------
Confidence 4568999999999999999999987 58899999998776677789999999999988866654432
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~-~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.......++|||++ +++|.+++..... .++...++.++.||+.||+|||++||+||||||+||+
T Consensus 84 --------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 149 (278)
T 1byg_A 84 --------------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149 (278)
T ss_dssp --------------CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred --------------EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEE
Confidence 23345789999999 6799999875433 3899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
++ .++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 150 ~~---~~~~~~l~Dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 150 VS---EDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp EC---TTSCEEECCCCC----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred Ee---CCCcEEEeeccccccccccc----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 94 78899999999997554322 23457889999999999899999999999999999998 999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
........ ..+.. .... .....+++.+.+++..||..||.+||++.++.+.|+++...
T Consensus 217 ~~~~~~~~---~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 217 RIPLKDVV---PRVEK-GYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TSCGGGHH---HHHTT-TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHH---HHHhc-CCCC---CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 76543222 22221 1111 12245689999999999999999999999999999887554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=331.13 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=206.8
Q ss_pred cccCCce-EEeeeecccCceeEEEEEE----cCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y-~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
.+++++| +++++||+|+||+||+|.. ..+++.||||++..... ...+.+|+++++.++|++++.++....
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE-- 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEe--
Confidence 4577787 9999999999999988864 35788999999886543 234789999999999988666544321
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.......++||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||
T Consensus 104 -----------------------~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~ 158 (318)
T 3lxp_A 104 -----------------------DAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHR 158 (318)
T ss_dssp -----------------------ETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred -----------------------cCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 12346789999999 7899998863 459999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+ +.++.+||+|||++......... +.......+|..|+|||++.+..++.++|||||||++|||+
T Consensus 159 Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 231 (318)
T 3lxp_A 159 DLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231 (318)
T ss_dssp CCSGGGEEE---CTTCCEEECCGGGCEECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CCchheEEE---cCCCCEEECCccccccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999 47789999999999877544321 11223556888999999999989999999999999999999
Q ss_pred hCCCCCCCChhhc-----------HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 234 RGSLPWQGLKAAT-----------KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 234 ~G~~pf~~~~~~~-----------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
+|..||....... ....+..........+ ....+++++.+++..||..||.+||++.++.+.|+.+
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 232 THCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp TTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 9999997643210 0111112222222222 2245688999999999999999999999999999887
Q ss_pred HHh
Q 013125 303 FSR 305 (449)
Q Consensus 303 ~~~ 305 (449)
...
T Consensus 309 ~~~ 311 (318)
T 3lxp_A 309 HEK 311 (318)
T ss_dssp HHH
T ss_pred HHh
Confidence 654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.97 Aligned_cols=280 Identities=18% Similarity=0.189 Sum_probs=198.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh--
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL-- 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-- 80 (449)
-++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+++++.++|+++++++....+.......
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 3789999999999999999999999999999999875432 34588999999999999999988765432210000
Q ss_pred -hhhhc---------------------------ccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc--CCCCHH
Q 013125 81 -TIIFS---------------------------STLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR--RKFSLK 129 (449)
Q Consensus 81 -~~~~~---------------------------~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~--~~~~~~ 129 (449)
..++. .................+.++||||+ +++|.+++.... ...+..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 00000 00000000001112344689999999 889999987532 235667
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccc-----cccCCCCCCCCcc
Q 013125 130 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-----PYRENKNLTGTAR 204 (449)
Q Consensus 130 ~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~-----~~~~~~~~~gt~~ 204 (449)
.++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++........... .+.......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7999999999999999999999999999999994 7889999999999877654321110 0122345689999
Q ss_pred ccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCC
Q 013125 205 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSL 284 (449)
Q Consensus 205 y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 284 (449)
|+|||++.+..++.++|||||||++|||++|..|+.. .......+... ..+......++++.+++..||..
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL----KFPLLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT----CCCHHHHHHCHHHHHHHHHHHCS
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc----CCCcccccCChhHHHHHHHHccC
Confidence 9999999999999999999999999999998766532 11122222111 22222333467889999999999
Q ss_pred CCCCCCCHHHHHH
Q 013125 285 TFDQRPDYGFLKR 297 (449)
Q Consensus 285 ~p~~Rp~~~~l~~ 297 (449)
||.+||++.++.+
T Consensus 313 ~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 313 SPTERPEATDIIE 325 (332)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CCCcCCCHHHHhh
Confidence 9999999888754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=337.70 Aligned_cols=259 Identities=21% Similarity=0.244 Sum_probs=199.2
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++....+|++++.||+|+||.||+|++..+++ ||+|.+.... ....+|+++++.++|++++.++.......
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~------ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK--RFKNRELQIMRIVKHPNVVDLKAFFYSNG------ 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEES------
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc--chHHHHHHHHHhCCCCCcceEEEEEEecC------
Confidence 45567899999999999999999999977666 7888765432 22357999999999998877655432110
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
........++||||+.+++...+.. ....++...++.++.||+.||+|||++||+||||||+
T Consensus 106 ---------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (394)
T 4e7w_A 106 ---------------DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170 (394)
T ss_dssp ---------------SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ---------------CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 0023345789999998777665542 2567999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~ 237 (449)
|||++ ..++.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 171 Nill~--~~~~~~kL~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 171 NLLLD--PPSGVLKLIDFGSAKILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp GEEEE--TTTTEEEECCCTTCEECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred HEEEc--CCCCcEEEeeCCCcccccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99994 2678999999999987654332 2356789999999999875 48999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCH-----------------------H-HhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPI-----------------------E-VLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~-----------------------~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
||.+....... ..+......... . ......++++.+|+..||..||.+||++.
T Consensus 241 pf~~~~~~~~l---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (394)
T 4e7w_A 241 LFPGESGIDQL---VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317 (394)
T ss_dssp SSCCSSHHHHH---HHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCHHHHH---HHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHH
Confidence 99986654332 223222211111 1 12234678999999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 318 e~l~ 321 (394)
T 4e7w_A 318 EALC 321 (394)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 7744
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=333.65 Aligned_cols=240 Identities=20% Similarity=0.246 Sum_probs=198.3
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----------CchhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
+.++|++++.||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.++|++++.++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~------ 95 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL------ 95 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE------
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE------
Confidence 4579999999999999999999999999999999987643 233577899999999888755544
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~-sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
.+....+..++|||++ ++ +|.+++.. ...++...++.++.||+.||+|||++||+|
T Consensus 96 ---------------------~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 153 (335)
T 3dls_A 96 ---------------------DIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIH 153 (335)
T ss_dssp ---------------------EEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ---------------------EEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEE
Confidence 3445677899999998 44 88888764 557999999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLY 231 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~e 231 (449)
|||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++||
T Consensus 154 ~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 222 (335)
T 3dls_A 154 RDIKDENIVIA---EDFTIKLIDFGSAAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222 (335)
T ss_dssp SCCSGGGEEEC---TTSCEEECCCTTCEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHH
T ss_pred eccCHHHEEEc---CCCcEEEeecccceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHH
Confidence 99999999994 778999999999987654332 134578999999999998876 889999999999999
Q ss_pred HHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 232 l~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|++|..||...... .......+ ..+++++.+++..||..||.+||++.++.+
T Consensus 223 l~~g~~pf~~~~~~---------~~~~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 223 LVFEENPFCELEET---------VEAAIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp HHHSSCSCSSGGGG---------TTTCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCchhhHHHH---------HhhccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999864321 11122222 235789999999999999999999887755
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=333.91 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=199.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-------CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+.++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+|+++++.++|++++.++.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-------- 95 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-------- 95 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE--------
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh--------
Confidence 457999999999999999999999999999999987532 22346888999999999887655443
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh----------------------------------
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---------------------------------- 122 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---------------------------------- 122 (449)
+....+..|+||||+ +++|.+++...
T Consensus 96 -------------------~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (345)
T 3hko_A 96 -------------------VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156 (345)
T ss_dssp -------------------EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--
T ss_pred -------------------hhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccc
Confidence 445677899999999 99999887410
Q ss_pred -----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCC
Q 013125 123 -----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 197 (449)
Q Consensus 123 -----~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~ 197 (449)
...+++..++.++.||+.||+|||++||+||||||+|||+.. +....+||+|||+++.+........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~ 232 (345)
T 3hko_A 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEY---YGMT 232 (345)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC---------
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCcccc---cccc
Confidence 112357788999999999999999999999999999999941 1233899999999987654332211 1124
Q ss_pred CCCCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHH
Q 013125 198 NLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFA 275 (449)
Q Consensus 198 ~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (449)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... .....+.......+. .....+++++.
T Consensus 233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~ 308 (345)
T 3hko_A 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA---DTISQVLNKKLCFEN-PNYNVLSPLAR 308 (345)
T ss_dssp --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCTTS-GGGGGSCHHHH
T ss_pred ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcccccCC-cccccCCHHHH
Confidence 5679999999999975 67899999999999999999999999876544 333344444433332 22345688999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHH
Q 013125 276 SYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 276 ~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+++..||..||.+||++.++.+
T Consensus 309 ~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 309 DLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999999988755
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.84 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=205.5
Q ss_pred ccCCceEEee-eecccCceeEEEEEE--cCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGR-KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~-~LG~G~fg~Vy~a~~--~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+..++|++.+ .||+|+||+||+|.+ ..+++.||||++..... ...+.+|+++++.++|++++..+..
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------ 86 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI------ 86 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE------
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE------
Confidence 3457899999 999999999999955 56678999999875432 2357889999999998876655432
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
. ..+..++|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+||||
T Consensus 87 ---------------------~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~di 143 (291)
T 1xbb_A 87 ---------------------C-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143 (291)
T ss_dssp ---------------------E-ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ---------------------E-CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCC
Confidence 2 346689999999 7899999876 566999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+|||++ .++.+||+|||++.......... .......+|..|+|||++.+..++.++|||||||++|||++
T Consensus 144 kp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 216 (291)
T 1xbb_A 144 AARNVLLV---TQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216 (291)
T ss_dssp SGGGEEEE---ETTEEEECCCTTCEECCTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred CcceEEEe---CCCcEEEccCCcceeeccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhc
Confidence 99999995 67899999999998765433211 11223456789999999998889999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|..||.+..... ....+.. ..... ....+++++.+++..||..||.+||++.++.+.|++++...
T Consensus 217 g~~p~~~~~~~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 217 GQKPYRGMKGSE---VTAMLEK-GERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp TCCSSTTCCHHH---HHHHHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHH---HHHHHHc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 999998765432 2222222 11111 22456899999999999999999999999999999987653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.92 Aligned_cols=271 Identities=21% Similarity=0.307 Sum_probs=201.2
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH--cCCCcceeeEeecchhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL--QGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l--~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.+.++|+++++||+|+||.||+|++ +++.||||++... .......|.+++..+ +|++++.++......
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~------ 103 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKG------ 103 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES------
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC------
Confidence 45678999999999999999999988 4889999998643 233455666666554 676655544332111
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------Ccc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFL 151 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--------gii 151 (449)
.......|+||||+ +++|.+++.. ..+++..++.++.|++.||+|||++ ||+
T Consensus 104 -----------------~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 164 (337)
T 3mdy_A 104 -----------------TGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164 (337)
T ss_dssp -----------------CGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEE
T ss_pred -----------------CCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEE
Confidence 01126789999999 8899999964 4699999999999999999999998 999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCcc------chHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR------DDLESL 225 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~------~DvwSl 225 (449)
||||||+|||++ .++.+||+|||+|+.+......... ......||+.|+|||++.+..++.. +|||||
T Consensus 165 H~Dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 165 HRDLKSKNILVK---KNGTCCIADLGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp CSCCCGGGEEEC---TTSCEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred ecccchHHEEEC---CCCCEEEEeCCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 999999999994 7889999999999876544332211 1235689999999999988776665 999999
Q ss_pred HHHHHHHHhC----------CCCCCCChhhc-HHHHHHHHH-HhhcC--CCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 226 GYVLLYFLRG----------SLPWQGLKAAT-KKQKYDKIC-EKKVS--TPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 226 G~il~el~~G----------~~pf~~~~~~~-~~~~~~~i~-~~~~~--~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
||++|||++| ..||....... ......... ..... .+.......+++++.+++..||..||.+||+
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC
Confidence 9999999999 77886543322 112222221 11212 2222222345788999999999999999999
Q ss_pred HHHHHHHHHHHHHhcC
Q 013125 292 YGFLKRLFHDLFSREG 307 (449)
Q Consensus 292 ~~~l~~~l~~~~~~~~ 307 (449)
+.++.+.|+.+....+
T Consensus 319 ~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 319 ALRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHhhcc
Confidence 9999999999877654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=332.37 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=196.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++.+.||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++|++++.++........
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 115 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS---- 115 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS----
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC----
Confidence 568999999999999999999999999999999998764332 347789999999999987776554321100
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.......|+|||+++++|.+++ ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 116 -----------------~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 175 (371)
T 4exu_A 116 -----------------LRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 175 (371)
T ss_dssp -----------------STTCCCCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred -----------------cccceeEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHe
Confidence 0011234999999998887765 45699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 176 ll---~~~~~~kL~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 242 (371)
T 4exu_A 176 AV---NEDCELKILDFGLARHADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242 (371)
T ss_dssp EE---CTTCCEEECSTTCC------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred EE---CCCCCEEEEecCcccccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 99 478899999999997654322 35678999999999987 67999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCC--------------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+........ .+....... .........++++.+|+..||..||.+||++.
T Consensus 243 ~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 319 (371)
T 4exu_A 243 KGKDYLDQLT---QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319 (371)
T ss_dssp CCSSHHHHHH---HHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCChHHHHH---HHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH
Confidence 8865443222 222211111 11223345678999999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 320 ell~ 323 (371)
T 4exu_A 320 QALT 323 (371)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 7744
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.14 Aligned_cols=262 Identities=18% Similarity=0.265 Sum_probs=204.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCC---ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..+|++.+.||+|+||+||+|.+..++ ..||+|++..... ...+.+|+++++.++|++++.++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~--------- 94 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI--------- 94 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEE---------
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeE---------
Confidence 357999999999999999999975433 3589998876443 2347889999999999886655433
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
+....+..++|||++ +++|.+++......++...++.++.||+.||+|||++||+||||||+
T Consensus 95 -----------------~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~ 157 (298)
T 3f66_A 95 -----------------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAAR 157 (298)
T ss_dssp -----------------ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -----------------EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchh
Confidence 234556789999999 77999999766677999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~ 237 (449)
|||+ +.++.+||+|||+++......... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 158 Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 158 NCML---DEKFTVKVADFGLARDMYDKEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp GEEE---CTTCCEEECSCGGGCCCSCGGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eEEE---CCCCCEEECcccccccccccchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999 478899999999998664432111 112345567889999999999999999999999999999999 677
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
||.+........ .+........ ...++..+.+++..||..+|.+||++.++.+.|++++...
T Consensus 232 ~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 232 PYPDVNTFDITV---YLLQGRRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp SSTTSCTTTHHH---HHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCccCCHHHHHH---HHhcCCCCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 777655433222 2222221111 2345889999999999999999999999999999987753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=354.68 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=208.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..++|++.++||+|+||+||+|.+.. +..||||+++.... .+.+.+|+++++.|+|++++.+++.+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~----------- 331 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV----------- 331 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----------
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-----------
Confidence 567899999999999999999999864 46799999886543 45689999999999999877765432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
. .+..||||||+ +++|.+++... +..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 332 ----------------~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 332 ----------------S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp ----------------C-SSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----------------e-eccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 2 25679999999 78999999753 45699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf 239 (449)
|++ .++.+||+|||+++...... +.......++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 395 ll~---~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~ 465 (535)
T 2h8h_A 395 LVG---ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465 (535)
T ss_dssp EEC---GGGCEEECCTTSTTTCCCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSS
T ss_pred EEc---CCCcEEEcccccceecCCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 994 67899999999997654321 111234567889999999998899999999999999999999 99999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.+..... .+..+ ......+. ...++.++.+||..||..||++||++++|.+.|++++..
T Consensus 466 ~~~~~~~---~~~~i-~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 466 PGMVNRE---VLDQV-ERGYRMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHH---HHHHH-HTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHH---HHHHH-HcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 8865532 22222 22222222 235688999999999999999999999999998876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=330.12 Aligned_cols=248 Identities=25% Similarity=0.300 Sum_probs=204.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
...++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++.++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~---------- 107 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH---------- 107 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEE----------
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEE----------
Confidence 346799999999999999999999999999999999865421 23477899999999888755543
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.++...+..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||
T Consensus 108 -----------------~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 169 (335)
T 2owb_A 108 -----------------GFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 169 (335)
T ss_dssp -----------------EEEECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred -----------------EEEecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCc
Confidence 3445667899999999 7899998775 46799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||++ .++.+||+|||++......... .....||..|+|||++.+..++.++|||||||++|||++|..
T Consensus 170 ~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 239 (335)
T 2owb_A 170 GNLFLN---EDLEVKIGDFGLATKVEYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239 (335)
T ss_dssp GGEEEC---TTCCEEECCCTTCEECCSTTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhEEEc---CCCCEEEeeccCceecccCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcC
Confidence 999994 7789999999999876533221 235678999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||...... ..+..+.......+ ..+++++.+++..||..||.+||++.++.+
T Consensus 240 pf~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 240 PFETSCLK---ETYLRIKKNEYSIP-----KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTCCSSHH---HHHHHHHHTCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCCHH---HHHHHHhcCCCCCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99875433 23333333333332 345789999999999999999999887754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=322.66 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=210.1
Q ss_pred ccCCceEEee-eecccCceeEEEEEEc--CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+..++|.+.+ .||+|+||.||+|.+. .+++.||||++..... ...+.+|+++++.++|++++..+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~------- 78 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV------- 78 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-------
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEE-------
Confidence 4467888887 9999999999999864 4678899999876533 2347899999999998876665432
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
. ..+..++|||++ +++|.+++......+++..++.++.||+.||+|||++||+|||||
T Consensus 79 --------------------~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 137 (287)
T 1u59_A 79 --------------------C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137 (287)
T ss_dssp --------------------E-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred --------------------e-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCc
Confidence 2 345689999999 779999987656679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+||+++ .++.+||+|||++.......... .......+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 138 p~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 210 (287)
T 1u59_A 138 ARNVLLV---NRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210 (287)
T ss_dssp GGGEEEE---ETTEEEECCCTTCEECTTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred hheEEEc---CCCCEEECcccceeeeccCccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999995 77899999999998765433211 11234567899999999998889999999999999999998 9
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 307 (449)
..||.+..... ....+.... .. .....+++++.+++..||..+|.+||++.++.+.|+.++...+
T Consensus 211 ~~p~~~~~~~~---~~~~i~~~~-~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 211 QKPYKKMKGPE---VMAFIEQGK-RM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CCTTTTCCTHH---HHHHHHTTC-CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHH---HHHHHhcCC-cC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 99998765432 222222221 11 1224568999999999999999999999999999999877654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.62 Aligned_cols=274 Identities=17% Similarity=0.213 Sum_probs=194.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.+.+|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+. |++++.++........
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~---- 100 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE---- 100 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT----
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc----
Confidence 446799999999999999999999999999999998754432 335788999999996 8887776554321100
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIK 156 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~--~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHrDLk 156 (449)
.........++||||++++|.+++... ...+++..++.++.||+.||+|||++| |+|||||
T Consensus 101 ---------------~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dik 165 (337)
T 3ll6_A 101 ---------------ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLK 165 (337)
T ss_dssp ---------------TSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCC
T ss_pred ---------------ccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCC
Confidence 011345568999999999999988753 456999999999999999999999999 9999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCcccc-----ccCCCCCCCCccccccccc---cCCCCCccchHHHHHHH
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP-----YRENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYV 228 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlG~i 228 (449)
|+|||++ .++.+||+|||+++............ ........||+.|+|||++ .+..++.++|||||||+
T Consensus 166 p~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 166 VENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242 (337)
T ss_dssp GGGCEEC---TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred cccEEEC---CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence 9999994 77899999999998765432211000 0112255689999999998 56678999999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCC
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 308 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~ 308 (449)
+|||++|..||.+.... .+.......+.. ...+..+.+++..||..||.+||++.++.+.|+.+......
T Consensus 243 l~el~~g~~p~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKL-------RIVNGKYSIPPH---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp HHHHHHSSCCC-------------------CCCCTT---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHhCCCCCcchhHH-------HhhcCcccCCcc---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 99999999999764321 122223332222 33467799999999999999999999999999988776554
Q ss_pred C
Q 013125 309 D 309 (449)
Q Consensus 309 ~ 309 (449)
.
T Consensus 313 ~ 313 (337)
T 3ll6_A 313 N 313 (337)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.06 Aligned_cols=267 Identities=20% Similarity=0.242 Sum_probs=208.3
Q ss_pred cccCCceEEeeeecccCceeEEEEE----EcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
.+..++|+++++||+|+||.||+|+ +..+++.||||++..... ...+.+|+++++.++|++++..+....
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY---- 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE----
Confidence 4567889999999999999999998 456889999999876433 235789999999999988766544321
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
.......++|||++ +++|.+++......++...++.++.||+.||+|||++||+||||
T Consensus 113 ---------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di 171 (326)
T 2w1i_A 113 ---------------------SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171 (326)
T ss_dssp ---------------------C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ---------------------ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCC
Confidence 12334789999999 88999999876677999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||++ .++.+||+|||++.......... .......++..|+|||++.+..++.++|||||||++|||++|
T Consensus 172 kp~NIli~---~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg 244 (326)
T 2w1i_A 172 ATRNILVE---NENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244 (326)
T ss_dssp CGGGEEEE---ETTEEEECCCTTCEECCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEc---CCCcEEEecCcchhhcccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhc
Confidence 99999995 67899999999998765443211 112345678889999999998899999999999999999999
Q ss_pred CCCCCCChhhc------------HHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 013125 236 SLPWQGLKAAT------------KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303 (449)
Q Consensus 236 ~~pf~~~~~~~------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~ 303 (449)
..||....... ....+...+......+. ...+++++.+++..||..||.+||++.+|.+.|+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99987532110 00011111222212221 2456899999999999999999999999999998875
Q ss_pred H
Q 013125 304 S 304 (449)
Q Consensus 304 ~ 304 (449)
.
T Consensus 322 ~ 322 (326)
T 2w1i_A 322 D 322 (326)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=330.73 Aligned_cols=255 Identities=25% Similarity=0.323 Sum_probs=200.4
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----------CchhHHHHHHHHHHHcCCCcceeeEeec
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSKIRLVVFHV 72 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----------~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 72 (449)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+++++.++|++++..+..
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-- 83 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-- 83 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE--
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE--
Confidence 346689999999999999999999999999999999976431 12347899999999999886665432
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 151 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gii 151 (449)
... +..|+||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+
T Consensus 84 -------------------------~~~-~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 136 (322)
T 2ycf_A 84 -------------------------FDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGII 136 (322)
T ss_dssp -------------------------EES-SSEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -------------------------EcC-CceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 222 3479999999 7799888764 56799999999999999999999999999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYV 228 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~i 228 (449)
||||||+|||++..+....+||+|||+++....... .....||+.|+|||++. ...++.++|||||||+
T Consensus 137 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 208 (322)
T 2ycf_A 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208 (322)
T ss_dssp CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHH
T ss_pred ccCCCHHHEEEecCCCCCeEEEccCccceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHH
Confidence 999999999996433445699999999987643211 12346899999999974 4568999999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|+|++|..||........ ....+...... ..+..+...+.++.+++..||..||.+||++.++.+
T Consensus 209 l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 209 LFICLSGYPPFSEHRTQVS--LKDQITSGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHSSCSSCSTTCSSC--HHHHHHHTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCCCcccchHHH--HHHHHHhCccc-cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999999999986543321 11222233322 334556677899999999999999999999887643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=325.03 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=194.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
..++|+++++||+|+||+||+|++..+++.||||++.. .....+.+|+++++.++ |++++.++....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----------- 101 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVK----------- 101 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----------
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeec-----------
Confidence 46899999999999999999999999999999999875 34567899999999997 776555443221
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.......++|||++ +++|.+++. .++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 102 --------------~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~ 163 (330)
T 3nsz_A 102 --------------DPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163 (330)
T ss_dssp --------------CTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred --------------cCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 12356789999999 788888764 48999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+ .+...+||+|||+|+....... .....||..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 164 ~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 164 D--HEHRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp E--TTTTEEEECCCTTCEECCTTCC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred c--CCCCEEEEEeCCCceEcCCCCc--------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 5 2344899999999987654332 235578999999999987 5689999999999999999999999954
Q ss_pred Chhh-cHHHHHHHH----------HHhhcCCCH-------------------HHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 242 LKAA-TKKQKYDKI----------CEKKVSTPI-------------------EVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 242 ~~~~-~~~~~~~~i----------~~~~~~~~~-------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
.... .....+... ......... .......++++.+++..||..||.+||+
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 313 (330)
T 3nsz_A 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313 (330)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC
Confidence 3221 111111110 000000000 0011225789999999999999999999
Q ss_pred HHHHHH
Q 013125 292 YGFLKR 297 (449)
Q Consensus 292 ~~~l~~ 297 (449)
++++.+
T Consensus 314 a~e~l~ 319 (330)
T 3nsz_A 314 AREAME 319 (330)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 887754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=331.18 Aligned_cols=266 Identities=17% Similarity=0.209 Sum_probs=206.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
..++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+++++.++|++++.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~--------------- 100 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL--------------- 100 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCE---------------
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeE---------------
Confidence 457999999999999999999996 4688999998775533 3457889999888888765554
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
..++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 101 ------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~ 168 (321)
T 2qkw_B 101 ------------IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSI 168 (321)
T ss_dssp ------------EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCST
T ss_pred ------------EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHH
Confidence 34445677889999999 889998876432 35899999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+ +.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 169 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 169 NILL---DENFVPKITDFGISKKGTELDQTH-----LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp TEEE---CTTCCEEECCCTTCEECSSSSCCC-----CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred HEEE---CCCCCEEEeecccccccccccccc-----cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCc
Confidence 9999 478899999999998754332211 12345689999999999998999999999999999999999999
Q ss_pred CCCChhhcHHHHHHH----HHHhhcC-----CCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 239 WQGLKAATKKQKYDK----ICEKKVS-----TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 239 f~~~~~~~~~~~~~~----i~~~~~~-----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
|.+............ .....+. ..........+..+.+++..||..||.+||++.++.+.|+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 986543321111110 0000000 0011112234678999999999999999999999999999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=322.30 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=204.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~----------- 80 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF----------- 80 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCE-----------
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeee-----------
Confidence 456899999999999999999999999999999999765421 2346789999999888865554
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
..++...+..++|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||
T Consensus 81 ----------------~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p 143 (294)
T 2rku_A 81 ----------------HGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 143 (294)
T ss_dssp ----------------EEEEECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ----------------eeeeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 33445677899999999 7899988775 46799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+ +.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 144 ~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 213 (294)
T 2rku_A 144 GNLFL---NEDLEVKIGDFGLATKVEYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213 (294)
T ss_dssp GGEEE---CTTCCEEECCCTTCEECCSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HhEEE---cCCCCEEEEeccCceecccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999 47889999999999876533221 235678999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.+.... +.+..+.......+ ...++.+.+++..||..||.+||++.++.+
T Consensus 214 p~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 214 PFETSCLK---ETYLRIKKNEYSIP-----KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TTCCSSHH---HHHHHHHTTCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCCHH---HHHHHHhhccCCCc-----cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 99875443 23333333333322 345789999999999999999999988755
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=318.88 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=203.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+.-++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~---------- 80 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY---------- 80 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE----------
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEE----------
Confidence 4558999999999999999999999999999999987532 2234688899999999888755443
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.+....+..++|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||
T Consensus 81 -----------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 142 (284)
T 2vgo_A 81 -----------------NYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKP 142 (284)
T ss_dssp -----------------EEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred -----------------EEEEcCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 3445667889999999 7799998876 45699999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+||+++ .++.+||+|||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 143 ~Nil~~---~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (284)
T 2vgo_A 143 ENLLMG---YKGELKIADFGWSVHAPSLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210 (284)
T ss_dssp GGEEEC---TTCCEEECCCTTCEECSSSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEc---CCCCEEEecccccccCcccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCC
Confidence 999994 77899999999997654322 235678999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||...... .....+.......+ ...+.++.+++..||..||.+||++.++.+
T Consensus 211 pf~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 211 PFDSPSHT---ETHRRIVNVDLKFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTCCSSHH---HHHHHHHTTCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCHh---HHHHHHhccccCCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 99875443 23333333333332 345789999999999999999999988755
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=318.04 Aligned_cols=266 Identities=19% Similarity=0.230 Sum_probs=209.8
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++..++++|++++.||+|+||.||+|.+..+++.||+|++... ...+.+|+++++.++|++++..+..........
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~-- 80 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDP-- 80 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCc--
Confidence 3566789999999999999999999999989999999998753 356889999999999999888766442211000
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
...............++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 81 ---------~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 151 (284)
T 2a19_B 81 ---------ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPS 151 (284)
T ss_dssp -----------------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ---------ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHH
Confidence 0000001112345679999999 77999999764 357999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+. .++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 152 Nil~~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 220 (284)
T 2a19_B 152 NIFLV---DTKQVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220 (284)
T ss_dssp GEEEE---ETTEEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSS
T ss_pred HEEEc---CCCCEEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCc
Confidence 99995 778999999999987654332 1345789999999999999999999999999999999999988
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
|.... .....+..... ...++..+.+++..||..||.+||++.++.+.|..+
T Consensus 221 ~~~~~-----~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 221 AFETS-----KFFTDLRDGII-------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHH-----HHHHHHHTTCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHH-----HHHHHhhcccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 75321 12222222111 134578999999999999999999999998888765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=332.45 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=196.0
Q ss_pred CCceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCC------CCchhHHHHHHHHHHHc-CCCcceeeEeecchh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHV 75 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~------~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~ 75 (449)
-++|+++++||+|+||.||+|++. .+++.||||+++.. .....+.+|+++++.+. |++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~------------ 120 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF------------ 120 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTT------------
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCc------------
Confidence 379999999999999999999984 58899999987642 22345778999999995 554
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
++.+..+.......++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+|||
T Consensus 121 ---------------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 184 (355)
T 1vzo_A 121 ---------------LVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRD 184 (355)
T ss_dssp ---------------BCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ---------------eeEEEEEEeeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 444444556677899999999 8899998876 45799999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHHHHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el 232 (449)
|||+|||+ +.++.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 185 lkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~el 255 (355)
T 1vzo_A 185 IKLENILL---DSNGHVVLTDFGLSKEFVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255 (355)
T ss_dssp CCGGGEEE---CTTSCEEESCSSEEEECCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHH
T ss_pred CCHHHEEE---CCCCcEEEeeCCCCeecccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHH
Confidence 99999999 47889999999999876433221 1234679999999999986 3478999999999999999
Q ss_pred HhCCCCCCCChhhcH-HHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Q 013125 233 LRGSLPWQGLKAATK-KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 297 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~~ 297 (449)
++|..||........ ......+....... ...++..+.+++..||..||.+|| +++++.+
T Consensus 256 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 256 LTGASPFTVDGEKNSQAEISRRILKSEPPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHSSCTTSCTTSCCCHHHHHHHHHHCCCCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHCCCCCccCCccchHHHHHHHHhccCCCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 999999986443322 22222333222222 244578999999999999999999 7666543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.13 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=184.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh---HH-HHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LL-YEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~---~~-~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
++..++|+++++||+|+||+||+|++..+++.||+|++........ .. .+...++.++|++
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~--------------- 67 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF--------------- 67 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTT---------------
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCe---------------
Confidence 4677999999999999999999999999999999999875433221 22 2222344445554
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRD 154 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrD 154 (449)
++.+..+....+..|+||||+.++|.+++.. ....+++..++.++.||+.||+|||++ ||+|||
T Consensus 68 ------------iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 135 (290)
T 3fme_A 68 ------------TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD 135 (290)
T ss_dssp ------------BCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCC
T ss_pred ------------EEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCC
Confidence 4455555567788999999998899887764 356799999999999999999999998 999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccc----cCCCCCccchHHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwSlG~il~ 230 (449)
|||+|||+ +..+.+||+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|
T Consensus 136 lkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 204 (290)
T 3fme_A 136 VKPSNVLI---NALGQVKMCDFGISGYLVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204 (290)
T ss_dssp CSGGGCEE---CTTCCEEBCCC-----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH
T ss_pred CCHHHEEE---CCCCCEEEeecCCccccccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH
Confidence 99999999 4778999999999986654322 1244789999999996 5667899999999999999
Q ss_pred HHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 231 el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||++|..||...... ...+........... ....+++++.+++..||..||.+||++.++.+
T Consensus 205 ~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 205 ELAILRFPYDSWGTP--FQQLKQVVEEPSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHTSCSSCCCSCH--HHHHHHHHHSCCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCccccCch--HHHHHHHhccCCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 999999999864322 222222222222211 12346889999999999999999999998865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.39 Aligned_cols=258 Identities=17% Similarity=0.215 Sum_probs=175.1
Q ss_pred ccCCceEEee-eecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHH-HHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~-~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+.++|.+.+ .||+|+||+||+|.+..+++.||||++... .....|+ ..++.+.|++++.++.....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~-------- 93 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYEN-------- 93 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEE--------
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhh--------
Confidence 4678999966 599999999999999999999999998642 2333444 34566677776655443211
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
........++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 94 ---------------~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 94 ---------------MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp ---------------EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ---------------ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 112345689999999 779999987543 469999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||++..+..+.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred EEEEecCCCceEEEeccccceecccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9996444567799999999986553321 3557899999999999888999999999999999999999999
Q ss_pred CCChhhcHHHH-HHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQK-YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+......... ...+.......+ ...+..+++++.+++..||..||.+||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQYGFP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------------------CCC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccchhhhhhHHHhhhccccccC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 87544322111 111112222222 1223456899999999999999999999988865
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=331.17 Aligned_cols=257 Identities=18% Similarity=0.210 Sum_probs=196.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-------------hhHHHHHHHHHHHcCCCcceeeEe
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------PQLLYEAKVYKILQGGSKIRLVVF 70 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-------------~~~~~E~~~l~~l~~~~~~~~~~~ 70 (449)
.+.++|++++.||+|+||.||+|.+.. ++.||||++...... ..+.+|+++++.++|++++.++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 467899999999999999999999854 889999987543221 457899999999999987766543
Q ss_pred ecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 013125 71 HVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 150 (449)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gi 150 (449)
.... -.......|+||||++++|.+.+......++...++.++.||+.||.|||++||
T Consensus 98 ~~~~----------------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 155 (362)
T 3pg1_A 98 FVHF----------------------EEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGV 155 (362)
T ss_dssp EEEC----------------------CTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEec----------------------cCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 3111 013345789999999999999988656679999999999999999999999999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHH
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVL 229 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 229 (449)
+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 156 vH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 156 VHRDLHPGNILL---ADNNDITICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp CCCCCCGGGEEE---CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred EecCCChHHEEE---cCCCCEEEEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 999999999999 4788999999999975443322 235678999999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCC---------------------------HHHhhccChHHHHHHHHHHh
Q 013125 230 LYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP---------------------------IEVLCKSHPAEFASYFHYCQ 282 (449)
Q Consensus 230 ~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~~~l 282 (449)
|+|++|+.||.+....... ..+........ ........++.+.+++..||
T Consensus 225 ~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 301 (362)
T 3pg1_A 225 AEMFNRKALFRGSTFYNQL---NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKML 301 (362)
T ss_dssp HHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHh
Confidence 9999999999886544322 22222221111 22333455788999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 013125 283 SLTFDQRPDYGFLKR 297 (449)
Q Consensus 283 ~~~p~~Rp~~~~l~~ 297 (449)
..||.+||++.++.+
T Consensus 302 ~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 302 EFNPQRRISTEQALR 316 (362)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHHc
Confidence 999999999887744
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=317.18 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=195.9
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+++..++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+++++.++|++++..+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-------- 77 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY-------- 77 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE--------
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEE--------
Confidence 567789999999999999999999999989999999987542 2234578899999999888755543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
.+....+..|+|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+||||
T Consensus 78 -------------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 137 (276)
T 2h6d_A 78 -------------------QVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137 (276)
T ss_dssp -------------------EEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCC
T ss_pred -------------------EEEecCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 3445667899999999 7899999876 456999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHh
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~ 234 (449)
||+||+++ .++.+||+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++
T Consensus 138 ~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 206 (276)
T 2h6d_A 138 KPENVLLD---AHMNAKIADFGLSNMMSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206 (276)
T ss_dssp CGGGEEEC---TTSCEEECCCCGGGCCCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred ChhhEEEC---CCCCEEEeecccccccCCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh
Confidence 99999994 778999999999976544321 134578999999999998775 689999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|..||...... .....+.......+ ...+.++.+++..||..||.+||++.++.+
T Consensus 207 g~~p~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 207 GTLPFDDEHVP---TLFKKIRGGVFYIP-----EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SSCSSCCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCcHH---HHHHHhhcCcccCc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 99999875432 23333333332222 345789999999999999999999998865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.90 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=178.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++|++++..
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-------------- 76 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL-------------- 76 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCE--------------
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeE--------------
Confidence 6799999999999999999999999999999997542 223457889999998888765544
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+....+..++|||++ +++|.+++......++...++.++.||+.||+|||++||+||||||+||
T Consensus 77 -------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 77 -------------YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143 (278)
T ss_dssp -------------EEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred -------------EEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 33445677899999999 7899999886557799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ +.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 144 li---~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 144 LL---TRNMNIKIADFGLATQLKMPHEK-------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp EE---CTTCCEEECCCTTCEECC-----------------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred EE---cCCCCEEEEeecceeeccCCCCc-------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99 47889999999999876533221 134578999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... ....+....... ....+.++.+++..||..||.+||++.++.+
T Consensus 214 ~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 214 TDTVKN---TLNKVVLADYEM-----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCSCC--------CCSSCCCC-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ChhHHH---HHHHHhhcccCC-----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 754322 122211111111 2345789999999999999999999887643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.59 Aligned_cols=266 Identities=16% Similarity=0.113 Sum_probs=187.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCcceeeEeec---chhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQ--GGSKIRLVVFHV---DHVI 76 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~--~~~~~~~~~~~~---~~~~ 76 (449)
..|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.|+ |++++..+.... +...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999887543 223667877777776 777555332111 0000
Q ss_pred hhhhhhhhcccCCCcCeeEEecc-----cCCeeEEEEecCCCCHHHHHHHhcCCCCHHHH------HHHHHHHHHHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGV-----DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV------LMLADQMIARIEYV 145 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~------~~i~~qil~~L~~L 145 (449)
.++.+.+..... .....||||||+.++|.+++...+..+..... ..++.||+.||+||
T Consensus 142 -----------~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 142 -----------VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp -----------ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred -----------cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 001111100000 11457999999999999999876555665566 67789999999999
Q ss_pred HhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHH
Q 013125 146 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLE 223 (449)
Q Consensus 146 H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvw 223 (449)
|++||+||||||+|||++ .++.+||+|||+|+...... ....+|+.|+|||++.+ ..++.++|||
T Consensus 211 H~~~ivHrDikp~NIll~---~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~Diw 277 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIM---PDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAW 277 (371)
T ss_dssp HHTTEEETTCSGGGEEEC---TTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred HHCCCccCcCCHHHEEEC---CCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHH
Confidence 999999999999999994 77899999999998654321 13456799999999987 6799999999
Q ss_pred HHHHHHHHHHhCCCCCCCChhhcHHHHHHHH--HHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 224 SLGYVLLYFLRGSLPWQGLKAATKKQKYDKI--CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 224 SlG~il~el~~G~~pf~~~~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||||++|||++|+.||.+....... .+..+ ............+..+++++.+++..||..||.+||++.++.+
T Consensus 278 SlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 278 QLGLSIYRVWCLFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHHHSSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999999999876432110 00000 0000001111123467899999999999999999999988754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=321.25 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=203.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
..++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------ 87 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG------------ 87 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEE------------
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEE------------
Confidence 45789999999999999999999999999999999875432 345789999999998887555433
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.......|+||||+ +++|.+++. ...++...++.++.||+.||.|||++||+||||||+||
T Consensus 88 ---------------~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 150 (303)
T 3a7i_A 88 ---------------SYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150 (303)
T ss_dssp ---------------EEEETTEEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ---------------EEecCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheE
Confidence 345567889999999 779998876 45799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+++ .++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 151 l~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 151 LLS---EHGEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp EEC---TTSCEEECCCTTCEECBTTBCC-------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEC---CCCCEEEeecccceecCccccc-------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 994 7789999999999876543321 235678999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...... ....+.... . ......++..+.+++..||..||.+||++.++.+
T Consensus 221 ~~~~~~---~~~~~~~~~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 221 ELHPMK---VLFLIPKNN-P---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp TSCHHH---HHHHHHHSC-C---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcCHHH---HHHHhhcCC-C---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 754432 222222211 1 1223466889999999999999999999988865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.19 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=203.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEc-CCCceEEEEEecCCC----CchhHHHHHHHHHHH---cCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGT----KHPQLLYEAKVYKIL---QGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l---~~~~~~~~~~~~~~~~~ 76 (449)
..++|++++.||+|+||.||+|++. .+++.||+|++.... ....+.+|+.+++.+ .|++++.++..+...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~-- 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS-- 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE--
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec--
Confidence 4689999999999999999999995 678899999876432 233578899988887 688766655433100
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
........++|||++.++|.+++.... ..++...++.++.||+.||+|||++||+||||
T Consensus 87 --------------------~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dl 146 (326)
T 1blx_A 87 --------------------RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 146 (326)
T ss_dssp --------------------ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred --------------------ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 012456789999999889999988653 34999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||++ .++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|
T Consensus 147 kp~Nili~---~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (326)
T 1blx_A 147 KPQNILVT---SSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215 (326)
T ss_dssp CGGGEEEC---TTCCEEECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CHHHeEEc---CCCCEEEecCcccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 99999994 78899999999997654221 12356789999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhc----------------------CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKV----------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
+.||.+...... +..+..... ..+.......++..+.+++..||..||.+||++.
T Consensus 216 ~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 292 (326)
T 1blx_A 216 KPLFRGSSDVDQ---LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292 (326)
T ss_dssp SCSCCCSSHHHH---HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCCHHHH---HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence 999988655432 233332111 1122334456789999999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 293 e~l~ 296 (326)
T 1blx_A 293 SALS 296 (326)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 7743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=319.51 Aligned_cols=260 Identities=18% Similarity=0.257 Sum_probs=203.1
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCc---eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+|++.++||+|+||+||+|.+..+++ .||+|++...... ..+.+|+++++.++|++++.++...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---------- 91 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM---------- 91 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE----------
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----------
Confidence 57778999999999999999765544 7999998764432 3477899999999988766554332
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.......++|||++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 92 ----------------~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni 155 (298)
T 3pls_A 92 ----------------LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNC 155 (298)
T ss_dssp ----------------CCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----------------ecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 12334458999999 8999999986667799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G-~~pf 239 (449)
|+ +.++.+||+|||+++........ .........+|..|+|||++.+..++.++|||||||++|+|++| .+||
T Consensus 156 li---~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 156 ML---DESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp EE---CTTCCEEECCTTSSCTTTTGGGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred EE---cCCCcEEeCcCCCcccccCCccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 99 47789999999999755432211 11123456788999999999999999999999999999999995 5555
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
.......... .+.. ....+. ...+++.+.+++..||..||.+||++.++.+.|++++...
T Consensus 230 ~~~~~~~~~~---~~~~-~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 230 RHIDPFDLTH---FLAQ-GRRLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp TTSCGGGHHH---HHHT-TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCHHHHHH---Hhhc-CCCCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 5544332222 2222 222221 2345889999999999999999999999999999988764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.60 Aligned_cols=249 Identities=19% Similarity=0.213 Sum_probs=197.4
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHH-cCCCcceeeEeecchh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKIL-QGGSKIRLVVFHVDHV 75 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~ 75 (449)
|...+.++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+|+..+..+ +|++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~-------- 76 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY-------- 76 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCE--------
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeee--------
Confidence 344567899999999999999999999999999999999875422 23467788888887 77765544
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFL 151 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~gii 151 (449)
..+....+..++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+
T Consensus 77 -------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv 137 (289)
T 1x8b_A 77 -------------------FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137 (289)
T ss_dssp -------------------EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -------------------eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 44445677899999999 88999998754 26699999999999999999999999999
Q ss_pred ccCCCCCcEEeecCC----------------CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-
Q 013125 152 HRDIKPDNFLMGLGR----------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI- 214 (449)
Q Consensus 152 HrDLkp~Nill~~~~----------------~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 214 (449)
||||||+|||++... ....+||+|||++....... ...||..|+|||++.+.
T Consensus 138 H~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~ 206 (289)
T 1x8b_A 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENY 206 (289)
T ss_dssp CSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCC
T ss_pred ecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCC
Confidence 999999999995322 44579999999998765432 34689999999999876
Q ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 215 EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 215 ~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
.++.++|||||||++|+|++|.+++.... ....+...... .....+++++.+++..||..||.+||++.+
T Consensus 207 ~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 276 (289)
T 1x8b_A 207 THLPKADIFALALTVVCAAGAEPLPRNGD------QWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMA 276 (289)
T ss_dssp TTHHHHHHHHHHHHHHHHTTCCCCCSSSH------HHHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCcchh------HHHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHH
Confidence 56789999999999999999988775432 12223232222 222456899999999999999999999887
Q ss_pred HHH
Q 013125 295 LKR 297 (449)
Q Consensus 295 l~~ 297 (449)
+.+
T Consensus 277 ll~ 279 (289)
T 1x8b_A 277 LVK 279 (289)
T ss_dssp HHT
T ss_pred Hhh
Confidence 744
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=323.67 Aligned_cols=265 Identities=20% Similarity=0.304 Sum_probs=198.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC---CCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+..++|++++.||+|+||.||+|.+.. +++.||+|++...... ..+.+|+++++.++|++++.++.......
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS- 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc-
Confidence 456899999999999999999998864 5568999998755332 34788999999999998777655432110
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGF 150 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-----~~~~~~~~~~~i~~qil~~L~~LH~~gi 150 (449)
.......++|||++ +++|.+++... ...+++..++.++.||+.||.|||++||
T Consensus 110 ---------------------~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (313)
T 3brb_A 110 ---------------------SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF 168 (313)
T ss_dssp --------------------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ---------------------ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 01123569999999 78999998642 3569999999999999999999999999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHH
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~ 230 (449)
+||||||+|||++ .++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|
T Consensus 169 vH~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 169 LHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp CCCCCSGGGEEEC---TTSCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEc---CCCcEEEeecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence 9999999999994 7789999999999866543211 1223456788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 231 YFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 231 el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
||++ |..||.+....... ..+...... .....+++++.+++..||..+|.+||++.+|.+.|++++..
T Consensus 241 el~~~g~~p~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 241 EIATRGMTPYPGVQNHEMY---DYLLHGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHTTSCCSSTTCCGGGHH---HHHHTTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCccCCHHHHH---HHHHcCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999 99999876554322 222222111 11245688999999999999999999999999999988764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.96 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=200.2
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.+..|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.++|++++.++.....
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 96 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES------- 96 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc-------
Confidence 45679999999999999999999999999999998865422 2347889999999999987766543211
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKP 157 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHrDLkp 157 (449)
........|+||||+ +++|.+++.. ...++...++.++.||+.||.|||++| |+||||||
T Consensus 97 ----------------~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp 159 (290)
T 1t4h_A 97 ----------------TVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp ----------------ESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred ----------------ccCCCceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCH
Confidence 123456789999999 8899999875 467999999999999999999999999 99999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+. ...+.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 160 ~Nil~~--~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~ 227 (290)
T 1t4h_A 160 DNIFIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp GGEEES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEE--CCCCCEEEeeCCCcccccccc---------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCC
Confidence 999994 257899999999996543322 134578999999998875 59999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||.+..... .....+... ..........++++.+++..||..||.+||++.++.+
T Consensus 228 pf~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 228 PYSECQNAA--QIYRRVTSG---VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTTCSSHH--HHHHHHTTT---CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCcHH--HHHHHHhcc---CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 998744321 222222221 1222334456789999999999999999999887754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=331.68 Aligned_cols=268 Identities=25% Similarity=0.318 Sum_probs=197.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.+++......
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~--------------- 80 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE--------------- 80 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHH---------------
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccch---------------
Confidence 45689999999999999999999999999999999987532 23457889999999875431110
Q ss_pred hhcccCCCcCeeEEecc----cCCeeEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCC
Q 013125 83 IFSSTLGGIPNIKWYGV----DGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIK 156 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~----~~~~~~lv~e~~g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLk 156 (449)
....+++++.+..+.. .+...++|||+++++|.+++... ...++...++.++.||+.||+|||++ ||+|||||
T Consensus 81 -~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dik 159 (373)
T 1q8y_A 81 -DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159 (373)
T ss_dssp -HHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS
T ss_pred -hccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence 0001123333322222 33478999999999999999864 34599999999999999999999998 99999999
Q ss_pred CCcEEeecC---CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 157 PDNFLMGLG---RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 157 p~Nill~~~---~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
|+|||+... +..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH
Confidence 999999532 234489999999998765332 2457899999999999999999999999999999999
Q ss_pred hCCCCCCCChhhc---HHHHHHHHHHhhcCCCHHHh-------------------------------------hccChHH
Q 013125 234 RGSLPWQGLKAAT---KKQKYDKICEKKVSTPIEVL-------------------------------------CKSHPAE 273 (449)
Q Consensus 234 ~G~~pf~~~~~~~---~~~~~~~i~~~~~~~~~~~~-------------------------------------~~~~~~~ 273 (449)
+|..||.+..... ....+..+.......|.... ....+.+
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (373)
T 1q8y_A 230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309 (373)
T ss_dssp HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred hCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence 9999998654221 22233333332222222110 1223578
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 274 FASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 274 ~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.+|+..||..||.+||++.++.+
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHHhccCccccCCHHHHhh
Confidence 899999999999999999887744
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.09 Aligned_cols=260 Identities=19% Similarity=0.239 Sum_probs=205.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceE--EEEEecCC---CCchhHHHHHHHHHHH-cCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV--AVKIENSG---TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v--AvKv~~~~---~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~ 77 (449)
+--++|++.+.||+|+||.||+|++..++..+ |+|++... .....+.+|+++++.+ +|++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~---------- 91 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL---------- 91 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCE----------
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhh----------
Confidence 34479999999999999999999998888765 99987643 2344588899999988 67765444
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHH
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIAR 141 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qil~~ 141 (449)
..+....+..|+|||++ +++|.+++.... ..++...++.++.||+.|
T Consensus 92 -----------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~a 154 (327)
T 1fvr_A 92 -----------------LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154 (327)
T ss_dssp -----------------EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHH
T ss_pred -----------------ceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHH
Confidence 44445678899999999 889999987532 469999999999999999
Q ss_pred HHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccch
Q 013125 142 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 221 (449)
Q Consensus 142 L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D 221 (449)
|+|||++||+||||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+..++.++|
T Consensus 155 L~~LH~~~ivH~dlkp~NIl~~---~~~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~D 223 (327)
T 1fvr_A 155 MDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSD 223 (327)
T ss_dssp HHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHH
T ss_pred HHHHHhCCccCCCCccceEEEc---CCCeEEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhc
Confidence 9999999999999999999994 67899999999997432211 122445688999999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 222 LESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 222 vwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
||||||++|||++ |..||.+.... .....+... .... ....+++++.+++..||..+|.+||++.++.+.|.
T Consensus 224 i~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 224 VWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQG-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHGGGT-CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCCCCCCCcHH---HHHHHhhcC-CCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999999999998 99999876543 222222221 1111 12345789999999999999999999999999999
Q ss_pred HHHHhcCC
Q 013125 301 DLFSREGY 308 (449)
Q Consensus 301 ~~~~~~~~ 308 (449)
.++.....
T Consensus 297 ~~~~~~~~ 304 (327)
T 1fvr_A 297 RMLEERKT 304 (327)
T ss_dssp HHHHSSSC
T ss_pred HHHHhhcC
Confidence 98876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.60 Aligned_cols=256 Identities=26% Similarity=0.320 Sum_probs=202.1
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
|..-+-++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++..
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~---------- 70 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---------- 70 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCE----------
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceee----------
Confidence 444456899999999999999999999999999999999864322 3457889999999888865544
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
..+....+..|+|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+|||||
T Consensus 71 -----------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 132 (276)
T 2yex_A 71 -----------------YGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132 (276)
T ss_dssp -----------------EEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred -----------------eeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 33445677889999999 7799888753 4569999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhC
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G 235 (449)
|+||+++ .++.+||+|||++......... .......||..|+|||++.+..+ +.++|||||||++|||++|
T Consensus 133 p~Nil~~---~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 204 (276)
T 2yex_A 133 PENLLLD---ERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (276)
T ss_dssp GGGEEEC---TTCCEEECCCTTCEECEETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred hHHEEEc---cCCCEEEeeCCCccccCCCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence 9999994 7789999999999865433211 11235678999999999988775 7899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||.+...... .+..+....... ......++.+.+++..||..||.+||++.++.+
T Consensus 205 ~~p~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 205 ELPWDQPSDSCQ--EYSDWKEKKTYL---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SCCCSCSCTTSH--HHHHHHTTCTTS---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCchHHH--HHHHhhhccccc---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 999987554321 222222221111 123456889999999999999999999887643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=353.93 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=200.0
Q ss_pred ceEEe-eeecccCceeEEEEEE--cCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 8 KYKLG-RKIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 8 ~y~i~-~~LG~G~fg~Vy~a~~--~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.+.+. ++||+|+||+||+|.+ ..+++.||||+++.... ...+.+|+++++.++|++++.+++.+
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--------- 439 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--------- 439 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEE---------
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE---------
Confidence 34443 4899999999999965 45678899999875432 24688999999999999877665432
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
..+..++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 440 -------------------~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~N 499 (635)
T 4fl3_A 440 -------------------EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 499 (635)
T ss_dssp -------------------ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -------------------ecCCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHh
Confidence 234578999999 8899999875 5679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
||++ .++.+||+|||+|+.+...... +.......+|..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 500 ILl~---~~~~~kL~DFGla~~~~~~~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~P 572 (635)
T 4fl3_A 500 VLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572 (635)
T ss_dssp EEEE---ETTEEEECCTTHHHHTTC-----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred EEEe---CCCCEEEEEcCCccccccCccc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9995 7789999999999876543221 111234457889999999999999999999999999999998 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|.+....... ..+ ......+. ...+|+++.++|..||..||.+||++.+|.+.|++++..
T Consensus 573 f~~~~~~~~~---~~i-~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 573 YRGMKGSEVT---AML-EKGERMGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp STTCCHHHHH---HHH-HTTCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHH---HHH-HcCCCCCC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9987654322 222 22222221 245689999999999999999999999999999988753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.97 Aligned_cols=252 Identities=17% Similarity=0.318 Sum_probs=197.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-..++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+|+++++.++|++++..+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------------ 83 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG------------ 83 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEE------------
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeee------------
Confidence 45789999999999999999999999999999999986543 3456889999999999887655443
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+....+..++|||++ +++|.+++......++...++.++.||+.||.|||++||+||||||+||
T Consensus 84 ---------------~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 148 (302)
T 2j7t_A 84 ---------------AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNV 148 (302)
T ss_dssp ---------------EEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred ---------------eeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 334567889999999 8899988887677899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G 235 (449)
++ +.++.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|
T Consensus 149 l~---~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 218 (302)
T 2j7t_A 149 LM---TLEGDIRLADFGVSAKNLKTL-------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218 (302)
T ss_dssp EE---CTTSCEEECCCHHHHHHHHHH-------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred EE---CCCCCEEEEECCCCccccccc-------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence 99 477899999999975432111 0123457899999999984 66789999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||....... ....+..... +.......++.++.+++..||..||.+||++.++.+
T Consensus 219 ~~p~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 219 EPPHHELNPMR---VLLKIAKSDP--PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCTTTTSCHHH---HHHHHHHSCC--CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCCCccCCHHH---HHHHHhccCC--cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99998765432 2222222221 111122455889999999999999999999887643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=341.44 Aligned_cols=257 Identities=13% Similarity=0.092 Sum_probs=185.0
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHH---cCCCcceeeEeecchhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKIL---QGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l---~~~~~~~~~~~~~~~~~~ 77 (449)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.+ +|++++.++........
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~- 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD- 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE-
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh-
Confidence 578999999999999999999998899999999986431 134578899555544 56666554321110000
Q ss_pred hhhhhhhcccCCCcCeeEEecccCC-----eeEEEEecCCCCHHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHH
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGE-----DNVLVLDLLGPSLEDLFVYCRRKFS-------LKTVLMLADQMIARIEYV 145 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~g~sL~~~~~~~~~~~~-------~~~~~~i~~qil~~L~~L 145 (449)
++ ..++-+.+.......+ ..|+||||++++|.+++.... .++ +..++.++.||+.||+||
T Consensus 151 -----~~--~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 151 -----LV--KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp -----EE--ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred -----hh--hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHH
Confidence 00 0001111111111111 368999999999999998642 233 478888999999999999
Q ss_pred HhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-----------
Q 013125 146 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----------- 214 (449)
Q Consensus 146 H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------- 214 (449)
|++||+||||||+|||++ .++.+||+|||+|+..... .....| +.|+|||++.+.
T Consensus 223 H~~~ivHrDikp~NIll~---~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 288 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRT 288 (377)
T ss_dssp HHTTEECSCCCGGGEEEC---TTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred HhCCeecCCCCHHHEEEc---CCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccc
Confidence 999999999999999994 7789999999999853321 135567 999999999987
Q ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 215 EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 215 ~~s~~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
.++.++|||||||++|||++|+.||.+....... .... ..+..+++++.+++..||..||.+||++.+
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGS-------EWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC------CCS-------GGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCcccccccch-------hhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 8999999999999999999999999764432111 1111 112466899999999999999999999998
Q ss_pred HHH
Q 013125 295 LKR 297 (449)
Q Consensus 295 l~~ 297 (449)
+.+
T Consensus 357 ~l~ 359 (377)
T 3byv_A 357 AME 359 (377)
T ss_dssp HHT
T ss_pred Hhh
Confidence 865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=315.04 Aligned_cols=250 Identities=18% Similarity=0.165 Sum_probs=203.3
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----------chhHHHHHHHHHHHc-CCCcceeeEeec
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQLLYEAKVYKILQ-GGSKIRLVVFHV 72 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----------~~~~~~E~~~l~~l~-~~~~~~~~~~~~ 72 (449)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+. |++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~------ 88 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ------ 88 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC------
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee------
Confidence 45899999999999999999999999999999999875431 234678999999986 776544
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 151 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gii 151 (449)
+..+.......++|||++ +++|.+++.. ...++...++.++.||+.||+|||++||+
T Consensus 89 ---------------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 146 (298)
T 1phk_A 89 ---------------------LKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIV 146 (298)
T ss_dssp ---------------------EEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------------------eeeeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 444445678899999999 7899999876 46799999999999999999999999999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc------CCCCCccchHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESL 225 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSl 225 (449)
||||||+||++ +.++.+||+|||++........ .....||+.|+|||++. ...++.++|||||
T Consensus 147 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 215 (298)
T 1phk_A 147 HRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215 (298)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred cCCCCcceEEE---cCCCcEEEecccchhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhH
Confidence 99999999999 4788999999999987654322 23567899999999885 4568899999999
Q ss_pred HHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 226 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 226 G~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||++|||++|..||.+.... .....+.......+. ..+..++.++.+++..||..||.+||++.++.+
T Consensus 216 G~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 216 GVIMYTLLAGSPPFWHRKQM---LMLRMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCcCccHH---HHHHHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 99999999999999875443 233334444433332 223466899999999999999999999887743
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=327.12 Aligned_cols=272 Identities=17% Similarity=0.221 Sum_probs=195.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHH--HHcCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK--ILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~--~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.-++|++++.||+|+||.||+|++ +++.||||++.... ...+..|.+++. .++|++++.++.....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~-------- 78 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDER-------- 78 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE--------
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccc--------
Confidence 4568999999999999999999987 78999999986432 234455555543 3677776665432211
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------Ccc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFL 151 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---------gii 151 (449)
.........|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++ ||+
T Consensus 79 --------------~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv 142 (336)
T 3g2f_A 79 --------------VTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142 (336)
T ss_dssp --------------ECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE
T ss_pred --------------cccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhcccccccccee
Confidence 1223345678999999 8899999864 4568999999999999999999999 999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCcc-ccccCCCCCCCCccccccccccC-------CCCCccchHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-IPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLE 223 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dvw 223 (449)
||||||+|||++ .++.+||+|||+|+.......... ..........||+.|+|||++.+ ..++.++|||
T Consensus 143 H~Dikp~Nill~---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 143 HRDLNSRNVLVK---NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp CSSCSGGGEEEC---TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred ecccccceEEEc---CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 999999999994 778999999999987654322110 00112235679999999999987 4567789999
Q ss_pred HHHHHHHHHHhCCCCCCCChhhc--------------HHHHHHHHH-HhhcCCCHHHhhc---cChHHHHHHHHHHhCCC
Q 013125 224 SLGYVLLYFLRGSLPWQGLKAAT--------------KKQKYDKIC-EKKVSTPIEVLCK---SHPAEFASYFHYCQSLT 285 (449)
Q Consensus 224 SlG~il~el~~G~~pf~~~~~~~--------------~~~~~~~i~-~~~~~~~~~~~~~---~~~~~~~~l~~~~l~~~ 285 (449)
||||++|||++|..||....... ......... ........+..+. ..++++.+++..||..|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 99999999999976664322110 011111111 1111111111111 13568999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHh
Q 013125 286 FDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 286 p~~Rp~~~~l~~~l~~~~~~ 305 (449)
|.+||++.++.+.|++++..
T Consensus 300 P~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred hhhCcchHHHHHHHHHHHHH
Confidence 99999999999999988754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=318.39 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=204.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.+.++|+++++||+|+||+||+|++..+++.||||++... .....+.+|+++++.++|++++..+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~----------- 87 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF----------- 87 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEE-----------
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEE-----------
Confidence 4568999999999999999999999999999999997643 2344688999999999888755543
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.+.......++|||++ +++|.+.+.. ...++...++.++.||+.||+|||++||+||||||+
T Consensus 88 ----------------~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~ 150 (287)
T 2wei_A 88 ----------------EILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150 (287)
T ss_dssp ----------------EEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ----------------EEEeCCCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChh
Confidence 3345667889999999 8899888765 457999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++...+....+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|..|
T Consensus 151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p 221 (287)
T 2wei_A 151 NILLESKEKDCDIKIIDFGLSTCFQQNTK--------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221 (287)
T ss_dssp GEEESCSSTTCCEEECSTTGGGTBCCCSS--------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hEEEecCCCcccEEEeccCcceeecCCCc--------cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCC
Confidence 99996444456899999999976543321 1234588999999998764 89999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|.+.... .....+.......+.+ .+..+++++.+++..||..||.+||++.++.+
T Consensus 222 ~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 222 FYGKNEY---DILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SCCSSHH---HHHHHHHHCCCCCCSG-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHH---HHHHHHHcCCCCCCch-hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 9876543 2333343443333322 23466889999999999999999999998865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.92 Aligned_cols=257 Identities=18% Similarity=0.286 Sum_probs=196.3
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
...++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+ +|++++..+.......
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~------ 94 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN------ 94 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC------
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc------
Confidence 35689999999999999999999999999999999987543 355688999999999 6877666554332110
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
........|+||||+ +++|.+++... ...++...++.++.||+.||.|||++||+||||||+|
T Consensus 95 ---------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 159 (326)
T 2x7f_A 95 ---------------PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 159 (326)
T ss_dssp -----------------CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred ---------------CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHH
Confidence 001246789999999 67999998864 3569999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHh
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~ 234 (449)
||++ .++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 160 Il~~---~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 229 (326)
T 2x7f_A 160 VLLT---ENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229 (326)
T ss_dssp EEEC---TTCCEEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH
T ss_pred EEEc---CCCCEEEeeCcCceecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh
Confidence 9994 788999999999976543221 123557899999999987 5668999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|..||.+..... ....+...... ......++..+.+++..||..||.+||++.++.+
T Consensus 230 g~~p~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 230 GAPPLCDMHPMR---ALFLIPRNPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SSCTTTTSCHHH---HHHHHHHSCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCcHHH---HHHHhhcCccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 999998755432 22222222111 1123456889999999999999999999988755
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.99 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=193.9
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcC--CCcceeeEeecchhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG--GSKIRLVVFHVDHVI 76 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~--~~~~~~~~~~~~~~~ 76 (449)
.+.+++|++++.||+|+||.||+|.+. +++.||||++...... ..+.+|+++++.+++ +
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~-------------- 88 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-------------- 88 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCT--------------
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCC--------------
Confidence 356788999999999999999999985 5889999998754332 357889999999975 4
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
++..+..+.......|+|||+.+++|.+++.. ...++...++.++.||+.||.|||++||+|||||
T Consensus 89 -------------~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 154 (313)
T 3cek_A 89 -------------KIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 154 (313)
T ss_dssp -------------TBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred -------------ceEEEEEEeecCCEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 34445555667788999999879999999886 5679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-----------CCCCccchHHHH
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESL 225 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSl 225 (449)
|+|||+. ++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||
T Consensus 155 p~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 155 PANFLIV----DGMLKLIDFGIANQMQPDTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp GGGEEEE----TTEEEECCCSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred cccEEEE----CCeEEEeeccccccccCccccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 9999993 5899999999998664432211 1235578999999999876 468889999999
Q ss_pred HHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 226 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 226 G~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||++|||++|..||...... ...+..+........ .....+.++.+++..||..||.+||++.++.+
T Consensus 226 G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSH--HHHHHHHHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhCCCchhhHHHH--HHHHHHHHhcccccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 99999999999999865332 122223332222211 12334788999999999999999999988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=315.17 Aligned_cols=252 Identities=10% Similarity=0.123 Sum_probs=200.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
.+.-++|++.++||+|+||+||+|++ +++.||||++...... ..+.+|+++++.++|++++.+++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------ 77 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ------ 77 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC------
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc------
Confidence 34568999999999999999999998 4888999998765322 24778888888888887666554321
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRD 154 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~-~~~~~~~~~i~~qil~~L~~LH~~g--iiHrD 154 (449)
.......++||||+ +++|.+++..... .+++..++.++.||+.||+|||++| |+|||
T Consensus 78 -------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~d 138 (271)
T 3kmu_A 78 -------------------SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA 138 (271)
T ss_dssp -------------------TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCC
T ss_pred -------------------cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCC
Confidence 11236789999999 7899999975433 5899999999999999999999999 99999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCc---cchHHHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR---RDDLESLGYVLLY 231 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DvwSlG~il~e 231 (449)
|||+|||+ +.++.++|+|||++.... .....||+.|+|||++.+..++. ++|||||||++||
T Consensus 139 ikp~Nil~---~~~~~~~l~~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 203 (271)
T 3kmu_A 139 LNSRSVMI---DEDMTARISMADVKFSFQ------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203 (271)
T ss_dssp CSGGGEEE---CTTSCEEEEGGGSCCTTS------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHH
T ss_pred CccceEEE---cCCcceeEEeccceeeec------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHH
Confidence 99999999 477889999998875322 12457899999999998766544 7999999999999
Q ss_pred HHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 232 l~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
|++|+.||.+..... ....+........ ....+++++.+++..||..||.+||++.++.+.|+++
T Consensus 204 l~~g~~p~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 204 LVTREVPFADLSNME---IGMKVALEGLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHHCSCTTTTSCHHH---HHHHHHHSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCCccccChHH---HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 999999998765432 2223333222222 2345689999999999999999999999999988876
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=324.37 Aligned_cols=259 Identities=19% Similarity=0.169 Sum_probs=189.0
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
-++|++.+.||+|+||.||+|++..+++.||||++.... .......|++.+..++|++++.++........
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~-------- 93 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE-------- 93 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS--------
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc--------
Confidence 368999999999999999999999999999999876543 24456778888888999988877654321100
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCc
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDN 159 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH--~~giiHrDLkp~N 159 (449)
......+.++||||+.++|...+.. ....++...++.++.||+.||.||| ++||+||||||+|
T Consensus 94 ------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~N 161 (360)
T 3e3p_A 94 ------------RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161 (360)
T ss_dssp ------------SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGG
T ss_pred ------------ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHH
Confidence 0112334789999998888766653 2456899999999999999999999 9999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~p 238 (449)
||++ ..++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 162 Ill~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p 231 (360)
T 3e3p_A 162 VLVN--EADGTLKLCDFGSAKKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231 (360)
T ss_dssp EEEE--TTTTEEEECCCTTCBCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEe--CCCCcEEEeeCCCceecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9995 2378999999999987654332 23567899999999987655 89999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHH-----------------------hh----ccChHHHHHHHHHHhCCCCCCCCC
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEV-----------------------LC----KSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~----~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
|.+...... +..+.......+... .. ...++++.+++..||..||.+||+
T Consensus 232 f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 308 (360)
T 3e3p_A 232 FRGDNSAGQ---LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308 (360)
T ss_dssp SCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCCChHHH---HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC
Confidence 988655432 233332222221111 11 114678999999999999999999
Q ss_pred HHHHHH
Q 013125 292 YGFLKR 297 (449)
Q Consensus 292 ~~~l~~ 297 (449)
+.++.+
T Consensus 309 ~~e~l~ 314 (360)
T 3e3p_A 309 PYEALC 314 (360)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 887744
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.26 Aligned_cols=252 Identities=19% Similarity=0.311 Sum_probs=199.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC------CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
+.++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+|+++++.++|++++..+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~------- 75 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL------- 75 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-------
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEE-------
Confidence 348999999999999999999999999999999998643 2234578999999999988866655432
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
+.......|+||||+.++|.+++... ...++...++.++.||+.||+|||++||+||||||
T Consensus 76 ------------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp 137 (305)
T 2wtk_C 76 ------------------YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKP 137 (305)
T ss_dssp ------------------ECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred ------------------EcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc
Confidence 12345678999999977788887754 45699999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC--CCccchHHHHHHHHHHHHhC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il~el~~G 235 (449)
+|||++ .++.+||+|||++.......... ......||..|+|||++.+.. ++.++|||||||++|||++|
T Consensus 138 ~NIl~~---~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 209 (305)
T 2wtk_C 138 GNLLLT---TGGTLKISALGVAEALHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209 (305)
T ss_dssp GGEEEC---TTCCEEECCCTTCEECCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred ccEEEc---CCCcEEeeccccccccCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence 999994 78899999999998765332211 123557899999999998754 37899999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||.+.... .....+.......+ ..+++.+.+++..||..||.+||++.++.+
T Consensus 210 ~~p~~~~~~~---~~~~~i~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 210 LYPFEGDNIY---KLFENIGKGSYAIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp SCSCCCSSHH---HHHHHHHHCCCCCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCchHH---HHHHHHhcCCCCCC-----CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999875432 23333333333222 356889999999999999999999988755
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.66 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=198.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcC-CCc--eEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TNE--IVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
.+..++|+++++||+|+||+||+|++.. +++ .||||+++... ....+.+|+++++.++|++++..+...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--- 90 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV--- 90 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE---
Confidence 3557899999999999999999998643 333 69999876532 123578999999999998866654432
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
.. ...++|+|++ +++|.+++......++...++.++.||+.||+|||++||+||
T Consensus 91 ------------------------~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 145 (291)
T 1u46_A 91 ------------------------LT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 145 (291)
T ss_dssp ------------------------CS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ------------------------cc-CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 22 3378999999 899999998766779999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||++ .++.+||+|||++.......... .......+|..|+|||++.+..++.++|||||||++|||+
T Consensus 146 dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 146 DLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp CCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CCchheEEEc---CCCCEEEccccccccccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999995 67899999999998765433211 1123456788999999999888999999999999999999
Q ss_pred h-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 234 R-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 234 ~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
+ |..||.+.... .....+.......+ ....++.++.+++..||..||.+||++.++.+.|+++..
T Consensus 219 ~~g~~p~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 219 TYGQEPWIGLNGS---QILHKIDKEGERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TTSCCTTTTCCHH---HHHHHHHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred hCCCCCcccCCHH---HHHHHHHccCCCCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 9 99999876543 23333333222222 224568999999999999999999999999998887643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=319.52 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=199.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|++++..+....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------- 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII--------- 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---------
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe---------
Confidence 4799999999999999999999999999999999875432 234788999999999988766554321
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccc
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG-----FLH 152 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~g-----iiH 152 (449)
.......++||||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+|
T Consensus 76 ----------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH 139 (279)
T 2w5a_A 76 ----------------DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139 (279)
T ss_dssp ----------------EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred ----------------cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence 23456789999999 77999998754 234999999999999999999999999 999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF 232 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el 232 (449)
|||||+|||+ +.++.+||+|||+++........ .....||..|+|||++.+..++.++|||||||++|+|
T Consensus 140 ~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 209 (279)
T 2w5a_A 140 RDLKPANVFL---DGKQNVKLGDFGLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209 (279)
T ss_dssp CCCSGGGEEE---CSSSCEEECCCCHHHHC---CHH-------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHH
T ss_pred eccchhhEEE---cCCCCEEEecCchheeecccccc-------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999 47889999999999765432210 1234689999999999999999999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|..||...... .....+...... .....++.++.+++..||..||.+||++.+|.+
T Consensus 210 ~~g~~p~~~~~~~---~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 210 CALMPPFTAFSQK---ELAGKIREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHSSCSSCCSSHH---HHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHCCCCCcccCHH---HHHHHHhhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 9999999876543 223333333221 122356889999999999999999999888755
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.90 Aligned_cols=268 Identities=19% Similarity=0.257 Sum_probs=200.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.+++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++|++++.++......
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------- 98 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE------- 98 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-------
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-------
Confidence 45689999999999999999999999999999999875432 234578999999999999877665433210
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.......++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||
T Consensus 99 ----------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp 162 (317)
T 2buj_A 99 ----------------RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKP 162 (317)
T ss_dssp ----------------ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ----------------cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 11345779999999 77999988763 46799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCcc--ccccCCCCCCCCccccccccccCCC---CCccchHHHHHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH--IPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYF 232 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlG~il~el 232 (449)
+|||+ +.++.+||+|||++........... ..........||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 163 ~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 239 (317)
T 2buj_A 163 TNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239 (317)
T ss_dssp GGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHH
T ss_pred HHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHH
Confidence 99999 4788999999999875432111000 0000011335689999999988654 68999999999999999
Q ss_pred HhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 233 LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 233 ~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
++|..||......... ...........+. ...++.++.+++..||..||.+||++.++.+.|+.+
T Consensus 240 ~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 240 MFGEGPYDMVFQKGDS--VALAVQNQLSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHSSCTTHHHHHTTSC--HHHHHHCC--CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HhCCCChhhhhcccch--hhHHhhccCCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 9999999643221111 1111122222221 234578999999999999999999999998888754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.97 Aligned_cols=243 Identities=22% Similarity=0.338 Sum_probs=198.9
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcC--CCcceeeEee
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG--GSKIRLVVFH 71 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--------~~~~~~~E~~~l~~l~~--~~~~~~~~~~ 71 (449)
++.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+++ +
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~--------- 108 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS--------- 108 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC---------
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC---------
Confidence 4567899999999999999999999999999999999986542 22457789999999975 4
Q ss_pred cchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013125 72 VDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 149 (449)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g--~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g 149 (449)
+++.+..+....+..++|+|++. ++|.+++.. ...++...++.++.||+.||+|||++|
T Consensus 109 ------------------~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ 169 (320)
T 3a99_A 109 ------------------GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG 169 (320)
T ss_dssp ------------------SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ------------------CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34445555567788999999993 899998876 567999999999999999999999999
Q ss_pred ccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHH
Q 013125 150 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYV 228 (449)
Q Consensus 150 iiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~i 228 (449)
|+||||||+|||++ .+.+.+||+|||+++....... ....||+.|+|||++.+..+ +.++|||||||+
T Consensus 170 ivH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 238 (320)
T 3a99_A 170 VLHRDIKDENILID--LNRGELKLIDFGSGALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238 (320)
T ss_dssp EECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred cEeCCCCHHHEEEe--CCCCCEEEeeCccccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHH
Confidence 99999999999994 2568999999999987654321 35578999999999987765 788999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|||++|..||..... +....... ...+++++.+++..||..||.+||++.+|.+
T Consensus 239 l~el~~g~~pf~~~~~---------~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 239 LYDMVCGDIPFEHDEE---------IIRGQVFF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHSSCSCCSHHH---------HHHCCCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHCCCCCCChhh---------hhcccccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999976321 11222221 2456889999999999999999999987744
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=326.45 Aligned_cols=271 Identities=24% Similarity=0.306 Sum_probs=206.6
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHH--HcCCCcceeeEeecchhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~--l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.+.++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|+++++. ++|++++.++......
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~------ 108 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKD------ 108 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC------
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc------
Confidence 45678999999999999999999998 5899999998643 34457889999888 6777766554432110
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFL 151 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--------~~gii 151 (449)
.......|+||||+ +++|.+++.. ..+++..++.++.||+.||+||| ++||+
T Consensus 109 -----------------~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 169 (342)
T 1b6c_B 109 -----------------NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169 (342)
T ss_dssp -----------------CSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred -----------------CCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCee
Confidence 00113789999999 7799999874 46999999999999999999999 89999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC------CCccchHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESL 225 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwSl 225 (449)
||||||+|||+ +.++.+||+|||++............ ......||+.|+|||++.+.. ++.++|||||
T Consensus 170 H~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 170 HRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp CSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEE---CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred eCCCCHHHEEE---CCCCCEEEEECCCceecccccccccc---ccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 99999999999 47789999999999877654321110 124567999999999998763 3478999999
Q ss_pred HHHHHHHHhC----------CCCCCCChhhc--HHHHHHHHHHhhcCCCHHH--hhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 226 GYVLLYFLRG----------SLPWQGLKAAT--KKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 226 G~il~el~~G----------~~pf~~~~~~~--~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
||++|||++| ..||....... .......+.........+. .....+..+.+++..||..||.+||+
T Consensus 244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 9999999999 78987653321 1222222323222222222 11234678999999999999999999
Q ss_pred HHHHHHHHHHHHHhcC
Q 013125 292 YGFLKRLFHDLFSREG 307 (449)
Q Consensus 292 ~~~l~~~l~~~~~~~~ 307 (449)
+.++.+.|+++....+
T Consensus 324 ~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 324 ALRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhc
Confidence 9999999999877654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=323.93 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=196.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++.++........
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 97 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS---- 97 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS----
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc----
Confidence 468999999999999999999999999999999998754332 346789999999999987776554321100
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.......|+|||+++++|.+++ ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 98 -----------------~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NI 157 (353)
T 3coi_A 98 -----------------LRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 157 (353)
T ss_dssp -----------------GGGCCCCEEEEECCSEEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred -----------------cccceeEEEEeccccCCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 0112346999999988888765 34699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|++ .++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 158 l~~---~~~~~kl~Dfg~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 224 (353)
T 3coi_A 158 AVN---EDCELKILDFGLARHADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224 (353)
T ss_dssp EEC---TTCCEEECSTTCTTC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred eEC---CCCcEEEeecccccCCCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 994 78899999999997543321 34578999999999887 67899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCC--------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+...... +..+.......+ ........++++.+++..||..||.+||++.
T Consensus 225 ~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 301 (353)
T 3coi_A 225 KGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301 (353)
T ss_dssp BSSCHHHH---HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCHHHH---HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence 88654332 222222111111 1122345688999999999999999999988
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 302 e~l~ 305 (353)
T 3coi_A 302 QALT 305 (353)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 7644
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=327.31 Aligned_cols=261 Identities=17% Similarity=0.215 Sum_probs=199.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+..++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+|+++++.++|++++.++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~------------ 93 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR------------ 93 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC------------
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE------------
Confidence 5678999999999999999999985 468899999987543 233678999999988888755543
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSR---GFLHR 153 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---~~~~~~~~~~i~~qil~~L~~LH~~---giiHr 153 (449)
.++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ ||+||
T Consensus 94 ---------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~ 158 (326)
T 3uim_A 94 ---------------GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158 (326)
T ss_dssp ---------------EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred ---------------EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence 3445667889999999 889999987532 3499999999999999999999999 99999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+ +.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 229 (326)
T 3uim_A 159 DVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 229 (326)
T ss_dssp CCSGGGEEE---CTTCCEEECCCSSCEECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH
T ss_pred CCchhhEEE---CCCCCEEeccCccccccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHH
Confidence 999999999 47789999999999876543321 123556999999999999889999999999999999999
Q ss_pred hCCCCCCCChhhcHH-HHHHHHHHhhcC-CC---------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013125 234 RGSLPWQGLKAATKK-QKYDKICEKKVS-TP---------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~-~~~~~i~~~~~~-~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~ 301 (449)
+|..||......... ............ .. ........+..+.+++..||..||.+||++.+|.+.|+.
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 230 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 999999632111000 000000010000 00 001112235789999999999999999999999888764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.06 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=206.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCC---CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+..++|++++.||+|+||.||+|.+..+ +..||+|+....... ..+.+|+.+++.++|++++.+++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~------ 460 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI------ 460 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE------
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE------
Confidence 5568899999999999999999998643 457999987754332 4578899999999999877665432
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
..+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+|||||
T Consensus 461 ----------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDik 518 (656)
T 2j0j_A 461 ----------------------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518 (656)
T ss_dssp ----------------------CSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ----------------------ecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 235679999999 899999998766679999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+|||++ .++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 519 p~NILl~---~~~~vkL~DFG~a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g 589 (656)
T 2j0j_A 519 ARNVLVS---SNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589 (656)
T ss_dssp GGGEEEE---ETTEEEECCCCCCCSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred hHhEEEe---CCCCEEEEecCCCeecCCCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcC
Confidence 9999995 6789999999999876443221 1224456789999999998899999999999999999997 9
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhc
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 306 (449)
..||.+..... .+..+.... ..+ ....+|+.+.+++..||..||.+||++.+|.+.|++++..+
T Consensus 590 ~~Pf~~~~~~~---~~~~i~~~~-~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 590 VKPFQGVKNND---VIGRIENGE-RLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCTTTTCCHHH---HHHHHHHTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHH---HHHHHHcCC-CCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99998865432 233332222 111 12456899999999999999999999999999999887653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.43 Aligned_cols=270 Identities=19% Similarity=0.228 Sum_probs=197.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
+.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++|++++..+....+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERR-------- 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC--------
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc--------
Confidence 4578999999999999999999999999999999886432 2345788999999999999888876554321
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
++.............|+|||++ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 76 ------~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~ 149 (303)
T 1zy4_A 76 ------NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI 149 (303)
T ss_dssp ------CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ------chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE
Confidence 1112222334557789999999 789999998766678899999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCcc-----c--cccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHh
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRH-----I--PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~-----~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~ 234 (449)
+.++.+||+|||++........... . .........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 150 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 150 ---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ---CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred ---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 4788999999999976543211000 0 00112356789999999999865 68999999999999999998
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||..... .......+.......+ .......+..+.+++..||..||.+||++.++.+
T Consensus 227 ---p~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 227 ---PFSTGME--RVNILKKLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---CCSSHHH--HHHHHHHHHSTTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCCchh--HHHHHHhccccccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 5553221 1222333332222222 2334556788999999999999999999887754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=314.85 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=197.4
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
|..+++||+|+||.||+|.+ +++.||+|++..... ...+.+|+++++.++|++++..+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~-------------- 96 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL-------------- 96 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEE--------------
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEE--------------
Confidence 44558999999999999986 678999998764321 23578999999999988755544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~--~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.++...+..++|||++ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 97 -------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~N 163 (307)
T 2nru_A 97 -------------GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163 (307)
T ss_dssp -------------EEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -------------EEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHH
Confidence 3445667889999999 89999988743 3459999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|++ +.++.+||+|||++.......... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 164 ili---~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 164 ILL---DEAFTAKISDFGLARASEKFAQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp EEE---CTTCCEEECCCTTCEECCSCSSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred EEE---cCCCcEEEeecccccccccccccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence 999 478899999999998765432211 1235678999999998876 5889999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHH--------HhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIE--------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~--------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
.+.........+....... ..... ......+..+.+++..||..+|.+||++.++.+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 235 DEHREPQLLLDIKEEIEDE-EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp CTTBSSSBTTHHHHHHHTT-SCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccCcchHHHHHHHHHhhhh-hhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 8755432222221111111 11111 11122357899999999999999999999999998876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=321.30 Aligned_cols=259 Identities=21% Similarity=0.248 Sum_probs=181.6
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+++++.++|++++.
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-------------- 77 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS-------------- 77 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCC--------------
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEee--------------
Confidence 56789999999999999999999998899999999876432 2334667777777777665444
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-------RRKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-------~~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
++.+....+..++||||+ +++|.+++... ...++...++.++.||+.||+|||++||+|
T Consensus 78 -------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 144 (303)
T 2vwi_A 78 -------------YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 144 (303)
T ss_dssp -------------EEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred -------------EEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 444455667899999999 88999998742 345899999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLY 231 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~e 231 (449)
|||||+||++ +.++.+||+|||++........... ........||+.|+|||++.+ ..++.++|||||||++||
T Consensus 145 ~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 219 (303)
T 2vwi_A 145 RDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219 (303)
T ss_dssp CCCSGGGEEE---CTTCCEEECCCHHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHH
T ss_pred CCCChhhEEE---cCCCCEEEEeccchheeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHH
Confidence 9999999999 4788999999999976543221100 011235678999999999876 568999999999999999
Q ss_pred HHhCCCCCCCChhhcHHHHHHHHHHhhcCCC-----HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTP-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 232 l~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|++|..||.+....... ........... .......++.++.+++..||..||.+||++.++.+
T Consensus 220 l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 220 LATGAAPYHKYPPMKVL---MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHSSCTTTTSCGGGHH---HHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCccCchhhHH---HHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 99999999876543322 11112111111 11233566889999999999999999999988754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=315.42 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=189.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--------CchhHHHHHHHHHHH----cCCCcceeeEe
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKIL----QGGSKIRLVVF 70 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--------~~~~~~~E~~~l~~l----~~~~~~~~~~~ 70 (449)
..+.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..+ +|++++.
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~---- 102 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR---- 102 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC----
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee----
Confidence 467789999999999999999999999999999999986542 223466799999988 5665444
Q ss_pred ecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEec-C-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 71 HVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL-L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~-~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
+..++...+..++|+|+ + +++|.+++.. ...+++..++.++.||+.||+|||++
T Consensus 103 -----------------------~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~ 158 (312)
T 2iwi_A 103 -----------------------LLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSR 158 (312)
T ss_dssp -----------------------EEEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------EEEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44444566788999998 4 8899999876 45699999999999999999999999
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHH
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGY 227 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~ 227 (449)
||+||||||+||+++ ..++.+||+|||++........ ....||..|+|||++.+..+ +.++|||||||
T Consensus 159 ~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 227 (312)
T 2iwi_A 159 GVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227 (312)
T ss_dssp TEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred CeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHH
Confidence 999999999999994 2578999999999987654321 35578999999999887665 45899999999
Q ss_pred HHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 228 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 228 il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|||++|+.||.... .+.......+ ..++.++.+++..||..+|.+||++.++.+
T Consensus 228 il~~l~~g~~pf~~~~---------~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 228 LLYDMVCGDIPFERDQ---------EILEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHHSSCSCCSHH---------HHHHTCCCCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCChH---------HHhhhccCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999997632 1222232222 345789999999999999999999988754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=323.89 Aligned_cols=263 Identities=17% Similarity=0.258 Sum_probs=196.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
++..++|++.+.||+|+||.||+|.+.. .||+|+++... ....+.+|+.+++.++|++++..+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~---------- 95 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM---------- 95 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCC----------
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEE----------
Confidence 4567899999999999999999999843 49999886532 233467888888888887655443
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.+.......++|||++ +++|.+++......++...++.++.||+.||+|||++||+||||||
T Consensus 96 -----------------~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp 158 (319)
T 2y4i_B 96 -----------------GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKS 158 (319)
T ss_dssp -----------------EEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCS
T ss_pred -----------------EEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCh
Confidence 3345567789999999 7899999876555799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC---------CCCCccchHHHHHHH
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---------IEQSRRDDLESLGYV 228 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DvwSlG~i 228 (449)
+|||+ +++.+||+|||+++.......... ........||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~NIl~----~~~~~~l~Dfg~~~~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 159 KNVFY----DNGKVVITDFGLFSISGVLQAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp TTEEE----C--CCEECCCSCCC------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred hhEEE----eCCCEEEeecCCcccccccccccc--ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 99999 367999999999876532211110 111234568999999999875 357899999999999
Q ss_pred HHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcC
Q 013125 229 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307 (449)
Q Consensus 229 l~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 307 (449)
+|||++|..||.+..... ....+....... .....++.++.+++..||..||.+||++.++.+.|+++.....
T Consensus 233 l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 233 WYELHAREWPFKTQPAEA---IIWQMGTGMKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHHSSCSSSSCCHHH---HHHHHHTTCCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHHHhCCCCCCCCCHHH---HHHHhccCCCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 999999999998754432 222222221111 1123467899999999999999999999999998887655443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.90 Aligned_cols=245 Identities=21% Similarity=0.254 Sum_probs=191.5
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
...||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++.++.
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-------------------- 86 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-------------------- 86 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEE--------------------
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEee--------------------
Confidence 3499999999999999999999999999876432 445889999999999887665443
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 166 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~--~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~ 166 (449)
+....+..++|||++ +++|.+++..... .++...+..++.||+.||+|||++||+||||||+||+++ .
T Consensus 87 -------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~ 157 (295)
T 2clq_A 87 -------SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--T 157 (295)
T ss_dssp -------EEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--T
T ss_pred -------EEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--C
Confidence 335567889999999 8899999886533 467899999999999999999999999999999999995 2
Q ss_pred CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCChh
Q 013125 167 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKA 244 (449)
Q Consensus 167 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il~el~~G~~pf~~~~~ 244 (449)
.++.+||+|||++......... .....||..|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 158 ~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 158 YSGVLKISDFGTSKRLAGINPC-------TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp TTCCEEECCTTTCEESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred CCCCEEEeecccccccCCCCCc-------ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 3789999999999876543211 23567899999999987654 88999999999999999999999976432
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
... ............ .....+++++.+++..||..||.+||++.++.+
T Consensus 231 ~~~--~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 231 PQA--AMFKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHH--HHHHHHHHCCCC---CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred hhH--HHHhhccccccc---cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 211 111111111111 123456889999999999999999999887743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=315.30 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=180.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchh---HH-HHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LL-YEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~---~~-~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-++|++++.||+|+||.||+|.+..+++.||||++........ .. .+..+++.++|+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i----------------- 86 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI----------------- 86 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTB-----------------
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCce-----------------
Confidence 3689999999999999999999999999999999876543222 22 23334555566654
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp~Ni 160 (449)
..+..+....+..|+|||++++.+..+.......++...++.++.||+.||.|||++ ||+||||||+||
T Consensus 87 ----------~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 87 ----------VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp ----------CCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred ----------eeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 444445566788999999998888777776677899999999999999999999995 999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G 235 (449)
|+ +.++.+||+|||++........ .....||+.|+|||++. +..++.++|||||||++|||++|
T Consensus 157 l~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (318)
T 2dyl_A 157 LL---DERGQIKLCDFGISGRLVDDKA--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225 (318)
T ss_dssp EE---CTTSCEEECCCTTC----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred EE---CCCCCEEEEECCCchhccCCcc--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence 99 4788999999999976544322 13457899999999984 55689999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||...... ...+..+........ .....++.++.+++..||..||.+||++.++.+
T Consensus 226 ~~pf~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 226 QFPYKNCKTD--FEVLTKVLQEEPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCTTTTCCSH--HHHHHHHHHSCCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCCCcc--HHHHHHHhccCCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999864322 223333333221111 112346889999999999999999999998865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=320.57 Aligned_cols=254 Identities=19% Similarity=0.302 Sum_probs=175.8
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCch---hHHHHHH-HHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAK-VYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~---~~~~E~~-~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
+..++|++++.||+|+||.||+|.+..+++.||||++....... .+..|+. +++.++|++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~n---------------- 82 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY---------------- 82 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTT----------------
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCc----------------
Confidence 45689999999999999999999999999999999987653322 2344444 444455555
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRD 154 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~----~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrD 154 (449)
++.+..+....+..++||||+.++|.+++... ...++...+..++.|++.||.|||+. ||+|||
T Consensus 83 -----------iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~d 151 (327)
T 3aln_A 83 -----------IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 151 (327)
T ss_dssp -----------BCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSC
T ss_pred -----------EeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECC
Confidence 44454555667889999999988998887642 46799999999999999999999998 999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccc----cCCCCCccchHHHHHHHHH
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwSlG~il~ 230 (449)
|||+|||++ .++.+||+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|
T Consensus 152 lkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 220 (327)
T 3aln_A 152 IKPSNILLD---RSGNIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220 (327)
T ss_dssp CCGGGEEEE---TTTEEEECCCSSSCC--------------------------------------CCSHHHHHHHHHHHH
T ss_pred CCHHHEEEc---CCCCEEEccCCCceecccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHH
Confidence 999999995 788999999999976644321 1234789999999998 4667899999999999999
Q ss_pred HHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 231 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 231 el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||++|..||.+..... ..+..+...............+++++.+++..||..||.+||++.++.+
T Consensus 221 ~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 221 ELATGRFPYPKWNSVF--DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHSCCCSSCC---------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchHH--HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 9999999998643211 1111111111111111122456889999999999999999999988855
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=320.66 Aligned_cols=252 Identities=16% Similarity=0.228 Sum_probs=200.0
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-------------------hhHHHHHHHHHHHcCCC
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------------PQLLYEAKVYKILQGGS 63 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-------------------~~~~~E~~~l~~l~~~~ 63 (449)
++..++|++++.||+|+||.||+|.+ +++.||||++...... ..+.+|+++++.++|++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 45668999999999999999999998 8999999987643110 67889999999998887
Q ss_pred cceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHH------HHHh-cCCCCHHHHHHHH
Q 013125 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL------FVYC-RRKFSLKTVLMLA 135 (449)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~------~~~~-~~~~~~~~~~~i~ 135 (449)
++..++ +....+..|+||||+ +++|.++ +... ...++...++.++
T Consensus 105 i~~~~~---------------------------~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~ 157 (348)
T 2pml_X 105 CLTCEG---------------------------IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157 (348)
T ss_dssp BCCCSE---------------------------EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHH
T ss_pred cceEEE---------------------------EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHH
Confidence 555433 345567899999999 7799887 4422 4569999999999
Q ss_pred HHHHHHHHHHHh-CCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC
Q 013125 136 DQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 214 (449)
Q Consensus 136 ~qil~~L~~LH~-~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 214 (449)
.||+.||.|||+ +||+||||||+||++ +.++.+||+|||++....... .....||..|+|||++.+.
T Consensus 158 ~qi~~~l~~lH~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 158 KSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp HHHHHHHHHHHHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSC
T ss_pred HHHHHHHHHHhccCCEeecCCChHhEEE---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCC
Confidence 999999999999 999999999999999 478899999999998765431 2356789999999999987
Q ss_pred -CCCc-cchHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCH--------------HHhhccChHHHHHHH
Q 013125 215 -EQSR-RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI--------------EVLCKSHPAEFASYF 278 (449)
Q Consensus 215 -~~s~-~~DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~--------------~~~~~~~~~~~~~l~ 278 (449)
.++. ++|||||||++|||++|..||.+.... ......+.......+. .......+.++.+++
T Consensus 226 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 303 (348)
T 2pml_X 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303 (348)
T ss_dssp CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHH
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHH
Confidence 5665 999999999999999999999875442 2333333333333331 111245688999999
Q ss_pred HHHhCCCCCCCCCHHHHHH
Q 013125 279 HYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 279 ~~~l~~~p~~Rp~~~~l~~ 297 (449)
..||..||.+||++.++.+
T Consensus 304 ~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 304 KLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHCCSSGGGSCCHHHHHT
T ss_pred HHHccCChhhCCCHHHHhc
Confidence 9999999999999887754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.72 Aligned_cols=260 Identities=14% Similarity=0.103 Sum_probs=188.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
..|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|.........+.....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~----- 152 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF----- 152 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC-----
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc-----
Confidence 35889999999999999999999999999999987332 24467899999988877432211111000000
Q ss_pred hhhcccCCCcCeeEEeccc-----CCeeEEEEecCCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 013125 82 IIFSSTLGGIPNIKWYGVD-----GEDNVLVLDLLGPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGF 150 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~g~sL~~~~~~~------~~~~~~~~~~~i~~qil~~L~~LH~~gi 150 (449)
........+.+.+..++.. ....+++|++++++|.+++..+ ...+++..++.++.||+.||+|||++||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 0000011122222111111 3456899999999999998643 3347788899999999999999999999
Q ss_pred cccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccc----------cCCCCCccc
Q 013125 151 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH----------LGIEQSRRD 220 (449)
Q Consensus 151 iHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~ 220 (449)
+||||||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++
T Consensus 233 iHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 233 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred ccCCcccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 999999999999 47788999999998764432 134567 999999999 566689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 221 DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 221 DvwSlG~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|||||||++|||++|+.||.+........ .. -..+..+|+++.+++..||..||.+||++.++.+
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~-------~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSE-------WI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSG-------GG-----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHH-------HH-----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999999999998754322111 01 1112456899999999999999999999877644
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=306.05 Aligned_cols=234 Identities=12% Similarity=0.059 Sum_probs=186.4
Q ss_pred Cc-ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 2 ER-IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 2 ~~-i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
|+ +++++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|++++..++|++++.+
T Consensus 25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~-------- 96 (286)
T 3uqc_A 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV-------- 96 (286)
T ss_dssp TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCE--------
T ss_pred CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCccee--------
Confidence 44 8899999999999999999999999999999999998865432 457889999988888765544
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
+.++...+..|+||||+ |++|.+++.. .....++..++.||+.||+|||++||+|||
T Consensus 97 -------------------~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~D 154 (286)
T 3uqc_A 97 -------------------LDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSI 154 (286)
T ss_dssp -------------------EEEEEETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred -------------------eEEEEECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 44455677899999999 7899998842 346677899999999999999999999999
Q ss_pred CCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 155 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 155 Lkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
|||+|||++ .++.+||+++|. ++ .++.++|||||||++|||++
T Consensus 155 ikp~NIll~---~~g~~kl~~~~~---------------------------~~-------~~~~~~Di~slG~il~ellt 197 (286)
T 3uqc_A 155 DHPSRVRVS---IDGDVVLAYPAT---------------------------MP-------DANPQDDIRGIGASLYALLV 197 (286)
T ss_dssp CSGGGEEEE---TTSCEEECSCCC---------------------------CT-------TCCHHHHHHHHHHHHHHHHH
T ss_pred CCcccEEEc---CCCCEEEEeccc---------------------------cC-------CCCchhHHHHHHHHHHHHHH
Confidence 999999995 778898875532 22 36889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
|+.||.+.............. .....+.......+|+++.+++..||..||.+| ++.++.+.|+++..
T Consensus 198 g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 198 NRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SEECSCCCSBCCCSEECCBCT-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCCCCCcCCcchhhHHHHHHh-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 999998755422110000000 112333455667789999999999999999999 99999998887643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=325.29 Aligned_cols=254 Identities=19% Similarity=0.191 Sum_probs=185.9
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
..+|.+.+.||+|+||+||. ....+++.||||++... ......+|+++++.+ +|++++.++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~l~---------------- 84 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPE-CFSFADREVQLLRESDEHPNVIRYF---------------- 84 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTT-TEEECHHHHHHHHHSCCCTTBCCEE----------------
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHH-HHHHHHHHHHHHHhccCCCCcCeEE----------------
Confidence 35799999999999999764 33467899999998653 334578899999998 677765543
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeec
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 164 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~ 164 (449)
.+.......|||||+++++|.+++......+....++.++.||+.||+|||++||+||||||+|||++.
T Consensus 85 -----------~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 85 -----------CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153 (432)
T ss_dssp -----------EEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECC
T ss_pred -----------EEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEec
Confidence 334567788999999999999998865555666677899999999999999999999999999999953
Q ss_pred CC--CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc---CCCCCccchHHHHHHHHHHHHh-CCCC
Q 013125 165 GR--KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLR-GSLP 238 (449)
Q Consensus 165 ~~--~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il~el~~-G~~p 238 (449)
.+ ....+||+|||+|+........ +.......||+.|+|||++. ...++.++|||||||++|||++ |..|
T Consensus 154 ~~~~~~~~~kL~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~p 229 (432)
T 3p23_A 154 PNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229 (432)
T ss_dssp CBTTTBCCEEECCTTEEECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBT
T ss_pred CCCCCceeEEEecccceeeccCCCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 22 2346889999999876543211 11224568999999999998 4567889999999999999999 9999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|...... ....+. ..............+..+.+++..||..||.+||++.++.+
T Consensus 230 f~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 230 FGKSLQR----QANILL-GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TBSTTTH----HHHHHT-TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhHH----HHHHHh-ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9654322 111111 11111111111222567899999999999999999988763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.74 Aligned_cols=259 Identities=22% Similarity=0.196 Sum_probs=187.9
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++.+++.|.+.+.||+|+||+||.+. ..+++.||||++... ..+.+.+|+++++.+ +|++++++
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~------------- 74 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRY------------- 74 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCE-------------
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeE-------------
Confidence 56778899999999999999998764 457899999987653 234578899999876 67765554
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRD 154 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~------~~~~~~~~i~~qil~~L~~LH~~giiHrD 154 (449)
+.+.......|+|||+++++|.+++...... .+...++.++.||+.||+|||++||+|||
T Consensus 75 --------------~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 140 (434)
T 2rio_A 75 --------------YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRD 140 (434)
T ss_dssp --------------EEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --------------EEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccC
Confidence 3344567889999999988999998743211 12234578999999999999999999999
Q ss_pred CCCCcEEeecC----------CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-------CCCC
Q 013125 155 IKPDNFLMGLG----------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-------IEQS 217 (449)
Q Consensus 155 Lkp~Nill~~~----------~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s 217 (449)
|||+|||++.. +....+||+|||+|+.......... .......||+.|+|||++.+ ..++
T Consensus 141 Lkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 217 (434)
T 2rio_A 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217 (434)
T ss_dssp CSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCC
T ss_pred CChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcc
Confidence 99999999632 2356899999999987654322110 01235679999999999976 5689
Q ss_pred ccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCH--HHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 218 RRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI--EVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 218 ~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
.++|||||||++|||++ |..||.+..... ..+.......+. ......+++++.+++..||..||.+||++.+
T Consensus 218 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (434)
T 2rio_A 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292 (434)
T ss_dssp THHHHHHHHHHHHHHHTTSCCTTCSTTTHH-----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhhhhHhHHHHHHHHHhCCCCCCCCchhhH-----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence 99999999999999999 999997643321 122222222211 0111233678999999999999999999988
Q ss_pred HHH
Q 013125 295 LKR 297 (449)
Q Consensus 295 l~~ 297 (449)
+.+
T Consensus 293 il~ 295 (434)
T 2rio_A 293 VLR 295 (434)
T ss_dssp HHT
T ss_pred HHh
Confidence 754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=301.44 Aligned_cols=238 Identities=21% Similarity=0.250 Sum_probs=179.3
Q ss_pred cccCCceEEe-eeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHH-HHHcCCCcceeeEeecchhhhhhh
Q 013125 3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY-KILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 3 ~i~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l-~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.++ ++|.+. +.||+|+||.||+|.+..+++.||||++.. .....+|+.++ +.++|++++.++....
T Consensus 14 ~~~-~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~-------- 81 (299)
T 3m2w_A 14 AII-DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYE-------- 81 (299)
T ss_dssp CGG-GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEE--------
T ss_pred ccc-cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhh--------
Confidence 445 556666 889999999999999999999999999863 35678899888 5557777666544321
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.........|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 82 ---------------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 146 (299)
T 3m2w_A 82 ---------------NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 146 (299)
T ss_dssp ---------------EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ---------------hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 1122356789999999 789999998653 46999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||++..+.++.+||+|||++.... +..++.++|||||||++|||++|..|
T Consensus 147 Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~p 197 (299)
T 3m2w_A 147 NLLYTSKRPNAILKLTDFGFAKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPP 197 (299)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCS
T ss_pred HEEEecCCCCCcEEEeccccccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999643337899999999986432 12467789999999999999999999
Q ss_pred CCCChhhcHHHHH-HHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 239 WQGLKAATKKQKY-DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 239 f~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|.+.......... ..+.......+ ...+..+++++.+++..||..||.+||++.++.+
T Consensus 198 f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 198 FYSNHGLAISPGMKTRIRMGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCC-------CCSCCSSCTTCCSSC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCcchhhhHHHHHHHhhccccCC-chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9765432110000 00111111222 2333567899999999999999999999988755
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.19 Aligned_cols=247 Identities=17% Similarity=0.214 Sum_probs=190.2
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcC-CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
|+++.++|++++.||+|+||.||+|.+.. +++.||||++...... ..+.+|+++++.++|++++.++..+...
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 151 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT--- 151 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE---
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec---
Confidence 56788999999999999999999999976 7899999988654332 2467899999999988877665433211
Q ss_pred hhhhhhhcccCCCcCeeEEecccC-CeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDG-EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
...+ ...||||||+ |++|.+++. ..+++.+++.++.||+.||+|||++||+||||
T Consensus 152 --------------------~~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDl 208 (681)
T 2pzi_A 152 --------------------DRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDL 208 (681)
T ss_dssp --------------------CTTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred --------------------CCCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccc
Confidence 0111 1269999999 788887653 37999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||++ .+.+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|
T Consensus 209 kp~NIll~----~~~~kl~DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g 272 (681)
T 2pzi_A 209 KPENIMLT----EEQLKLIDLGAVSRINSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLD 272 (681)
T ss_dssp SGGGEEEC----SSCEEECCCTTCEETTCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSC
T ss_pred ChHHeEEe----CCcEEEEecccchhcccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhC
Confidence 99999994 358999999999875432 245799999999998765 48999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKRLFHDLFS 304 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~-~~~l~~~l~~~~~ 304 (449)
..||.+..... ....... ...++.+.+++..||..||.+||+ .+++...|..++.
T Consensus 273 ~~~~~~~~~~~------------~~~~~~~--~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 273 LPTRNGRYVDG------------LPEDDPV--LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CCEETTEECSS------------CCTTCHH--HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred CCCCccccccc------------ccccccc--cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 99987632211 0000010 112578999999999999999995 5666666665543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.41 Aligned_cols=261 Identities=18% Similarity=0.212 Sum_probs=194.8
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.++|++.++||+|+||+||+|.+..+++.||||++..... ...+.+|+++++.++|++++.++.......
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~------- 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ------- 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC-------
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc-------
Confidence 4899999999999999999999999999999998875432 334788999999999998877665432110
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~--~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
.....+..|+||||+ |++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 86 --------------~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~N 151 (676)
T 3qa8_A 86 --------------KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151 (676)
T ss_dssp --------------CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTT
T ss_pred --------------cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 112356789999999 8999999875432 58999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||++.++....+||+|||++........ .....||..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 152 ILl~~~g~~~~vKL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 152 IVLQPGPQRLIHKIIDLGYAKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp EEEECCSSSCEEEECSCCCCCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred eEeecCCCceeEEEcccccccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 9997444455699999999987654332 23567899999999999999999999999999999999999999
Q ss_pred CCChhhcH------HHHHHHH-----HHhhc-----CCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 240 QGLKAATK------KQKYDKI-----CEKKV-----STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 240 ~~~~~~~~------~~~~~~i-----~~~~~-----~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
.+...... ......+ ..... ......+....++.+.+++..||..||.+||++.++
T Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 224 LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred CcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 76321100 0000000 00000 001112334467899999999999999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=311.16 Aligned_cols=267 Identities=20% Similarity=0.130 Sum_probs=188.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----------hhHHHHHHHHHHHc---------CCCcc
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQ---------GGSKI 65 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----------~~~~~E~~~l~~l~---------~~~~~ 65 (449)
..++|+++++||+|+||+||+|++ +++.||||++...... ..+.+|+++++.++ |++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999998 7899999998754321 56889999999997 88888
Q ss_pred eeeEeecc----hhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHH
Q 013125 66 RLVVFHVD----HVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 140 (449)
Q Consensus 66 ~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~ 140 (449)
.+...+.. |..+..+...+....+.... .--.......||||||+ ++++.+.+. ...+++..++.++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~-~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND-RPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSC-CSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhcccccc-CccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHH
Confidence 87766432 22222222221110000000 00001267899999998 776655553 366899999999999999
Q ss_pred HHHHHH-hCCccccCCCCCcEEeecCC-----------------CCCeEEEEeecceeeecCCCCCccccccCCCCCCCC
Q 013125 141 RIEYVH-SRGFLHRDIKPDNFLMGLGR-----------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 202 (449)
Q Consensus 141 ~L~~LH-~~giiHrDLkp~Nill~~~~-----------------~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt 202 (449)
||+||| ++||+||||||+|||+...+ ....+||+|||+|+..... ..+||
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt 240 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFC 240 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECC
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEe
Confidence 999999 99999999999999996321 0128999999999876532 34789
Q ss_pred ccccccccccCCCCCccchHHHHHHH-HHHHHhCCCCCCCChhhcHHHHHHHHHHh-h-cCCCHHHhhccChHHHHHHHH
Q 013125 203 ARYASCNTHLGIEQSRRDDLESLGYV-LLYFLRGSLPWQGLKAATKKQKYDKICEK-K-VSTPIEVLCKSHPAEFASYFH 279 (449)
Q Consensus 203 ~~y~aPE~~~~~~~s~~~DvwSlG~i-l~el~~G~~pf~~~~~~~~~~~~~~i~~~-~-~~~~~~~~~~~~~~~~~~l~~ 279 (449)
+.|+|||++.+.. +.++||||||++ .++++.|..||.+... .......+... . ...+.......+++++.+|+.
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence 9999999999876 899999998877 7788889999854210 01112222211 1 112223344556889999999
Q ss_pred HHhCCCCCCCCCHHHHH
Q 013125 280 YCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 280 ~~l~~~p~~Rp~~~~l~ 296 (449)
.||..| ++.++.
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999876 665553
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-31 Score=271.90 Aligned_cols=182 Identities=16% Similarity=0.121 Sum_probs=125.5
Q ss_pred eecccCceeEEEEEEcCCCceEEEEEecCCCC------------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 14 ~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~------------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.++.|++|.+..++....|+.||+|++..... ..++.+|+++|+.+.+..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~------------------ 302 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGF------------------ 302 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTC------------------
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCC------------------
Confidence 45678888777777777899999999875421 234788999998885333
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+++.+..++.++...||||||+ |++|.+++.. ...++.. .|+.||+.||+|||++|||||||||+||
T Consensus 303 --------~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNI 370 (569)
T 4azs_A 303 --------DAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNV 370 (569)
T ss_dssp --------CCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGE
T ss_pred --------CeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhE
Confidence 6778888899999999999999 9999999975 4567654 4789999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|++ +++.+||+|||+|+........ ..+.+||+.|+|||++.+. +...+|+||+|++++++.+|.
T Consensus 371 LL~---~dg~vKL~DFGlAr~~~~~~~~-------~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 371 MVD---ARQHARLIDFGSIVTTPQDCSW-------PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp EEC---TTSCEEECCCTTEESCC---CC-------SHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred EEC---CCCCEEEeecccCeeCCCCCcc-------ccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 994 7889999999999876544322 2356899999999999874 677899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=242.83 Aligned_cols=188 Identities=18% Similarity=0.129 Sum_probs=138.0
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
...+.||+|+||+||+|.. .++.+++|+...... ...+.+|+++++.++|++++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~------------ 404 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAP------------ 404 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCC------------
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCce------------
Confidence 3467899999999999954 677899997654321 1236899999999998875522
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
..++...+..||||||+ |++|.+++.. ++.++.||+.||+|||++||+||||||+
T Consensus 405 ---------------~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~ 460 (540)
T 3en9_A 405 ---------------YIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTS 460 (540)
T ss_dssp ---------------CEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTT
T ss_pred ---------------EEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHH
Confidence 22333556679999999 7999988753 5689999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC--CCCCccchHHHHHHHHHHHHhCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGS 236 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il~el~~G~ 236 (449)
|||++ . .+||+|||+|+............+.......||+.|+|||++.+ ..|+..+|+||..+-..+-+.++
T Consensus 461 NILl~---~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r 535 (540)
T 3en9_A 461 NFIFD---K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR 535 (540)
T ss_dssp SEEES---S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred HEEEC---C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence 99993 3 99999999998775432110000011235689999999999987 56888899999999999888887
Q ss_pred CCCC
Q 013125 237 LPWQ 240 (449)
Q Consensus 237 ~pf~ 240 (449)
.+|.
T Consensus 536 ~rY~ 539 (540)
T 3en9_A 536 ARYV 539 (540)
T ss_dssp SCCC
T ss_pred cccC
Confidence 7764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-24 Score=203.23 Aligned_cols=131 Identities=21% Similarity=0.362 Sum_probs=103.0
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCcc
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------HPQLLYEAKVYKILQGGSKI 65 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--------------------~~~~~~E~~~l~~l~~~~~~ 65 (449)
+..|.+++.||+|+||.||+|.+ .+++.||||++..... ...+.+|+++++.+++ +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---C
Confidence 34566779999999999999999 8899999999864321 1247789999999872 2
Q ss_pred eeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 013125 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~ 144 (449)
. ++.+. ..+..|+||||+ |++|.+ +. ......++.||+.||+|
T Consensus 165 ~------------------------v~~~~----~~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~ 208 (282)
T 1zar_A 165 A------------------------VPKVY----AWEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAK 208 (282)
T ss_dssp S------------------------SCCEE----EEETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHH
T ss_pred C------------------------cCeEE----eccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHH
Confidence 2 22221 124569999999 779887 31 13455799999999999
Q ss_pred HHhCCccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 145 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 145 LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
||++||+||||||+|||++ ++.+||+|||+|+
T Consensus 209 lH~~giiHrDlkp~NILl~----~~~vkl~DFG~a~ 240 (282)
T 1zar_A 209 FYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 240 (282)
T ss_dssp HHHTTEECSCCSTTSEEEE----TTEEEECCCTTCE
T ss_pred HHHCCCEeCCCCHHHEEEE----CCcEEEEECCCCe
Confidence 9999999999999999993 7899999999986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.4e-22 Score=186.14 Aligned_cols=137 Identities=22% Similarity=0.275 Sum_probs=105.8
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCce--EEEEEecCCCCc--------------------------hhHHHHHHHHHHH
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKH--------------------------PQLLYEAKVYKIL 59 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvKv~~~~~~~--------------------------~~~~~E~~~l~~l 59 (449)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ..+.+|+++++.|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778888 999987543110 1467899999999
Q ss_pred cCCCcceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCC--C----CHHHHHHHhcCCCCHHHHHH
Q 013125 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLG--P----SLEDLFVYCRRKFSLKTVLM 133 (449)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g--~----sL~~~~~~~~~~~~~~~~~~ 133 (449)
.+.++ .+|.+..+ ...+|||||++ + +|.++... .+...+..
T Consensus 128 ~~~~i-------------------------~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~ 174 (258)
T 1zth_A 128 KEAGV-------------------------SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEG 174 (258)
T ss_dssp HHTTC-------------------------CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHH
T ss_pred HhCCC-------------------------CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHH
Confidence 87642 12333322 35689999995 2 56655321 23456788
Q ss_pred HHHHHHHHHHHHH-hCCccccCCCCCcEEeecCCCCCeEEEEeecceeee
Q 013125 134 LADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182 (449)
Q Consensus 134 i~~qil~~L~~LH-~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~ 182 (449)
++.||+.+|.||| ++||+||||||+|||+. . .++|+|||+|...
T Consensus 175 i~~qi~~~l~~lH~~~givHrDlkp~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 175 IFNDVVENVKRLYQEAELVHADLSEYNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHHTSCEECSSCSTTSEEES---S--SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHCCEEeCCCCHHHEEEc---C--cEEEEECcccccC
Confidence 9999999999999 99999999999999993 3 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.3e-18 Score=165.92 Aligned_cols=137 Identities=21% Similarity=0.276 Sum_probs=94.0
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----------------chhH--------HHHHHHHHHHcCCC
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HPQL--------LYEAKVYKILQGGS 63 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----------------~~~~--------~~E~~~l~~l~~~~ 63 (449)
-|.++++||.|+||.||+|.+. +|+.||||+++.... .... .+|...+..|.+..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999984 689999998653200 0011 23445555553322
Q ss_pred cceeeEeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013125 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 142 (449)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L 142 (449)
+ .++.... . ...+|||||+ |.+|..+. ..+....++.||+.+|
T Consensus 175 v-------------------------~vp~p~~--~--~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l 218 (397)
T 4gyi_A 175 F-------------------------PVPEPIA--Q--SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALI 218 (397)
T ss_dssp C-------------------------SCCCEEE--E--ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHH
T ss_pred C-------------------------CCCeeee--c--cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHH
Confidence 1 1222221 1 2348999999 66665432 2234567889999999
Q ss_pred HHHHhCCccccCCCCCcEEeecCCCC-------CeEEEEeecceee
Q 013125 143 EYVHSRGFLHRDIKPDNFLMGLGRKA-------NQVYIIDFGLAKK 181 (449)
Q Consensus 143 ~~LH~~giiHrDLkp~Nill~~~~~~-------~~vkL~DfGla~~ 181 (449)
.+||.+|||||||||.|||++.+.+. ..++|+||+.+..
T Consensus 219 ~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 219 LRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp HHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999999999999999632211 1489999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=7e-12 Score=116.74 Aligned_cols=137 Identities=17% Similarity=0.194 Sum_probs=105.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|++...++.|+++.||++.. .++.+++|+.... .....+.+|+++++.|....
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~--------------------- 70 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL--------------------- 70 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS---------------------
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCC---------------------
Confidence 4599999999999999999975 3678999997642 22346899999999997522
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS---------------- 147 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~---------------- 147 (449)
.+|.+..++......|+|||++ |.+|.+.+. +......++.++..+|..||+
T Consensus 71 -----~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 139 (263)
T 3tm0_A 71 -----PVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRL 139 (263)
T ss_dssp -----CCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHH
T ss_pred -----CCCeEEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHH
Confidence 5677777777778899999999 777765421 122344778899999999998
Q ss_pred -------------------------------------------CCccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 148 -------------------------------------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 148 -------------------------------------------~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
..++|+|++|.|||+. +...+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 140 AELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999994 44455799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=6.9e-11 Score=109.49 Aligned_cols=135 Identities=18% Similarity=0.132 Sum_probs=95.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
..|.+....+.|..+.||++.. .+++.+++|+.... ....+.+|+.+++.+.+..+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~---------------------- 75 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGV---------------------- 75 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTC----------------------
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCC----------------------
Confidence 3466655555667799999964 45678999997654 33568899999999976431
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG---------------- 149 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g---------------- 149 (449)
.+|.+..++..++..++|||++ |.++. . . ..+ ...++.+++..|..||+..
T Consensus 76 ---~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~-~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~ 143 (264)
T 1nd4_A 76 ---PCAAVLDVVTEAGRDWLLLGEVPGQDLL--S---S-HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIER 143 (264)
T ss_dssp ---CBCCEEEEEECSSCEEEEEECCSSEETT--T---S-CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHH
T ss_pred ---CCCeEEEeccCCCCCEEEEEecCCcccC--c---C-cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Confidence 3566666666667789999999 65653 1 1 111 2255667777777777643
Q ss_pred ------------------------------------------ccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 150 ------------------------------------------FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 150 ------------------------------------------iiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
++|+|++|.|||+. +++.+.|+|||.+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 144 ARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999994 44455699998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.1e-09 Score=106.66 Aligned_cols=141 Identities=15% Similarity=0.194 Sum_probs=99.7
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEec--CCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~--~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.-++.|+.|.++.||++... +..+++|+.. ... ....+.+|..+++.|....+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~v-------------------- 98 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDV-------------------- 98 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSS--------------------
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCC--------------------
Confidence 35778999999999999763 4678889765 322 23468899999999986321
Q ss_pred cccCCCcCeeEEecccC---CeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------
Q 013125 85 SSTLGGIPNIKWYGVDG---EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------- 147 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~---~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~------------- 147 (449)
.+|.++.++.+. ...|+|||++ |..+.+. ....++......++.+++..|..||+
T Consensus 99 -----pvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~ 170 (359)
T 3dxp_A 99 -----PVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK 170 (359)
T ss_dssp -----CCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred -----CCCcEEEECCCCCccCCeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence 355565555544 3479999999 5555331 12346788888899999999999997
Q ss_pred ---------------------------------------------CCccccCCCCCcEEeecCCCCCeEEEEeecceee
Q 013125 148 ---------------------------------------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 148 ---------------------------------------------~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~ 181 (449)
..++|+|+++.|||+..+ ....+.|+||+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEE
T ss_pred CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECcccccc
Confidence 368999999999999511 113468999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.5e-10 Score=110.20 Aligned_cols=191 Identities=17% Similarity=0.208 Sum_probs=118.4
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCc
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI 91 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 91 (449)
++.++.|.+..||++. ..+++|+.........+.+|+++++.+.....+ .+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v------------------------~v 75 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPL------------------------PI 75 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSS------------------------CC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCC------------------------CC
Confidence 4568999999999873 458899865332234688999999988543211 35
Q ss_pred CeeEEecccCC---eeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------
Q 013125 92 PNIKWYGVDGE---DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------- 147 (449)
Q Consensus 92 ~~~~~~~~~~~---~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-------------------- 147 (449)
|.+...+.... ..|+||+++ |.++.+... ..++..+...++.|++..|..||+
T Consensus 76 P~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~ 152 (304)
T 3sg8_A 76 PEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINE 152 (304)
T ss_dssp CCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHH
T ss_pred CceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHH
Confidence 55555544333 348899999 666654322 246777777888888888888885
Q ss_pred --------------------------------------CCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCc
Q 013125 148 --------------------------------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 189 (449)
Q Consensus 148 --------------------------------------~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~ 189 (449)
..++|+|++|.||++..+ +...+.|+||+.+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~ 231 (304)
T 3sg8_A 153 DNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFI 231 (304)
T ss_dssp HHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHH
T ss_pred HHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHH
Confidence 136999999999999511 14567899999987643211000
Q ss_pred cccccCCCC-CCCCc-------cc--cc-cccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 190 HIPYRENKN-LTGTA-------RY--AS-CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 190 ~~~~~~~~~-~~gt~-------~y--~a-PE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
.. .... ..+.. .| .. |+..... ....++|+++.++|.+.+|..+|.
T Consensus 232 ~~---~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 232 SL---MEDDEEYGMEFVSKILNHYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TT---CCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HH---HhhccccCHHHHHHHHHHcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 0000 00000 00 01 1111110 123689999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=3.1e-07 Score=87.34 Aligned_cols=138 Identities=22% Similarity=0.266 Sum_probs=87.4
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCc
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGI 91 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 91 (449)
++.++.|....||+. +..+++|+-........+.+|+++++.|.+...+ .+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v------------------------~V 74 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKV------------------------NI 74 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSS------------------------BC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCC------------------------CC
Confidence 456788998999988 4668899853222234678999999999864211 35
Q ss_pred CeeEEecc-cCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 013125 92 PNIKWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS---------------------- 147 (449)
Q Consensus 92 ~~~~~~~~-~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~---------------------- 147 (449)
|.+..++. .....++||+++ |.++.+.. -..++......++.|+...|..||+
T Consensus 75 P~~~~~~~~~~g~~~~v~e~i~G~~l~~~~---~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~ 151 (306)
T 3tdw_A 75 PQYVYIGKRSDGNPFVGYRKVQGQILGEDG---MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILL 151 (306)
T ss_dssp CCEEEEEECTTSCEEEEEECCCSEECHHHH---HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHH
T ss_pred CCeEeecccCCCceEEEEeccCCeECchhh---hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHH
Confidence 66665553 455678999999 65554421 1123333444444444444444443
Q ss_pred --------------------------------------CCccccCCCCCcEEeecCCCCCe-EEEEeecceee
Q 013125 148 --------------------------------------RGFLHRDIKPDNFLMGLGRKANQ-VYIIDFGLAKK 181 (449)
Q Consensus 148 --------------------------------------~giiHrDLkp~Nill~~~~~~~~-vkL~DfGla~~ 181 (449)
..++|+|+++.|||+..++..+. +.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 152 LSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24689999999999952111344 58999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1e-06 Score=81.78 Aligned_cols=132 Identities=17% Similarity=0.159 Sum_probs=89.2
Q ss_pred eecccCce-eEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcC
Q 013125 14 KIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIP 92 (449)
Q Consensus 14 ~LG~G~fg-~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 92 (449)
.+..|..+ .||+......+..+++|+.... ....+.+|..+|+.|...- -+|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~v--------------------------PVP 83 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFM--------------------------PLP 83 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTS--------------------------CCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCC--------------------------CcC
Confidence 44556555 6999887666778999986532 2345788999999886431 477
Q ss_pred eeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------
Q 013125 93 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR----------------------- 148 (449)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~----------------------- 148 (449)
.+..++...+..++|||++ |.++.+..... ......+..++...|..||..
T Consensus 84 ~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 84 TIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp CEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred eEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 7877888888899999999 66665543221 112223444444555555531
Q ss_pred -----------------------------------CccccCCCCCcEEeecCCCCCeEEEEeeccee
Q 013125 149 -----------------------------------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180 (449)
Q Consensus 149 -----------------------------------giiHrDLkp~Nill~~~~~~~~vkL~DfGla~ 180 (449)
.++|+|+++.|||+. +.+.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 168999999999994 45556799998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.8e-06 Score=83.70 Aligned_cols=77 Identities=14% Similarity=0.129 Sum_probs=50.6
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCC---------CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-.+.||.|.++.||++.+..+++.|+||..... ....++..|.++++.+......
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~---------------- 97 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPH---------------- 97 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGG----------------
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCC----------------
Confidence 467899999999999976556778999975422 1234568899999988653100
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCC
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP 113 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~ 113 (449)
.+|.++.+. .+..++|||++.+
T Consensus 98 --------~vP~~~~~d--~~~~~lvmE~l~g 119 (397)
T 2olc_A 98 --------LVPRVFYSD--TEMAVTVMEDLSH 119 (397)
T ss_dssp --------GSCCEEEEE--TTTTEEEECCCTT
T ss_pred --------CcCeEEEEc--CCccEEEEEeCCC
Confidence 355555543 3456899999944
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=3.1e-06 Score=81.98 Aligned_cols=81 Identities=11% Similarity=0.282 Sum_probs=54.1
Q ss_pred eEEeeee-cccCceeEEEEEEc--C----CCceEEEEEecCCC-----CchhHHHHHHHHHHHcCC-CcceeeEeecchh
Q 013125 9 YKLGRKI-GSGSFGEIFLASHV--D----TNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG-SKIRLVVFHVDHV 75 (449)
Q Consensus 9 y~i~~~L-G~G~fg~Vy~a~~~--~----~~~~vAvKv~~~~~-----~~~~~~~E~~~l~~l~~~-~~~~~~~~~~~~~ 75 (449)
....+.| +.|....+|++... . +++.+++|+..... ....+.+|+.+++.|... .+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~v----------- 90 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDV----------- 90 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCS-----------
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCC-----------
Confidence 4456788 88999999998753 0 15678899865432 124678999999988643 10
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccC---CeeEEEEecC-CCC
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDG---EDNVLVLDLL-GPS 114 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~---~~~~lv~e~~-g~s 114 (449)
.+|.++.++.+. ...++|||++ |..
T Consensus 91 --------------pvP~v~~~~~~~~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 91 --------------PVPRVRWIETTGDVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp --------------CCCCEEEEECSSTTTSSCEEEEECCCCBC
T ss_pred --------------CCCcEEEEccCCCccCCceEEEEecCCCC
Confidence 356666555443 3468999999 433
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=5.9e-05 Score=72.19 Aligned_cols=46 Identities=11% Similarity=0.059 Sum_probs=29.0
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~ 61 (449)
++.|+.|..+.||++... +..+++|+... ....+..|..+++.|..
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~--~~~~~~~e~~~l~~L~~ 82 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHR--PEKKALFSIFAQDYLAK 82 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECS--CHHHHHHHHHHHHHHHH
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCC--CHHHHHHHHHHHHHHHH
Confidence 456666788999999763 34588998865 23455667888887764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00017 Score=71.45 Aligned_cols=32 Identities=13% Similarity=0.328 Sum_probs=25.9
Q ss_pred HhCCccccCCCCCcEEeecCCCCCeEEEEeecceee
Q 013125 146 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 146 H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~ 181 (449)
+...++|+|+++.|||+. .++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~---~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVT---QDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEEC---SSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEe---CCC-CEEEeCccccc
Confidence 356799999999999994 333 99999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00024 Score=66.91 Aligned_cols=46 Identities=17% Similarity=0.070 Sum_probs=33.1
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~ 63 (449)
++.|+.|....+|++ +.+++|+...... .....+|+.+++.+....
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g 69 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAG 69 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcC
Confidence 788999999999999 4588998765321 123467999998887544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.001 Score=62.08 Aligned_cols=59 Identities=12% Similarity=0.006 Sum_probs=46.3
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCC
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGG 62 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~ 62 (449)
++.+.+..-++.+|.|..+.||++.. .+|+.|++|+...... ...+..|+..|+.|...
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~ 71 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRS 71 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCS
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhh
Confidence 45677888899999999999999986 4578899998654322 23478899999999654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0004 Score=65.77 Aligned_cols=78 Identities=26% Similarity=0.322 Sum_probs=57.5
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCC
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLG 89 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (449)
.-.+.|+.|.+..+|+... .+..+++|+.... ....+..|+..|+.|.....+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v------------------------ 91 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSI------------------------ 91 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSS------------------------
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCC------------------------
Confidence 3467899999999999975 4667889986532 234578899999998653211
Q ss_pred CcCeeEEecccCCeeEEEEecC-CCC
Q 013125 90 GIPNIKWYGVDGEDNVLVLDLL-GPS 114 (449)
Q Consensus 90 ~i~~~~~~~~~~~~~~lv~e~~-g~s 114 (449)
.+|.+..++......++|||++ |..
T Consensus 92 ~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 92 NVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp BCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred CcceEEEEeecCCceEEEEEeccCCC
Confidence 4677777777777899999999 443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00043 Score=65.63 Aligned_cols=51 Identities=12% Similarity=0.130 Sum_probs=33.8
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~ 62 (449)
.-.+.|+.|....+|++... +..+++|+.........+..|..+++.|...
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~ 75 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAK 75 (322)
T ss_dssp EEEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred eEeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHC
Confidence 34567888888999999763 3368899877543445678899999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0015 Score=62.34 Aligned_cols=34 Identities=38% Similarity=0.451 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEeecCCC-CCeEEEEeecceee
Q 013125 148 RGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKK 181 (449)
Q Consensus 148 ~giiHrDLkp~Nill~~~~~-~~~vkL~DfGla~~ 181 (449)
..++|+|+++.|||+..+.. .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 46999999999999942100 26789999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0032 Score=62.34 Aligned_cols=52 Identities=15% Similarity=0.241 Sum_probs=38.4
Q ss_pred EeeeecccCceeEEEEEEcC-------CCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGS 63 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvKv~~~~~~~-~~~~~E~~~l~~l~~~~ 63 (449)
-++.|+.|....||++.... .++.|++|+.... .. ..+..|..+++.|....
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g 136 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERH 136 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCC
Confidence 46778889899999998643 2578999987432 22 56678999999887544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0053 Score=59.64 Aligned_cols=139 Identities=17% Similarity=0.174 Sum_probs=77.2
Q ss_pred eeeecccCceeEEEEEEcC-------CCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
++.|..|-...+|++.... +++.|++|+..... ......+|.++++.|....
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~g-------------------- 114 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERS-------------------- 114 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTT--------------------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcC--------------------
Confidence 4567778888999998642 34789999864322 2334678999999887654
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHH--------------HHHHHh-------cCCCC--HHHHHHHHHHHH
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE--------------DLFVYC-------RRKFS--LKTVLMLADQMI 139 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~--------------~~~~~~-------~~~~~--~~~~~~i~~qil 139 (449)
..|.+..++.+ .+|||++ |.+|. +.+... ++... +.++..+..|+.
T Consensus 115 ------v~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~ 184 (379)
T 3feg_A 115 ------LGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQ 184 (379)
T ss_dssp ------SSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHH
T ss_pred ------CCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHH
Confidence 23444444333 2889998 43221 111111 11122 345555554442
Q ss_pred H-------------------HHHHHH----h----CCccccCCCCCcEEeecC-CCCCeEEEEeeccee
Q 013125 140 A-------------------RIEYVH----S----RGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAK 180 (449)
Q Consensus 140 ~-------------------~L~~LH----~----~giiHrDLkp~Nill~~~-~~~~~vkL~DfGla~ 180 (449)
. .++.|. . ..++|+|+.+.|||+..+ +..+.+.|+||..|.
T Consensus 185 ~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 185 DLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 233332 2 248999999999999521 113689999997764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0068 Score=58.58 Aligned_cols=53 Identities=19% Similarity=0.154 Sum_probs=32.5
Q ss_pred EeeeecccCceeEEEEEEcC--------CCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~--------~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~ 63 (449)
-.+.|+.|....+|++.... .++.+++|+...... ......|.++++.|....
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g 98 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYK 98 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTT
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcC
Confidence 35678888888999998643 126789998654321 112468899998886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.013 Score=58.33 Aligned_cols=53 Identities=13% Similarity=0.042 Sum_probs=36.0
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~ 63 (449)
-++.|+.|-...+|++.....+..+++|+...... .....+|..+++.|....
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g 165 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN 165 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC
Confidence 45678889899999998754457899998754321 112368999999997654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.016 Score=54.83 Aligned_cols=48 Identities=13% Similarity=0.084 Sum_probs=34.2
Q ss_pred eeecccCceeEEEEEEcCCCceEEEEEecCC-CCchhHHHHHHHHHHHcCC
Q 013125 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGG 62 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-~~~~~~~~E~~~l~~l~~~ 62 (449)
..|+ |....||++.. .+++.+++|+.... .....+..|..+++.|...
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~ 80 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVND 80 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHc
Confidence 4566 88889998864 34567999998643 2345677899999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.45 E-value=0.064 Score=47.26 Aligned_cols=98 Identities=14% Similarity=0.135 Sum_probs=62.4
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccc
Q 013125 113 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 191 (449)
Q Consensus 113 ~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~ 191 (449)
.+|.++++..+.++++++++.++.|.+.+|.-+-. +.-..+=+-|..|++. .+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence 37899999889999999999999999999877622 1111233345777774 666666553 1110
Q ss_pred cccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 192 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
.....+.+||... ...+.+.=|||||+++|.-+-
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123456777653 345678899999999998774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.29 E-value=0.17 Score=48.07 Aligned_cols=31 Identities=32% Similarity=0.540 Sum_probs=25.8
Q ss_pred CCccccCCCCCcEEeecCCCCCeEEEEeecceee
Q 013125 148 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181 (449)
Q Consensus 148 ~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~ 181 (449)
..++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 4699999999999994 456799999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.69 E-value=0.18 Score=49.54 Aligned_cols=53 Identities=19% Similarity=0.189 Sum_probs=36.5
Q ss_pred EeeeecccCceeEEEEEEcCC-------CceEEEEEecCCCC-chhHHHHHHHHHHHcCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~ 63 (449)
-++.|..|-...+|++..... ++.|++|+...... .-...+|.++++.|....
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~g 134 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNIN 134 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTT
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcC
Confidence 456677788889999987421 57899998654322 123468999999887554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.66 E-value=0.94 Score=43.94 Aligned_cols=31 Identities=29% Similarity=0.547 Sum_probs=25.0
Q ss_pred ccccCCCCCcEEeecC---CCCCeEEEEeeccee
Q 013125 150 FLHRDIKPDNFLMGLG---RKANQVYIIDFGLAK 180 (449)
Q Consensus 150 iiHrDLkp~Nill~~~---~~~~~vkL~DfGla~ 180 (449)
++|+|+.+.|||+..+ ++...++++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999531 356789999997764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 449 | ||||
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-84 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-83 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-29 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-29 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-28 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-28 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-27 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-26 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-25 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-25 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-22 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-22 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-22 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-21 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-21 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-21 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-19 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-19 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-18 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-18 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-17 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-17 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-17 |
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 258 bits (659), Expect = 4e-84
Identities = 164/318 (51%), Positives = 209/318 (65%), Gaps = 28/318 (8%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA--- 58
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
IPN+ ++G +G NVLV+DLLGPSLEDL C
Sbjct: 59 -------GCTG----------------IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG 95
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKK 181
RKFS+KTV M A QM+AR++ +H + ++RDIKPDNFL+G + AN +Y++DFG+ K
Sbjct: 96 RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
YRDP T +HIPYRE KNL+GTARY S NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQG
Sbjct: 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 215
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
LKAAT KQKY++I EKK STP+ LC P EF Y HY ++L FD PDY +L+ LF
Sbjct: 216 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
Query: 302 LFSREGYDFDFVFDWTIL 319
+ R D FDW +L
Sbjct: 276 VLERLNTTEDENFDWNLL 293
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 257 bits (656), Expect = 2e-83
Identities = 205/325 (63%), Positives = 258/325 (79%), Gaps = 26/325 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF
Sbjct: 61 GGV--------------------------GIPTIRWCGAEGDYNVMVMELLGPSLEDLFN 94
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+C RKFSLKTVL+LADQMI+RIEY+HS+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAK
Sbjct: 95 FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
KYRD T++HIPYRENKNLTGTARYAS NTHLGIEQSRRDDLESLGYVL+YF GSLPWQ
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
GLKAATK+QKY++I EKK+STPIEVLCK +P+EFA+Y ++C+SL FD +PDY +L++LF
Sbjct: 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 301 DLFSREGYDFDFVFDWTILKYQQTQ 325
+LF R+G+ +D+VFDW +LK+ ++
Sbjct: 275 NLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 1e-29
Identities = 53/313 (16%), Positives = 106/313 (33%), Gaps = 52/313 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSK 64
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH------- 59
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY 121
+ P I +YG + + ++ + D +
Sbjct: 60 ------ECNS-----------------PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 96
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ + + ++ +I + Y+ + +HRD+KP N L+ ++ + DFG++
Sbjct: 97 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 153
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+ D N + GT Y S G S + D+ S+G L+ G P
Sbjct: 154 QLIDSMANSFV---------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY---GFLKR 297
A + + E + + + + DY +
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
Query: 298 LFHDLFSREGYDF 310
L +FS E DF
Sbjct: 265 LPSGVFSLEFQDF 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-29
Identities = 48/285 (16%), Positives = 99/285 (34%), Gaps = 42/285 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIR 66
KY + +G G FG + + + K ++ GT + E + I +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------ 59
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK 125
H I ++ E+ V++ + + G + + +
Sbjct: 60 -----------HR----------NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE 98
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
+ + ++ Q+ ++++HS H DI+P+N + R+++ + II+FG A++ +
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPG 157
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245
R + Y + H S D+ SLG ++ L G P+
Sbjct: 158 DNFRLLF--------TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA---E 206
Query: 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
T +Q + I + + E K E + R
Sbjct: 207 TNQQIIENIMNAEYTFDEEAF-KEISIEAMDFVDRLLVKERKSRM 250
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 114 bits (286), Expect = 6e-29
Identities = 54/289 (18%), Positives = 91/289 (31%), Gaps = 49/289 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
Y + ++GSG+FG + T + K + E +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN-------- 81
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVY 121
+ H P + + D + VL+L+ L G L D
Sbjct: 82 -----QLHH-----------------PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 119
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
K S V+ Q ++++H +H DIKP+N + +KA+ V IIDFGLA K
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATK 178
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ T TA +A+ D+ ++G + L G P+ G
Sbjct: 179 LNPDEIVKVT--------TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ + + S E + +R
Sbjct: 231 ---EDDLETLQNVKRCDWEFDEDAF-SSVSPEAKDFIKNLLQKEPRKRL 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 114 bits (285), Expect = 7e-29
Identities = 45/286 (15%), Positives = 95/286 (33%), Gaps = 43/286 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
Y + ++G+G+FG + + T A K + + E + +L+
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR----- 81
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR 124
H + N+ D + V++ + + G L +
Sbjct: 82 ------------HP----------TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 119
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
K S + Q+ + ++H ++H D+KP+N + +++N++ +IDFGL
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDP 178
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244
+ + TGTA +A+ G D+ S+G + L G P+ G
Sbjct: 179 KQSVKVT--------TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--- 227
Query: 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ + + + + + R
Sbjct: 228 ENDDETLRNVKSCDWNMDDSAF-SGISEDGKDFIRKLLLADPNTRM 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-28
Identities = 53/310 (17%), Positives = 107/310 (34%), Gaps = 58/310 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKIR 66
+++ ++G G+FG+++ A + +T+ + A K+ S + + E +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA--------- 64
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYC 122
DH PNI K +N ++++ G +++ + +
Sbjct: 65 ----SCDH-----------------PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 103
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
R + + ++ Q + + Y+H +HRD+K N L + + DFG++ K
Sbjct: 104 ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKN 160
Query: 183 RDPTTNRHIPYRENKNLTGTARYAS-----CNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237
R + GT + + C T + D+ SLG L+
Sbjct: 161 TRTIQRRD-------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297
P L + KI + + P + F + C D R L +
Sbjct: 214 PHHEL---NPMRVLLKIAKSE--PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
Query: 298 LFHDLFSREG 307
H + +
Sbjct: 269 --HPFVTVDS 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 4e-28
Identities = 64/283 (22%), Positives = 102/283 (36%), Gaps = 42/283 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+++GR +G G FG ++LA + I+A+K+ K +L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF----------------------KAQL 44
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
V+H + + I I + Y D L+L+ + KF
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 104
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 187
+ ++ + Y HS+ +HRDIKP+N L+G A ++ I DFG +
Sbjct: 105 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV------- 154
Query: 188 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 247
H P L GT Y G + DL SLG + FL G P++ T
Sbjct: 155 --HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTY 209
Query: 248 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
++ Y +I + + P V QRP
Sbjct: 210 QETYKRISRVEFTFPDFV-----TEGARDLISRLLKHNPSQRP 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-28
Identities = 55/264 (20%), Positives = 99/264 (37%), Gaps = 45/264 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
+K G+ +G GSF + LA + T+ A+KI + K ++ Y + ++
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS----- 63
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVY 121
+DH P K Y D E L L ++
Sbjct: 64 -----RLDH-----------------PFFVKLYFTFQDDEKLYFGLSYAKNGELLK-YIR 100
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
F ++++ +EY+H +G +HRD+KP+N L+ + + I DFG AK
Sbjct: 101 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKV 157
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ + GTA+Y S + DL +LG ++ + G P++
Sbjct: 158 LSPESKQARA-----NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212
Query: 242 LKAATKKQKYDKICEKKVSTPIEV 265
+ + KI + + P +
Sbjct: 213 ---GNEYLIFQKIIKLEYDFPEKF 233
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-28
Identities = 60/294 (20%), Positives = 105/294 (35%), Gaps = 53/294 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
+ +G++IGSGSFG ++ VAVK+ N PQ E V +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR------ 59
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFV 120
H NI + G + +V G SL
Sbjct: 60 -------KTRH-----------------VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH 95
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
KF + ++ +A Q ++Y+H++ +HRD+K +N + + V I DFGLA
Sbjct: 96 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLAT 152
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237
+ + + L+G+ + + S + D+ + G VL + G L
Sbjct: 153 VKSRWSGSHQF-----EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
P+ + + Q + +S + + + P C D+RP
Sbjct: 208 PYSNIN--NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL 259
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-28
Identities = 65/308 (21%), Positives = 103/308 (33%), Gaps = 39/308 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY+ KIG G+FGE+F A H T + VA+K L E K+ ++L+ +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
+ L+ Y LV D L L
Sbjct: 71 VVNLIEICRTKA-------------------SPYNRCKGSIYLVFDFCEHDLAGLLSNVL 111
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
KF+L + + ++ + Y+H LHRD+K N L+ + + + DFGLA+ +
Sbjct: 112 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFS 168
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGL 242
++ Y N T Y LG DL G ++ S QG
Sbjct: 169 LAKNSQPNRY---TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG- 224
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
T++ + I + S EV + + L + RL +
Sbjct: 225 --NTEQHQLALISQLCGSITPEVW------PNVDNYELYEKLELVKGQKRKVKDRLKAYV 276
Query: 303 FSREGYDF 310
D
Sbjct: 277 RDPYALDL 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 106 bits (266), Expect = 9e-27
Identities = 54/288 (18%), Positives = 100/288 (34%), Gaps = 39/288 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+LG +G G E+ LA + + VAVK+ + + + EA+ L
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
+ + + G +V++ + V+
Sbjct: 68 AIVAVYDTGEAE-----------------------TPAGPLPYIVMEYVDGVTLRDIVHT 104
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+ K + + + + H G +HRD+KP N ++ N V ++DFG+A+
Sbjct: 105 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAI 161
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
D + + + GTA+Y S G R D+ SLG VL L G P+ G
Sbjct: 162 ADSGNSVT----QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG- 216
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ + + P + A+ + + + R
Sbjct: 217 --DSPVSVAYQHVREDP-IPPSARHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-26
Identities = 55/310 (17%), Positives = 97/310 (31%), Gaps = 63/310 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ R+IG GSFG ++ A V +E+VA+K + S K ++ E + +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ----- 70
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLF 119
+ H PN ++ G LV++ S DL
Sbjct: 71 --------KLRH-----------------PNTIQYRGCYLREHTAWLVMEYCLGSASDLL 105
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
++ + + + + Y+HS +HRD+K N L+ + V + DFG A
Sbjct: 106 EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 162
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGS 236
+ GT + + + + D+ SLG +
Sbjct: 163 SIMAPANS-----------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 237 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296
P + I + + F ++ C RP L
Sbjct: 212 PPLFNM---NAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLL 265
Query: 297 RLFHDLFSRE 306
+ H RE
Sbjct: 266 K--HRFVLRE 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 2e-26
Identities = 67/274 (24%), Positives = 102/274 (37%), Gaps = 47/274 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSK 64
+ L + +G G++GE+ LA + T E VAVKI + + + E + K
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK------- 58
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV--LVLDLLGPSLEDLFVY 121
++H N+ K+YG E N+ L L+ +
Sbjct: 59 ------MLNH-----------------ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 95
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
Q++A + Y+H G HRDIKP+N L+ + + + I DFGLA
Sbjct: 96 PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV 152
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 240
+R R + + GT Y + E + D+ S G VL L G LPW
Sbjct: 153 FRYNNRERLL-----NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 274
+ Q+Y EKK S P
Sbjct: 208 Q--PSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 4e-26
Identities = 47/259 (18%), Positives = 95/259 (36%), Gaps = 43/259 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
+ + +G G+FG++ L T A+KI + ++ + ++LQ
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ----- 60
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 125
+ H + + L + + +LF + R+
Sbjct: 61 -----NTRHPFL----------------TALKYAFQTHDRLCFVMEYANGGELFFHLSRE 99
Query: 126 --FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
F+ + ++++ +EY+HSR ++RDIK +N ++ K + I DFGL K+
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGI 156
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243
GT Y + + R D LG V+ + G LP+
Sbjct: 157 SDGATMK-------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-- 207
Query: 244 AATKKQKYDKICEKKVSTP 262
++ ++ I +++ P
Sbjct: 208 -QDHERLFELILMEEIRFP 225
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 6e-26
Identities = 53/303 (17%), Positives = 112/303 (36%), Gaps = 53/303 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIR 66
KL ++G+G FGE+++ + + + VAVK ++ L EA + K
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMK--------- 63
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLFVYC 122
+ H + + Y V ++ + ++ + + G ++ L
Sbjct: 64 ----QLQH-----------------QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPS 102
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
K ++ +L +A Q+ + ++ R ++HRD++ N L+ I DFGLA+
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLI 159
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 241
D + ++ + + + D+ S G +L + G +P+ G
Sbjct: 160 EDNEYTAR------EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
++ + V + P E C + RP + +L+ + D
Sbjct: 214 -------MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 302 LFS 304
F+
Sbjct: 267 FFT 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 7e-26
Identities = 50/244 (20%), Positives = 94/244 (38%), Gaps = 30/244 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+Y++G +GSG FG ++ V N VA+K + +I G
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-------------VEKDRISDWGELPNG 51
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-F 126
++ V++ ++ FS G+ + + + VL+L+ P + R
Sbjct: 52 TRVPMEVVLLKKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 107
Query: 127 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 186
+ Q++ + + H+ G LHRDIK +N L + ++ +IDFG +D
Sbjct: 108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTV 165
Query: 187 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245
+ GT Y+ R + SLG +L + G +P++ +
Sbjct: 166 YT---------DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
Query: 246 TKKQ 249
+ Q
Sbjct: 217 IRGQ 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-25
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 40/257 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+ L + +G GSFG++FLA TN+ A+K K +L + V + + R++
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKA----LKKDVVLMDDDVECTMV---EKRVL 56
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRK 125
+H + + L + G L + K
Sbjct: 57 SLAWEHPFL----------------THMFCTFQTKENLFFVMEYLNGGDLMYH-IQSCHK 99
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
F L A ++I ++++HS+G ++RD+K DN L+ K + I DFG+ K+
Sbjct: 100 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLG 156
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245
+ GT Y + LG + + D S G +L L G P+ G
Sbjct: 157 DAKTN-------TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---Q 206
Query: 246 TKKQKYDKICEKKVSTP 262
+++ + I P
Sbjct: 207 DEEELFHSIRMDNPFYP 223
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-25
Identities = 52/274 (18%), Positives = 93/274 (33%), Gaps = 54/274 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
KY KIG G+ G ++ A V T + VA++ K ++ E V +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-------- 72
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVY 121
+ PNI + G++ +V++ L G SL D+
Sbjct: 73 -----ENKN-----------------PNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--V 108
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ + + + +E++HS +HRDIK DN L+ V + DFG +
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 165
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ R + GT + + + D+ SLG + + + G P+
Sbjct: 166 ITPEQSKRS-------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 242 ------LKAATKKQKYDKICEKKVSTPIEVLCKS 269
L + +K+S
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 102 bits (254), Expect = 3e-25
Identities = 47/286 (16%), Positives = 88/286 (30%), Gaps = 30/286 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK--ILQGGSKI 65
Y+ +G G + H T + AVKI + E + + L+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR 124
R V H + + +K LV DL+ L D ++ +
Sbjct: 64 RKVSGHPNII-----------------QLKDTYETNTFFFLVFDLMKKGELFD-YLTEKV 105
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
S K + ++ I +H +HRD+KP+N L+ + + DFG + +
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDP 162
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244
R + + + + H G + D+ S G ++ L GS P+
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH--- 217
Query: 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ I + + +R
Sbjct: 218 RKQMLMLRMIMSGNYQFGSPEW-DDYSDTVKDLVSRFLVVQPQKRY 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 7e-25
Identities = 51/289 (17%), Positives = 95/289 (32%), Gaps = 46/289 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSK 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 124
+R V + VLV +L+ ++ +
Sbjct: 71 VRFYDSWESTV-----------------------KGKKCIVLVTELMTSGTLKTYLKRFK 107
Query: 125 KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+K + Q++ ++++H+R +HRD+K DN + V I D GLA
Sbjct: 108 VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLK 165
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
R K + GT + + + + D+ + G +L P+
Sbjct: 166 RASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE- 214
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
Q Y ++ + K E C D+R
Sbjct: 215 -CQNAAQIYRRVTSGVKPASFD---KVAIPEVKEIIEGCIRQNKDERYS 259
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-24
Identities = 51/290 (17%), Positives = 93/290 (32%), Gaps = 37/290 (12%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
II + +G G G++ + T E A+K+ P+ E +++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRA---- 61
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFV-Y 121
I + ++ + G + ++V++ L G L
Sbjct: 62 --------SQCPHIVRIVDVYENLYAGRKCL----------LIVMECLDGGELFSRIQDR 103
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ F+ + + + I+Y+HS HRD+KP+N L R + + DFG AK+
Sbjct: 104 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ Y T Y + + + D+ SLG ++ L G P+
Sbjct: 164 TTSHNSLTTPCY--------TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
Query: 242 L-KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
A +I + P E QR
Sbjct: 216 NHGLAISPGMKTRIRMGQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRM 264
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-24
Identities = 66/316 (20%), Positives = 110/316 (34%), Gaps = 55/316 (17%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R V Y + IG+GSFG ++ A D+ E+VA+K + E ++ +
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMR---- 68
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFV 120
+DH I L F S+ + LVLD + +
Sbjct: 69 ---------KLDHCNIVRLRYFFYSSGEKKDEVYLN--------LVLDYVPETVYRVARH 111
Query: 121 YCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
Y R K + V + Q+ + Y+HS G HRDIKP N L + + DFG
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGS 169
Query: 179 AKKYRD----PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234
AK+ + YR + + G Y + D+ S G VL L
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDY-----------TSSIDVWSAGCVLAELLL 218
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294
G + G + + +I + + E + + +P F ++ +
Sbjct: 219 GQPIFPG---DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW-------- 267
Query: 295 LKRLFHDLFSREGYDF 310
++F E
Sbjct: 268 -TKVFRPRTPPEAIAL 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (251), Expect = 2e-24
Identities = 54/290 (18%), Positives = 102/290 (35%), Gaps = 50/290 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSK 64
Y +G+G+F E+ LA T ++VA+K + K + E V
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH------- 62
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFV 120
+ H PNI + G L++ L+ G L D +
Sbjct: 63 ------KIKH-----------------PNIVALDDIYESGGHLYLIMQLVSGGELFD-RI 98
Query: 121 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 180
+ ++ + L Q++ ++Y+H G +HRD+KP+N L + +++ I DFGL+K
Sbjct: 99 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
Query: 181 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240
+ GT Y + S+ D S+G + L G P+
Sbjct: 159 MEDPGSVLSTA--------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ +++I + + + + ++R
Sbjct: 211 D---ENDAKLFEQILKAEYEFDSPYW-DDISDSAKDFIRHLMEKDPEKRF 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 101 bits (253), Expect = 2e-24
Identities = 55/261 (21%), Positives = 98/261 (37%), Gaps = 38/261 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+ + R IG G FGE++ DT ++ A+K + K R+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD----------------------KKRIK 43
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI---KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 125
+ + + ++ ++ + G P I + + +LDL+ +
Sbjct: 44 MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 103
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
FS + A ++I +E++H+R ++RD+KP N L+ + V I D GLA +
Sbjct: 104 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK 160
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 244
+ + GT Y + G+ D SLG +L LRG P++ K
Sbjct: 161 KPHASV---------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211
Query: 245 ATKKQKYDKICEKKVSTPIEV 265
K + V P
Sbjct: 212 KDKHEIDRMTLTMAVELPDSF 232
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (250), Expect = 4e-24
Identities = 63/321 (19%), Positives = 105/321 (32%), Gaps = 33/321 (10%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQ 60
E +Y L RK+G G F ++LA + N VA+K + E K+ + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV 120
+ +H++ G + + + L +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL-----------LALIKK 116
Query: 121 YCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLM---GLGRKANQVYIIDF 176
Y R L V ++ Q++ ++Y+ G +H DIKP+N LM Q+ I D
Sbjct: 117 YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176
Query: 177 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 236
G A Y + TN T Y S LG D+ S ++ + G
Sbjct: 177 GNACWYDEHYTNSI----------QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
Query: 237 LPWQGLKAATKKQKYD---KICEKKVSTPIEVLCKSHPAEF----ASYFHYCQSLTFDQR 289
++ + + + D +I E P +L L F
Sbjct: 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286
Query: 290 PDYGFLKRLFHDLFSREGYDF 310
D K F ++E DF
Sbjct: 287 EDVLTEKYKFSKDEAKEISDF 307
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 5e-24
Identities = 55/297 (18%), Positives = 92/297 (30%), Gaps = 55/297 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y++ IG+GS+G +I+ K + + L+ E + +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR------ 58
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC 122
+ H I I V++ G L +
Sbjct: 59 -------ELKHPNIVRYYDRIIDRTNTTLYI------------VMEYCEGGDLASVITKG 99
Query: 123 RRK---FSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYII 174
++ + VL + Q+ ++ H R LHRD+KP N + V +
Sbjct: 100 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLG 156
Query: 175 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234
DFGLA+ T+ K GT Y S + + + D+ SLG +L
Sbjct: 157 DFGLARILNHDTSFA-------KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 209
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
P+ ++K+ KI E K E +L RP
Sbjct: 210 LMPPFTAF---SQKELAGKIREGKFRRIPYRY----SDELNEIITRMLNLKDYHRPS 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 1e-23
Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 53/303 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSKIR 66
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMK--------- 67
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVL--DLLGPSLEDLFVYCR 123
+ H + + Y V E+ + ++ + SL D
Sbjct: 68 ----KLRH-----------------EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGET 106
Query: 124 RKF-SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
K+ L ++ +A Q+ + + YV ++HRD++ N L+G + + DFGLA+
Sbjct: 107 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI 163
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 241
D Y + ++ + L + + D+ S G +L +G +P+ G
Sbjct: 164 EDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
+ ++ D++ E+ P C P C ++RP + +L+ D
Sbjct: 218 M---VNREVLDQV-ERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 302 LFS 304
F+
Sbjct: 271 YFT 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.1 bits (246), Expect = 1e-23
Identities = 63/320 (19%), Positives = 114/320 (35%), Gaps = 52/320 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSKI 65
++ + +G+GSFG + L H ++ A+KI + K Q+ + +ILQ
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ----- 96
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 125
V+ + L + + Y GE + +
Sbjct: 97 -----AVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEM-------------FSHLRRIGR 137
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
FS A Q++ EY+HS ++RD+KP+N L+ + + DFG AK+ +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR 194
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245
T GT + L ++ D +LG ++ G P+
Sbjct: 195 TWTLC----------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---D 241
Query: 246 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305
Q Y+KI KV P ++ L D +G LK +D+ +
Sbjct: 242 QPIQIYEKIVSGKVRFPSHF-----SSDLKDLLRNL--LQVDLTKRFGNLKNGVNDIKNH 294
Query: 306 EGYDFDFVFDWTILKYQQTQ 325
+ + DW + ++ +
Sbjct: 295 K---WFATTDWIAIYQRKVE 311
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 59/304 (19%), Positives = 106/304 (34%), Gaps = 31/304 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ R IG G+FG +F A + +VAVK+ E S EA +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF 119
+ ++L+ + ++F G N + + + +
Sbjct: 74 DNPNIVKLLGVCAVG---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
S L +A Q+ A + Y+ R F+HRD+ N L+G + V I DFGL+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 187
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLP 238
+ Y+ + N R+ + + D+ + G VL G P
Sbjct: 188 RNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----F 294
+ G+ ++ + + + E + P E + C S RP +
Sbjct: 243 YYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 295 LKRL 298
L+R+
Sbjct: 296 LQRM 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 97.6 bits (242), Expect = 3e-23
Identities = 57/304 (18%), Positives = 110/304 (36%), Gaps = 42/304 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLR------- 87
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFS 127
I L I + P + + V+ D + L+ + +
Sbjct: 88 -----GGPNIITLADIVKDPVSRTPALVFEHVNNTD-----------FKQLY----QTLT 127
Query: 128 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 187
+ +++ ++Y HS G +HRD+KP N + + + ++ +ID+GLA+ Y
Sbjct: 128 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 188 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAAT 246
+ + + + D+ SLG +L + P+
Sbjct: 186 YNVR--------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHD 235
Query: 247 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 306
+ +I + + + + E F+ +R + H + S E
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV-SPE 294
Query: 307 GYDF 310
DF
Sbjct: 295 ALDF 298
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.7 bits (240), Expect = 6e-23
Identities = 54/257 (21%), Positives = 100/257 (38%), Gaps = 44/257 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+++ R +G+GSFG + L A+K+ +++ K + RL+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKV-----LKKEIVVRLKQVEHTN---DERLM 57
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK 125
+ V H P I + +G D + +++D + + ++
Sbjct: 58 LSIVTH-----------------PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR 100
Query: 126 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 185
F A ++ +EY+HS+ ++RD+KP+N L+ K + I DFG AK D
Sbjct: 101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDV 157
Query: 186 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 245
T L GT Y + ++ D S G ++ L G P+ +
Sbjct: 158 TY----------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---S 204
Query: 246 TKKQKYDKICEKKVSTP 262
+ Y+KI ++ P
Sbjct: 205 NTMKTYEKILNAELRFP 221
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 6e-23
Identities = 53/303 (17%), Positives = 108/303 (35%), Gaps = 40/303 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+ +IG G++G++F A + + VA+K + E V + L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET- 66
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC 122
+H + L + + + + + ++ + L
Sbjct: 67 ---------FEHPNVVRLFDVCT--------VSRTDRETKLTLVFEHVDQDLTTYLDKVP 109
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+T+ + Q++ ++++HS +HRD+KP N L+ + Q+ + DFGLA+ Y
Sbjct: 110 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIY 166
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
+ T Y + L + DL S+G + R ++G
Sbjct: 167 SFQMALTSV--------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG- 217
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
++ + KI + P E A FH + ++ + L DL
Sbjct: 218 --SSDVDQLGKIL-DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD--IDELGKDL 272
Query: 303 FSR 305
+
Sbjct: 273 LLK 275
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 6e-23
Identities = 64/300 (21%), Positives = 100/300 (33%), Gaps = 56/300 (18%)
Query: 4 IIGVK-YKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-----ENSGTKHPQLLYEAK 54
+IG K +L K+G GSFG + + VAVK + + E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 55 VYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL- 111
+DH N+ + YGV + +V +L
Sbjct: 64 AMH-------------SLDH-----------------RNLIRLYGVVLTPPMKMVTELAP 93
Query: 112 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
SL D + F L T+ A Q+ + Y+ S+ F+HRD+ N L+ + V
Sbjct: 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLV 150
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 231
I DFGL + + Y ++ + + + S D G L
Sbjct: 151 KIGDFGLMRALPQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 206
Query: 232 FL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
G PW GL Q KI ++ P C P + + C + + RP
Sbjct: 207 MFTYGQEPWIGL---NGSQILHKIDKEGERLPRPEDC---PQDIYNVMVQCWAHKPEDRP 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 1e-22
Identities = 57/300 (19%), Positives = 116/300 (38%), Gaps = 53/300 (17%)
Query: 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSKIR 66
+++GSG+FG + + + VAVKI + P +LL EA V +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ--------- 63
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCRR 124
+D+ P I + G+ + E +LV+++ + ++ R
Sbjct: 64 ----QLDN-----------------PYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNR 102
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
K ++ L Q+ ++Y+ F+HRD+ N L+ + I DFGL+K R
Sbjct: 103 HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRA 159
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLK 243
Y+ + ++ + + S + D+ S G ++ G P++G+K
Sbjct: 160 DENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215
Query: 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 303
+ +K +++ P P E + C + + RP + ++ + +
Sbjct: 216 GSEVTAMLEK--GERMGCPAGC-----PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 4e-22
Identities = 56/307 (18%), Positives = 111/307 (36%), Gaps = 57/307 (18%)
Query: 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRL 67
++G G+FG + + + VA+K+ GT+ +++ EA++
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH---------- 64
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRR 124
+D+ P I + GV + + LV+++ G L V R
Sbjct: 65 ---QLDN-----------------PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE 104
Query: 125 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 184
+ + V L Q+ ++Y+ + F+HRD+ N L+ + I DFGL+K
Sbjct: 105 EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGA 161
Query: 185 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLK 243
+ ++ + + S R D+ S G + L G P++ +
Sbjct: 162 DDSYYTA----RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM- 216
Query: 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----FLKRLF 299
+ I + K P E + C ++ RPD+ ++ +
Sbjct: 217 --KGPEVMAFIEQGKRMECPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
Query: 300 HDLFSRE 306
+ L S+
Sbjct: 271 YSLASKV 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 4e-22
Identities = 59/309 (19%), Positives = 95/309 (30%), Gaps = 43/309 (13%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+G +Y IG G++G + A VA+K T + L E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
+ I + I +D LV L+G L L
Sbjct: 66 ENIIGINDIIRAPTI----------------------EQMKDVYLVTHLMGADLYKLL-- 101
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ S + Q++ ++Y+HS LHRD+KP N L+ + I DFGLA+
Sbjct: 102 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARV 158
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
+ A N ++ D+ S+G +L L + G
Sbjct: 159 ADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPG 215
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
+ + I S E L L + RLF +
Sbjct: 216 ---KHYLDQLNHILGILGSPSQEDL------NCIINLKARNYLLSLPHKNKVPWNRLFPN 266
Query: 302 LFSREGYDF 310
+ D
Sbjct: 267 A-DSKALDL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 4e-22
Identities = 57/306 (18%), Positives = 99/306 (32%), Gaps = 59/306 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+ KL + IG G FG++ L + VAVK + L EA V
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMT---------- 55
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDN---VLVLDLL-GPSLED-LFVY 121
+ H N+ + GV E+ +V + + SL D L
Sbjct: 56 ---QLRH-----------------SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 95
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
R +L + + +EY+ F+HRD+ N L+ + N + DFGL K+
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE 152
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQ 240
++ + + S + D+ S G +L G +P+
Sbjct: 153 ASSTQDTGK----------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300
+ K ++ + + P C L RP + L+
Sbjct: 203 RI---PLKDVVPRVEKGYKMDAPDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
Query: 301 DLFSRE 306
+ + E
Sbjct: 256 HIKTHE 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 6e-22
Identities = 62/309 (20%), Positives = 113/309 (36%), Gaps = 56/309 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ +LGR IG G FG++ ++ VA+K S + + L EA +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR---- 63
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDL 118
DH P+I K GV E+ V ++++L L
Sbjct: 64 ---------QFDH-----------------PHIVKLIGVITENPVWIIMELCTLGELRSF 97
Query: 119 FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ L ++++ A Q+ + Y+ S+ F+HRDI N L+ + V + DFGL
Sbjct: 98 LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGL 154
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSL 237
++ D T Y + ++ + + + D+ G + L G
Sbjct: 155 SRYMEDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297
P+QG+ K + + + + + + P S C + +RP + LK
Sbjct: 209 PFQGV-------KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
Query: 298 LFHDLFSRE 306
+ E
Sbjct: 262 QLSTILEEE 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 1e-21
Identities = 55/318 (17%), Positives = 100/318 (31%), Gaps = 78/318 (24%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEI-----VAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +GSG+FG++ A+ ++ VAVK+ + ++ L+ E K+ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSL 115
H NI G L+ + L
Sbjct: 98 G------------SH-----------------ENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 116 EDLFVYCRRKFS----------------------LKTVLMLADQMIARIEYVHSRGFLHR 153
+ R KFS + +L A Q+ +E++ + +HR
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188
Query: 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 213
D+ N L+ V I DFGLA+ + Y N ++ + +
Sbjct: 189 DLAARNVLVT---HGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFE 240
Query: 214 IEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 272
+ + D+ S G +L G P+ G+ + K+ +
Sbjct: 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGI---PVDANFYKLIQNGFKMDQPFYA---TE 294
Query: 273 EFASYFHYCQSLTFDQRP 290
E C + +RP
Sbjct: 295 EIYIIMQSCWAFDSRKRP 312
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.5 bits (229), Expect = 1e-21
Identities = 56/303 (18%), Positives = 108/303 (35%), Gaps = 51/303 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIR 66
+ K+G G +GE++ + VAVK ++ + + L EA V K
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK--------- 68
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDL----LGPSLEDLFVY 121
+ H PN+ + GV + + G L+ L
Sbjct: 69 ----EIKH-----------------PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 107
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
R++ S +L +A Q+ + +EY+ + F+HRD+ N L+G + + V + DFGL++
Sbjct: 108 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRL 164
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
T H + ++ + + + S + D+ + G +L +
Sbjct: 165 MTGDTYTAHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
+ ++ EK C P + C RP + + + F
Sbjct: 219 ---GIDLSQVYELLEKDYRMERPEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
Query: 302 LFS 304
+F
Sbjct: 273 MFQ 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 1e-21
Identities = 53/295 (17%), Positives = 95/295 (32%), Gaps = 54/295 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E + K
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-- 68
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLLGPSLE 116
+ H PN+ + V + D +L+L+L+
Sbjct: 69 -----------EIQH-----------------PNVITLHEVYENKTDVILILELVAGGEL 100
Query: 117 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIID 175
F+ + + + Q++ + Y+HS H D+KP+N ++ ++ IID
Sbjct: 101 FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235
FGLA K ++I GT + + D+ S+G + L G
Sbjct: 161 FGLAHKIDFGNEFKNI--------FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
Query: 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ P+ G TK++ + E + A + +R
Sbjct: 213 ASPFLG---DTKQETLANVSAVNYEFEDEYF-SNTSALAKDFIRRLLVKDPKKRM 263
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 2e-21
Identities = 61/308 (19%), Positives = 108/308 (35%), Gaps = 51/308 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ +GSG++G + A T VAVK S + E ++ K ++ +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
I L+ + + D LV L+G L ++
Sbjct: 79 VIGLL---------------------DVFTPARSLEEFNDVYLVTHLMGADLNNI--VKC 115
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
+K + V L Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTD 172
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGL 242
D T T Y + L ++ D+ S+G ++ L G + G
Sbjct: 173 DEMTGYVA----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG- 221
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
+ I + E+L K +Y + Q P F
Sbjct: 222 --TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-----SLTQMPKMNFANVFIG-- 272
Query: 303 FSREGYDF 310
+ D
Sbjct: 273 ANPLAVDL 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 4e-21
Identities = 55/278 (19%), Positives = 106/278 (38%), Gaps = 46/278 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y+ + +GSG++G + A T VA+K S + E ++ K ++ +
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 78
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
I L+ + T + LV+ +G L L
Sbjct: 79 VIGLLDVFTPDETLDDFTDFY---------------------LVMPFMGTDLGKLM--KH 115
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
K + L QM+ + Y+H+ G +HRD+KP N + + ++ I+DFGLA++
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQAD 172
Query: 184 DPTTNR--HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241
T YR + + RY ++ D+ S+G ++ + G ++G
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH 279
+ + +I + + P E + + E +Y
Sbjct: 222 ---SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 90.6 bits (224), Expect = 6e-21
Identities = 49/301 (16%), Positives = 100/301 (33%), Gaps = 53/301 (17%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKV 55
+ I K+ + IG+G FGE+ + VA+K + + L EA +
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 56 YKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI---KWYGVDGEDNVLVLDLL- 111
DH PN+ + +++ + +
Sbjct: 81 MG-------------QFDH-----------------PNVIHLEGVVTKSTPVMIITEFME 110
Query: 112 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 171
SL+ +F++ ++ + + A ++Y+ ++HRD+ N L+
Sbjct: 111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVC 167
Query: 172 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 231
+ DFGL++ D T++ Y R+ + + + D+ S G V+
Sbjct: 168 KVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 232 FL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 290
+ G P+ + T + + I + P P+ C + RP
Sbjct: 226 VMSYGERPYWDM---TNQDVINAIEQDYRLPPPM----DCPSALHQLMLDCWQKDRNHRP 278
Query: 291 D 291
Sbjct: 279 K 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 7e-21
Identities = 58/311 (18%), Positives = 115/311 (36%), Gaps = 46/311 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ + IGSG+ G + A + VA+K + T + E + K + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
I L+ + + +D LV++L+ +L +
Sbjct: 78 IISLLNVFTPQKTLE---------------------EFQDVYLVMELMDANLCQ---VIQ 113
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
+ + + L QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG 170
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243
T Y + LG+ D+ S+G ++ +R + + G
Sbjct: 171 TSFMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-- 220
Query: 244 AATKKQKYDKICEKKVSTPIEVLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK--RLF 299
+++K+ E+ + E + K P + LTF +
Sbjct: 221 -RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 300 HDLFSREGYDF 310
+ L + + D
Sbjct: 280 NKLKASQARDL 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 7e-21
Identities = 53/291 (18%), Positives = 97/291 (33%), Gaps = 50/291 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQG 61
+K + +GSG+FG ++ + E V + + S + ++L EA V
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA---- 66
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 121
VD+ + + + ++ + L D
Sbjct: 67 ---------SVDN--------------PHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE 103
Query: 122 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 181
+ + +L Q+ + Y+ R +HRD+ N L+ V I DFGLAK
Sbjct: 104 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 160
Query: 182 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQ 240
H + ++ + + L + + D+ S G + + GS P+
Sbjct: 161 LGAEEKEYHA-----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215
Query: 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
G+ A + I EK P +C + C + D RP
Sbjct: 216 GIPA----SEISSILEKGERLPQPPIC---TIDVYMIMVKCWMIDADSRPK 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 2e-20
Identities = 49/289 (16%), Positives = 101/289 (34%), Gaps = 53/289 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
+++G+G FG + VA+K I+ + + EAKV
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMM---------- 54
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCR 123
++ H + + YGV ++ + + L + R
Sbjct: 55 ---NLSH-----------------EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 94
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
+F + +L + + +EY+ S+ FLHRD+ N L+ V + DFGL++
Sbjct: 95 HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL 151
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGL 242
D Y + R++ + + S + D+ + G ++ G +P++
Sbjct: 152 DDE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
T + + I + + + + + C D+RP
Sbjct: 206 ---TNSETAEHIAQGLRLYRPHLA----SEKVYTIMYSCWHEKADERPT 247
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 88.8 bits (219), Expect = 2e-20
Identities = 61/307 (19%), Positives = 106/307 (34%), Gaps = 55/307 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY KIG G++G ++ A + + E A+K + + E + K L+ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
++L + VLV + L L+ L C
Sbjct: 62 IVKLY---------------------------DVIHTKKRLVLVFEHLDQDLKKLLDVCE 94
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
T Q++ I Y H R LHRD+KP N L+ + ++ I DFGLA+ +
Sbjct: 95 GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151
Query: 184 DPTTNRH-----IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238
P + YR L G+ +Y S D+ S+G + + G+
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKY-----------STTIDIWSVGCIFAEMVNGTPL 200
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 298
+ G ++ + +I + + TP + ++ L
Sbjct: 201 FPG---VSEADQLMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 299 FHDLFSR 305
DL S+
Sbjct: 257 GIDLLSK 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 6e-20
Identities = 53/268 (19%), Positives = 113/268 (42%), Gaps = 37/268 (13%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKI 58
E++ ++L + +G+G++G++FL + DT ++ A+K+ K ++ +AK +
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV----LKKATIVQKAKTTEH 74
Query: 59 LQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDL 118
+ R V+ H+ + + + L+LD +
Sbjct: 75 TR---TERQVLEHIRQSPF-------------LVTLHYAFQTETKLHLILDYINGGELFT 118
Query: 119 FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ R +F+ V + +++ +E++H G ++RDIK +N L+ V + DFGL
Sbjct: 119 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGL 175
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ--SRRDDLESLGYVLLYFLRGS 236
+K++ T R + GT Y + + G + + D SLG ++ L G+
Sbjct: 176 SKEFVADETERAYDFC------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 237 LPWQGLKAATKKQKYDKICEKKVSTPIE 264
P+ +K +I + + +
Sbjct: 230 SPFTV---DGEKNSQAEISRRILKSEPP 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 8e-20
Identities = 61/308 (19%), Positives = 104/308 (33%), Gaps = 53/308 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY+ KIG G++G +F A + +T+EIVA+K ++ L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 123
H + V +H + LV + L+ F C
Sbjct: 60 -------HKNIVRLH-----------------DVLHSDKKLTLVFEFCDQDLKKYFDSCN 95
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
+ V Q++ + + HSR LHRD+KP N L+ + ++ + +FGLA+ +
Sbjct: 96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFG 152
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGL 242
P T Y + G + S D+ S G + P
Sbjct: 153 IPVRCYS-------AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--F 203
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
+ +I + E ++ S + P L + L
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEE--------QWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 303 FSREGYDF 310
+ G D
Sbjct: 256 -NATGRDL 262
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 2e-19
Identities = 56/303 (18%), Positives = 100/303 (33%), Gaps = 45/303 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV-YKILQGGSKIR 66
++ KIG G++G ++ A + T E+VA+K T+ + A +L+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK------ 56
Query: 67 LVVFHVDHVIIHALTIIFSSTLGGIPNI---KWYGVDGEDNVLVLDLLGPSLEDLF-VYC 122
++H PNI LV + L L+
Sbjct: 57 ----ELNH-----------------PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
L + Q++ + + HS LHRD+KP N L+ + + DFGLA+ +
Sbjct: 96 LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF 152
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242
P + A S D+ SLG + + + G
Sbjct: 153 GVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG- 205
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302
++ + +I + + TP EV+ + + + D L L
Sbjct: 206 --DSEIDQLFRIF-RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
Query: 303 FSR 305
S+
Sbjct: 263 LSQ 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 3e-19
Identities = 52/313 (16%), Positives = 94/313 (30%), Gaps = 71/313 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +G+G+FG++ A D VAVK+ T+ L+ E KV L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSL 115
+H NI G G +++ + L
Sbjct: 84 G------------NH-----------------MNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 116 EDL-----------------FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158
+ L+ +L + Q+ + ++ S+ +HRD+
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174
Query: 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR 218
N L+ I DFGLA+ ++ + Y N ++ + + +
Sbjct: 175 NILL---THGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTF 226
Query: 219 RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYF 278
D+ S G L K+ K+ ++ PAE
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMIKEGFRMLSPEHA---PAEMYDIM 281
Query: 279 HYCQSLTFDQRPD 291
C +RP
Sbjct: 282 KTCWDADPLKRPT 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 3e-19
Identities = 51/289 (17%), Positives = 100/289 (34%), Gaps = 53/289 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSKIRL 67
++IGSG FG + L ++ ++ VA+K I + EA+V
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMM---------- 55
Query: 68 VVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCR 123
+ H P + + YGV + LV + + L D R
Sbjct: 56 ---KLSH-----------------PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 95
Query: 124 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 183
F+ +T+L + + + Y+ +HRD+ N L+ + + + DFG+ +
Sbjct: 96 GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL 152
Query: 184 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGL 242
D + ++AS S + D+ S G ++ G +P++
Sbjct: 153 DDQYTSSTGTK------FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
+ + + I L +H + + +C + RP
Sbjct: 207 ---SNSEVVEDI-STGFRLYKPRLASTHVYQIMN---HCWKERPEDRPA 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 1e-18
Identities = 56/304 (18%), Positives = 92/304 (30%), Gaps = 56/304 (18%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQGGSKI 65
+G G F ++ A +TN+IVA+K E + L E K+ +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-------- 55
Query: 66 RLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYC 122
+ H PNI G + LV D + LE +
Sbjct: 56 -----ELSH-----------------PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN 93
Query: 123 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 182
+ + + +EY+H LHRD+KP+N L+ + + + DFGLAK +
Sbjct: 94 SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF 150
Query: 183 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQG 241
P + T Y + G D+ ++G +L L G
Sbjct: 151 GSPNRAYT-------HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203
Query: 242 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 301
+ + +I E + E F + D
Sbjct: 204 ---DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLD 258
Query: 302 LFSR 305
L
Sbjct: 259 LIQG 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 1e-18
Identities = 58/305 (19%), Positives = 106/305 (34%), Gaps = 34/305 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
+ KLG+ +G G+FG++ A T VAVK+ G H + KIL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI-- 71
Query: 63 SKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVL----DLLGPSLEDL 118
H+ + L + GG + + L + P
Sbjct: 72 -------HIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 119 FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
+ +L+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I DFGL
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGL 180
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SL 237
A+ Y + ++ + T + + D+ S G +L +
Sbjct: 181 ARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297
P+ G+K +++ + ++ E C QRP + L
Sbjct: 236 PYPGVKID---EEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVE 289
Query: 298 LFHDL 302
+L
Sbjct: 290 HLGNL 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 1e-18
Identities = 49/293 (16%), Positives = 88/293 (30%), Gaps = 42/293 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
K IG G+FG++ A + I S H E +V L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--- 68
Query: 64 KIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC- 122
H I + ++ + G + + + L D
Sbjct: 69 ---------HHPNI--INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117
Query: 123 ---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
S + +L A + ++Y+ + F+HRD+ N L+G + I DFGL+
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS 174
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLP 238
+ R+ + + + D+ S G +L + G P
Sbjct: 175 RGQEVYVKKTMG--------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
+ G+ T + Y+K+ + E C +RP
Sbjct: 227 YCGM---TCAELYEKLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPS 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 6e-18
Identities = 45/306 (14%), Positives = 99/306 (32%), Gaps = 56/306 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNE----IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ IG+G FGE++ ++ VA+K + + L EA +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG---- 64
Query: 62 GSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNVLVLDL---LGPSLED 117
H NI + GV + +++ +L+
Sbjct: 65 ---------QFSH-----------------HNIIRLEGVISKYKPMMIITEYMENGALDK 98
Query: 118 LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 177
+FS+ ++ + + A ++Y+ + ++HRD+ N L+ + DFG
Sbjct: 99 FLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFG 155
Query: 178 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237
L++ D + R+ + + + D+ S G V+ +
Sbjct: 156 LSRVLEDDPEATYT----TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
Query: 238 PWQGLKAATKKQKYDKICEK-KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296
+ + I + ++ TP++ P+ C +RP + +
Sbjct: 212 RPYW--ELSNHEVMKAINDGFRLPTPMDC-----PSAIYQLMMQCWQQERARRPKFADIV 264
Query: 297 RLFHDL 302
+ L
Sbjct: 265 SILDKL 270
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.1 bits (194), Expect = 8e-18
Identities = 31/192 (16%), Positives = 66/192 (34%), Gaps = 24/192 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLV 68
+G+ +G G +F + VK G + + E + Y L
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLH-------- 52
Query: 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL 128
F V + L G+ K Y + N +++ E + + +
Sbjct: 53 -FSVLAIRSARNEFRALQKLQGLAVPKVYAWE--GNAVLM-------ELIDAKELYRVRV 102
Query: 129 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 188
+ + D ++ + + RG +H D+ N L+ ++IIDF + + +
Sbjct: 103 ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWR 158
Query: 189 RHIPYRENKNLT 200
+ R+ +N+
Sbjct: 159 EIL-ERDVRNII 169
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 1e-17
Identities = 73/337 (21%), Positives = 107/337 (31%), Gaps = 71/337 (21%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSK 64
I L IG G FGE++ E VAVKI +S + EA++Y+ +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS-REERSWFREAEIYQTVM---- 53
Query: 65 IRLVVFHVDHVIIHALTIIFSSTLGGIPNI-KWYGVDGEDNV------LVLDLL-GPSLE 116
+ H NI + D +DN LV D SL
Sbjct: 54 -------LRH-----------------ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 89
Query: 117 D------LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 170
D + V K +L T LA + + HRD+K N L+ K
Sbjct: 90 DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGT 146
Query: 171 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY------ASCNTHLGIEQSRRDDLES 224
I D GLA ++ T I + GT RY E +R D+ +
Sbjct: 147 CCIADLGLAVRHDSATDTIDIAP---NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203
Query: 225 LGYVLLYFLRGSLPWQG------------LKAATKKQKYDKICEKKVSTPIEVLCKSHPA 272
+G V R + ++ +CE+K+ I +S A
Sbjct: 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 263
Query: 273 --EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 307
A C R +K+ L +EG
Sbjct: 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 5e-17
Identities = 53/297 (17%), Positives = 103/297 (34%), Gaps = 40/297 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI---ENSGTKHPQLLYEAKVYK 57
+ LG+ +G G+FG++ LA + ++ VAVK+ + + L+ E ++ K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 58 ILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPN--IKWYGVDGEDNVLVLDLLGPSL 115
++ I + L +I G ++ G +
Sbjct: 74 MIGKHKNI--INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE----------YS 121
Query: 116 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 175
+ + S K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I D
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIAD 178
Query: 176 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-R 234
FGLA+ + N ++ + + + D+ S G +L
Sbjct: 179 FGLARDIHHIDYYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233
Query: 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291
G P+ G+ ++ + + E E C QRP
Sbjct: 234 GGSPYPGV---PVEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPT 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 6e-17
Identities = 59/317 (18%), Positives = 110/317 (34%), Gaps = 45/317 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
K + R++G GSFG ++ + VA+K S + + L EA V K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 60 QGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF 119
H ++ L ++ + G + + D L L P++ +
Sbjct: 81 N------------CHHVVRLLGVV---SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 120 VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 179
V SL ++ +A ++ + Y+++ F+HRD+ N ++ + V I DFG+
Sbjct: 126 V--LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT 180
Query: 180 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLP 238
+ + YR+ R+ S + + D+ S G VL P
Sbjct: 181 RDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235
Query: 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----F 294
+QGL + +Q + E + + P C RP +
Sbjct: 236 YQGL---SNEQVLRFVMEGGLLDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 295 LKRLFHDLFSREGYDFD 311
+K F + +
Sbjct: 289 IKEEMEPGFREVSFYYS 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 7e-17
Identities = 50/308 (16%), Positives = 102/308 (33%), Gaps = 49/308 (15%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKHP---QLLYEAKVYKILQ 60
+ IG G FG ++ + +D + AVK N T Q L E + K
Sbjct: 27 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 61 GGSKIRLVVFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNV-LVLDLL-GPSLEDL 118
H + + + + E + +VL + L +
Sbjct: 87 ----------HPNVLSLL-----------------GICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 119 FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 178
++K ++ Q+ ++++ S+ F+HRD+ N ++ + V + DFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGL 176
Query: 179 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSL 237
A+ D + ++ + + + + + D+ S G +L + RG+
Sbjct: 177 ARDMYDKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
Query: 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297
P+ + + + + E P C + RP + L
Sbjct: 234 PYPDV---NTFDITVYLLQGRRLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 298 LFHDLFSR 305
+FS
Sbjct: 287 RISAIFST 294
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 449 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.76 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-59 Score=448.17 Aligned_cols=298 Identities=69% Similarity=1.232 Sum_probs=263.5
Q ss_pred CCcccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 1 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
|+--+|+||+++++||+|+||+||+|++..+++.||||++.......++..|+++++.++|++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~----------------- 63 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV----------------- 63 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTST-----------------
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCC-----------------
Confidence 677889999999999999999999999999999999999888777778999999999999887
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
.++.+..++...+..++||||+++++.+.+....+.++...++.++.|++.||+|||++|||||||||+||
T Consensus 64 ---------~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NI 134 (299)
T d1ckia_ 64 ---------GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134 (299)
T ss_dssp ---------TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ---------cccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhc
Confidence 44555666778889999999999999998888788899999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+...+.+..+||+|||+|+.+.........+++......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 135 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp EECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 99766667889999999999988776666666667778899999999999999999999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccccc
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 320 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 320 (449)
+.........+..........+.+..+.++|+++.+++..||..+|++||++.+|.+.|++++...+...+..|||..++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~ 294 (299)
T d1ckia_ 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294 (299)
T ss_dssp CCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGG
T ss_pred ccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhc
Confidence 87766655555556666677788888889999999999999999999999999999999999999999999999999988
Q ss_pred cccc
Q 013125 321 YQQT 324 (449)
Q Consensus 321 ~~~~ 324 (449)
+.+.
T Consensus 295 ~~~~ 298 (299)
T d1ckia_ 295 FGAS 298 (299)
T ss_dssp GTCC
T ss_pred CCCC
Confidence 7553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-58 Score=440.50 Aligned_cols=291 Identities=57% Similarity=0.996 Sum_probs=263.8
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+|++++|+++++||+|+||+||+|++..+++.||||++......+.+.+|+++++.|++.+
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~------------------- 61 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT------------------- 61 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCT-------------------
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCC-------------------
Confidence 4789999999999999999999999999999999999887777778899999999998765
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+++.+..++......|+||||++++|.+++...+..++..++..++.|++.||+|||++||+||||||+|||+
T Consensus 62 -------~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili 134 (293)
T d1csna_ 62 -------GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 134 (293)
T ss_dssp -------TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred -------CCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence 6777788888899999999999999999998877889999999999999999999999999999999999999
Q ss_pred ecC--CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 163 GLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 163 ~~~--~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+.. ...+.+||+|||+|+.+.........+.+.....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 642 235789999999999988776666666666778899999999999999999999999999999999999999999
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCcccccccc
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 319 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 319 (449)
+.........+..+...+...+.+.+++++|+++.+++..||..+|++||+|+.|.+.|++++.+.+...++.|||.++
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp SCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred CccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 8777666667777777777788888999999999999999999999999999999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=390.67 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=206.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+++.||+|++.. ......+.+|+++++.++|+++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~------------ 73 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG------------ 73 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE------------
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEE------------
Confidence 689999999999999999999999999999998753 233456789999999999987665543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.+.+..||||||| +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 74 ---------------~~~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Ni 137 (263)
T d2j4za1 74 ---------------YFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137 (263)
T ss_dssp ---------------EEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ---------------EEEECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccc
Confidence 445678899999999 8899998875 45799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+|+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 138 ll---~~~~~~kl~DFG~a~~~~~~~---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 205 (263)
T d2j4za1 138 LL---GSAGELKIADFGWSVHAPSSR---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205 (263)
T ss_dssp EE---CTTSCEEECCCCSCSCCCCCC---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ee---cCCCCEeecccceeeecCCCc---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC
Confidence 99 477899999999997654432 235689999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.... +.+..+.......| ..+++++.+++..||..||.+||+++++.+
T Consensus 206 ~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 206 ANTYQ---ETYKRISRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CSSHH---HHHHHHHTTCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCHH---HHHHHHHcCCCCCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 75443 34445555444433 346899999999999999999999988754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=396.74 Aligned_cols=268 Identities=22% Similarity=0.324 Sum_probs=214.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..++|++++.||+|+||+||+|++..+++.||||++... .....+.+|+++++.++|++++.++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~----------- 74 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY----------- 74 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEE-----------
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEE-----------
Confidence 346899999999999999999999999999999997632 3345688999999999998766543
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.++.+.+..||||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+
T Consensus 75 ----------------~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~ 137 (288)
T d1uu3a_ 75 ----------------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 137 (288)
T ss_dssp ----------------EEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ----------------EEEEECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcc
Confidence 3446678899999999 8899998775 567999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
|||+ ++++.+||+|||+|+.+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus 138 NIll---~~~~~vkl~DFG~a~~~~~~~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (288)
T d1uu3a_ 138 NILL---NEDMHIQITDFGTAKVLSPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209 (288)
T ss_dssp GEEE---CTTSCEEECCCTTCEECC---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccc---CCCceEEecccccceecccCCccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCC
Confidence 9999 478899999999998765433211 12466899999999999999999999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHhcCCCCCccccccc
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI 318 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 318 (449)
|.+.+. .+.+..+.......| ..+++++++|+..||..||.+||+++++.+. .. +. ...|...+||..
T Consensus 210 f~~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~-~~-i~--~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 210 FRAGNE---YLIFQKIIKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GP-LK--AHPFFESVTWEN 277 (288)
T ss_dssp SCCSSH---HHHHHHHHTTCCCCC-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH-HH-HH--TSGGGTTCCCTT
T ss_pred CCCcCH---HHHHHHHHcCCCCCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC-HH-HH--cCCccCCCCHHH
Confidence 987543 344555555554444 3568899999999999999999999876442 11 11 234445567754
Q ss_pred cc
Q 013125 319 LK 320 (449)
Q Consensus 319 l~ 320 (449)
+.
T Consensus 278 l~ 279 (288)
T d1uu3a_ 278 LH 279 (288)
T ss_dssp GG
T ss_pred hh
Confidence 43
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=395.23 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=204.8
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.++|+++++||+|+||+||+|++..+++.||||++... ...+.+.+|+++++.++|++++.++.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~-------------- 84 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-------------- 84 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEE--------------
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeE--------------
Confidence 35899999999999999999999999999999987643 33446899999999999998666544
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+....+..||||||| |++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 85 -------------~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl 149 (293)
T d1yhwa1 85 -------------SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (293)
T ss_dssp -------------EEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred -------------EEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE
Confidence 345667899999999 8899987764 569999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+ .++.+||+|||+|+.+...... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 150 ~---~~~~vkl~DFG~a~~~~~~~~~-------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 150 G---MDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp C---TTCCEEECCCTTCEECCSTTCC-------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C---CCCcEeeccchhheeecccccc-------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 4 7789999999999876543321 24668999999999999999999999999999999999999999875
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
... ..+..+....... ......+++++++|+..||..||.+||++.++.
T Consensus 220 ~~~---~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 220 NPL---RALYLIATNGTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp CHH---HHHHHHHHHCSCC--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CHH---HHHHHHHhCCCCC--CCCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 543 2233333322111 122355689999999999999999999988763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=393.31 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=206.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
|-.++|+++++||+|+||+||+|+.. ..||||+++.... ...+.+|+++++.++|+|++.+++.+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-------- 73 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-------- 73 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE--------
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE--------
Confidence 55789999999999999999999753 3599999865422 23578899999999999877665432
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.....+|||||+ +++|.+++......+++..++.++.||+.||+|||++|||||||||+
T Consensus 74 --------------------~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~ 133 (276)
T d1uwha_ 74 --------------------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133 (276)
T ss_dssp --------------------CSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred --------------------eccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHH
Confidence 234679999999 79999998766677999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC---CCCccchHHHHHHHHHHHHhC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlG~il~el~~G 235 (449)
|||++ .++.+||+|||+|+........ .......||+.|+|||++.+. .|+.++|||||||++|||+||
T Consensus 134 NiLl~---~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg 205 (276)
T d1uwha_ 134 NIFLH---EDLTVKIGDFGLATVKSRWSGS-----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205 (276)
T ss_dssp GEEEE---TTSSEEECCCCCSCC-----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HEEEc---CCCCEEEccccceeeccccCCc-----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHC
Confidence 99994 7889999999999865433221 112467899999999998753 489999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
+.||.+..... .....+...............+|+++.+++..||..||++||++.+|.+.|+.+.+
T Consensus 206 ~~Pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 206 QLPYSNINNRD--QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp SCTTTTCCCHH--HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCChHH--HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99998765432 22222233333444455566789999999999999999999999999999887654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-52 Score=397.04 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=197.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
+.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|+++++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~------------ 74 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD------------ 74 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEE------------
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEE------------
Confidence 5688999999999999999999999999999999987542 2345778999999999987666543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.+.+..||||||| |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 ---------------~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni 138 (307)
T d1a06a_ 75 ---------------IYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138 (307)
T ss_dssp ---------------EEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ---------------EEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence 445678899999999 8999998875 56799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+...++++.+||+|||+|+....... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 139 l~~~~~~~~~vkl~DFG~a~~~~~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 139 LYYSLDEDSKIMISDFGLSKMEDPGSV--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp EESSSSTTCCEEECCC--------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecccCCCceEEEeccceeEEccCCCe--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 997555678999999999986544322 235689999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.... .....+.......+. .....+++++.+|+..||..||++||++.++.+
T Consensus 211 ~~~~~---~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 211 DENDA---KLFEQILKAEYEFDS-PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CSSHH---HHHHHHHTTCCCCCT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHH---HHHHHHhccCCCCCC-ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 75543 344455554444332 234567899999999999999999999887744
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=391.63 Aligned_cols=249 Identities=26% Similarity=0.317 Sum_probs=201.7
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
-++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|+++++++.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~------------- 70 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG------------- 70 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEE-------------
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEee-------------
Confidence 368999999999999999999999999999999986542 2345889999999999987666544
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
+..+.+..||||||+ |++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 71 --------------~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NIL 135 (271)
T d1nvra_ 71 --------------HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 135 (271)
T ss_dssp --------------EEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred --------------eeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEE
Confidence 445678899999999 8899998864 457999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
++ +++.+||+|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|||++|++||.
T Consensus 136 l~---~~~~~KL~DFG~a~~~~~~~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 136 LD---ERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp EC---TTCCEEECCCTTCEECEETTEE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred EC---CCCCEEEccchhheeeccCCcc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 94 7789999999999876543221 11346789999999999998876 678999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+...... .+..+...... ...+..+++++.+|+..||..||.+||+++++
T Consensus 208 ~~~~~~~--~~~~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 208 QPSDSCQ--EYSDWKEKKTY---LNPWKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp SSSTTSH--HHHHHHTTCTT---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCChHHH--HHHHHhcCCCC---CCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 7544322 22222222211 12235568899999999999999999998876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=390.60 Aligned_cols=248 Identities=17% Similarity=0.306 Sum_probs=204.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|+|+++++..
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-------------- 77 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-------------- 77 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEE--------------
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE--------------
Confidence 569999999999999999999999999999999875433 3468899999999999987766543
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+.+.+..||||||| +++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 -------------~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~ 144 (288)
T d2jfla1 78 -------------FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT 144 (288)
T ss_dssp -------------EEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred -------------EeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC
Confidence 35667899999999 8899998877677899999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLP 238 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il~el~~G~~p 238 (449)
.++.+||+|||+|+....... .....+||+.|+|||++. +..|+.++|||||||++|||++|+.|
T Consensus 145 ---~~~~~Kl~DFG~a~~~~~~~~-------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P 214 (288)
T d2jfla1 145 ---LDGDIKLADFGVSAKNTRTIQ-------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214 (288)
T ss_dssp ---TTSCEEECCCTTCEECHHHHH-------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred ---CCCCEEEEechhhhccCCCcc-------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence 788999999999976543211 123568999999999984 45689999999999999999999999
Q ss_pred CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 239 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 239 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
|.+..... .+..+..... +.......+++++.+|+..||+.||.+||++.++.
T Consensus 215 f~~~~~~~---~~~~i~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 215 HHELNPMR---VLLKIAKSEP--PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp TTTSCGGG---HHHHHHHSCC--CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCCHHH---HHHHHHcCCC--CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 98865543 3334443322 11122245689999999999999999999988763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=384.45 Aligned_cols=255 Identities=21% Similarity=0.247 Sum_probs=204.1
Q ss_pred CcccCCce-EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 2 ERIIGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 2 ~~i~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
|...++|| ++.++||+|+||+||+|++..+++.||+|++..... ...+.+|+++++.++|++++++++.....
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-- 80 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-- 80 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE--
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec--
Confidence 34456777 788899999999999999999999999998765422 23478999999999999988876543211
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccc
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHR 153 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~g--iiHr 153 (449)
.......||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++| |+||
T Consensus 81 ---------------------~~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHr 138 (270)
T d1t4ha_ 81 ---------------------VKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138 (270)
T ss_dssp ---------------------SSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred ---------------------cccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeC
Confidence 12346689999999 8899998876 467999999999999999999999998 9999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+. ++++.+||+|||+|+...... ....+||+.|+|||++.+ .++.++|||||||++|||+
T Consensus 139 DiKp~NILl~--~~~~~~Kl~DFGla~~~~~~~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 139 DLKCDNIFIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp CCCGGGEEES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH
T ss_pred CcChhhceee--CCCCCEEEeecCcceeccCCc---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHH
Confidence 9999999994 346799999999997543321 236689999999999876 5999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|+.||.+.... ...+..+... ..........++++.+++..||..||++||+++++.+
T Consensus 207 ~g~~Pf~~~~~~--~~~~~~i~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 207 TSEYPYSECQNA--AQIYRRVTSG---VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HSSCTTTTCSSH--HHHHHHHTTT---CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HCCCCCCCcccH--HHHHHHHHcC---CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 999999865432 2233333222 1222344566889999999999999999999888744
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=388.01 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=194.5
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|+++++++....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~---------- 73 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII---------- 73 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEE----------
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE----------
Confidence 6899999999999999999999999999999998765322 24788999999999998777655432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG-----FLHR 153 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---~~~~~~~~~~~i~~qil~~L~~LH~~g-----iiHr 153 (449)
....+..||||||| +++|.+++... ...+++..++.++.||+.||+|||++| ||||
T Consensus 74 ---------------~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHr 138 (269)
T d2java1 74 ---------------DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138 (269)
T ss_dssp ---------------C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC--------
T ss_pred ---------------eCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeC
Confidence 12345689999999 89999988643 467999999999999999999999976 9999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+ +.++.+||+|||+|+........ .....||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 139 DiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~ 208 (269)
T d2java1 139 DLKPANVFL---DGKQNVKLGDFGLARILNHDTSF-------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208 (269)
T ss_dssp -CCGGGEEE---CTTSCEEECCHHHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cCchhhcCc---CCCCcEEEeeccceeecccCCCc-------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh
Confidence 999999999 47889999999999876543221 24678999999999999999999999999999999999
Q ss_pred hCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 234 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 234 ~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+|+.||.+.... +.+..+....... ....+++++.+|+..||..||.+||++.+|.+
T Consensus 209 tg~~Pf~~~~~~---~~~~~i~~~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 209 ALMPPFTAFSQK---ELAGKIREGKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HSSCSCCCSSHH---HHHHHHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCHH---HHHHHHHcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999876543 3444444443322 22456889999999999999999999887743
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-51 Score=390.29 Aligned_cols=259 Identities=19% Similarity=0.287 Sum_probs=211.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
|-.++|+++++||+|+||+||+|++..+++.||||+++.+.. .+++.+|+++++.++|+|++++++.
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~------------ 81 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV------------ 81 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEE------------
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCcc------------
Confidence 456789999999999999999999999999999999876543 4568999999999999987766543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.+.+..+|||||+ +|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 82 ---------------~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NI 146 (287)
T d1opja_ 82 ---------------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146 (287)
T ss_dssp ---------------ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ---------------EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeE
Confidence 35667889999999 88999988754 45689999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 147 Ll---~~~~~~Kl~DFG~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 147 LV---GENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp EE---CGGGCEEECCCCCTTTCCSSSSE------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred EE---CCCCcEEEccccceeecCCCCce------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 99 47789999999999866543321 1234568899999999999999999999999999999999666654
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
..... ..+..++......+. ...+|+++.+|+..||..||.+||++.+|.+.|+.+++
T Consensus 218 ~~~~~---~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 218 PGIDL---SQVYELLEKDYRMER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCH---HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CcchH---HHHHHHHhcCCCCCC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 32221 222233333333332 24568999999999999999999999999888876644
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-51 Score=397.08 Aligned_cols=254 Identities=18% Similarity=0.263 Sum_probs=212.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
.++ ++|++++.||+|+||+||+|++..+|+.||||++..... .+.+.+|+++++.|+|++++.++.
T Consensus 23 ~il-~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~----------- 90 (350)
T d1koaa2 23 HVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD----------- 90 (350)
T ss_dssp CGG-GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEE-----------
T ss_pred CCc-cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEE-----------
Confidence 344 689999999999999999999999999999999875432 335789999999999998666544
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
++.+.+..||||||| |++|.+++......+++..++.++.||+.||+|||++|||||||||+|
T Consensus 91 ----------------~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~N 154 (350)
T d1koaa2 91 ----------------AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154 (350)
T ss_dssp ----------------EEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ----------------EEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhH
Confidence 345678899999999 899999886556679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+.. +.++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 155 Ill~~-~~~~~vkL~DFG~a~~~~~~~~--------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf 225 (350)
T d1koaa2 155 IMFTT-KRSNELKLIDFGLTAHLDPKQS--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 225 (350)
T ss_dssp EEESS-TTSCCEEECCCTTCEECCTTSC--------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeecc-CCCCeEEEeecchheecccccc--------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCC
Confidence 99952 2357899999999987654432 23568999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+.... +.+..+.......+ ...+..+++++++|+..||..||.+||++.++.+
T Consensus 226 ~~~~~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 226 GGENDD---ETLRNVKSCDWNMD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCSSHH---HHHHHHHHTCCCSC-CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCHH---HHHHHHHhCCCCCC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 876443 44555555544433 3344567899999999999999999999887644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=380.81 Aligned_cols=255 Identities=19% Similarity=0.295 Sum_probs=200.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.++|+++++||+|+||+||+|++. +++.||||+++... ..+++.+|+++++.++|+|++++++.+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~------------- 69 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC------------- 69 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-------------
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCccccccee-------------
Confidence 479999999999999999999985 56789999987653 345689999999999999877766543
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
...+..++||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 70 --------------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill- 134 (263)
T d1sm2a_ 70 --------------LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV- 134 (263)
T ss_dssp --------------CSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE-
T ss_pred --------------ccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee-
Confidence 4567789999999 899999887666779999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
++++.+||+|||+|+........ ......||..|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 135 --~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 135 --GENQVIKVSDFGMTRFVLDDQYT------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp --CGGGCEEECSCC------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred --cCCCCeEecccchheeccCCCce------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 47889999999999876544321 1234578999999999999999999999999999999999 56666654
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
... +.+..+.. ....+.+ ..+++++.+++..||+.||++||++++|.+.|+++.+
T Consensus 207 ~~~---~~~~~i~~-~~~~~~p---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 207 SNS---EVVEDIST-GFRLYKP---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHH---HHHHHHHH-TCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH---HHHHHHHh-cCCCCCc---cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 332 33333333 2222222 3458899999999999999999999999999988754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=399.23 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=201.1
Q ss_pred cccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 3 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
++..++|+++++||+|+||+||+|++..+++.||+|+++.... ...+.+|+++++.++|+++++++.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~---------- 71 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG---------- 71 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEE----------
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEE----------
Confidence 4678999999999999999999999999999999999875432 235788999999999987666554
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKP 157 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-giiHrDLkp 157 (449)
++.+.+..||||||+ |++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||
T Consensus 72 -----------------~~~~~~~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP 133 (322)
T d1s9ja_ 72 -----------------AFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 133 (322)
T ss_dssp -----------------EEECSSEEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSG
T ss_pred -----------------EEEECCEEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCH
Confidence 345667899999999 7899999876 45699999999999999999999985 999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+ ++++.+||+|||+|+...... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.
T Consensus 134 ~NILl---~~~~~vkl~DFGla~~~~~~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~ 201 (322)
T d1s9ja_ 134 SNILV---NSRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201 (322)
T ss_dssp GGEEE---CTTCCEEECCCCCCHHHHHHT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred HHeeE---CCCCCEEEeeCCCccccCCCc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999 478899999999998654322 246789999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHh-----------------------------------hc-CCCHHHhhccChHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEK-----------------------------------KV-STPIEVLCKSHPAEFASYFHYC 281 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~-----------------------------------~~-~~~~~~~~~~~~~~~~~l~~~~ 281 (449)
||.+................ .. ..+........+.++.+++..|
T Consensus 202 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 281 (322)
T d1s9ja_ 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281 (322)
T ss_dssp CSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHH
Confidence 99875432111100000000 00 0000000012357899999999
Q ss_pred hCCCCCCCCCHHHHHH
Q 013125 282 QSLTFDQRPDYGFLKR 297 (449)
Q Consensus 282 l~~~p~~Rp~~~~l~~ 297 (449)
|..||.+||+++++.+
T Consensus 282 L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 282 LIKNPAERADLKQLMV 297 (322)
T ss_dssp TCSSTTTSCCHHHHHT
T ss_pred cCCChhHCcCHHHHhh
Confidence 9999999999998866
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-51 Score=387.71 Aligned_cols=263 Identities=19% Similarity=0.290 Sum_probs=201.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCc---eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
+..++|++.+.||+|+||+||+|++..+++ .||||.+...... ..+.+|+++++.++|+|++++++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~------- 95 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV------- 95 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-------
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEE-------
Confidence 445789999999999999999999976654 5889987654332 358899999999999987766554
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
+...+..|+||||+ +++|.+++......+++.+++.++.||+.||+|||++||+|||||
T Consensus 96 --------------------~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlK 155 (299)
T d1jpaa_ 96 --------------------VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA 155 (299)
T ss_dssp --------------------ECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred --------------------EeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccc
Confidence 35567889999999 889999887666779999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+|||+ +.++.+||+|||+|+.......... +.......||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 156 p~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g 230 (299)
T d1jpaa_ 156 ARNILV---NSNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230 (299)
T ss_dssp GGGEEE---CTTCCEEECCC-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cceEEE---CCCCcEEECCcccceEccCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCC
Confidence 999999 4788999999999987654332111 111224567999999999999999999999999999999998 8
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
+.||.+.... +.+..+.. ....+. ...+|+++.+++..||..||.+||++.+|.+.|+++++.
T Consensus 231 ~~Pf~~~~~~---~~~~~i~~-~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 231 ERPYWDMTNQ---DVINAIEQ-DYRLPP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCTTTTCCHH---HHHHHHHT-TCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCHH---HHHHHHHc-CCCCCC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 9999886553 23333332 222222 235689999999999999999999999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=380.78 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=208.5
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
|-.++|+++++||+|+||+||+|++. +++.||||+++... ..+.+.+|+++++.++|+|++++++.+
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~----------- 77 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV----------- 77 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----------
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeee-----------
Confidence 55689999999999999999999975 57789999987653 345689999999999999888776532
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+..++||||+ +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 78 -----------------~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NI 140 (272)
T d1qpca_ 78 -----------------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140 (272)
T ss_dssp -----------------CSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred -----------------ccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhe
Confidence 234578999999 89998876532 34699999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G-~~pf 239 (449)
|+ ++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||
T Consensus 141 ll---~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 141 LV---SDTLSCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp EE---CTTSCEEECCCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ee---ecccceeeccccceEEccCCcc------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 99 4789999999999987654322 123456789999999999988999999999999999999995 4555
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
...... +.+..+.. ....+.+ ..+|+++.+++..||+.||++||++++|.+.|++++..
T Consensus 212 ~~~~~~---~~~~~i~~-~~~~~~p---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 212 PGMTNP---EVIQNLER-GYRMVRP---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHH---HHHHHHHT-TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHHh-cCCCCCc---ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 543332 23333322 2222222 45689999999999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=381.97 Aligned_cols=253 Identities=20% Similarity=0.250 Sum_probs=210.4
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
+.++|+++++||+|+||+||+|++..+|+.||||+++... ..+.+.+|+++++.|+|+++++++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~------- 80 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE------- 80 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE-------
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE-------
Confidence 5789999999999999999999999999999999986431 1235789999999999998666544
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
+..+.+..||||||| |++|.+++.. ...+++..++.++.||+.||+|||++||+||||
T Consensus 81 --------------------~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDi 139 (293)
T d1jksa_ 81 --------------------VYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDL 139 (293)
T ss_dssp --------------------EEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred --------------------EEEECCEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeeccc
Confidence 345678899999999 8999999876 457999999999999999999999999999999
Q ss_pred CCCcEEeecCC-CCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 013125 156 KPDNFLMGLGR-KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 156 kp~Nill~~~~-~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~ 234 (449)
||+|||+...+ ....+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 140 Kp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 211 (293)
T d1jksa_ 140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211 (293)
T ss_dssp SGGGEEESCSSSSSCCEEECCCTTCEECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCCcccceEecchhhhhhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc
Confidence 99999995321 233699999999987654332 235688999999999999999999999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|+.||.+.... +.+..+.......+ .......++++.+|+..||..||.+||+++++.+
T Consensus 212 g~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 212 GASPFLGDTKQ---ETLANVSAVNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SSCSSCCSSHH---HHHHHHHTTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHH---HHHHHHHhcCCCCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999876543 34444545444433 4445677899999999999999999999887744
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=382.20 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=209.3
Q ss_pred CCceEEee-eecccCceeEEEEEEcC--CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGR-KIGSGSFGEIFLASHVD--TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~-~LG~G~fg~Vy~a~~~~--~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
.++|.+.+ +||+|+||+||+|.+.. ++..||||+++.... ...+.+|+++++.++|++++++++.+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-------- 78 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-------- 78 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--------
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeee--------
Confidence 36788988 59999999999998753 455799999876543 23588999999999999887766542
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
..+..||||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+
T Consensus 79 --------------------~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~ 138 (285)
T d1u59a_ 79 --------------------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR 138 (285)
T ss_dssp --------------------ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred --------------------ccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchh
Confidence 234579999999 88999988765678999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~ 237 (449)
|||++ .++.+||+|||+|+......... .......||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 139 Nill~---~~~~~Kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 139 NVLLV---NRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp GEEEE---ETTEEEECCCTTCEECTTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred heeec---cCCceeeccchhhhccccccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence 99995 78899999999998775543211 12245678999999999999999999999999999999998 999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
||.+.... +.+..+.... ..+. ...+|+++.+|+..||..||++||++.+|.+.|+..+..
T Consensus 212 Pf~~~~~~---~~~~~i~~~~-~~~~---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 212 PYKKMKGP---EVMAFIEQGK-RMEC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTTTCCTH---HHHHHHHTTC-CCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHH---HHHHHHHcCC-CCCC---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99986543 2333333222 2221 245689999999999999999999999999999877543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-50 Score=386.89 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=199.5
Q ss_pred ceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 8 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|++++++++.
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~------------ 83 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC------------ 83 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEE------------
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEE------------
Confidence 599999999999999999999999999999998765332 247889999999999987766543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..+.+..|||||||.+++.+.+......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 84 ---------------~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl 148 (309)
T d1u5ra_ 84 ---------------YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148 (309)
T ss_dssp ---------------EEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred ---------------EEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence 34567899999999444444444456789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
+ .++.+||+|||+|+.... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||
T Consensus 149 ~---~~~~~Kl~DFG~a~~~~~-----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 149 S---EPGLVKLGDFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp E---TTTEEEECCCTTCBSSSS-----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred C---CCCCEEEeecccccccCC-----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 5 789999999999975432 235689999999999875 35899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.+.... +.+..+.......+. ...+++++.+|+..||..||.+||++.++.+
T Consensus 215 ~~~~~~---~~~~~i~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 215 FNMNAM---SALYHIAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTSCHH---HHHHHHHHSCCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHH---HHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 875543 344444444333322 2356889999999999999999999988754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=386.11 Aligned_cols=240 Identities=22% Similarity=0.308 Sum_probs=204.6
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
=++|++++.||+|+||.||+|++..+++.||||++++. .....+.+|+++++.++|++++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l------------- 70 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL------------- 70 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCE-------------
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEE-------------
Confidence 36899999999999999999999999999999998642 334568899999999998875554
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+....+.+..|+||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 71 --------------~~~~~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~N 135 (337)
T d1o6la_ 71 --------------KYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135 (337)
T ss_dssp --------------EEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred --------------EeeeccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHH
Confidence 44456778999999999 8999988876 5679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ +.++.+||+|||+|+........ ....+||+.|+|||++.+..|+.++|||||||++|||++|++||
T Consensus 136 ILl---~~~g~vkl~DFG~a~~~~~~~~~-------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf 205 (337)
T d1o6la_ 136 LML---DKDGHIKITDFGLCKEGISDGAT-------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205 (337)
T ss_dssp EEE---CTTSCEEECCCTTCBCSCCTTCC-------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred eEe---cCCCCEEEeecccccccccCCcc-------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCC
Confidence 999 47899999999999865543321 24678999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
.+.+.. +.+..+.......| ..+++++.+|+..||..||.+|++
T Consensus 206 ~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 206 YNQDHE---RLFELILMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp CCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCcCHH---HHHHHHhcCCCCCC-----ccCCHHHHHHHHhhccCCchhhcc
Confidence 986543 44455555555444 456889999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.3e-51 Score=395.57 Aligned_cols=251 Identities=23% Similarity=0.228 Sum_probs=209.4
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.|+|++++.++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~---------------- 92 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH---------------- 92 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEE----------------
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEE----------------
Confidence 689999999999999999999999999999999876432 23477899999999988766554
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
.++.+.+..||||||| |++|.+.+......+++.+++.++.||+.||+|||++||+||||||+|||+.
T Consensus 93 -----------~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~ 161 (352)
T d1koba_ 93 -----------DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 161 (352)
T ss_dssp -----------EEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred -----------EEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccc
Confidence 3445678899999999 8999888776566799999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
. ...+.+||+|||+|+.+..... .....||+.|+|||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 162 ~-~~~~~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 162 T-KKASSVKIIDFGLATKLNPDEI--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp S-TTCCCEEECCCTTCEECCTTSC--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred c-cCCCeEEEeecccceecCCCCc--------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2467999999999988765432 235678999999999999999999999999999999999999998765
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.. +.+..+.......+ ...+.++++++.+|+..||..||.+||++.++.+
T Consensus 233 ~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 233 DL---ETLQNVKRCDWEFD-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HH---HHHHHHHHCCCCCC-SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HH---HHHHHHHhCCCCCC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 43 34444544443333 3344567899999999999999999999887743
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.9e-50 Score=378.24 Aligned_cols=264 Identities=21% Similarity=0.312 Sum_probs=206.0
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIH 78 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (449)
.+.+||++++.||+|+||+||+|++..+++.||||+++.... ...+.+|+++++.++|+++++.+......
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~---- 79 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE---- 79 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE----
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec----
Confidence 467899999999999999999999999999999999875432 12478899999999999988776543211
Q ss_pred hhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 013125 79 ALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 157 (449)
Q Consensus 79 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp 157 (449)
.......||||||+ |++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 80 -------------------~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP 139 (277)
T d1o6ya_ 80 -------------------TPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139 (277)
T ss_dssp -------------------CSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -------------------cCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccC
Confidence 12234579999999 7889887765 56799999999999999999999999999999999
Q ss_pred CcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCC
Q 013125 158 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 237 (449)
Q Consensus 158 ~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~ 237 (449)
+|||+. ..+.++|+|||.+.......... ......+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 140 ~NIll~---~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 140 ANIMIS---ATNAVKVMDFGIARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp GGEEEE---TTSCEEECCCTTCEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccC---ccccceeehhhhhhhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence 999995 78899999999987654433221 12346789999999999999999999999999999999999999
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDL 302 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-~~~~l~~~l~~~ 302 (449)
||.+.... +.+..+.... ..+.......+|+++.+++..||..||.+|| +++++.+.|..+
T Consensus 213 Pf~~~~~~---~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 213 PFTGDSPV---SVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SCCCSSHH---HHHHHHHHCC-CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCcCHH---HHHHHHHhcC-CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 99876543 3333333332 3334455567899999999999999999999 788887766543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=378.52 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=198.9
Q ss_pred eeecccCceeEEEEEEc--CCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcc
Q 013125 13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSS 86 (449)
Q Consensus 13 ~~LG~G~fg~Vy~a~~~--~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (449)
++||+|+||+||+|.+. .+++.||||+++.... .+.+.+|+++++.++|+|++++++.+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~--------------- 77 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--------------- 77 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE---------------
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEe---------------
Confidence 46999999999999864 4567899999865432 23588999999999999887765532
Q ss_pred cCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeecC
Q 013125 87 TLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 165 (449)
Q Consensus 87 ~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~ 165 (449)
..+..||||||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 -------------~~~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~-- 141 (277)
T d1xbba_ 78 -------------EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-- 141 (277)
T ss_dssp -------------ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred -------------ccCCEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc--
Confidence 234578999999 8899998875 56799999999999999999999999999999999999995
Q ss_pred CCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCChh
Q 013125 166 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 244 (449)
Q Consensus 166 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~ 244 (449)
.++.+||+|||+|+......... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 142 -~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 142 -TQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp -ETTEEEECCCTTCEECCTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred -ccCcccccchhhhhhcccccccc----ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 78999999999998765443221 12235678999999999999999999999999999999997 9999998654
Q ss_pred hcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 245 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
.. ....+.. ....+. ...+|+++.+|+..||..||++||++.+|.+.|++.+.
T Consensus 217 ~~---~~~~i~~-~~~~~~---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 217 SE---VTAMLEK-GERMGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HH---HHHHHHT-TCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HH---HHHHHHc-CCCCCC---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 32 2223322 222222 24568999999999999999999999999988887754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=386.18 Aligned_cols=255 Identities=19% Similarity=0.285 Sum_probs=205.8
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCc-----eEEEEEecCC---CCchhHHHHHHHHHHH-cCCCcceeeEeecchh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSG---TKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHV 75 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAvKv~~~~---~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~ 75 (449)
-.++|+++++||+|+||+||+|++..+++ .||+|++... .....+.+|+.++..+ +|++++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~------ 108 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG------ 108 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE------
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE------
Confidence 34789999999999999999999876544 6999987643 2244588999999998 7887666554
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc----------------------CCCCHHHHH
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------------------RKFSLKTVL 132 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~----------------------~~~~~~~~~ 132 (449)
+....+..|+||||| +|+|.+++.... ..+++..++
T Consensus 109 ---------------------~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 167 (325)
T d1rjba_ 109 ---------------------ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 167 (325)
T ss_dssp ---------------------EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHH
T ss_pred ---------------------EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHH
Confidence 345667889999999 999999986532 248899999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc
Q 013125 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 212 (449)
Q Consensus 133 ~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (449)
.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+......... ......||+.|+|||++.
T Consensus 168 ~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 168 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLF 239 (325)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHhCCeeeccCchhccccc---cCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHc
Confidence 9999999999999999999999999999994 78999999999998765443221 123556899999999999
Q ss_pred CCCCCccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 213 GIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 213 ~~~~s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
+..++.++|||||||++|||++ |.+||.+.... ..+.+++......+.+ ..+|+++.+|+..||+.||++||+
T Consensus 240 ~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~---~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt 313 (325)
T d1rjba_ 240 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD---ANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPS 313 (325)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999997 89999876543 2334444544443332 345899999999999999999999
Q ss_pred HHHHHHHHH
Q 013125 292 YGFLKRLFH 300 (449)
Q Consensus 292 ~~~l~~~l~ 300 (449)
+++|.+.|.
T Consensus 314 ~~ei~~~L~ 322 (325)
T d1rjba_ 314 FPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999988775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-49 Score=380.86 Aligned_cols=241 Identities=23% Similarity=0.343 Sum_probs=203.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+++.||||+++.. .....+.+|+.+++.++|+++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~------------ 71 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG------------ 71 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEE------------
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheee------------
Confidence 5799999999999999999999999999999998632 33456889999999999887665543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
++.+.+..|+||||+ |++|..++.. ...++...++.++.||+.||+|||++||+||||||+||
T Consensus 72 ---------------~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 135 (316)
T d1fota_ 72 ---------------TFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135 (316)
T ss_dssp ---------------EEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred ---------------eEeeCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence 446678899999999 7888877765 66789999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+|+...... ...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 136 Ll---~~~g~vkL~DFG~a~~~~~~~----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~ 202 (316)
T d1fota_ 136 LL---DKNGHIKITDFGFAKYVPDVT----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202 (316)
T ss_dssp EE---CTTSCEEECCCSSCEECSSCB----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred eE---cCCCCEEEecCccceEecccc----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence 99 478899999999998765432 36789999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 296 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~ 296 (449)
+.... +.+..+.......| ..+++++.+++..||..||.+|+ ++++|+
T Consensus 203 ~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il 255 (316)
T d1fota_ 203 DSNTM---KTYEKILNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255 (316)
T ss_dssp CSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CcCHH---HHHHHHHcCCCCCC-----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHH
Confidence 75443 44555555554444 34588999999999999999996 566553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-49 Score=386.33 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=204.7
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|+++++||+|+||+||+|++..+|+.||||++... .....+.+|+++++.++|++++.++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~------------ 108 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF------------ 108 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEE------------
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccc------------
Confidence 6899999999999999999999999999999987532 23445789999999999887665543
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
+.......++|||++ |++|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+||
T Consensus 109 ---------------~~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NI 172 (350)
T d1rdqe_ 109 ---------------SFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp ---------------EEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ---------------ccccccccccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHc
Confidence 345677889999999 8899888875 45799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
|+ +.++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 173 Ll---~~~g~ikL~DFG~a~~~~~~~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 173 LI---DQQGYIQVTDFGFAKRVKGRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp EE---CTTSCEEECCCTTCEECSSCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cc---CCCCCEEeeeceeeeeccccc----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence 99 478899999999998765432 35689999999999999999999999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-----~~~~l~~ 297 (449)
+... ...+..+.......| ..+++++.+++..||..||.+|+ ++++|.+
T Consensus 240 ~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 240 ADQP---IQIYEKIVSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CSSH---HHHHHHHHHCCCCCC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CcCH---HHHHHHHhcCCCCCC-----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 7543 345555555554444 35688999999999999999995 6666643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=384.18 Aligned_cols=252 Identities=17% Similarity=0.236 Sum_probs=212.2
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
-+||++++.||+|+||+||+|.+..+++.||||+++.... ...+.+|+++|+.++|+++++++.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~--------------- 68 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE--------------- 68 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEE---------------
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEE---------------
Confidence 4899999999999999999999999999999999876543 234779999999999987666543
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
++.+.+..||||||| |++|.+++...+..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 69 ------------~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~ 136 (321)
T d1tkia_ 69 ------------SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp ------------EEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred ------------EEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeec
Confidence 345678899999999 8899999876566799999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
. ++...+||+|||+++....... .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+..
T Consensus 137 ~-~~~~~ikl~DFG~~~~~~~~~~--------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 137 T-RRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp S-SSCCCEEECCCTTCEECCTTCE--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C-CCceEEEEcccchhhccccCCc--------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 2 2456899999999987654322 134578999999999999999999999999999999999999998765
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.. ..+..+.......+ ...+..+++++.+|+..||..||.+||+++++.+
T Consensus 208 ~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 208 NQ---QIIENIMNAEYTFD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HH---HHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HH---HHHHHHHhCCCCCC-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 43 44555655555544 4445677899999999999999999999988754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-49 Score=388.28 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=195.3
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++|++++.||+|+||+||+|++..+|+.||||++... .....+.+|..+++.+++.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~------------------ 65 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD------------------ 65 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC------------------
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC------------------
Confidence 5799999999999999999999999999999997532 22333556666565554221
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
|++|..++.++...+..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus 66 ------hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NI 138 (364)
T d1omwa3 66 ------CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138 (364)
T ss_dssp ------CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ------CCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeecccee
Confidence 224555555667778899999999 8999998876 56789999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +..+.+||+|||+|+.+..... ...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||
T Consensus 139 Ll---~~~g~iKl~DFGla~~~~~~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf 206 (364)
T d1omwa3 139 LL---DEHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206 (364)
T ss_dssp EE---CSSSCEEECCCTTCEECSSSCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EE---cCCCcEEEeeeceeeecCCCcc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCC
Confidence 99 4788999999999987654332 35689999999999974 56899999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.+............+.... ......+++++.+||..||..||.+||+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 207 RQHKTKDKHEIDRMTLTMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp CSSCSSCHHHHHHHSSSCC-----CCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred CCCCHHHHHHHHHhcccCC-----CCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 8765544333322221111 12234678999999999999999999983
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=386.99 Aligned_cols=257 Identities=19% Similarity=0.183 Sum_probs=203.0
Q ss_pred CCceEEee-eecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhhhhhh
Q 013125 6 GVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 6 ~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
-++|.+++ .||+|+||+||+|++..+++.||||+++. ...+.+|++++.++ +|+++++++....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~----------- 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYE----------- 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEE-----------
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEe-----------
Confidence 36799875 59999999999999999999999999863 45688999987655 7888776654321
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.......+.||||||| ||+|.+++... ...|++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 76 ------------~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIl 143 (335)
T d2ozaa1 76 ------------NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 143 (335)
T ss_dssp ------------EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ------------ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccc
Confidence 1112356789999999 88999998754 356999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+...+..+.+||+|||+|+....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+
T Consensus 144 l~~~~~~~~~Kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 144 YTSKRPNAILKLTDFGFAKETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp ESCSSTTCCEEECCCTTCEECCCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred cccccccccccccccceeeeccCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 96544567899999999987665432 2366899999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHH-HHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKY-DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+ ..+.......|. ..+..+++++.+|+..||..||++||++.++.+
T Consensus 216 ~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 216 NHGLAISPGMKTRIRMGQYEFPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TTCC--------CCCSCSSSCCT-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHHHhcCCCCCCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 5543322222 112222222222 223456889999999999999999999988754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=373.27 Aligned_cols=263 Identities=17% Similarity=0.242 Sum_probs=202.6
Q ss_pred CcccCCceEEeeeecccCceeEEEEEEcCCC----ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecch
Q 013125 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDH 74 (449)
Q Consensus 2 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 74 (449)
.+|-.+.|++.+.||+|+||+||+|.+..++ ..||||++...... ..+.+|+++++.++|+|++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~---- 77 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV---- 77 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE----
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEE----
Confidence 3566788999999999999999999986554 46999998754332 247899999999999987766554
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 153 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHr 153 (449)
....+..++||||+ ++++.+++......+++..++.++.||+.||+|||+++|+||
T Consensus 78 -----------------------~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHr 134 (283)
T d1mqba_ 78 -----------------------ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR 134 (283)
T ss_dssp -----------------------ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -----------------------EecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccC
Confidence 34567789999999 888888887767789999999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 233 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~ 233 (449)
||||+|||+ +.++.+||+|||+|+.......... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 135 DlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~ 207 (283)
T d1mqba_ 135 DLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 207 (283)
T ss_dssp CCCGGGEEE---CTTCCEEECCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccceEEE---CCCCeEEEcccchhhcccCCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHH
Confidence 999999999 4789999999999987654332111 123456899999999999999999999999999999999
Q ss_pred hCCCC-CCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 234 RGSLP-WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 234 ~G~~p-f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
+|..| |.+... .+.+..+ ......+.+ ..+|.++.+++..||..||++||++.+|.+.|+.+++.
T Consensus 208 t~~~~~~~~~~~---~~~~~~i-~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 208 TYGERPYWELSN---HEVMKAI-NDGFRLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTSCCTTTTCCH---HHHHHHH-HTTCCCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hCCCCccccCCH---HHHHHHH-hccCCCCCc---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 96555 444332 2233333 333333322 35689999999999999999999999999999887664
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=371.71 Aligned_cols=251 Identities=18% Similarity=0.303 Sum_probs=209.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.++|+++++||+|+||+||+|++ ++++.||||+++... ..+.+.+|+++++.++|++++++++.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~-------------- 67 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV-------------- 67 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEE--------------
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEE--------------
Confidence 47899999999999999999998 477889999988654 35568999999999999987766554
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
..+.+..++||||+ +|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 -------------~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill- 133 (258)
T d1k2pa_ 68 -------------CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV- 133 (258)
T ss_dssp -------------ECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE-
T ss_pred -------------EeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE-
Confidence 34567899999999 788988877667789999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~~~ 242 (449)
+.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 134 --~~~~~~kl~DfG~a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 134 --NDQGVVKVSDFGLSRYVLDDEYT------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp --CTTCCEEECCCSSCCBCSSSSCC------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred --cCCCcEEECcchhheeccCCCce------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 47889999999999865543321 1235678999999999999999999999999999999998 89999987
Q ss_pred hhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013125 243 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 300 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~ 300 (449)
.... ....+... ...+.+ ...++++.+++..||+.||++||++++|.+.|.
T Consensus 206 ~~~~---~~~~i~~~-~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 206 TNSE---TAEHIAQG-LRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp CHHH---HHHHHHTT-CCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH---HHHHHHhC-CCCCCc---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 6543 33334332 222222 455889999999999999999999999888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=372.43 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=200.4
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCC---ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
|-.++|++++.||+|+||+||+|++..++ ..||||+++..... ..+.+|+++++.++|+|++.+++.+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~------ 77 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI------ 77 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE------
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE------
Confidence 45689999999999999999999986543 46889987654332 3478999999999999877765432
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
..+..|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+|||||
T Consensus 78 ----------------------~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlK 135 (273)
T d1mp8a_ 78 ----------------------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135 (273)
T ss_dssp ----------------------CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ----------------------ecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccc
Confidence 235689999999 889998887767789999999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-C
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 235 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G 235 (449)
|+||+++ ..+.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 136 p~NIll~---~~~~~Kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g 206 (273)
T d1mp8a_ 136 ARNVLVS---SNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206 (273)
T ss_dssp GGGEEEE---ETTEEEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTS
T ss_pred hhheeec---CCCcEEEccchhheeccCCcce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcC
Confidence 9999995 7889999999999876543221 1235578999999999999999999999999999999998 8
Q ss_pred CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 236 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.+||.+..... .+..+.... ..+ ...++|+++.+|+..||..||.+||++.+|.+.|+.++..
T Consensus 207 ~~P~~~~~~~~---~~~~i~~~~-~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 207 VKPFQGVKNND---VIGRIENGE-RLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCTTTTCCGGG---HHHHHHTTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHH---HHHHHHcCC-CCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99998876543 333333322 122 2356789999999999999999999999999999887654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-48 Score=367.09 Aligned_cols=250 Identities=19% Similarity=0.165 Sum_probs=207.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc-----------hhHHHHHHHHHHHc-CCCcceeeEeec
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQ-GGSKIRLVVFHV 72 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~-----------~~~~~E~~~l~~l~-~~~~~~~~~~~~ 72 (449)
+.++|++++.||+|+||+||+|++..+++.||||++...... +.+.+|+.+++.++ |++++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~----- 75 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL----- 75 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE-----
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE-----
Confidence 458999999999999999999999999999999998754321 24778999999997 7765544
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 151 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~gii 151 (449)
+.++.+.+..||||||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+
T Consensus 76 ----------------------~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iv 132 (277)
T d1phka_ 76 ----------------------KDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIV 132 (277)
T ss_dssp ----------------------EEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ----------------------EeecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence 44456778999999999 8899999976 55799999999999999999999999999
Q ss_pred ccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC------CCCCccchHHHH
Q 013125 152 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESL 225 (449)
Q Consensus 152 HrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwSl 225 (449)
||||||+|||+ +.++.+||+|||+|+....... .....||..|+|||.+.+ ..++.++||||+
T Consensus 133 HrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diwsl 201 (277)
T d1phka_ 133 HRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 201 (277)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred ccccccceEEE---cCCCCeEEccchheeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEccc
Confidence 99999999999 4789999999999987654322 235689999999998863 346889999999
Q ss_pred HHHHHHHHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 226 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 226 G~il~el~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
||++|||++|+.||.+.... .....+.......+.+ ...++++++++|+..||..||++||+++++.+
T Consensus 202 Gvilyeml~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 202 GVIMYTLLAGSPPFWHRKQM---LMLRMIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chhhhhhccCCCCCCCCCHH---HHHHHHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99999999999999986543 3444455554443322 33567899999999999999999999887643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=372.45 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=197.2
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCC-CcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGG-SKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~-~~~~~~~~~~~~ 74 (449)
|-.++|+++++||+|+||+||+|++.. +++.||||+++.... ...+.+|..++..+.|+ +++....
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~----- 84 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG----- 84 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE-----
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee-----
Confidence 445789999999999999999999754 346899999875433 22467788888777544 4333322
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQM 138 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~qi 138 (449)
.+.......++||||| +++|.+++.... ..+++.+++.++.||
T Consensus 85 ---------------------~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 143 (299)
T d1ywna1 85 ---------------------ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143 (299)
T ss_dssp ---------------------EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHH
T ss_pred ---------------------eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHH
Confidence 2223456789999999 899999987532 348899999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCc
Q 013125 139 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR 218 (449)
Q Consensus 139 l~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ 218 (449)
+.||+|||++|||||||||+|||+ ++++.+||+|||+|+......... ......||+.|+|||++.+..++.
T Consensus 144 ~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~ 215 (299)
T d1ywna1 144 AKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTI 215 (299)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCc
Confidence 999999999999999999999999 478899999999998765443221 234668999999999999999999
Q ss_pred cchHHHHHHHHHHHHhC-CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 219 RDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 219 ~~DvwSlG~il~el~~G-~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++|||||||++|||++| .+||.+.... ..+..++......+. ...+++++.+++..||..||.+||++.+|.+
T Consensus 216 ~sDiwS~Gvil~ellt~~~~p~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~ 289 (299)
T d1ywna1 216 QSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCCS---HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccceeehHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999986 5688765433 223333333333222 2446889999999999999999999999999
Q ss_pred HHHHHHHh
Q 013125 298 LFHDLFSR 305 (449)
Q Consensus 298 ~l~~~~~~ 305 (449)
.|+++++.
T Consensus 290 ~L~~ilq~ 297 (299)
T d1ywna1 290 HLGNLLQA 297 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhC
Confidence 99988764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=376.24 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=200.9
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCc----eEEEEEecCCC---CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGT---KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvKv~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
..|+++++||+|+||+||+|.+..+++ +||+|.++... ....+.+|+++++.++|+|++++++.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-------- 80 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-------- 80 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEE--------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--------
Confidence 469999999999999999999987776 58888775432 234689999999999999888776543
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 158 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~ 158 (449)
.+ +..++++|++ +++|.+.+......+++..++.++.||+.||+|||++|||||||||+
T Consensus 81 -------------------~~-~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~ 140 (317)
T d1xkka_ 81 -------------------LT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 140 (317)
T ss_dssp -------------------ES-SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -------------------ec-CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhh
Confidence 23 3456666776 99999988877788999999999999999999999999999999999
Q ss_pred cEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 013125 159 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 237 (449)
Q Consensus 159 Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~ 237 (449)
|||++ .++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |.+
T Consensus 141 NIll~---~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~ 212 (317)
T d1xkka_ 141 NVLVK---TPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212 (317)
T ss_dssp GEEEE---ETTEEEECCCSHHHHTTTTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cceeC---CCCCeEeeccccceecccccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCC
Confidence 99995 78899999999998765433211 1234568999999999999999999999999999999998 899
Q ss_pred CCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 238 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 238 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
||.+........ ++......+.+ ..+++++.+++..||..||.+||++.+|.+.|..+.+
T Consensus 213 p~~~~~~~~~~~----~i~~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 213 PYDGIPASEISS----ILEKGERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TTTTSCGGGHHH----HHHHTCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHH----HHHcCCCCCCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 998866543222 22223333322 3458899999999999999999999999888776543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=372.91 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=201.6
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCC-----CCchhHHHHHHHHH-HHcCCCcceeeEeecchhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYK-ILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~-----~~~~~~~~E~~~l~-~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
++|++++.||+|+||+||+|++..+++.||||++... .....+..|..++. .++|++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~------------- 68 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM------------- 68 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE-------------
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEE-------------
Confidence 5799999999999999999999999999999998632 33345677777665 5788865554
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 159 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~N 159 (449)
+.+..+.+..||||||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 69 --------------~~~~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~N 133 (320)
T d1xjda_ 69 --------------FCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 133 (320)
T ss_dssp --------------EEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred --------------EEEEccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccc
Confidence 44456778899999999 8899998875 5679999999999999999999999999999999999
Q ss_pred EEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013125 160 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 160 ill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
||+ ++.+.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 134 iL~---~~~~~~kl~DFG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF 203 (320)
T d1xjda_ 134 ILL---DKDGHIKIADFGMCKENMLGDAK-------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203 (320)
T ss_dssp EEE---CTTSCEEECCCTTCBCCCCTTCC-------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eee---cCCCceeccccchhhhccccccc-------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCC
Confidence 999 47899999999999865443221 24568999999999999999999999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHH-HH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG-FL 295 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~-~l 295 (449)
.+.... +.+..+.......| +.+++++.+|+..||..||.+||++. +|
T Consensus 204 ~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 204 HGQDEE---ELFHSIRMDNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CCSSHH---HHHHHHHHCCCCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCCCHH---HHHHHHHcCCCCCC-----ccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 886543 34444544443333 45689999999999999999999974 44
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=368.40 Aligned_cols=240 Identities=22% Similarity=0.324 Sum_probs=196.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--------CchhHHHHHHHHHHHc--CCCcceeeEeecch
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQ--GGSKIRLVVFHVDH 74 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--------~~~~~~~E~~~l~~l~--~~~~~~~~~~~~~~ 74 (449)
++++|++++.||+|+||+||+|++..+++.||||++.... ...++.+|+.+++.++ |+++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nI---------- 71 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV---------- 71 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB----------
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCc----------
Confidence 5789999999999999999999999999999999876431 1234678999999997 4544
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-C-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-G-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 152 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g-~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiH 152 (449)
..++.++.+.+..|+|||++ + +++.+++.. ...+++.+++.++.||+.||+|||++||+|
T Consensus 72 -----------------v~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiH 133 (273)
T d1xwsa_ 72 -----------------IRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLH 133 (273)
T ss_dssp -----------------CCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred -----------------cEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 44455556778899999999 4 467777665 567999999999999999999999999999
Q ss_pred cCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC-CccchHHHHHHHHHH
Q 013125 153 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLY 231 (449)
Q Consensus 153 rDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il~e 231 (449)
|||||+|||+. .+.+.+||+|||+|+...... .....||+.|+|||++.+..+ +.++|||||||++||
T Consensus 134 rDiKp~NIll~--~~~~~vkl~DFG~a~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilye 202 (273)
T d1xwsa_ 134 RDIKDENILID--LNRGELKLIDFGSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202 (273)
T ss_dssp SCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred ccCcccceEEe--cCCCeEEECccccceeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehh
Confidence 99999999995 245799999999998654332 246789999999999987765 678999999999999
Q ss_pred HHhCCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 232 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 232 l~~G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
|++|+.||.+.. .+.......+ ..+++++.+++..||..||.+||+++++.+
T Consensus 203 ll~g~~Pf~~~~---------~i~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 203 MVCGDIPFEHDE---------EIIRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHSSCSCCSHH---------HHHHCCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhCCCCCCCch---------HHhhcccCCC-----CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 999999998632 1223333322 456899999999999999999999887743
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=368.92 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=199.7
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
|-.++|+++++||+|+||+||+|++..+ +.||||+++.... .+.+.+|+.+++.++|++++++++.+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~----------- 81 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV----------- 81 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----------
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEE-----------
Confidence 4468999999999999999999998655 5699999876543 45699999999999999877765432
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~-~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
..+..++||||+ +|+|..++.. ....+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 82 -----------------~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 82 -----------------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp -----------------CSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred -----------------ecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence 234578999999 8888887764 345799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-C
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-W 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~p-f 239 (449)
|+ ++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..| |
T Consensus 145 ll---~~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 145 LV---GENLVCKVADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp EE---CGGGCEEECCCCTTC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred EE---CCCCcEEEcccchhhhccCCCce------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 99 47789999999999866433221 12345789999999999999999999999999999999996555 4
Q ss_pred CCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 304 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 304 (449)
.+... .+.+..+.. ....+. ...+++++.+++..||+.||++||++++|.+.|++.+.
T Consensus 216 ~~~~~---~~~~~~i~~-~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 216 PGMVN---REVLDQVER-GYRMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TTCCH---HHHHHHHHT-TCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCH---HHHHHHHHh-cCCCCC---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 44332 233333332 333332 24568999999999999999999999999888886654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=367.84 Aligned_cols=257 Identities=23% Similarity=0.277 Sum_probs=199.0
Q ss_pred cCCceEEeeeecccCceeEEEEEEcC-CC--ceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~--~~vAvKv~~~~~~-----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
-.++|+++++||+|+||+||+|++.. ++ ..||||+++.... ...+.+|+++++.++|++++.+++.+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~----- 80 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV----- 80 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 34679999999999999999998753 32 3689998765421 23578999999999999877765543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
. ....++||||+ ++++.+.+......+++..++.++.||+.||+|||++||+||||
T Consensus 81 ----------------------~-~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDi 137 (273)
T d1u46a_ 81 ----------------------L-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137 (273)
T ss_dssp ----------------------C-SSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ----------------------e-ecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeee
Confidence 2 24568999999 88999888876778999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR- 234 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~- 234 (449)
||+|||+. .++.+||+|||+++......... .......||..|+|||++.+..++.++|||||||++|||++
T Consensus 138 kp~NIll~---~~~~vkl~DfGl~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~ 210 (273)
T d1u46a_ 138 AARNLLLA---TRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210 (273)
T ss_dssp CGGGEEEE---ETTEEEECCCTTCEECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred cHHHhccc---cccceeeccchhhhhcccCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhC
Confidence 99999995 67899999999999765543321 11234567889999999999999999999999999999998
Q ss_pred CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 235 GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
|..||.+.... +.+..+.......+. ...+|.++.+|+..||..||++||++.+|.+.|+++
T Consensus 211 G~~Pf~~~~~~---~~~~~i~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 211 GQEPWIGLNGS---QILHKIDKEGERLPR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCTTTTCCHH---HHHHHHHTSCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcCHH---HHHHHHHhCCCCCCC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 89999876554 334444444443332 245689999999999999999999999998887754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=369.90 Aligned_cols=250 Identities=20% Similarity=0.229 Sum_probs=197.0
Q ss_pred EeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
.+++||+|+||+||+|++..+++.||||+++.... ...+.+|+++++.++|++++.++.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~-------------- 67 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD-------------- 67 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEE--------------
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEe--------------
Confidence 47899999999999999999999999999764321 235789999999999998666544
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
+....++.||||||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 -------------~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli- 133 (299)
T d1ua2a_ 68 -------------AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL- 133 (299)
T ss_dssp -------------EECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-
T ss_pred -------------eeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe-
Confidence 345667899999999666665555556779999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
+..+.+||+|||+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.
T Consensus 134 --~~~~~~KL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 134 --DENGVLKLADFGLAKSFGSPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp --CTTCCEEECCCGGGSTTTSCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cCCCccccccCccccccCCCcc-------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 4789999999999976554332 12356899999999998755 5799999999999999999999999886
Q ss_pred hhhcHHHHHHHHHHhh--------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 243 KAATKKQKYDKICEKK--------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 243 ~~~~~~~~~~~i~~~~--------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
...+....+.+..... ...+........++++.+|+..||..||.+||+++++.+
T Consensus 205 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 6554333332221100 012233444566789999999999999999999887643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=368.51 Aligned_cols=260 Identities=20% Similarity=0.252 Sum_probs=201.1
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCC-CceEEEEEecCC----CCchhHHHHHHHHHHH---cCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSG----TKHPQLLYEAKVYKIL---QGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvKv~~~~----~~~~~~~~E~~~l~~l---~~~~~~~~~~~~~~~~~ 76 (449)
..++|+++++||+|+||+||+|++..+ ++.||||+++.. .....+.+|+.+++.| +|+++++++..+...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~-- 82 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS-- 82 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE--
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc--
Confidence 357999999999999999999999765 677999987543 2233578899998887 588877765543211
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 155 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~-~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDL 155 (449)
........+++||++.+++..+.. .....+++..++.++.||+.||+|||++||+||||
T Consensus 83 --------------------~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDi 142 (305)
T d1blxa_ 83 --------------------RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 142 (305)
T ss_dssp --------------------ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred --------------------ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCC
Confidence 112346789999999666555444 33566999999999999999999999999999999
Q ss_pred CCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhC
Q 013125 156 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 235 (449)
Q Consensus 156 kp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G 235 (449)
||+|||+ +..+.+||+|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|
T Consensus 143 Kp~NILi---~~~~~~kl~dfg~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g 211 (305)
T d1blxa_ 143 KPQNILV---TSSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211 (305)
T ss_dssp CGGGEEE---CTTCCEEECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CccEEEE---cCCCCeeecchhhhhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHC
Confidence 9999999 478899999999987543322 13467899999999999999999999999999999999999
Q ss_pred CCCCCCChhhcHHHHHHHHHHh-------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 236 SLPWQGLKAATKKQKYDKICEK-------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 236 ~~pf~~~~~~~~~~~~~~i~~~-------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
++||.+.........+...... ....+........++++.+|+..||..||.+||++.++.
T Consensus 212 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 9999986654333332222110 011122333455678999999999999999999988764
Q ss_pred H
Q 013125 297 R 297 (449)
Q Consensus 297 ~ 297 (449)
+
T Consensus 292 ~ 292 (305)
T d1blxa_ 292 S 292 (305)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=365.32 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=201.2
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
++|+++++||+|+||+||+|++..+++.||||+++... ....+.+|+++++.++|+++++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~-------------- 67 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL-------------- 67 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEE--------------
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEec--------------
Confidence 58999999999999999999999999999999986542 245688999999999988765543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.+....+..|+||||+++++.+++... ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 68 -------------~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl 134 (298)
T d1gz8a_ 68 -------------DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134 (298)
T ss_dssp -------------EEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred -------------cccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchhee
Confidence 444667889999999988877776543 456999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+ +.++.+||+|||+|+....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.
T Consensus 135 ~---~~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 135 I---NTEGAIKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp E---CTTSCEEECSTTHHHHHCCCSB-------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred e---cccCcceeccCCcceeccCCcc-------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 9 4788999999999987654322 124568999999999887766 5899999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHh---------------------hcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKICEK---------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~---------------------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+.........+...... ....+........++++.+|+..||..||.+||+++++.+
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 76544322222111110 0011122233456788999999999999999999988744
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=360.78 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=199.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTII 83 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 83 (449)
|--++|+++++||+|+||.||+|.+ ++..||||+++.+...+.+.+|+++++.++|++++.+++.+.
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----------- 70 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----------- 70 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEEC-----------
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----------
Confidence 3457899999999999999999998 577899999988777778999999999999998777665432
Q ss_pred hcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 84 FSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 84 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
...+..|+||||+ +|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 71 ---------------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil 135 (262)
T d1byga_ 71 ---------------EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 135 (262)
T ss_dssp ---------------CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---------------ecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhe
Confidence 2335679999999 999999986533 45899999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~-G~~pf~ 240 (449)
+ +.++.+||+|||+++...... ....+|..|+|||++.+..++.++|||||||++|||++ |++||.
T Consensus 136 ~---~~~~~~kl~dfg~s~~~~~~~----------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 136 V---SEDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp E---CTTSCEEECCCCC----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred e---cCCCCEeecccccceecCCCC----------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 9 478999999999998654322 24567899999999999999999999999999999998 799998
Q ss_pred CChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
+..... .+..+.. ....+. ...+++++.+++..||..||.+||++.+|.+.|+++
T Consensus 203 ~~~~~~---~~~~i~~-~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 203 RIPLKD---VVPRVEK-GYKMDA---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TSCGGG---HHHHHTT-TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHH---HHHHHHc-CCCCCC---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 765543 2333322 222222 235588999999999999999999999999988765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-48 Score=369.00 Aligned_cols=256 Identities=20% Similarity=0.310 Sum_probs=205.9
Q ss_pred cCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCcceeeEeecchhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSKIRLVVFHVDHVI 76 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~~---~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 76 (449)
-.++|+++++||+|+||+||+|++. .+++.||||+++..... ..+.+|+++++.++|++++.+++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~------ 84 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV------ 84 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE------
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee------
Confidence 3578999999999999999999975 35578999998765432 358899999999999986665543
Q ss_pred hhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----------------------CCCCHHHHH
Q 013125 77 IHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVL 132 (449)
Q Consensus 77 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-----------------------~~~~~~~~~ 132 (449)
....+..++|||++ +++|.+++.... ..+++..++
T Consensus 85 ---------------------~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 143 (301)
T d1lufa_ 85 ---------------------CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 143 (301)
T ss_dssp ---------------------ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHH
T ss_pred ---------------------eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHH
Confidence 35567889999999 899999886421 248899999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc
Q 013125 133 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 212 (449)
Q Consensus 133 ~i~~qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (449)
.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+........ .......||+.|+|||.+.
T Consensus 144 ~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 144 CIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHH
T ss_pred HHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHc
Confidence 999999999999999999999999999999 47889999999999865433221 1224567899999999999
Q ss_pred CCCCCccchHHHHHHHHHHHHhCC-CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 213 GIEQSRRDDLESLGYVLLYFLRGS-LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 213 ~~~~s~~~DvwSlG~il~el~~G~-~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
+..++.++|||||||++|||++|. +||.+.... +.+..+...... + ....+|+++.+|+..||+.+|++||+
T Consensus 216 ~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~---e~~~~v~~~~~~-~---~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 216 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVIYYVRDGNIL-A---CPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCCChhhhhccchhhHHHHHccCCCCCCCCCHH---HHHHHHHcCCCC-C---CCccchHHHHHHHHHHcCCChhHCcC
Confidence 999999999999999999999985 678775443 334444333321 1 23466899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 013125 292 YGFLKRLFHDL 302 (449)
Q Consensus 292 ~~~l~~~l~~~ 302 (449)
+.+|.+.|+++
T Consensus 289 ~~ev~~~L~~i 299 (301)
T d1lufa_ 289 FCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHh
Confidence 99999988865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=365.07 Aligned_cols=266 Identities=23% Similarity=0.260 Sum_probs=200.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+||+++++||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++|++++.++.......
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~------- 82 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA------- 82 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc-------
Confidence 79999999999999999999999999999999875432 2345789999999999999888876543221
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
..+.....+.|+|||++++.+...+......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 83 ------------~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl 150 (318)
T d3blha1 83 ------------SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150 (318)
T ss_dssp --------------------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ------------ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee
Confidence 11233456789999999888877777667789999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+.++.+||+|||+|+.......... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 151 ---~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 151 ---TRDGVLKLADFGLARAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp ---CTTSCEEECCCTTCEECCC-----C---CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ---cCCCcEEeeecceeeeccccccccc---ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 4788999999999987654332211 123466899999999998865 689999999999999999999999988
Q ss_pred ChhhcHHHHHHHHHHhhcCCC----------------------HHHh--hccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTP----------------------IEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~----------------------~~~~--~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
.........+..+........ .... .....+++.+|+..||..||++||+++++.+
T Consensus 225 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 665544444333221110000 0000 0112457788999999999999999887643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=367.97 Aligned_cols=262 Identities=21% Similarity=0.229 Sum_probs=201.7
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
++.||+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++|+.|+|+++++++.......
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~------ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT------ 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS------
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc------
Confidence 34899999999999999999999999999999999875433 235789999999999999887665432210
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.......|+++++++++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 80 ----------------~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NIL 141 (345)
T d1pmea_ 80 ----------------IEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 141 (345)
T ss_dssp ----------------TTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred ----------------ccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEE
Confidence 123345678888889999999874 57999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+ +.++.+||+|||+|+......... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||.
T Consensus 142 l---~~~~~~kl~DfG~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 142 L---NTTCDLKICDFGLARVADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp E---CTTCCEEECCCTTCEECCGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred E---CCCCCEEEcccCceeeccCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 9 478899999999998765432211 1124567999999999985 4567999999999999999999999998
Q ss_pred CChhhcHHHHHHHHH-----------------------HhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 241 GLKAATKKQKYDKIC-----------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
+....+.......+. ......+........++++.+|+..||..||.+||++.++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 765433222221110 001112233445566788999999999999999999888754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=368.12 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=198.5
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHAL 80 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 80 (449)
+.++|+++++||+|+||+||+|++..+++.||||+++..... ..+.+|+++|+.++|+++++++.......
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~----- 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE----- 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS-----
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc-----
Confidence 679999999999999999999999999999999998754332 24789999999999999887655432210
Q ss_pred hhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 013125 81 TIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 160 (449)
Q Consensus 81 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Ni 160 (449)
......+.|+||||++.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 91 ----------------~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NI 152 (346)
T d1cm8a_ 91 ----------------TLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 152 (346)
T ss_dssp ----------------STTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ----------------cccccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchh
Confidence 0123346799999999888887763 5799999999999999999999999999999999999
Q ss_pred EeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013125 161 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPW 239 (449)
Q Consensus 161 ll~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf 239 (449)
|+ +.++.+||+|||+|+...... ....||+.|+|||++.+. .++.++||||+||++|||++|++||
T Consensus 153 L~---~~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf 219 (346)
T d1cm8a_ 153 AV---NEDCELKILDFGLARQADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219 (346)
T ss_dssp EE---CTTCCEEECCCTTCEECCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred hc---ccccccccccccceeccCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC
Confidence 99 488999999999998765433 356899999999999875 4699999999999999999999999
Q ss_pred CCChhhcHHHHHHHHHHhhcCCC--------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 240 QGLKAATKKQKYDKICEKKVSTP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 240 ~~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
.+........... ......+ ......+.++++.+|+..||..||.+||++.
T Consensus 220 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 220 KGSDHLDQLKEIM---KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp CCSSHHHHHHHHH---HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCChHHHHHHHH---hccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 8865443322222 2111111 1222345578899999999999999999998
Q ss_pred HHHH
Q 013125 294 FLKR 297 (449)
Q Consensus 294 ~l~~ 297 (449)
++.+
T Consensus 297 eiL~ 300 (346)
T d1cm8a_ 297 EALA 300 (346)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 8755
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=360.84 Aligned_cols=260 Identities=20% Similarity=0.324 Sum_probs=205.1
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcCCC-------ceEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCcceeeEeec
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGTKH---PQLLYEAKVYKIL-QGGSKIRLVVFHV 72 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAvKv~~~~~~~---~~~~~E~~~l~~l-~~~~~~~~~~~~~ 72 (449)
|-.++|++++.||+|+||.||+|++..++ ..||||+++.+... ..+.+|...+..+ +|++++.+++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~-- 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA-- 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE--
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc--
Confidence 34689999999999999999999986554 36999998765442 3477788888888 67776665443
Q ss_pred chhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------------CCCCHHHHHHHHH
Q 013125 73 DHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLAD 136 (449)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------------~~~~~~~~~~i~~ 136 (449)
..+....++||||+ +|+|.+++.... ..+++.+++.++.
T Consensus 88 -------------------------~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 142 (299)
T d1fgka_ 88 -------------------------CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142 (299)
T ss_dssp -------------------------ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHH
T ss_pred -------------------------cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHH
Confidence 45667889999999 999999986432 4589999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||+|||++|||||||||+|||+ +.++.+||+|||+++......... ......||+.|+|||++.+..|
T Consensus 143 qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y 214 (299)
T d1fgka_ 143 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIY 214 (299)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCC
T ss_pred HHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCC
Confidence 99999999999999999999999999 478899999999998776544321 2345678999999999999999
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||++ |.+||.+.... +.+..+ ......+. ...+++++.+|+..||+.||.+||++.+|
T Consensus 215 ~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~~~~i-~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~ei 287 (299)
T d1fgka_ 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFKLL-KEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQL 287 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH-HTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CchhhhHHhHHHHHHhccCCCCCCCCCCHH---HHHHHH-HcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence 999999999999999998 79999875543 222332 22322222 24568999999999999999999999999
Q ss_pred HHHHHHHHHh
Q 013125 296 KRLFHDLFSR 305 (449)
Q Consensus 296 ~~~l~~~~~~ 305 (449)
.+.|++++..
T Consensus 288 l~~L~~i~a~ 297 (299)
T d1fgka_ 288 VEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhhc
Confidence 9999888653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.8e-47 Score=357.62 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=198.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+||+++++||+|+||+||+|++. +++.||||+++... ....+.+|+.+++.++|+++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~-------------- 66 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY-------------- 66 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEE--------------
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeee--------------
Confidence 69999999999999999999985 78999999986542 244688999999999988766543
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
.+....+..|++||++++++...+....+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 67 -------------~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll 133 (286)
T d1ob3a_ 67 -------------DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133 (286)
T ss_dssp -------------EEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred -------------eecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE
Confidence 3445678899999999888777777667889999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+.++.+||+|||+|......... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 134 ---~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 134 ---NREGELKIADFGLARAFGIPVRK-------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp ---CTTSCEEECCTTHHHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ---cCCCCEEecccccceecccCccc-------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 47899999999999876543321 2355789999999998765 469999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhh---------------------cCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 242 LKAATKKQKYDKICEKK---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~---------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
....+....+....... ...+........++++.+|+..||..||++||++.++.
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 65443322222211100 01111223345678999999999999999999988774
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=366.18 Aligned_cols=256 Identities=24% Similarity=0.256 Sum_probs=198.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhc
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFS 85 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (449)
.-+|+.+++||+|+||+||+|++..+++.||||++.... ....+|+++++.++|++++.++......
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~----------- 85 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSS----------- 85 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC-----------
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEec-----------
Confidence 347999999999999999999999999999999987543 3345899999999999988776543211
Q ss_pred ccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 86 STLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 86 ~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~---~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
....+..+.||||||+++++.+.+.. ....+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 86 ----------~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl 155 (350)
T d1q5ka_ 86 ----------GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155 (350)
T ss_dssp ------------CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred ----------CccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE
Confidence 01134456799999997776655542 35579999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
. .+...+||+|||+|+....... .....||..|+|||++.+ ..++.++||||+||++|||++|..||.+
T Consensus 156 ~--~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 156 D--PDTAVLKLCDFGSAKQLVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp C--TTTCCEEECCCTTCEECCTTSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred e--cCCCceeEecccchhhccCCcc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 4 2335899999999987654332 235689999999998875 4689999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHH------------------------HhhccChHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTPIE------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
..... .+..+.......... ......++++.+|+..||..||.+||++.++.+
T Consensus 226 ~~~~~---~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 226 DSGVD---QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp SSHHH---HHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHH---HHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 65443 233333222211111 112345778999999999999999999887643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=359.09 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=210.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEc-----CCCceEEEEEecCCCC---chhHHHHHHHHHHH-cCCCcceeeEeecch
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKIL-QGGSKIRLVVFHVDH 74 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvKv~~~~~~---~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~ 74 (449)
|-.++|+++++||+|+||.||+|++. .+++.||||+++.... ...+.+|+.++..+ +|++++++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g----- 94 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG----- 94 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE-----
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE-----
Confidence 34589999999999999999999863 4567899999876543 22478899999999 5776555544
Q ss_pred hhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc-----------------CCCCHHHHHHHHH
Q 013125 75 VIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------------RKFSLKTVLMLAD 136 (449)
Q Consensus 75 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~-----------------~~~~~~~~~~i~~ 136 (449)
+..+....++||||| +++|.+++.... ..+++..++.++.
T Consensus 95 ----------------------~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 152 (311)
T d1t46a_ 95 ----------------------ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152 (311)
T ss_dssp ----------------------EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred ----------------------EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHH
Confidence 445667889999999 899999886532 2589999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCC
Q 013125 137 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 216 (449)
Q Consensus 137 qil~~L~~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (449)
||+.||+|||++|++||||||+|||++ ..+.+||+|||+++........ .......||+.|+|||++.+..+
T Consensus 153 qi~~gl~~LH~~~ivHrDLKp~NIl~~---~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 224 (311)
T d1t46a_ 153 QVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVY 224 (311)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHhCCeeeccccccccccc---ccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCC
Confidence 999999999999999999999999994 7899999999999876543321 12346688999999999999999
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHH
Q 013125 217 SRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 295 (449)
Q Consensus 217 s~~~DvwSlG~il~el~~-G~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l 295 (449)
+.++|||||||++|||+| |.+||.+.... ..+.+++........+ ...|+++.+|+..||+.||.+||++.+|
T Consensus 225 ~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---~~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVD---SKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---HHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcccccchHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999998 66667664433 2333444444444333 3458899999999999999999999999
Q ss_pred HHHHHHHHHh
Q 013125 296 KRLFHDLFSR 305 (449)
Q Consensus 296 ~~~l~~~~~~ 305 (449)
.+.|++.+..
T Consensus 299 l~~L~~~i~~ 308 (311)
T d1t46a_ 299 VQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHhhcc
Confidence 9999887664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=359.79 Aligned_cols=257 Identities=18% Similarity=0.217 Sum_probs=204.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCce--EEEEEecCCC---CchhHHHHHHHHHHH-cCCCcceeeEeecchhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGT---KHPQLLYEAKVYKIL-QGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvKv~~~~~---~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 79 (449)
-++|++.++||+|+||+||+|++..++.. ||||.+.... ....+.+|++++..+ +|++++.+++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~---------- 78 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG---------- 78 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEE----------
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEE----------
Confidence 46899999999999999999999888764 6777765432 344689999999998 6887666544
Q ss_pred hhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHH
Q 013125 80 LTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIE 143 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~---------------~~~~~~~~~~~i~~qil~~L~ 143 (449)
+..+.+..++||||+ +|+|.+++... ...+++..++.++.||+.||.
T Consensus 79 -----------------~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~ 141 (309)
T d1fvra_ 79 -----------------ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 141 (309)
T ss_dssp -----------------EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred -----------------EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHH
Confidence 445677899999999 89999998632 356999999999999999999
Q ss_pred HHHhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHH
Q 013125 144 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLE 223 (449)
Q Consensus 144 ~LH~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw 223 (449)
|||++||+||||||+|||+ +..+.+||+|||+|+....... .....||..|+|||.+.+..++.++|||
T Consensus 142 ~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvw 210 (309)
T d1fvra_ 142 YLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVW 210 (309)
T ss_dssp HHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHH
T ss_pred hhhcCCccccccccceEEE---cCCCceEEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceee
Confidence 9999999999999999999 4778999999999975443222 2355789999999999999999999999
Q ss_pred HHHHHHHHHHhCC-CCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 224 SLGYVLLYFLRGS-LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 224 SlG~il~el~~G~-~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||||++|||++|. +||.+.... +.+..+... ...+. ...+++++.+|+.+||..||++||++++|.+.|+.+
T Consensus 211 SfGvil~ell~~~~~p~~~~~~~---~~~~~i~~~-~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 211 SYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQG-YRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHH---HHHHHGGGT-CCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHhcCCCCCCCCCHH---HHHHHHHhc-CCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999965 678765432 333333332 22222 245689999999999999999999999999999988
Q ss_pred HHhcC
Q 013125 303 FSREG 307 (449)
Q Consensus 303 ~~~~~ 307 (449)
++...
T Consensus 284 ~~~~~ 288 (309)
T d1fvra_ 284 LEERK 288 (309)
T ss_dssp HHSSS
T ss_pred HhcCc
Confidence 76543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=354.92 Aligned_cols=257 Identities=18% Similarity=0.242 Sum_probs=202.1
Q ss_pred EeeeecccCceeEEEEEEcCCC---ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 11 LGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~~~---~~vAvKv~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.++||+|+||+||+|++..++ ..||||+++.... ..++.+|++++..++|++++++++.+.
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------------ 98 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL------------ 98 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE------------
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE------------
Confidence 4679999999999999986543 3589999875433 235899999999999999887765432
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
......++||||| +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 99 --------------~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl- 163 (311)
T d1r0pa_ 99 --------------RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML- 163 (311)
T ss_dssp --------------ETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred --------------ecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE-
Confidence 2345789999999 889999887666678899999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCh
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 243 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~~~ 243 (449)
++++.+||+|||+++.......... .......||..|+|||++....++.++||||||+++|||++|..||....
T Consensus 164 --~~~~~~kL~DFG~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 164 --DEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp --CTTCCEEECSSGGGCCTTTTTCCCT---TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred --CCCCCEEEecccchhhccccccccc---eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 5789999999999987654432221 12345678999999999999999999999999999999999777776533
Q ss_pred hhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHh
Q 013125 244 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 305 (449)
Q Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 305 (449)
.. .+....+.... ..+. ...+++++.+++..||..||.+||++.+|.+.|+.++..
T Consensus 239 ~~--~~~~~~i~~g~-~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 239 NT--FDITVYLLQGR-RLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ------CHHHHHTTC-CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CH--HHHHHHHHcCC-CCCC---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 22 12222233322 2221 245688999999999999999999999999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=357.28 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=206.9
Q ss_pred ccCCceEEeeeecccCceeEEEEEEcC-----CCceEEEEEecCCCCch---hHHHHHHHHHHHcCCCcceeeEeecchh
Q 013125 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSKIRLVVFHVDHV 75 (449)
Q Consensus 4 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvKv~~~~~~~~---~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 75 (449)
|-.++|+++++||+|+||+||+|.+.. ++..||||+++...... .+.+|+++++.++|++++.+++.+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~---- 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE----
Confidence 456899999999999999999998852 35689999987654332 378999999999999877665543
Q ss_pred hhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHH
Q 013125 76 IIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYV 145 (449)
Q Consensus 76 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~---------~~~~~~~~~~i~~qil~~L~~L 145 (449)
...+..++||||+ +|+|.+++.... ..++...+..++.|++.||.||
T Consensus 93 -----------------------~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L 149 (308)
T d1p4oa_ 93 -----------------------SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149 (308)
T ss_dssp -----------------------CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999 899999876431 3478999999999999999999
Q ss_pred HhCCccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHH
Q 013125 146 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL 225 (449)
Q Consensus 146 H~~giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 225 (449)
|+++|+||||||+|||+ ++++.+||+|||+|+......... ......||+.|+|||.+.+..++.++|||||
T Consensus 150 H~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~ 221 (308)
T d1p4oa_ 150 NANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221 (308)
T ss_dssp HHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred hhCCeeeceEcCCceee---cCCceEEEeecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccH
Confidence 99999999999999999 588999999999998665433211 1234578999999999999999999999999
Q ss_pred HHHHHHHHhC-CCCCCCChhhcHHHHHHHHHHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 013125 226 GYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 302 (449)
Q Consensus 226 G~il~el~~G-~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~~~l~~~ 302 (449)
||++|||++| .+||.+.... +.+..+..... .+. ...+|+.+.+++..||+.+|++||++++|.+.|++.
T Consensus 222 G~il~El~t~~~~p~~~~~~~---~~~~~i~~~~~-~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 222 GVVLWEIATLAEQPYQGLSNE---QVLRFVMEGGL-LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHHHTSCCTTTTSCHH---HHHHHHHTTCC-CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHHhCCCCCCCCCCHH---HHHHHHHhCCC-CCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999999997 5888775543 34444443332 211 245688999999999999999999999998877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=356.42 Aligned_cols=270 Identities=23% Similarity=0.259 Sum_probs=201.6
Q ss_pred cCCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHH--HHHcCCCcceeeEeecchhhhhhhhh
Q 013125 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 5 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l--~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+..+|.+.++||+|+||+||+|++ +|+.||||+++... .....+|.+++ ..++|+|++.+++.+...
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~-------- 69 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKD-------- 69 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE--------
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeC--------
Confidence 457899999999999999999987 68899999986543 23344555444 457888888776654321
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccc
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS--------RGFLHR 153 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~--------~giiHr 153 (449)
+......|+||||+ +++|.++++. ..+++..++.++.|++.||.|||+ +||+||
T Consensus 70 ---------------~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 70 ---------------NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp ---------------CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred ---------------CCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 11224679999999 8899999974 469999999999999999999996 599999
Q ss_pred CCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC------CCccchHHHHHH
Q 013125 154 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGY 227 (449)
Q Consensus 154 DLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwSlG~ 227 (449)
||||+|||+ ++++.+||+|||+++........... ......||+.|+|||++.+.. ++.++|||||||
T Consensus 133 DlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 133 DLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC-------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred ccCccceEE---cCCCCeEEEecCccccccCCCcceec---cccceecccCcCChhhccccccccCCCcCcchhhhhhHH
Confidence 999999999 47899999999999987654332111 123568999999999987653 577899999999
Q ss_pred HHHHHHhCCCCCCCChh------------hcHHHHHHHHHHhhcCCCHHHh--hccChHHHHHHHHHHhCCCCCCCCCHH
Q 013125 228 VLLYFLRGSLPWQGLKA------------ATKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYG 293 (449)
Q Consensus 228 il~el~~G~~pf~~~~~------------~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 293 (449)
++|||+||..||..... .........+.......+.+.. ....+..+.+++..||..||.+||++.
T Consensus 207 vl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 286 (303)
T d1vjya_ 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 99999999887743221 1111222222333332222222 122346799999999999999999999
Q ss_pred HHHHHHHHHHHhcCC
Q 013125 294 FLKRLFHDLFSREGY 308 (449)
Q Consensus 294 ~l~~~l~~~~~~~~~ 308 (449)
+|.+.|+++..+++.
T Consensus 287 ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 287 RIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHhcCC
Confidence 999999998877654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-45 Score=351.99 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=193.5
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCcceeeEeecchhhhhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
.++|+++++||+|+||+||+|++..+++.||||+++.. ...++.+|+++|+.++ |++++.++...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~------------- 99 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIV------------- 99 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEE-------------
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEE-------------
Confidence 46899999999999999999999999999999998753 4567889999999996 77655543321
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 163 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill~ 163 (449)
........++||||+ +++|..+ .+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 100 ------------~~~~~~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~ 163 (328)
T d3bqca1 100 ------------KDPVSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163 (328)
T ss_dssp ------------ECTTTCSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred ------------EecCCCceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence 112456789999999 6777654 45699999999999999999999999999999999999995
Q ss_pred cCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCC
Q 013125 164 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGL 242 (449)
Q Consensus 164 ~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~~ 242 (449)
.+++.+||+|||+|+....... .....+|+.|+|||++.+.. ++.++||||+||++|||++|..||...
T Consensus 164 --~~~~~vkl~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 164 --HEHRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp --TTTTEEEECCGGGCEECCTTCC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred --CCCCeeeecccccceeccCCCc--------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 3456799999999987654432 24668899999999988765 799999999999999999999999764
Q ss_pred hhhc-HHHHHHHHHHh----------hcCC-------------------CHHHhhccChHHHHHHHHHHhCCCCCCCCCH
Q 013125 243 KAAT-KKQKYDKICEK----------KVST-------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 292 (449)
Q Consensus 243 ~~~~-~~~~~~~i~~~----------~~~~-------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~ 292 (449)
.... ....+..++.. .... .........++++.+|+..||..||.+||++
T Consensus 234 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta 313 (328)
T d3bqca1 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313 (328)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred chhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH
Confidence 3321 11111111110 0000 0011123356789999999999999999998
Q ss_pred HHHHH
Q 013125 293 GFLKR 297 (449)
Q Consensus 293 ~~l~~ 297 (449)
+++.+
T Consensus 314 ~e~L~ 318 (328)
T d3bqca1 314 REAME 318 (328)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 87643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=357.11 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=196.7
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
.+||+++++||+|+||+||+|++..+++.||||++...... .++.+|+++++.|+|++++.++......
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~------- 89 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA------- 89 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC-------
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec-------
Confidence 57999999999999999999999999999999998754332 2478999999999999987665432111
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
....+....|++++++|++|.+++. .+++++..++.++.||+.||+|||++||+||||||+|||
T Consensus 90 --------------~~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NIL 153 (348)
T d2gfsa1 90 --------------RSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153 (348)
T ss_dssp --------------SSTTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred --------------cccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccc
Confidence 0112345567777777999999885 467999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 240 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~ 240 (449)
+ +.++.+|++|||+|...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|++||.
T Consensus 154 i---~~~~~~kl~dfg~a~~~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 154 V---NEDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp E---CTTCCEEECCC----CCTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred c---cccccccccccchhcccCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 9 47899999999999754332 23668999999999887765 6899999999999999999999998
Q ss_pred CChhhcHHHHHHHHHHhhcCCC--------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHH
Q 013125 241 GLKAATKKQKYDKICEKKVSTP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 294 (449)
Q Consensus 241 ~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 294 (449)
+.+...... .+.......+ ......+.++++.+|+..||..||.+||++.+
T Consensus 221 ~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 221 GTDHIDQLK---LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp CSSHHHHHH---HHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCHHHHHH---HHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 865443322 2222222221 22233456788999999999999999999887
Q ss_pred HHH
Q 013125 295 LKR 297 (449)
Q Consensus 295 l~~ 297 (449)
+.+
T Consensus 298 lL~ 300 (348)
T d2gfsa1 298 ALA 300 (348)
T ss_dssp HHT
T ss_pred Hhc
Confidence 744
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=354.63 Aligned_cols=254 Identities=20% Similarity=0.225 Sum_probs=189.3
Q ss_pred CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhh
Q 013125 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALT 81 (449)
Q Consensus 6 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 81 (449)
-++|+++++||+|+||+||+|++..+++.||||++...... .++.+|+++++.++|++++.++......
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~------- 88 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ------- 88 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC-------
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecc-------
Confidence 37899999999999999999999999999999998765332 2478999999999999887765543211
Q ss_pred hhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 013125 82 IIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 161 (449)
Q Consensus 82 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nil 161 (449)
.......+.|+||||+.+++.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 89 --------------~~~~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil 151 (355)
T d2b1pa1 89 --------------KTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_dssp --------------CSTTTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred --------------cccccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccc
Confidence 011345788999999987777665 457999999999999999999999999999999999999
Q ss_pred eecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 162 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 162 l~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+. .++.++++|||+++....... .....+|+.|+|||++.+..++.++||||+||++|||++|++||.+
T Consensus 152 ~~---~~~~~kl~df~~~~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 152 VK---SDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp EC---TTCCEEECCCCC-----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc---cccceeeechhhhhccccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 94 788999999999886654332 2466789999999999999999999999999999999999999987
Q ss_pred ChhhcHHHHHHHHHHhhcCCCHH-------------------------------------HhhccChHHHHHHHHHHhCC
Q 013125 242 LKAATKKQKYDKICEKKVSTPIE-------------------------------------VLCKSHPAEFASYFHYCQSL 284 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~~~-------------------------------------~~~~~~~~~~~~l~~~~l~~ 284 (449)
......... +.........+ ......++++.+|+..||..
T Consensus 221 ~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~ 297 (355)
T d2b1pa1 221 RDYIDQWNK---VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297 (355)
T ss_dssp SSHHHHHHH---HHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCHHHHHHH---HHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcC
Confidence 654332222 22212111111 00111245788899999999
Q ss_pred CCCCCCCHHHHHH
Q 013125 285 TFDQRPDYGFLKR 297 (449)
Q Consensus 285 ~p~~Rp~~~~l~~ 297 (449)
||++||+++++.+
T Consensus 298 dP~~R~ta~elL~ 310 (355)
T d2b1pa1 298 DPAKRISVDDALQ 310 (355)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999887743
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=350.67 Aligned_cols=244 Identities=20% Similarity=0.340 Sum_probs=196.3
Q ss_pred CceEEeeeecccCceeEEEEEEc---CCCceEEEEEecCC------CCchhHHHHHHHHHHHcCCCcceeeEeecchhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVII 77 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvKv~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (449)
++|+++++||+|+||+||+|++. .+++.||||+++.. .....+.+|+++++.++|.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~p-------------- 89 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP-------------- 89 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCT--------------
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCC--------------
Confidence 77999999999999999999984 46889999987532 23446789999999998854
Q ss_pred hhhhhhhcccCCCcCeeEEecccCCeeEEEEecC-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 013125 78 HALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 156 (449)
Q Consensus 78 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLk 156 (449)
++..+..+.......++||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+|||||
T Consensus 90 ------------nIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiK 156 (322)
T d1vzoa_ 90 ------------FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK 156 (322)
T ss_dssp ------------TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred ------------eEEEeeeeeccCCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCC
Confidence 3444555556778899999999 8999998876 4568899999999999999999999999999999
Q ss_pred CCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC--CCccchHHHHHHHHHHHHh
Q 013125 157 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLR 234 (449)
Q Consensus 157 p~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il~el~~ 234 (449)
|+|||+ +.++.+||+|||+|+.+...... ......|++.|++||.+.+.. ++.++|||||||+||||++
T Consensus 157 p~Nill---~~~~~vkL~DFG~a~~~~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 157 LENILL---DSNGHVVLTDFGLSKEFVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp GGGEEE---CTTSCEEESCSSEEEECCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred ccceee---cCCCCEEEeeccchhhhcccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence 999999 47789999999999876543321 123567899999999997654 6889999999999999999
Q ss_pred CCCCCCCChhhcHHHHHHHH-HHhhcCCCHHHhhccChHHHHHHHHHHhCCCCCCCCC
Q 013125 235 GSLPWQGLKAATKKQKYDKI-CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 291 (449)
Q Consensus 235 G~~pf~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 291 (449)
|+.||.+.........+... .......+ ..+++++.+++..||..||.+||+
T Consensus 228 G~~PF~~~~~~~~~~~i~~~~~~~~~~~~-----~~~s~~~~~li~~~l~~dP~~R~s 280 (322)
T d1vzoa_ 228 GASPFTVDGEKNSQAEISRRILKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLG 280 (322)
T ss_dssp SSCTTSCTTSCCCHHHHHHHHHHCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred CCCCCCCCCHHHHHHHHHHhcccCCCCCc-----ccCCHHHHHHHHHHcccCHHHcCC
Confidence 99999887655444433322 12222222 346899999999999999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=343.70 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=196.1
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
+||+++++||+|+||+||+|++..+++.||||+++.... ..++.+|+.+++.++|++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~--------------- 66 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--------------- 66 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCE---------------
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEee---------------
Confidence 589999999999999999999999999999999865432 2357899999999988875554
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 162 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~giiHrDLkp~Nill 162 (449)
+.+.......++|++++.+.....+....+.++...++.++.|++.||+|||++||+||||||+|||+
T Consensus 67 ------------~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli 134 (292)
T d1unla_ 67 ------------HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134 (292)
T ss_dssp ------------EEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ------------ccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc
Confidence 44456778899999999555555555567889999999999999999999999999999999999999
Q ss_pred ecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 013125 163 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 241 (449)
Q Consensus 163 ~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il~el~~G~~pf~~ 241 (449)
+..+.+||+|||.|+........ .....++..|++||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 135 ---~~~~~~kl~DFG~a~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 135 ---NRNGELKLANFGLARAFGIPVRC-------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp ---CTTCCEEECCCTTCEECCSCCSC-------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ---ccCCceeeeecchhhcccCCCcc-------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 47789999999999877654332 23456788899999988765 69999999999999999999998754
Q ss_pred ChhhcHHHHHHHHHHhhcCCC------------------------HHHhhccChHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013125 242 LKAATKKQKYDKICEKKVSTP------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 296 (449)
Q Consensus 242 ~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~l~ 296 (449)
..+. .+.+..+........ ........++++.+|+..||..||.+||+++++.
T Consensus 205 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 205 GNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp CSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCH--HHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 3322 222333322221111 1112234567889999999999999999988763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-41 Score=329.40 Aligned_cols=270 Identities=23% Similarity=0.271 Sum_probs=191.2
Q ss_pred Cccc-CCceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCcceeeEeecchhhhhh
Q 013125 2 ERII-GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHA 79 (449)
Q Consensus 2 ~~i~-~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (449)
|+++ ++||+++++||+|+||+||+|++..+++.||||+++.+.. .+.+.+|+++++.++|.+......
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~---------- 76 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS---------- 76 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHH----------
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhh----------
Confidence 5655 4689999999999999999999999999999999976432 345788999999999877543211
Q ss_pred hhhhhcccCCCcCeeEEecc--cCCeeEEEEecC--CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q 013125 80 LTIIFSSTLGGIPNIKWYGV--DGEDNVLVLDLL--GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHS-RGFLHR 153 (449)
Q Consensus 80 ~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~--g~sL~~~~~~~-~~~~~~~~~~~i~~qil~~L~~LH~-~giiHr 153 (449)
..++++..+..+.. .....+++++++ +++........ ...+++..++.++.||+.||+|||+ +||+||
T Consensus 77 ------~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr 150 (362)
T d1q8ya_ 77 ------MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT 150 (362)
T ss_dssp ------HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred ------cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccc
Confidence 11235555543332 334555666655 44444443332 4568999999999999999999998 899999
Q ss_pred CCCCCcEEeecCCC---CCeEEEEeecceeeecCCCCCccccccCCCCCCCCccccccccccCCCCCccchHHHHHHHHH
Q 013125 154 DIKPDNFLMGLGRK---ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 230 (449)
Q Consensus 154 DLkp~Nill~~~~~---~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il~ 230 (449)
||||+|||+...+. ...++|+|||.|....... ...+||+.|+|||++.+..++.++||||+||+++
T Consensus 151 DlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 220 (362)
T d1q8ya_ 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220 (362)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred cCChhHeeeeccCcccccceeeEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHH
Confidence 99999999953221 1359999999998654332 3568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCChhhc---HHHHHHHHHHhhcCCCHHHh-------------------------------------hccC
Q 013125 231 YFLRGSLPWQGLKAAT---KKQKYDKICEKKVSTPIEVL-------------------------------------CKSH 270 (449)
Q Consensus 231 el~~G~~pf~~~~~~~---~~~~~~~i~~~~~~~~~~~~-------------------------------------~~~~ 270 (449)
+|++|+.||....... ....+..........+.... ....
T Consensus 221 el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (362)
T d1q8ya_ 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300 (362)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred HHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCccc
Confidence 9999999997643221 11112222111111111110 1123
Q ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 013125 271 PAEFASYFHYCQSLTFDQRPDYGFLKR 297 (449)
Q Consensus 271 ~~~~~~l~~~~l~~~p~~Rp~~~~l~~ 297 (449)
++++.+|+..||..||.+||+++++.+
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 567888999999999999999877643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.2e-25 Score=195.77 Aligned_cols=164 Identities=18% Similarity=0.268 Sum_probs=110.6
Q ss_pred eEEeeeecccCceeEEEEEEcCCCceEEEEEecCCCC------------c--------hhHHHHHHHHHHHcCCCcceee
Q 013125 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------H--------PQLLYEAKVYKILQGGSKIRLV 68 (449)
Q Consensus 9 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~------------~--------~~~~~E~~~l~~l~~~~~~~~~ 68 (449)
+.++++||+|+||+||+|.+. +++.||||++..... . .....|...+..+.+.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~----- 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA----- 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS-----
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC-----
Confidence 568999999999999999984 688999998653210 0 01223445555554433
Q ss_pred EeecchhhhhhhhhhhcccCCCcCeeEEecccCCeeEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013125 69 VFHVDHVIIHALTIIFSSTLGGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 148 (449)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~ 148 (449)
++..+.+ ...+++||++++... ..++...+..++.||+.+|.|||++
T Consensus 76 ----------------------v~~~~~~----~~~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~ 122 (191)
T d1zara2 76 ----------------------VPKVYAW----EGNAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHR 122 (191)
T ss_dssp ----------------------SCCEEEE----ETTEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHT
T ss_pred ----------------------cceEEEe----cCCEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhC
Confidence 2322222 124799999955322 1245566778999999999999999
Q ss_pred CccccCCCCCcEEeecCCCCCeEEEEeecceeeecCCCCCccccccCCCCCCCCcccccc--c---cccCCCCCccchHH
Q 013125 149 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC--N---THLGIEQSRRDDLE 223 (449)
Q Consensus 149 giiHrDLkp~Nill~~~~~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~s~~~Dvw 223 (449)
||+||||||+|||++ .+.++|+|||+|.....+.. ..|... + .+....|+.++|+|
T Consensus 123 giiHrDiKP~NILv~----~~~~~liDFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~ 183 (191)
T d1zara2 123 GIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDIN 183 (191)
T ss_dssp TEECSCCSTTSEEEE----TTEEEECCCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHH
T ss_pred CEEEccCChhheeee----CCCEEEEECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHH
Confidence 999999999999994 45699999999976543221 111111 1 12235678899999
Q ss_pred HHHHHHH
Q 013125 224 SLGYVLL 230 (449)
Q Consensus 224 SlG~il~ 230 (449)
|+.--+.
T Consensus 184 s~~~~~~ 190 (191)
T d1zara2 184 SAIDRIL 190 (191)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9875543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=1e-06 Score=79.12 Aligned_cols=82 Identities=16% Similarity=0.159 Sum_probs=58.0
Q ss_pred CceEEeeeecccCceeEEEEEEcCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhh
Q 013125 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIF 84 (449)
Q Consensus 7 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (449)
+.|++.+..+-++.+.||+... .++.+++|+..... ....+.+|...++.|....
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~v--------------------- 70 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL--------------------- 70 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS---------------------
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccC---------------------
Confidence 5678777766566679998863 55667888765432 2335788999998886432
Q ss_pred cccCCCcCeeEEecccCCeeEEEEecC-CCCHH
Q 013125 85 SSTLGGIPNIKWYGVDGEDNVLVLDLL-GPSLE 116 (449)
Q Consensus 85 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~ 116 (449)
-+|.+..++..++..++||+++ |.++.
T Consensus 71 -----pvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 71 -----PVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp -----CCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred -----CCCcEEEEEecCCceEEEEEeccccccc
Confidence 4677777777778889999999 54543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=1.5e-05 Score=76.05 Aligned_cols=76 Identities=14% Similarity=0.153 Sum_probs=49.4
Q ss_pred eeeecccCceeEEEEEEcCCCceEEEEEecC------C---CCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhh
Q 013125 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENS------G---TKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTI 82 (449)
Q Consensus 12 ~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~------~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 82 (449)
.+.||.|....||++.+..+++.|+||.-.. . ....+...|.++|+.+.....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p------------------ 92 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP------------------ 92 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCG------------------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCC------------------
Confidence 5679999999999999877788899995321 1 123356779998887754321
Q ss_pred hhcccCCCcCeeEEecccCCeeEEEEecCCC
Q 013125 83 IFSSTLGGIPNIKWYGVDGEDNVLVLDLLGP 113 (449)
Q Consensus 83 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~g~ 113 (449)
..+|.++.+. ....++|||++++
T Consensus 93 ------~~vP~v~~~d--~~~~~lvmE~L~~ 115 (392)
T d2pula1 93 ------HLVPRVFYSD--TEMAVTVMEDLSH 115 (392)
T ss_dssp ------GGSCCEEEEE--TTTTEEEECCCTT
T ss_pred ------CCcceEEEEc--CCCCEEEEeccCC
Confidence 1466666554 4456899999943
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=3.4e-05 Score=68.40 Aligned_cols=74 Identities=19% Similarity=0.148 Sum_probs=52.1
Q ss_pred eecccCc-eeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCcceeeEeecchhhhhhhhhhhcccCCCcC
Q 013125 14 KIGSGSF-GEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSKIRLVVFHVDHVIIHALTIIFSSTLGGIP 92 (449)
Q Consensus 14 ~LG~G~f-g~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 92 (449)
.+..|.. +.||++.. ..+..+++|..... ....+..|+.+++.|....+ .+|
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gv-------------------------pvP 69 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGV-------------------------PCA 69 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTC-------------------------CBC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCC-------------------------CCC
Confidence 4455543 68999875 45666888986543 34457889999998876431 366
Q ss_pred eeEEecccCCeeEEEEecC-CCC
Q 013125 93 NIKWYGVDGEDNVLVLDLL-GPS 114 (449)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~-g~s 114 (449)
.++.++.+.+..++||+++ |.+
T Consensus 70 ~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 70 AVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CEEEEEECSSCEEEEEECCSSEE
T ss_pred ceeeecccccceEEEEEeeeccc
Confidence 6776777778889999999 444
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.84 E-value=0.0035 Score=59.01 Aligned_cols=53 Identities=15% Similarity=0.233 Sum_probs=37.5
Q ss_pred EeeeecccCceeEEEEEEcC-------CCceEEEEEecCCCCchhHHHHHHHHHHHcCCC
Q 013125 11 LGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 11 i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~ 63 (449)
-+++|+-|-.-.+|++.... ..+.|++++...........+|..+++.+...+
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~g 105 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERH 105 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTT
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCC
Confidence 35688888888999998753 345688888764333334678999988886544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.80 E-value=0.0018 Score=58.86 Aligned_cols=52 Identities=12% Similarity=0.130 Sum_probs=33.3
Q ss_pred EEeeeecccCceeEEEEEEcCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC
Q 013125 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 10 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvKv~~~~~~~~~~~~E~~~l~~l~~~~ 63 (449)
.-.+.|..|---+.|+++.. +..+++|+.......+.+..|++++..|....
T Consensus 21 ~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 21 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp EEEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTT
T ss_pred eEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhhcc
Confidence 33455556766789999763 34588999866555667888999999887654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.76 E-value=0.0016 Score=59.74 Aligned_cols=42 Identities=14% Similarity=0.147 Sum_probs=32.1
Q ss_pred eeEEEEEEcCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCC
Q 013125 21 GEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGS 63 (449)
Q Consensus 21 g~Vy~a~~~~~~~~vAvKv~~~~~-~~~~~~~E~~~l~~l~~~~ 63 (449)
-.||++.. .+|+.|++|+..... ...++..|...+..|....
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~g 78 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE 78 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcC
Confidence 37999976 467889999987543 3556888999999987654
|